data_2lwf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lwf _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.7 mptt . . . . . 0 C--O 1.205 -1.253 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -113.32 164.64 13.31 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.568 -175.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.0 mt -62.33 -28.02 69.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.159 0.983 . . . . 0.0 111.404 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 m -59.45 -21.91 60.73 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.033 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -104.92 11.58 33.43 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 122.717 0.407 . . . . 0.0 110.264 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.425 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 8.1 m -104.7 142.9 33.88 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -173.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -86.26 159.64 19.38 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.506 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.11 133.35 53.12 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -128.17 138.87 33.92 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -74.93 143.53 29.41 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.41 2.074 . . . . 0.0 110.573 173.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.62 -15.74 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-O 120.913 0.387 . . . . 0.0 112.01 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p -71.77 -38.21 70.38 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 121.615 0.722 . . . . 0.0 111.183 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -93.16 54.2 2.09 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.873 0.844 . . . . 0.0 110.645 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.38 -18.41 10.91 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.425 -1.261 . . . . 0.0 112.981 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -72.25 -27.25 62.39 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.52 0.676 . . . . 0.0 109.692 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.9 m -93.89 3.3 55.6 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.977 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mm -79.63 128.56 74.34 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.26 130.65 41.79 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.957 2.438 . . . . 0.0 113.335 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.1 p -92.9 39.01 1.03 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.224 1.011 . . . . 0.0 109.475 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -109.55 177.63 4.68 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.259 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.6 t -93.94 140.53 29.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.75 -155.08 26.15 Favored Glycine 0 N--CA 1.417 -2.62 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.641 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.465 HG13 ' CH2' ' A' ' 146' ' ' TRP . 6.3 p -121.23 149.17 24.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -137.63 149.58 46.72 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 120.848 0.356 . . . . 0.0 110.543 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.14 118.65 29.18 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.79 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.6 t -91.78 121.0 41.87 Favored 'Isoleucine or valine' 0 C--O 1.263 1.787 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.367 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.527 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 67.4 m-85 -108.76 130.0 55.37 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.691 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -76.91 -175.08 3.35 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.231 0.539 . . . . 0.0 110.257 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -28.09 63.76 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 124.14 0.976 . . . . 0.0 113.547 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.7 m -91.74 3.45 55.07 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.803 0.335 . . . . 0.0 111.492 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.4 t70 62.33 67.75 0.71 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-O 122.724 1.25 . . . . 0.0 111.598 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 8.1 mm-40 -136.82 145.73 44.82 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.556 -1.656 . . . . 0.0 109.814 174.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.496 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 3.0 tm? -89.87 116.71 28.15 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.308 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -122.86 -14.49 7.64 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.259 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.58 115.03 5.91 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.819 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.404 HG23 ' HB ' ' A' ' 147' ' ' ILE . 12.3 m -111.21 142.26 24.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.79 159.76 29.81 Favored Glycine 0 N--CA 1.424 -2.14 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.227 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.2 pt -115.09 139.94 38.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.5 m -151.0 157.77 43.3 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.622 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -79.3 -23.32 43.61 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -135.49 105.39 6.2 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 173.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.4 mt -60.14 -56.94 14.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.38 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.95 -50.73 45.56 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.559 0.744 . . . . 0.0 112.767 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.23 -52.19 66.73 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 123.75 0.656 . . . . 0.0 111.109 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.1 t -61.26 -48.62 80.6 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.293 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 54.7 t -56.9 -54.48 29.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 123.103 0.561 . . . . 0.0 111.097 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.0 m -61.04 -35.53 77.15 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 123.607 0.567 . . . . 0.0 111.463 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.91 -58.96 3.97 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.836 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.287 19.6 p80 -74.8 -24.66 58.68 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -175.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.6 mt -77.93 -24.82 48.14 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.217 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -85.49 -16.82 38.31 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.867 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.0 t -80.55 -50.48 9.95 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.58 85.0 61.3 Favored Pre-proline 0 CA--C 1.557 1.236 0 CA-C-O 122.341 1.067 . . . . 0.0 109.929 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.505 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 16.6 Cg_exo -71.87 12.02 0.62 Allowed 'Trans proline' 0 N--CA 1.479 0.623 0 C-N-CA 124.031 3.154 . . . . 0.0 114.806 -176.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -66.47 -39.32 88.73 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.341 0.591 . . . . 0.0 109.886 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.8 mt -88.16 20.71 3.08 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.092 0.473 . . . . 0.0 111.802 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.505 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 89.2 m -79.99 99.44 7.64 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 121.497 0.665 . . . . 0.0 111.069 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.43 -64.64 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 174.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.4 p -161.43 162.92 30.73 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.9 p -137.14 137.05 46.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.425 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 94.8 mttt -106.4 125.56 51.15 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 175.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.0 m -115.34 134.35 58.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.412 0.625 . . . . 0.0 111.929 -174.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.65 96.16 0.63 Allowed Glycine 0 N--CA 1.422 -2.249 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.417 HD13 ' N ' ' A' ' 130' ' ' ILE . 2.6 mp -89.27 121.37 39.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.2 p -116.12 125.25 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 175.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -72.38 -8.87 57.24 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -89.62 122.06 68.55 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -83.12 27.12 0.62 Allowed 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.769 2.313 . . . . 0.0 113.224 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.421 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 24.2 t70 -78.96 129.38 34.42 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.532 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -69.9 -31.15 68.79 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.422 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.72 -38.45 62.29 Favored 'General case' 0 C--O 1.203 -1.37 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.297 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.09 -43.75 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 92.4 mt -59.08 -48.4 81.75 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.345 0.593 . . . . 0.0 110.244 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.6 m -70.69 -34.3 71.82 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.272 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.45 -47.05 74.4 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 123.109 0.564 . . . . 0.0 109.759 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.83 -49.25 78.43 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -49.17 -43.9 42.38 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.002 0.921 . . . . 0.0 110.305 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -65.55 -48.71 71.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.43 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.64 -37.12 85.09 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.773 0.321 . . . . 0.0 110.871 177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.465 ' CH2' HG13 ' A' ' 89' ' ' VAL . 25.0 m0 -63.47 -53.55 50.29 Favored 'General case' 0 C--O 1.254 1.333 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.53 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 151' ' ' ILE . 11.8 tt -63.41 -41.21 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.829 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -60.24 -36.94 78.9 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.435 ' O ' HG22 ' A' ' 153' ' ' VAL . 24.4 mt-10 -54.96 -46.97 75.11 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 118.94 0.791 . . . . 0.0 110.56 176.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.496 ' CG ' ' HB3' ' A' ' 99' ' ' LEU 0.323 18.9 m-70 -77.85 -29.81 50.67 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 118.769 -1.172 . . . . 0.0 114.011 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 147' ' ' ILE . 68.7 mt -60.68 -44.87 98.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 172.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.27 -48.65 64.44 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 149' ' ' GLU . 21.8 m -80.01 -32.1 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -175.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.7 t -131.7 -30.21 1.66 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.44 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.41 15.61 56.78 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.642 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -77.11 120.56 22.37 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 42.8 t -138.46 80.65 26.57 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -77.69 161.48 30.71 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.431 2.754 . . . . 0.0 113.278 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -52.84 -23.77 21.81 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 124.543 3.495 . . . . 0.0 114.197 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.4 -29.97 75.77 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.574 -0.346 . . . . 0.0 112.87 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 C--N 1.314 -0.947 0 CA-C-O 122.347 1.07 . . . . 0.0 110.17 -178.609 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.2 m -123.25 -179.08 4.18 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.76 -17.75 63.46 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.3 m -63.69 -26.76 68.81 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.789 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -84.16 -20.53 32.29 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.436 0.636 . . . . 0.0 109.668 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.475 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 2.7 m -76.82 154.35 33.98 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.036 -0.983 . . . . 0.0 113.512 -168.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -100.9 158.61 15.86 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.887 0.875 . . . . 0.0 109.133 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.68 128.82 55.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.98 0.419 . . . . 0.0 110.175 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.01 129.09 25.1 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -65.39 143.84 77.82 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 121.663 1.575 . . . . 0.0 108.74 170.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.532 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -65.12 -13.19 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -176.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.8 p -76.12 -16.22 59.93 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.56 0.695 . . . . 0.0 110.809 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -92.97 30.58 1.57 Allowed 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.53 -40.33 37.52 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.532 1.133 . . . . 0.0 113.414 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -72.95 -17.95 61.43 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.642 0.734 . . . . 0.0 110.789 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.0 m -103.65 -1.05 28.75 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.389 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.4 mm -65.38 134.07 95.57 Favored Pre-proline 0 C--O 1.243 0.731 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.59 129.92 31.48 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.84 2.36 . . . . 0.0 112.205 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.4 p -99.16 49.51 0.95 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.872 0.844 . . . . 0.0 109.922 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -124.99 -179.44 4.55 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.983 -176.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.7 t -95.37 145.02 25.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.27 -156.5 28.43 Favored Glycine 0 N--CA 1.414 -2.79 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.538 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.2 m -110.67 151.05 12.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 123.996 0.918 . . . . 0.0 109.916 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -141.85 147.18 36.76 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 120.713 0.292 . . . . 0.0 110.214 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.91 122.22 37.38 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.77 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.57 117.05 40.21 Favored 'Isoleucine or valine' 0 C--O 1.26 1.655 0 C-N-CA 123.377 0.671 . . . . 0.0 110.36 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.613 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 47.1 m-85 -107.39 134.5 50.36 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -79.94 -167.93 1.45 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.262 0.554 . . . . 0.0 112.114 -174.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -56.88 -32.56 65.98 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.244 1.417 . . . . 0.0 110.667 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.9 m -90.72 7.42 39.65 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.924 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 69.93 16.45 7.67 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.347 1.07 . . . . 0.0 111.055 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -92.3 139.63 30.41 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 120.93 -1.106 . . . . 0.0 110.327 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.613 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.3 tm? -82.43 129.68 34.95 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.645 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -125.78 -43.52 1.85 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 123.771 0.669 . . . . 0.0 111.078 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -124.29 131.09 53.5 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.835 -171.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.9 m -123.02 151.85 27.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 174.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -158.82 168.67 35.01 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.282 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.5 pt -120.35 144.76 28.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 123.259 0.624 . . . . 0.0 109.958 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 71.1 m -150.03 154.64 38.51 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.916 0.389 . . . . 0.0 111.61 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -78.59 -28.16 45.73 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -142.23 103.16 4.24 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.4 mt -55.2 -54.7 21.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.462 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.14 -43.79 64.21 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.08 -54.8 24.39 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 123.381 0.426 . . . . 0.0 111.904 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.1 m -70.86 -41.14 71.8 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.81 -56.74 15.38 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.8 m -58.3 -40.22 81.41 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 123.753 0.658 . . . . 0.0 111.228 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.03 -55.64 30.39 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 120.989 0.423 . . . . 0.0 111.281 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -75.03 -27.39 60.04 Favored 'General case' 0 C--O 1.21 -0.99 0 C-N-CA 119.275 -0.97 . . . . 0.0 113.265 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.453 HD22 ' SG ' ' A' ' 123' ' ' CYS . 64.5 mt -76.33 -24.49 54.28 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.051 -0.659 . . . . 0.0 112.061 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -88.71 -11.21 45.82 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.305 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.2 m -90.64 -43.62 10.05 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.89 175.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.31 93.85 24.72 Favored Pre-proline 0 CA--C 1.551 1.008 0 CA-C-O 121.826 0.822 . . . . 0.0 110.727 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.804 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 6.2 Cg_exo -77.41 10.65 2.4 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.388 2.725 . . . . 0.0 113.779 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.13 -42.33 85.58 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.695 0.798 . . . . 0.0 112.259 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.3 mt -105.84 20.67 18.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.181 0.515 . . . . 0.0 110.432 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.804 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 81.5 m -80.72 88.62 5.76 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -127.0 -55.11 0.14 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.9 p -158.76 162.73 37.13 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.99 136.22 42.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.475 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 67.6 mttm -106.6 125.54 51.14 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.51 133.54 60.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.102 0.477 . . . . 0.0 111.292 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.13 104.32 1.0 Allowed Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 130' ' ' ILE . 2.0 mp -87.72 133.22 30.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -177.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.5 p -122.46 151.68 26.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -95.61 7.0 47.53 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.69 0.757 . . . . 0.0 110.425 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -127.08 99.88 27.88 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.789 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -84.84 34.03 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.388 2.726 . . . . 0.0 113.511 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -85.07 140.13 31.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -58.7 -28.31 65.67 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.98 -43.07 62.66 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -66.09 -42.51 91.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.11 -46.69 87.95 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.704 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 43.2 m -71.27 -28.22 63.99 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.748 0.309 . . . . 0.0 110.755 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.2 -54.6 42.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.83 -41.16 99.21 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 123.928 0.767 . . . . 0.0 110.148 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.468 ' O ' HG23 ' A' ' 147' ' ' ILE . 90.4 t90 -53.51 -46.88 70.26 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.735 0.814 . . . . 0.0 109.39 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.413 ' HZ1' ' CD ' ' A' ' 148' ' ' GLU . 9.6 mmmt -57.79 -50.98 71.45 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.424 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 4.0 mm? -57.7 -49.61 75.95 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.297 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -57.69 -51.99 67.26 Favored 'General case' 0 C--O 1.255 1.353 0 O-C-N 124.488 1.117 . . . . 0.0 112.23 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.569 ' O ' HG12 ' A' ' 151' ' ' ILE . 11.7 tt -70.21 -51.07 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.4 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.413 ' CD ' ' HZ1' ' A' ' 144' ' ' LYS . 51.2 mt-10 -62.88 -33.12 74.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -174.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 153' ' ' VAL . 10.1 pt-20 -63.86 -42.88 97.43 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.17 177.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -74.88 -27.21 60.14 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 147' ' ' ILE . 44.8 mm -62.09 -45.66 98.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.05 -37.95 78.84 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.649 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 149' ' ' GLU . 5.5 p -88.52 -60.13 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.1 p -90.71 -28.72 18.14 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 70.81 34.86 66.05 Favored Glycine 0 N--CA 1.467 0.761 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.018 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 99' ' ' LEU . 71.9 mmtt -87.36 114.98 24.46 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 122.528 0.331 . . . . 0.0 110.521 -176.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.9 t -133.9 87.86 34.04 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -88.2 153.28 6.85 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.826 2.351 . . . . 0.0 112.358 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.98 -27.39 28.26 Favored 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 123.908 3.072 . . . . 0.0 113.245 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -63.51 -37.57 94.99 Favored Glycine 0 CA--C 1.502 -0.778 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.86 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 C--N 1.306 -1.313 0 CA-C-O 121.243 0.544 . . . . 0.0 109.934 -177.321 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 C--O 1.214 -0.793 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.8 m -134.7 169.48 17.26 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.912 -0.492 . . . . 0.0 110.882 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.7 mt -58.33 -22.85 54.75 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.334 1.053 . . . . 0.0 112.107 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.452 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 38.2 m -60.68 -44.16 96.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 124.116 0.966 . . . . 0.0 112.067 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.452 ' OE2' ' HB ' ' A' ' 70' ' ' THR . 1.5 mp0 -89.62 3.98 50.89 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.126 0.488 . . . . 0.0 110.25 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.536 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 3.2 m -92.96 128.45 38.82 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.501 -175.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -78.69 159.19 28.11 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 122.74 0.416 . . . . 0.0 110.982 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.51 125.26 54.01 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 122.659 0.384 . . . . 0.0 110.583 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -124.19 131.09 24.17 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.89 149.68 86.28 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 121.988 1.792 . . . . 0.0 110.014 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.91 -12.29 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.874 -0.516 . . . . 0.0 111.814 -176.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.4 p -78.02 -17.79 56.67 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.171 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -94.14 38.93 1.08 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.413 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -57.93 -29.5 65.18 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.053 0.941 . . . . 0.0 112.496 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.27 -20.76 60.03 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.374 0.606 . . . . 0.0 110.4 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.7 m -96.88 6.71 48.14 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.519 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' A' ' 80' ' ' ALA . 45.2 mm -77.43 123.03 86.86 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -56.22 130.39 39.92 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.976 2.451 . . . . 0.0 113.695 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.1 p -91.6 76.26 5.78 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.344 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 107' ' ' ASN . . . -144.3 177.79 8.37 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.629 -177.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.9 t -91.18 137.72 32.15 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.46 -149.56 16.65 Favored Glycine 0 N--CA 1.414 -2.833 0 C-N-CA 119.482 -1.342 . . . . 0.0 112.732 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.492 HG12 ' CH2' ' A' ' 146' ' ' TRP . 4.8 p -128.34 149.75 33.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -136.25 157.14 47.53 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.437 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . . . -127.69 114.83 17.84 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 123.775 0.83 . . . . 0.0 109.442 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.1 t -89.0 119.25 35.8 Favored 'Isoleucine or valine' 0 C--O 1.264 1.834 0 CA-C-O 120.944 0.402 . . . . 0.0 111.008 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 7.3 m-85 -103.35 127.18 50.76 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.165 0.986 . . . . 0.0 109.052 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -79.52 -168.54 1.58 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.555 0.693 . . . . 0.0 112.242 -173.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -57.7 -41.46 81.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.683 1.193 . . . . 0.0 109.993 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.8 t -84.83 12.11 7.99 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.841 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 70.94 20.17 5.45 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 32.7 mt-10 -103.62 148.83 25.54 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 118.865 -1.134 . . . . 0.0 112.211 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 2.1 tm? -80.02 117.72 21.11 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.813 174.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.4 ' O ' ' HG3' ' A' ' 158' ' ' PRO . 1.7 mp0 -113.85 -39.51 3.97 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.15 173.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -124.45 115.25 20.61 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.564 -1.254 . . . . 0.0 112.248 -171.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 m -98.55 147.22 7.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 172.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.19 147.79 17.94 Favored Glycine 0 C--N 1.283 -2.396 0 C-N-CA 118.876 -1.631 . . . . 0.0 112.418 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.4 pt -112.7 138.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 m -152.52 161.54 42.44 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -81.68 -22.56 37.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.502 0.668 . . . . 0.0 109.875 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 86' ' ' ALA . 6.6 t30 -141.91 100.2 3.69 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.1 mt -48.61 -58.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.91 1.284 . . . . 0.0 113.528 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.63 -53.89 13.5 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -36.47 76.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.424 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.4 t -76.11 -52.01 11.03 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.6 t -55.63 -54.45 25.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.429 0.691 . . . . 0.0 111.785 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 m -59.93 -47.77 84.43 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.405 0.44 . . . . 0.0 111.218 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.34 -55.2 36.58 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.257 24.1 p80 -76.84 -25.51 53.28 Favored 'General case' 0 C--O 1.216 -0.658 0 C-N-CA 118.516 -1.274 . . . . 0.0 113.959 -175.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 72.2 mt -77.91 -36.17 49.82 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.499 -0.88 . . . . 0.0 112.056 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -75.97 -19.12 58.99 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.451 -0.899 . . . . 0.0 110.645 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 57.3 m -80.3 -42.71 22.55 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.754 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -134.9 95.06 15.74 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 121.912 0.863 . . . . 0.0 110.804 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.76 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 83.1 Cg_endo -81.42 24.4 0.7 Allowed 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 123.418 2.745 . . . . 0.0 114.633 -174.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -67.41 -34.26 76.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.826 0.822 . . . . 0.0 110.254 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.8 mt -109.37 20.78 17.86 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.242 0.544 . . . . 0.0 110.549 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.76 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 67.5 m -81.14 84.06 6.64 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -122.93 -58.12 0.2 Allowed Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 174.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 12.4 p -163.18 169.19 19.68 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 123.652 0.781 . . . . 0.0 109.048 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.95 139.59 36.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-O 121.257 0.551 . . . . 0.0 109.852 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.536 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 89.4 mttt -106.34 132.51 52.3 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.72 139.18 45.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.274 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.95 101.21 0.61 Allowed Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.61 120.67 35.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.06 130.86 62.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -79.32 -19.08 51.24 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.09 0.471 . . . . 0.0 111.845 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -105.14 101.02 28.0 Favored Pre-proline 0 N--CA 1.435 -1.18 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -86.11 36.24 0.5 Allowed 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 123.061 2.507 . . . . 0.0 112.449 -173.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.69 137.37 54.08 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -61.25 -31.49 71.29 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 123.066 0.229 . . . . 0.0 111.475 -173.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.14 -35.27 66.47 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.814 0.34 . . . . 0.0 110.148 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 63.9 t -69.74 -41.44 79.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.316 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.8 mt -59.52 -48.12 82.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.064 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.7 m -64.58 -36.51 84.48 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.553 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -62.69 -52.29 63.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.083 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.43 -46.06 91.41 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.163 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 86.4 t90 -51.09 -48.84 61.57 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 123.944 0.778 . . . . 0.0 109.421 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.565 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 88.5 tttt -63.58 -57.17 10.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.072 -177.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.499 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 10.4 mp -58.32 -41.65 85.02 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.492 ' CH2' HG12 ' A' ' 89' ' ' VAL . 30.0 m0 -57.79 -52.35 65.83 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-O 120.739 0.304 . . . . 0.0 111.723 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.479 ' O ' HG13 ' A' ' 151' ' ' ILE . 14.5 tt -66.93 -39.07 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.765 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 53.0 mt-10 -60.65 -39.42 88.23 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 21.7 mm-40 -56.67 -44.49 81.45 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.97 0.414 . . . . 0.0 110.853 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -76.73 -30.26 56.54 Favored 'General case' 0 C--O 1.249 1.068 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.535 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 147' ' ' ILE . 74.7 mt -67.12 -45.7 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 122.23 0.212 . . . . 0.0 111.263 178.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -62.46 -38.68 90.75 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 149' ' ' GLU . 7.7 p -81.23 -54.63 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 69.2 p -105.82 -36.28 7.07 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.148 -173.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.68 17.95 57.45 Favored Glycine 0 C--N 1.311 -0.811 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.71 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -75.27 107.29 7.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 117.105 0.453 . . . . 0.0 109.82 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.2 106.75 33.15 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.4 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 13.1 Cg_endo -90.36 162.37 4.54 Favored 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 122.908 2.405 . . . . 0.0 112.913 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.66 -25.39 80.81 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.107 2.538 . . . . 0.0 112.844 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -64.87 -33.65 87.8 Favored Glycine 0 C--N 1.33 0.224 0 N-CA-C 114.348 0.499 . . . . 0.0 114.348 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.3 m120 . . . . . 0 C--O 1.246 0.888 0 CA-C-O 121.454 0.645 . . . . 0.0 111.922 -179.763 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? . . . . . 0 N--CA 1.439 -0.99 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.2 p -107.28 156.72 18.57 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.98 -175.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.16 -24.17 66.6 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.37 1.068 . . . . 0.0 109.882 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.1 m -60.0 -26.88 66.4 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.218 1.007 . . . . 0.0 110.68 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -93.52 -10.42 34.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.385 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.472 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 3.1 m -81.13 126.15 31.12 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -172.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -79.85 155.45 27.82 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.916 0.388 . . . . 0.0 111.942 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -103.13 128.75 49.94 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 123.633 0.773 . . . . 0.0 109.873 -174.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -122.46 136.15 26.27 Favored Pre-proline 0 C--N 1.307 -1.255 0 C-N-CA 123.767 0.827 . . . . 0.0 109.212 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -73.52 140.02 29.31 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.355 2.037 . . . . 0.0 109.84 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.5 -11.24 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -174.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.8 t -71.41 -23.89 61.95 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.021 0.438 . . . . 0.0 110.308 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.96 53.79 0.68 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.208 1.004 . . . . 0.0 110.244 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.404 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -62.35 -22.11 65.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.177 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.85 -16.55 60.68 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.747 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.3 m -94.14 -1.9 53.51 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.099 0.476 . . . . 0.0 110.419 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 80' ' ' ALA . 43.4 mm -77.05 129.79 77.38 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.04 129.81 36.25 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.94 2.426 . . . . 0.0 113.236 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.5 p -90.81 65.77 5.87 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.633 0.73 . . . . 0.0 109.615 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.98 -177.88 4.83 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.999 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.3 t -99.03 143.34 29.42 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.37 -147.78 13.74 Favored Glycine 0 N--CA 1.415 -2.756 0 C-N-CA 119.462 -1.352 . . . . 0.0 112.725 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.496 HG13 ' CH2' ' A' ' 146' ' ' TRP . 5.0 p -127.34 149.0 32.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 C-N-CA 123.542 0.737 . . . . 0.0 109.235 -174.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -141.49 156.01 45.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 120.832 0.348 . . . . 0.0 110.197 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.46 121.08 33.88 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.299 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 50.2 t -96.88 119.03 44.41 Favored 'Isoleucine or valine' 0 C--O 1.259 1.557 0 CA-C-O 121.25 0.548 . . . . 0.0 110.582 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.545 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 47.3 m-85 -110.69 137.24 48.61 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.305 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 98' ' ' GLU . 2.8 p30 -80.58 -169.46 2.15 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.736 -0.785 . . . . 0.0 110.657 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -57.73 -23.78 53.68 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.371 1.069 . . . . 0.0 112.688 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.2 t -108.91 17.53 21.67 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 120.718 0.294 . . . . 0.0 111.143 -174.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.2 t70 66.71 20.78 10.67 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 123.028 1.394 . . . . 0.0 110.713 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.478 ' HB2' ' OD2' ' A' ' 94' ' ' ASP . 80.5 mm-40 -83.64 104.26 13.62 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.856 175.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.545 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.0 tm? -66.19 115.46 6.21 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 174.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -122.64 -13.5 7.94 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -148.17 125.4 11.51 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.169 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.444 HG23 ' NE1' ' A' ' 143' ' ' TRP . 21.9 m -117.08 143.77 26.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 171.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -150.66 157.58 27.26 Favored Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 119.693 -1.241 . . . . 0.0 112.249 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.2 pt -117.36 134.55 60.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.2 m -146.49 161.96 39.33 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.009 0.433 . . . . 0.0 111.574 -175.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -76.9 -34.25 57.73 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.255 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -132.71 109.31 9.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.8 mt -56.76 -58.14 6.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.774 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.85 -50.26 64.12 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.1 -50.27 72.61 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.569 0.543 . . . . 0.0 111.193 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.4 t -63.3 -52.14 63.17 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.213 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.5 t -55.54 -53.94 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 C-N-CA 123.012 0.525 . . . . 0.0 110.529 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.3 m -58.32 -47.49 83.55 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 123.792 0.683 . . . . 0.0 111.381 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.58 -58.18 8.87 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 123.483 0.489 . . . . 0.0 111.617 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -72.13 -26.4 62.1 Favored 'General case' 0 C--O 1.209 -1.066 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.8 mt -74.78 -28.01 60.56 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.416 -0.913 . . . . 0.0 111.159 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -87.08 -3.75 59.1 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.433 0.635 . . . . 0.0 110.483 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.9 m -95.28 -51.07 4.75 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.16 97.95 27.84 Favored Pre-proline 0 N--CA 1.428 -1.539 0 CA-C-O 121.597 0.713 . . . . 0.0 111.108 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.798 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 6.5 Cg_exo -77.53 24.64 0.5 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.66 2.907 . . . . 0.0 113.156 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -62.17 -41.39 98.27 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.301 1.04 . . . . 0.0 110.72 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.3 mt -119.94 21.19 11.99 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.099 -172.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.798 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 72.9 m -74.27 88.99 2.03 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.169 0.509 . . . . 0.0 112.276 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.39 -55.18 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.4 p -161.97 161.6 28.68 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.6 p -139.75 139.28 38.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 120.982 0.42 . . . . 0.0 110.372 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.472 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 63.0 mttm -108.03 129.72 55.11 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 26.2 m -120.16 139.35 47.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.884 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.24 114.44 1.64 Allowed Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 130' ' ' ILE . 2.7 mp -90.66 113.42 26.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.6 p -101.25 142.46 15.97 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -88.46 -5.61 58.14 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.204 0.526 . . . . 0.0 111.907 -171.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -125.93 92.27 46.45 Favored Pre-proline 0 N--CA 1.43 -1.445 0 CA-C-O 121.683 0.754 . . . . 0.0 109.222 174.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.39 46.75 1.89 Allowed 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 123.617 2.878 . . . . 0.0 111.892 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -80.54 141.53 35.03 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -53.26 -39.34 63.8 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.66 -38.53 64.92 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.486 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.9 t -70.52 -40.39 77.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.957 0.408 . . . . 0.0 110.149 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 92.6 mt -61.1 -48.03 83.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.347 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 36.4 m -68.47 -30.61 69.51 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.913 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.507 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 58.4 tt0 -62.93 -54.13 43.3 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.82 96.82 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 123.932 0.77 . . . . 0.0 109.869 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.444 ' NE1' HG23 ' A' ' 102' ' ' VAL . 89.9 t90 -52.31 -49.31 64.45 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.923 0.764 . . . . 0.0 109.755 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -63.03 -47.08 84.56 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.416 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.565 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 80.5 mt -59.2 -49.54 77.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.079 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.496 ' CH2' HG13 ' A' ' 89' ' ' VAL . 26.0 m0 -62.56 -48.26 80.27 Favored 'General case' 0 C--O 1.256 1.402 0 O-C-N 123.995 0.81 . . . . 0.0 112.068 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.591 ' O ' HG12 ' A' ' 151' ' ' ILE . 9.1 tt -63.01 -43.25 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.364 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.528 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 31.9 mt-10 -60.42 -29.91 69.29 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 6.6 mm-40 -59.68 -49.31 78.22 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.426 ' CG ' ' HB3' ' A' ' 99' ' ' LEU 0.259 17.2 m-70 -78.5 -22.08 47.96 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -178.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 147' ' ' ILE . 48.3 mm -60.51 -42.6 91.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 148' ' ' GLU . 39.9 mttm -81.6 -46.34 14.55 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.176 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 149' ' ' GLU . 30.7 m -78.73 -46.49 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.4 p -110.88 -6.56 14.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 119.04 -1.064 . . . . 0.0 112.697 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.42 26.12 70.48 Favored Glycine 0 C--N 1.336 0.541 0 O-C-N 123.742 0.651 . . . . 0.0 113.803 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -91.36 109.02 20.29 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.18 0.514 . . . . 0.0 112.041 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 t -131.41 78.94 70.79 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -90.4 160.53 4.51 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.177 2.585 . . . . 0.0 112.426 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.54 -34.27 19.68 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 124.354 3.37 . . . . 0.0 115.047 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -69.34 -27.38 73.67 Favored Glycine 0 CA--C 1.501 -0.833 0 C-N-CA 121.375 -0.44 . . . . 0.0 112.595 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.408 ' ND2' HD11 ' A' ' 147' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.312 -1.05 0 CA-C-O 121.244 0.545 . . . . 0.0 109.75 -177.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp . . . . . 0 C--O 1.219 -0.528 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.513 ' HB2' ' OE1' ' A' ' 149' ' ' GLU . 36.9 p -149.65 170.3 19.01 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.98 -176.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.4 HD22 ' CE3' ' A' ' 146' ' ' TRP . 17.8 mt -71.4 -23.45 61.88 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 123.423 0.689 . . . . 0.0 110.31 177.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 m -63.6 -25.51 68.26 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.862 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -102.7 8.08 39.61 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.1 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.5 m -103.57 141.06 36.67 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 122.001 -0.437 . . . . 0.0 110.768 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.01 151.41 35.62 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-O 120.921 0.391 . . . . 0.0 111.116 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -107.0 133.17 52.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.678 -173.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.33 132.07 24.31 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 123.312 0.645 . . . . 0.0 109.551 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -70.47 139.41 37.72 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.333 2.022 . . . . 0.0 109.48 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.76 -7.05 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -174.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 t -69.7 -31.13 68.99 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.103 0.478 . . . . 0.0 109.726 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -98.49 53.68 1.04 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.901 0.858 . . . . 0.0 109.767 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.94 -28.62 57.75 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.842 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.36 -33.17 65.44 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.245 1.018 . . . . 0.0 111.627 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.8 m -96.88 12.59 31.69 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -172.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.6 mm -80.93 128.13 72.38 Favored Pre-proline 0 N--CA 1.446 -0.642 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.73 130.74 40.15 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.143 2.562 . . . . 0.0 114.128 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.1 p -92.97 31.68 1.38 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 122.178 0.99 . . . . 0.0 110.655 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.75 -179.09 3.84 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.114 -177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 t -93.6 147.86 22.62 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.59 -150.09 21.19 Favored Glycine 0 N--CA 1.419 -2.488 0 C-N-CA 119.692 -1.242 . . . . 0.0 112.686 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 m -115.42 149.02 17.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 124.336 1.055 . . . . 0.0 109.55 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -144.22 160.24 41.31 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -141.02 131.68 25.6 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.707 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.1 t -106.61 126.84 62.4 Favored 'Isoleucine or valine' 0 C--O 1.26 1.615 0 CA-C-O 121.097 0.475 . . . . 0.0 110.669 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -113.19 135.13 54.16 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.469 1.107 . . . . 0.0 108.551 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -85.56 -170.26 3.03 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.553 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -63.06 -25.38 68.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.76 0.824 . . . . 0.0 111.372 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.3 m -82.39 4.78 22.68 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.112 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.5 t70 69.77 19.16 7.28 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.474 1.11 . . . . 0.0 111.621 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -111.12 147.09 35.63 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.596 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.406 HD11 HG12 ' A' ' 102' ' ' VAL . 2.8 tm? -78.27 125.85 29.94 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.264 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.411 ' O ' ' HG2' ' A' ' 158' ' ' PRO . 50.0 mt-30 -127.92 -13.84 5.12 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 123.925 0.766 . . . . 0.0 112.634 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.452 ' HA ' ' OD1' ' A' ' 161' ' ' ASN . 92.5 t80 -147.63 120.66 8.81 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.515 -0.874 . . . . 0.0 112.741 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.406 HG12 HD11 ' A' ' 99' ' ' LEU . 17.5 m -109.95 142.11 23.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 170.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -146.36 167.76 27.93 Favored Glycine 0 C--N 1.294 -1.759 0 C-N-CA 119.987 -1.101 . . . . 0.0 112.422 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.0 pt -125.86 147.98 30.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.4 t -157.17 164.08 38.17 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.113 0.483 . . . . 0.0 110.032 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.1 -17.9 24.32 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -142.81 87.09 1.97 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 77.7 mt -47.24 -54.94 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.483 1.113 . . . . 0.0 113.231 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.27 -30.57 12.13 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.54 -57.91 3.67 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.2 m -60.56 -43.95 96.69 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.462 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.7 t -58.48 -60.19 2.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.075 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.6 m -60.73 -44.01 97.18 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 123.827 0.705 . . . . 0.0 110.813 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.39 -50.69 72.57 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.114 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -77.05 -25.27 52.25 Favored 'General case' 0 C--O 1.204 -1.305 0 C-N-CA 118.343 -1.343 . . . . 0.0 112.056 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 64.2 mt -73.93 -28.66 61.63 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.612 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.39 -7.41 59.31 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.294 175.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.7 m -90.01 -52.96 4.7 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 121' ' ' GLU . 16.9 m -117.65 102.4 51.7 Favored Pre-proline 0 N--CA 1.435 -1.193 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.794 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 16.4 Cg_exo -73.33 4.03 4.2 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.858 2.372 . . . . 0.0 110.575 173.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 119' ' ' VAL . 12.2 tp10 -55.83 -44.36 77.87 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 125.328 1.451 . . . . 0.0 111.0 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 75.1 mt -105.35 11.15 33.11 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.407 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.794 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 90.4 m -67.95 96.66 0.61 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.621 0.724 . . . . 0.0 111.873 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.4 -63.31 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.569 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 174.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.3 p -155.64 162.13 40.66 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.35 137.83 33.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -108.22 142.21 38.82 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.68 137.57 56.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 120.698 0.285 . . . . 0.0 110.904 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.73 108.92 0.83 Allowed Glycine 0 N--CA 1.423 -2.223 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.51 113.4 23.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.98 132.32 46.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -69.02 -27.29 65.54 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.9 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -85.01 110.7 30.35 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -97.07 19.0 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.752 2.301 . . . . 0.0 113.607 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.526 ' O ' HG21 ' A' ' 138' ' ' VAL . 14.8 t70 -72.97 140.09 47.16 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -57.93 -33.12 68.46 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.61 -38.73 47.47 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.187 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 135' ' ' ASP . 10.5 m -71.3 -31.96 45.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.316 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.2 mt -62.36 -46.1 90.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.1 m -69.34 -30.59 68.66 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.43 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.483 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 29.7 tt0 -66.68 -47.43 72.46 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 122.781 0.433 . . . . 0.0 110.778 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.22 90.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -50.88 -45.47 60.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.5 1.12 . . . . 0.0 110.027 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.75 -48.09 83.36 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.645 1.178 . . . . 0.0 111.31 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 69.6 mt -63.77 -41.57 97.94 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.128 0.489 . . . . 0.0 110.543 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.4 ' CE3' HD22 ' A' ' 69' ' ' LEU . 24.7 m0 -62.24 -50.62 71.0 Favored 'General case' 0 C--O 1.257 1.499 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.971 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.483 ' O ' HG13 ' A' ' 151' ' ' ILE . 14.1 tt -66.71 -40.73 86.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.285 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -65.38 -34.44 78.31 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.513 ' OE1' ' HB2' ' A' ' 68' ' ' SER . 3.8 pt-20 -63.12 -37.36 86.91 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 118.282 -1.367 . . . . 0.0 109.225 176.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.408 ' HA ' HG12 ' A' ' 153' ' ' VAL 0.263 72.8 m-70 -73.91 -31.91 63.3 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 177.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 147' ' ' ILE . 71.1 mt -61.35 -38.27 79.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 174.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -83.0 -20.96 34.08 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 149' ' ' GLU . 12.6 p -101.75 -41.42 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.9 t -113.16 -19.33 11.87 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.546 -0.721 . . . . 0.0 111.714 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.58 8.61 82.78 Favored Glycine 0 C--O 1.239 0.44 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.449 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -76.91 128.32 34.33 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.8 p -158.6 77.37 3.3 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 113.192 -1.822 . . . . 0.0 106.725 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.411 ' HG2' ' O ' ' A' ' 100' ' ' GLN . 2.8 Cg_exo -83.42 167.55 13.5 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.925 3.083 . . . . 0.0 113.893 -175.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.18 -13.82 5.49 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 125.184 3.923 . . . . 0.0 115.475 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -70.85 -42.29 61.11 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 175.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 101' ' ' PHE . 18.9 m120 . . . . . 0 CA--C 1.496 -1.129 0 CA-C-O 121.007 0.432 . . . . 0.0 110.985 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 N--CA 1.443 -0.798 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.5 p -120.63 176.24 5.61 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.34 -33.0 70.6 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.114 1.366 . . . . 0.0 112.379 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -67.19 -16.25 64.19 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.902 0.858 . . . . 0.0 110.508 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -109.23 13.13 24.54 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.343 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 m -105.05 155.28 19.13 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.731 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -94.88 151.61 19.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.441 HD22 ' HZ3' ' A' ' 127' ' ' LYS . 3.1 tm? -104.59 133.22 49.82 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.396 0.617 . . . . 0.0 110.661 -174.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -127.91 136.19 28.63 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 115.098 -0.955 . . . . 0.0 108.601 176.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -71.16 140.84 38.33 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.209 1.939 . . . . 0.0 109.405 172.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.67 -11.65 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.105 0.478 . . . . 0.0 111.51 -174.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.9 p -68.51 -39.58 81.18 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.09 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -96.95 54.13 1.25 Allowed 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.342 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.426 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -61.9 -17.57 57.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.746 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.78 -23.79 64.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.585 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.9 m -88.69 -0.57 57.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.631 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.426 HG12 ' HA ' ' A' ' 80' ' ' ALA . 45.3 mm -77.82 133.91 65.46 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -56.21 129.61 35.75 Favored 'Trans proline' 0 C--O 1.251 1.155 0 C-N-CA 122.196 1.93 . . . . 0.0 112.413 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.8 p -95.13 70.86 3.28 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 121.873 0.844 . . . . 0.0 108.995 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.06 -176.34 5.05 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.064 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.6 t -97.68 134.82 40.35 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.977 0.418 . . . . 0.0 110.099 -173.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.34 -152.17 19.9 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.509 HG11 ' CH2' ' A' ' 146' ' ' TRP . 6.2 p -124.71 147.34 29.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -177.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -135.95 151.89 50.41 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 120.756 0.312 . . . . 0.0 110.223 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.08 123.16 41.68 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.081 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.5 t -95.46 118.35 41.47 Favored 'Isoleucine or valine' 0 C--O 1.263 1.773 0 C-N-CA 123.387 0.675 . . . . 0.0 110.32 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.496 ' CE1' ' HB2' ' A' ' 99' ' ' LEU . 96.8 m-85 -106.91 134.53 49.93 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.113 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.488 ' O ' ' HA3' ' A' ' 124' ' ' GLY . 3.9 p-10 -78.64 -166.96 0.96 Allowed 'General case' 0 C--N 1.317 -0.822 0 O-C-N 123.666 0.604 . . . . 0.0 111.116 -175.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 123' ' ' CYS . 75.4 mmtt -53.0 -34.57 56.84 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.719 1.208 . . . . 0.0 111.311 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.5 m -82.31 -2.93 54.26 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.192 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.9 t70 67.44 23.44 9.08 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.677 1.191 . . . . 0.0 108.297 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.449 ' OE1' HG23 ' A' ' 154' ' ' THR . 0.1 OUTLIER -99.67 158.71 15.58 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.496 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 3.5 tm? -97.71 124.57 42.09 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.69 0.757 . . . . 0.0 111.612 -169.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.473 HE21 ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -119.75 -45.91 2.48 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.738 173.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -124.88 134.63 52.63 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.525 -173.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.549 HG21 HD22 ' A' ' 161' ' ' ASN . 17.4 m -126.2 145.2 34.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -150.95 155.76 26.32 Favored Glycine 0 N--CA 1.42 -2.379 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.964 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.8 pt -110.56 139.14 35.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.0 t -142.93 155.03 44.64 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.358 0.599 . . . . 0.0 110.664 -175.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -87.04 -26.29 23.8 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -142.93 84.74 1.85 Allowed 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 69.5 mt -44.47 -58.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.245 1.418 . . . . 0.0 114.767 -172.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.2 -44.48 22.37 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.13 -34.29 76.08 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.2 t -79.53 -45.81 18.56 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.9 -53.54 36.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.066 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.4 p -61.63 -44.83 96.25 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 123.47 0.481 . . . . 0.0 111.625 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.13 -61.3 2.56 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -78.14 -23.78 47.61 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 119.014 -1.074 . . . . 0.0 113.827 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.421 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 80.7 mt -81.83 -30.7 32.02 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.413 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -88.21 -9.88 51.58 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.04 -1.064 . . . . 0.0 109.826 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.3 t -82.94 -47.37 11.85 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.34 95.14 18.56 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-O 121.765 0.793 . . . . 0.0 110.339 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.809 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 2.8 Cg_exo -76.65 24.47 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.64 2.893 . . . . 0.0 114.499 -176.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.57 -42.47 82.53 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.428 0.632 . . . . 0.0 111.078 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 75.4 mt -102.95 21.27 15.97 Favored 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.558 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.809 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 84.0 m -85.81 105.03 16.03 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 94' ' ' ASP . . . -137.81 -58.95 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 173.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 56.9 p -156.4 169.09 25.4 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.1 p -142.09 133.97 26.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.092 0.472 . . . . 0.0 109.924 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.441 ' HZ3' HD22 ' A' ' 74' ' ' LEU . 56.4 mttp -106.94 125.83 51.52 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.5 m -113.34 135.22 53.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.254 0.549 . . . . 0.0 111.286 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.77 98.31 0.67 Allowed Glycine 0 N--CA 1.414 -2.798 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.373 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 40.5 mm -75.75 112.44 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.101 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.5 m -98.39 145.95 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.113 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -71.26 -36.94 71.92 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.208 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -92.39 105.09 12.85 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -93.76 27.78 0.32 Allowed 'Trans proline' 0 C--O 1.243 0.748 0 C-N-CA 122.737 2.291 . . . . 0.0 113.352 -174.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.443 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 15.7 t70 -89.98 144.12 26.19 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -53.38 -34.31 57.17 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.51 68.68 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.78 -34.72 61.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.762 -175.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 96.6 mt -62.17 -53.44 55.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.156 175.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.5 m -66.9 -30.48 70.64 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.326 0.584 . . . . 0.0 110.373 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -65.01 -50.91 64.43 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 123.656 0.782 . . . . 0.0 109.425 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.42 -43.61 98.57 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.488 ' NE1' HG23 ' A' ' 102' ' ' VAL . 79.6 t90 -52.73 -46.66 67.51 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.119 176.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -66.79 -44.88 80.1 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.211 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.543 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 11.1 mp -61.14 -41.77 97.33 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.151 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.509 ' CH2' HG11 ' A' ' 89' ' ' VAL . 33.6 m0 -62.38 -50.66 70.69 Favored 'General case' 0 C--O 1.254 1.314 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 151' ' ' ILE . 8.9 tt -62.51 -40.73 89.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.382 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.37 -32.49 74.16 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 22.3 mm-40 -56.12 -41.63 75.57 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.724 0.773 . . . . 0.0 109.96 175.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . 0.321 5.4 m-70 -83.46 -26.37 30.35 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.297 -1.361 . . . . 0.0 113.768 176.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 147' ' ' ILE . 73.6 mt -61.22 -42.61 94.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 O-C-N 121.974 -0.454 . . . . 0.0 110.372 173.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -69.43 -34.7 74.82 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.1 p -92.01 -40.81 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.449 HG23 ' OE1' ' A' ' 98' ' ' GLU . 3.7 t -118.55 -35.28 3.78 Favored 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -176.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 74.76 34.3 53.65 Favored Glycine 0 N--CA 1.47 0.962 0 C-N-CA 120.429 -0.891 . . . . 0.0 114.207 175.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -65.23 -66.37 0.55 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.28 12.2 p 41.13 75.99 0.55 Allowed Pre-proline 0 CA--C 1.573 1.859 0 C-N-CA 125.002 1.321 . . . . 0.0 113.951 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -90.72 161.49 4.19 Favored 'Trans proline' 0 CA--C 1.556 1.603 0 C-N-CA 123.245 2.63 . . . . 0.0 114.085 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -50.38 -34.12 39.98 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 124.435 3.423 . . . . 0.0 114.472 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -59.35 -45.33 95.62 Favored Glycine 0 CA--C 1.495 -1.194 0 CA-C-O 121.121 0.29 . . . . 0.0 112.762 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.549 HD22 HG21 ' A' ' 102' ' ' VAL . 34.0 t-20 . . . . . 0 C--N 1.301 -1.539 0 CA-C-O 122.42 1.105 . . . . 0.0 108.715 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.485 0 CA-C-O 121.323 0.582 . . . . 0.0 111.578 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.495 ' HA ' ' CD1' ' A' ' 146' ' ' TRP . 70.1 m -147.89 -178.78 6.46 Favored 'General case' 0 N--CA 1.413 -2.278 0 O-C-N 122.001 -0.437 . . . . 0.0 110.495 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -54.44 -24.75 21.39 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.785 1.634 . . . . 0.0 113.725 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.1 m -66.56 -29.14 69.15 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.103 0.478 . . . . 0.0 111.296 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -107.74 11.24 28.5 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.522 0.677 . . . . 0.0 110.911 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 m -97.17 136.03 38.27 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.409 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 12.6 pt-20 -74.45 149.59 40.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.705 0.288 . . . . 0.0 111.148 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -112.99 126.2 55.23 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.351 0.66 . . . . 0.0 109.294 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.98 135.11 24.57 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -71.63 138.68 32.6 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.256 1.971 . . . . 0.0 109.189 172.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.4 -8.78 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.262 -176.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.0 t -67.35 -23.04 65.56 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -112.93 53.26 0.76 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.12 -22.81 52.57 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.724 1.21 . . . . 0.0 112.413 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.23 -28.09 69.5 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.369 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.6 t -88.6 9.37 24.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.885 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.5 mm -80.31 129.05 70.88 Favored Pre-proline 0 C--N 1.314 -0.955 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.43 130.29 39.79 Favored 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.982 2.455 . . . . 0.0 113.34 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.5 p -92.39 80.18 4.94 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.282 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.81 -179.44 6.99 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.469 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.9 t -100.82 134.74 43.35 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.61 -150.2 14.69 Favored Glycine 0 N--CA 1.418 -2.53 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.33 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.515 HG12 ' CH2' ' A' ' 146' ' ' TRP . 7.6 p -122.86 149.78 26.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -137.85 155.3 49.13 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.25 115.58 20.61 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 123.518 0.727 . . . . 0.0 109.559 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.4 t -91.6 121.51 42.14 Favored 'Isoleucine or valine' 0 C--O 1.258 1.528 0 CA-C-O 121.097 0.475 . . . . 0.0 110.944 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.512 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 61.8 m-85 -109.86 131.66 54.86 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 124.154 0.982 . . . . 0.0 108.651 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.489 ' OD1' ' HB2' ' A' ' 98' ' ' GLU . 1.3 p-10 -78.64 -168.16 1.31 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -64.18 -24.92 67.85 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 123.168 0.587 . . . . 0.0 110.812 -176.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.0 m -81.91 2.2 31.64 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.025 0.53 . . . . 0.0 112.065 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.2 t70 68.92 24.76 6.26 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 123.419 1.58 . . . . 0.0 108.866 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.489 ' HB2' ' OD1' ' A' ' 94' ' ' ASP . 24.0 mm-40 -96.73 115.53 27.59 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.689 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.512 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 2.4 tm? -68.68 113.14 5.9 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 173.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.441 ' HB3' ' HG2' ' A' ' 158' ' ' PRO . 22.0 mt-30 -125.31 -13.21 6.71 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.692 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -146.57 114.96 6.7 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.563 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.428 HG22 ' NE1' ' A' ' 143' ' ' TRP . 27.4 m -103.41 149.86 7.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 172.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -160.35 152.47 23.24 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 119.502 -1.333 . . . . 0.0 112.419 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.5 pt -112.78 140.51 32.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.0 m -150.89 169.57 21.41 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -76.93 -42.96 37.25 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.455 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -138.8 98.55 3.58 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 65.1 mt -44.13 -57.41 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 125.05 1.34 . . . . 0.0 114.23 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.3 -41.94 63.36 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.76 -41.74 74.77 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.052 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.3 t -66.04 -49.05 69.06 Favored 'General case' 0 C--O 1.254 1.302 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.814 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 72.6 t -57.38 -53.51 42.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.097 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.1 t -62.92 -35.65 80.79 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.362 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.13 -61.77 2.32 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.95 -0.469 . . . . 0.0 112.019 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -79.29 -22.99 43.87 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.409 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 67.8 mt -76.63 -25.34 53.73 Favored 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.403 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -87.75 -18.67 28.91 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.822 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.8 m -74.41 -47.1 35.91 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -138.99 95.07 9.67 Favored Pre-proline 0 CA--C 1.554 1.12 0 CA-C-O 121.807 0.813 . . . . 0.0 110.28 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.627 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 11.7 Cg_exo -74.07 24.13 0.35 Allowed 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 123.859 3.039 . . . . 0.0 115.036 -176.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -65.27 -43.37 91.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.33 0.586 . . . . 0.0 109.87 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.2 mt -99.4 19.91 14.7 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.167 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.627 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 98.3 m -74.01 94.25 2.34 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.347 0.594 . . . . 0.0 111.722 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.84 -68.01 0.06 OUTLIER Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.4 p -159.71 163.26 34.9 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.72 140.7 40.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 120.963 0.411 . . . . 0.0 110.341 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 92.2 mttt -106.11 126.35 52.1 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.6 m -113.38 133.84 57.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.007 0.432 . . . . 0.0 111.405 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -124.82 101.54 0.66 Allowed Glycine 0 N--CA 1.417 -2.596 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 130' ' ' ILE . 2.1 mp -84.72 109.67 18.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.33 164.36 2.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.135 -173.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -59.39 -62.74 1.65 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.775 0.672 . . . . 0.0 110.937 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 135' ' ' ASP . 18.7 mm-40 -99.92 146.55 32.09 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -82.31 32.47 0.52 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 122.405 2.07 . . . . 0.0 109.92 172.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 133' ' ' GLU . 13.5 t70 -77.01 135.36 38.66 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.653 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -58.81 -31.63 68.63 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.31 -46.04 51.92 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.481 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 135' ' ' ASP . 11.9 m -68.42 -32.65 56.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.756 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 94.5 mt -65.25 -51.3 61.69 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.903 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.4 m -65.65 -35.32 80.46 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.721 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.501 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 28.2 tt0 -61.67 -52.67 63.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.47 -42.39 99.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.545 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.428 ' NE1' HG22 ' A' ' 102' ' ' VAL . 84.6 t90 -53.5 -50.95 64.3 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.476 0.71 . . . . 0.0 109.497 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 58.9 tttm -59.97 -52.56 64.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.387 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.58 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 85.5 mt -58.54 -49.76 76.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.376 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.515 ' CH2' HG12 ' A' ' 89' ' ' VAL . 41.8 m0 -59.32 -48.77 80.36 Favored 'General case' 0 C--O 1.249 1.038 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.502 ' O ' HG13 ' A' ' 151' ' ' ILE . 12.6 tt -63.42 -42.75 97.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.795 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 45.2 mt-10 -62.68 -33.31 74.82 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.72 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 20.6 mm-40 -55.92 -51.06 68.96 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.311 0.577 . . . . 0.0 110.447 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.479 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 2.7 t60 -77.89 -21.19 51.61 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.281 -175.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 147' ' ' ILE . 68.1 mt -68.99 -32.28 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.189 0.519 . . . . 0.0 109.889 175.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 148' ' ' GLU . 74.9 mmtt -77.71 -48.27 17.1 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.058 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.28 -56.8 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 47.0 p -106.16 -27.59 10.98 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.339 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 151' ' ' ILE . . . 98.11 31.84 6.39 Favored Glycine 0 CA--C 1.502 -0.777 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.947 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -94.25 101.81 13.8 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.8 p -129.45 79.24 74.29 Favored Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.441 ' HG2' ' HB3' ' A' ' 100' ' ' GLN . 4.2 Cg_exo -84.47 165.88 12.31 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.6 2.867 . . . . 0.0 113.738 -172.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -47.87 -27.77 8.99 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 124.889 3.726 . . . . 0.0 114.807 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -63.86 -39.83 97.77 Favored Glycine 0 CA--C 1.523 0.548 0 O-C-N 123.305 0.378 . . . . 0.0 112.473 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.4 m120 . . . . . 0 CA--C 1.501 -0.936 0 CA-C-O 121.042 0.448 . . . . 0.0 111.202 179.199 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 11.0 mmpt? . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.967 0.413 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 p -78.56 163.48 25.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 123.327 0.651 . . . . 0.0 110.87 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.497 ' HG ' ' CG ' ' A' ' 146' ' ' TRP . 10.7 mt -51.82 -33.26 35.02 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -177.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.8 m -62.35 -25.87 68.14 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.958 0.409 . . . . 0.0 110.71 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -96.98 -12.05 23.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.217 0.532 . . . . 0.0 110.341 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.8 m -78.55 145.96 34.55 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.11 -174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -84.01 153.39 23.88 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.258 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -108.87 134.81 51.05 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 124.413 1.085 . . . . 0.0 109.684 -173.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -125.43 138.72 32.34 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -72.63 141.86 35.12 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.71 2.274 . . . . 0.0 110.627 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.58 -13.76 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.451 -176.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.3 t -66.48 -28.86 68.91 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.432 0.634 . . . . 0.0 110.206 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -103.49 53.79 0.76 Allowed 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.929 0.871 . . . . 0.0 109.408 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.43 -18.56 18.69 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.789 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.55 -24.34 45.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.013 0.435 . . . . 0.0 110.077 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.1 m -88.43 -1.28 57.95 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.982 0.42 . . . . 0.0 111.234 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.9 mm -72.18 128.15 89.41 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -51.5 132.67 41.22 Favored 'Trans proline' 0 C--O 1.241 0.657 0 C-N-CA 123.525 2.817 . . . . 0.0 113.147 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.4 p -94.92 28.58 2.68 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.407 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.59 -176.85 3.61 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.027 -176.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.3 t -98.6 145.24 27.04 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 159.55 -148.26 16.7 Favored Glycine 0 N--CA 1.416 -2.696 0 C-N-CA 119.802 -1.19 . . . . 0.0 112.729 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.68 150.56 29.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -138.31 154.15 49.01 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.97 121.41 34.35 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.628 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.24 124.08 46.59 Favored 'Isoleucine or valine' 0 C--O 1.27 2.146 0 O-C-N 123.641 0.588 . . . . 0.0 110.228 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -114.82 142.02 47.11 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.684 1.194 . . . . 0.0 108.949 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -90.95 -164.16 1.14 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.407 ' HB3' ' HZ2' ' A' ' 95' ' ' LYS . 1.8 mmmp? -70.07 -12.32 61.52 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 122.465 0.306 . . . . 0.0 111.603 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.0 m -94.59 -2.47 51.42 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 66.6 26.78 9.7 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.148 0.979 . . . . 0.0 109.754 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -90.18 127.92 36.23 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-O 121.078 0.466 . . . . 0.0 110.571 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.55 119.64 20.66 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -128.17 -18.4 4.12 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.257 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -147.29 118.15 7.63 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.354 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.432 HG23 ' NE1' ' A' ' 143' ' ' TRP . 11.6 m -109.27 139.62 31.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -149.54 158.0 27.48 Favored Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.711 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.3 pt -115.59 147.81 18.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.0 m -154.08 156.21 36.86 Favored 'General case' 0 C--O 1.251 1.134 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.18 -27.99 29.63 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -127.39 105.88 8.83 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.438 ' O ' HG22 ' A' ' 112' ' ' VAL . 78.0 mt -61.05 -60.79 2.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.145 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -44.69 -58.06 3.29 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -175.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.38 -37.23 86.38 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.6 m -71.59 -46.38 59.44 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 123.23 0.331 . . . . 0.0 110.815 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 108' ' ' ILE . 85.3 t -58.68 -56.06 19.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.437 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 16.6 m -57.16 -42.05 80.33 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 124.248 0.968 . . . . 0.0 111.619 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.89 -59.08 5.22 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -73.06 -24.06 60.64 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 69.8 mt -73.13 -33.35 65.47 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.827 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 113' ' ' SER . 34.8 mmtp -78.7 -20.2 50.68 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.118 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.7 m -80.92 -46.26 15.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.471 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.46 92.78 26.86 Favored Pre-proline 0 CA--C 1.557 1.226 0 CA-C-O 121.815 0.817 . . . . 0.0 110.295 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.586 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 3.8 Cg_exo -76.48 16.64 0.86 Allowed 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 123.933 3.089 . . . . 0.0 114.126 -175.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.27 -38.08 89.18 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.618 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.8 mt -101.51 20.55 15.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.745 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 90.4 m -75.04 93.12 2.69 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.647 176.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.03 -65.86 0.07 OUTLIER Glycine 0 N--CA 1.435 -1.405 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.8 p -158.89 167.52 29.19 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.0 p -144.82 139.24 23.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.464 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -106.56 137.53 44.41 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.6 m -125.7 133.35 69.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.359 0.599 . . . . 0.0 111.785 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -112.89 102.58 1.31 Allowed Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.07 115.48 20.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 p -108.33 138.3 35.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -66.83 -45.17 79.11 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.306 0.574 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -94.5 114.2 62.85 Favored Pre-proline 0 C--N 1.292 -1.919 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.639 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -82.91 32.92 0.52 Allowed 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 123.049 2.499 . . . . 0.0 111.755 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.431 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 17.6 t70 -73.59 136.86 43.99 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.814 -177.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -61.1 -30.14 70.18 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.69 -50.42 36.72 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.2 t -60.96 -39.76 83.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 O-C-N 124.179 0.924 . . . . 0.0 110.591 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.2 mt -61.47 -55.32 32.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.513 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.0 m -60.78 -38.4 85.16 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.038 0.447 . . . . 0.0 111.025 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -59.71 -52.63 64.65 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.205 1.002 . . . . 0.0 110.765 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.29 94.84 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.156 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.432 ' NE1' HG23 ' A' ' 102' ' ' VAL . 89.3 t90 -56.4 -45.21 80.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.533 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -63.89 -43.32 96.37 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.737 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.7 -46.2 90.7 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.066 0.46 . . . . 0.0 110.929 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.497 ' CG ' ' HG ' ' A' ' 69' ' ' LEU . 26.0 m0 -63.9 -46.28 85.58 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.502 ' O ' HG13 ' A' ' 151' ' ' ILE . 7.9 tt -63.25 -42.12 95.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.547 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.428 ' HB3' ' NZ ' ' A' ' 152' ' ' LYS . 49.8 mt-10 -64.77 -31.6 72.9 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 146' ' ' TRP . 7.1 mm-40 -50.42 -50.63 51.38 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.558 0.536 . . . . 0.0 110.02 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.404 ' HA ' HG23 ' A' ' 153' ' ' VAL 0.282 33.2 m-70 -81.95 -28.45 32.72 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -178.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 147' ' ' ILE . 71.3 mt -57.06 -40.52 73.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 120.943 0.401 . . . . 0.0 110.137 172.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.428 ' NZ ' ' HB3' ' A' ' 148' ' ' GLU . 62.3 mttp -75.32 -46.69 31.8 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.404 HG23 ' HA ' ' A' ' 150' ' ' HIS . 30.9 m -78.04 -39.69 25.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -175.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 33.1 p -119.1 -35.32 3.65 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.951 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.92 17.23 59.93 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -85.14 108.22 17.59 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.13 0.49 . . . . 0.0 111.787 -177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 40.8 t -128.3 84.19 63.94 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 173.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -76.41 164.51 30.67 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 122.798 2.332 . . . . 0.0 111.923 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.34 -31.05 45.49 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 123.159 2.573 . . . . 0.0 112.697 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.29 -24.13 71.96 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.176 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.31 -1.149 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 CA--C 1.507 -0.699 0 CA-C-O 122.116 0.96 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.0 p -129.92 164.33 24.44 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.894 -170.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.491 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 17.9 mt -68.86 -13.59 62.51 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 t -70.25 -19.6 63.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.322 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -104.72 1.33 29.23 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.491 ' OG1' ' HA ' ' A' ' 69' ' ' LEU . 6.8 m -92.78 134.53 34.97 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -172.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.16 152.35 38.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.295 1.038 . . . . 0.0 110.681 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -109.75 129.59 55.6 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 4.3 mm? -121.02 136.04 25.31 Favored Pre-proline 0 C--N 1.307 -1.247 0 C-N-CA 123.762 0.825 . . . . 0.0 109.705 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 27.6 Cg_exo -69.5 139.64 41.62 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.348 2.032 . . . . 0.0 110.247 172.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.03 -12.98 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.248 0.547 . . . . 0.0 111.469 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.0 t -74.62 -20.81 59.76 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.466 0.651 . . . . 0.0 109.968 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -104.85 53.15 0.73 Allowed 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.807 0.813 . . . . 0.0 109.557 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.476 ' HB2' ' OG ' ' A' ' 113' ' ' SER . . . -56.13 -28.94 59.86 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.835 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.41 -26.23 67.89 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.6 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.3 t -92.08 -4.98 53.65 Favored 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.737 0.815 . . . . 0.0 110.38 -174.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.14 130.36 86.51 Favored Pre-proline 0 N--CA 1.443 -0.808 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.85 131.38 38.01 Favored 'Trans proline' 0 C--O 1.248 0.982 0 C-N-CA 123.348 2.699 . . . . 0.0 112.976 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.0 p -91.39 27.59 1.91 Allowed 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.66 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.95 -176.95 3.6 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.825 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.6 t -96.85 154.33 17.36 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 154.15 -154.1 25.28 Favored Glycine 0 N--CA 1.423 -2.185 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.264 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.41 152.12 14.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 123.708 0.803 . . . . 0.0 110.045 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -144.69 154.35 42.67 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -130.78 126.23 35.81 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 123.248 0.619 . . . . 0.0 109.394 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.4 t -102.97 126.0 57.29 Favored 'Isoleucine or valine' 0 C--O 1.263 1.793 0 CA-C-O 121.102 0.477 . . . . 0.0 110.032 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -113.09 133.44 55.0 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -79.16 -169.44 1.84 Allowed 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.525 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -57.22 -36.38 70.82 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.733 0.413 . . . . 0.0 110.29 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.3 m -77.46 0.5 22.44 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.536 0.734 . . . . 0.0 111.586 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.0 t70 65.88 27.16 10.99 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 122.752 1.263 . . . . 0.0 110.246 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -98.64 137.4 37.33 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.252 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.69 125.08 28.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.557 ' O ' ' HG2' ' A' ' 158' ' ' PRO . 41.9 mt-30 -129.1 -17.11 3.93 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.103 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.459 ' HA ' ' OD1' ' A' ' 161' ' ' ASN . 89.5 t80 -154.61 126.0 7.39 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 118.635 -1.226 . . . . 0.0 111.911 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.5 m -114.62 145.05 20.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 170.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.0 168.95 31.33 Favored Glycine 0 C--N 1.281 -2.487 0 C-N-CA 119.276 -1.44 . . . . 0.0 112.709 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.3 pt -120.13 148.53 23.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.4 t -150.84 155.63 39.59 Favored 'General case' 0 N--CA 1.417 -2.112 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.593 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.91 -23.12 24.02 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.405 ' C ' HD21 ' A' ' 107' ' ' ASN . 0.2 OUTLIER -141.67 98.19 3.3 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.0 mt -55.26 -60.4 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.46 -47.72 27.05 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.75 90.65 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 p -79.05 -43.1 24.92 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.607 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 76.3 t -55.47 -54.76 21.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 O-C-N 123.294 0.371 . . . . 0.0 110.805 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.476 ' OG ' ' HB2' ' A' ' 80' ' ' ALA . 20.1 m -56.94 -46.9 81.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 123.924 0.765 . . . . 0.0 110.696 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.5 -55.08 38.24 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.046 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.261 29.2 p80 -71.53 -26.44 62.66 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 89.9 mt -78.13 -27.68 48.29 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.233 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 113' ' ' SER . 74.9 mmtt -84.9 -9.15 58.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.166 0.508 . . . . 0.0 110.314 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.6 t -93.32 -50.57 5.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.08 94.48 27.71 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-O 121.742 0.782 . . . . 0.0 110.507 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.695 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 15.0 Cg_exo -71.88 19.58 0.28 Allowed 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.986 3.124 . . . . 0.0 114.322 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.68 -43.42 98.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.462 0.649 . . . . 0.0 109.755 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.1 mt -100.35 20.13 15.38 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.911 -176.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.695 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 91.0 m -77.16 86.03 3.63 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.706 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.42 -63.96 0.09 OUTLIER Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 175.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.0 p -164.01 157.56 18.55 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 123.004 0.522 . . . . 0.0 109.601 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.21 139.0 46.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-O 121.018 0.437 . . . . 0.0 110.472 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.439 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 74.6 mttt -106.71 137.48 44.66 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.02 132.61 71.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.038 0.447 . . . . 0.0 110.802 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -117.18 99.37 0.83 Allowed Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.68 117.56 29.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.454 0.645 . . . . 0.0 109.743 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.92 131.18 69.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.58 8.4 7.96 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -108.35 107.62 60.33 Favored Pre-proline 0 N--CA 1.423 -1.783 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -84.04 26.42 0.65 Allowed 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.558 2.172 . . . . 0.0 110.713 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.552 ' O ' HG22 ' A' ' 138' ' ' VAL . 14.1 t70 -71.92 127.83 33.82 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -62.51 -28.4 69.82 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -173.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.54 -33.34 54.18 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.359 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 135' ' ' ASP . 10.1 m -77.38 -32.71 18.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.833 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 97.0 mt -64.25 -46.73 82.46 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.0 m -67.03 -33.92 76.58 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.225 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.587 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 9.4 tt0 -64.56 -50.82 65.78 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.528 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.23 -41.17 98.17 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.376 0.422 . . . . 0.0 110.234 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -55.61 -47.36 76.67 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.588 0.709 . . . . 0.0 109.592 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.78 -42.78 98.2 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.875 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 60.9 mt -64.98 -47.46 77.48 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.812 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -62.45 -46.11 90.01 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.015 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.58 ' O ' HG13 ' A' ' 151' ' ' ILE . 13.0 tt -67.15 -46.88 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.543 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -67.47 -29.28 68.69 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -175.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.483 ' O ' HG22 ' A' ' 153' ' ' VAL . 9.2 pt-20 -65.11 -44.09 89.89 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.931 176.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -69.96 -24.1 63.29 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 147' ' ' ILE . 57.1 mt -66.77 -43.73 89.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 172.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -71.27 -50.64 30.64 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 149' ' ' GLU . 35.2 m -80.01 -40.37 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -176.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.6 p -116.99 -4.84 11.47 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -174.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.37 34.33 89.61 Favored Glycine 0 C--O 1.222 -0.643 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.871 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -93.64 110.2 21.81 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.9 t -141.4 79.07 17.83 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 173.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.557 ' HG2' ' O ' ' A' ' 100' ' ' GLN . 3.1 Cg_exo -82.77 160.47 16.33 Favored 'Trans proline' 0 C--O 1.248 0.982 0 C-N-CA 122.66 2.24 . . . . 0.0 112.834 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -56.48 -17.17 20.75 Favored 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 124.268 3.312 . . . . 0.0 113.997 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -67.69 -38.79 90.22 Favored Glycine 0 CA--C 1.523 0.588 0 O-C-N 123.573 0.546 . . . . 0.0 112.892 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' A' ' 101' ' ' PHE . 11.0 m120 . . . . . 0 CA--C 1.492 -1.252 0 CA-C-O 121.991 0.9 . . . . 0.0 111.634 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt . . . . . 0 N--CA 1.433 -1.296 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.8 m -76.52 164.59 25.8 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 121.38 0.61 . . . . 0.0 111.719 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.438 HD12 ' OH ' ' A' ' 93' ' ' TYR . 3.1 tm? -46.52 -40.03 11.87 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 126.637 1.975 . . . . 0.0 114.108 -174.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.0 m -56.24 -32.83 64.85 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.314 0.578 . . . . 0.0 111.891 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -102.72 10.0 38.82 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.356 -0.384 . . . . 0.0 112.029 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.567 HG21 ' CH2' ' A' ' 146' ' ' TRP . 30.1 m -85.58 147.66 26.3 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.256 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.08 149.64 46.31 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.23 0.612 . . . . 0.0 111.262 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -110.65 133.49 53.27 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.829 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.26 141.53 41.08 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -79.97 144.84 17.23 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.082 1.854 . . . . 0.0 110.885 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.473 HD12 ' SG ' ' A' ' 123' ' ' CYS . 0.1 OUTLIER -80.03 -12.95 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.094 0.473 . . . . 0.0 110.676 -178.077 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.25 -11.81 61.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 124.522 1.129 . . . . 0.0 111.205 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -128.19 53.42 1.81 Allowed 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.86 -19.15 5.9 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.996 -175.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -78.21 -20.39 51.91 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.321 0.582 . . . . 0.0 110.577 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.0 m -91.11 6.81 43.47 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.234 0.54 . . . . 0.0 110.769 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.4 mm -82.56 130.05 60.3 Favored Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -53.23 137.02 63.54 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.531 2.821 . . . . 0.0 113.287 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.3 p -101.52 27.13 6.57 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.813 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.25 -175.99 3.39 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.649 -174.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.9 t -95.39 141.56 28.8 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 158.87 -153.43 24.55 Favored Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.511 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.8 m -109.21 150.56 11.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 C-N-CA 124.393 1.077 . . . . 0.0 110.06 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -142.78 148.43 37.15 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.38 118.04 21.57 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.244 0.618 . . . . 0.0 109.883 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.5 t -97.32 127.59 49.43 Favored 'Isoleucine or valine' 0 C--O 1.263 1.782 0 CA-C-O 121.358 0.599 . . . . 0.0 111.895 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 43.3 m-85 -107.4 146.47 31.61 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 125.047 1.339 . . . . 0.0 109.32 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -95.2 -172.24 2.62 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -65.34 -23.05 66.9 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 m -77.13 -4.08 42.67 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.78 0.8 . . . . 0.0 109.396 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.3 t70 66.12 29.57 9.81 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.727 1.611 . . . . 0.0 109.626 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 5.1 mm-40 -99.14 144.1 28.66 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 114.066 -1.425 . . . . 0.0 108.255 175.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.511 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 1.5 tm? -85.89 125.12 33.09 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.546 ' O ' ' HG2' ' A' ' 158' ' ' PRO . 1.4 mp0 -116.5 -23.55 8.22 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 123.978 0.799 . . . . 0.0 113.013 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -149.4 120.47 7.73 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 117.587 -1.645 . . . . 0.0 112.715 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.462 HG23 ' HB ' ' A' ' 147' ' ' ILE . 30.5 m -105.06 145.29 13.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.809 171.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.55 166.97 30.84 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.544 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.5 pt -123.0 144.84 31.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 122.889 0.476 . . . . 0.0 109.806 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.2 m -152.62 157.37 40.88 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.334 0.588 . . . . 0.0 111.526 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -86.74 -22.18 26.13 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 172.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -137.44 91.33 2.59 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.596 -1.183 . . . . 0.0 108.086 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.19 -62.3 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -173.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.77 -43.19 27.2 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -175.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.4 -48.57 79.13 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.054 0.221 . . . . 0.0 111.526 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.3 m -65.04 -41.51 95.13 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 120.683 0.277 . . . . 0.0 111.154 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.6 t -61.7 -57.15 13.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.009 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.5 p -60.85 -35.61 77.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 123.778 0.674 . . . . 0.0 111.811 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.77 -61.27 2.39 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 122.975 0.51 . . . . 0.0 111.642 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -79.57 -21.68 44.76 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -73.02 -41.28 64.41 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.77 -15.1 59.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.556 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.6 m -80.9 -59.09 2.8 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.409 ' C ' ' H ' ' A' ' 121' ' ' GLU . 7.1 p -122.3 95.25 47.28 Favored Pre-proline 0 N--CA 1.428 -1.528 0 CA-C-O 122.087 0.946 . . . . 0.0 110.847 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.53 21.12 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.794 2.996 . . . . 0.0 113.22 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.409 ' H ' ' C ' ' A' ' 119' ' ' VAL . 36.3 tt0 -69.1 -33.21 73.14 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.2 mt -94.59 21.49 7.23 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.169 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 77' ' ' ILE . 38.2 t -68.61 108.37 3.32 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 176.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.35 -72.82 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.3 p -169.41 173.17 6.68 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.9 p -144.49 139.8 23.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -106.27 129.91 54.22 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.54 136.1 60.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.436 0.636 . . . . 0.0 111.52 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -116.59 96.79 0.73 Allowed Glycine 0 N--CA 1.418 -2.511 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.441 HD11 ' N ' ' A' ' 130' ' ' ILE . 2.7 mp -78.74 114.27 19.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.5 124.13 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.705 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -78.83 -5.17 52.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.499 0.666 . . . . 0.0 110.582 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -111.65 84.31 5.11 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 172.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.83 39.29 0.7 Allowed 'Trans proline' 0 N--CA 1.48 0.684 0 C-N-CA 123.619 2.879 . . . . 0.0 113.026 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.509 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 14.4 t70 -76.87 138.88 40.04 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.059 -175.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -54.15 -38.09 65.13 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.892 1.277 . . . . 0.0 113.494 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.02 -44.57 54.01 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.84 -43.58 95.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.775 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 96.5 mt -57.25 -52.88 63.53 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.125 0.488 . . . . 0.0 110.708 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.6 m -69.42 -34.37 74.36 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.117 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.476 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 52.9 tt0 -66.84 -45.65 77.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.071 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.9 -38.21 90.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.174 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.446 ' O ' HG22 ' A' ' 147' ' ' ILE . 89.3 t90 -55.72 -48.58 74.94 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -60.9 -38.24 85.02 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.372 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.598 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 71.4 mt -63.97 -56.92 11.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.274 0.559 . . . . 0.0 109.559 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.567 ' CH2' HG21 ' A' ' 72' ' ' THR . 20.8 m0 -54.61 -50.48 67.98 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.581 ' O ' HG13 ' A' ' 151' ' ' ILE . 13.1 tt -61.51 -46.53 96.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.334 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -66.45 -27.23 67.66 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 17.5 mm-40 -59.94 -46.13 90.37 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 121.224 0.535 . . . . 0.0 109.671 175.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.511 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 7.5 t60 -81.8 -21.43 37.71 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.578 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 147' ' ' ILE . 53.7 mt -67.2 -53.51 32.48 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.71 -26.2 68.54 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.3 p -84.37 -35.73 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.4 t -137.86 -2.88 1.87 Allowed 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -174.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 78.93 29.28 52.14 Favored Glycine 0 CA--C 1.516 0.126 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.816 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -91.82 108.86 20.22 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.78 90.36 7.72 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.546 ' HG2' ' O ' ' A' ' 100' ' ' GLN . 7.9 Cg_exo -80.17 159.67 23.47 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.986 2.457 . . . . 0.0 113.21 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -43.14 -40.79 9.3 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 124.822 3.682 . . . . 0.0 115.262 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -65.23 -23.2 69.74 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 114.395 0.518 . . . . 0.0 114.395 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 C--N 1.315 -0.905 0 CA-C-O 121.467 0.651 . . . . 0.0 111.062 178.769 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 110.651 -0.129 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.0 m -72.93 177.24 5.04 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.1 mt -52.65 -25.27 10.32 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -171.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -68.71 -30.92 69.67 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.864 0.364 . . . . 0.0 110.695 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -87.62 -20.44 26.35 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.315 0.579 . . . . 0.0 110.752 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.409 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 4.4 m -74.99 133.74 41.62 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.219 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -71.53 154.02 41.76 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.056 0.455 . . . . 0.0 111.042 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -108.7 125.1 51.53 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.561 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.4 130.73 23.4 Favored Pre-proline 0 C--N 1.3 -1.583 0 C-N-CA 123.881 0.873 . . . . 0.0 109.411 174.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.87 139.59 36.7 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.179 1.919 . . . . 0.0 110.163 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.413 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -76.72 -13.48 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.431 -175.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.3 t -69.6 -25.67 64.07 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.433 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -109.63 54.25 0.67 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 122.29 1.043 . . . . 0.0 110.098 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.04 -19.76 20.67 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.822 -1.535 . . . . 0.0 113.302 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -73.57 -19.6 60.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.434 0.635 . . . . 0.0 110.965 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.0 m -93.13 2.43 56.71 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.559 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.0 mm -76.7 126.62 85.7 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.57 130.66 41.33 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.535 2.157 . . . . 0.0 113.21 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.0 p -94.05 30.65 1.82 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.247 1.023 . . . . 0.0 109.731 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.48 -179.78 4.45 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.445 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.4 t -93.71 138.38 31.98 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.17 -155.61 26.81 Favored Glycine 0 N--CA 1.421 -2.33 0 C-N-CA 119.362 -1.399 . . . . 0.0 113.049 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 t -115.78 151.6 17.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -140.56 148.11 40.48 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.12 118.29 25.8 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.887 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.81 115.02 29.2 Favored 'Isoleucine or valine' 0 C--O 1.262 1.712 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.586 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 4.9 m-85 -100.32 137.28 38.96 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.92 -168.36 2.21 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.365 0.602 . . . . 0.0 110.891 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -64.99 -29.57 70.5 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.42 1.088 . . . . 0.0 111.271 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.1 t -81.42 -1.25 45.0 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.806 0.812 . . . . 0.0 109.363 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 t70 73.95 27.74 1.6 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.635 1.574 . . . . 0.0 112.538 172.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 11.8 pt-20 -120.09 166.65 13.11 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 117.588 -1.645 . . . . 0.0 111.207 172.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -80.29 130.14 34.99 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.913 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.11 -47.13 2.59 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.106 171.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -124.1 125.74 45.0 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.789 -173.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.0 m -114.42 140.92 32.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.28 162.09 29.38 Favored Glycine 0 N--CA 1.42 -2.423 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.185 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.8 pt -124.82 151.7 30.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.6 t -159.92 159.23 32.08 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.35 -15.35 53.11 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 176.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -140.87 96.89 3.08 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.0 mt -56.34 -52.69 49.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.841 -177.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.14 -46.22 61.89 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.81 -48.23 81.54 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.733 0.413 . . . . 0.0 111.702 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.9 m -68.53 -44.21 75.06 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.239 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.6 t -57.94 -58.78 4.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.392 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 43.5 p -63.05 -32.06 73.34 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.51 -61.16 2.26 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.52 ' HA ' ' OG ' ' A' ' 118' ' ' SER . 19.7 p80 -77.15 -21.88 53.41 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -174.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.427 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 53.6 mt -76.09 -23.97 55.0 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.779 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -89.46 -31.01 17.89 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.046 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.52 ' OG ' ' HA ' ' A' ' 115' ' ' HIS . 4.2 p -73.99 -27.91 61.21 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.352 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.23 98.07 3.78 Favored Pre-proline 0 CA--C 1.559 1.31 0 CA-C-O 121.899 0.857 . . . . 0.0 110.691 173.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.775 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 94.5 Cg_endo -82.21 22.39 0.87 Allowed 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 123.288 2.659 . . . . 0.0 113.514 -177.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -63.42 -43.34 97.75 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.707 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.1 mt -104.99 18.01 23.13 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.161 0.505 . . . . 0.0 110.954 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.775 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 83.0 m -78.65 99.78 6.74 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.732 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.34 -49.48 0.06 OUTLIER Glycine 0 C--N 1.3 -1.43 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.0 p -165.59 168.14 16.66 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.095 0.958 . . . . 0.0 109.633 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.66 137.08 31.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-O 121.081 0.467 . . . . 0.0 110.48 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.409 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 98.1 mttt -106.43 138.58 42.36 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.19 130.99 73.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.136 0.493 . . . . 0.0 112.179 -176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -118.33 102.11 0.94 Allowed Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mp -94.89 136.47 25.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 121.031 0.443 . . . . 0.0 110.154 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.97 141.67 44.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.99 -46.09 90.76 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -88.39 116.33 65.93 Favored Pre-proline 0 C--N 1.308 -1.199 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.163 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.32 39.41 0.78 Allowed 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 123.488 2.792 . . . . 0.0 112.539 -175.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.41 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 23.9 t70 -73.74 129.2 37.45 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.996 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 24.1 mmtp -61.81 -27.85 69.05 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.54 -45.47 59.14 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.3 t -62.07 -41.46 91.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 O-C-N 124.192 0.932 . . . . 0.0 110.171 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 90.3 mt -63.03 -50.48 70.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.679 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 48.8 m -63.57 -33.63 76.02 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 120.914 0.388 . . . . 0.0 110.793 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.34 -54.88 34.03 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.805 1.242 . . . . 0.0 110.378 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.39 93.53 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.217 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -55.39 -45.68 76.6 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.304 0.642 . . . . 0.0 109.303 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -61.09 -46.27 91.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.79 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.2 mp -60.36 -38.37 83.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.851 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.419 ' O ' ' HG3' ' A' ' 149' ' ' GLU . 41.0 m0 -73.64 -46.87 44.05 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.957 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.7 tt -65.9 -40.98 89.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.444 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.72 -36.44 80.59 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.581 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -60.95 -39.12 88.27 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.331 -179.015 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -79.46 -31.25 42.43 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.132 -175.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.445 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 70.9 mt -70.87 -32.34 48.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.422 0.63 . . . . 0.0 109.87 175.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -84.85 -33.42 22.87 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 149' ' ' GLU . 14.8 p -83.52 -51.43 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.409 HG22 HG12 ' A' ' 153' ' ' VAL . 71.1 p -108.78 -35.54 6.37 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.172 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 151' ' ' ILE . . . 99.71 28.27 7.53 Favored Glycine 0 C--N 1.317 -0.519 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.719 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.82 125.75 47.35 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.51 87.78 10.16 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-O 121.904 0.859 . . . . 0.0 109.881 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -69.98 160.58 49.12 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.16 3.24 . . . . 0.0 113.811 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -45.7 -35.51 13.22 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 124.997 3.798 . . . . 0.0 115.365 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -70.84 -26.18 74.45 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.88 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 C--N 1.318 -0.796 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.31 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.53 ' HB2' ' OE2' ' A' ' 149' ' ' GLU . 28.1 p -121.99 179.29 4.57 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.48 HD13 ' OH ' ' A' ' 93' ' ' TYR . 38.9 mt -73.93 -17.17 61.06 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.6 m -72.28 -20.34 61.53 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.47 0.653 . . . . 0.0 109.648 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -92.18 -3.31 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.016 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.465 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.6 m -98.81 150.5 21.8 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.955 -172.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 9.4 pt-20 -90.25 155.01 19.3 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.176 0.99 . . . . 0.0 109.845 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.0 125.11 48.62 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -123.66 141.01 35.47 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.068 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -71.37 134.55 24.86 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.192 1.928 . . . . 0.0 109.215 170.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -21.53 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.0 t -73.29 -26.7 61.18 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.193 0.521 . . . . 0.0 110.678 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -94.56 56.09 2.04 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.845 0.831 . . . . 0.0 110.12 177.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.44 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -48.84 -21.57 0.66 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.204 1.402 . . . . 0.0 114.015 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -64.56 -27.57 69.05 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.433 0.635 . . . . 0.0 110.763 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.407 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 22.8 m -83.09 1.43 40.29 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.083 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 80' ' ' ALA . 26.8 mm -90.75 113.97 59.74 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 82' ' ' SER . 72.2 Cg_exo -54.7 135.27 66.54 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.737 2.958 . . . . 0.0 112.593 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.7 p -98.6 34.21 2.09 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.969 0.89 . . . . 0.0 110.885 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.73 -176.64 3.19 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.174 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.7 t -95.96 145.62 25.26 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.17 -149.13 15.27 Favored Glycine 0 N--CA 1.416 -2.69 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.266 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.471 HG13 ' CH2' ' A' ' 146' ' ' TRP . 6.7 p -125.98 149.26 30.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -176.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -137.37 149.85 47.28 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.901 0.382 . . . . 0.0 110.747 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.32 117.6 28.2 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.278 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.31 116.75 34.16 Favored 'Isoleucine or valine' 0 C--O 1.26 1.627 0 CA-C-O 121.092 0.472 . . . . 0.0 110.753 -177.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.48 ' OH ' HD13 ' A' ' 69' ' ' LEU . 88.3 m-85 -106.35 134.42 49.51 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.705 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -79.18 -171.0 2.47 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -58.46 -30.79 67.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.808 0.843 . . . . 0.0 111.093 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.4 m -82.72 1.72 37.33 Favored 'General case' 0 C--O 1.25 1.114 0 C-N-CA 123.506 0.722 . . . . 0.0 112.269 -176.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.2 t70 69.41 26.68 5.17 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.499 1.142 . . . . 0.0 109.39 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 4.3 mm-40 -102.13 140.14 36.81 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.925 176.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.498 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 2.8 tm? -89.69 110.84 21.7 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.464 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -105.13 -25.99 12.27 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.051 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -143.82 120.96 11.47 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 118.822 -1.151 . . . . 0.0 113.54 -176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.425 HG11 HD11 ' A' ' 99' ' ' LEU . 6.2 m -108.51 144.01 17.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 169.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -154.84 158.86 28.61 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.4 pt -117.25 144.3 25.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.6 m -150.75 160.39 43.89 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.147 0.498 . . . . 0.0 111.113 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -84.97 -21.85 29.39 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -136.13 105.46 6.03 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.55 -58.01 8.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 123.535 0.522 . . . . 0.0 111.92 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.17 -55.28 10.79 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.07 99.56 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 123.064 0.227 . . . . 0.0 111.316 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.2 t -65.87 -51.23 60.59 Favored 'General case' 0 C--O 1.251 1.148 0 O-C-N 123.774 0.671 . . . . 0.0 110.019 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 56.6 t -56.14 -54.77 23.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.972 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.461 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 22.9 t -60.12 -44.41 94.92 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 123.779 0.674 . . . . 0.0 111.1 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.75 -54.12 38.45 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -80.07 -26.3 39.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.442 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 66.9 mt -77.68 -26.48 50.31 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.845 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 113' ' ' SER . 33.7 mmtp -78.84 -26.05 44.12 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.395 174.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.2 t -74.0 -53.85 9.16 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.346 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.0 p -129.05 99.04 22.43 Favored Pre-proline 0 N--CA 1.431 -1.381 0 CA-C-O 121.996 0.903 . . . . 0.0 110.767 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.82 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 73.9 Cg_endo -79.56 11.53 2.67 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 123.525 2.817 . . . . 0.0 113.653 -177.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -58.03 -42.93 86.37 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 123.984 0.913 . . . . 0.0 109.865 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.0 mt -104.16 20.29 18.58 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.898 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.82 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 96.8 m -85.99 92.75 8.78 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.188 0.518 . . . . 0.0 111.944 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.42 -60.4 0.09 OUTLIER Glycine 0 C--N 1.299 -1.5 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 173.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 9.8 p -156.06 161.62 40.39 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.5 p -138.53 139.6 41.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-O 121.007 0.432 . . . . 0.0 110.159 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.465 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 82.9 mttt -106.54 128.36 54.05 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 174.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.86 136.16 56.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.095 0.474 . . . . 0.0 111.137 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.52 110.02 1.26 Allowed Glycine 0 N--CA 1.425 -2.064 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.429 HD11 ' N ' ' A' ' 130' ' ' ILE . 2.7 mp -94.24 104.91 16.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.17 134.56 28.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.269 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -65.12 -30.02 70.92 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.23 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -109.24 100.67 42.05 Favored Pre-proline 0 N--CA 1.439 -1.016 0 CA-C-O 121.362 0.601 . . . . 0.0 109.768 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.72 37.92 0.71 Allowed 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.916 2.411 . . . . 0.0 112.282 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.438 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 22.3 t70 -69.15 143.77 54.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.188 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -52.44 -44.44 65.49 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.493 0.717 . . . . 0.0 112.337 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.11 -38.76 69.24 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.409 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.06 -42.04 90.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 96.7 mt -58.33 -47.73 82.81 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.5 m -66.04 -38.88 89.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.633 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -62.63 -45.39 93.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.85 0.357 . . . . 0.0 110.091 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.6 -50.06 75.03 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.914 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -53.55 -47.81 69.67 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.143 0.977 . . . . 0.0 110.492 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 14.6 tmtt? -63.37 -45.78 89.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.633 -176.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 11.0 mp -67.41 -38.86 85.27 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.691 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.471 ' CH2' HG13 ' A' ' 89' ' ' VAL . 27.2 m0 -63.16 -45.01 93.87 Favored 'General case' 0 C--O 1.257 1.482 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.47 ' O ' HG13 ' A' ' 151' ' ' ILE . 12.7 tt -65.41 -39.14 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.397 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 38.0 mt-10 -57.71 -42.5 83.88 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-O 118.9 -0.572 . . . . 0.0 111.967 176.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.53 ' OE2' ' HB2' ' A' ' 68' ' ' SER . 6.8 mm-40 -46.39 -51.84 14.14 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.782 0.676 . . . . 0.0 110.059 178.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.498 ' CG ' ' HB3' ' A' ' 99' ' ' LEU 0.34 13.7 m-70 -78.88 -27.85 44.04 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 179.177 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 147' ' ' ILE . 76.5 mt -61.18 -47.5 93.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.536 0.684 . . . . 0.0 109.319 172.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -68.1 -50.4 55.19 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.309 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 149' ' ' GLU . 16.9 m -80.75 -26.77 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -174.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.3 t -138.13 -26.25 0.93 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.39 23.5 16.47 Favored Glycine 0 C--N 1.316 -0.54 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.69 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -78.88 112.96 16.57 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.06 74.26 21.63 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 170.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -90.88 168.84 3.69 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 123.219 2.612 . . . . 0.0 114.09 -171.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -56.74 -17.73 24.18 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 124.0 3.134 . . . . 0.0 113.727 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -67.8 -38.48 89.5 Favored Glycine 0 C--O 1.219 -0.794 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 . . . . . 0 C--O 1.243 0.729 0 CA-C-O 121.574 0.702 . . . . 0.0 109.734 -179.47 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.42 ' HB2' ' OE2' ' A' ' 71' ' ' GLU . 57.8 mtpt . . . . . 0 N--CA 1.442 -0.827 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.1 p -110.49 172.09 7.07 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.824 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.94 -27.77 68.47 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.455 0.702 . . . . 0.0 110.983 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 m -62.67 -31.1 71.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.573 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.42 ' OE2' ' HB2' ' A' ' 67' ' ' LYS . 29.5 mt-10 -95.03 2.62 55.32 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.124 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.492 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.1 m -91.29 145.42 24.67 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.491 -176.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 17.0 pt-20 -89.31 151.05 22.31 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -113.88 130.61 56.47 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.814 0.34 . . . . 0.0 110.84 -172.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -128.35 127.77 23.68 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -63.49 138.11 63.48 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.181 1.921 . . . . 0.0 109.616 173.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -14.46 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -172.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.7 t -65.58 -30.97 71.78 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.265 0.555 . . . . 0.0 110.081 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.62 53.07 0.82 Allowed 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 122.41 1.1 . . . . 0.0 109.377 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -56.64 -24.24 46.94 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.702 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.73 -31.1 71.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.378 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.5 m -92.39 3.46 55.4 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.452 HG12 ' HA ' ' A' ' 80' ' ' ALA . 44.6 mm -69.2 125.02 91.65 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -52.9 129.76 34.49 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.006 2.47 . . . . 0.0 113.71 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 p -95.5 32.79 1.72 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.089 0.947 . . . . 0.0 111.048 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.05 -176.96 3.23 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.924 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.4 m -93.42 149.67 21.05 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 123.504 0.502 . . . . 0.0 110.105 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.62 -153.78 24.99 Favored Glycine 0 N--CA 1.417 -2.571 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.435 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.586 ' HB ' ' CH2' ' A' ' 146' ' ' TRP . 2.6 t -114.36 151.3 16.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -175.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -140.31 151.88 45.41 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.02 174.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 127' ' ' LYS . . . -130.24 120.76 24.95 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 123.554 0.742 . . . . 0.0 109.697 -178.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.51 125.93 45.06 Favored 'Isoleucine or valine' 0 C--O 1.263 1.801 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.314 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -112.64 132.58 55.1 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 124.156 0.983 . . . . 0.0 109.234 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -77.61 -173.26 2.9 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 123.825 0.703 . . . . 0.0 110.542 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -55.42 -31.08 61.57 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.1 t -95.46 11.55 32.54 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 122.021 -0.425 . . . . 0.0 110.885 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.45 33.16 13.89 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 176.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -102.99 125.37 49.72 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 118.571 -1.252 . . . . 0.0 111.914 172.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.424 ' CD2' ' HB2' ' A' ' 91' ' ' ALA . 2.5 tm? -60.71 112.68 2.11 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.637 174.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 158' ' ' PRO . 48.5 mt-30 -124.52 -14.66 6.81 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.24 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -144.16 125.33 14.56 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.371 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.1 m -117.11 151.76 18.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 173.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -160.3 160.04 31.36 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.4 pt -124.91 147.28 29.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.6 t -157.46 164.56 37.31 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.434 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 0.6 OUTLIER -80.55 -28.03 37.4 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.339 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -131.09 99.4 4.87 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 77.7 mt -57.83 -52.01 63.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.261 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.63 -52.46 39.36 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.82 -47.18 87.52 Favored 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 123.456 0.473 . . . . 0.0 111.147 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.0 t -62.8 -50.78 69.63 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.435 -177.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.0 t -59.22 -52.97 54.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.028 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.4 m -63.13 -35.35 79.99 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 123.337 0.398 . . . . 0.0 111.812 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.09 -61.14 1.99 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.37 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.276 21.5 p80 -73.5 -25.92 60.66 Favored 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -174.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.4 mt -77.62 -24.06 49.67 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.681 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -87.48 -9.13 55.41 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.204 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.6 m -92.07 -51.61 5.1 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.59 95.73 42.33 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-O 121.681 0.753 . . . . 0.0 111.052 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.82 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 3.1 Cg_exo -79.27 32.56 0.47 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.58 2.853 . . . . 0.0 112.877 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -70.33 -43.17 70.81 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.779 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.1 mt -114.12 21.87 14.37 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.706 -174.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.82 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 94.7 m -76.06 93.06 3.24 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -127.25 -61.84 0.14 Allowed Glycine 0 C--N 1.307 -1.073 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.0 m -158.78 166.93 30.78 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.2 p -133.83 142.32 41.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.268 0.556 . . . . 0.0 110.088 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.492 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 30.6 mmtm -105.67 129.22 53.94 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.21 136.36 60.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.272 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.44 100.06 0.79 Allowed Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.416 HD11 ' N ' ' A' ' 130' ' ' ILE . 2.5 mp -88.06 101.66 11.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -101.09 134.53 40.93 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.797 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.015 -174.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -66.48 -34.61 78.31 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -83.89 117.33 68.4 Favored Pre-proline 0 C--N 1.301 -1.513 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.871 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -91.49 21.03 0.82 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.879 2.386 . . . . 0.0 111.787 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.97 131.39 45.39 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.944 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -59.19 -33.39 70.9 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.849 -174.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.81 -45.27 68.25 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.29 -44.23 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.16 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 99.0 mt -59.77 -45.78 91.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.944 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.3 m -69.36 -38.43 78.08 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.479 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.555 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 29.0 tt0 -62.29 -51.23 68.52 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.329 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.3 -40.84 95.64 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.41 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.446 ' O ' HG22 ' A' ' 147' ' ' ILE . 79.3 t90 -51.41 -46.64 62.98 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.49 0.716 . . . . 0.0 109.603 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.44 -50.92 57.22 Favored 'General case' 0 C--O 1.211 -0.951 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.486 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 85.5 mt -51.57 -41.63 61.29 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.242 0.617 . . . . 0.0 111.673 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.586 ' CH2' ' HB ' ' A' ' 89' ' ' VAL . 31.6 m0 -69.68 -57.79 4.71 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.444 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.601 ' O ' HG12 ' A' ' 151' ' ' ILE . 15.1 tt -67.25 -42.16 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 C-N-CA 119.644 -0.823 . . . . 0.0 111.844 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.447 ' HA ' ' CG1' ' A' ' 151' ' ' ILE . 26.7 mt-10 -67.64 -28.62 67.88 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -174.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.495 ' O ' HG22 ' A' ' 153' ' ' VAL . 12.3 pt-20 -67.31 -37.45 83.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 118.887 -1.125 . . . . 0.0 109.063 175.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -75.41 -30.05 59.95 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 120.579 -0.449 . . . . 0.0 109.792 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 147' ' ' ILE . 41.8 mm -58.82 -44.49 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 121.272 0.558 . . . . 0.0 109.712 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -81.18 -36.25 30.38 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -174.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 149' ' ' GLU . 31.3 m -97.14 -24.84 4.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -176.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.95 -1.67 7.17 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 56.44 33.87 62.74 Favored Glycine 0 N--CA 1.47 0.926 0 N-CA-C 117.473 1.749 . . . . 0.0 117.473 170.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -100.16 108.3 20.38 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 118.225 1.012 . . . . 0.0 111.459 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 t -126.57 78.0 72.87 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 174.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.405 ' HG2' ' O ' ' A' ' 100' ' ' GLN . 7.4 Cg_exo -77.77 155.2 30.82 Favored 'Trans proline' 0 C--O 1.257 1.444 0 C-N-CA 122.93 2.42 . . . . 0.0 113.225 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.9 -22.49 54.6 Favored 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 123.425 2.75 . . . . 0.0 111.893 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -56.66 -37.68 77.81 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.581 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 . . . . . 0 C--N 1.3 -1.584 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.206 -178.49 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.1 mttp . . . . . 0 N--CA 1.441 -0.914 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.2 m -124.84 165.75 17.48 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.188 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.0 mt -57.79 -26.82 62.46 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.142 1.377 . . . . 0.0 113.85 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.3 m -65.68 -21.81 66.58 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.947 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -98.93 -10.44 22.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.334 0.588 . . . . 0.0 110.401 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 3.2 m -83.28 136.88 34.22 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.325 -171.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.74 154.06 28.81 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 120.614 0.245 . . . . 0.0 110.882 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -108.4 128.72 55.02 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.244 0.618 . . . . 0.0 110.634 -172.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -121.96 131.01 24.5 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -66.08 139.0 54.2 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.119 1.879 . . . . 0.0 109.489 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.437 HG13 ' SG ' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -72.14 -12.9 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-O 121.384 0.611 . . . . 0.0 111.926 -174.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.5 p -75.45 -26.35 58.21 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.885 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.09 53.57 0.8 Allowed 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 122.167 0.984 . . . . 0.0 109.97 177.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -59.21 -22.84 61.66 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 113.792 -1.549 . . . . 0.0 112.329 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.11 -24.1 64.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.583 0.706 . . . . 0.0 109.497 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.9 t -93.91 4.97 53.14 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.391 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.452 HG12 ' HA ' ' A' ' 80' ' ' ALA . 43.5 mm -81.15 124.93 80.59 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -51.58 133.95 45.19 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.287 2.658 . . . . 0.0 112.926 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.2 p -96.47 29.07 3.04 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.9 0.857 . . . . 0.0 110.578 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.05 -176.58 3.47 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.545 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.6 t -101.54 142.15 33.34 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.3 -147.85 12.73 Favored Glycine 0 N--CA 1.413 -2.854 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.471 HG13 ' CH2' ' A' ' 146' ' ' TRP . 7.6 p -126.01 148.81 30.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -136.57 149.04 47.87 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 120.9 0.381 . . . . 0.0 110.537 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.26 121.82 41.39 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.603 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.7 t -96.81 114.23 33.18 Favored 'Isoleucine or valine' 0 C--O 1.265 1.894 0 CA-C-O 121.171 0.51 . . . . 0.0 110.363 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 70.6 m-85 -102.52 133.86 46.81 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.379 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -81.21 -172.34 3.72 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.516 ' HZ3' ' HB3' ' A' ' 95' ' ' LYS . 8.2 mtpm? -67.07 -16.3 64.25 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.8 m -88.8 1.6 54.98 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 122.277 0.231 . . . . 0.0 110.469 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 67.83 27.01 7.5 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.147 0.979 . . . . 0.0 110.715 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 4.6 mm-40 -103.85 151.72 22.76 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.402 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.495 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 3.0 tm? -102.47 110.99 23.1 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.426 -174.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -107.4 -32.96 7.52 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.903 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -131.6 134.99 46.61 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.262 -0.975 . . . . 0.0 112.049 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.5 m -130.47 142.8 42.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -153.8 153.96 25.19 Favored Glycine 0 N--CA 1.425 -2.063 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.086 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.8 pt -111.87 141.13 28.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.3 m -149.86 163.77 37.16 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 120.901 0.382 . . . . 0.0 111.55 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -82.92 -30.61 28.29 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -131.56 104.31 6.89 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.25 -53.57 46.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 O-C-N 123.162 0.289 . . . . 0.0 111.72 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.01 -58.53 4.32 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.84 89.33 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.286 0.366 . . . . 0.0 111.349 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.9 m -63.46 -49.61 72.99 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.249 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.4 t -58.15 -54.68 29.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.0 m -58.56 -43.75 89.46 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.049 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.66 -59.93 4.16 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -77.1 -30.8 55.48 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.7 mt -76.59 -27.74 55.91 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 119.542 -0.863 . . . . 0.0 113.054 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -81.35 -19.03 43.65 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.891 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.9 m -81.68 -57.76 3.31 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.381 175.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.0 p -116.13 96.26 46.86 Favored Pre-proline 0 N--CA 1.441 -0.914 0 CA-C-O 122.421 1.105 . . . . 0.0 109.987 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 123' ' ' CYS . 82.1 Cg_endo -83.68 22.76 0.89 Allowed 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.154 2.569 . . . . 0.0 113.749 -175.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -64.52 -32.2 73.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.006 0.908 . . . . 0.0 109.719 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.4 mt -113.5 21.48 15.08 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.171 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.437 ' SG ' HG13 ' A' ' 77' ' ' ILE . 34.9 t -75.52 78.99 2.54 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.383 -178.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -130.89 -56.83 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.4 p -165.38 164.09 19.74 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 122.664 0.385 . . . . 0.0 110.508 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.51 137.04 36.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 120.963 0.411 . . . . 0.0 109.956 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.457 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 77.3 mttt -106.53 130.61 54.27 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 173.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.1 m -113.92 133.72 59.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 120.892 0.377 . . . . 0.0 111.16 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -123.22 106.19 0.98 Allowed Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 130' ' ' ILE . 2.8 mp -93.26 111.78 25.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.6 164.07 2.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.99 -41.68 74.08 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.485 ' C ' ' H ' ' A' ' 135' ' ' ASP . 47.4 mt-10 -100.48 116.97 63.75 Favored Pre-proline 0 C--N 1.303 -1.416 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.957 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -81.02 27.09 0.58 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.783 2.322 . . . . 0.0 109.763 173.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 133' ' ' GLU . 29.1 t70 -85.96 145.87 26.94 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.426 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -53.7 -42.75 68.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.08 -37.75 88.59 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 120.977 0.418 . . . . 0.0 111.629 -177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.0 t -79.52 -40.82 21.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.105 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.07 -46.53 90.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.242 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.0 m -67.68 -33.82 75.69 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.337 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -65.61 -48.37 72.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.184 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.23 -43.92 96.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.942 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 91.6 t90 -55.04 -43.32 73.67 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.351 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 25.1 mmtt -60.86 -58.51 8.12 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.57 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 10.9 mp -55.79 -38.13 69.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 118.306 0.503 . . . . 0.0 112.297 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.471 ' CH2' HG13 ' A' ' 89' ' ' VAL . 27.0 m0 -65.12 -53.08 50.83 Favored 'General case' 0 C--O 1.265 1.88 0 O-C-N 123.518 0.511 . . . . 0.0 111.698 177.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.419 ' O ' HG12 ' A' ' 151' ' ' ILE . 8.5 tt -62.42 -46.69 95.81 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.649 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 144' ' ' LYS . 53.6 mm-40 -60.04 -30.95 69.53 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 123.457 0.703 . . . . 0.0 112.596 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 30.8 mm-40 -56.31 -56.85 15.93 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.469 0.652 . . . . 0.0 109.673 174.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.495 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 27.0 m-70 -73.17 -31.89 64.51 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.582 -0.847 . . . . 0.0 113.138 -177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 147' ' ' ILE . 35.3 mm -57.06 -42.81 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 120.423 0.154 . . . . 0.0 111.024 175.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -72.86 -58.36 3.39 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.28 -22.93 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.2 t -129.49 -24.89 2.72 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.109 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 76.55 34.66 43.8 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.783 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -89.85 115.1 26.92 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.459 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.43 86.87 2.38 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-O 122.213 1.006 . . . . 0.0 110.029 175.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -90.68 169.12 3.83 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 123.02 2.48 . . . . 0.0 112.266 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -51.23 -18.23 4.81 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 124.594 3.53 . . . . 0.0 114.993 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.15 -41.57 86.3 Favored Glycine 0 C--N 1.31 -0.887 0 CA-C-N 116.498 -0.319 . . . . 0.0 112.407 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 61.4 t30 . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 122.767 1.27 . . . . 0.0 109.065 -175.771 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.462 ' HB3' ' HZ3' ' A' ' 67' ' ' LYS . 7.4 mtpm? . . . . . 0 N--CA 1.436 -1.174 0 CA-C-O 120.95 0.405 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.8 p -114.43 -174.15 2.43 Favored 'General case' 0 N--CA 1.414 -2.233 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.207 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.72 -26.21 68.57 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.82 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.6 m -61.81 -30.0 70.53 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.18 0.992 . . . . 0.0 111.109 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -87.06 -1.06 57.6 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.155 0.582 . . . . 0.0 110.165 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.3 m -114.33 145.45 41.77 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -170.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.94 156.97 17.58 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.03 0.532 . . . . 0.0 110.862 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -115.51 134.34 55.16 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.769 0.828 . . . . 0.0 110.766 -172.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -130.47 129.44 22.79 Favored Pre-proline 0 C--O 1.214 -0.77 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -62.79 147.68 94.37 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.074 1.85 . . . . 0.0 110.376 172.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -5.41 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -172.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.0 p -69.44 -26.21 64.49 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 121.16 0.505 . . . . 0.0 111.271 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.26 52.77 0.71 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.692 0.758 . . . . 0.0 110.538 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.51 -27.13 67.36 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.027 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.16 -24.33 64.97 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.355 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.5 m -93.01 2.09 56.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.963 0.411 . . . . 0.0 110.966 -177.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.5 mm -79.25 130.53 68.77 Favored Pre-proline 0 C--O 1.243 0.746 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.554 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -52.3 140.39 52.44 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 124.2 3.267 . . . . 0.0 113.61 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.4 p -98.68 29.53 3.68 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.501 0.667 . . . . 0.0 111.387 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.57 -177.08 3.68 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.157 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.8 t -99.97 152.01 20.68 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 154.28 -143.36 9.97 Favored Glycine 0 N--CA 1.412 -2.933 0 C-N-CA 119.847 -1.168 . . . . 0.0 112.47 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.31 149.36 21.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 C-N-CA 123.485 0.714 . . . . 0.0 110.029 -174.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -143.34 146.06 33.22 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.672 0.273 . . . . 0.0 110.28 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -118.45 127.27 53.5 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.054 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -105.4 118.86 53.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.28 0.562 . . . . 0.0 110.938 -176.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 43.9 m-85 -108.52 141.05 40.98 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -80.32 -169.79 2.25 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.431 ' HD2' ' HA2' ' A' ' 124' ' ' GLY . 4.9 mmmp? -67.38 -15.2 63.55 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.9 m -89.19 -3.1 58.7 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 65.51 35.29 7.33 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.686 1.194 . . . . 0.0 112.221 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -100.72 145.16 28.82 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.361 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -90.46 109.2 20.33 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.35 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -105.85 -41.99 5.27 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.915 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -125.29 139.38 53.76 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.425 0.631 . . . . 0.0 112.477 -171.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.551 HG22 HD22 ' A' ' 161' ' ' ASN . 27.2 m -132.54 146.31 33.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 172.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.67 165.67 30.61 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 119.756 -1.212 . . . . 0.0 111.815 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.4 pt -116.99 155.0 18.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.0 t -158.64 160.16 36.19 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.183 0.515 . . . . 0.0 110.082 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -85.51 -22.31 28.23 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.55 91.97 2.37 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 70.2 mt -50.87 -60.03 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 123.857 0.863 . . . . 0.0 112.468 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.74 -46.25 29.73 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.18 -55.05 39.93 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.503 0.502 . . . . 0.0 111.075 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.2 m -61.42 -46.07 91.65 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.761 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 75.7 t -56.63 -54.94 22.76 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 C-N-CA 123.023 0.529 . . . . 0.0 111.263 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.1 t -61.29 -46.7 89.24 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 123.259 0.349 . . . . 0.0 110.606 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.27 -60.24 3.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -75.12 -21.94 58.54 Favored 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 118.619 -1.232 . . . . 0.0 113.752 -172.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.0 mt -79.68 -24.19 41.93 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.483 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -88.12 -25.29 23.08 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.39 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.9 t -76.74 -42.03 42.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.823 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.54 91.27 14.15 Favored Pre-proline 0 N--CA 1.437 -1.108 0 CA-C-O 121.895 0.855 . . . . 0.0 110.473 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.746 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 2.7 Cg_exo -75.72 18.31 0.62 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.263 2.642 . . . . 0.0 113.62 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -59.91 -42.96 95.04 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.25 1.02 . . . . 0.0 110.6 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.2 mt -107.18 20.54 18.84 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.435 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.746 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 66.3 m -72.56 120.87 18.77 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.539 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.431 ' HA2' ' HD2' ' A' ' 95' ' ' LYS . . . -163.79 -70.39 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 174.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 21.8 m -146.48 159.37 43.49 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 9.6 p -139.87 139.01 38.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.034 0.445 . . . . 0.0 110.45 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -106.51 142.2 36.55 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.47 126.0 71.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.633 0.73 . . . . 0.0 112.325 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -113.69 102.67 1.26 Allowed Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 130' ' ' ILE . 2.6 mp -84.63 121.94 37.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.5 p -125.33 131.05 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.67 -0.62 57.14 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.518 0.675 . . . . 0.0 111.422 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -94.8 109.66 45.1 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -88.8 32.37 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.353 2.035 . . . . 0.0 112.557 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.417 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 11.4 t70 -83.51 139.68 32.76 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -176.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 mmmm -59.44 -34.45 72.53 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.69 -43.44 69.03 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 123.113 0.258 . . . . 0.0 110.825 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.4 m -69.42 -34.52 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 120.768 0.318 . . . . 0.0 110.911 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.2 mt -66.52 -52.34 46.83 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.007 0.432 . . . . 0.0 110.082 177.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.6 m -65.58 -30.41 71.14 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.064 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.497 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 58.6 tt0 -62.57 -54.21 43.14 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.817 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.21 -37.62 86.0 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 123.992 0.808 . . . . 0.0 110.105 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -54.34 -47.95 71.96 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 123.617 0.573 . . . . 0.0 110.109 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 98.0 mttt -64.63 -49.74 69.88 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.21 177.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.569 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 93.7 mt -50.83 -47.39 60.17 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.416 0.448 . . . . 0.0 111.439 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -63.08 -53.9 46.48 Favored 'General case' 0 C--O 1.265 1.871 0 C-N-CA 123.287 0.635 . . . . 0.0 112.604 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 151' ' ' ILE . 10.4 tt -64.33 -41.13 91.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.741 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 67.4 mt-10 -65.55 -30.05 70.75 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 119.265 -0.398 . . . . 0.0 111.92 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 21.0 mm-40 -54.89 -48.17 73.35 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . 0.272 13.4 m-70 -76.28 -29.54 57.46 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 147' ' ' ILE . 77.3 mt -61.31 -43.94 97.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 173.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -66.78 -49.65 65.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.7 m -79.28 -33.12 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.8 t -133.16 -28.06 1.55 Allowed 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.686 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.1 33.18 5.56 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.524 -0.845 . . . . 0.0 112.259 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -83.59 111.64 19.29 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.448 0.642 . . . . 0.0 112.583 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 p -155.84 70.96 5.3 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.746 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -90.11 165.3 4.71 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.33 2.687 . . . . 0.0 113.105 -174.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -51.68 -23.87 16.39 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 124.092 3.195 . . . . 0.0 114.275 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -67.49 -20.75 72.03 Favored Glycine 0 C--O 1.205 -1.658 0 C-N-CA 121.821 -0.228 . . . . 0.0 112.9 177.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.551 HD22 HG22 ' A' ' 102' ' ' VAL . 16.5 t-20 . . . . . 0 C--N 1.311 -1.099 0 CA-C-O 121.656 0.741 . . . . 0.0 109.93 -175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? . . . . . 0 N--CA 1.444 -0.745 0 CA-C-O 121.05 0.452 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.9 p -130.84 161.73 31.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.674 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.427 ' H ' ' HG3' ' A' ' 149' ' ' GLU . 72.2 mt -59.77 -28.16 67.17 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.408 0.683 . . . . 0.0 111.03 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.0 m -61.29 -20.61 63.09 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.896 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -111.28 8.03 21.31 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.92 -0.487 . . . . 0.0 110.497 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.514 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.0 m -96.19 135.88 37.41 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.257 -172.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.9 150.05 47.17 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.901 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -118.3 121.22 39.88 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -173.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.13 126.16 27.22 Favored Pre-proline 0 C--N 1.296 -1.724 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -63.76 139.65 70.01 Favored 'Trans proline' 0 C--N 1.326 -0.621 0 C-N-CA 121.903 1.735 . . . . 0.0 108.507 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.23 -12.31 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-O 121.422 0.63 . . . . 0.0 111.189 -174.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 p -67.6 -31.71 71.93 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.355 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -97.85 55.48 1.19 Allowed 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.43 0.633 . . . . 0.0 111.045 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.406 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -53.3 -23.39 9.04 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.441 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -69.35 -24.97 63.97 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.114 0.483 . . . . 0.0 110.971 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.8 m -89.64 6.88 39.32 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.465 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.406 HG12 ' HA ' ' A' ' 80' ' ' ALA . 38.1 mm -85.6 115.76 62.85 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -56.27 132.43 51.85 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 123.235 2.624 . . . . 0.0 113.492 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.9 p -89.58 36.38 0.84 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.758 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.32 -176.66 3.15 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.608 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.3 t -104.42 150.11 24.82 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.49 -146.21 13.81 Favored Glycine 0 N--CA 1.414 -2.782 0 C-N-CA 120.26 -0.972 . . . . 0.0 111.264 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.6 p -121.04 147.29 24.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -137.54 151.92 48.91 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 120.916 0.389 . . . . 0.0 110.522 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.32 124.43 42.95 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 124.001 0.92 . . . . 0.0 108.818 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.9 t -101.47 124.94 55.54 Favored 'Isoleucine or valine' 0 C--O 1.262 1.759 0 CA-C-O 121.166 0.508 . . . . 0.0 110.85 -176.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.45 ' HD2' ' O ' ' A' ' 97' ' ' ASP . 12.5 m-85 -111.28 133.11 53.85 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -78.92 -167.19 1.06 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.94 0.4 . . . . 0.0 110.972 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -57.86 -27.44 63.24 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.823 0.849 . . . . 0.0 111.077 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.7 m -86.03 -1.68 57.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.874 0.369 . . . . 0.0 110.397 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.45 ' O ' ' HD2' ' A' ' 93' ' ' TYR . 25.7 t70 64.36 34.65 10.35 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 124.849 1.26 . . . . 0.0 109.156 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -100.4 124.83 46.41 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.621 175.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.502 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 3.1 tm? -66.91 118.06 9.87 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -127.28 -14.67 5.34 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.526 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -147.26 133.88 19.89 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.334 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.448 HG21 ' NE1' ' A' ' 143' ' ' TRP . 16.3 m -124.06 138.02 55.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.162 174.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -155.98 157.49 27.86 Favored Glycine 0 C--N 1.305 -1.191 0 C-N-CA 119.788 -1.196 . . . . 0.0 112.846 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.9 144.01 21.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 123.126 0.57 . . . . 0.0 109.899 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 m -150.41 161.06 43.24 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-O 120.546 0.213 . . . . 0.0 110.642 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -85.67 -24.3 27.1 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -135.11 101.95 5.04 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 74.3 mt -60.1 -50.35 80.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.056 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.2 -57.35 9.91 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.67 96.73 Favored 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 123.38 0.425 . . . . 0.0 111.044 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.3 t -58.74 -61.18 2.81 Favored 'General case' 0 C--O 1.252 1.22 0 O-C-N 123.872 0.732 . . . . 0.0 109.961 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.4 t -54.66 -53.54 30.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 123.455 0.702 . . . . 0.0 111.581 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.0 t -59.48 -45.43 91.7 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.814 0.696 . . . . 0.0 111.385 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.26 -48.12 79.51 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -75.04 -27.88 60.2 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 119.069 -1.052 . . . . 0.0 113.536 -176.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 88.7 mt -73.62 -26.28 60.71 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.983 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -86.27 -17.7 33.97 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.466 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.0 m -83.63 -40.26 19.22 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.93 97.0 5.88 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-O 121.702 0.763 . . . . 0.0 110.581 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.631 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 9.8 Cg_exo -73.76 13.72 0.74 Allowed 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 123.757 2.971 . . . . 0.0 114.291 -177.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -55.56 -39.49 70.7 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.435 0.694 . . . . 0.0 111.063 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.2 mt -109.46 20.81 17.79 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.004 -177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.631 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 63.6 m -70.82 120.29 16.2 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.222 174.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -170.44 -68.9 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.0 p -152.06 152.49 32.46 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 114.882 -0.659 . . . . 0.0 109.695 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.12 137.23 48.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.112 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.514 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 95.0 mttt -106.89 131.36 54.07 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.86 137.28 55.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 120.932 0.396 . . . . 0.0 111.326 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.04 107.68 1.35 Allowed Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 130' ' ' ILE . 2.1 mp -91.79 109.85 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-O 121.717 0.77 . . . . 0.0 110.985 -176.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.8 p -111.28 125.78 68.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -87.25 -13.06 44.83 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.384 -172.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -92.36 113.83 60.47 Favored Pre-proline 0 N--CA 1.427 -1.595 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -77.84 45.41 1.78 Allowed 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 123.379 2.719 . . . . 0.0 112.923 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.482 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 10.0 t70 -82.18 121.29 26.43 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -67.15 -27.49 67.34 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.13 -39.44 25.59 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.45 -41.62 90.71 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 O-C-N 123.299 0.375 . . . . 0.0 110.265 176.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.0 mt -57.59 -48.12 80.25 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.907 0.384 . . . . 0.0 110.491 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.2 m -69.05 -35.99 77.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.77 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -65.63 -44.78 85.41 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 122.891 0.477 . . . . 0.0 109.977 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.83 -45.04 94.46 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.448 ' NE1' HG21 ' A' ' 102' ' ' VAL . 90.4 t90 -54.07 -44.25 70.97 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.583 176.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -63.96 -52.9 57.55 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.513 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.57 -38.52 78.04 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 23.5 m0 -64.27 -46.58 83.08 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.609 ' O ' HG12 ' A' ' 151' ' ' ILE . 10.5 tt -63.16 -45.09 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.244 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 17.8 mm-40 -57.26 -39.07 74.86 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.61 0.764 . . . . 0.0 111.674 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 69' ' ' LEU . 4.4 mm-40 -52.09 -49.33 63.78 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.431 0.692 . . . . 0.0 111.6 174.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.502 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 12.7 t60 -80.16 -23.4 41.1 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.892 -177.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 147' ' ' ILE . 43.2 mm -63.39 -50.68 77.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.028 174.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 148' ' ' GLU . 68.3 mttm -56.45 -45.05 81.04 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.966 0.412 . . . . 0.0 111.338 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 33.9 m -80.9 -33.47 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 41.4 p -130.88 -36.11 1.38 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 119.336 -0.945 . . . . 0.0 113.097 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.96 30.7 41.87 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.512 -175.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -82.01 116.58 21.69 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 122.535 -0.391 . . . . 0.0 110.327 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.9 t -131.14 80.34 68.95 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 173.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -75.72 162.37 35.37 Favored 'Trans proline' 0 C--O 1.241 0.662 0 C-N-CA 122.925 2.417 . . . . 0.0 112.517 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.0 -17.5 19.56 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 124.457 3.438 . . . . 0.0 113.432 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -77.57 -38.88 27.07 Favored Glycine 0 C--N 1.304 -1.195 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.858 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.239 0.517 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? . . . . . 0 N--CA 1.436 -1.141 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.9 p -116.69 156.48 27.04 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.739 -175.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.411 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 18.7 mt -64.21 -13.38 48.58 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.2 m -68.7 -22.55 64.35 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.566 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -101.84 6.85 41.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.775 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 69' ' ' LEU . 6.9 m -104.02 137.61 41.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -172.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -83.27 161.01 21.61 Favored 'General case' 0 C--O 1.246 0.903 0 O-C-N 123.282 0.364 . . . . 0.0 110.315 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -117.41 130.32 56.41 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.028 0.531 . . . . 0.0 110.572 -174.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.02 120.7 22.62 Favored Pre-proline 0 C--N 1.311 -1.087 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -61.41 140.3 87.07 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.001 1.801 . . . . 0.0 109.593 172.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.67 -12.02 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -170.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.4 t -67.01 -35.87 80.89 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 120.78 0.324 . . . . 0.0 110.832 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -90.34 53.91 2.61 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.38 1.086 . . . . 0.0 110.457 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.422 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -60.56 -20.05 59.28 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.58 -177.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -78.09 -22.88 48.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.479 0.657 . . . . 0.0 109.623 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 m -91.49 0.2 57.54 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.836 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 80' ' ' ALA . 39.2 mm -78.86 121.46 83.46 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -51.64 130.31 33.15 Favored 'Trans proline' 0 C--O 1.252 1.225 0 C-N-CA 123.596 2.864 . . . . 0.0 114.234 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.8 p -91.43 77.02 5.83 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-O 122.285 1.04 . . . . 0.0 109.248 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 108' ' ' ILE . . . -148.89 176.23 10.59 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.535 -177.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 t -92.19 147.27 23.06 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 160.46 -154.03 25.0 Favored Glycine 0 N--CA 1.415 -2.734 0 C-N-CA 120.117 -1.04 . . . . 0.0 110.967 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.439 HG13 ' CH2' ' A' ' 146' ' ' TRP . 7.6 p -123.62 146.83 28.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -136.09 150.18 49.02 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 120.693 0.282 . . . . 0.0 110.351 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.34 124.37 44.39 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.826 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -97.85 118.99 45.28 Favored 'Isoleucine or valine' 0 C--O 1.264 1.829 0 C-N-CA 123.071 0.548 . . . . 0.0 110.969 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 96.4 m-85 -113.13 145.73 40.44 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.522 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -89.85 -167.95 2.0 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.412 ' HD2' ' HA2' ' A' ' 124' ' ' GLY . 3.0 mmmp? -69.47 -18.14 63.68 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.773 -0.58 . . . . 0.0 111.572 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 m -85.09 -1.49 56.92 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 60.59 34.1 20.27 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 125.554 1.542 . . . . 0.0 113.55 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 40.5 mt-10 -105.19 154.57 20.03 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.433 174.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.44 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.4 tm? -93.19 113.51 25.75 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.725 -172.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -107.49 -29.32 9.28 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.216 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -143.63 138.73 29.2 Favored 'General case' 0 C--O 1.214 -0.771 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.227 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.573 HG21 HD22 ' A' ' 161' ' ' ASN . 30.9 m -129.64 148.79 33.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 172.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.66 162.88 31.87 Favored Glycine 0 N--CA 1.422 -2.262 0 C-N-CA 119.989 -1.1 . . . . 0.0 112.382 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.7 pt -118.06 150.37 20.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 123.469 0.707 . . . . 0.0 109.407 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.4 t -157.0 170.36 22.72 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-O 121.288 0.566 . . . . 0.0 110.756 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -90.86 -25.48 19.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.672 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -142.9 90.92 2.24 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 86' ' ' ALA . 78.6 mt -39.21 -60.45 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.777 1.631 . . . . 0.0 114.256 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.51 -41.23 29.36 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.6 -47.77 71.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.043 0.449 . . . . 0.0 110.992 -175.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.1 m -70.88 -40.11 72.44 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.9 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 79.6 t -56.46 -57.16 10.07 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 O-C-N 123.308 0.38 . . . . 0.0 110.786 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 22.7 t -60.46 -46.84 88.6 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.804 0.69 . . . . 0.0 111.442 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -51.26 -53.18 37.89 Favored 'General case' 0 C--O 1.25 1.114 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -81.95 -22.17 36.83 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 118.791 -1.164 . . . . 0.0 113.674 -178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.8 mt -75.73 -29.71 58.99 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.849 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 113' ' ' SER . 34.1 mmtp -75.62 -24.76 56.52 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 121.67 0.748 . . . . 0.0 109.021 175.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.7 m -76.42 -54.28 6.96 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.587 174.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 m -113.27 90.56 17.01 Favored Pre-proline 0 C--O 1.243 0.712 0 CA-C-O 121.877 0.846 . . . . 0.0 112.852 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.718 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 11.6 Cg_exo -73.85 -3.93 14.58 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.726 2.284 . . . . 0.0 112.253 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.06 -29.72 70.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.504 0.668 . . . . 0.0 109.557 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.9 mt -99.64 10.98 40.4 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.134 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.718 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 83.8 m -72.51 106.01 4.42 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.383 173.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.412 ' HA2' ' HD2' ' A' ' 95' ' ' LYS . . . -148.82 -73.74 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 173.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.6 m -146.51 155.7 42.72 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.05 138.37 47.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 O-C-N 122.0 -0.438 . . . . 0.0 109.924 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -106.12 133.81 50.24 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.74 126.12 74.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.554 0.692 . . . . 0.0 112.188 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -117.02 106.1 1.4 Allowed Glycine 0 N--CA 1.423 -2.191 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.56 111.76 26.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.9 p -92.39 139.54 17.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.54 -44.48 50.89 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.785 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -75.08 114.43 34.99 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 172.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -88.9 37.74 0.42 Allowed 'Trans proline' 0 C--N 1.321 -0.907 0 C-N-CA 122.513 2.142 . . . . 0.0 111.776 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 138' ' ' VAL . 14.2 t70 -74.11 134.65 42.89 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -177.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -60.7 -29.98 69.67 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -176.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.9 -41.89 61.46 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 135' ' ' ASP . 16.2 m -69.55 -31.29 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 120.583 -0.447 . . . . 0.0 109.908 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.28 -48.9 73.93 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.971 175.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.9 m -68.33 -34.12 75.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.384 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.584 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 28.9 tt0 -62.87 -50.18 71.9 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.067 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.87 97.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.29 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.507 ' NE1' HG23 ' A' ' 102' ' ' VAL . 90.6 t90 -56.02 -47.13 78.37 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.984 176.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -62.4 -42.61 99.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.078 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 67.9 mt -63.05 -52.22 63.66 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.674 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.439 ' CH2' HG13 ' A' ' 89' ' ' VAL . 28.5 m0 -56.85 -48.24 78.54 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.338 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 151' ' ' ILE . 11.2 tt -63.55 -43.79 98.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.659 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.7 -29.99 70.61 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 9.5 mm-40 -64.53 -41.77 96.18 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.017 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . 0.261 60.5 m-70 -76.89 -29.94 55.98 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.505 -0.878 . . . . 0.0 112.853 178.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 147' ' ' ILE . 71.9 mt -58.29 -37.98 66.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 171.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -78.82 -49.82 12.32 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 27.8 m -78.7 -20.85 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.8 t -138.01 -31.27 0.78 Allowed 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.299 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 88.65 11.2 66.33 Favored Glycine 0 CA--C 1.502 -0.735 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.018 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -83.13 103.94 12.94 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.33 0.586 . . . . 0.0 110.592 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.4 p -140.49 76.1 25.72 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.293 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -73.67 159.47 45.65 Favored 'Trans proline' 0 C--O 1.249 1.035 0 C-N-CA 123.194 2.596 . . . . 0.0 112.349 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.5 -23.88 26.55 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.995 3.13 . . . . 0.0 113.958 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -59.14 -41.82 96.81 Favored Glycine 0 CA--C 1.497 -1.037 0 CA-C-O 121.104 0.28 . . . . 0.0 112.671 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.573 HD22 HG21 ' A' ' 102' ' ' VAL . 44.9 t-20 . . . . . 0 C--N 1.305 -1.342 0 CA-C-O 121.926 0.87 . . . . 0.0 108.971 -175.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.487 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 7.8 mmpt? . . . . . 0 N--CA 1.436 -1.14 0 CA-C-O 120.867 0.365 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.647 ' HB3' ' OE1' ' A' ' 149' ' ' GLU . 66.6 m -133.04 175.49 9.33 Favored 'General case' 0 N--CA 1.422 -1.843 0 O-C-N 122.015 -0.428 . . . . 0.0 111.448 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.2 mt -70.76 -23.52 62.43 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 m -69.83 -15.85 63.17 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.189 0.995 . . . . 0.0 109.323 176.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -107.83 8.21 28.58 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.63 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.6 m -103.7 142.09 34.94 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.58 149.24 40.2 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 123.735 0.647 . . . . 0.0 111.284 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.11 133.07 51.39 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.8 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.73 128.73 24.53 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -67.41 142.85 61.28 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.786 1.657 . . . . 0.0 109.357 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.16 -11.79 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.3 p -66.53 -37.75 85.68 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.505 0.669 . . . . 0.0 110.249 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -95.14 50.89 1.29 Allowed 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.845 0.831 . . . . 0.0 110.525 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.78 -27.76 66.84 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.944 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -73.26 -20.92 60.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.532 0.682 . . . . 0.0 110.39 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.0 m -95.99 7.52 46.16 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.406 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.1 mm -78.1 130.59 71.97 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -53.07 132.1 46.08 Favored 'Trans proline' 0 C--O 1.242 0.725 0 C-N-CA 123.417 2.745 . . . . 0.0 113.457 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.9 p -95.3 34.74 1.38 Allowed 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.306 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.98 179.36 4.35 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.957 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 t -95.97 140.04 31.3 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.3 -154.08 24.08 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 119.915 -1.136 . . . . 0.0 111.998 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 m -108.29 146.83 13.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 123.823 0.849 . . . . 0.0 109.88 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -141.36 154.98 45.96 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -135.06 126.45 28.47 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.278 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.63 122.05 52.15 Favored 'Isoleucine or valine' 0 C--O 1.269 2.107 0 CA-C-O 120.932 0.396 . . . . 0.0 110.463 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 77.5 m-85 -109.43 137.92 46.56 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.888 1.275 . . . . 0.0 108.759 177.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -83.61 -166.86 1.5 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.512 ' HE3' ' O ' ' A' ' 123' ' ' CYS . 8.2 mptt -65.21 -26.42 68.12 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 122.913 0.485 . . . . 0.0 111.209 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.8 m -85.51 1.25 49.72 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 122.816 0.447 . . . . 0.0 110.591 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 65.7 28.72 11.02 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 123.87 0.868 . . . . 0.0 111.21 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -100.26 123.32 44.36 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.618 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.0 tm? -70.04 127.74 33.88 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.199 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.456 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 43.6 mt-30 -126.99 -43.31 1.68 Allowed 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.992 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -126.06 121.51 33.17 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 118.819 -1.153 . . . . 0.0 112.143 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.5 m -112.1 151.72 14.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.99 160.73 30.61 Favored Glycine 0 N--CA 1.425 -2.094 0 C-N-CA 119.382 -1.389 . . . . 0.0 112.655 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.2 pt -119.07 137.3 53.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 m -152.34 166.36 32.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.914 0.387 . . . . 0.0 111.676 -177.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -85.11 -32.68 22.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.066 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -127.7 106.01 8.85 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.9 mt -61.74 -59.61 4.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.624 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.94 -56.74 5.08 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.2 95.05 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.982 0.176 . . . . 0.0 111.276 -177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.4 m -64.28 -47.84 78.01 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.715 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.75 -55.09 26.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.005 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.9 m -57.33 -42.55 82.14 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.073 0.858 . . . . 0.0 111.781 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.98 -56.43 21.81 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 122.695 0.398 . . . . 0.0 111.889 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.27 23.7 p80 -71.61 -22.16 61.75 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.0 mt -73.75 -27.24 61.07 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.12 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -87.56 -15.67 36.78 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.253 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.5 m -87.02 -42.89 12.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.335 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.7 p -135.21 91.46 19.19 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-O 121.722 0.773 . . . . 0.0 110.007 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.643 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 7.4 Cg_exo -75.01 12.35 1.24 Allowed 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 123.396 2.73 . . . . 0.0 114.11 -176.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.38 -42.98 96.96 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.99 0.424 . . . . 0.0 109.958 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 39.7 mt -94.87 18.26 12.18 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.184 -176.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 84.8 m -76.85 85.6 3.42 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.467 0.651 . . . . 0.0 112.486 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -128.74 -59.59 0.11 Allowed Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 11.3 p -164.7 158.05 17.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -132.23 141.02 46.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -109.44 138.81 45.25 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 135.06 65.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.085 0.469 . . . . 0.0 110.739 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.3 99.75 0.74 Allowed Glycine 0 N--CA 1.419 -2.497 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.43 HD11 ' N ' ' A' ' 130' ' ' ILE . 2.0 mp -81.66 108.86 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.06 131.03 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.73 8.37 10.18 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.579 0.704 . . . . 0.0 111.977 -175.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 135' ' ' ASP . 31.8 mt-10 -124.84 91.73 48.92 Favored Pre-proline 0 N--CA 1.421 -1.879 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 171.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.65 31.52 0.48 Allowed 'Trans proline' 0 N--CA 1.481 0.794 0 C-N-CA 123.102 2.534 . . . . 0.0 112.083 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 133' ' ' GLU . 13.3 t70 -86.41 141.69 28.97 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.214 -176.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -58.34 -26.57 63.25 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -67.14 -44.91 78.63 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.3 t -75.53 -40.05 40.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.402 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.22 -51.42 70.04 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.797 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 29.3 m -67.58 -32.42 73.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.011 0.434 . . . . 0.0 110.539 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.543 ' O ' HD21 ' A' ' 145' ' ' LEU . 51.7 tt0 -64.35 -56.7 12.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.264 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.27 92.28 Favored 'General case' 0 C--O 1.225 -0.197 0 O-C-N 123.221 0.326 . . . . 0.0 110.147 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -53.69 -43.77 69.22 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.733 0.813 . . . . 0.0 109.726 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.562 ' HE3' ' OE1' ' A' ' 148' ' ' GLU . 56.9 tptt -64.27 -43.98 93.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.361 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.543 HD21 ' O ' ' A' ' 141' ' ' GLN . 2.5 mm? -64.3 -42.57 96.3 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.735 178.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -62.09 -49.14 77.12 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.063 -0.972 . . . . 0.0 112.044 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.51 ' O ' HG13 ' A' ' 151' ' ' ILE . 13.7 tt -69.21 -45.74 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.258 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.562 ' OE1' ' HE3' ' A' ' 144' ' ' LYS . 30.5 mt-10 -68.64 -29.61 68.13 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -175.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.647 ' OE1' ' HB3' ' A' ' 68' ' ' SER . 5.4 pt-20 -67.09 -42.72 84.14 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 118.459 -1.297 . . . . 0.0 108.683 176.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.435 ' N ' ' HG3' ' A' ' 149' ' ' GLU 0.263 24.5 m-70 -74.88 -23.38 58.38 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -179.287 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 147' ' ' ILE . 76.8 mt -66.87 -30.47 49.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -84.42 -42.57 15.52 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 149' ' ' GLU . 5.2 p -80.94 -51.47 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.0 p -96.79 -28.63 14.18 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 121.663 -0.648 . . . . 0.0 111.931 -176.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.96 29.92 62.72 Favored Glycine 0 N--CA 1.467 0.702 0 CA-C-N 114.727 -1.124 . . . . 0.0 115.415 174.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -91.47 -70.58 0.68 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 117.391 0.595 . . . . 0.0 110.702 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.289 7.7 p 41.4 83.27 0.21 Allowed Pre-proline 0 CA--C 1.567 1.613 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.456 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 58.9 Cg_endo -70.11 169.26 19.79 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.945 2.43 . . . . 0.0 112.593 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -45.75 -25.7 2.69 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 125.175 3.917 . . . . 0.0 115.694 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -57.64 -47.84 85.66 Favored Glycine 0 C--O 1.238 0.365 0 O-C-N 123.55 0.532 . . . . 0.0 113.388 -175.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.6 m120 . . . . . 0 CA--C 1.497 -1.093 0 CA-C-O 121.005 0.431 . . . . 0.0 111.785 -179.441 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.7 mttp . . . . . 0 CA--C 1.495 -1.156 0 CA-C-O 121.809 0.814 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.2 m -136.78 172.48 12.95 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.482 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.476 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 61.3 mt -59.87 -16.14 26.74 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.8 1.24 . . . . 0.0 114.241 -175.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.5 t -65.32 -19.97 66.19 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.24 0.616 . . . . 0.0 111.164 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -106.45 -7.36 17.62 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.426 0.631 . . . . 0.0 110.263 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.496 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 4.4 m -84.94 129.6 34.78 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.131 -172.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -81.56 150.99 27.92 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.806 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -104.99 129.1 53.51 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 123.277 0.631 . . . . 0.0 109.657 -175.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.2 140.27 35.71 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -68.27 145.56 66.42 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.532 2.155 . . . . 0.0 110.133 173.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -13.54 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-O 121.429 0.633 . . . . 0.0 110.667 -177.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.4 t -78.42 -15.1 59.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -97.95 47.89 1.01 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.804 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.415 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -61.42 -28.95 69.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.295 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -69.18 -26.02 64.64 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.001 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.7 m -90.87 -5.53 55.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.393 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' A' ' 80' ' ' ALA . 44.1 mm -70.16 125.28 91.92 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -178.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.51 134.96 66.99 Favored 'Trans proline' 0 C--O 1.244 0.823 0 C-N-CA 123.049 2.5 . . . . 0.0 113.399 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.8 p -91.81 26.77 2.28 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.925 0.869 . . . . 0.0 109.727 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.91 -178.73 4.18 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.405 -173.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.5 t -95.83 138.85 32.89 Favored 'General case' 0 N--CA 1.425 -1.704 0 O-C-N 124.034 0.833 . . . . 0.0 109.404 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.46 -151.22 20.25 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 118.503 -1.808 . . . . 0.0 114.422 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.418 ' HB ' ' CH2' ' A' ' 146' ' ' TRP . 5.6 t -120.34 150.28 23.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -139.25 149.26 44.12 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.346 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.14 120.59 34.67 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 123.918 0.887 . . . . 0.0 109.32 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.7 t -99.69 121.76 50.73 Favored 'Isoleucine or valine' 0 C--O 1.263 1.804 0 CA-C-O 121.059 0.457 . . . . 0.0 110.608 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -109.66 132.06 54.49 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.45 -172.48 4.16 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.774 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -22.27 66.88 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.382 0.673 . . . . 0.0 112.201 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.9 m -84.68 0.39 50.53 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 123.001 0.52 . . . . 0.0 109.986 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 69.33 16.55 8.35 Favored 'General case' 0 C--O 1.249 1.079 0 C-N-CA 125.023 1.329 . . . . 0.0 111.707 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -86.84 135.77 33.21 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.124 0.488 . . . . 0.0 110.322 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -80.75 112.22 17.93 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 174.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -125.0 -13.72 6.78 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.944 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.415 ' HA ' ' OD1' ' A' ' 161' ' ' ASN . 57.4 t80 -145.83 122.65 11.26 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 118.707 -1.197 . . . . 0.0 111.08 177.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.433 HG22 ' HB ' ' A' ' 147' ' ' ILE . 18.6 m -123.27 141.32 44.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 171.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -157.23 157.91 28.47 Favored Glycine 0 N--CA 1.413 -2.895 0 C-N-CA 119.068 -1.539 . . . . 0.0 111.719 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.7 pt -110.91 137.84 41.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 121.192 0.52 . . . . 0.0 109.733 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.5 m -149.77 136.41 19.28 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.56 ' HD2' ' C ' ' A' ' 106' ' ' ARG . 4.5 ppt_? -76.74 -12.0 59.92 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.751 0.786 . . . . 0.0 109.894 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -133.7 86.76 2.32 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.6 mt -55.68 -55.32 18.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.157 -174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.64 -60.25 2.3 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.05 -37.99 87.06 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.033 0.208 . . . . 0.0 111.432 -176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.7 t -63.65 -55.32 24.42 Favored 'General case' 0 C--O 1.248 0.985 0 O-C-N 123.836 0.71 . . . . 0.0 109.913 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.9 t -57.94 -51.61 68.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.351 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.9 m -60.1 -37.92 81.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.327 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.13 -58.86 6.8 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 120.937 0.399 . . . . 0.0 111.47 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -77.63 -22.36 50.84 Favored 'General case' 0 C--O 1.203 -1.367 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.04 -26.03 25.58 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 119.062 -1.055 . . . . 0.0 113.326 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -88.12 -16.95 32.09 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.3 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -94.81 -20.1 19.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.004 0.43 . . . . 0.0 111.158 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.9 p -152.73 94.0 3.19 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-O 121.809 0.814 . . . . 0.0 110.534 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.692 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 16.1 Cg_exo -68.84 14.28 0.2 Allowed 'Trans proline' 0 CA--C 1.556 1.579 0 C-N-CA 124.123 3.215 . . . . 0.0 116.729 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -66.39 -28.27 68.5 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 121.464 -0.773 . . . . 0.0 111.503 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.9 mt -107.25 20.86 18.38 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 121.683 -0.636 . . . . 0.0 111.502 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.692 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 89.4 m -79.68 99.05 7.21 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.73 -65.28 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.6 p -160.05 162.05 34.09 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.095 0.558 . . . . 0.0 109.52 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.38 137.78 43.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-O 121.155 0.503 . . . . 0.0 110.375 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.496 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 79.5 mttt -109.11 137.27 47.27 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.36 138.69 53.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 120.57 0.224 . . . . 0.0 110.863 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.72 113.34 1.85 Allowed Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.32 107.59 18.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 p -93.53 143.22 11.97 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.572 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -58.63 -50.21 74.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.275 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.416 ' C ' ' H ' ' A' ' 135' ' ' ASP . 43.3 mt-10 -94.52 119.42 66.35 Favored Pre-proline 0 C--N 1.303 -1.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.176 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.07 27.16 0.62 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.066 2.51 . . . . 0.0 110.877 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 133' ' ' GLU . 24.6 t70 -67.15 133.56 50.04 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.402 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -59.54 -33.77 71.82 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.85 -42.24 58.34 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.55 -43.07 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.004 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.69 -49.26 78.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.74 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 44.8 m -69.1 -31.1 69.58 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.084 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.481 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 27.9 tt0 -63.26 -50.64 69.36 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 122.946 0.498 . . . . 0.0 109.884 178.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.85 -45.26 93.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.698 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -51.13 -46.69 62.02 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.251 1.021 . . . . 0.0 110.284 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -61.0 -48.82 80.04 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.179 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 61.7 mt -62.8 -43.23 99.35 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.79 -176.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.418 ' CH2' ' HB ' ' A' ' 89' ' ' VAL . 30.8 m0 -61.48 -47.51 85.35 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.21 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.507 ' O ' HG13 ' A' ' 151' ' ' ILE . 14.9 tt -67.68 -39.75 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.404 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -62.74 -33.71 75.69 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 153' ' ' VAL . 7.3 mm-40 -55.24 -45.95 76.02 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.401 0.619 . . . . 0.0 109.685 173.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.404 ' HA ' HG12 ' A' ' 153' ' ' VAL 0.255 74.3 m-70 -80.5 -27.36 37.74 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.295 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 147' ' ' ILE . 79.8 mt -61.29 -41.07 88.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.469 ' HZ1' ' HB2' ' A' ' 152' ' ' LYS . 9.7 mtmp? -71.06 -43.98 66.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.326 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 149' ' ' GLU . 7.3 p -81.7 -56.4 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.4 p -99.47 -34.36 10.3 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 121.811 -0.556 . . . . 0.0 112.264 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.74 34.67 27.21 Favored Glycine 0 C--N 1.304 -1.226 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.715 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -106.83 106.49 17.05 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.76 87.52 46.41 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 173.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -86.14 169.87 8.53 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 123.896 3.064 . . . . 0.0 113.251 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -45.23 -30.57 5.3 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 124.928 3.752 . . . . 0.0 116.177 -175.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.76 -30.31 72.67 Favored Glycine 0 C--O 1.246 0.896 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.312 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.415 ' OD1' ' HA ' ' A' ' 101' ' ' PHE . 14.7 m120 . . . . . 0 C--N 1.311 -1.075 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.433 ' N ' ' HD3' ' A' ' 67' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.44 -0.944 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.7 m -114.41 168.98 9.38 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.331 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 146' ' ' TRP . 2.9 tm? -65.32 -35.0 79.65 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.429 1.092 . . . . 0.0 109.829 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.8 m -55.97 -28.69 58.2 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.798 176.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.421 ' CD ' ' HZ2' ' A' ' 67' ' ' LYS . 36.6 mt-10 -93.94 -4.08 50.45 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.752 -0.593 . . . . 0.0 111.575 -176.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.531 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.3 m -78.02 141.67 38.73 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -173.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -88.45 148.64 24.08 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.659 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.06 133.94 48.16 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 122.84 0.456 . . . . 0.0 109.94 -174.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -126.44 126.45 24.61 Favored Pre-proline 0 C--N 1.315 -0.928 0 C-N-CA 123.652 0.781 . . . . 0.0 108.902 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.464 ' HB2' HG23 ' A' ' 78' ' ' THR . 25.5 Cg_exo -67.67 141.85 56.28 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 121.843 1.695 . . . . 0.0 109.139 172.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -5.0 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -174.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.464 HG23 ' HB2' ' A' ' 76' ' ' PRO . 9.1 t -68.32 -30.0 68.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -99.43 52.97 0.94 Allowed 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.364 1.078 . . . . 0.0 109.61 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.55 -24.11 66.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.102 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -76.32 -19.41 58.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.782 0.801 . . . . 0.0 110.244 176.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.3 t -87.49 -6.97 58.15 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.243 -174.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.7 mm -67.43 125.84 91.71 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.391 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -53.77 137.37 67.45 Favored 'Trans proline' 0 C--O 1.243 0.739 0 C-N-CA 123.584 2.856 . . . . 0.0 113.95 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.8 p -93.69 35.72 1.12 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.25 1.024 . . . . 0.0 109.129 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.439 ' O ' HG13 ' A' ' 108' ' ' ILE . . . -102.64 175.37 5.52 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.229 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.7 t -97.53 134.76 40.32 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.28 -154.88 24.68 Favored Glycine 0 N--CA 1.412 -2.902 0 C-N-CA 119.952 -1.118 . . . . 0.0 111.069 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.456 ' HB ' ' CH2' ' A' ' 146' ' ' TRP . 3.2 t -115.24 156.44 16.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -145.61 149.52 34.68 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.58 121.97 35.15 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.462 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.9 t -94.93 118.74 41.75 Favored 'Isoleucine or valine' 0 C--O 1.259 1.558 0 CA-C-O 121.332 0.587 . . . . 0.0 110.351 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.57 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 7.3 m-85 -108.82 134.49 51.44 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.367 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.92 -179.33 6.92 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -73.99 3.18 7.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -175.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.5 m -94.18 0.0 55.49 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 171.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 t70 61.51 62.94 1.24 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.036 1.334 . . . . 0.0 108.538 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -141.39 146.49 36.67 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.3 -177.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -96.3 116.67 29.4 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.92 0.762 . . . . 0.0 110.745 -172.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.419 ' HA ' ' HG2' ' A' ' 158' ' ' PRO . 2.4 mp0 -112.08 -28.39 8.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.329 178.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -145.91 127.07 14.72 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.12 -1.032 . . . . 0.0 112.493 -175.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.423 HG23 ' NE1' ' A' ' 143' ' ' TRP . 20.0 m -114.98 143.55 24.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 172.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.46 170.38 31.03 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.4 pt -133.14 146.84 31.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.1 t -151.22 162.42 40.92 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.979 -0.289 . . . . 0.0 110.29 -176.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -85.38 -22.67 28.3 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -142.43 86.16 1.94 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 86' ' ' ALA . 73.0 mt -43.94 -52.45 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.663 1.185 . . . . 0.0 113.304 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.65 -40.33 19.52 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.78 -51.76 37.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.444 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.9 m -63.19 -45.92 89.5 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.688 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.31 -57.13 11.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.33 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.4 t -62.94 -40.89 99.01 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 123.404 0.44 . . . . 0.0 111.13 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.69 -54.31 47.67 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.261 19.7 p80 -78.69 -25.79 44.81 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 118.922 -1.111 . . . . 0.0 113.94 -177.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 70.5 mt -75.19 -28.35 59.97 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 119.781 -0.767 . . . . 0.0 112.127 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -86.11 -23.34 26.67 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.738 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.1 m -72.89 -46.36 53.2 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.4 p -139.26 91.69 11.02 Favored Pre-proline 0 N--CA 1.438 -1.075 0 CA-C-O 122.22 1.009 . . . . 0.0 110.022 177.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -74.84 29.75 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.945 3.096 . . . . 0.0 113.82 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -70.83 -42.87 69.64 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.362 0.601 . . . . 0.0 110.533 -177.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.62 21.29 4.08 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.219 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 35.9 m -71.56 99.32 2.04 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.334 0.587 . . . . 0.0 111.856 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.32 -59.9 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.1 p -164.72 160.84 20.24 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.79 138.01 46.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.531 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 97.9 mttt -106.71 135.36 48.38 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.0 m -120.88 131.41 72.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 120.81 0.338 . . . . 0.0 110.1 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -115.81 106.58 1.57 Allowed Glycine 0 N--CA 1.408 -3.228 0 C-N-CA 119.868 -1.158 . . . . 0.0 111.85 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 mp -82.23 112.37 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.25 144.26 20.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.31 4.51 53.37 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.204 -171.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -94.58 112.4 57.69 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -84.73 8.32 4.7 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 122.592 2.195 . . . . 0.0 116.065 -170.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -97.64 146.81 24.95 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.131 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -54.85 -34.67 63.16 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.692 1.197 . . . . 0.0 111.891 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.96 -44.23 90.08 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 120.658 0.266 . . . . 0.0 110.665 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.46 -36.38 48.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.615 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.82 -45.08 95.86 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.1 m -71.94 -32.14 67.02 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 121.072 0.463 . . . . 0.0 110.698 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.424 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 26.6 tt0 -63.69 -46.31 86.06 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 175.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.77 -42.25 95.24 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.843 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.423 ' NE1' HG23 ' A' ' 102' ' ' VAL . 91.9 t90 -49.83 -45.89 50.67 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.488 0.715 . . . . 0.0 109.633 176.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.672 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 84.6 mttt -62.09 -50.74 70.74 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.13 177.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 86.9 mt -54.32 -47.54 72.36 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.532 0.52 . . . . 0.0 110.679 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.456 ' CH2' ' HB ' ' A' ' 89' ' ' VAL . 14.3 m0 -62.02 -54.46 41.26 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.538 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.445 ' O ' HG12 ' A' ' 151' ' ' ILE . 11.1 tt -59.19 -42.78 87.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 O-C-N 123.424 0.452 . . . . 0.0 110.274 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.672 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 37.3 mt-10 -56.01 -47.67 77.34 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 123.547 0.53 . . . . 0.0 110.913 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.419 ' O ' HG21 ' A' ' 153' ' ' VAL . 15.4 mt-10 -56.86 -47.02 81.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.83 -28.2 30.33 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 118.496 -1.282 . . . . 0.0 112.751 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.518 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 38.2 pt -76.85 -26.77 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.906 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -78.5 -30.9 47.47 Favored 'General case' 0 C--N 1.264 -3.123 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.079 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 149' ' ' GLU . 35.1 m -86.57 -46.33 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 176.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 70.8 p -99.99 -19.02 16.76 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 119.409 -0.917 . . . . 0.0 113.031 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 151' ' ' ILE . . . 67.52 34.69 84.99 Favored Glycine 0 N--CA 1.468 0.822 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 174.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -78.95 -74.94 0.26 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 117.1 0.45 . . . . 0.0 111.958 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.1 t 54.13 69.52 2.12 Favored Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 123.865 0.866 . . . . 0.0 109.014 -174.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.419 ' HG2' ' HA ' ' A' ' 100' ' ' GLN . 2.8 Cg_exo -81.44 156.94 19.27 Favored 'Trans proline' 0 C--O 1.242 0.696 0 C-N-CA 122.804 2.336 . . . . 0.0 112.84 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.92 -35.92 41.96 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 124.298 3.332 . . . . 0.0 114.159 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -64.86 -30.52 78.21 Favored Glycine 0 CA--C 1.498 -1.011 0 O-C-N 123.336 0.397 . . . . 0.0 112.933 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . 0.409 ' OD1' HG21 ' A' ' 102' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.297 -1.677 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -176.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.529 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.22 -41.98 15.11 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 123.137 0.273 . . . . 0.0 111.462 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -167.29 -164.52 0.61 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.92 110.98 1.95 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 71' ' ' GLU . 8.1 p -78.68 135.93 24.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.248 -175.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -112.66 -53.77 2.68 Favored 'General case' 0 C--O 1.205 -1.253 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.6 m -113.32 164.64 13.31 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.568 -175.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.0 mt -62.33 -28.02 69.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.159 0.983 . . . . 0.0 111.404 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 m -59.45 -21.91 60.73 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.033 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.427 ' HB2' HG23 ' A' ' 66' ' ' VAL . 31.8 mt-10 -104.92 11.58 33.43 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 122.717 0.407 . . . . 0.0 110.264 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.425 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 8.1 m -104.7 142.9 33.88 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -173.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -86.26 159.64 19.38 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.506 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.11 133.35 53.12 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -128.17 138.87 33.92 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -74.93 143.53 29.41 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.41 2.074 . . . . 0.0 110.573 173.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.62 -15.74 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-O 120.913 0.387 . . . . 0.0 112.01 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p -71.77 -38.21 70.38 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 121.615 0.722 . . . . 0.0 111.183 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -93.16 54.2 2.09 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.873 0.844 . . . . 0.0 110.645 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.38 -18.41 10.91 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.425 -1.261 . . . . 0.0 112.981 -177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -72.25 -27.25 62.39 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.52 0.676 . . . . 0.0 109.692 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.9 m -93.89 3.3 55.6 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.977 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mm -79.63 128.56 74.34 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.26 130.65 41.79 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.957 2.438 . . . . 0.0 113.335 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.1 p -92.9 39.01 1.03 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.224 1.011 . . . . 0.0 109.475 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -109.55 177.63 4.68 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.259 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.6 t -93.94 140.53 29.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.75 -155.08 26.15 Favored Glycine 0 N--CA 1.417 -2.62 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.641 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.465 HG13 ' CH2' ' A' ' 146' ' ' TRP . 6.3 p -121.23 149.17 24.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -137.63 149.58 46.72 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 120.848 0.356 . . . . 0.0 110.543 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.14 118.65 29.18 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.79 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.6 t -91.78 121.0 41.87 Favored 'Isoleucine or valine' 0 C--O 1.263 1.787 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.367 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.527 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 67.4 m-85 -108.76 130.0 55.37 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.691 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -76.91 -175.08 3.35 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.231 0.539 . . . . 0.0 110.257 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -28.09 63.76 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 124.14 0.976 . . . . 0.0 113.547 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.7 m -91.74 3.45 55.07 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.803 0.335 . . . . 0.0 111.492 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.4 t70 62.33 67.75 0.71 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-O 122.724 1.25 . . . . 0.0 111.598 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 8.1 mm-40 -136.82 145.73 44.82 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.556 -1.656 . . . . 0.0 109.814 174.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.496 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 3.0 tm? -89.87 116.71 28.15 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.308 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -122.86 -14.49 7.64 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.259 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.58 115.03 5.91 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.819 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.404 HG23 ' HB ' ' A' ' 147' ' ' ILE . 12.3 m -111.21 142.26 24.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.79 159.76 29.81 Favored Glycine 0 N--CA 1.424 -2.14 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.227 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.2 pt -115.09 139.94 38.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.5 m -151.0 157.77 43.3 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.622 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -79.3 -23.32 43.61 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -135.49 105.39 6.2 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 173.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.4 mt -60.14 -56.94 14.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.38 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.95 -50.73 45.56 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.559 0.744 . . . . 0.0 112.767 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.23 -52.19 66.73 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 123.75 0.656 . . . . 0.0 111.109 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.1 t -61.26 -48.62 80.6 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.293 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 54.7 t -56.9 -54.48 29.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 123.103 0.561 . . . . 0.0 111.097 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.0 m -61.04 -35.53 77.15 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 123.607 0.567 . . . . 0.0 111.463 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.91 -58.96 3.97 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.836 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.426 ' HB3' HG13 ' A' ' 171' ' ' VAL 0.287 19.6 p80 -74.8 -24.66 58.68 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -175.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.6 mt -77.93 -24.82 48.14 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.217 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -85.49 -16.82 38.31 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.867 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.0 t -80.55 -50.48 9.95 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.58 85.0 61.3 Favored Pre-proline 0 CA--C 1.557 1.236 0 CA-C-O 122.341 1.067 . . . . 0.0 109.929 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.505 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 16.6 Cg_exo -71.87 12.02 0.62 Allowed 'Trans proline' 0 N--CA 1.479 0.623 0 C-N-CA 124.031 3.154 . . . . 0.0 114.806 -176.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -66.47 -39.32 88.73 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.341 0.591 . . . . 0.0 109.886 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.8 mt -88.16 20.71 3.08 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.092 0.473 . . . . 0.0 111.802 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.505 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 89.2 m -79.99 99.44 7.64 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 121.497 0.665 . . . . 0.0 111.069 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.43 -64.64 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 174.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.4 p -161.43 162.92 30.73 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.9 p -137.14 137.05 46.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.425 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 94.8 mttt -106.4 125.56 51.15 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 175.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.0 m -115.34 134.35 58.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.412 0.625 . . . . 0.0 111.929 -174.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.65 96.16 0.63 Allowed Glycine 0 N--CA 1.422 -2.249 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.417 HD13 ' N ' ' A' ' 130' ' ' ILE . 2.6 mp -89.27 121.37 39.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.2 p -116.12 125.25 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 175.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -72.38 -8.87 57.24 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -89.62 122.06 68.55 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -83.12 27.12 0.62 Allowed 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.769 2.313 . . . . 0.0 113.224 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.421 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 24.2 t70 -78.96 129.38 34.42 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.532 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -69.9 -31.15 68.79 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.422 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.72 -38.45 62.29 Favored 'General case' 0 C--O 1.203 -1.37 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.297 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.09 -43.75 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 92.4 mt -59.08 -48.4 81.75 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.345 0.593 . . . . 0.0 110.244 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.6 m -70.69 -34.3 71.82 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.272 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.45 -47.05 74.4 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 123.109 0.564 . . . . 0.0 109.759 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.83 -49.25 78.43 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -49.17 -43.9 42.38 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.002 0.921 . . . . 0.0 110.305 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -65.55 -48.71 71.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.43 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.64 -37.12 85.09 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.773 0.321 . . . . 0.0 110.871 177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.465 ' CH2' HG13 ' A' ' 89' ' ' VAL . 25.0 m0 -63.47 -53.55 50.29 Favored 'General case' 0 C--O 1.254 1.333 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.53 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 151' ' ' ILE . 11.8 tt -63.41 -41.21 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.829 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -60.24 -36.94 78.9 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.435 ' O ' HG22 ' A' ' 153' ' ' VAL . 24.4 mt-10 -54.96 -46.97 75.11 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 118.94 0.791 . . . . 0.0 110.56 176.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.496 ' CG ' ' HB3' ' A' ' 99' ' ' LEU 0.323 18.9 m-70 -77.85 -29.81 50.67 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 118.769 -1.172 . . . . 0.0 114.011 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 147' ' ' ILE . 68.7 mt -60.68 -44.87 98.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 172.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.27 -48.65 64.44 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 149' ' ' GLU . 21.8 m -80.01 -32.1 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -175.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.7 t -131.7 -30.21 1.66 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.44 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.41 15.61 56.78 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.642 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -77.11 120.56 22.37 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 42.8 t -138.46 80.65 26.57 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -77.69 161.48 30.71 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.431 2.754 . . . . 0.0 113.278 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -52.84 -23.77 21.81 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 124.543 3.495 . . . . 0.0 114.197 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.4 -29.97 75.77 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.574 -0.346 . . . . 0.0 112.87 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -95.34 -8.68 35.08 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.347 1.07 . . . . 0.0 110.17 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -98.55 154.69 17.72 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.954 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 28.2 m -86.71 77.42 9.33 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.6 0.714 . . . . 0.0 110.194 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -123.98 -104.36 1.62 Allowed Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -92.04 111.11 22.53 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -87.42 86.91 7.28 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.791 0.805 . . . . 0.0 111.055 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 19.5 m -79.02 -31.29 44.64 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.543 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -87.7 -15.58 36.72 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.854 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.9 t -93.54 -33.66 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.214 0.531 . . . . 0.0 110.262 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -121.57 104.74 9.86 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.426 HG13 ' HB3' ' A' ' 115' ' ' HIS . 35.8 m -111.42 131.43 62.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -170.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 10.3 m 66.7 1.05 2.06 Favored 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 124.99 1.316 . . . . 0.0 112.853 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 92.1 mt -85.33 -27.2 26.07 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.526 -0.733 . . . . 0.0 110.486 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . 0.279 20.7 mm-40 45.7 72.56 0.21 Allowed 'General case' 0 C--O 1.244 0.796 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -148.24 47.33 1.06 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.945 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -74.91 96.75 3.19 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 170.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -76.02 93.71 3.32 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.258 -164.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -176.78 89.43 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -77.14 158.5 30.37 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.041 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 21.5 p80 . . . . . 0 C--N 1.298 -1.662 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.504 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 52.3 ttm . . . . . 0 CA--C 1.513 -0.451 0 CA-C-O 121.223 0.535 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.37 178.06 7.84 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.8 m -108.97 135.22 50.51 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.83 110.48 1.55 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.0 t -61.33 118.07 3.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.226 -173.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -95.39 -82.01 0.39 Allowed 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.992 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.2 m -123.25 -179.08 4.18 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.76 -17.75 63.46 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.3 m -63.69 -26.76 68.81 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.789 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -84.16 -20.53 32.29 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.436 0.636 . . . . 0.0 109.668 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.475 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 2.7 m -76.82 154.35 33.98 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.036 -0.983 . . . . 0.0 113.512 -168.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -100.9 158.61 15.86 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.887 0.875 . . . . 0.0 109.133 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.68 128.82 55.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.98 0.419 . . . . 0.0 110.175 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.01 129.09 25.1 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -65.39 143.84 77.82 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 121.663 1.575 . . . . 0.0 108.74 170.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.532 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -65.12 -13.19 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -176.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.8 p -76.12 -16.22 59.93 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.56 0.695 . . . . 0.0 110.809 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -92.97 30.58 1.57 Allowed 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.53 -40.33 37.52 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.532 1.133 . . . . 0.0 113.414 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -72.95 -17.95 61.43 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.642 0.734 . . . . 0.0 110.789 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.0 m -103.65 -1.05 28.75 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.389 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.4 mm -65.38 134.07 95.57 Favored Pre-proline 0 C--O 1.243 0.731 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.59 129.92 31.48 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.84 2.36 . . . . 0.0 112.205 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.4 p -99.16 49.51 0.95 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.872 0.844 . . . . 0.0 109.922 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -124.99 -179.44 4.55 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.983 -176.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.7 t -95.37 145.02 25.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.27 -156.5 28.43 Favored Glycine 0 N--CA 1.414 -2.79 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.538 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.2 m -110.67 151.05 12.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 123.996 0.918 . . . . 0.0 109.916 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -141.85 147.18 36.76 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 120.713 0.292 . . . . 0.0 110.214 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.91 122.22 37.38 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.77 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.57 117.05 40.21 Favored 'Isoleucine or valine' 0 C--O 1.26 1.655 0 C-N-CA 123.377 0.671 . . . . 0.0 110.36 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.613 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 47.1 m-85 -107.39 134.5 50.36 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -79.94 -167.93 1.45 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.262 0.554 . . . . 0.0 112.114 -174.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -56.88 -32.56 65.98 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.244 1.417 . . . . 0.0 110.667 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.9 m -90.72 7.42 39.65 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.924 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 69.93 16.45 7.67 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.347 1.07 . . . . 0.0 111.055 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -92.3 139.63 30.41 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 120.93 -1.106 . . . . 0.0 110.327 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.613 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.3 tm? -82.43 129.68 34.95 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.645 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -125.78 -43.52 1.85 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 123.771 0.669 . . . . 0.0 111.078 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -124.29 131.09 53.5 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.835 -171.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.9 m -123.02 151.85 27.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 174.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -158.82 168.67 35.01 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.282 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.5 pt -120.35 144.76 28.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 123.259 0.624 . . . . 0.0 109.958 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 71.1 m -150.03 154.64 38.51 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.916 0.389 . . . . 0.0 111.61 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -78.59 -28.16 45.73 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -142.23 103.16 4.24 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.4 mt -55.2 -54.7 21.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.462 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.14 -43.79 64.21 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.08 -54.8 24.39 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 123.381 0.426 . . . . 0.0 111.904 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.1 m -70.86 -41.14 71.8 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.81 -56.74 15.38 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.8 m -58.3 -40.22 81.41 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 123.753 0.658 . . . . 0.0 111.228 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.03 -55.64 30.39 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 120.989 0.423 . . . . 0.0 111.281 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -75.03 -27.39 60.04 Favored 'General case' 0 C--O 1.21 -0.99 0 C-N-CA 119.275 -0.97 . . . . 0.0 113.265 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.453 HD22 ' SG ' ' A' ' 123' ' ' CYS . 64.5 mt -76.33 -24.49 54.28 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.051 -0.659 . . . . 0.0 112.061 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -88.71 -11.21 45.82 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.305 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.2 m -90.64 -43.62 10.05 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.89 175.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.31 93.85 24.72 Favored Pre-proline 0 CA--C 1.551 1.008 0 CA-C-O 121.826 0.822 . . . . 0.0 110.727 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.804 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 6.2 Cg_exo -77.41 10.65 2.4 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.388 2.725 . . . . 0.0 113.779 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.13 -42.33 85.58 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.695 0.798 . . . . 0.0 112.259 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.3 mt -105.84 20.67 18.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.181 0.515 . . . . 0.0 110.432 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.804 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 81.5 m -80.72 88.62 5.76 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -127.0 -55.11 0.14 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.9 p -158.76 162.73 37.13 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.99 136.22 42.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.475 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 67.6 mttm -106.6 125.54 51.14 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.51 133.54 60.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.102 0.477 . . . . 0.0 111.292 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.13 104.32 1.0 Allowed Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 130' ' ' ILE . 2.0 mp -87.72 133.22 30.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -177.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.5 p -122.46 151.68 26.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -95.61 7.0 47.53 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.69 0.757 . . . . 0.0 110.425 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -127.08 99.88 27.88 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.789 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -84.84 34.03 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.388 2.726 . . . . 0.0 113.511 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -85.07 140.13 31.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -58.7 -28.31 65.67 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.98 -43.07 62.66 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -66.09 -42.51 91.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.11 -46.69 87.95 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.704 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 43.2 m -71.27 -28.22 63.99 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.748 0.309 . . . . 0.0 110.755 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.2 -54.6 42.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.83 -41.16 99.21 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 123.928 0.767 . . . . 0.0 110.148 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.468 ' O ' HG23 ' A' ' 147' ' ' ILE . 90.4 t90 -53.51 -46.88 70.26 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.735 0.814 . . . . 0.0 109.39 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.413 ' HZ1' ' CD ' ' A' ' 148' ' ' GLU . 9.6 mmmt -57.79 -50.98 71.45 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.424 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 4.0 mm? -57.7 -49.61 75.95 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.297 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -57.69 -51.99 67.26 Favored 'General case' 0 C--O 1.255 1.353 0 O-C-N 124.488 1.117 . . . . 0.0 112.23 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.569 ' O ' HG12 ' A' ' 151' ' ' ILE . 11.7 tt -70.21 -51.07 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.4 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.413 ' CD ' ' HZ1' ' A' ' 144' ' ' LYS . 51.2 mt-10 -62.88 -33.12 74.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -174.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 153' ' ' VAL . 10.1 pt-20 -63.86 -42.88 97.43 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.17 177.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -74.88 -27.21 60.14 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 147' ' ' ILE . 44.8 mm -62.09 -45.66 98.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.05 -37.95 78.84 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.649 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 149' ' ' GLU . 5.5 p -88.52 -60.13 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.1 p -90.71 -28.72 18.14 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 70.81 34.86 66.05 Favored Glycine 0 N--CA 1.467 0.761 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.018 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 99' ' ' LEU . 71.9 mmtt -87.36 114.98 24.46 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 122.528 0.331 . . . . 0.0 110.521 -176.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.9 t -133.9 87.86 34.04 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -88.2 153.28 6.85 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.826 2.351 . . . . 0.0 112.358 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 162' ' ' LYS . 76.3 Cg_exo -51.98 -27.39 28.26 Favored 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 123.908 3.072 . . . . 0.0 113.245 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -63.51 -37.57 94.99 Favored Glycine 0 CA--C 1.502 -0.778 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.86 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -93.66 -24.93 17.7 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.243 0.544 . . . . 0.0 109.934 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.428 ' HB3' ' HZ1' ' A' ' 162' ' ' LYS . 6.9 mtpm? -68.94 171.26 8.32 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.008 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.8 m -82.89 85.98 7.03 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-O 121.914 0.864 . . . . 0.0 109.324 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -175.58 -159.29 21.27 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -127.09 128.75 46.73 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 118.178 0.989 . . . . 0.0 111.135 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -143.46 164.01 31.51 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 1.6 m -55.62 -4.85 0.11 Allowed 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -172.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -87.96 -31.31 19.45 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 121.183 -0.948 . . . . 0.0 111.359 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.01 -1.11 8.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.182 0.515 . . . . 0.0 111.098 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -150.12 107.78 3.67 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -178.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.87 117.85 27.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.106 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 33.4 m 67.4 -59.65 0.4 Allowed 'General case' 0 CA--C 1.558 1.267 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 173.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -84.68 82.98 8.18 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 122.145 -0.347 . . . . 0.0 111.058 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 178.99 172.53 0.8 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -108.05 -21.3 12.86 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -64.44 117.99 8.1 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -134.42 152.26 51.69 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.343 -174.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -98.66 170.07 9.05 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -159.79 140.08 11.88 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 . . . . . 0 C--N 1.304 -1.372 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.226 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 C--O 1.238 0.459 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.67 26.72 14.65 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.356 1.062 . . . . 0.0 112.775 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 m -74.83 137.42 41.84 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.612 176.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.17 134.99 23.59 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.787 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.7 t -97.72 129.88 47.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -108.73 -36.83 6.05 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.627 -173.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.8 m -134.7 169.48 17.26 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.912 -0.492 . . . . 0.0 110.882 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.7 mt -58.33 -22.85 54.75 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.334 1.053 . . . . 0.0 112.107 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.452 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 38.2 m -60.68 -44.16 96.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 124.116 0.966 . . . . 0.0 112.067 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.452 ' OE2' ' HB ' ' A' ' 70' ' ' THR . 1.5 mp0 -89.62 3.98 50.89 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.126 0.488 . . . . 0.0 110.25 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.536 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 3.2 m -92.96 128.45 38.82 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.501 -175.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -78.69 159.19 28.11 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 122.74 0.416 . . . . 0.0 110.982 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.51 125.26 54.01 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 122.659 0.384 . . . . 0.0 110.583 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -124.19 131.09 24.17 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.89 149.68 86.28 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 121.988 1.792 . . . . 0.0 110.014 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.91 -12.29 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.874 -0.516 . . . . 0.0 111.814 -176.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.4 p -78.02 -17.79 56.67 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.171 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -94.14 38.93 1.08 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.413 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -57.93 -29.5 65.18 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.053 0.941 . . . . 0.0 112.496 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.27 -20.76 60.03 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.374 0.606 . . . . 0.0 110.4 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.7 m -96.88 6.71 48.14 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.519 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' A' ' 80' ' ' ALA . 45.2 mm -77.43 123.03 86.86 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -56.22 130.39 39.92 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.976 2.451 . . . . 0.0 113.695 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.1 p -91.6 76.26 5.78 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.344 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 107' ' ' ASN . . . -144.3 177.79 8.37 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.629 -177.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.9 t -91.18 137.72 32.15 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.46 -149.56 16.65 Favored Glycine 0 N--CA 1.414 -2.833 0 C-N-CA 119.482 -1.342 . . . . 0.0 112.732 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.492 HG12 ' CH2' ' A' ' 146' ' ' TRP . 4.8 p -128.34 149.75 33.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -136.25 157.14 47.53 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.437 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . . . -127.69 114.83 17.84 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 123.775 0.83 . . . . 0.0 109.442 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.1 t -89.0 119.25 35.8 Favored 'Isoleucine or valine' 0 C--O 1.264 1.834 0 CA-C-O 120.944 0.402 . . . . 0.0 111.008 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 7.3 m-85 -103.35 127.18 50.76 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.165 0.986 . . . . 0.0 109.052 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -79.52 -168.54 1.58 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.555 0.693 . . . . 0.0 112.242 -173.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -57.7 -41.46 81.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.683 1.193 . . . . 0.0 109.993 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.8 t -84.83 12.11 7.99 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.841 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 70.94 20.17 5.45 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 32.7 mt-10 -103.62 148.83 25.54 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 118.865 -1.134 . . . . 0.0 112.211 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 2.1 tm? -80.02 117.72 21.11 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.813 174.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.4 ' O ' ' HG3' ' A' ' 158' ' ' PRO . 1.7 mp0 -113.85 -39.51 3.97 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.15 173.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -124.45 115.25 20.61 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.564 -1.254 . . . . 0.0 112.248 -171.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 m -98.55 147.22 7.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 172.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.19 147.79 17.94 Favored Glycine 0 C--N 1.283 -2.396 0 C-N-CA 118.876 -1.631 . . . . 0.0 112.418 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.4 pt -112.7 138.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 m -152.52 161.54 42.44 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -81.68 -22.56 37.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.502 0.668 . . . . 0.0 109.875 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 86' ' ' ALA . 6.6 t30 -141.91 100.2 3.69 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.1 mt -48.61 -58.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.91 1.284 . . . . 0.0 113.528 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.63 -53.89 13.5 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.47 -36.47 76.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.424 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.4 t -76.11 -52.01 11.03 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.6 t -55.63 -54.45 25.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.429 0.691 . . . . 0.0 111.785 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 m -59.93 -47.77 84.43 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.405 0.44 . . . . 0.0 111.218 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.34 -55.2 36.58 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.257 24.1 p80 -76.84 -25.51 53.28 Favored 'General case' 0 C--O 1.216 -0.658 0 C-N-CA 118.516 -1.274 . . . . 0.0 113.959 -175.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 72.2 mt -77.91 -36.17 49.82 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.499 -0.88 . . . . 0.0 112.056 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -75.97 -19.12 58.99 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.451 -0.899 . . . . 0.0 110.645 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 57.3 m -80.3 -42.71 22.55 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.754 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -134.9 95.06 15.74 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 121.912 0.863 . . . . 0.0 110.804 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.76 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 83.1 Cg_endo -81.42 24.4 0.7 Allowed 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 123.418 2.745 . . . . 0.0 114.633 -174.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -67.41 -34.26 76.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.826 0.822 . . . . 0.0 110.254 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.8 mt -109.37 20.78 17.86 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.242 0.544 . . . . 0.0 110.549 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.76 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 67.5 m -81.14 84.06 6.64 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -122.93 -58.12 0.2 Allowed Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 174.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 12.4 p -163.18 169.19 19.68 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 123.652 0.781 . . . . 0.0 109.048 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.95 139.59 36.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-O 121.257 0.551 . . . . 0.0 109.852 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.536 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 89.4 mttt -106.34 132.51 52.3 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.72 139.18 45.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.274 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.95 101.21 0.61 Allowed Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.61 120.67 35.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.06 130.86 62.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -79.32 -19.08 51.24 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.09 0.471 . . . . 0.0 111.845 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -105.14 101.02 28.0 Favored Pre-proline 0 N--CA 1.435 -1.18 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -86.11 36.24 0.5 Allowed 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 123.061 2.507 . . . . 0.0 112.449 -173.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.69 137.37 54.08 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -61.25 -31.49 71.29 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 123.066 0.229 . . . . 0.0 111.475 -173.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.14 -35.27 66.47 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.814 0.34 . . . . 0.0 110.148 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 63.9 t -69.74 -41.44 79.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.316 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.8 mt -59.52 -48.12 82.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.064 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.7 m -64.58 -36.51 84.48 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.553 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -62.69 -52.29 63.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.083 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.43 -46.06 91.41 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.163 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 86.4 t90 -51.09 -48.84 61.57 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 123.944 0.778 . . . . 0.0 109.421 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.565 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 88.5 tttt -63.58 -57.17 10.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.072 -177.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.499 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 10.4 mp -58.32 -41.65 85.02 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.492 ' CH2' HG12 ' A' ' 89' ' ' VAL . 30.0 m0 -57.79 -52.35 65.83 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-O 120.739 0.304 . . . . 0.0 111.723 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.479 ' O ' HG13 ' A' ' 151' ' ' ILE . 14.5 tt -66.93 -39.07 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.765 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 53.0 mt-10 -60.65 -39.42 88.23 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 21.7 mm-40 -56.67 -44.49 81.45 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.97 0.414 . . . . 0.0 110.853 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -76.73 -30.26 56.54 Favored 'General case' 0 C--O 1.249 1.068 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.535 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 147' ' ' ILE . 74.7 mt -67.12 -45.7 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 122.23 0.212 . . . . 0.0 111.263 178.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -62.46 -38.68 90.75 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 149' ' ' GLU . 7.7 p -81.23 -54.63 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 69.2 p -105.82 -36.28 7.07 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.148 -173.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.68 17.95 57.45 Favored Glycine 0 C--N 1.311 -0.811 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.71 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -75.27 107.29 7.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 117.105 0.453 . . . . 0.0 109.82 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.2 106.75 33.15 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.4 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 13.1 Cg_endo -90.36 162.37 4.54 Favored 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 122.908 2.405 . . . . 0.0 112.913 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 162' ' ' LYS . 50.8 Cg_exo -60.66 -25.39 80.81 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.107 2.538 . . . . 0.0 112.844 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -64.87 -33.65 87.8 Favored Glycine 0 C--N 1.33 0.224 0 N-CA-C 114.348 0.499 . . . . 0.0 114.348 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -92.25 -19.55 22.07 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-O 121.454 0.645 . . . . 0.0 111.922 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.423 ' HZ2' ' HB3' ' A' ' 162' ' ' LYS . 7.8 mtpm? -70.55 130.99 43.29 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 173.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.2 m -55.33 109.78 0.59 Allowed 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -173.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 169.03 175.38 38.34 Favored Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -87.65 110.87 20.72 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.562 ' O ' ' HG2' ' A' ' 170' ' ' LYS . 28.2 t-20 -122.76 155.91 35.55 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.97 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.9 m -50.02 -32.74 16.03 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.665 1.186 . . . . 0.0 113.361 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -74.97 -19.54 60.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.404 ' O ' HD12 ' A' ' 173' ' ' LEU . 27.3 m -108.96 -12.67 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 120.805 0.336 . . . . 0.0 111.463 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 166' ' ' ASN . 13.1 ptmm? -106.43 85.21 2.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.062 0.934 . . . . 0.0 110.993 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 13.4 p -128.46 -136.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.499 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.7 m -41.45 -45.78 3.26 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.235 1.814 . . . . 0.0 112.844 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 169' ' ' VAL . 2.7 pp -64.15 -21.93 66.74 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -111.0 5.64 20.44 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.751 0.786 . . . . 0.0 111.212 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -81.8 -28.1 33.34 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 171.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -84.05 134.07 34.63 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -75.02 113.94 12.92 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -61.37 -28.82 69.51 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 123.877 0.735 . . . . 0.0 111.755 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 43.1 t60 58.16 31.18 20.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.294 1.038 . . . . 0.0 110.669 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 9.7 t60 . . . . . 0 C--N 1.301 -1.534 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 -178.564 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.512 -0.511 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.68 14.3 24.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.191 0.52 . . . . 0.0 110.228 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 130' ' ' ILE . 32.9 m -112.94 144.33 42.7 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 59.83 55.88 3.73 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.289 0.993 . . . . 0.0 109.427 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 t -92.02 137.78 21.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.482 -174.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -115.48 -51.91 2.67 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.2 p -107.28 156.72 18.57 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.98 -175.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.16 -24.17 66.6 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.37 1.068 . . . . 0.0 109.882 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.1 m -60.0 -26.88 66.4 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.218 1.007 . . . . 0.0 110.68 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -93.52 -10.42 34.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.385 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.472 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 3.1 m -81.13 126.15 31.12 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -172.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -79.85 155.45 27.82 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.916 0.388 . . . . 0.0 111.942 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -103.13 128.75 49.94 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 123.633 0.773 . . . . 0.0 109.873 -174.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -122.46 136.15 26.27 Favored Pre-proline 0 C--N 1.307 -1.255 0 C-N-CA 123.767 0.827 . . . . 0.0 109.212 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -73.52 140.02 29.31 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.355 2.037 . . . . 0.0 109.84 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.5 -11.24 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -174.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.8 t -71.41 -23.89 61.95 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.021 0.438 . . . . 0.0 110.308 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.96 53.79 0.68 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.208 1.004 . . . . 0.0 110.244 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.404 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -62.35 -22.11 65.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.177 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.85 -16.55 60.68 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.747 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.3 m -94.14 -1.9 53.51 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.099 0.476 . . . . 0.0 110.419 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 80' ' ' ALA . 43.4 mm -77.05 129.79 77.38 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.04 129.81 36.25 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.94 2.426 . . . . 0.0 113.236 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.5 p -90.81 65.77 5.87 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.633 0.73 . . . . 0.0 109.615 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.98 -177.88 4.83 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.999 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.3 t -99.03 143.34 29.42 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.37 -147.78 13.74 Favored Glycine 0 N--CA 1.415 -2.756 0 C-N-CA 119.462 -1.352 . . . . 0.0 112.725 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.496 HG13 ' CH2' ' A' ' 146' ' ' TRP . 5.0 p -127.34 149.0 32.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 C-N-CA 123.542 0.737 . . . . 0.0 109.235 -174.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -141.49 156.01 45.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 120.832 0.348 . . . . 0.0 110.197 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.46 121.08 33.88 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.299 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 50.2 t -96.88 119.03 44.41 Favored 'Isoleucine or valine' 0 C--O 1.259 1.557 0 CA-C-O 121.25 0.548 . . . . 0.0 110.582 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.545 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 47.3 m-85 -110.69 137.24 48.61 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.305 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 98' ' ' GLU . 2.8 p30 -80.58 -169.46 2.15 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.736 -0.785 . . . . 0.0 110.657 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -57.73 -23.78 53.68 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.371 1.069 . . . . 0.0 112.688 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.2 t -108.91 17.53 21.67 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 120.718 0.294 . . . . 0.0 111.143 -174.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.2 t70 66.71 20.78 10.67 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 123.028 1.394 . . . . 0.0 110.713 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.478 ' HB2' ' OD2' ' A' ' 94' ' ' ASP . 80.5 mm-40 -83.64 104.26 13.62 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.856 175.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.545 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.0 tm? -66.19 115.46 6.21 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 174.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -122.64 -13.5 7.94 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -148.17 125.4 11.51 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.169 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.444 HG23 ' NE1' ' A' ' 143' ' ' TRP . 21.9 m -117.08 143.77 26.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 171.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -150.66 157.58 27.26 Favored Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 119.693 -1.241 . . . . 0.0 112.249 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.2 pt -117.36 134.55 60.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.2 m -146.49 161.96 39.33 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.009 0.433 . . . . 0.0 111.574 -175.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -76.9 -34.25 57.73 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.255 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -132.71 109.31 9.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.8 mt -56.76 -58.14 6.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.774 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.85 -50.26 64.12 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.1 -50.27 72.61 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.569 0.543 . . . . 0.0 111.193 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.4 t -63.3 -52.14 63.17 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.213 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.5 t -55.54 -53.94 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 C-N-CA 123.012 0.525 . . . . 0.0 110.529 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.3 m -58.32 -47.49 83.55 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 123.792 0.683 . . . . 0.0 111.381 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.58 -58.18 8.87 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 123.483 0.489 . . . . 0.0 111.617 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -72.13 -26.4 62.1 Favored 'General case' 0 C--O 1.209 -1.066 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.8 mt -74.78 -28.01 60.56 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.416 -0.913 . . . . 0.0 111.159 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -87.08 -3.75 59.1 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.433 0.635 . . . . 0.0 110.483 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.9 m -95.28 -51.07 4.75 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.16 97.95 27.84 Favored Pre-proline 0 N--CA 1.428 -1.539 0 CA-C-O 121.597 0.713 . . . . 0.0 111.108 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.798 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 6.5 Cg_exo -77.53 24.64 0.5 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.66 2.907 . . . . 0.0 113.156 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -62.17 -41.39 98.27 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.301 1.04 . . . . 0.0 110.72 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.3 mt -119.94 21.19 11.99 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.099 -172.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.798 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 72.9 m -74.27 88.99 2.03 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.169 0.509 . . . . 0.0 112.276 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.39 -55.18 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.4 p -161.97 161.6 28.68 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.6 p -139.75 139.28 38.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 120.982 0.42 . . . . 0.0 110.372 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.472 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 63.0 mttm -108.03 129.72 55.11 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 26.2 m -120.16 139.35 47.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.884 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.24 114.44 1.64 Allowed Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 130' ' ' ILE . 2.7 mp -90.66 113.42 26.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.6 p -101.25 142.46 15.97 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -88.46 -5.61 58.14 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.204 0.526 . . . . 0.0 111.907 -171.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -125.93 92.27 46.45 Favored Pre-proline 0 N--CA 1.43 -1.445 0 CA-C-O 121.683 0.754 . . . . 0.0 109.222 174.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.39 46.75 1.89 Allowed 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 123.617 2.878 . . . . 0.0 111.892 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -80.54 141.53 35.03 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -53.26 -39.34 63.8 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.66 -38.53 64.92 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.486 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.9 t -70.52 -40.39 77.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.957 0.408 . . . . 0.0 110.149 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 92.6 mt -61.1 -48.03 83.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.347 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 36.4 m -68.47 -30.61 69.51 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.913 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.507 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 58.4 tt0 -62.93 -54.13 43.3 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.82 96.82 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 123.932 0.77 . . . . 0.0 109.869 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.444 ' NE1' HG23 ' A' ' 102' ' ' VAL . 89.9 t90 -52.31 -49.31 64.45 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.923 0.764 . . . . 0.0 109.755 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -63.03 -47.08 84.56 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.416 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.565 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 80.5 mt -59.2 -49.54 77.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.079 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.496 ' CH2' HG13 ' A' ' 89' ' ' VAL . 26.0 m0 -62.56 -48.26 80.27 Favored 'General case' 0 C--O 1.256 1.402 0 O-C-N 123.995 0.81 . . . . 0.0 112.068 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.591 ' O ' HG12 ' A' ' 151' ' ' ILE . 9.1 tt -63.01 -43.25 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.364 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.528 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 31.9 mt-10 -60.42 -29.91 69.29 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 6.6 mm-40 -59.68 -49.31 78.22 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.426 ' CG ' ' HB3' ' A' ' 99' ' ' LEU 0.259 17.2 m-70 -78.5 -22.08 47.96 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -178.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 147' ' ' ILE . 48.3 mm -60.51 -42.6 91.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 148' ' ' GLU . 39.9 mttm -81.6 -46.34 14.55 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.176 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 149' ' ' GLU . 30.7 m -78.73 -46.49 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.4 p -110.88 -6.56 14.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 119.04 -1.064 . . . . 0.0 112.697 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.42 26.12 70.48 Favored Glycine 0 C--N 1.336 0.541 0 O-C-N 123.742 0.651 . . . . 0.0 113.803 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -91.36 109.02 20.29 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.18 0.514 . . . . 0.0 112.041 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 t -131.41 78.94 70.79 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -90.4 160.53 4.51 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.177 2.585 . . . . 0.0 112.426 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.54 -34.27 19.68 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 124.354 3.37 . . . . 0.0 115.047 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -69.34 -27.38 73.67 Favored Glycine 0 CA--C 1.501 -0.833 0 C-N-CA 121.375 -0.44 . . . . 0.0 112.595 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.408 ' ND2' HD11 ' A' ' 147' ' ' ILE . 0.2 OUTLIER -103.39 -20.41 14.09 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.244 0.545 . . . . 0.0 109.75 -177.092 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -75.73 -69.01 0.52 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.8 p -92.85 155.15 17.81 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -78.68 78.22 1.68 Allowed Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.496 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -64.62 120.05 11.65 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -56.15 -33.51 65.28 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 124.298 1.039 . . . . 0.0 112.514 -173.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.2 m -64.49 -34.56 78.49 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 120.806 0.336 . . . . 0.0 110.85 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.41 -56.53 3.27 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.75 -32.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp 60.06 12.5 3.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.681 1.192 . . . . 0.0 114.014 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.03 0.76 10.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 CA-C-O 122.873 1.32 . . . . 0.0 108.872 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 4.9 m -99.33 66.94 1.53 Allowed 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.758 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.79 110.0 1.2 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.773 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 70.15 -62.12 0.44 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.727 1.611 . . . . 0.0 111.122 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -141.09 178.18 7.55 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 125.053 1.341 . . . . 0.0 108.027 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -63.01 116.11 5.02 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -79.21 139.48 37.94 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.246 0.546 . . . . 0.0 111.292 -175.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -111.22 103.45 11.87 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.081 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 78.3 t60 66.62 88.22 0.11 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.114 0.884 . . . . 0.0 112.165 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 3.0 t60 . . . . . 0 C--N 1.314 -0.935 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.468 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.466 0.372 0 CA-C-O 120.444 0.164 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -126.61 -21.55 4.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.981 0.42 . . . . 0.0 110.278 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.2 t -140.84 -68.72 0.4 Allowed 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 38.84 96.52 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.725 1.61 . . . . 0.0 115.068 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.43 110.16 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.068 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -56.11 -60.49 3.41 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -168.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.513 ' HB2' ' OE1' ' A' ' 149' ' ' GLU . 36.9 p -149.65 170.3 19.01 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.98 -176.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.4 HD22 ' CE3' ' A' ' 146' ' ' TRP . 17.8 mt -71.4 -23.45 61.88 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 123.423 0.689 . . . . 0.0 110.31 177.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 m -63.6 -25.51 68.26 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.862 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -102.7 8.08 39.61 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.1 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.5 m -103.57 141.06 36.67 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 122.001 -0.437 . . . . 0.0 110.768 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.01 151.41 35.62 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-O 120.921 0.391 . . . . 0.0 111.116 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -107.0 133.17 52.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.678 -173.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.33 132.07 24.31 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 123.312 0.645 . . . . 0.0 109.551 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -70.47 139.41 37.72 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.333 2.022 . . . . 0.0 109.48 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.76 -7.05 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -174.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 t -69.7 -31.13 68.99 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.103 0.478 . . . . 0.0 109.726 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -98.49 53.68 1.04 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.901 0.858 . . . . 0.0 109.767 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.94 -28.62 57.75 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.842 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.36 -33.17 65.44 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.245 1.018 . . . . 0.0 111.627 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.8 m -96.88 12.59 31.69 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -172.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.6 mm -80.93 128.13 72.38 Favored Pre-proline 0 N--CA 1.446 -0.642 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.73 130.74 40.15 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.143 2.562 . . . . 0.0 114.128 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.1 p -92.97 31.68 1.38 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 122.178 0.99 . . . . 0.0 110.655 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.75 -179.09 3.84 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.114 -177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 t -93.6 147.86 22.62 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.59 -150.09 21.19 Favored Glycine 0 N--CA 1.419 -2.488 0 C-N-CA 119.692 -1.242 . . . . 0.0 112.686 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 m -115.42 149.02 17.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 124.336 1.055 . . . . 0.0 109.55 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -144.22 160.24 41.31 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -141.02 131.68 25.6 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.707 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.1 t -106.61 126.84 62.4 Favored 'Isoleucine or valine' 0 C--O 1.26 1.615 0 CA-C-O 121.097 0.475 . . . . 0.0 110.669 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -113.19 135.13 54.16 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.469 1.107 . . . . 0.0 108.551 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -85.56 -170.26 3.03 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.553 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -63.06 -25.38 68.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.76 0.824 . . . . 0.0 111.372 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.3 m -82.39 4.78 22.68 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.112 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.5 t70 69.77 19.16 7.28 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.474 1.11 . . . . 0.0 111.621 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -111.12 147.09 35.63 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.596 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.406 HD11 HG12 ' A' ' 102' ' ' VAL . 2.8 tm? -78.27 125.85 29.94 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.264 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.411 ' O ' ' HG2' ' A' ' 158' ' ' PRO . 50.0 mt-30 -127.92 -13.84 5.12 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 123.925 0.766 . . . . 0.0 112.634 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.452 ' HA ' ' OD1' ' A' ' 161' ' ' ASN . 92.5 t80 -147.63 120.66 8.81 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.515 -0.874 . . . . 0.0 112.741 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.406 HG12 HD11 ' A' ' 99' ' ' LEU . 17.5 m -109.95 142.11 23.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 170.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -146.36 167.76 27.93 Favored Glycine 0 C--N 1.294 -1.759 0 C-N-CA 119.987 -1.101 . . . . 0.0 112.422 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.0 pt -125.86 147.98 30.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.4 t -157.17 164.08 38.17 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.113 0.483 . . . . 0.0 110.032 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.1 -17.9 24.32 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -142.81 87.09 1.97 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 77.7 mt -47.24 -54.94 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.483 1.113 . . . . 0.0 113.231 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.27 -30.57 12.13 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.54 -57.91 3.67 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.2 m -60.56 -43.95 96.69 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.462 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.7 t -58.48 -60.19 2.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.075 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.6 m -60.73 -44.01 97.18 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 123.827 0.705 . . . . 0.0 110.813 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.39 -50.69 72.57 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.114 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -77.05 -25.27 52.25 Favored 'General case' 0 C--O 1.204 -1.305 0 C-N-CA 118.343 -1.343 . . . . 0.0 112.056 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 64.2 mt -73.93 -28.66 61.63 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.612 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.39 -7.41 59.31 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.294 175.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.7 m -90.01 -52.96 4.7 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 121' ' ' GLU . 16.9 m -117.65 102.4 51.7 Favored Pre-proline 0 N--CA 1.435 -1.193 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.794 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 16.4 Cg_exo -73.33 4.03 4.2 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.858 2.372 . . . . 0.0 110.575 173.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 119' ' ' VAL . 12.2 tp10 -55.83 -44.36 77.87 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 125.328 1.451 . . . . 0.0 111.0 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 75.1 mt -105.35 11.15 33.11 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.407 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.794 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 90.4 m -67.95 96.66 0.61 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.621 0.724 . . . . 0.0 111.873 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.4 -63.31 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.569 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 174.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.3 p -155.64 162.13 40.66 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.35 137.83 33.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -108.22 142.21 38.82 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.68 137.57 56.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 120.698 0.285 . . . . 0.0 110.904 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.73 108.92 0.83 Allowed Glycine 0 N--CA 1.423 -2.223 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.51 113.4 23.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.98 132.32 46.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -69.02 -27.29 65.54 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.9 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -85.01 110.7 30.35 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -97.07 19.0 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.752 2.301 . . . . 0.0 113.607 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.526 ' O ' HG21 ' A' ' 138' ' ' VAL . 14.8 t70 -72.97 140.09 47.16 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -57.93 -33.12 68.46 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.61 -38.73 47.47 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.187 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 135' ' ' ASP . 10.5 m -71.3 -31.96 45.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.316 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.2 mt -62.36 -46.1 90.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.1 m -69.34 -30.59 68.66 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.43 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.483 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 29.7 tt0 -66.68 -47.43 72.46 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 122.781 0.433 . . . . 0.0 110.778 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.22 90.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -50.88 -45.47 60.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.5 1.12 . . . . 0.0 110.027 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.75 -48.09 83.36 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.645 1.178 . . . . 0.0 111.31 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 69.6 mt -63.77 -41.57 97.94 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.128 0.489 . . . . 0.0 110.543 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.4 ' CE3' HD22 ' A' ' 69' ' ' LEU . 24.7 m0 -62.24 -50.62 71.0 Favored 'General case' 0 C--O 1.257 1.499 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.971 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.483 ' O ' HG13 ' A' ' 151' ' ' ILE . 14.1 tt -66.71 -40.73 86.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.285 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -65.38 -34.44 78.31 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.513 ' OE1' ' HB2' ' A' ' 68' ' ' SER . 3.8 pt-20 -63.12 -37.36 86.91 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 118.282 -1.367 . . . . 0.0 109.225 176.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.408 ' HA ' HG12 ' A' ' 153' ' ' VAL 0.263 72.8 m-70 -73.91 -31.91 63.3 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 177.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 147' ' ' ILE . 71.1 mt -61.35 -38.27 79.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 174.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -83.0 -20.96 34.08 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 149' ' ' GLU . 12.6 p -101.75 -41.42 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.9 t -113.16 -19.33 11.87 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.546 -0.721 . . . . 0.0 111.714 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.58 8.61 82.78 Favored Glycine 0 C--O 1.239 0.44 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.449 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -76.91 128.32 34.33 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.8 p -158.6 77.37 3.3 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 113.192 -1.822 . . . . 0.0 106.725 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.411 ' HG2' ' O ' ' A' ' 100' ' ' GLN . 2.8 Cg_exo -83.42 167.55 13.5 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.925 3.083 . . . . 0.0 113.893 -175.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.472 ' HA ' ' HB2' ' A' ' 162' ' ' LYS . 11.3 Cg_endo -54.18 -13.82 5.49 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 125.184 3.923 . . . . 0.0 115.475 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -70.85 -42.29 61.11 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 175.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 101' ' ' PHE . 18.9 m120 -91.61 -30.77 16.17 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-O 121.007 0.432 . . . . 0.0 110.985 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 159' ' ' PRO . 56.0 mtpt -72.8 161.42 30.75 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 172.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.1 m -76.2 101.23 5.31 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.95 -61.03 0.02 OUTLIER Glycine 0 N--CA 1.426 -2.03 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.017 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -125.61 128.25 47.59 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 117.048 0.424 . . . . 0.0 111.693 -174.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -92.47 -12.18 32.71 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 15.8 m -60.94 -16.8 46.58 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-O 121.713 0.768 . . . . 0.0 112.217 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -82.94 -13.72 55.51 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.547 -0.72 . . . . 0.0 111.612 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.24 -33.48 2.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 57.4 tttp 77.01 135.79 0.06 Allowed 'General case' 0 C--O 1.243 0.75 0 C-N-CA 126.197 1.799 . . . . 0.0 109.84 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 32.8 t -83.3 80.56 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.709 0.766 . . . . 0.0 110.224 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 12.9 p -115.07 -47.67 2.85 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.701 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 76.07 -179.78 0.16 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.0 1.32 . . . . 0.0 112.509 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -42.12 95.26 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -95.66 95.16 8.16 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 168.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -56.79 99.15 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -168.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -100.6 169.23 9.19 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.492 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -108.68 106.84 17.06 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -125.29 -70.21 0.76 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.038 0.447 . . . . 0.0 110.126 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 . . . . . 0 C--N 1.303 -1.425 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.467 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 CA--C 1.496 -1.108 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.28 150.02 40.81 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.5 m -77.09 115.85 17.23 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 79.46 145.62 0.09 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.136 1.374 . . . . 0.0 111.704 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 t -59.43 136.2 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.917 0.887 . . . . 0.0 110.984 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -86.52 -77.48 0.31 Allowed 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.5 p -120.63 176.24 5.61 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.34 -33.0 70.6 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.114 1.366 . . . . 0.0 112.379 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -67.19 -16.25 64.19 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.902 0.858 . . . . 0.0 110.508 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -109.23 13.13 24.54 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.343 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.2 m -105.05 155.28 19.13 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.731 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -94.88 151.61 19.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.441 HD22 ' HZ3' ' A' ' 127' ' ' LYS . 3.1 tm? -104.59 133.22 49.82 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.396 0.617 . . . . 0.0 110.661 -174.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -127.91 136.19 28.63 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 115.098 -0.955 . . . . 0.0 108.601 176.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -71.16 140.84 38.33 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.209 1.939 . . . . 0.0 109.405 172.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.67 -11.65 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.105 0.478 . . . . 0.0 111.51 -174.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.9 p -68.51 -39.58 81.18 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.09 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -96.95 54.13 1.25 Allowed 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.342 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.426 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -61.9 -17.57 57.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.746 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.78 -23.79 64.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.585 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.9 m -88.69 -0.57 57.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.631 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.426 HG12 ' HA ' ' A' ' 80' ' ' ALA . 45.3 mm -77.82 133.91 65.46 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -56.21 129.61 35.75 Favored 'Trans proline' 0 C--O 1.251 1.155 0 C-N-CA 122.196 1.93 . . . . 0.0 112.413 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.8 p -95.13 70.86 3.28 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 121.873 0.844 . . . . 0.0 108.995 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.06 -176.34 5.05 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.064 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.6 t -97.68 134.82 40.35 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.977 0.418 . . . . 0.0 110.099 -173.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.34 -152.17 19.9 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.509 HG11 ' CH2' ' A' ' 146' ' ' TRP . 6.2 p -124.71 147.34 29.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -177.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -135.95 151.89 50.41 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 120.756 0.312 . . . . 0.0 110.223 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.08 123.16 41.68 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.081 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.5 t -95.46 118.35 41.47 Favored 'Isoleucine or valine' 0 C--O 1.263 1.773 0 C-N-CA 123.387 0.675 . . . . 0.0 110.32 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.496 ' CE1' ' HB2' ' A' ' 99' ' ' LEU . 96.8 m-85 -106.91 134.53 49.93 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.113 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.488 ' O ' ' HA3' ' A' ' 124' ' ' GLY . 3.9 p-10 -78.64 -166.96 0.96 Allowed 'General case' 0 C--N 1.317 -0.822 0 O-C-N 123.666 0.604 . . . . 0.0 111.116 -175.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 123' ' ' CYS . 75.4 mmtt -53.0 -34.57 56.84 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.719 1.208 . . . . 0.0 111.311 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.5 m -82.31 -2.93 54.26 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.192 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.9 t70 67.44 23.44 9.08 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.677 1.191 . . . . 0.0 108.297 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.449 ' OE1' HG23 ' A' ' 154' ' ' THR . 0.1 OUTLIER -99.67 158.71 15.58 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.496 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 3.5 tm? -97.71 124.57 42.09 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.69 0.757 . . . . 0.0 111.612 -169.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.473 HE21 ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -119.75 -45.91 2.48 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.738 173.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -124.88 134.63 52.63 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.525 -173.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.549 HG21 HD22 ' A' ' 161' ' ' ASN . 17.4 m -126.2 145.2 34.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -150.95 155.76 26.32 Favored Glycine 0 N--CA 1.42 -2.379 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.964 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.8 pt -110.56 139.14 35.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.0 t -142.93 155.03 44.64 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.358 0.599 . . . . 0.0 110.664 -175.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -87.04 -26.29 23.8 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -142.93 84.74 1.85 Allowed 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 69.5 mt -44.47 -58.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.245 1.418 . . . . 0.0 114.767 -172.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.2 -44.48 22.37 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.13 -34.29 76.08 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.2 t -79.53 -45.81 18.56 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.9 -53.54 36.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.066 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.4 p -61.63 -44.83 96.25 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 123.47 0.481 . . . . 0.0 111.625 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.13 -61.3 2.56 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -78.14 -23.78 47.61 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 119.014 -1.074 . . . . 0.0 113.827 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.421 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 80.7 mt -81.83 -30.7 32.02 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.413 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -88.21 -9.88 51.58 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.04 -1.064 . . . . 0.0 109.826 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.3 t -82.94 -47.37 11.85 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.34 95.14 18.56 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-O 121.765 0.793 . . . . 0.0 110.339 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.809 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 2.8 Cg_exo -76.65 24.47 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.64 2.893 . . . . 0.0 114.499 -176.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.57 -42.47 82.53 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.428 0.632 . . . . 0.0 111.078 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 75.4 mt -102.95 21.27 15.97 Favored 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.558 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.809 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 84.0 m -85.81 105.03 16.03 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 94' ' ' ASP . . . -137.81 -58.95 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 173.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 56.9 p -156.4 169.09 25.4 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.1 p -142.09 133.97 26.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.092 0.472 . . . . 0.0 109.924 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.441 ' HZ3' HD22 ' A' ' 74' ' ' LEU . 56.4 mttp -106.94 125.83 51.52 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.5 m -113.34 135.22 53.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.254 0.549 . . . . 0.0 111.286 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.77 98.31 0.67 Allowed Glycine 0 N--CA 1.414 -2.798 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.373 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 40.5 mm -75.75 112.44 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.101 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.5 m -98.39 145.95 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.113 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -71.26 -36.94 71.92 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.208 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -92.39 105.09 12.85 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -93.76 27.78 0.32 Allowed 'Trans proline' 0 C--O 1.243 0.748 0 C-N-CA 122.737 2.291 . . . . 0.0 113.352 -174.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.443 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 15.7 t70 -89.98 144.12 26.19 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -53.38 -34.31 57.17 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.51 68.68 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.78 -34.72 61.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.762 -175.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 96.6 mt -62.17 -53.44 55.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.156 175.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.5 m -66.9 -30.48 70.64 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.326 0.584 . . . . 0.0 110.373 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -65.01 -50.91 64.43 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 123.656 0.782 . . . . 0.0 109.425 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.42 -43.61 98.57 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.488 ' NE1' HG23 ' A' ' 102' ' ' VAL . 79.6 t90 -52.73 -46.66 67.51 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.119 176.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -66.79 -44.88 80.1 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.211 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.543 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 11.1 mp -61.14 -41.77 97.33 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.151 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.509 ' CH2' HG11 ' A' ' 89' ' ' VAL . 33.6 m0 -62.38 -50.66 70.69 Favored 'General case' 0 C--O 1.254 1.314 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 151' ' ' ILE . 8.9 tt -62.51 -40.73 89.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.382 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.37 -32.49 74.16 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 22.3 mm-40 -56.12 -41.63 75.57 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.724 0.773 . . . . 0.0 109.96 175.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . 0.321 5.4 m-70 -83.46 -26.37 30.35 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.297 -1.361 . . . . 0.0 113.768 176.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 147' ' ' ILE . 73.6 mt -61.22 -42.61 94.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 O-C-N 121.974 -0.454 . . . . 0.0 110.372 173.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -69.43 -34.7 74.82 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.1 p -92.01 -40.81 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.449 HG23 ' OE1' ' A' ' 98' ' ' GLU . 3.7 t -118.55 -35.28 3.78 Favored 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -176.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 74.76 34.3 53.65 Favored Glycine 0 N--CA 1.47 0.962 0 C-N-CA 120.429 -0.891 . . . . 0.0 114.207 175.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -65.23 -66.37 0.55 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.28 12.2 p 41.13 75.99 0.55 Allowed Pre-proline 0 CA--C 1.573 1.859 0 C-N-CA 125.002 1.321 . . . . 0.0 113.951 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -90.72 161.49 4.19 Favored 'Trans proline' 0 CA--C 1.556 1.603 0 C-N-CA 123.245 2.63 . . . . 0.0 114.085 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -50.38 -34.12 39.98 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 124.435 3.423 . . . . 0.0 114.472 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 165' ' ' ASN . . . -59.35 -45.33 95.62 Favored Glycine 0 CA--C 1.495 -1.194 0 CA-C-O 121.121 0.29 . . . . 0.0 112.762 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.549 HD22 HG21 ' A' ' 102' ' ' VAL . 34.0 t-20 -76.76 -25.75 53.76 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.42 1.105 . . . . 0.0 108.715 -174.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -83.77 0.8 45.83 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.333 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.0 m 68.83 13.8 8.88 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.525 1.13 . . . . 0.0 111.854 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -80.06 -23.42 61.48 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.421 ' HB3' ' HA2' ' A' ' 160' ' ' GLY . 24.5 t30 -105.89 112.79 25.99 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -73.06 -25.93 61.09 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.046 -174.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.3 m -48.77 -35.27 13.94 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -171.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 -72.04 -21.3 61.55 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.2 m -124.62 13.23 4.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.481 0.658 . . . . 0.0 110.086 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -87.5 33.4 0.7 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.925 0.869 . . . . 0.0 110.128 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.75 90.76 2.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 4.9 m -145.63 123.27 11.81 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -80.31 -69.61 0.58 Allowed 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.57 151.92 22.61 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -80.14 144.61 32.9 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 121.172 -0.211 . . . . 0.0 110.767 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -70.78 110.04 5.33 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -91.29 169.51 10.75 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.695 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 41.9 m80 76.69 179.42 0.16 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.837 1.255 . . . . 0.0 109.077 -173.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -97.25 90.82 5.25 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 75.9 t60 . . . . . 0 C--N 1.304 -1.402 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.436 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.5 ttm . . . . . 0 CA--C 1.506 -0.741 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -158.61 -179.0 7.68 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.5 m -144.65 73.69 1.38 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 64.01 -173.91 0.17 Allowed 'General case' 0 C--O 1.245 0.855 0 CA-C-N 114.299 -1.318 . . . . 0.0 111.125 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.1 t -76.73 126.47 37.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.39 -77.49 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.323 0.582 . . . . 0.0 111.578 -174.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.495 ' HA ' ' CD1' ' A' ' 146' ' ' TRP . 70.1 m -147.89 -178.78 6.46 Favored 'General case' 0 N--CA 1.413 -2.278 0 O-C-N 122.001 -0.437 . . . . 0.0 110.495 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -54.44 -24.75 21.39 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.785 1.634 . . . . 0.0 113.725 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.1 m -66.56 -29.14 69.15 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.103 0.478 . . . . 0.0 111.296 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -107.74 11.24 28.5 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.522 0.677 . . . . 0.0 110.911 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 m -97.17 136.03 38.27 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.409 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 12.6 pt-20 -74.45 149.59 40.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.705 0.288 . . . . 0.0 111.148 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -112.99 126.2 55.23 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.351 0.66 . . . . 0.0 109.294 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.98 135.11 24.57 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -71.63 138.68 32.6 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.256 1.971 . . . . 0.0 109.189 172.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.4 -8.78 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.262 -176.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.0 t -67.35 -23.04 65.56 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -112.93 53.26 0.76 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.12 -22.81 52.57 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.724 1.21 . . . . 0.0 112.413 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.23 -28.09 69.5 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.369 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.6 t -88.6 9.37 24.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.885 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.5 mm -80.31 129.05 70.88 Favored Pre-proline 0 C--N 1.314 -0.955 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.43 130.29 39.79 Favored 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.982 2.455 . . . . 0.0 113.34 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.5 p -92.39 80.18 4.94 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.282 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.81 -179.44 6.99 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.469 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.9 t -100.82 134.74 43.35 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.61 -150.2 14.69 Favored Glycine 0 N--CA 1.418 -2.53 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.33 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.515 HG12 ' CH2' ' A' ' 146' ' ' TRP . 7.6 p -122.86 149.78 26.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -137.85 155.3 49.13 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.25 115.58 20.61 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 123.518 0.727 . . . . 0.0 109.559 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.4 t -91.6 121.51 42.14 Favored 'Isoleucine or valine' 0 C--O 1.258 1.528 0 CA-C-O 121.097 0.475 . . . . 0.0 110.944 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.512 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 61.8 m-85 -109.86 131.66 54.86 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 124.154 0.982 . . . . 0.0 108.651 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.489 ' OD1' ' HB2' ' A' ' 98' ' ' GLU . 1.3 p-10 -78.64 -168.16 1.31 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -64.18 -24.92 67.85 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 123.168 0.587 . . . . 0.0 110.812 -176.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.0 m -81.91 2.2 31.64 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.025 0.53 . . . . 0.0 112.065 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.2 t70 68.92 24.76 6.26 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 123.419 1.58 . . . . 0.0 108.866 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.489 ' HB2' ' OD1' ' A' ' 94' ' ' ASP . 24.0 mm-40 -96.73 115.53 27.59 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.689 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.512 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 2.4 tm? -68.68 113.14 5.9 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 173.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.441 ' HB3' ' HG2' ' A' ' 158' ' ' PRO . 22.0 mt-30 -125.31 -13.21 6.71 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.692 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -146.57 114.96 6.7 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.563 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.428 HG22 ' NE1' ' A' ' 143' ' ' TRP . 27.4 m -103.41 149.86 7.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 172.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -160.35 152.47 23.24 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 119.502 -1.333 . . . . 0.0 112.419 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.5 pt -112.78 140.51 32.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.0 m -150.89 169.57 21.41 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -76.93 -42.96 37.25 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.455 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -138.8 98.55 3.58 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 65.1 mt -44.13 -57.41 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 125.05 1.34 . . . . 0.0 114.23 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.3 -41.94 63.36 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.76 -41.74 74.77 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.052 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.3 t -66.04 -49.05 69.06 Favored 'General case' 0 C--O 1.254 1.302 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.814 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 72.6 t -57.38 -53.51 42.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.097 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.1 t -62.92 -35.65 80.79 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.362 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.13 -61.77 2.32 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.95 -0.469 . . . . 0.0 112.019 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -79.29 -22.99 43.87 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.409 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 67.8 mt -76.63 -25.34 53.73 Favored 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.403 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -87.75 -18.67 28.91 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.822 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.8 m -74.41 -47.1 35.91 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -138.99 95.07 9.67 Favored Pre-proline 0 CA--C 1.554 1.12 0 CA-C-O 121.807 0.813 . . . . 0.0 110.28 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.627 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 11.7 Cg_exo -74.07 24.13 0.35 Allowed 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 123.859 3.039 . . . . 0.0 115.036 -176.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -65.27 -43.37 91.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.33 0.586 . . . . 0.0 109.87 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.2 mt -99.4 19.91 14.7 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.167 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.627 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 98.3 m -74.01 94.25 2.34 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.347 0.594 . . . . 0.0 111.722 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.84 -68.01 0.06 OUTLIER Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.4 p -159.71 163.26 34.9 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.72 140.7 40.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 120.963 0.411 . . . . 0.0 110.341 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 92.2 mttt -106.11 126.35 52.1 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.6 m -113.38 133.84 57.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.007 0.432 . . . . 0.0 111.405 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -124.82 101.54 0.66 Allowed Glycine 0 N--CA 1.417 -2.596 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 130' ' ' ILE . 2.1 mp -84.72 109.67 18.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.33 164.36 2.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.135 -173.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -59.39 -62.74 1.65 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.775 0.672 . . . . 0.0 110.937 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 135' ' ' ASP . 18.7 mm-40 -99.92 146.55 32.09 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -82.31 32.47 0.52 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 122.405 2.07 . . . . 0.0 109.92 172.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 133' ' ' GLU . 13.5 t70 -77.01 135.36 38.66 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.653 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -58.81 -31.63 68.63 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.31 -46.04 51.92 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.481 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 135' ' ' ASP . 11.9 m -68.42 -32.65 56.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.756 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 94.5 mt -65.25 -51.3 61.69 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.903 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.4 m -65.65 -35.32 80.46 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.721 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.501 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 28.2 tt0 -61.67 -52.67 63.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.47 -42.39 99.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.545 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.428 ' NE1' HG22 ' A' ' 102' ' ' VAL . 84.6 t90 -53.5 -50.95 64.3 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.476 0.71 . . . . 0.0 109.497 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 58.9 tttm -59.97 -52.56 64.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.387 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.58 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 85.5 mt -58.54 -49.76 76.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.376 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.515 ' CH2' HG12 ' A' ' 89' ' ' VAL . 41.8 m0 -59.32 -48.77 80.36 Favored 'General case' 0 C--O 1.249 1.038 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.502 ' O ' HG13 ' A' ' 151' ' ' ILE . 12.6 tt -63.42 -42.75 97.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.795 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 45.2 mt-10 -62.68 -33.31 74.82 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.72 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 20.6 mm-40 -55.92 -51.06 68.96 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.311 0.577 . . . . 0.0 110.447 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.479 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 2.7 t60 -77.89 -21.19 51.61 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.281 -175.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 147' ' ' ILE . 68.1 mt -68.99 -32.28 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.189 0.519 . . . . 0.0 109.889 175.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 148' ' ' GLU . 74.9 mmtt -77.71 -48.27 17.1 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.058 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.28 -56.8 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 47.0 p -106.16 -27.59 10.98 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.339 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 151' ' ' ILE . . . 98.11 31.84 6.39 Favored Glycine 0 CA--C 1.502 -0.777 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.947 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -94.25 101.81 13.8 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.8 p -129.45 79.24 74.29 Favored Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.441 ' HG2' ' HB3' ' A' ' 100' ' ' GLN . 4.2 Cg_exo -84.47 165.88 12.31 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.6 2.867 . . . . 0.0 113.738 -172.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -47.87 -27.77 8.99 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 124.889 3.726 . . . . 0.0 114.807 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -63.86 -39.83 97.77 Favored Glycine 0 CA--C 1.523 0.548 0 O-C-N 123.305 0.378 . . . . 0.0 112.473 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -94.65 -20.82 19.24 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 121.042 0.448 . . . . 0.0 111.202 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -76.53 171.43 14.65 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.802 174.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 6.8 m -78.57 141.46 38.08 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.01 -11.79 11.65 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.202 -0.999 . . . . 0.0 114.112 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -114.5 129.71 56.68 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 117.621 0.71 . . . . 0.0 110.546 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -113.61 -8.89 13.27 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.984 0.421 . . . . 0.0 109.882 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.9 m -59.8 -43.38 94.47 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 122.834 0.454 . . . . 0.0 111.397 -176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -87.24 -14.03 42.16 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.882 0.372 . . . . 0.0 111.292 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.5 t -95.0 -9.71 9.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.553 0.692 . . . . 0.0 110.169 -176.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -77.09 79.58 3.62 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.761 0.791 . . . . 0.0 110.962 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.9 p -104.3 -33.36 3.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.792 173.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 14.9 t -128.53 146.98 50.67 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 68.31 164.42 0.23 Allowed 'General case' 0 C--O 1.245 0.829 0 CA-C-O 121.805 0.812 . . . . 0.0 111.974 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -92.55 -19.48 21.9 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.343 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 70.72 -44.02 0.57 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.304 1.442 . . . . 0.0 112.714 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -72.32 109.84 6.33 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -72.65 134.65 45.2 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 59.45 67.78 0.86 Allowed 'General case' 0 CA--C 1.506 -0.74 0 O-C-N 124.191 0.932 . . . . 0.0 108.764 -167.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -86.4 75.79 9.74 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.465 1.126 . . . . 0.0 110.082 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 3.7 t60 . . . . . 0 N--CA 1.416 -2.147 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -178.51 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 CA--C 1.512 -0.493 0 CA-C-O 120.857 0.361 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -140.17 -58.84 0.54 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.0 m -163.7 98.35 0.88 Allowed 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.03 171.38 10.78 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.8 p -101.66 157.64 4.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 11.0 mmpt? -82.58 -173.53 4.67 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 122.893 0.477 . . . . 0.0 110.786 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 p -78.56 163.48 25.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 123.327 0.651 . . . . 0.0 110.87 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.497 ' HG ' ' CG ' ' A' ' 146' ' ' TRP . 10.7 mt -51.82 -33.26 35.02 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -177.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.8 m -62.35 -25.87 68.14 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.958 0.409 . . . . 0.0 110.71 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -96.98 -12.05 23.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.217 0.532 . . . . 0.0 110.341 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.8 m -78.55 145.96 34.55 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.11 -174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -84.01 153.39 23.88 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.258 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -108.87 134.81 51.05 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 124.413 1.085 . . . . 0.0 109.684 -173.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -125.43 138.72 32.34 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -72.63 141.86 35.12 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.71 2.274 . . . . 0.0 110.627 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.58 -13.76 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.451 -176.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.3 t -66.48 -28.86 68.91 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.432 0.634 . . . . 0.0 110.206 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -103.49 53.79 0.76 Allowed 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.929 0.871 . . . . 0.0 109.408 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.43 -18.56 18.69 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.789 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.55 -24.34 45.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.013 0.435 . . . . 0.0 110.077 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.1 m -88.43 -1.28 57.95 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.982 0.42 . . . . 0.0 111.234 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.9 mm -72.18 128.15 89.41 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -51.5 132.67 41.22 Favored 'Trans proline' 0 C--O 1.241 0.657 0 C-N-CA 123.525 2.817 . . . . 0.0 113.147 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.4 p -94.92 28.58 2.68 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.407 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.59 -176.85 3.61 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.027 -176.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.3 t -98.6 145.24 27.04 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 159.55 -148.26 16.7 Favored Glycine 0 N--CA 1.416 -2.696 0 C-N-CA 119.802 -1.19 . . . . 0.0 112.729 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.68 150.56 29.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -138.31 154.15 49.01 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.97 121.41 34.35 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.628 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.24 124.08 46.59 Favored 'Isoleucine or valine' 0 C--O 1.27 2.146 0 O-C-N 123.641 0.588 . . . . 0.0 110.228 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -114.82 142.02 47.11 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.684 1.194 . . . . 0.0 108.949 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -90.95 -164.16 1.14 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.407 ' HB3' ' HZ2' ' A' ' 95' ' ' LYS . 1.8 mmmp? -70.07 -12.32 61.52 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 122.465 0.306 . . . . 0.0 111.603 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.0 m -94.59 -2.47 51.42 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 66.6 26.78 9.7 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.148 0.979 . . . . 0.0 109.754 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -90.18 127.92 36.23 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-O 121.078 0.466 . . . . 0.0 110.571 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.55 119.64 20.66 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -128.17 -18.4 4.12 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.257 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -147.29 118.15 7.63 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.354 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.432 HG23 ' NE1' ' A' ' 143' ' ' TRP . 11.6 m -109.27 139.62 31.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -149.54 158.0 27.48 Favored Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.711 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.3 pt -115.59 147.81 18.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.0 m -154.08 156.21 36.86 Favored 'General case' 0 C--O 1.251 1.134 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.18 -27.99 29.63 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -127.39 105.88 8.83 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.438 ' O ' HG22 ' A' ' 112' ' ' VAL . 78.0 mt -61.05 -60.79 2.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.145 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -44.69 -58.06 3.29 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -175.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.38 -37.23 86.38 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.6 m -71.59 -46.38 59.44 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 123.23 0.331 . . . . 0.0 110.815 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 108' ' ' ILE . 85.3 t -58.68 -56.06 19.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.437 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 16.6 m -57.16 -42.05 80.33 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 124.248 0.968 . . . . 0.0 111.619 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.89 -59.08 5.22 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -73.06 -24.06 60.64 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 69.8 mt -73.13 -33.35 65.47 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.827 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 113' ' ' SER . 34.8 mmtp -78.7 -20.2 50.68 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.118 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.7 m -80.92 -46.26 15.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.471 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.46 92.78 26.86 Favored Pre-proline 0 CA--C 1.557 1.226 0 CA-C-O 121.815 0.817 . . . . 0.0 110.295 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.586 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 3.8 Cg_exo -76.48 16.64 0.86 Allowed 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 123.933 3.089 . . . . 0.0 114.126 -175.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.27 -38.08 89.18 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.618 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.8 mt -101.51 20.55 15.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.745 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 90.4 m -75.04 93.12 2.69 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.647 176.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.03 -65.86 0.07 OUTLIER Glycine 0 N--CA 1.435 -1.405 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.8 p -158.89 167.52 29.19 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.0 p -144.82 139.24 23.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.464 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -106.56 137.53 44.41 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.6 m -125.7 133.35 69.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.359 0.599 . . . . 0.0 111.785 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -112.89 102.58 1.31 Allowed Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.07 115.48 20.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 p -108.33 138.3 35.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -66.83 -45.17 79.11 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.306 0.574 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -94.5 114.2 62.85 Favored Pre-proline 0 C--N 1.292 -1.919 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.639 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -82.91 32.92 0.52 Allowed 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 123.049 2.499 . . . . 0.0 111.755 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.431 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 17.6 t70 -73.59 136.86 43.99 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.814 -177.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -61.1 -30.14 70.18 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.69 -50.42 36.72 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.2 t -60.96 -39.76 83.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 O-C-N 124.179 0.924 . . . . 0.0 110.591 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.2 mt -61.47 -55.32 32.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.513 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.0 m -60.78 -38.4 85.16 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.038 0.447 . . . . 0.0 111.025 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -59.71 -52.63 64.65 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.205 1.002 . . . . 0.0 110.765 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.29 94.84 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.156 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.432 ' NE1' HG23 ' A' ' 102' ' ' VAL . 89.3 t90 -56.4 -45.21 80.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.533 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -63.89 -43.32 96.37 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.737 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.7 -46.2 90.7 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.066 0.46 . . . . 0.0 110.929 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.497 ' CG ' ' HG ' ' A' ' 69' ' ' LEU . 26.0 m0 -63.9 -46.28 85.58 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.502 ' O ' HG13 ' A' ' 151' ' ' ILE . 7.9 tt -63.25 -42.12 95.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.547 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.428 ' HB3' ' NZ ' ' A' ' 152' ' ' LYS . 49.8 mt-10 -64.77 -31.6 72.9 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 146' ' ' TRP . 7.1 mm-40 -50.42 -50.63 51.38 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.558 0.536 . . . . 0.0 110.02 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.404 ' HA ' HG23 ' A' ' 153' ' ' VAL 0.282 33.2 m-70 -81.95 -28.45 32.72 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -178.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 147' ' ' ILE . 71.3 mt -57.06 -40.52 73.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 120.943 0.401 . . . . 0.0 110.137 172.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.428 ' NZ ' ' HB3' ' A' ' 148' ' ' GLU . 62.3 mttp -75.32 -46.69 31.8 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.404 HG23 ' HA ' ' A' ' 150' ' ' HIS . 30.9 m -78.04 -39.69 25.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -175.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 33.1 p -119.1 -35.32 3.65 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.951 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.92 17.23 59.93 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -85.14 108.22 17.59 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.13 0.49 . . . . 0.0 111.787 -177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 40.8 t -128.3 84.19 63.94 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 173.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -76.41 164.51 30.67 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 122.798 2.332 . . . . 0.0 111.923 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.417 ' HA ' ' CD ' ' A' ' 162' ' ' LYS . 72.4 Cg_exo -52.34 -31.05 45.49 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 123.159 2.573 . . . . 0.0 112.697 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.29 -24.13 71.96 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.176 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.69 -9.74 42.73 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.417 ' CD ' ' HA ' ' A' ' 159' ' ' PRO . 7.7 mtpm? -79.49 170.77 16.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.685 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 14.4 t -110.43 138.44 46.82 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 144.66 -141.18 9.81 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -72.15 113.17 8.89 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 174.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.435 ' HB3' HG21 ' A' ' 169' ' ' VAL . 27.3 t-20 -134.39 135.06 42.36 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.529 -174.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.2 m -70.49 -22.18 62.68 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.858 0.863 . . . . 0.0 112.35 -176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -88.31 -47.82 8.12 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.435 HG21 ' HB3' ' A' ' 166' ' ' ASN . 33.0 m -83.26 -30.02 8.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.19 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.33 134.96 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.37 1.468 . . . . 0.0 113.634 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 51.9 t -87.15 -48.08 15.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 21.7 m -101.36 109.46 21.3 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 172.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -60.66 -33.58 73.03 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -170.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.0 -23.04 41.8 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 121.138 -0.225 . . . . 0.0 110.415 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.8 t60 53.74 80.44 0.11 Allowed 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.586 1.155 . . . . 0.0 107.944 -171.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -72.18 114.24 10.08 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -174.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -80.0 110.58 15.53 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.05 -175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -81.94 115.06 20.94 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -80.49 117.1 20.92 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.092 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 9.3 t60 . . . . . 0 C--N 1.301 -1.522 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.402 ' H3 ' ' CD ' ' A' ' 132' ' ' GLU . 27.2 ttt . . . . . 0 CA--C 1.508 -0.656 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -169.29 -35.83 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.927 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.5 m -95.12 107.51 19.58 Favored 'General case' 0 C--O 1.253 1.28 0 CA-C-O 121.321 0.581 . . . . 0.0 111.584 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -150.09 123.54 9.05 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 36.6 t -116.34 143.47 26.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -104.79 -52.61 2.83 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 122.116 0.96 . . . . 0.0 108.945 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.0 p -129.92 164.33 24.44 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.894 -170.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.491 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 17.9 mt -68.86 -13.59 62.51 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 t -70.25 -19.6 63.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.322 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -104.72 1.33 29.23 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.491 ' OG1' ' HA ' ' A' ' 69' ' ' LEU . 6.8 m -92.78 134.53 34.97 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -172.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.16 152.35 38.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.295 1.038 . . . . 0.0 110.681 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -109.75 129.59 55.6 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 4.3 mm? -121.02 136.04 25.31 Favored Pre-proline 0 C--N 1.307 -1.247 0 C-N-CA 123.762 0.825 . . . . 0.0 109.705 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 75' ' ' LEU . 27.6 Cg_exo -69.5 139.64 41.62 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.348 2.032 . . . . 0.0 110.247 172.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.03 -12.98 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.248 0.547 . . . . 0.0 111.469 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.0 t -74.62 -20.81 59.76 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.466 0.651 . . . . 0.0 109.968 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -104.85 53.15 0.73 Allowed 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.807 0.813 . . . . 0.0 109.557 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.476 ' HB2' ' OG ' ' A' ' 113' ' ' SER . . . -56.13 -28.94 59.86 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.835 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.41 -26.23 67.89 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.6 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.3 t -92.08 -4.98 53.65 Favored 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.737 0.815 . . . . 0.0 110.38 -174.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.14 130.36 86.51 Favored Pre-proline 0 N--CA 1.443 -0.808 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.85 131.38 38.01 Favored 'Trans proline' 0 C--O 1.248 0.982 0 C-N-CA 123.348 2.699 . . . . 0.0 112.976 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.0 p -91.39 27.59 1.91 Allowed 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.66 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.95 -176.95 3.6 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.825 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.6 t -96.85 154.33 17.36 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 154.15 -154.1 25.28 Favored Glycine 0 N--CA 1.423 -2.185 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.264 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.41 152.12 14.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 123.708 0.803 . . . . 0.0 110.045 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -144.69 154.35 42.67 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -130.78 126.23 35.81 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 123.248 0.619 . . . . 0.0 109.394 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.4 t -102.97 126.0 57.29 Favored 'Isoleucine or valine' 0 C--O 1.263 1.793 0 CA-C-O 121.102 0.477 . . . . 0.0 110.032 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -113.09 133.44 55.0 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -79.16 -169.44 1.84 Allowed 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.525 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -57.22 -36.38 70.82 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.733 0.413 . . . . 0.0 110.29 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.3 m -77.46 0.5 22.44 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.536 0.734 . . . . 0.0 111.586 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.0 t70 65.88 27.16 10.99 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 122.752 1.263 . . . . 0.0 110.246 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -98.64 137.4 37.33 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.252 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.69 125.08 28.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.557 ' O ' ' HG2' ' A' ' 158' ' ' PRO . 41.9 mt-30 -129.1 -17.11 3.93 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.103 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.459 ' HA ' ' OD1' ' A' ' 161' ' ' ASN . 89.5 t80 -154.61 126.0 7.39 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 118.635 -1.226 . . . . 0.0 111.911 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.5 m -114.62 145.05 20.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 170.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.0 168.95 31.33 Favored Glycine 0 C--N 1.281 -2.487 0 C-N-CA 119.276 -1.44 . . . . 0.0 112.709 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.3 pt -120.13 148.53 23.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.4 t -150.84 155.63 39.59 Favored 'General case' 0 N--CA 1.417 -2.112 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.593 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.91 -23.12 24.02 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.405 ' C ' HD21 ' A' ' 107' ' ' ASN . 0.2 OUTLIER -141.67 98.19 3.3 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.0 mt -55.26 -60.4 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.46 -47.72 27.05 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.75 90.65 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 p -79.05 -43.1 24.92 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.607 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 76.3 t -55.47 -54.76 21.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 O-C-N 123.294 0.371 . . . . 0.0 110.805 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.476 ' OG ' ' HB2' ' A' ' 80' ' ' ALA . 20.1 m -56.94 -46.9 81.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 123.924 0.765 . . . . 0.0 110.696 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.5 -55.08 38.24 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.046 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.261 29.2 p80 -71.53 -26.44 62.66 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 89.9 mt -78.13 -27.68 48.29 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.233 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 113' ' ' SER . 74.9 mmtt -84.9 -9.15 58.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.166 0.508 . . . . 0.0 110.314 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.6 t -93.32 -50.57 5.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.08 94.48 27.71 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-O 121.742 0.782 . . . . 0.0 110.507 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.695 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 15.0 Cg_exo -71.88 19.58 0.28 Allowed 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.986 3.124 . . . . 0.0 114.322 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.68 -43.42 98.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.462 0.649 . . . . 0.0 109.755 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.1 mt -100.35 20.13 15.38 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.911 -176.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.695 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 91.0 m -77.16 86.03 3.63 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.706 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.42 -63.96 0.09 OUTLIER Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 175.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.0 p -164.01 157.56 18.55 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 123.004 0.522 . . . . 0.0 109.601 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.21 139.0 46.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-O 121.018 0.437 . . . . 0.0 110.472 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.439 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 74.6 mttt -106.71 137.48 44.66 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.02 132.61 71.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.038 0.447 . . . . 0.0 110.802 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -117.18 99.37 0.83 Allowed Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.68 117.56 29.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.454 0.645 . . . . 0.0 109.743 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.92 131.18 69.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.402 ' CD ' ' H3 ' ' A' ' 62' ' ' MET . 42.7 mt-10 -80.58 8.4 7.96 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -108.35 107.62 60.33 Favored Pre-proline 0 N--CA 1.423 -1.783 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -84.04 26.42 0.65 Allowed 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.558 2.172 . . . . 0.0 110.713 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.552 ' O ' HG22 ' A' ' 138' ' ' VAL . 14.1 t70 -71.92 127.83 33.82 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -62.51 -28.4 69.82 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -173.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.54 -33.34 54.18 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.359 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 135' ' ' ASP . 10.1 m -77.38 -32.71 18.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.833 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 97.0 mt -64.25 -46.73 82.46 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.0 m -67.03 -33.92 76.58 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.225 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.587 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 9.4 tt0 -64.56 -50.82 65.78 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.528 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.23 -41.17 98.17 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.376 0.422 . . . . 0.0 110.234 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -55.61 -47.36 76.67 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.588 0.709 . . . . 0.0 109.592 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.78 -42.78 98.2 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.875 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 60.9 mt -64.98 -47.46 77.48 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.812 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -62.45 -46.11 90.01 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.015 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.58 ' O ' HG13 ' A' ' 151' ' ' ILE . 13.0 tt -67.15 -46.88 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.543 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -67.47 -29.28 68.69 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -175.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.483 ' O ' HG22 ' A' ' 153' ' ' VAL . 9.2 pt-20 -65.11 -44.09 89.89 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.931 176.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -69.96 -24.1 63.29 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 147' ' ' ILE . 57.1 mt -66.77 -43.73 89.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 172.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -71.27 -50.64 30.64 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 149' ' ' GLU . 35.2 m -80.01 -40.37 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -176.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.6 p -116.99 -4.84 11.47 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -174.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.37 34.33 89.61 Favored Glycine 0 C--O 1.222 -0.643 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.871 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -93.64 110.2 21.81 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.9 t -141.4 79.07 17.83 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 173.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.557 ' HG2' ' O ' ' A' ' 100' ' ' GLN . 3.1 Cg_exo -82.77 160.47 16.33 Favored 'Trans proline' 0 C--O 1.248 0.982 0 C-N-CA 122.66 2.24 . . . . 0.0 112.834 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -56.48 -17.17 20.75 Favored 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 124.268 3.312 . . . . 0.0 113.997 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -67.69 -38.79 90.22 Favored Glycine 0 CA--C 1.523 0.588 0 O-C-N 123.573 0.546 . . . . 0.0 112.892 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' A' ' 101' ' ' PHE . 11.0 m120 -87.54 -21.75 25.24 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 121.991 0.9 . . . . 0.0 111.634 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -83.88 160.47 21.13 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 174.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 57.9 m -87.1 79.77 8.55 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 117.817 -1.553 . . . . 0.0 109.781 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -140.97 -49.6 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 113.687 -1.597 . . . . 0.0 109.351 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -117.03 110.16 17.9 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.408 ' OD1' ' HG3' ' A' ' 170' ' ' LYS . 19.4 t-20 -114.62 11.68 17.03 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.381 0.61 . . . . 0.0 110.126 -174.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 28.7 m -56.25 -24.57 43.44 Favored 'General case' 0 CA--C 1.559 1.309 0 CA-C-O 121.294 0.569 . . . . 0.0 112.003 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -73.11 -22.68 60.5 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.1 -0.375 . . . . 0.0 111.274 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 53.3 t -102.98 -33.87 3.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.408 ' HG3' ' OD1' ' A' ' 166' ' ' ASN . 55.8 mtpt -68.88 1.4 3.4 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.74 -32.05 56.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.278 0.561 . . . . 0.0 110.684 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 4.6 m -92.71 -9.54 40.37 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.344 0.592 . . . . 0.0 109.539 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -85.06 67.47 10.21 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.822 0.82 . . . . 0.0 112.65 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.544 ' OE2' ' HA ' ' A' ' 177' ' ' HIS . 37.1 tt0 -104.45 98.96 8.66 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -68.57 -47.36 66.98 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -100.04 90.41 4.38 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.544 ' HA ' ' OE2' ' A' ' 174' ' ' GLU . 16.2 p80 -69.47 117.03 10.56 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -66.33 127.36 31.92 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.98 -171.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -179.54 -39.11 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 10.5 p80 . . . . . 0 CA--C 1.497 -1.064 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 175.277 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -138.18 147.39 43.78 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 131' ' ' VAL . 16.2 m -73.77 101.49 3.73 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.86 0.362 . . . . 0.0 110.406 177.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.81 95.67 4.87 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 172.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.65 142.53 16.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.541 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -79.8 -152.55 0.07 Allowed 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.931 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.8 m -76.52 164.59 25.8 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 121.38 0.61 . . . . 0.0 111.719 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.438 HD12 ' OH ' ' A' ' 93' ' ' TYR . 3.1 tm? -46.52 -40.03 11.87 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 126.637 1.975 . . . . 0.0 114.108 -174.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.0 m -56.24 -32.83 64.85 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.314 0.578 . . . . 0.0 111.891 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -102.72 10.0 38.82 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.356 -0.384 . . . . 0.0 112.029 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.567 HG21 ' CH2' ' A' ' 146' ' ' TRP . 30.1 m -85.58 147.66 26.3 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.256 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.08 149.64 46.31 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.23 0.612 . . . . 0.0 111.262 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -110.65 133.49 53.27 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.829 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -127.26 141.53 41.08 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -79.97 144.84 17.23 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.082 1.854 . . . . 0.0 110.885 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.473 HD12 ' SG ' ' A' ' 123' ' ' CYS . 0.1 OUTLIER -80.03 -12.95 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.094 0.473 . . . . 0.0 110.676 -178.077 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.25 -11.81 61.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 124.522 1.129 . . . . 0.0 111.205 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -128.19 53.42 1.81 Allowed 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.86 -19.15 5.9 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.996 -175.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -78.21 -20.39 51.91 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.321 0.582 . . . . 0.0 110.577 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.0 m -91.11 6.81 43.47 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.234 0.54 . . . . 0.0 110.769 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.4 mm -82.56 130.05 60.3 Favored Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -53.23 137.02 63.54 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.531 2.821 . . . . 0.0 113.287 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.3 p -101.52 27.13 6.57 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.813 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.25 -175.99 3.39 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.649 -174.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.9 t -95.39 141.56 28.8 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 158.87 -153.43 24.55 Favored Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.511 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.8 m -109.21 150.56 11.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 C-N-CA 124.393 1.077 . . . . 0.0 110.06 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -142.78 148.43 37.15 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.38 118.04 21.57 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.244 0.618 . . . . 0.0 109.883 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.5 t -97.32 127.59 49.43 Favored 'Isoleucine or valine' 0 C--O 1.263 1.782 0 CA-C-O 121.358 0.599 . . . . 0.0 111.895 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 43.3 m-85 -107.4 146.47 31.61 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 125.047 1.339 . . . . 0.0 109.32 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -95.2 -172.24 2.62 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -65.34 -23.05 66.9 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 m -77.13 -4.08 42.67 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.78 0.8 . . . . 0.0 109.396 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.3 t70 66.12 29.57 9.81 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.727 1.611 . . . . 0.0 109.626 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 5.1 mm-40 -99.14 144.1 28.66 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 114.066 -1.425 . . . . 0.0 108.255 175.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.511 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 1.5 tm? -85.89 125.12 33.09 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.546 ' O ' ' HG2' ' A' ' 158' ' ' PRO . 1.4 mp0 -116.5 -23.55 8.22 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 123.978 0.799 . . . . 0.0 113.013 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -149.4 120.47 7.73 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 117.587 -1.645 . . . . 0.0 112.715 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.462 HG23 ' HB ' ' A' ' 147' ' ' ILE . 30.5 m -105.06 145.29 13.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.809 171.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.55 166.97 30.84 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.544 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.5 pt -123.0 144.84 31.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 122.889 0.476 . . . . 0.0 109.806 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.2 m -152.62 157.37 40.88 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.334 0.588 . . . . 0.0 111.526 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -86.74 -22.18 26.13 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 172.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -137.44 91.33 2.59 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.596 -1.183 . . . . 0.0 108.086 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.19 -62.3 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -173.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.77 -43.19 27.2 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -175.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.4 -48.57 79.13 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.054 0.221 . . . . 0.0 111.526 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.3 m -65.04 -41.51 95.13 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 120.683 0.277 . . . . 0.0 111.154 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.6 t -61.7 -57.15 13.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.009 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.5 p -60.85 -35.61 77.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 123.778 0.674 . . . . 0.0 111.811 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.77 -61.27 2.39 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 122.975 0.51 . . . . 0.0 111.642 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.403 ' HB3' ' O ' ' A' ' 168' ' ' PHE . 27.5 p80 -79.57 -21.68 44.76 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -73.02 -41.28 64.41 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.77 -15.1 59.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.556 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.506 ' HA ' ' CE1' ' A' ' 175' ' ' HIS . 49.6 m -80.9 -59.09 2.8 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.409 ' C ' ' H ' ' A' ' 121' ' ' GLU . 7.1 p -122.3 95.25 47.28 Favored Pre-proline 0 N--CA 1.428 -1.528 0 CA-C-O 122.087 0.946 . . . . 0.0 110.847 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.53 21.12 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.794 2.996 . . . . 0.0 113.22 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.409 ' H ' ' C ' ' A' ' 119' ' ' VAL . 36.3 tt0 -69.1 -33.21 73.14 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.2 mt -94.59 21.49 7.23 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.169 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 77' ' ' ILE . 38.2 t -68.61 108.37 3.32 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 176.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.35 -72.82 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.3 p -169.41 173.17 6.68 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.9 p -144.49 139.8 23.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -106.27 129.91 54.22 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.54 136.1 60.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.436 0.636 . . . . 0.0 111.52 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -116.59 96.79 0.73 Allowed Glycine 0 N--CA 1.418 -2.511 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.441 HD11 ' N ' ' A' ' 130' ' ' ILE . 2.7 mp -78.74 114.27 19.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 64' ' ' SER . 13.6 p -104.5 124.13 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.705 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -78.83 -5.17 52.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.499 0.666 . . . . 0.0 110.582 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -111.65 84.31 5.11 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 172.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.83 39.29 0.7 Allowed 'Trans proline' 0 N--CA 1.48 0.684 0 C-N-CA 123.619 2.879 . . . . 0.0 113.026 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.509 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 14.4 t70 -76.87 138.88 40.04 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.059 -175.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -54.15 -38.09 65.13 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.892 1.277 . . . . 0.0 113.494 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.02 -44.57 54.01 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.84 -43.58 95.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.775 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 96.5 mt -57.25 -52.88 63.53 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.125 0.488 . . . . 0.0 110.708 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.6 m -69.42 -34.37 74.36 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.117 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.476 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 52.9 tt0 -66.84 -45.65 77.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.071 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.9 -38.21 90.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.174 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.446 ' O ' HG22 ' A' ' 147' ' ' ILE . 89.3 t90 -55.72 -48.58 74.94 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -60.9 -38.24 85.02 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.372 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.598 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 71.4 mt -63.97 -56.92 11.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.274 0.559 . . . . 0.0 109.559 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.567 ' CH2' HG21 ' A' ' 72' ' ' THR . 20.8 m0 -54.61 -50.48 67.98 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.581 ' O ' HG13 ' A' ' 151' ' ' ILE . 13.1 tt -61.51 -46.53 96.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.334 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -66.45 -27.23 67.66 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 17.5 mm-40 -59.94 -46.13 90.37 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 121.224 0.535 . . . . 0.0 109.671 175.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.511 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 7.5 t60 -81.8 -21.43 37.71 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.578 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 147' ' ' ILE . 53.7 mt -67.2 -53.51 32.48 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.71 -26.2 68.54 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.3 p -84.37 -35.73 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.4 t -137.86 -2.88 1.87 Allowed 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -174.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 78.93 29.28 52.14 Favored Glycine 0 CA--C 1.516 0.126 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.816 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -91.82 108.86 20.22 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.488 ' O ' ' HD2' ' A' ' 162' ' ' LYS . 2.1 t -142.78 90.36 7.72 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 173.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.546 ' HG2' ' O ' ' A' ' 100' ' ' GLN . 7.9 Cg_exo -80.17 159.67 23.47 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.986 2.457 . . . . 0.0 113.21 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -43.14 -40.79 9.3 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 124.822 3.682 . . . . 0.0 115.262 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -65.23 -23.2 69.74 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 114.395 0.518 . . . . 0.0 114.395 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -103.43 -19.63 14.35 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.467 0.651 . . . . 0.0 111.062 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.488 ' HD2' ' O ' ' A' ' 157' ' ' VAL . 61.0 mtpt -79.46 -65.03 1.05 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.089 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.3 m -102.95 -152.72 0.45 Allowed 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.293 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -75.57 143.33 30.18 Favored Glycine 0 N--CA 1.422 -2.249 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.36 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -73.01 122.58 21.97 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 40.1 m-80 -103.34 -79.54 0.53 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.977 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 39.4 m -60.92 -32.56 72.04 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -170.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.403 ' O ' ' HB3' ' A' ' 115' ' ' HIS . 12.5 m-85 -76.04 -7.09 53.88 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.033 -174.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.53 14.99 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 123.052 0.541 . . . . 0.0 109.638 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 166' ' ' ASN . 16.0 tptm -85.05 -16.15 41.67 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 41.5 t 53.56 -79.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 127.062 2.145 . . . . 0.0 115.229 172.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 14.9 m -95.84 -44.42 7.41 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.323 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.408 ' HB2' ' HG3' ' A' ' 170' ' ' LYS . 82.9 mt -65.16 -40.62 94.58 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.253 -173.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -126.39 70.06 1.24 Allowed 'General case' 0 N--CA 1.425 -1.72 0 CA-C-O 121.905 0.86 . . . . 0.0 109.049 174.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.506 ' CE1' ' HA ' ' A' ' 118' ' ' SER . 20.0 t60 -86.23 -49.67 7.54 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 174.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -101.03 116.56 33.14 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -66.23 108.0 2.15 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -109.58 147.17 33.46 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -167.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -100.9 -162.49 0.94 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 75.8 m80 . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.556 176.704 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 84.5 mtp . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.89 77.7 1.27 Allowed 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 m -100.8 28.51 5.14 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.681 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -151.6 106.09 3.22 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.037 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 50.7 t -84.56 140.69 15.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.84 -178.12 6.25 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.651 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.0 m -72.93 177.24 5.04 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.1 mt -52.65 -25.27 10.32 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -171.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -68.71 -30.92 69.67 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.864 0.364 . . . . 0.0 110.695 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -87.62 -20.44 26.35 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.315 0.579 . . . . 0.0 110.752 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.409 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 4.4 m -74.99 133.74 41.62 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.219 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -71.53 154.02 41.76 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.056 0.455 . . . . 0.0 111.042 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -108.7 125.1 51.53 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.561 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.4 130.73 23.4 Favored Pre-proline 0 C--N 1.3 -1.583 0 C-N-CA 123.881 0.873 . . . . 0.0 109.411 174.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.87 139.59 36.7 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.179 1.919 . . . . 0.0 110.163 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.413 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -76.72 -13.48 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.431 -175.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.3 t -69.6 -25.67 64.07 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.433 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -109.63 54.25 0.67 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 122.29 1.043 . . . . 0.0 110.098 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.04 -19.76 20.67 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.822 -1.535 . . . . 0.0 113.302 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -73.57 -19.6 60.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.434 0.635 . . . . 0.0 110.965 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.0 m -93.13 2.43 56.71 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.559 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.0 mm -76.7 126.62 85.7 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.57 130.66 41.33 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.535 2.157 . . . . 0.0 113.21 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.0 p -94.05 30.65 1.82 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.247 1.023 . . . . 0.0 109.731 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.48 -179.78 4.45 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.445 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.4 t -93.71 138.38 31.98 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.17 -155.61 26.81 Favored Glycine 0 N--CA 1.421 -2.33 0 C-N-CA 119.362 -1.399 . . . . 0.0 113.049 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 t -115.78 151.6 17.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -140.56 148.11 40.48 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.12 118.29 25.8 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.887 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.81 115.02 29.2 Favored 'Isoleucine or valine' 0 C--O 1.262 1.712 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.586 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 4.9 m-85 -100.32 137.28 38.96 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.92 -168.36 2.21 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.365 0.602 . . . . 0.0 110.891 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -64.99 -29.57 70.5 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.42 1.088 . . . . 0.0 111.271 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.1 t -81.42 -1.25 45.0 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.806 0.812 . . . . 0.0 109.363 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 t70 73.95 27.74 1.6 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.635 1.574 . . . . 0.0 112.538 172.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 11.8 pt-20 -120.09 166.65 13.11 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 117.588 -1.645 . . . . 0.0 111.207 172.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -80.29 130.14 34.99 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.913 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.11 -47.13 2.59 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.106 171.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -124.1 125.74 45.0 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.789 -173.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.0 m -114.42 140.92 32.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.28 162.09 29.38 Favored Glycine 0 N--CA 1.42 -2.423 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.185 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.8 pt -124.82 151.7 30.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.6 t -159.92 159.23 32.08 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.35 -15.35 53.11 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 176.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -140.87 96.89 3.08 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.0 mt -56.34 -52.69 49.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.841 -177.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.14 -46.22 61.89 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.81 -48.23 81.54 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.733 0.413 . . . . 0.0 111.702 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.9 m -68.53 -44.21 75.06 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.239 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.6 t -57.94 -58.78 4.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.392 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 43.5 p -63.05 -32.06 73.34 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.51 -61.16 2.26 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.52 ' HA ' ' OG ' ' A' ' 118' ' ' SER . 19.7 p80 -77.15 -21.88 53.41 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -174.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.427 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 53.6 mt -76.09 -23.97 55.0 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.779 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -89.46 -31.01 17.89 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.046 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.52 ' OG ' ' HA ' ' A' ' 115' ' ' HIS . 4.2 p -73.99 -27.91 61.21 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.352 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.23 98.07 3.78 Favored Pre-proline 0 CA--C 1.559 1.31 0 CA-C-O 121.899 0.857 . . . . 0.0 110.691 173.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.775 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 94.5 Cg_endo -82.21 22.39 0.87 Allowed 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 123.288 2.659 . . . . 0.0 113.514 -177.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -63.42 -43.34 97.75 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.707 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.1 mt -104.99 18.01 23.13 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.161 0.505 . . . . 0.0 110.954 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.775 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 83.0 m -78.65 99.78 6.74 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.732 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.34 -49.48 0.06 OUTLIER Glycine 0 C--N 1.3 -1.43 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.0 p -165.59 168.14 16.66 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.095 0.958 . . . . 0.0 109.633 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.66 137.08 31.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-O 121.081 0.467 . . . . 0.0 110.48 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.409 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 98.1 mttt -106.43 138.58 42.36 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.19 130.99 73.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.136 0.493 . . . . 0.0 112.179 -176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -118.33 102.11 0.94 Allowed Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mp -94.89 136.47 25.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 121.031 0.443 . . . . 0.0 110.154 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.97 141.67 44.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.99 -46.09 90.76 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -88.39 116.33 65.93 Favored Pre-proline 0 C--N 1.308 -1.199 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.163 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.32 39.41 0.78 Allowed 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 123.488 2.792 . . . . 0.0 112.539 -175.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.41 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 23.9 t70 -73.74 129.2 37.45 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.996 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 24.1 mmtp -61.81 -27.85 69.05 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.54 -45.47 59.14 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.3 t -62.07 -41.46 91.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 O-C-N 124.192 0.932 . . . . 0.0 110.171 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 90.3 mt -63.03 -50.48 70.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.679 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 48.8 m -63.57 -33.63 76.02 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 120.914 0.388 . . . . 0.0 110.793 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.34 -54.88 34.03 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.805 1.242 . . . . 0.0 110.378 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.39 93.53 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.217 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -55.39 -45.68 76.6 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.304 0.642 . . . . 0.0 109.303 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -61.09 -46.27 91.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.79 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.2 mp -60.36 -38.37 83.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.851 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.419 ' O ' ' HG3' ' A' ' 149' ' ' GLU . 41.0 m0 -73.64 -46.87 44.05 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.957 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.7 tt -65.9 -40.98 89.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.444 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.72 -36.44 80.59 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.581 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -60.95 -39.12 88.27 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.331 -179.015 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -79.46 -31.25 42.43 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.132 -175.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.445 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 70.9 mt -70.87 -32.34 48.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.422 0.63 . . . . 0.0 109.87 175.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -84.85 -33.42 22.87 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 149' ' ' GLU . 14.8 p -83.52 -51.43 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.409 HG22 HG12 ' A' ' 153' ' ' VAL . 71.1 p -108.78 -35.54 6.37 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.172 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 151' ' ' ILE . . . 99.71 28.27 7.53 Favored Glycine 0 C--N 1.317 -0.519 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.719 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.82 125.75 47.35 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.51 87.78 10.16 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-O 121.904 0.859 . . . . 0.0 109.881 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -69.98 160.58 49.12 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.16 3.24 . . . . 0.0 113.811 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 162' ' ' LYS . 5.7 Cg_exo -45.7 -35.51 13.22 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 124.997 3.798 . . . . 0.0 115.365 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -70.84 -26.18 74.45 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.88 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -84.87 -25.82 27.76 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 159' ' ' PRO . 6.5 mtpm? -83.73 -176.08 6.12 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.621 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.1 m -85.97 85.21 7.38 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.612 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.07 127.23 2.15 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -79.26 110.29 14.39 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -132.32 162.42 31.09 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.9 m -55.4 -28.27 53.02 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.786 0.834 . . . . 0.0 112.256 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -67.83 -19.68 65.09 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 25.0 t -106.55 -8.41 10.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp 64.09 -165.49 0.24 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.074 0.95 . . . . 0.0 109.506 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 55.2 t -90.32 -52.59 10.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 57.4 p 63.17 -47.88 0.22 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 126.715 2.006 . . . . 0.0 115.407 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 96.6 mt -54.2 -51.8 63.25 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 175' ' ' HIS . 0.6 OUTLIER -159.88 174.57 14.24 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -174.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.408 ' H ' ' CD ' ' A' ' 174' ' ' GLU . 81.0 t60 -84.91 -36.75 21.26 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 122.363 0.265 . . . . 0.0 110.309 176.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -80.45 90.68 5.66 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.49 0.662 . . . . 0.0 109.942 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -84.5 118.28 24.21 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.032 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -146.58 -60.39 0.3 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -97.45 -35.6 10.61 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 33.2 m80 . . . . . 0 C--O 1.205 -1.253 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 174.818 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 C--O 1.236 0.386 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.86 100.31 11.49 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.0 t -99.02 -35.49 10.03 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.23 116.46 32.86 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.4 t -104.08 120.33 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 121.146 0.498 . . . . 0.0 110.832 -175.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.39 -72.59 0.61 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.53 ' HB2' ' OE2' ' A' ' 149' ' ' GLU . 28.1 p -121.99 179.29 4.57 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.48 HD13 ' OH ' ' A' ' 93' ' ' TYR . 38.9 mt -73.93 -17.17 61.06 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.6 m -72.28 -20.34 61.53 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.47 0.653 . . . . 0.0 109.648 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -92.18 -3.31 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.016 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.465 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.6 m -98.81 150.5 21.8 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.955 -172.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 9.4 pt-20 -90.25 155.01 19.3 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.176 0.99 . . . . 0.0 109.845 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.0 125.11 48.62 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -123.66 141.01 35.47 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.068 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -71.37 134.55 24.86 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.192 1.928 . . . . 0.0 109.215 170.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -21.53 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.0 t -73.29 -26.7 61.18 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.193 0.521 . . . . 0.0 110.678 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -94.56 56.09 2.04 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.845 0.831 . . . . 0.0 110.12 177.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.44 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -48.84 -21.57 0.66 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.204 1.402 . . . . 0.0 114.015 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -64.56 -27.57 69.05 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.433 0.635 . . . . 0.0 110.763 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.407 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 22.8 m -83.09 1.43 40.29 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.083 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 80' ' ' ALA . 26.8 mm -90.75 113.97 59.74 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 82' ' ' SER . 72.2 Cg_exo -54.7 135.27 66.54 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.737 2.958 . . . . 0.0 112.593 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.7 p -98.6 34.21 2.09 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.969 0.89 . . . . 0.0 110.885 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.73 -176.64 3.19 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.174 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.7 t -95.96 145.62 25.26 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.17 -149.13 15.27 Favored Glycine 0 N--CA 1.416 -2.69 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.266 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.471 HG13 ' CH2' ' A' ' 146' ' ' TRP . 6.7 p -125.98 149.26 30.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -176.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -137.37 149.85 47.28 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.901 0.382 . . . . 0.0 110.747 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.32 117.6 28.2 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.278 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.31 116.75 34.16 Favored 'Isoleucine or valine' 0 C--O 1.26 1.627 0 CA-C-O 121.092 0.472 . . . . 0.0 110.753 -177.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.48 ' OH ' HD13 ' A' ' 69' ' ' LEU . 88.3 m-85 -106.35 134.42 49.51 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.705 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -79.18 -171.0 2.47 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -58.46 -30.79 67.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.808 0.843 . . . . 0.0 111.093 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.4 m -82.72 1.72 37.33 Favored 'General case' 0 C--O 1.25 1.114 0 C-N-CA 123.506 0.722 . . . . 0.0 112.269 -176.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.2 t70 69.41 26.68 5.17 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.499 1.142 . . . . 0.0 109.39 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 4.3 mm-40 -102.13 140.14 36.81 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.925 176.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.498 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 2.8 tm? -89.69 110.84 21.7 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.464 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -105.13 -25.99 12.27 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.051 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -143.82 120.96 11.47 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 118.822 -1.151 . . . . 0.0 113.54 -176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.425 HG11 HD11 ' A' ' 99' ' ' LEU . 6.2 m -108.51 144.01 17.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 169.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -154.84 158.86 28.61 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.4 pt -117.25 144.3 25.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.6 m -150.75 160.39 43.89 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.147 0.498 . . . . 0.0 111.113 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -84.97 -21.85 29.39 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -136.13 105.46 6.03 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.55 -58.01 8.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 123.535 0.522 . . . . 0.0 111.92 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.17 -55.28 10.79 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.07 99.56 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 123.064 0.227 . . . . 0.0 111.316 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.2 t -65.87 -51.23 60.59 Favored 'General case' 0 C--O 1.251 1.148 0 O-C-N 123.774 0.671 . . . . 0.0 110.019 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 56.6 t -56.14 -54.77 23.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.972 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.461 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 22.9 t -60.12 -44.41 94.92 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 123.779 0.674 . . . . 0.0 111.1 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.75 -54.12 38.45 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -80.07 -26.3 39.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.442 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 66.9 mt -77.68 -26.48 50.31 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.845 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 113' ' ' SER . 33.7 mmtp -78.84 -26.05 44.12 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.395 174.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.2 t -74.0 -53.85 9.16 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.346 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.0 p -129.05 99.04 22.43 Favored Pre-proline 0 N--CA 1.431 -1.381 0 CA-C-O 121.996 0.903 . . . . 0.0 110.767 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.82 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 73.9 Cg_endo -79.56 11.53 2.67 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 123.525 2.817 . . . . 0.0 113.653 -177.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -58.03 -42.93 86.37 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 123.984 0.913 . . . . 0.0 109.865 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.0 mt -104.16 20.29 18.58 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.898 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.82 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 96.8 m -85.99 92.75 8.78 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.188 0.518 . . . . 0.0 111.944 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.42 -60.4 0.09 OUTLIER Glycine 0 C--N 1.299 -1.5 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 173.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 9.8 p -156.06 161.62 40.39 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.5 p -138.53 139.6 41.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-O 121.007 0.432 . . . . 0.0 110.159 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.465 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 82.9 mttt -106.54 128.36 54.05 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 174.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.86 136.16 56.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.095 0.474 . . . . 0.0 111.137 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.52 110.02 1.26 Allowed Glycine 0 N--CA 1.425 -2.064 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.429 HD11 ' N ' ' A' ' 130' ' ' ILE . 2.7 mp -94.24 104.91 16.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.17 134.56 28.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.269 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -65.12 -30.02 70.92 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.23 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -109.24 100.67 42.05 Favored Pre-proline 0 N--CA 1.439 -1.016 0 CA-C-O 121.362 0.601 . . . . 0.0 109.768 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.72 37.92 0.71 Allowed 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.916 2.411 . . . . 0.0 112.282 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.438 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 22.3 t70 -69.15 143.77 54.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.188 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -52.44 -44.44 65.49 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.493 0.717 . . . . 0.0 112.337 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.11 -38.76 69.24 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.409 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.06 -42.04 90.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 96.7 mt -58.33 -47.73 82.81 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.5 m -66.04 -38.88 89.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.633 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -62.63 -45.39 93.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.85 0.357 . . . . 0.0 110.091 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.6 -50.06 75.03 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.914 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -53.55 -47.81 69.67 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.143 0.977 . . . . 0.0 110.492 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 14.6 tmtt? -63.37 -45.78 89.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.633 -176.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 11.0 mp -67.41 -38.86 85.27 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.691 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.471 ' CH2' HG13 ' A' ' 89' ' ' VAL . 27.2 m0 -63.16 -45.01 93.87 Favored 'General case' 0 C--O 1.257 1.482 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.47 ' O ' HG13 ' A' ' 151' ' ' ILE . 12.7 tt -65.41 -39.14 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.397 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 38.0 mt-10 -57.71 -42.5 83.88 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-O 118.9 -0.572 . . . . 0.0 111.967 176.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.53 ' OE2' ' HB2' ' A' ' 68' ' ' SER . 6.8 mm-40 -46.39 -51.84 14.14 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.782 0.676 . . . . 0.0 110.059 178.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.498 ' CG ' ' HB3' ' A' ' 99' ' ' LEU 0.34 13.7 m-70 -78.88 -27.85 44.04 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 179.177 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 147' ' ' ILE . 76.5 mt -61.18 -47.5 93.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.536 0.684 . . . . 0.0 109.319 172.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -68.1 -50.4 55.19 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.309 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 149' ' ' GLU . 16.9 m -80.75 -26.77 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -174.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.3 t -138.13 -26.25 0.93 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.39 23.5 16.47 Favored Glycine 0 C--N 1.316 -0.54 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.69 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -78.88 112.96 16.57 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.06 74.26 21.63 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 170.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -90.88 168.84 3.69 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 123.219 2.612 . . . . 0.0 114.09 -171.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -56.74 -17.73 24.18 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 124.0 3.134 . . . . 0.0 113.727 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -67.8 -38.48 89.5 Favored Glycine 0 C--O 1.219 -0.794 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -94.09 -33.11 13.5 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.574 0.702 . . . . 0.0 109.734 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -75.51 176.33 7.67 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.478 175.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.5 m -82.34 88.04 6.57 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 173.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -146.77 -54.34 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.861 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.433 ' O ' HG21 ' A' ' 169' ' ' VAL . 23.6 t-20 -95.4 110.25 22.31 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 175.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -71.06 -8.19 51.67 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -171.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 m -72.39 -45.78 58.22 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.928 0.394 . . . . 0.0 110.152 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -82.34 -44.54 16.06 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.632 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 165' ' ' ASN . 35.9 m -86.99 13.91 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -172.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -77.94 134.37 37.89 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.046 -1.062 . . . . 0.0 108.92 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 30.8 t -93.3 156.38 3.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 14.9 m -55.69 -42.81 75.72 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-O 121.157 0.503 . . . . 0.0 109.983 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.35 118.59 27.85 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 174.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -100.51 150.64 22.46 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.319 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -125.13 108.72 12.08 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 172.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -86.12 92.28 8.69 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-O 121.782 0.801 . . . . 0.0 110.783 -172.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -72.6 97.84 2.22 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.223 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -154.85 23.33 0.45 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.091 0.948 . . . . 0.0 109.941 175.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -93.0 -14.06 27.89 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 . . . . . 0 N--CA 1.421 -1.907 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 176.281 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.0 mtp . . . . . 0 CA--C 1.506 -0.731 0 CA-C-O 121.266 0.555 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.91 102.53 11.54 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 169.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.7 m -94.42 -45.86 7.27 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.361 0.601 . . . . 0.0 111.002 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.22 99.79 12.29 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.2 t -127.05 124.68 65.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.321 -176.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.42 ' HB2' ' OE2' ' A' ' 71' ' ' GLU . 57.8 mtpt -117.03 -54.23 2.43 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.1 p -110.49 172.09 7.07 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.824 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.94 -27.77 68.47 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.455 0.702 . . . . 0.0 110.983 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 m -62.67 -31.1 71.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.573 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.42 ' OE2' ' HB2' ' A' ' 67' ' ' LYS . 29.5 mt-10 -95.03 2.62 55.32 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.124 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.492 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.1 m -91.29 145.42 24.67 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.491 -176.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 17.0 pt-20 -89.31 151.05 22.31 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -113.88 130.61 56.47 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.814 0.34 . . . . 0.0 110.84 -172.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -128.35 127.77 23.68 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -63.49 138.11 63.48 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.181 1.921 . . . . 0.0 109.616 173.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -14.46 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -172.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.7 t -65.58 -30.97 71.78 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.265 0.555 . . . . 0.0 110.081 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.62 53.07 0.82 Allowed 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 122.41 1.1 . . . . 0.0 109.377 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -56.64 -24.24 46.94 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.702 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.73 -31.1 71.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.378 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.5 m -92.39 3.46 55.4 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.452 HG12 ' HA ' ' A' ' 80' ' ' ALA . 44.6 mm -69.2 125.02 91.65 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -52.9 129.76 34.49 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.006 2.47 . . . . 0.0 113.71 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 p -95.5 32.79 1.72 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.089 0.947 . . . . 0.0 111.048 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.05 -176.96 3.23 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.924 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.4 m -93.42 149.67 21.05 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 123.504 0.502 . . . . 0.0 110.105 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.62 -153.78 24.99 Favored Glycine 0 N--CA 1.417 -2.571 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.435 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.586 ' HB ' ' CH2' ' A' ' 146' ' ' TRP . 2.6 t -114.36 151.3 16.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -175.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -140.31 151.88 45.41 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.02 174.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 127' ' ' LYS . . . -130.24 120.76 24.95 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 123.554 0.742 . . . . 0.0 109.697 -178.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.51 125.93 45.06 Favored 'Isoleucine or valine' 0 C--O 1.263 1.801 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.314 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -112.64 132.58 55.1 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 124.156 0.983 . . . . 0.0 109.234 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -77.61 -173.26 2.9 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 123.825 0.703 . . . . 0.0 110.542 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -55.42 -31.08 61.57 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.1 t -95.46 11.55 32.54 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 122.021 -0.425 . . . . 0.0 110.885 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.45 33.16 13.89 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 176.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -102.99 125.37 49.72 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 118.571 -1.252 . . . . 0.0 111.914 172.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.424 ' CD2' ' HB2' ' A' ' 91' ' ' ALA . 2.5 tm? -60.71 112.68 2.11 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.637 174.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 158' ' ' PRO . 48.5 mt-30 -124.52 -14.66 6.81 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.24 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -144.16 125.33 14.56 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.371 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.1 m -117.11 151.76 18.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 173.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -160.3 160.04 31.36 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.4 pt -124.91 147.28 29.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.6 t -157.46 164.56 37.31 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.434 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 0.6 OUTLIER -80.55 -28.03 37.4 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.339 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -131.09 99.4 4.87 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 77.7 mt -57.83 -52.01 63.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.261 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.63 -52.46 39.36 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.82 -47.18 87.52 Favored 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 123.456 0.473 . . . . 0.0 111.147 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.0 t -62.8 -50.78 69.63 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.435 -177.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.0 t -59.22 -52.97 54.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.028 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.4 m -63.13 -35.35 79.99 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 123.337 0.398 . . . . 0.0 111.812 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.09 -61.14 1.99 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.37 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.276 21.5 p80 -73.5 -25.92 60.66 Favored 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -174.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.4 mt -77.62 -24.06 49.67 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.681 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -87.48 -9.13 55.41 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.204 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.6 m -92.07 -51.61 5.1 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.59 95.73 42.33 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-O 121.681 0.753 . . . . 0.0 111.052 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.82 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 3.1 Cg_exo -79.27 32.56 0.47 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.58 2.853 . . . . 0.0 112.877 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -70.33 -43.17 70.81 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.779 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.1 mt -114.12 21.87 14.37 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.706 -174.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.82 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 94.7 m -76.06 93.06 3.24 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -127.25 -61.84 0.14 Allowed Glycine 0 C--N 1.307 -1.073 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.0 m -158.78 166.93 30.78 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.2 p -133.83 142.32 41.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.268 0.556 . . . . 0.0 110.088 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.492 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 30.6 mmtm -105.67 129.22 53.94 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.21 136.36 60.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.272 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.44 100.06 0.79 Allowed Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.416 HD11 ' N ' ' A' ' 130' ' ' ILE . 2.5 mp -88.06 101.66 11.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -101.09 134.53 40.93 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.797 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.015 -174.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -66.48 -34.61 78.31 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -83.89 117.33 68.4 Favored Pre-proline 0 C--N 1.301 -1.513 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.871 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -91.49 21.03 0.82 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.879 2.386 . . . . 0.0 111.787 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.97 131.39 45.39 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.944 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -59.19 -33.39 70.9 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.849 -174.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.81 -45.27 68.25 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.29 -44.23 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.16 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 99.0 mt -59.77 -45.78 91.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.944 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.3 m -69.36 -38.43 78.08 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.479 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.555 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 29.0 tt0 -62.29 -51.23 68.52 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.329 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.3 -40.84 95.64 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.41 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.446 ' O ' HG22 ' A' ' 147' ' ' ILE . 79.3 t90 -51.41 -46.64 62.98 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.49 0.716 . . . . 0.0 109.603 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.44 -50.92 57.22 Favored 'General case' 0 C--O 1.211 -0.951 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.486 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 85.5 mt -51.57 -41.63 61.29 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.242 0.617 . . . . 0.0 111.673 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.586 ' CH2' ' HB ' ' A' ' 89' ' ' VAL . 31.6 m0 -69.68 -57.79 4.71 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.444 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.601 ' O ' HG12 ' A' ' 151' ' ' ILE . 15.1 tt -67.25 -42.16 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 C-N-CA 119.644 -0.823 . . . . 0.0 111.844 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.447 ' HA ' ' CG1' ' A' ' 151' ' ' ILE . 26.7 mt-10 -67.64 -28.62 67.88 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -174.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.495 ' O ' HG22 ' A' ' 153' ' ' VAL . 12.3 pt-20 -67.31 -37.45 83.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 118.887 -1.125 . . . . 0.0 109.063 175.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -75.41 -30.05 59.95 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 120.579 -0.449 . . . . 0.0 109.792 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 147' ' ' ILE . 41.8 mm -58.82 -44.49 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 121.272 0.558 . . . . 0.0 109.712 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -81.18 -36.25 30.38 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -174.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 149' ' ' GLU . 31.3 m -97.14 -24.84 4.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -176.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.95 -1.67 7.17 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 56.44 33.87 62.74 Favored Glycine 0 N--CA 1.47 0.926 0 N-CA-C 117.473 1.749 . . . . 0.0 117.473 170.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -100.16 108.3 20.38 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 118.225 1.012 . . . . 0.0 111.459 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 t -126.57 78.0 72.87 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 174.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.405 ' HG2' ' O ' ' A' ' 100' ' ' GLN . 7.4 Cg_exo -77.77 155.2 30.82 Favored 'Trans proline' 0 C--O 1.257 1.444 0 C-N-CA 122.93 2.42 . . . . 0.0 113.225 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.9 -22.49 54.6 Favored 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 123.425 2.75 . . . . 0.0 111.893 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -56.66 -37.68 77.81 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.581 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -100.61 -27.24 13.5 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.206 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -76.01 -82.1 0.08 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.025 0.441 . . . . 0.0 110.663 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.9 t -179.38 164.42 1.33 Allowed 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.18 -21.05 15.87 Favored Glycine 0 C--N 1.307 -1.059 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.196 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -100.89 163.42 12.31 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.409 ' O ' HG22 ' A' ' 169' ' ' VAL . 6.4 t30 -131.68 -21.9 2.45 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 171.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -21.04 49.12 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -174.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -83.28 -14.62 52.7 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 120.112 -0.635 . . . . 0.0 112.424 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.44 ' O ' ' HG2' ' A' ' 170' ' ' LYS . 34.4 m -101.46 -34.59 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 119.586 -0.845 . . . . 0.0 109.678 173.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 169' ' ' VAL . 68.2 mmtt -168.71 146.11 3.86 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.041 1.736 . . . . 0.0 108.367 175.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 14.9 p -58.15 -52.48 58.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 19.6 m -124.32 -20.53 5.2 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.775 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.31 105.43 3.48 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.47 0.652 . . . . 0.0 110.539 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -81.16 134.63 35.66 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.752 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -121.88 -71.66 0.72 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.283 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -86.27 84.99 7.34 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.084 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -73.63 138.56 44.9 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.367 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -124.97 152.17 44.53 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -139.54 141.96 37.24 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.915 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 78.3 t60 . . . . . 0 N--CA 1.418 -2.035 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.597 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 52.1 tpp . . . . . 0 CA--C 1.515 -0.372 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -141.27 132.27 26.14 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p -79.65 -15.71 57.1 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.496 0.665 . . . . 0.0 110.785 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.89 81.67 8.45 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.726 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.81 127.35 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -113.62 -53.53 2.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -174.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.2 m -124.84 165.75 17.48 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.188 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.0 mt -57.79 -26.82 62.46 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.142 1.377 . . . . 0.0 113.85 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.3 m -65.68 -21.81 66.58 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.947 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -98.93 -10.44 22.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.334 0.588 . . . . 0.0 110.401 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 3.2 m -83.28 136.88 34.22 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.325 -171.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.74 154.06 28.81 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 120.614 0.245 . . . . 0.0 110.882 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -108.4 128.72 55.02 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.244 0.618 . . . . 0.0 110.634 -172.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -121.96 131.01 24.5 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -66.08 139.0 54.2 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.119 1.879 . . . . 0.0 109.489 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.437 HG13 ' SG ' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -72.14 -12.9 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-O 121.384 0.611 . . . . 0.0 111.926 -174.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.5 p -75.45 -26.35 58.21 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.885 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.09 53.57 0.8 Allowed 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 122.167 0.984 . . . . 0.0 109.97 177.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -59.21 -22.84 61.66 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 113.792 -1.549 . . . . 0.0 112.329 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.11 -24.1 64.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.583 0.706 . . . . 0.0 109.497 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.9 t -93.91 4.97 53.14 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.391 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.452 HG12 ' HA ' ' A' ' 80' ' ' ALA . 43.5 mm -81.15 124.93 80.59 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -51.58 133.95 45.19 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.287 2.658 . . . . 0.0 112.926 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.2 p -96.47 29.07 3.04 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.9 0.857 . . . . 0.0 110.578 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.05 -176.58 3.47 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.545 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.6 t -101.54 142.15 33.34 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.3 -147.85 12.73 Favored Glycine 0 N--CA 1.413 -2.854 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.471 HG13 ' CH2' ' A' ' 146' ' ' TRP . 7.6 p -126.01 148.81 30.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -136.57 149.04 47.87 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 120.9 0.381 . . . . 0.0 110.537 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.26 121.82 41.39 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.603 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.7 t -96.81 114.23 33.18 Favored 'Isoleucine or valine' 0 C--O 1.265 1.894 0 CA-C-O 121.171 0.51 . . . . 0.0 110.363 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 70.6 m-85 -102.52 133.86 46.81 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.379 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -81.21 -172.34 3.72 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.516 ' HZ3' ' HB3' ' A' ' 95' ' ' LYS . 8.2 mtpm? -67.07 -16.3 64.25 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.8 m -88.8 1.6 54.98 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 122.277 0.231 . . . . 0.0 110.469 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 67.83 27.01 7.5 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.147 0.979 . . . . 0.0 110.715 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 4.6 mm-40 -103.85 151.72 22.76 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.402 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.495 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 3.0 tm? -102.47 110.99 23.1 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.426 -174.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -107.4 -32.96 7.52 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.903 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -131.6 134.99 46.61 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.262 -0.975 . . . . 0.0 112.049 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.5 m -130.47 142.8 42.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -153.8 153.96 25.19 Favored Glycine 0 N--CA 1.425 -2.063 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.086 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.8 pt -111.87 141.13 28.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.3 m -149.86 163.77 37.16 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 120.901 0.382 . . . . 0.0 111.55 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -82.92 -30.61 28.29 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -131.56 104.31 6.89 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.2 mt -60.25 -53.57 46.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 O-C-N 123.162 0.289 . . . . 0.0 111.72 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.01 -58.53 4.32 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.84 89.33 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.286 0.366 . . . . 0.0 111.349 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.9 m -63.46 -49.61 72.99 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.249 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.4 t -58.15 -54.68 29.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.0 m -58.56 -43.75 89.46 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.049 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.66 -59.93 4.16 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -77.1 -30.8 55.48 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.7 mt -76.59 -27.74 55.91 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 119.542 -0.863 . . . . 0.0 113.054 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -81.35 -19.03 43.65 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.891 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.9 m -81.68 -57.76 3.31 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.381 175.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.0 p -116.13 96.26 46.86 Favored Pre-proline 0 N--CA 1.441 -0.914 0 CA-C-O 122.421 1.105 . . . . 0.0 109.987 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 123' ' ' CYS . 82.1 Cg_endo -83.68 22.76 0.89 Allowed 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.154 2.569 . . . . 0.0 113.749 -175.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -64.52 -32.2 73.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.006 0.908 . . . . 0.0 109.719 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.4 mt -113.5 21.48 15.08 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.171 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.437 ' SG ' HG13 ' A' ' 77' ' ' ILE . 34.9 t -75.52 78.99 2.54 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.383 -178.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -130.89 -56.83 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.4 p -165.38 164.09 19.74 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 122.664 0.385 . . . . 0.0 110.508 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.51 137.04 36.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 120.963 0.411 . . . . 0.0 109.956 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.457 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 77.3 mttt -106.53 130.61 54.27 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 173.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.1 m -113.92 133.72 59.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 120.892 0.377 . . . . 0.0 111.16 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -123.22 106.19 0.98 Allowed Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 130' ' ' ILE . 2.8 mp -93.26 111.78 25.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.6 164.07 2.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.99 -41.68 74.08 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.485 ' C ' ' H ' ' A' ' 135' ' ' ASP . 47.4 mt-10 -100.48 116.97 63.75 Favored Pre-proline 0 C--N 1.303 -1.416 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.957 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -81.02 27.09 0.58 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.783 2.322 . . . . 0.0 109.763 173.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 133' ' ' GLU . 29.1 t70 -85.96 145.87 26.94 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.426 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -53.7 -42.75 68.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.08 -37.75 88.59 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 120.977 0.418 . . . . 0.0 111.629 -177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.0 t -79.52 -40.82 21.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.105 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.07 -46.53 90.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.242 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.0 m -67.68 -33.82 75.69 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.337 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -65.61 -48.37 72.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.184 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.23 -43.92 96.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.942 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 91.6 t90 -55.04 -43.32 73.67 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.351 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 25.1 mmtt -60.86 -58.51 8.12 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.57 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 10.9 mp -55.79 -38.13 69.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 118.306 0.503 . . . . 0.0 112.297 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.471 ' CH2' HG13 ' A' ' 89' ' ' VAL . 27.0 m0 -65.12 -53.08 50.83 Favored 'General case' 0 C--O 1.265 1.88 0 O-C-N 123.518 0.511 . . . . 0.0 111.698 177.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.419 ' O ' HG12 ' A' ' 151' ' ' ILE . 8.5 tt -62.42 -46.69 95.81 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.649 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 144' ' ' LYS . 53.6 mm-40 -60.04 -30.95 69.53 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 123.457 0.703 . . . . 0.0 112.596 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 30.8 mm-40 -56.31 -56.85 15.93 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.469 0.652 . . . . 0.0 109.673 174.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.495 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 27.0 m-70 -73.17 -31.89 64.51 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.582 -0.847 . . . . 0.0 113.138 -177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 147' ' ' ILE . 35.3 mm -57.06 -42.81 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 120.423 0.154 . . . . 0.0 111.024 175.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -72.86 -58.36 3.39 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.28 -22.93 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.2 t -129.49 -24.89 2.72 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.109 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 76.55 34.66 43.8 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.783 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -89.85 115.1 26.92 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.459 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.43 86.87 2.38 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-O 122.213 1.006 . . . . 0.0 110.029 175.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -90.68 169.12 3.83 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 123.02 2.48 . . . . 0.0 112.266 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -51.23 -18.23 4.81 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 124.594 3.53 . . . . 0.0 114.993 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.15 -41.57 86.3 Favored Glycine 0 C--N 1.31 -0.887 0 CA-C-N 116.498 -0.319 . . . . 0.0 112.407 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -92.96 5.71 50.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.767 1.27 . . . . 0.0 109.065 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -114.81 -170.34 1.72 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.8 t -102.35 89.87 3.71 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 172.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.15 -58.61 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.212 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -92.75 110.05 21.49 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -80.97 -25.81 37.04 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.768 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.3 m -56.97 -25.77 58.71 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -77.3 -25.9 51.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.8 t -108.22 -24.01 4.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 121.558 0.694 . . . . 0.0 109.864 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.401 ' HA ' ' CE ' ' A' ' 170' ' ' LYS . 3.1 mmpt? 73.69 -71.85 0.13 Allowed 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.637 1.575 . . . . 0.0 112.508 -176.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 44.8 t 58.68 76.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 122.106 0.955 . . . . 0.0 109.45 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 52.6 m -77.25 -30.73 54.61 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.626 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.51 88.07 7.57 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.411 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -99.14 -31.36 11.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.985 0.898 . . . . 0.0 108.946 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -139.6 171.27 14.49 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -99.82 142.62 31.06 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -71.93 93.79 1.39 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.41 0.624 . . . . 0.0 111.432 -176.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -104.79 -13.82 15.74 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.041 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -161.79 -49.53 0.04 OUTLIER 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 173.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 . . . . . 0 C--N 1.307 -1.265 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.252 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 CA--C 1.504 -0.801 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.34 99.97 0.44 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.603 0.716 . . . . 0.0 109.916 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 m -103.51 173.89 6.11 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.942 -175.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.35 103.76 15.97 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.847 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.5 t -86.34 117.0 30.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.462 ' HB3' ' HZ3' ' A' ' 67' ' ' LYS . 7.4 mtpm? -104.68 -86.77 0.45 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.513 -176.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.8 p -114.43 -174.15 2.43 Favored 'General case' 0 N--CA 1.414 -2.233 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.207 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.72 -26.21 68.57 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.82 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.6 m -61.81 -30.0 70.53 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.18 0.992 . . . . 0.0 111.109 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -87.06 -1.06 57.6 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.155 0.582 . . . . 0.0 110.165 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.3 m -114.33 145.45 41.77 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -170.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.94 156.97 17.58 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.03 0.532 . . . . 0.0 110.862 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -115.51 134.34 55.16 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.769 0.828 . . . . 0.0 110.766 -172.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -130.47 129.44 22.79 Favored Pre-proline 0 C--O 1.214 -0.77 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -62.79 147.68 94.37 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.074 1.85 . . . . 0.0 110.376 172.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -5.41 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -172.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.0 p -69.44 -26.21 64.49 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 121.16 0.505 . . . . 0.0 111.271 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.26 52.77 0.71 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.692 0.758 . . . . 0.0 110.538 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.51 -27.13 67.36 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.027 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.16 -24.33 64.97 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.355 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.5 m -93.01 2.09 56.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.963 0.411 . . . . 0.0 110.966 -177.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.5 mm -79.25 130.53 68.77 Favored Pre-proline 0 C--O 1.243 0.746 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.554 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -52.3 140.39 52.44 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 124.2 3.267 . . . . 0.0 113.61 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.4 p -98.68 29.53 3.68 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.501 0.667 . . . . 0.0 111.387 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.57 -177.08 3.68 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.157 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.8 t -99.97 152.01 20.68 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 154.28 -143.36 9.97 Favored Glycine 0 N--CA 1.412 -2.933 0 C-N-CA 119.847 -1.168 . . . . 0.0 112.47 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.2 m -119.31 149.36 21.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 C-N-CA 123.485 0.714 . . . . 0.0 110.029 -174.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -143.34 146.06 33.22 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.672 0.273 . . . . 0.0 110.28 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -118.45 127.27 53.5 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.054 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -105.4 118.86 53.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.28 0.562 . . . . 0.0 110.938 -176.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 43.9 m-85 -108.52 141.05 40.98 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -80.32 -169.79 2.25 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.431 ' HD2' ' HA2' ' A' ' 124' ' ' GLY . 4.9 mmmp? -67.38 -15.2 63.55 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.9 m -89.19 -3.1 58.7 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 65.51 35.29 7.33 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.686 1.194 . . . . 0.0 112.221 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -100.72 145.16 28.82 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.361 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -90.46 109.2 20.33 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.35 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -105.85 -41.99 5.27 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.915 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -125.29 139.38 53.76 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.425 0.631 . . . . 0.0 112.477 -171.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.551 HG22 HD22 ' A' ' 161' ' ' ASN . 27.2 m -132.54 146.31 33.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 172.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.67 165.67 30.61 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 119.756 -1.212 . . . . 0.0 111.815 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.4 pt -116.99 155.0 18.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.0 t -158.64 160.16 36.19 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.183 0.515 . . . . 0.0 110.082 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -85.51 -22.31 28.23 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.55 91.97 2.37 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 70.2 mt -50.87 -60.03 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 123.857 0.863 . . . . 0.0 112.468 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.74 -46.25 29.73 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.18 -55.05 39.93 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.503 0.502 . . . . 0.0 111.075 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.2 m -61.42 -46.07 91.65 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.761 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 75.7 t -56.63 -54.94 22.76 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 C-N-CA 123.023 0.529 . . . . 0.0 111.263 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.1 t -61.29 -46.7 89.24 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 123.259 0.349 . . . . 0.0 110.606 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.27 -60.24 3.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -75.12 -21.94 58.54 Favored 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 118.619 -1.232 . . . . 0.0 113.752 -172.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.0 mt -79.68 -24.19 41.93 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.483 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -88.12 -25.29 23.08 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.39 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.9 t -76.74 -42.03 42.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.823 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.54 91.27 14.15 Favored Pre-proline 0 N--CA 1.437 -1.108 0 CA-C-O 121.895 0.855 . . . . 0.0 110.473 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.746 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 2.7 Cg_exo -75.72 18.31 0.62 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.263 2.642 . . . . 0.0 113.62 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -59.91 -42.96 95.04 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.25 1.02 . . . . 0.0 110.6 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.2 mt -107.18 20.54 18.84 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.435 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.746 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 66.3 m -72.56 120.87 18.77 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.539 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.431 ' HA2' ' HD2' ' A' ' 95' ' ' LYS . . . -163.79 -70.39 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 174.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 21.8 m -146.48 159.37 43.49 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 9.6 p -139.87 139.01 38.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.034 0.445 . . . . 0.0 110.45 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -106.51 142.2 36.55 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.47 126.0 71.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.633 0.73 . . . . 0.0 112.325 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -113.69 102.67 1.26 Allowed Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 130' ' ' ILE . 2.6 mp -84.63 121.94 37.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.5 p -125.33 131.05 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.67 -0.62 57.14 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.518 0.675 . . . . 0.0 111.422 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -94.8 109.66 45.1 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -88.8 32.37 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.353 2.035 . . . . 0.0 112.557 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.417 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 11.4 t70 -83.51 139.68 32.76 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -176.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 mmmm -59.44 -34.45 72.53 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.69 -43.44 69.03 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 123.113 0.258 . . . . 0.0 110.825 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.4 m -69.42 -34.52 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 120.768 0.318 . . . . 0.0 110.911 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.2 mt -66.52 -52.34 46.83 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.007 0.432 . . . . 0.0 110.082 177.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.6 m -65.58 -30.41 71.14 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.064 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.497 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 58.6 tt0 -62.57 -54.21 43.14 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.817 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.21 -37.62 86.0 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 123.992 0.808 . . . . 0.0 110.105 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -54.34 -47.95 71.96 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 123.617 0.573 . . . . 0.0 110.109 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 98.0 mttt -64.63 -49.74 69.88 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.21 177.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.569 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 93.7 mt -50.83 -47.39 60.17 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.416 0.448 . . . . 0.0 111.439 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -63.08 -53.9 46.48 Favored 'General case' 0 C--O 1.265 1.871 0 C-N-CA 123.287 0.635 . . . . 0.0 112.604 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 151' ' ' ILE . 10.4 tt -64.33 -41.13 91.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.741 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 67.4 mt-10 -65.55 -30.05 70.75 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 119.265 -0.398 . . . . 0.0 111.92 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 21.0 mm-40 -54.89 -48.17 73.35 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . 0.272 13.4 m-70 -76.28 -29.54 57.46 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 147' ' ' ILE . 77.3 mt -61.31 -43.94 97.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 173.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -66.78 -49.65 65.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.7 m -79.28 -33.12 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.8 t -133.16 -28.06 1.55 Allowed 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.686 -176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.1 33.18 5.56 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.524 -0.845 . . . . 0.0 112.259 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -83.59 111.64 19.29 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.448 0.642 . . . . 0.0 112.583 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 p -155.84 70.96 5.3 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.746 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -90.11 165.3 4.71 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.33 2.687 . . . . 0.0 113.105 -174.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -51.68 -23.87 16.39 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 124.092 3.195 . . . . 0.0 114.275 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -67.49 -20.75 72.03 Favored Glycine 0 C--O 1.205 -1.658 0 C-N-CA 121.821 -0.228 . . . . 0.0 112.9 177.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.551 HD22 HG22 ' A' ' 102' ' ' VAL . 16.5 t-20 -113.86 -8.88 13.13 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.656 0.741 . . . . 0.0 109.93 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -84.34 -176.24 6.16 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.0 m -62.53 -33.52 75.07 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 124.57 1.148 . . . . 0.0 112.721 -176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.52 50.11 3.23 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -115.06 140.98 48.62 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 122.873 0.469 . . . . 0.0 109.922 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -131.63 -68.33 0.65 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -60.44 -24.53 65.28 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -169.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -85.47 -21.05 28.86 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.613 -0.679 . . . . 0.0 112.697 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.7 m -104.85 -26.72 3.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.755 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 69.02 88.04 0.11 Allowed 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -175.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 14.3 p -48.4 115.02 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -170.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.0 t -178.59 -44.0 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.929 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 64.9 mt -95.83 102.9 14.75 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.176 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 54.51 100.51 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.914 1.686 . . . . 0.0 115.547 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -130.04 134.74 47.6 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 169.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -76.52 100.26 5.22 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.246 -175.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -82.26 113.56 20.16 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.624 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 83.4 t60 71.35 116.09 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.2 1.0 . . . . 0.0 111.547 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -92.16 136.71 32.96 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 . . . . . 0 C--N 1.29 -1.985 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.684 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.509 -0.616 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -167.6 161.3 13.54 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 t -121.14 166.85 13.35 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.1 69.53 5.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.885 0.85 . . . . 0.0 110.24 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.51 120.53 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.072 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -123.98 -28.25 3.79 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.645 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.9 p -130.84 161.73 31.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.674 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.427 ' H ' ' HG3' ' A' ' 149' ' ' GLU . 72.2 mt -59.77 -28.16 67.17 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.408 0.683 . . . . 0.0 111.03 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.0 m -61.29 -20.61 63.09 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.896 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -111.28 8.03 21.31 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.92 -0.487 . . . . 0.0 110.497 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.514 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.0 m -96.19 135.88 37.41 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.257 -172.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.9 150.05 47.17 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.901 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -118.3 121.22 39.88 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -173.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.13 126.16 27.22 Favored Pre-proline 0 C--N 1.296 -1.724 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -63.76 139.65 70.01 Favored 'Trans proline' 0 C--N 1.326 -0.621 0 C-N-CA 121.903 1.735 . . . . 0.0 108.507 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.23 -12.31 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-O 121.422 0.63 . . . . 0.0 111.189 -174.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 p -67.6 -31.71 71.93 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.355 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -97.85 55.48 1.19 Allowed 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.43 0.633 . . . . 0.0 111.045 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.406 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -53.3 -23.39 9.04 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.441 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -69.35 -24.97 63.97 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.114 0.483 . . . . 0.0 110.971 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.8 m -89.64 6.88 39.32 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.465 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.406 HG12 ' HA ' ' A' ' 80' ' ' ALA . 38.1 mm -85.6 115.76 62.85 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -56.27 132.43 51.85 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 123.235 2.624 . . . . 0.0 113.492 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.9 p -89.58 36.38 0.84 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.758 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.32 -176.66 3.15 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.608 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.3 t -104.42 150.11 24.82 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.49 -146.21 13.81 Favored Glycine 0 N--CA 1.414 -2.782 0 C-N-CA 120.26 -0.972 . . . . 0.0 111.264 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.6 p -121.04 147.29 24.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -137.54 151.92 48.91 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 120.916 0.389 . . . . 0.0 110.522 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.32 124.43 42.95 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 124.001 0.92 . . . . 0.0 108.818 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.9 t -101.47 124.94 55.54 Favored 'Isoleucine or valine' 0 C--O 1.262 1.759 0 CA-C-O 121.166 0.508 . . . . 0.0 110.85 -176.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.45 ' HD2' ' O ' ' A' ' 97' ' ' ASP . 12.5 m-85 -111.28 133.11 53.85 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -78.92 -167.19 1.06 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.94 0.4 . . . . 0.0 110.972 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -57.86 -27.44 63.24 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.823 0.849 . . . . 0.0 111.077 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.7 m -86.03 -1.68 57.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.874 0.369 . . . . 0.0 110.397 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.45 ' O ' ' HD2' ' A' ' 93' ' ' TYR . 25.7 t70 64.36 34.65 10.35 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 124.849 1.26 . . . . 0.0 109.156 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -100.4 124.83 46.41 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.621 175.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.502 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 3.1 tm? -66.91 118.06 9.87 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -127.28 -14.67 5.34 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.526 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -147.26 133.88 19.89 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.334 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.448 HG21 ' NE1' ' A' ' 143' ' ' TRP . 16.3 m -124.06 138.02 55.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.162 174.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -155.98 157.49 27.86 Favored Glycine 0 C--N 1.305 -1.191 0 C-N-CA 119.788 -1.196 . . . . 0.0 112.846 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.9 144.01 21.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 123.126 0.57 . . . . 0.0 109.899 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 m -150.41 161.06 43.24 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-O 120.546 0.213 . . . . 0.0 110.642 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -85.67 -24.3 27.1 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -135.11 101.95 5.04 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 74.3 mt -60.1 -50.35 80.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.056 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.2 -57.35 9.91 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.67 96.73 Favored 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 123.38 0.425 . . . . 0.0 111.044 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.3 t -58.74 -61.18 2.81 Favored 'General case' 0 C--O 1.252 1.22 0 O-C-N 123.872 0.732 . . . . 0.0 109.961 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.4 t -54.66 -53.54 30.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 123.455 0.702 . . . . 0.0 111.581 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.0 t -59.48 -45.43 91.7 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.814 0.696 . . . . 0.0 111.385 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.26 -48.12 79.51 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -75.04 -27.88 60.2 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 119.069 -1.052 . . . . 0.0 113.536 -176.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 88.7 mt -73.62 -26.28 60.71 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.983 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -86.27 -17.7 33.97 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.466 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.0 m -83.63 -40.26 19.22 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.93 97.0 5.88 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-O 121.702 0.763 . . . . 0.0 110.581 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.631 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 9.8 Cg_exo -73.76 13.72 0.74 Allowed 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 123.757 2.971 . . . . 0.0 114.291 -177.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -55.56 -39.49 70.7 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.435 0.694 . . . . 0.0 111.063 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.2 mt -109.46 20.81 17.79 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.004 -177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.631 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 63.6 m -70.82 120.29 16.2 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.222 174.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -170.44 -68.9 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.0 p -152.06 152.49 32.46 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 114.882 -0.659 . . . . 0.0 109.695 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.12 137.23 48.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.112 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.514 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 95.0 mttt -106.89 131.36 54.07 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.86 137.28 55.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 120.932 0.396 . . . . 0.0 111.326 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.04 107.68 1.35 Allowed Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 130' ' ' ILE . 2.1 mp -91.79 109.85 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-O 121.717 0.77 . . . . 0.0 110.985 -176.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.8 p -111.28 125.78 68.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -87.25 -13.06 44.83 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.384 -172.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -92.36 113.83 60.47 Favored Pre-proline 0 N--CA 1.427 -1.595 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -77.84 45.41 1.78 Allowed 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 123.379 2.719 . . . . 0.0 112.923 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.482 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 10.0 t70 -82.18 121.29 26.43 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -67.15 -27.49 67.34 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.13 -39.44 25.59 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.45 -41.62 90.71 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 O-C-N 123.299 0.375 . . . . 0.0 110.265 176.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.0 mt -57.59 -48.12 80.25 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.907 0.384 . . . . 0.0 110.491 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.2 m -69.05 -35.99 77.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.77 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -65.63 -44.78 85.41 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 122.891 0.477 . . . . 0.0 109.977 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.83 -45.04 94.46 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.448 ' NE1' HG21 ' A' ' 102' ' ' VAL . 90.4 t90 -54.07 -44.25 70.97 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.583 176.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -63.96 -52.9 57.55 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.513 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.57 -38.52 78.04 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 23.5 m0 -64.27 -46.58 83.08 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.609 ' O ' HG12 ' A' ' 151' ' ' ILE . 10.5 tt -63.16 -45.09 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.244 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 17.8 mm-40 -57.26 -39.07 74.86 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.61 0.764 . . . . 0.0 111.674 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 69' ' ' LEU . 4.4 mm-40 -52.09 -49.33 63.78 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.431 0.692 . . . . 0.0 111.6 174.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.502 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 12.7 t60 -80.16 -23.4 41.1 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.892 -177.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 147' ' ' ILE . 43.2 mm -63.39 -50.68 77.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.028 174.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 148' ' ' GLU . 68.3 mttm -56.45 -45.05 81.04 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.966 0.412 . . . . 0.0 111.338 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 33.9 m -80.9 -33.47 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 41.4 p -130.88 -36.11 1.38 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 119.336 -0.945 . . . . 0.0 113.097 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.96 30.7 41.87 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.512 -175.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -82.01 116.58 21.69 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 122.535 -0.391 . . . . 0.0 110.327 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.446 ' O ' ' HE2' ' A' ' 162' ' ' LYS . 10.9 t -131.14 80.34 68.95 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 173.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -75.72 162.37 35.37 Favored 'Trans proline' 0 C--O 1.241 0.662 0 C-N-CA 122.925 2.417 . . . . 0.0 112.517 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.0 -17.5 19.56 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 124.457 3.438 . . . . 0.0 113.432 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 165' ' ' ASN . . . -77.57 -38.88 27.07 Favored Glycine 0 C--N 1.304 -1.195 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.858 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -22.3 33.01 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.446 ' HE2' ' O ' ' A' ' 157' ' ' VAL . 41.3 mttm -81.53 176.14 9.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.148 176.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.5 m -87.44 70.83 9.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 172.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.8 -91.82 0.49 Allowed Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.537 ' O ' ' HA2' ' A' ' 160' ' ' GLY . 56.8 m-80 -97.98 110.14 22.77 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -118.65 28.82 8.08 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.417 -173.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 2.9 m -58.31 -17.76 22.17 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.444 1.098 . . . . 0.0 110.596 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -76.88 -12.44 59.96 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.544 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.35 8.38 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 O-C-N 122.224 -0.298 . . . . 0.0 111.31 176.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 167' ' ' THR . 55.7 tptt -167.16 109.06 0.66 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.831 0.348 . . . . 0.0 110.876 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.5 p -103.15 127.07 57.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 171.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 8.1 m -86.11 -52.74 5.49 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 120.991 0.424 . . . . 0.0 110.601 -174.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -133.83 133.65 41.86 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -94.74 124.47 38.8 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.742 0.782 . . . . 0.0 111.985 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -134.16 159.78 39.84 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -87.33 83.85 7.29 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.989 0.899 . . . . 0.0 108.695 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -107.0 93.61 4.65 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.568 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -131.48 85.91 2.3 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.083 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.7 t60 65.88 15.48 10.08 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.697 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 . . . . . 0 CA--C 1.486 -1.484 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.498 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 54.8 ttp . . . . . 0 C--O 1.217 -0.623 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.38 -54.8 6.88 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.0 m 71.37 149.33 0.09 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.709 1.204 . . . . 0.0 113.471 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.98 74.57 7.97 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 173.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.3 p -74.68 135.09 28.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 113.13 -1.85 . . . . 0.0 113.872 -171.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -117.06 -42.64 2.91 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 169.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.9 p -116.69 156.48 27.04 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.739 -175.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.411 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 18.7 mt -64.21 -13.38 48.58 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.2 m -68.7 -22.55 64.35 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.566 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -101.84 6.85 41.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.775 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 69' ' ' LEU . 6.9 m -104.02 137.61 41.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -172.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -83.27 161.01 21.61 Favored 'General case' 0 C--O 1.246 0.903 0 O-C-N 123.282 0.364 . . . . 0.0 110.315 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -117.41 130.32 56.41 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.028 0.531 . . . . 0.0 110.572 -174.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.02 120.7 22.62 Favored Pre-proline 0 C--N 1.311 -1.087 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -61.41 140.3 87.07 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.001 1.801 . . . . 0.0 109.593 172.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.67 -12.02 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -170.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.4 t -67.01 -35.87 80.89 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 120.78 0.324 . . . . 0.0 110.832 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -90.34 53.91 2.61 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.38 1.086 . . . . 0.0 110.457 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.422 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -60.56 -20.05 59.28 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.58 -177.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -78.09 -22.88 48.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.479 0.657 . . . . 0.0 109.623 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 m -91.49 0.2 57.54 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.836 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 80' ' ' ALA . 39.2 mm -78.86 121.46 83.46 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -51.64 130.31 33.15 Favored 'Trans proline' 0 C--O 1.252 1.225 0 C-N-CA 123.596 2.864 . . . . 0.0 114.234 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.8 p -91.43 77.02 5.83 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-O 122.285 1.04 . . . . 0.0 109.248 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 108' ' ' ILE . . . -148.89 176.23 10.59 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.535 -177.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 t -92.19 147.27 23.06 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 160.46 -154.03 25.0 Favored Glycine 0 N--CA 1.415 -2.734 0 C-N-CA 120.117 -1.04 . . . . 0.0 110.967 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.439 HG13 ' CH2' ' A' ' 146' ' ' TRP . 7.6 p -123.62 146.83 28.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -136.09 150.18 49.02 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 120.693 0.282 . . . . 0.0 110.351 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.34 124.37 44.39 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.826 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -97.85 118.99 45.28 Favored 'Isoleucine or valine' 0 C--O 1.264 1.829 0 C-N-CA 123.071 0.548 . . . . 0.0 110.969 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 96.4 m-85 -113.13 145.73 40.44 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.522 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -89.85 -167.95 2.0 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.412 ' HD2' ' HA2' ' A' ' 124' ' ' GLY . 3.0 mmmp? -69.47 -18.14 63.68 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.773 -0.58 . . . . 0.0 111.572 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 m -85.09 -1.49 56.92 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 60.59 34.1 20.27 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 125.554 1.542 . . . . 0.0 113.55 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 40.5 mt-10 -105.19 154.57 20.03 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.433 174.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.44 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.4 tm? -93.19 113.51 25.75 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.725 -172.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -107.49 -29.32 9.28 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.216 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -143.63 138.73 29.2 Favored 'General case' 0 C--O 1.214 -0.771 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.227 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.573 HG21 HD22 ' A' ' 161' ' ' ASN . 30.9 m -129.64 148.79 33.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 172.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.66 162.88 31.87 Favored Glycine 0 N--CA 1.422 -2.262 0 C-N-CA 119.989 -1.1 . . . . 0.0 112.382 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.7 pt -118.06 150.37 20.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 123.469 0.707 . . . . 0.0 109.407 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.4 t -157.0 170.36 22.72 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-O 121.288 0.566 . . . . 0.0 110.756 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -90.86 -25.48 19.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.672 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -142.9 90.92 2.24 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 86' ' ' ALA . 78.6 mt -39.21 -60.45 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.777 1.631 . . . . 0.0 114.256 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.51 -41.23 29.36 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.6 -47.77 71.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.043 0.449 . . . . 0.0 110.992 -175.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.1 m -70.88 -40.11 72.44 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.9 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 79.6 t -56.46 -57.16 10.07 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 O-C-N 123.308 0.38 . . . . 0.0 110.786 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 22.7 t -60.46 -46.84 88.6 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.804 0.69 . . . . 0.0 111.442 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -51.26 -53.18 37.89 Favored 'General case' 0 C--O 1.25 1.114 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -81.95 -22.17 36.83 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 118.791 -1.164 . . . . 0.0 113.674 -178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.8 mt -75.73 -29.71 58.99 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.849 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 113' ' ' SER . 34.1 mmtp -75.62 -24.76 56.52 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 121.67 0.748 . . . . 0.0 109.021 175.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.7 m -76.42 -54.28 6.96 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.587 174.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 m -113.27 90.56 17.01 Favored Pre-proline 0 C--O 1.243 0.712 0 CA-C-O 121.877 0.846 . . . . 0.0 112.852 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.718 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 11.6 Cg_exo -73.85 -3.93 14.58 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.726 2.284 . . . . 0.0 112.253 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.06 -29.72 70.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.504 0.668 . . . . 0.0 109.557 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.9 mt -99.64 10.98 40.4 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.134 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.718 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 83.8 m -72.51 106.01 4.42 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.383 173.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.412 ' HA2' ' HD2' ' A' ' 95' ' ' LYS . . . -148.82 -73.74 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 173.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.6 m -146.51 155.7 42.72 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.05 138.37 47.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 O-C-N 122.0 -0.438 . . . . 0.0 109.924 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -106.12 133.81 50.24 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.74 126.12 74.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.554 0.692 . . . . 0.0 112.188 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -117.02 106.1 1.4 Allowed Glycine 0 N--CA 1.423 -2.191 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.56 111.76 26.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.9 p -92.39 139.54 17.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.54 -44.48 50.89 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.785 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -75.08 114.43 34.99 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 172.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -88.9 37.74 0.42 Allowed 'Trans proline' 0 C--N 1.321 -0.907 0 C-N-CA 122.513 2.142 . . . . 0.0 111.776 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 138' ' ' VAL . 14.2 t70 -74.11 134.65 42.89 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -177.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -60.7 -29.98 69.67 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -176.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.9 -41.89 61.46 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 135' ' ' ASP . 16.2 m -69.55 -31.29 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 120.583 -0.447 . . . . 0.0 109.908 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.28 -48.9 73.93 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.971 175.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.9 m -68.33 -34.12 75.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.384 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.584 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 28.9 tt0 -62.87 -50.18 71.9 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.067 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.87 97.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.29 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.507 ' NE1' HG23 ' A' ' 102' ' ' VAL . 90.6 t90 -56.02 -47.13 78.37 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.984 176.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -62.4 -42.61 99.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.078 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 67.9 mt -63.05 -52.22 63.66 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.674 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.439 ' CH2' HG13 ' A' ' 89' ' ' VAL . 28.5 m0 -56.85 -48.24 78.54 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.338 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 151' ' ' ILE . 11.2 tt -63.55 -43.79 98.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.659 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.7 -29.99 70.61 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 9.5 mm-40 -64.53 -41.77 96.18 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.017 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . 0.261 60.5 m-70 -76.89 -29.94 55.98 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.505 -0.878 . . . . 0.0 112.853 178.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 147' ' ' ILE . 71.9 mt -58.29 -37.98 66.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 171.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -78.82 -49.82 12.32 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 27.8 m -78.7 -20.85 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.8 t -138.01 -31.27 0.78 Allowed 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.299 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 88.65 11.2 66.33 Favored Glycine 0 CA--C 1.502 -0.735 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.018 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -83.13 103.94 12.94 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.33 0.586 . . . . 0.0 110.592 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.4 p -140.49 76.1 25.72 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.293 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -73.67 159.47 45.65 Favored 'Trans proline' 0 C--O 1.249 1.035 0 C-N-CA 123.194 2.596 . . . . 0.0 112.349 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.5 -23.88 26.55 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.995 3.13 . . . . 0.0 113.958 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -59.14 -41.82 96.81 Favored Glycine 0 CA--C 1.497 -1.037 0 CA-C-O 121.104 0.28 . . . . 0.0 112.671 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.573 HD22 HG21 ' A' ' 102' ' ' VAL . 44.9 t-20 -76.5 -30.83 57.38 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.926 0.87 . . . . 0.0 108.971 -175.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.446 ' HB3' ' HZ1' ' A' ' 162' ' ' LYS . 4.4 mtpm? -87.45 1.23 54.02 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.193 -176.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 47.2 t 71.13 112.53 0.06 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 122.016 0.912 . . . . 0.0 109.12 -170.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -176.17 -54.14 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -79.32 112.67 16.79 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 172.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -83.46 11.22 7.27 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.1 p -75.21 -22.13 58.18 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-O 121.423 0.63 . . . . 0.0 110.607 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -82.56 -29.57 30.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.534 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.6 m -103.72 -4.43 9.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.507 0.67 . . . . 0.0 110.305 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 49.2 tptt 77.51 -61.81 0.4 Allowed 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.415 1.886 . . . . 0.0 111.451 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 29.6 m -81.98 156.19 4.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-O 120.734 0.302 . . . . 0.0 110.304 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 16.3 m -88.37 96.27 10.52 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.877 0.37 . . . . 0.0 111.099 -175.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.77 -60.06 2.37 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.3 147.47 23.17 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 9.4 t60 71.27 159.69 0.21 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 124.887 1.367 . . . . 0.0 107.599 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -100.69 140.27 35.2 Favored 'General case' 0 C--N 1.286 -2.173 0 O-C-N 120.399 -1.438 . . . . 0.0 112.586 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -69.79 97.29 1.07 Allowed 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.749 0.785 . . . . 0.0 111.069 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -85.96 122.44 30.0 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.708 -177.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -69.27 119.1 13.02 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 7.0 t60 . . . . . 0 C--N 1.298 -1.658 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.739 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 CA--C 1.499 -0.989 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.35 111.73 22.98 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.5 m -69.82 120.92 16.3 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.909 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.07 112.48 19.18 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.8 133.74 31.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.661 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.487 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 7.8 mmpt? -88.06 -70.13 0.65 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.27 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.647 ' HB3' ' OE1' ' A' ' 149' ' ' GLU . 66.6 m -133.04 175.49 9.33 Favored 'General case' 0 N--CA 1.422 -1.843 0 O-C-N 122.015 -0.428 . . . . 0.0 111.448 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.2 mt -70.76 -23.52 62.43 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 m -69.83 -15.85 63.17 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.189 0.995 . . . . 0.0 109.323 176.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -107.83 8.21 28.58 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.63 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.6 m -103.7 142.09 34.94 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.58 149.24 40.2 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 123.735 0.647 . . . . 0.0 111.284 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.11 133.07 51.39 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.8 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.73 128.73 24.53 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -67.41 142.85 61.28 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.786 1.657 . . . . 0.0 109.357 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.16 -11.79 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.3 p -66.53 -37.75 85.68 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.505 0.669 . . . . 0.0 110.249 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -95.14 50.89 1.29 Allowed 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.845 0.831 . . . . 0.0 110.525 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.78 -27.76 66.84 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.944 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -73.26 -20.92 60.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.532 0.682 . . . . 0.0 110.39 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.0 m -95.99 7.52 46.16 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.406 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.1 mm -78.1 130.59 71.97 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -53.07 132.1 46.08 Favored 'Trans proline' 0 C--O 1.242 0.725 0 C-N-CA 123.417 2.745 . . . . 0.0 113.457 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.9 p -95.3 34.74 1.38 Allowed 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.306 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.98 179.36 4.35 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.957 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 t -95.97 140.04 31.3 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.3 -154.08 24.08 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 119.915 -1.136 . . . . 0.0 111.998 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 m -108.29 146.83 13.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 123.823 0.849 . . . . 0.0 109.88 -177.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -141.36 154.98 45.96 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -135.06 126.45 28.47 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.278 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.63 122.05 52.15 Favored 'Isoleucine or valine' 0 C--O 1.269 2.107 0 CA-C-O 120.932 0.396 . . . . 0.0 110.463 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 77.5 m-85 -109.43 137.92 46.56 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.888 1.275 . . . . 0.0 108.759 177.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -83.61 -166.86 1.5 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.512 ' HE3' ' O ' ' A' ' 123' ' ' CYS . 8.2 mptt -65.21 -26.42 68.12 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 122.913 0.485 . . . . 0.0 111.209 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.8 m -85.51 1.25 49.72 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 122.816 0.447 . . . . 0.0 110.591 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 65.7 28.72 11.02 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 123.87 0.868 . . . . 0.0 111.21 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -100.26 123.32 44.36 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.618 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.0 tm? -70.04 127.74 33.88 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.199 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.456 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 43.6 mt-30 -126.99 -43.31 1.68 Allowed 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.992 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -126.06 121.51 33.17 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 118.819 -1.153 . . . . 0.0 112.143 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.5 m -112.1 151.72 14.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.99 160.73 30.61 Favored Glycine 0 N--CA 1.425 -2.094 0 C-N-CA 119.382 -1.389 . . . . 0.0 112.655 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.2 pt -119.07 137.3 53.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 m -152.34 166.36 32.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.914 0.387 . . . . 0.0 111.676 -177.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -85.11 -32.68 22.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.066 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -127.7 106.01 8.85 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.9 mt -61.74 -59.61 4.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.624 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.94 -56.74 5.08 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.2 95.05 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.982 0.176 . . . . 0.0 111.276 -177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.4 m -64.28 -47.84 78.01 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.715 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.75 -55.09 26.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.005 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.9 m -57.33 -42.55 82.14 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.073 0.858 . . . . 0.0 111.781 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.98 -56.43 21.81 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 122.695 0.398 . . . . 0.0 111.889 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.27 23.7 p80 -71.61 -22.16 61.75 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.0 mt -73.75 -27.24 61.07 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.12 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -87.56 -15.67 36.78 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.253 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.5 m -87.02 -42.89 12.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.335 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.7 p -135.21 91.46 19.19 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-O 121.722 0.773 . . . . 0.0 110.007 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.643 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 7.4 Cg_exo -75.01 12.35 1.24 Allowed 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 123.396 2.73 . . . . 0.0 114.11 -176.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.38 -42.98 96.96 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.99 0.424 . . . . 0.0 109.958 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 39.7 mt -94.87 18.26 12.18 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.184 -176.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 84.8 m -76.85 85.6 3.42 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.467 0.651 . . . . 0.0 112.486 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -128.74 -59.59 0.11 Allowed Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 11.3 p -164.7 158.05 17.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -132.23 141.02 46.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -109.44 138.81 45.25 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 135.06 65.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.085 0.469 . . . . 0.0 110.739 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.3 99.75 0.74 Allowed Glycine 0 N--CA 1.419 -2.497 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.43 HD11 ' N ' ' A' ' 130' ' ' ILE . 2.0 mp -81.66 108.86 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.06 131.03 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.73 8.37 10.18 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.579 0.704 . . . . 0.0 111.977 -175.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 135' ' ' ASP . 31.8 mt-10 -124.84 91.73 48.92 Favored Pre-proline 0 N--CA 1.421 -1.879 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 171.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.65 31.52 0.48 Allowed 'Trans proline' 0 N--CA 1.481 0.794 0 C-N-CA 123.102 2.534 . . . . 0.0 112.083 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 133' ' ' GLU . 13.3 t70 -86.41 141.69 28.97 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.214 -176.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.509 ' HZ3' ' CD ' ' A' ' 174' ' ' GLU . 26.3 mmtp -58.34 -26.57 63.25 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -67.14 -44.91 78.63 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.3 t -75.53 -40.05 40.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.402 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.22 -51.42 70.04 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.797 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 29.3 m -67.58 -32.42 73.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.011 0.434 . . . . 0.0 110.539 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.543 ' O ' HD21 ' A' ' 145' ' ' LEU . 51.7 tt0 -64.35 -56.7 12.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.264 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.27 92.28 Favored 'General case' 0 C--O 1.225 -0.197 0 O-C-N 123.221 0.326 . . . . 0.0 110.147 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -53.69 -43.77 69.22 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.733 0.813 . . . . 0.0 109.726 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.562 ' HE3' ' OE1' ' A' ' 148' ' ' GLU . 56.9 tptt -64.27 -43.98 93.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.361 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.543 HD21 ' O ' ' A' ' 141' ' ' GLN . 2.5 mm? -64.3 -42.57 96.3 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.735 178.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -62.09 -49.14 77.12 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.063 -0.972 . . . . 0.0 112.044 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.51 ' O ' HG13 ' A' ' 151' ' ' ILE . 13.7 tt -69.21 -45.74 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.258 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.562 ' OE1' ' HE3' ' A' ' 144' ' ' LYS . 30.5 mt-10 -68.64 -29.61 68.13 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -175.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.647 ' OE1' ' HB3' ' A' ' 68' ' ' SER . 5.4 pt-20 -67.09 -42.72 84.14 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 118.459 -1.297 . . . . 0.0 108.683 176.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.435 ' N ' ' HG3' ' A' ' 149' ' ' GLU 0.263 24.5 m-70 -74.88 -23.38 58.38 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -179.287 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 147' ' ' ILE . 76.8 mt -66.87 -30.47 49.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -84.42 -42.57 15.52 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 149' ' ' GLU . 5.2 p -80.94 -51.47 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.0 p -96.79 -28.63 14.18 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 121.663 -0.648 . . . . 0.0 111.931 -176.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.96 29.92 62.72 Favored Glycine 0 N--CA 1.467 0.702 0 CA-C-N 114.727 -1.124 . . . . 0.0 115.415 174.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -91.47 -70.58 0.68 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 117.391 0.595 . . . . 0.0 110.702 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.289 7.7 p 41.4 83.27 0.21 Allowed Pre-proline 0 CA--C 1.567 1.613 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.456 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 58.9 Cg_endo -70.11 169.26 19.79 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.945 2.43 . . . . 0.0 112.593 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -45.75 -25.7 2.69 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 125.175 3.917 . . . . 0.0 115.694 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -57.64 -47.84 85.66 Favored Glycine 0 C--O 1.238 0.365 0 O-C-N 123.55 0.532 . . . . 0.0 113.388 -175.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -85.72 -20.36 29.45 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 121.005 0.431 . . . . 0.0 111.785 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -64.26 -71.54 0.17 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.872 175.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 30.8 p 178.35 151.85 0.29 Allowed 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.383 0.673 . . . . 0.0 109.58 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.21 178.4 15.86 Favored Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.154 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -102.4 110.83 22.9 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -118.38 161.76 19.44 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.4 m -60.31 -19.03 53.5 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.201 1.4 . . . . 0.0 111.341 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -70.88 -27.77 64.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.108 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.52 -28.77 2.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 65.81 -83.53 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.097 1.359 . . . . 0.0 111.75 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 29.9 m -125.12 -0.41 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-O 121.079 0.466 . . . . 0.0 110.219 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 50.3 m -81.96 71.54 9.0 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 122.255 1.026 . . . . 0.0 111.224 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -116.32 119.94 37.31 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 171.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.509 ' CD ' ' HZ3' ' A' ' 136' ' ' LYS 0.25 11.2 pt-20 -75.49 75.47 2.54 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.859 1.314 . . . . 0.0 113.334 -176.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -140.65 88.92 2.23 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -80.33 85.41 5.82 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 119.334 -0.947 . . . . 0.0 108.998 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -48.83 117.84 2.28 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.194 -1.821 . . . . 0.0 112.334 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -147.86 80.5 1.49 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.929 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -86.34 82.16 8.09 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.566 -0.853 . . . . 0.0 111.2 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 . . . . . 0 C--N 1.313 -0.978 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.353 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.51 -0.565 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.09 97.64 6.93 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.7 m -88.58 -41.63 12.56 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.102 0.477 . . . . 0.0 109.733 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.74 142.62 3.74 Favored 'General case' 0 C--O 1.25 1.082 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 71' ' ' GLU . 7.2 p -64.82 125.58 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 124.326 1.016 . . . . 0.0 109.833 177.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -100.05 -53.73 3.07 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.809 0.814 . . . . 0.0 108.937 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.2 m -136.78 172.48 12.95 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.482 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.476 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 61.3 mt -59.87 -16.14 26.74 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.8 1.24 . . . . 0.0 114.241 -175.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.5 t -65.32 -19.97 66.19 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.24 0.616 . . . . 0.0 111.164 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.403 ' HB2' HG23 ' A' ' 66' ' ' VAL . 31.7 mt-10 -106.45 -7.36 17.62 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.426 0.631 . . . . 0.0 110.263 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.496 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 4.4 m -84.94 129.6 34.78 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.131 -172.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -81.56 150.99 27.92 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.806 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -104.99 129.1 53.51 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 123.277 0.631 . . . . 0.0 109.657 -175.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.2 140.27 35.71 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -68.27 145.56 66.42 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.532 2.155 . . . . 0.0 110.133 173.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -13.54 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-O 121.429 0.633 . . . . 0.0 110.667 -177.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.4 t -78.42 -15.1 59.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -97.95 47.89 1.01 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.804 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.415 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -61.42 -28.95 69.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.295 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -69.18 -26.02 64.64 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.001 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.7 m -90.87 -5.53 55.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.393 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' A' ' 80' ' ' ALA . 44.1 mm -70.16 125.28 91.92 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -178.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.51 134.96 66.99 Favored 'Trans proline' 0 C--O 1.244 0.823 0 C-N-CA 123.049 2.5 . . . . 0.0 113.399 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.8 p -91.81 26.77 2.28 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.925 0.869 . . . . 0.0 109.727 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.91 -178.73 4.18 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.405 -173.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.5 t -95.83 138.85 32.89 Favored 'General case' 0 N--CA 1.425 -1.704 0 O-C-N 124.034 0.833 . . . . 0.0 109.404 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.46 -151.22 20.25 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 118.503 -1.808 . . . . 0.0 114.422 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.418 ' HB ' ' CH2' ' A' ' 146' ' ' TRP . 5.6 t -120.34 150.28 23.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -139.25 149.26 44.12 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.346 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.14 120.59 34.67 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 123.918 0.887 . . . . 0.0 109.32 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.7 t -99.69 121.76 50.73 Favored 'Isoleucine or valine' 0 C--O 1.263 1.804 0 CA-C-O 121.059 0.457 . . . . 0.0 110.608 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -109.66 132.06 54.49 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.45 -172.48 4.16 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.774 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -22.27 66.88 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.382 0.673 . . . . 0.0 112.201 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.9 m -84.68 0.39 50.53 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 123.001 0.52 . . . . 0.0 109.986 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 69.33 16.55 8.35 Favored 'General case' 0 C--O 1.249 1.079 0 C-N-CA 125.023 1.329 . . . . 0.0 111.707 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -86.84 135.77 33.21 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.124 0.488 . . . . 0.0 110.322 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -80.75 112.22 17.93 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 174.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -125.0 -13.72 6.78 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.944 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.415 ' HA ' ' OD1' ' A' ' 161' ' ' ASN . 57.4 t80 -145.83 122.65 11.26 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 118.707 -1.197 . . . . 0.0 111.08 177.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.433 HG22 ' HB ' ' A' ' 147' ' ' ILE . 18.6 m -123.27 141.32 44.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 171.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -157.23 157.91 28.47 Favored Glycine 0 N--CA 1.413 -2.895 0 C-N-CA 119.068 -1.539 . . . . 0.0 111.719 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.7 pt -110.91 137.84 41.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 121.192 0.52 . . . . 0.0 109.733 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.5 m -149.77 136.41 19.28 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.56 ' HD2' ' C ' ' A' ' 106' ' ' ARG . 4.5 ppt_? -76.74 -12.0 59.92 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.751 0.786 . . . . 0.0 109.894 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -133.7 86.76 2.32 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.6 mt -55.68 -55.32 18.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.157 -174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.64 -60.25 2.3 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.05 -37.99 87.06 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.033 0.208 . . . . 0.0 111.432 -176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.7 t -63.65 -55.32 24.42 Favored 'General case' 0 C--O 1.248 0.985 0 O-C-N 123.836 0.71 . . . . 0.0 109.913 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.9 t -57.94 -51.61 68.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.351 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.9 m -60.1 -37.92 81.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.327 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.13 -58.86 6.8 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 120.937 0.399 . . . . 0.0 111.47 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -77.63 -22.36 50.84 Favored 'General case' 0 C--O 1.203 -1.367 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.04 -26.03 25.58 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 119.062 -1.055 . . . . 0.0 113.326 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -88.12 -16.95 32.09 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.3 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -94.81 -20.1 19.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.004 0.43 . . . . 0.0 111.158 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.9 p -152.73 94.0 3.19 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-O 121.809 0.814 . . . . 0.0 110.534 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.692 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 16.1 Cg_exo -68.84 14.28 0.2 Allowed 'Trans proline' 0 CA--C 1.556 1.579 0 C-N-CA 124.123 3.215 . . . . 0.0 116.729 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -66.39 -28.27 68.5 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 121.464 -0.773 . . . . 0.0 111.503 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.412 ' HG ' ' CZ ' ' A' ' 168' ' ' PHE . 61.9 mt -107.25 20.86 18.38 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 121.683 -0.636 . . . . 0.0 111.502 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.692 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 89.4 m -79.68 99.05 7.21 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.73 -65.28 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.6 p -160.05 162.05 34.09 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.095 0.558 . . . . 0.0 109.52 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.38 137.78 43.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-O 121.155 0.503 . . . . 0.0 110.375 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.496 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 79.5 mttt -109.11 137.27 47.27 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.36 138.69 53.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 120.57 0.224 . . . . 0.0 110.863 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.72 113.34 1.85 Allowed Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.32 107.59 18.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 p -93.53 143.22 11.97 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.572 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -58.63 -50.21 74.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.275 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.416 ' C ' ' H ' ' A' ' 135' ' ' ASP . 43.3 mt-10 -94.52 119.42 66.35 Favored Pre-proline 0 C--N 1.303 -1.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.176 -178.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.07 27.16 0.62 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.066 2.51 . . . . 0.0 110.877 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 133' ' ' GLU . 24.6 t70 -67.15 133.56 50.04 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.402 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -59.54 -33.77 71.82 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.85 -42.24 58.34 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.55 -43.07 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.004 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.69 -49.26 78.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.74 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 44.8 m -69.1 -31.1 69.58 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.084 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.481 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 27.9 tt0 -63.26 -50.64 69.36 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 122.946 0.498 . . . . 0.0 109.884 178.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.85 -45.26 93.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.698 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -51.13 -46.69 62.02 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.251 1.021 . . . . 0.0 110.284 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -61.0 -48.82 80.04 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.179 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 61.7 mt -62.8 -43.23 99.35 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.79 -176.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.418 ' CH2' ' HB ' ' A' ' 89' ' ' VAL . 30.8 m0 -61.48 -47.51 85.35 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.21 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.507 ' O ' HG13 ' A' ' 151' ' ' ILE . 14.9 tt -67.68 -39.75 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.404 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -62.74 -33.71 75.69 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 153' ' ' VAL . 7.3 mm-40 -55.24 -45.95 76.02 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.401 0.619 . . . . 0.0 109.685 173.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.404 ' HA ' HG12 ' A' ' 153' ' ' VAL 0.255 74.3 m-70 -80.5 -27.36 37.74 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.295 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 147' ' ' ILE . 79.8 mt -61.29 -41.07 88.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.469 ' HZ1' ' HB2' ' A' ' 152' ' ' LYS . 9.7 mtmp? -71.06 -43.98 66.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.326 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 149' ' ' GLU . 7.3 p -81.7 -56.4 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.4 p -99.47 -34.36 10.3 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 121.811 -0.556 . . . . 0.0 112.264 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.74 34.67 27.21 Favored Glycine 0 C--N 1.304 -1.226 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.715 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -106.83 106.49 17.05 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.76 87.52 46.41 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 173.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -86.14 169.87 8.53 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 123.896 3.064 . . . . 0.0 113.251 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -45.23 -30.57 5.3 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 124.928 3.752 . . . . 0.0 116.177 -175.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.76 -30.31 72.67 Favored Glycine 0 C--O 1.246 0.896 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.312 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.415 ' OD1' ' HA ' ' A' ' 101' ' ' PHE . 14.7 m120 -101.47 -21.07 14.87 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -68.8 162.62 25.96 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 38.3 m -69.03 103.53 1.88 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.791 0.805 . . . . 0.0 111.38 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 156.67 -158.55 28.84 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -125.18 167.72 14.43 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -162.09 160.26 27.16 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.6 m -52.98 -25.36 11.77 Favored 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 124.284 1.033 . . . . 0.0 112.412 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.412 ' CZ ' ' HG ' ' A' ' 122' ' ' LEU . 64.6 m-85 -84.78 -4.47 59.07 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 177.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.17 -34.12 5.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -176.16 140.51 0.4 Allowed 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 28.5 m -75.31 116.72 18.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 121.614 0.721 . . . . 0.0 112.321 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 16.7 m -105.58 -17.16 14.5 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.942 176.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.34 107.91 19.07 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -96.43 -46.17 6.48 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.378 1.085 . . . . 0.0 109.009 -178.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -86.34 99.89 11.92 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.221 -170.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -70.32 142.16 52.24 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.621 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -100.14 107.59 19.5 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 70.43 109.06 0.06 Allowed 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 123.984 0.914 . . . . 0.0 112.082 -171.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -121.76 14.46 10.89 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 . . . . . 0 N--CA 1.421 -1.886 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -176.236 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.36 27.54 15.51 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.597 1.159 . . . . 0.0 112.978 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 m -95.03 31.47 1.88 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 122.018 0.913 . . . . 0.0 110.676 -176.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.11 155.18 26.47 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.1 t -89.6 120.22 38.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-O 120.687 0.28 . . . . 0.0 110.551 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.433 ' N ' ' HD3' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -106.32 -47.89 3.7 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 177.713 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.7 m -114.41 168.98 9.38 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.331 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 146' ' ' TRP . 2.9 tm? -65.32 -35.0 79.65 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.429 1.092 . . . . 0.0 109.829 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.8 m -55.97 -28.69 58.2 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.798 176.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.421 ' CD ' ' HZ2' ' A' ' 67' ' ' LYS . 36.6 mt-10 -93.94 -4.08 50.45 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.752 -0.593 . . . . 0.0 111.575 -176.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.531 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.3 m -78.02 141.67 38.73 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -173.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -88.45 148.64 24.08 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.659 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.06 133.94 48.16 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 122.84 0.456 . . . . 0.0 109.94 -174.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -126.44 126.45 24.61 Favored Pre-proline 0 C--N 1.315 -0.928 0 C-N-CA 123.652 0.781 . . . . 0.0 108.902 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.464 ' HB2' HG23 ' A' ' 78' ' ' THR . 25.5 Cg_exo -67.67 141.85 56.28 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 121.843 1.695 . . . . 0.0 109.139 172.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -5.0 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -174.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.464 HG23 ' HB2' ' A' ' 76' ' ' PRO . 9.1 t -68.32 -30.0 68.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -99.43 52.97 0.94 Allowed 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.364 1.078 . . . . 0.0 109.61 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.55 -24.11 66.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.102 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -76.32 -19.41 58.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.782 0.801 . . . . 0.0 110.244 176.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.3 t -87.49 -6.97 58.15 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.243 -174.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.7 mm -67.43 125.84 91.71 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.391 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -53.77 137.37 67.45 Favored 'Trans proline' 0 C--O 1.243 0.739 0 C-N-CA 123.584 2.856 . . . . 0.0 113.95 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.8 p -93.69 35.72 1.12 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.25 1.024 . . . . 0.0 109.129 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.439 ' O ' HG13 ' A' ' 108' ' ' ILE . . . -102.64 175.37 5.52 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.229 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.7 t -97.53 134.76 40.32 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.28 -154.88 24.68 Favored Glycine 0 N--CA 1.412 -2.902 0 C-N-CA 119.952 -1.118 . . . . 0.0 111.069 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.456 ' HB ' ' CH2' ' A' ' 146' ' ' TRP . 3.2 t -115.24 156.44 16.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -145.61 149.52 34.68 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.58 121.97 35.15 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.462 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.9 t -94.93 118.74 41.75 Favored 'Isoleucine or valine' 0 C--O 1.259 1.558 0 CA-C-O 121.332 0.587 . . . . 0.0 110.351 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.57 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 7.3 m-85 -108.82 134.49 51.44 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.367 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.92 -179.33 6.92 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -73.99 3.18 7.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -175.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.5 m -94.18 0.0 55.49 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 171.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 t70 61.51 62.94 1.24 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.036 1.334 . . . . 0.0 108.538 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -141.39 146.49 36.67 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.3 -177.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -96.3 116.67 29.4 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.92 0.762 . . . . 0.0 110.745 -172.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.419 ' HA ' ' HG2' ' A' ' 158' ' ' PRO . 2.4 mp0 -112.08 -28.39 8.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.329 178.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -145.91 127.07 14.72 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.12 -1.032 . . . . 0.0 112.493 -175.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.423 HG23 ' NE1' ' A' ' 143' ' ' TRP . 20.0 m -114.98 143.55 24.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 172.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.46 170.38 31.03 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.4 pt -133.14 146.84 31.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.1 t -151.22 162.42 40.92 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.979 -0.289 . . . . 0.0 110.29 -176.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -85.38 -22.67 28.3 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -142.43 86.16 1.94 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 86' ' ' ALA . 73.0 mt -43.94 -52.45 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.663 1.185 . . . . 0.0 113.304 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.65 -40.33 19.52 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.78 -51.76 37.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.444 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.9 m -63.19 -45.92 89.5 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.688 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.31 -57.13 11.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.33 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.4 t -62.94 -40.89 99.01 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 123.404 0.44 . . . . 0.0 111.13 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.69 -54.31 47.67 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.261 19.7 p80 -78.69 -25.79 44.81 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 118.922 -1.111 . . . . 0.0 113.94 -177.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 70.5 mt -75.19 -28.35 59.97 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 119.781 -0.767 . . . . 0.0 112.127 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -86.11 -23.34 26.67 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.738 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.1 m -72.89 -46.36 53.2 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.4 p -139.26 91.69 11.02 Favored Pre-proline 0 N--CA 1.438 -1.075 0 CA-C-O 122.22 1.009 . . . . 0.0 110.022 177.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -74.84 29.75 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.945 3.096 . . . . 0.0 113.82 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -70.83 -42.87 69.64 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.362 0.601 . . . . 0.0 110.533 -177.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.62 21.29 4.08 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.219 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 35.9 m -71.56 99.32 2.04 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.334 0.587 . . . . 0.0 111.856 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.32 -59.9 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.1 p -164.72 160.84 20.24 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.79 138.01 46.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.531 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 97.9 mttt -106.71 135.36 48.38 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.0 m -120.88 131.41 72.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 120.81 0.338 . . . . 0.0 110.1 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -115.81 106.58 1.57 Allowed Glycine 0 N--CA 1.408 -3.228 0 C-N-CA 119.868 -1.158 . . . . 0.0 111.85 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 mp -82.23 112.37 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.25 144.26 20.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.31 4.51 53.37 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.204 -171.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -94.58 112.4 57.69 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -84.73 8.32 4.7 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 122.592 2.195 . . . . 0.0 116.065 -170.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -97.64 146.81 24.95 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.131 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -54.85 -34.67 63.16 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.692 1.197 . . . . 0.0 111.891 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.96 -44.23 90.08 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 120.658 0.266 . . . . 0.0 110.665 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.46 -36.38 48.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.615 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.82 -45.08 95.86 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.1 m -71.94 -32.14 67.02 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 121.072 0.463 . . . . 0.0 110.698 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.424 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 26.6 tt0 -63.69 -46.31 86.06 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 175.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.77 -42.25 95.24 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.843 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.423 ' NE1' HG23 ' A' ' 102' ' ' VAL . 91.9 t90 -49.83 -45.89 50.67 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.488 0.715 . . . . 0.0 109.633 176.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.672 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 84.6 mttt -62.09 -50.74 70.74 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.13 177.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 86.9 mt -54.32 -47.54 72.36 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.532 0.52 . . . . 0.0 110.679 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.456 ' CH2' ' HB ' ' A' ' 89' ' ' VAL . 14.3 m0 -62.02 -54.46 41.26 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.538 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.445 ' O ' HG12 ' A' ' 151' ' ' ILE . 11.1 tt -59.19 -42.78 87.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 O-C-N 123.424 0.452 . . . . 0.0 110.274 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.672 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 37.3 mt-10 -56.01 -47.67 77.34 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 123.547 0.53 . . . . 0.0 110.913 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.419 ' O ' HG21 ' A' ' 153' ' ' VAL . 15.4 mt-10 -56.86 -47.02 81.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.83 -28.2 30.33 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 118.496 -1.282 . . . . 0.0 112.751 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.518 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 38.2 pt -76.85 -26.77 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.906 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -78.5 -30.9 47.47 Favored 'General case' 0 C--N 1.264 -3.123 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.079 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 149' ' ' GLU . 35.1 m -86.57 -46.33 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 176.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 70.8 p -99.99 -19.02 16.76 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 119.409 -0.917 . . . . 0.0 113.031 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 151' ' ' ILE . . . 67.52 34.69 84.99 Favored Glycine 0 N--CA 1.468 0.822 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 174.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -78.95 -74.94 0.26 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 117.1 0.45 . . . . 0.0 111.958 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.1 t 54.13 69.52 2.12 Favored Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 123.865 0.866 . . . . 0.0 109.014 -174.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.419 ' HG2' ' HA ' ' A' ' 100' ' ' GLN . 2.8 Cg_exo -81.44 156.94 19.27 Favored 'Trans proline' 0 C--O 1.242 0.696 0 C-N-CA 122.804 2.336 . . . . 0.0 112.84 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.92 -35.92 41.96 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 124.298 3.332 . . . . 0.0 114.159 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -64.86 -30.52 78.21 Favored Glycine 0 CA--C 1.498 -1.011 0 O-C-N 123.336 0.397 . . . . 0.0 112.933 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.409 ' OD1' HG21 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -94.27 -29.57 15.0 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -176.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -71.47 -54.0 12.07 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.879 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.2 m -112.27 154.61 25.36 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.433 -173.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -88.23 9.23 75.92 Favored Glycine 0 C--N 1.316 -0.574 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.977 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -118.11 110.65 17.88 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 122.171 -0.605 . . . . 0.0 109.971 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -179.84 158.55 0.78 Allowed 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 22.3 m -56.34 -32.9 65.13 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 118.321 0.509 . . . . 0.0 111.391 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -70.69 -11.91 61.23 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.1 t -118.83 7.34 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 122.122 0.963 . . . . 0.0 109.097 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -92.38 36.8 0.99 Allowed 'General case' 0 C--N 1.316 -0.891 0 O-C-N 121.668 -0.645 . . . . 0.0 112.179 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.1 t -85.85 82.93 2.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.835 0.826 . . . . 0.0 110.909 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.5 153.97 18.16 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 170.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.31 -46.25 74.09 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 119.502 1.046 . . . . 0.0 111.261 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.46 32.94 2.61 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 120.952 0.406 . . . . 0.0 110.578 176.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -68.23 -42.39 79.84 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -79.3 124.48 28.43 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 171.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -100.47 113.79 26.85 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -57.31 -34.55 68.84 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.904 0.753 . . . . 0.0 111.624 -174.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -97.67 90.59 5.05 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--N 1.299 -1.626 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.535 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.7 mptt . . . . . 0 C--O 1.205 -1.253 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.417 ' HB3' ' OE2' ' A' ' 149' ' ' GLU . 15.6 m -113.32 164.64 13.31 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.568 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.402 HD13 ' OH ' ' A' ' 93' ' ' TYR . 35.0 mt -62.33 -28.02 69.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.159 0.983 . . . . 0.0 111.404 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 m -59.45 -21.91 60.73 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.033 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -104.92 11.58 33.43 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 122.717 0.407 . . . . 0.0 110.264 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.436 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 8.1 m -104.7 142.9 33.88 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -173.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -86.26 159.64 19.38 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.506 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.11 133.35 53.12 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.524 HD23 HG22 ' A' ' 128' ' ' VAL . 3.7 mm? -128.17 138.87 33.92 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -74.93 143.53 29.41 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.41 2.074 . . . . 0.0 110.573 173.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.62 -15.74 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-O 120.913 0.387 . . . . 0.0 112.01 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p -71.77 -38.21 70.38 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 121.615 0.722 . . . . 0.0 111.183 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -93.16 54.2 2.09 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.873 0.844 . . . . 0.0 110.645 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.52 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -56.38 -18.41 10.91 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.425 -1.261 . . . . 0.0 112.981 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -72.25 -27.25 62.39 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.52 0.676 . . . . 0.0 109.692 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.9 m -93.89 3.3 55.6 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.977 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.52 HG12 ' HA ' ' A' ' 80' ' ' ALA . 38.1 mm -79.63 128.56 74.34 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.26 130.65 41.79 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.957 2.438 . . . . 0.0 113.335 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.1 p -92.9 39.01 1.03 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.224 1.011 . . . . 0.0 109.475 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -109.55 177.63 4.68 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.259 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.6 t -93.94 140.53 29.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.75 -155.08 26.15 Favored Glycine 0 N--CA 1.417 -2.62 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.641 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.477 HG13 ' CH2' ' A' ' 146' ' ' TRP . 6.3 p -121.23 149.17 24.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -137.63 149.58 46.72 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 120.848 0.356 . . . . 0.0 110.543 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.403 ' HB1' HD23 ' A' ' 99' ' ' LEU . . . -122.14 118.65 29.18 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.79 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.6 t -91.78 121.0 41.87 Favored 'Isoleucine or valine' 0 C--O 1.263 1.787 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.367 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 67.4 m-85 -108.76 130.0 55.37 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.691 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -76.91 -175.08 3.35 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.231 0.539 . . . . 0.0 110.257 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.464 ' H ' ' HD2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -57.83 -28.09 63.76 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 124.14 0.976 . . . . 0.0 113.547 -178.726 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.7 m -91.74 3.45 55.07 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.803 0.335 . . . . 0.0 111.492 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.4 t70 62.33 67.75 0.71 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-O 122.724 1.25 . . . . 0.0 111.598 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 8.1 mm-40 -136.82 145.73 44.82 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.556 -1.656 . . . . 0.0 109.814 174.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.512 HD21 HG13 ' A' ' 102' ' ' VAL . 3.0 tm? -89.87 116.71 28.15 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.308 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -122.86 -14.49 7.64 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.259 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.58 115.03 5.91 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.819 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.512 HG13 HD21 ' A' ' 99' ' ' LEU . 12.3 m -111.21 142.26 24.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.79 159.76 29.81 Favored Glycine 0 N--CA 1.424 -2.14 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.227 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.2 pt -115.09 139.94 38.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.5 m -151.0 157.77 43.3 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.635 ' HD3' ' O ' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -79.3 -23.32 43.61 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -135.49 105.39 6.2 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 173.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.4 mt -60.14 -56.94 14.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.38 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.95 -50.73 45.56 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.559 0.744 . . . . 0.0 112.767 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.23 -52.19 66.73 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 123.75 0.656 . . . . 0.0 111.109 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.1 t -61.26 -48.62 80.6 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.293 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 54.7 t -56.9 -54.48 29.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 123.103 0.561 . . . . 0.0 111.097 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.0 m -61.04 -35.53 77.15 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 123.607 0.567 . . . . 0.0 111.463 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.91 -58.96 3.97 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.836 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.287 19.6 p80 -74.8 -24.66 58.68 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -175.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.6 mt -77.93 -24.82 48.14 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.217 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 117' ' ' LYS . 73.0 mmtt -85.49 -16.82 38.31 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.867 175.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.0 t -80.55 -50.48 9.95 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.58 85.0 61.3 Favored Pre-proline 0 CA--C 1.557 1.236 0 CA-C-O 122.341 1.067 . . . . 0.0 109.929 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.494 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 16.6 Cg_exo -71.87 12.02 0.62 Allowed 'Trans proline' 0 N--CA 1.479 0.623 0 C-N-CA 124.031 3.154 . . . . 0.0 114.806 -176.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -66.47 -39.32 88.73 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.341 0.591 . . . . 0.0 109.886 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.8 mt -88.16 20.71 3.08 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.092 0.473 . . . . 0.0 111.802 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.494 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 89.2 m -79.99 99.44 7.64 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 121.497 0.665 . . . . 0.0 111.069 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.43 -64.64 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 174.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.4 p -161.43 162.92 30.73 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.9 p -137.14 137.05 46.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.436 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 94.8 mttt -106.4 125.56 51.15 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 175.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.524 HG22 HD23 ' A' ' 75' ' ' LEU . 33.0 m -115.34 134.35 58.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.412 0.625 . . . . 0.0 111.929 -174.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.65 96.16 0.63 Allowed Glycine 0 N--CA 1.422 -2.249 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 130' ' ' ILE . 2.6 mp -89.27 121.37 39.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 133' ' ' GLU . 10.2 p -116.12 125.25 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 175.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -72.38 -8.87 57.24 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.461 ' H ' HG22 ' A' ' 131' ' ' VAL . 38.3 mt-10 -89.62 122.06 68.55 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -83.12 27.12 0.62 Allowed 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.769 2.313 . . . . 0.0 113.224 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.432 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 24.2 t70 -78.96 129.38 34.42 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.532 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -69.9 -31.15 68.79 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.422 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.72 -38.45 62.29 Favored 'General case' 0 C--O 1.203 -1.37 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.297 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.401 HG23 ' OD2' ' A' ' 135' ' ' ASP . 97.6 t -59.09 -43.75 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 92.4 mt -59.08 -48.4 81.75 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.345 0.593 . . . . 0.0 110.244 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.6 m -70.69 -34.3 71.82 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.272 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.45 -47.05 74.4 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 123.109 0.564 . . . . 0.0 109.759 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.83 -49.25 78.43 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -49.17 -43.9 42.38 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.002 0.921 . . . . 0.0 110.305 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -65.55 -48.71 71.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.43 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.64 -37.12 85.09 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.773 0.321 . . . . 0.0 110.871 177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.477 ' CH2' HG13 ' A' ' 89' ' ' VAL . 25.0 m0 -63.47 -53.55 50.29 Favored 'General case' 0 C--O 1.254 1.333 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.53 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.465 ' HB ' HG21 ' A' ' 102' ' ' VAL . 11.8 tt -63.41 -41.21 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.829 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -60.24 -36.94 78.9 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 153' ' ' VAL . 24.4 mt-10 -54.96 -46.97 75.11 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 118.94 0.791 . . . . 0.0 110.56 176.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.504 ' CG ' ' HB3' ' A' ' 99' ' ' LEU 0.323 18.9 m-70 -77.85 -29.81 50.67 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 118.769 -1.172 . . . . 0.0 114.011 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 147' ' ' ILE . 68.7 mt -60.68 -44.87 98.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 172.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.27 -48.65 64.44 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.433 HG22 ' HA ' ' A' ' 150' ' ' HIS . 21.8 m -80.01 -32.1 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -175.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.7 t -131.7 -30.21 1.66 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.44 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.41 15.61 56.78 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.642 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -77.11 120.56 22.37 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 42.8 t -138.46 80.65 26.57 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -77.69 161.48 30.71 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.431 2.754 . . . . 0.0 113.278 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -52.84 -23.77 21.81 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 124.543 3.495 . . . . 0.0 114.197 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.4 -29.97 75.77 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.574 -0.346 . . . . 0.0 112.87 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 C--N 1.314 -0.947 0 CA-C-O 122.347 1.07 . . . . 0.0 110.17 -178.609 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.2 m -123.25 -179.08 4.18 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.76 -17.75 63.46 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.3 m -63.69 -26.76 68.81 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.789 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -84.16 -20.53 32.29 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.436 0.636 . . . . 0.0 109.668 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.487 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 2.7 m -76.82 154.35 33.98 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.036 -0.983 . . . . 0.0 113.512 -168.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -100.9 158.61 15.86 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.887 0.875 . . . . 0.0 109.133 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.68 128.82 55.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.98 0.419 . . . . 0.0 110.175 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.492 HD23 HG22 ' A' ' 128' ' ' VAL . 3.9 mm? -123.01 129.09 25.1 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -65.39 143.84 77.82 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 121.663 1.575 . . . . 0.0 108.74 170.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.596 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -65.12 -13.19 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -176.333 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.8 p -76.12 -16.22 59.93 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.56 0.695 . . . . 0.0 110.809 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -92.97 30.58 1.57 Allowed 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -49.53 -40.33 37.52 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.532 1.133 . . . . 0.0 113.414 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -72.95 -17.95 61.43 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.642 0.734 . . . . 0.0 110.789 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.0 m -103.65 -1.05 28.75 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.389 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 80' ' ' ALA . 48.4 mm -65.38 134.07 95.57 Favored Pre-proline 0 C--O 1.243 0.731 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.59 129.92 31.48 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.84 2.36 . . . . 0.0 112.205 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.4 p -99.16 49.51 0.95 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.872 0.844 . . . . 0.0 109.922 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -124.99 -179.44 4.55 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.983 -176.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.7 t -95.37 145.02 25.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.27 -156.5 28.43 Favored Glycine 0 N--CA 1.414 -2.79 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.538 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.574 HG12 HG22 ' A' ' 104' ' ' ILE . 3.2 m -110.67 151.05 12.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 123.996 0.918 . . . . 0.0 109.916 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -141.85 147.18 36.76 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 120.713 0.292 . . . . 0.0 110.214 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.91 122.22 37.38 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.77 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.57 117.05 40.21 Favored 'Isoleucine or valine' 0 C--O 1.26 1.655 0 C-N-CA 123.377 0.671 . . . . 0.0 110.36 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.621 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 47.1 m-85 -107.39 134.5 50.36 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -79.94 -167.93 1.45 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.262 0.554 . . . . 0.0 112.114 -174.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -56.88 -32.56 65.98 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.244 1.417 . . . . 0.0 110.667 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.9 m -90.72 7.42 39.65 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.924 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 69.93 16.45 7.67 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.347 1.07 . . . . 0.0 111.055 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -92.3 139.63 30.41 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 120.93 -1.106 . . . . 0.0 110.327 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.621 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.3 tm? -82.43 129.68 34.95 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.645 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -125.78 -43.52 1.85 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 123.771 0.669 . . . . 0.0 111.078 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -124.29 131.09 53.5 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.835 -171.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.9 m -123.02 151.85 27.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 174.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -158.82 168.67 35.01 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.282 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.574 HG22 HG12 ' A' ' 89' ' ' VAL . 9.5 pt -120.35 144.76 28.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 123.259 0.624 . . . . 0.0 109.958 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 71.1 m -150.03 154.64 38.51 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.916 0.389 . . . . 0.0 111.61 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -78.59 -28.16 45.73 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -142.23 103.16 4.24 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.4 mt -55.2 -54.7 21.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.462 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.14 -43.79 64.21 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.08 -54.8 24.39 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 123.381 0.426 . . . . 0.0 111.904 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.1 m -70.86 -41.14 71.8 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.81 -56.74 15.38 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.8 m -58.3 -40.22 81.41 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 123.753 0.658 . . . . 0.0 111.228 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.03 -55.64 30.39 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 120.989 0.423 . . . . 0.0 111.281 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -75.03 -27.39 60.04 Favored 'General case' 0 C--O 1.21 -0.99 0 C-N-CA 119.275 -0.97 . . . . 0.0 113.265 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.442 HD22 ' SG ' ' A' ' 123' ' ' CYS . 64.5 mt -76.33 -24.49 54.28 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.051 -0.659 . . . . 0.0 112.061 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -88.71 -11.21 45.82 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.305 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.2 m -90.64 -43.62 10.05 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.89 175.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.31 93.85 24.72 Favored Pre-proline 0 CA--C 1.551 1.008 0 CA-C-O 121.826 0.822 . . . . 0.0 110.727 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.82 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 6.2 Cg_exo -77.41 10.65 2.4 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.388 2.725 . . . . 0.0 113.779 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.13 -42.33 85.58 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.695 0.798 . . . . 0.0 112.259 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.3 mt -105.84 20.67 18.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.181 0.515 . . . . 0.0 110.432 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.82 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 81.5 m -80.72 88.62 5.76 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -127.0 -55.11 0.14 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.9 p -158.76 162.73 37.13 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.99 136.22 42.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.487 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 67.6 mttm -106.6 125.54 51.14 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.492 HG22 HD23 ' A' ' 75' ' ' LEU . 32.8 m -114.51 133.54 60.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.102 0.477 . . . . 0.0 111.292 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.13 104.32 1.0 Allowed Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 mp -87.72 133.22 30.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 133' ' ' GLU . 14.5 p -122.46 151.68 26.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -95.61 7.0 47.53 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.69 0.757 . . . . 0.0 110.425 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.426 ' H ' HG22 ' A' ' 131' ' ' VAL . 36.5 mt-10 -127.08 99.88 27.88 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.789 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -84.84 34.03 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.388 2.726 . . . . 0.0 113.511 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -85.07 140.13 31.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -58.7 -28.31 65.67 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.98 -43.07 62.66 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -66.09 -42.51 91.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.11 -46.69 87.95 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.704 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 43.2 m -71.27 -28.22 63.99 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.748 0.309 . . . . 0.0 110.755 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.2 -54.6 42.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.83 -41.16 99.21 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 123.928 0.767 . . . . 0.0 110.148 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.47 ' O ' HG22 ' A' ' 147' ' ' ILE . 90.4 t90 -53.51 -46.88 70.26 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.735 0.814 . . . . 0.0 109.39 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -57.79 -50.98 71.45 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.424 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 4.0 mm? -57.7 -49.61 75.95 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.297 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -57.69 -51.99 67.26 Favored 'General case' 0 C--O 1.255 1.353 0 O-C-N 124.488 1.117 . . . . 0.0 112.23 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.583 ' O ' HG12 ' A' ' 151' ' ' ILE . 11.7 tt -70.21 -51.07 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.4 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.88 -33.12 74.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 153' ' ' VAL . 10.1 pt-20 -63.86 -42.88 97.43 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.17 177.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -74.88 -27.21 60.14 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 147' ' ' ILE . 44.8 mm -62.09 -45.66 98.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.05 -37.95 78.84 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.649 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 149' ' ' GLU . 5.5 p -88.52 -60.13 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.1 p -90.71 -28.72 18.14 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 70.81 34.86 66.05 Favored Glycine 0 N--CA 1.467 0.761 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.018 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 99' ' ' LEU . 71.9 mmtt -87.36 114.98 24.46 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 122.528 0.331 . . . . 0.0 110.521 -176.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.9 t -133.9 87.86 34.04 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -88.2 153.28 6.85 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.826 2.351 . . . . 0.0 112.358 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.98 -27.39 28.26 Favored 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 123.908 3.072 . . . . 0.0 113.245 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -63.51 -37.57 94.99 Favored Glycine 0 CA--C 1.502 -0.778 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.86 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 C--N 1.306 -1.313 0 CA-C-O 121.243 0.544 . . . . 0.0 109.934 -177.321 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 C--O 1.214 -0.793 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.8 m -134.7 169.48 17.26 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.912 -0.492 . . . . 0.0 110.882 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.7 mt -58.33 -22.85 54.75 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.334 1.053 . . . . 0.0 112.107 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.456 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 38.2 m -60.68 -44.16 96.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 124.116 0.966 . . . . 0.0 112.067 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.456 ' OE2' ' HB ' ' A' ' 70' ' ' THR . 1.5 mp0 -89.62 3.98 50.89 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.126 0.488 . . . . 0.0 110.25 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.549 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 3.2 m -92.96 128.45 38.82 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.501 -175.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 16.6 pt-20 -78.69 159.19 28.11 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 122.74 0.416 . . . . 0.0 110.982 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.51 125.26 54.01 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 122.659 0.384 . . . . 0.0 110.583 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -124.19 131.09 24.17 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.416 ' HD2' ' HG3' ' A' ' 79' ' ' GLU . 24.2 Cg_exo -65.89 149.68 86.28 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 121.988 1.792 . . . . 0.0 110.014 173.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.412 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -71.91 -12.29 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.874 -0.516 . . . . 0.0 111.814 -176.481 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.4 p -78.02 -17.79 56.67 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.171 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.416 ' HG3' ' HD2' ' A' ' 76' ' ' PRO . 21.8 mm-40 -94.14 38.93 1.08 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.521 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -57.93 -29.5 65.18 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.053 0.941 . . . . 0.0 112.496 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.27 -20.76 60.03 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.374 0.606 . . . . 0.0 110.4 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.7 m -96.88 6.71 48.14 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.519 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.521 HG12 ' HA ' ' A' ' 80' ' ' ALA . 45.2 mm -77.43 123.03 86.86 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -56.22 130.39 39.92 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.976 2.451 . . . . 0.0 113.695 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.1 p -91.6 76.26 5.78 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.344 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.3 177.79 8.37 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.629 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.9 t -91.18 137.72 32.15 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.401 ' HA2' HG12 ' A' ' 131' ' ' VAL . . . 164.46 -149.56 16.65 Favored Glycine 0 N--CA 1.414 -2.833 0 C-N-CA 119.482 -1.342 . . . . 0.0 112.732 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.508 HG13 ' CH2' ' A' ' 146' ' ' TRP . 4.8 p -128.34 149.75 33.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -136.25 157.14 47.53 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.436 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . . . -127.69 114.83 17.84 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 123.775 0.83 . . . . 0.0 109.442 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.1 t -89.0 119.25 35.8 Favored 'Isoleucine or valine' 0 C--O 1.264 1.834 0 CA-C-O 120.944 0.402 . . . . 0.0 111.008 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 7.3 m-85 -103.35 127.18 50.76 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.165 0.986 . . . . 0.0 109.052 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -79.52 -168.54 1.58 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.555 0.693 . . . . 0.0 112.242 -173.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -57.7 -41.46 81.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.683 1.193 . . . . 0.0 109.993 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.8 t -84.83 12.11 7.99 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.841 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 70.94 20.17 5.45 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 32.7 mt-10 -103.62 148.83 25.54 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 118.865 -1.134 . . . . 0.0 112.211 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.422 HD23 ' HB1' ' A' ' 91' ' ' ALA . 2.1 tm? -80.02 117.72 21.11 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.813 174.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 158' ' ' PRO . 1.7 mp0 -113.85 -39.51 3.97 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.15 173.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -124.45 115.25 20.61 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.564 -1.254 . . . . 0.0 112.248 -171.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.409 HG23 ' NE1' ' A' ' 143' ' ' TRP . 22.3 m -98.55 147.22 7.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 172.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.19 147.79 17.94 Favored Glycine 0 C--N 1.283 -2.396 0 C-N-CA 118.876 -1.631 . . . . 0.0 112.418 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.4 pt -112.7 138.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 m -152.52 161.54 42.44 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 106' ' ' ARG . 16.0 tpt180 -81.68 -22.56 37.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.502 0.668 . . . . 0.0 109.875 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.439 HD22 ' H ' ' A' ' 110' ' ' ALA . 6.6 t30 -141.91 100.2 3.69 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.1 mt -48.61 -58.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.91 1.284 . . . . 0.0 113.528 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.63 -53.89 13.5 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' H ' HD22 ' A' ' 107' ' ' ASN . . . -59.47 -36.47 76.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.424 -177.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.4 t -76.11 -52.01 11.03 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.6 t -55.63 -54.45 25.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.429 0.691 . . . . 0.0 111.785 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 m -59.93 -47.77 84.43 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.405 0.44 . . . . 0.0 111.218 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.34 -55.2 36.58 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.257 24.1 p80 -76.84 -25.51 53.28 Favored 'General case' 0 C--O 1.216 -0.658 0 C-N-CA 118.516 -1.274 . . . . 0.0 113.959 -175.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 72.2 mt -77.91 -36.17 49.82 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.499 -0.88 . . . . 0.0 112.056 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -75.97 -19.12 58.99 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.451 -0.899 . . . . 0.0 110.645 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 57.3 m -80.3 -42.71 22.55 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.754 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -134.9 95.06 15.74 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 121.912 0.863 . . . . 0.0 110.804 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.74 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 83.1 Cg_endo -81.42 24.4 0.7 Allowed 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 123.418 2.745 . . . . 0.0 114.633 -174.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -67.41 -34.26 76.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.826 0.822 . . . . 0.0 110.254 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.8 mt -109.37 20.78 17.86 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.242 0.544 . . . . 0.0 110.549 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.74 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 67.5 m -81.14 84.06 6.64 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -122.93 -58.12 0.2 Allowed Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 174.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 12.4 p -163.18 169.19 19.68 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 123.652 0.781 . . . . 0.0 109.048 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.95 139.59 36.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-O 121.257 0.551 . . . . 0.0 109.852 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.549 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 89.4 mttt -106.34 132.51 52.3 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.72 139.18 45.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.274 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.95 101.21 0.61 Allowed Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.61 120.67 35.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.401 HG12 ' HA2' ' A' ' 88' ' ' GLY . 7.7 p -110.06 130.86 62.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -79.32 -19.08 51.24 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.09 0.471 . . . . 0.0 111.845 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -105.14 101.02 28.0 Favored Pre-proline 0 N--CA 1.435 -1.18 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -86.11 36.24 0.5 Allowed 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 123.061 2.507 . . . . 0.0 112.449 -173.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.69 137.37 54.08 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -61.25 -31.49 71.29 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 123.066 0.229 . . . . 0.0 111.475 -173.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.14 -35.27 66.47 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.814 0.34 . . . . 0.0 110.148 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 63.9 t -69.74 -41.44 79.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.316 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.8 mt -59.52 -48.12 82.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.064 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.7 m -64.58 -36.51 84.48 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.553 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.69 -52.29 63.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.083 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.43 -46.06 91.41 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.163 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.409 ' NE1' HG23 ' A' ' 102' ' ' VAL . 86.4 t90 -51.09 -48.84 61.57 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 123.944 0.778 . . . . 0.0 109.421 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.554 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 88.5 tttt -63.58 -57.17 10.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.072 -177.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.506 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 10.4 mp -58.32 -41.65 85.02 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.508 ' CH2' HG13 ' A' ' 89' ' ' VAL . 30.0 m0 -57.79 -52.35 65.83 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-O 120.739 0.304 . . . . 0.0 111.723 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.478 ' O ' HG13 ' A' ' 151' ' ' ILE . 14.5 tt -66.93 -39.07 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.765 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 53.0 mt-10 -60.65 -39.42 88.23 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 21.7 mm-40 -56.67 -44.49 81.45 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.97 0.414 . . . . 0.0 110.853 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -76.73 -30.26 56.54 Favored 'General case' 0 C--O 1.249 1.068 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.535 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 147' ' ' ILE . 74.7 mt -67.12 -45.7 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 122.23 0.212 . . . . 0.0 111.263 178.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -62.46 -38.68 90.75 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 149' ' ' GLU . 7.7 p -81.23 -54.63 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.417 HG23 HG13 ' A' ' 153' ' ' VAL . 69.2 p -105.82 -36.28 7.07 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.148 -173.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.68 17.95 57.45 Favored Glycine 0 C--N 1.311 -0.811 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.71 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -75.27 107.29 7.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 117.105 0.453 . . . . 0.0 109.82 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.2 106.75 33.15 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.406 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 13.1 Cg_endo -90.36 162.37 4.54 Favored 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 122.908 2.405 . . . . 0.0 112.913 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.66 -25.39 80.81 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.107 2.538 . . . . 0.0 112.844 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -64.87 -33.65 87.8 Favored Glycine 0 C--N 1.33 0.224 0 N-CA-C 114.348 0.499 . . . . 0.0 114.348 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.428 HD22 ' HA ' ' A' ' 161' ' ' ASN . 3.3 m120 . . . . . 0 C--O 1.246 0.888 0 CA-C-O 121.454 0.645 . . . . 0.0 111.922 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? . . . . . 0 N--CA 1.439 -0.99 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.2 p -107.28 156.72 18.57 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.98 -175.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.16 -24.17 66.6 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.37 1.068 . . . . 0.0 109.882 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.1 m -60.0 -26.88 66.4 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.218 1.007 . . . . 0.0 110.68 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -93.52 -10.42 34.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.385 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.484 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 3.1 m -81.13 126.15 31.12 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -172.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 12.3 pt-20 -79.85 155.45 27.82 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.916 0.388 . . . . 0.0 111.942 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -103.13 128.75 49.94 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 123.633 0.773 . . . . 0.0 109.873 -174.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -122.46 136.15 26.27 Favored Pre-proline 0 C--N 1.307 -1.255 0 C-N-CA 123.767 0.827 . . . . 0.0 109.212 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -73.52 140.02 29.31 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.355 2.037 . . . . 0.0 109.84 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.5 -11.24 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -174.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.8 t -71.41 -23.89 61.95 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.021 0.438 . . . . 0.0 110.308 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.96 53.79 0.68 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.208 1.004 . . . . 0.0 110.244 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.507 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -62.35 -22.11 65.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.177 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.85 -16.55 60.68 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.747 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.3 m -94.14 -1.9 53.51 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.099 0.476 . . . . 0.0 110.419 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 80' ' ' ALA . 43.4 mm -77.05 129.79 77.38 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.04 129.81 36.25 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.94 2.426 . . . . 0.0 113.236 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.5 p -90.81 65.77 5.87 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.633 0.73 . . . . 0.0 109.615 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.98 -177.88 4.83 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.999 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.3 t -99.03 143.34 29.42 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.37 -147.78 13.74 Favored Glycine 0 N--CA 1.415 -2.756 0 C-N-CA 119.462 -1.352 . . . . 0.0 112.725 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.512 HG13 ' CH2' ' A' ' 146' ' ' TRP . 5.0 p -127.34 149.0 32.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 C-N-CA 123.542 0.737 . . . . 0.0 109.235 -174.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -141.49 156.01 45.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 120.832 0.348 . . . . 0.0 110.197 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.46 121.08 33.88 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.299 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 50.2 t -96.88 119.03 44.41 Favored 'Isoleucine or valine' 0 C--O 1.259 1.557 0 CA-C-O 121.25 0.548 . . . . 0.0 110.582 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 47.3 m-85 -110.69 137.24 48.61 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.305 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 98' ' ' GLU . 2.8 p30 -80.58 -169.46 2.15 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.736 -0.785 . . . . 0.0 110.657 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -57.73 -23.78 53.68 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.371 1.069 . . . . 0.0 112.688 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.2 t -108.91 17.53 21.67 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 120.718 0.294 . . . . 0.0 111.143 -174.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.2 t70 66.71 20.78 10.67 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 123.028 1.394 . . . . 0.0 110.713 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.49 ' HB2' ' OD2' ' A' ' 94' ' ' ASP . 80.5 mm-40 -83.64 104.26 13.62 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.856 175.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.555 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.0 tm? -66.19 115.46 6.21 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 174.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.432 ' HB3' ' HG2' ' A' ' 158' ' ' PRO . 43.1 mt-30 -122.64 -13.5 7.94 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -148.17 125.4 11.51 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.169 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.492 HG13 HD11 ' A' ' 99' ' ' LEU . 21.9 m -117.08 143.77 26.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 171.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -150.66 157.58 27.26 Favored Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 119.693 -1.241 . . . . 0.0 112.249 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.2 pt -117.36 134.55 60.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.2 m -146.49 161.96 39.33 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.009 0.433 . . . . 0.0 111.574 -175.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -76.9 -34.25 57.73 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.255 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -132.71 109.31 9.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.8 mt -56.76 -58.14 6.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.774 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.85 -50.26 64.12 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.1 -50.27 72.61 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.569 0.543 . . . . 0.0 111.193 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.4 t -63.3 -52.14 63.17 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.213 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.5 t -55.54 -53.94 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 C-N-CA 123.012 0.525 . . . . 0.0 110.529 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.3 m -58.32 -47.49 83.55 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 123.792 0.683 . . . . 0.0 111.381 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.58 -58.18 8.87 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 123.483 0.489 . . . . 0.0 111.617 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -72.13 -26.4 62.1 Favored 'General case' 0 C--O 1.209 -1.066 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.8 mt -74.78 -28.01 60.56 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.416 -0.913 . . . . 0.0 111.159 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -87.08 -3.75 59.1 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.433 0.635 . . . . 0.0 110.483 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.9 m -95.28 -51.07 4.75 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.16 97.95 27.84 Favored Pre-proline 0 N--CA 1.428 -1.539 0 CA-C-O 121.597 0.713 . . . . 0.0 111.108 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.807 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 6.5 Cg_exo -77.53 24.64 0.5 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.66 2.907 . . . . 0.0 113.156 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -62.17 -41.39 98.27 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.301 1.04 . . . . 0.0 110.72 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.3 mt -119.94 21.19 11.99 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.099 -172.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.807 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 72.9 m -74.27 88.99 2.03 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.169 0.509 . . . . 0.0 112.276 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.39 -55.18 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.4 p -161.97 161.6 28.68 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.6 p -139.75 139.28 38.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 120.982 0.42 . . . . 0.0 110.372 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.484 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 63.0 mttm -108.03 129.72 55.11 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 26.2 m -120.16 139.35 47.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.884 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.24 114.44 1.64 Allowed Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.66 113.42 26.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.6 p -101.25 142.46 15.97 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -88.46 -5.61 58.14 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.204 0.526 . . . . 0.0 111.907 -171.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -125.93 92.27 46.45 Favored Pre-proline 0 N--CA 1.43 -1.445 0 CA-C-O 121.683 0.754 . . . . 0.0 109.222 174.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.39 46.75 1.89 Allowed 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 123.617 2.878 . . . . 0.0 111.892 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -80.54 141.53 35.03 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -53.26 -39.34 63.8 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.66 -38.53 64.92 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.486 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.9 t -70.52 -40.39 77.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.957 0.408 . . . . 0.0 110.149 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 92.6 mt -61.1 -48.03 83.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.347 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 36.4 m -68.47 -30.61 69.51 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.913 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.519 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 58.4 tt0 -62.93 -54.13 43.3 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.82 96.82 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 123.932 0.77 . . . . 0.0 109.869 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.459 ' NE1' HG23 ' A' ' 102' ' ' VAL . 89.9 t90 -52.31 -49.31 64.45 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.923 0.764 . . . . 0.0 109.755 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -63.03 -47.08 84.56 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.416 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.572 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 80.5 mt -59.2 -49.54 77.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.079 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.512 ' CH2' HG13 ' A' ' 89' ' ' VAL . 26.0 m0 -62.56 -48.26 80.27 Favored 'General case' 0 C--O 1.256 1.402 0 O-C-N 123.995 0.81 . . . . 0.0 112.068 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.599 ' O ' HG12 ' A' ' 151' ' ' ILE . 9.1 tt -63.01 -43.25 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.364 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.522 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 31.9 mt-10 -60.42 -29.91 69.29 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 6.6 mm-40 -59.68 -49.31 78.22 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.443 ' HA ' HG22 ' A' ' 153' ' ' VAL 0.259 17.2 m-70 -78.5 -22.08 47.96 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -178.585 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 147' ' ' ILE . 48.3 mm -60.51 -42.6 91.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 148' ' ' GLU . 39.9 mttm -81.6 -46.34 14.55 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.176 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 149' ' ' GLU . 30.7 m -78.73 -46.49 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.4 p -110.88 -6.56 14.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 119.04 -1.064 . . . . 0.0 112.697 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.42 26.12 70.48 Favored Glycine 0 C--N 1.336 0.541 0 O-C-N 123.742 0.651 . . . . 0.0 113.803 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -91.36 109.02 20.29 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.18 0.514 . . . . 0.0 112.041 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 t -131.41 78.94 70.79 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.432 ' HG2' ' HB3' ' A' ' 100' ' ' GLN . 5.0 Cg_endo -90.4 160.53 4.51 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.177 2.585 . . . . 0.0 112.426 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.54 -34.27 19.68 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 124.354 3.37 . . . . 0.0 115.047 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -69.34 -27.38 73.67 Favored Glycine 0 CA--C 1.501 -0.833 0 C-N-CA 121.375 -0.44 . . . . 0.0 112.595 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.416 ' ND2' HD12 ' A' ' 147' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.312 -1.05 0 CA-C-O 121.244 0.545 . . . . 0.0 109.75 -177.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp . . . . . 0 C--O 1.219 -0.528 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.51 ' HB2' ' OE1' ' A' ' 149' ' ' GLU . 36.9 p -149.65 170.3 19.01 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.98 -176.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.48 HD22 ' HD2' ' A' ' 127' ' ' LYS . 17.8 mt -71.4 -23.45 61.88 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 123.423 0.689 . . . . 0.0 110.31 177.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 m -63.6 -25.51 68.26 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.862 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -102.7 8.08 39.61 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.1 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.405 ' HB ' ' HD3' ' A' ' 127' ' ' LYS . 22.5 m -103.57 141.06 36.67 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 122.001 -0.437 . . . . 0.0 110.768 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.01 151.41 35.62 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-O 120.921 0.391 . . . . 0.0 111.116 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -107.0 133.17 52.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.678 -173.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.33 132.07 24.31 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 123.312 0.645 . . . . 0.0 109.551 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -70.47 139.41 37.72 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.333 2.022 . . . . 0.0 109.48 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.76 -7.05 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -174.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 t -69.7 -31.13 68.99 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.103 0.478 . . . . 0.0 109.726 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -98.49 53.68 1.04 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.901 0.858 . . . . 0.0 109.767 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.94 -28.62 57.75 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.842 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.36 -33.17 65.44 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.245 1.018 . . . . 0.0 111.627 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.8 m -96.88 12.59 31.69 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -172.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.6 mm -80.93 128.13 72.38 Favored Pre-proline 0 N--CA 1.446 -0.642 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.73 130.74 40.15 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.143 2.562 . . . . 0.0 114.128 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.1 p -92.97 31.68 1.38 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 122.178 0.99 . . . . 0.0 110.655 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.75 -179.09 3.84 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.114 -177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 t -93.6 147.86 22.62 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.59 -150.09 21.19 Favored Glycine 0 N--CA 1.419 -2.488 0 C-N-CA 119.692 -1.242 . . . . 0.0 112.686 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.611 HG12 HG22 ' A' ' 104' ' ' ILE . 2.5 m -115.42 149.02 17.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 124.336 1.055 . . . . 0.0 109.55 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -144.22 160.24 41.31 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.408 ' HB1' ' CD2' ' A' ' 99' ' ' LEU . . . -141.02 131.68 25.6 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.707 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.1 t -106.61 126.84 62.4 Favored 'Isoleucine or valine' 0 C--O 1.26 1.615 0 CA-C-O 121.097 0.475 . . . . 0.0 110.669 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -113.19 135.13 54.16 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.469 1.107 . . . . 0.0 108.551 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -85.56 -170.26 3.03 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.553 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.501 ' H ' ' HD2' ' A' ' 95' ' ' LYS . 6.7 mptt -63.06 -25.38 68.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.76 0.824 . . . . 0.0 111.372 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.3 m -82.39 4.78 22.68 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.112 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.5 t70 69.77 19.16 7.28 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.474 1.11 . . . . 0.0 111.621 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -111.12 147.09 35.63 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.596 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.455 HD11 HG13 ' A' ' 102' ' ' VAL . 2.8 tm? -78.27 125.85 29.94 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.264 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -127.92 -13.84 5.12 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 123.925 0.766 . . . . 0.0 112.634 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.457 ' HA ' ' OD1' ' A' ' 161' ' ' ASN . 92.5 t80 -147.63 120.66 8.81 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.515 -0.874 . . . . 0.0 112.741 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.455 HG13 HD11 ' A' ' 99' ' ' LEU . 17.5 m -109.95 142.11 23.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 170.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -146.36 167.76 27.93 Favored Glycine 0 C--N 1.294 -1.759 0 C-N-CA 119.987 -1.101 . . . . 0.0 112.422 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.611 HG22 HG12 ' A' ' 89' ' ' VAL . 15.0 pt -125.86 147.98 30.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.4 t -157.17 164.08 38.17 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.113 0.483 . . . . 0.0 110.032 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.1 -17.9 24.32 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -142.81 87.09 1.97 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 77.7 mt -47.24 -54.94 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.483 1.113 . . . . 0.0 113.231 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.27 -30.57 12.13 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.54 -57.91 3.67 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.2 m -60.56 -43.95 96.69 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.462 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.7 t -58.48 -60.19 2.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.075 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.6 m -60.73 -44.01 97.18 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 123.827 0.705 . . . . 0.0 110.813 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.39 -50.69 72.57 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.114 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -77.05 -25.27 52.25 Favored 'General case' 0 C--O 1.204 -1.305 0 C-N-CA 118.343 -1.343 . . . . 0.0 112.056 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 64.2 mt -73.93 -28.66 61.63 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.612 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.39 -7.41 59.31 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.294 175.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.7 m -90.01 -52.96 4.7 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.9 m -117.65 102.4 51.7 Favored Pre-proline 0 N--CA 1.435 -1.193 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.817 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 16.4 Cg_exo -73.33 4.03 4.2 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.858 2.372 . . . . 0.0 110.575 173.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -55.83 -44.36 77.87 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 125.328 1.451 . . . . 0.0 111.0 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 75.1 mt -105.35 11.15 33.11 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.407 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.817 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 90.4 m -67.95 96.66 0.61 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.621 0.724 . . . . 0.0 111.873 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.4 -63.31 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.569 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 174.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.3 p -155.64 162.13 40.66 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.35 137.83 33.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.48 ' HD2' HD22 ' A' ' 69' ' ' LEU . 97.4 mttt -108.22 142.21 38.82 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.68 137.57 56.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 120.698 0.285 . . . . 0.0 110.904 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.73 108.92 0.83 Allowed Glycine 0 N--CA 1.423 -2.223 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.51 113.4 23.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 133' ' ' GLU . 7.4 p -100.98 132.32 46.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -69.02 -27.29 65.54 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.9 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.426 ' HB3' HG21 ' A' ' 138' ' ' VAL . 41.1 mt-10 -85.01 110.7 30.35 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -97.07 19.0 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.752 2.301 . . . . 0.0 113.607 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.503 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 14.8 t70 -72.97 140.09 47.16 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -57.93 -33.12 68.46 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.61 -38.73 47.47 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.187 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 135' ' ' ASP . 10.5 m -71.3 -31.96 45.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.316 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.2 mt -62.36 -46.1 90.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.1 m -69.34 -30.59 68.66 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.43 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.491 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 29.7 tt0 -66.68 -47.43 72.46 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 122.781 0.433 . . . . 0.0 110.778 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.22 90.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -50.88 -45.47 60.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.5 1.12 . . . . 0.0 110.027 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.75 -48.09 83.36 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.645 1.178 . . . . 0.0 111.31 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 69.6 mt -63.77 -41.57 97.94 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.128 0.489 . . . . 0.0 110.543 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -62.24 -50.62 71.0 Favored 'General case' 0 C--O 1.257 1.499 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.971 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 151' ' ' ILE . 14.1 tt -66.71 -40.73 86.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.285 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -65.38 -34.44 78.31 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.51 ' OE1' ' HB2' ' A' ' 68' ' ' SER . 3.8 pt-20 -63.12 -37.36 86.91 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 118.282 -1.367 . . . . 0.0 109.225 176.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.443 ' HA ' HG12 ' A' ' 153' ' ' VAL 0.263 72.8 m-70 -73.91 -31.91 63.3 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 177.647 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 147' ' ' ILE . 71.1 mt -61.35 -38.27 79.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 174.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' A' ' 149' ' ' GLU . 59.4 pttt -83.0 -20.96 34.08 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 149' ' ' GLU . 12.6 p -101.75 -41.42 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.9 t -113.16 -19.33 11.87 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.546 -0.721 . . . . 0.0 111.714 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.58 8.61 82.78 Favored Glycine 0 C--O 1.239 0.44 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.449 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -76.91 128.32 34.33 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.8 p -158.6 77.37 3.3 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 113.192 -1.822 . . . . 0.0 106.725 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -83.42 167.55 13.5 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.925 3.083 . . . . 0.0 113.893 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.18 -13.82 5.49 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 125.184 3.923 . . . . 0.0 115.475 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -70.85 -42.29 61.11 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 175.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' A' ' 101' ' ' PHE . 18.9 m120 . . . . . 0 CA--C 1.496 -1.129 0 CA-C-O 121.007 0.432 . . . . 0.0 110.985 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 N--CA 1.443 -0.798 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.5 p -120.63 176.24 5.61 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.34 -33.0 70.6 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.114 1.366 . . . . 0.0 112.379 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -67.19 -16.25 64.19 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.902 0.858 . . . . 0.0 110.508 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -109.23 13.13 24.54 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.343 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.402 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 13.2 m -105.05 155.28 19.13 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.731 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -94.88 151.61 19.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 125' ' ' SER . 3.1 tm? -104.59 133.22 49.82 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.396 0.617 . . . . 0.0 110.661 -174.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.4 HD23 HG22 ' A' ' 128' ' ' VAL . 3.8 mm? -127.91 136.19 28.63 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 115.098 -0.955 . . . . 0.0 108.601 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -71.16 140.84 38.33 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.209 1.939 . . . . 0.0 109.405 172.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.67 -11.65 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.105 0.478 . . . . 0.0 111.51 -174.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.9 p -68.51 -39.58 81.18 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.09 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -96.95 54.13 1.25 Allowed 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.342 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.531 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -61.9 -17.57 57.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.746 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.78 -23.79 64.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.585 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.9 m -88.69 -0.57 57.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.631 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.531 HG12 ' HA ' ' A' ' 80' ' ' ALA . 45.3 mm -77.82 133.91 65.46 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -56.21 129.61 35.75 Favored 'Trans proline' 0 C--O 1.251 1.155 0 C-N-CA 122.196 1.93 . . . . 0.0 112.413 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.8 p -95.13 70.86 3.28 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 121.873 0.844 . . . . 0.0 108.995 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.06 -176.34 5.05 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.064 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.6 t -97.68 134.82 40.35 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.977 0.418 . . . . 0.0 110.099 -173.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.34 -152.17 19.9 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.517 HG13 ' CH2' ' A' ' 146' ' ' TRP . 6.2 p -124.71 147.34 29.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -177.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -135.95 151.89 50.41 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 120.756 0.312 . . . . 0.0 110.223 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.08 123.16 41.68 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.081 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.5 t -95.46 118.35 41.47 Favored 'Isoleucine or valine' 0 C--O 1.263 1.773 0 C-N-CA 123.387 0.675 . . . . 0.0 110.32 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.501 ' CE1' ' HB2' ' A' ' 99' ' ' LEU . 96.8 m-85 -106.91 134.53 49.93 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.113 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.496 ' O ' ' HA3' ' A' ' 124' ' ' GLY . 3.9 p-10 -78.64 -166.96 0.96 Allowed 'General case' 0 C--N 1.317 -0.822 0 O-C-N 123.666 0.604 . . . . 0.0 111.116 -175.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 123' ' ' CYS . 75.4 mmtt -53.0 -34.57 56.84 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.719 1.208 . . . . 0.0 111.311 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.5 m -82.31 -2.93 54.26 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.192 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.9 t70 67.44 23.44 9.08 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.677 1.191 . . . . 0.0 108.297 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.457 ' OE1' HG21 ' A' ' 154' ' ' THR . 0.1 OUTLIER -99.67 158.71 15.58 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.545 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.501 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 3.5 tm? -97.71 124.57 42.09 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.69 0.757 . . . . 0.0 111.612 -169.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.508 HE21 ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -119.75 -45.91 2.48 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.738 173.888 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -124.88 134.63 52.63 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.525 -173.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.498 HG23 ' NE1' ' A' ' 143' ' ' TRP . 17.4 m -126.2 145.2 34.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -150.95 155.76 26.32 Favored Glycine 0 N--CA 1.42 -2.379 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.964 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.8 pt -110.56 139.14 35.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.0 t -142.93 155.03 44.64 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.358 0.599 . . . . 0.0 110.664 -175.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -87.04 -26.29 23.8 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -142.93 84.74 1.85 Allowed 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 69.5 mt -44.47 -58.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.245 1.418 . . . . 0.0 114.767 -172.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.2 -44.48 22.37 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.13 -34.29 76.08 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.2 t -79.53 -45.81 18.56 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.9 -53.54 36.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.066 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.4 p -61.63 -44.83 96.25 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 123.47 0.481 . . . . 0.0 111.625 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.13 -61.3 2.56 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -78.14 -23.78 47.61 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 119.014 -1.074 . . . . 0.0 113.827 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.419 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 80.7 mt -81.83 -30.7 32.02 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.413 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -88.21 -9.88 51.58 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.04 -1.064 . . . . 0.0 109.826 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.3 t -82.94 -47.37 11.85 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.34 95.14 18.56 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-O 121.765 0.793 . . . . 0.0 110.339 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.807 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 2.8 Cg_exo -76.65 24.47 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.64 2.893 . . . . 0.0 114.499 -176.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.57 -42.47 82.53 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.428 0.632 . . . . 0.0 111.078 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 75.4 mt -102.95 21.27 15.97 Favored 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.558 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.807 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 84.0 m -85.81 105.03 16.03 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 94' ' ' ASP . . . -137.81 -58.95 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 173.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.471 ' HB2' HD21 ' A' ' 74' ' ' LEU . 56.9 p -156.4 169.09 25.4 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.1 p -142.09 133.97 26.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.092 0.472 . . . . 0.0 109.924 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.402 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 56.4 mttp -106.94 125.83 51.52 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.4 HG22 HD23 ' A' ' 75' ' ' LEU . 28.5 m -113.34 135.22 53.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.254 0.549 . . . . 0.0 111.286 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.77 98.31 0.67 Allowed Glycine 0 N--CA 1.414 -2.798 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.373 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 40.5 mm -75.75 112.44 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.101 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.5 m -98.39 145.95 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.113 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -71.26 -36.94 71.92 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.208 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.49 ' HB2' HG11 ' A' ' 138' ' ' VAL . 18.8 mm-40 -92.39 105.09 12.85 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -93.76 27.78 0.32 Allowed 'Trans proline' 0 C--O 1.243 0.748 0 C-N-CA 122.737 2.291 . . . . 0.0 113.352 -174.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.456 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 15.7 t70 -89.98 144.12 26.19 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -53.38 -34.31 57.17 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.51 68.68 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.49 HG11 ' HB2' ' A' ' 133' ' ' GLU . 21.8 t -69.78 -34.72 61.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.762 -175.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 96.6 mt -62.17 -53.44 55.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.156 175.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.5 m -66.9 -30.48 70.64 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.326 0.584 . . . . 0.0 110.373 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -65.01 -50.91 64.43 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 123.656 0.782 . . . . 0.0 109.425 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.42 -43.61 98.57 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.498 ' NE1' HG23 ' A' ' 102' ' ' VAL . 79.6 t90 -52.73 -46.66 67.51 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.119 176.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -66.79 -44.88 80.1 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.211 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.552 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 11.1 mp -61.14 -41.77 97.33 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.151 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.517 ' CH2' HG13 ' A' ' 89' ' ' VAL . 33.6 m0 -62.38 -50.66 70.69 Favored 'General case' 0 C--O 1.254 1.314 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 151' ' ' ILE . 8.9 tt -62.51 -40.73 89.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.382 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.37 -32.49 74.16 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 22.3 mm-40 -56.12 -41.63 75.57 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.724 0.773 . . . . 0.0 109.96 175.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.415 ' HA ' HG12 ' A' ' 153' ' ' VAL 0.321 5.4 m-70 -83.46 -26.37 30.35 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.297 -1.361 . . . . 0.0 113.768 176.18 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 147' ' ' ILE . 73.6 mt -61.22 -42.61 94.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 O-C-N 121.974 -0.454 . . . . 0.0 110.372 173.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -69.43 -34.7 74.82 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 150' ' ' HIS . 12.1 p -92.01 -40.81 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.457 HG21 ' OE1' ' A' ' 98' ' ' GLU . 3.7 t -118.55 -35.28 3.78 Favored 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -176.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 74.76 34.3 53.65 Favored Glycine 0 N--CA 1.47 0.962 0 C-N-CA 120.429 -0.891 . . . . 0.0 114.207 175.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -65.23 -66.37 0.55 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.28 12.2 p 41.13 75.99 0.55 Allowed Pre-proline 0 CA--C 1.573 1.859 0 C-N-CA 125.002 1.321 . . . . 0.0 113.951 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -90.72 161.49 4.19 Favored 'Trans proline' 0 CA--C 1.556 1.603 0 C-N-CA 123.245 2.63 . . . . 0.0 114.085 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -50.38 -34.12 39.98 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 124.435 3.423 . . . . 0.0 114.472 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -59.35 -45.33 95.62 Favored Glycine 0 CA--C 1.495 -1.194 0 CA-C-O 121.121 0.29 . . . . 0.0 112.762 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.539 0 CA-C-O 122.42 1.105 . . . . 0.0 108.715 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.485 0 CA-C-O 121.323 0.582 . . . . 0.0 111.578 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.516 ' HA ' ' CD1' ' A' ' 146' ' ' TRP . 70.1 m -147.89 -178.78 6.46 Favored 'General case' 0 N--CA 1.413 -2.278 0 O-C-N 122.001 -0.437 . . . . 0.0 110.495 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -54.44 -24.75 21.39 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.785 1.634 . . . . 0.0 113.725 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.1 m -66.56 -29.14 69.15 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.103 0.478 . . . . 0.0 111.296 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -107.74 11.24 28.5 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.522 0.677 . . . . 0.0 110.911 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.402 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 10.1 m -97.17 136.03 38.27 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.409 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 12.6 pt-20 -74.45 149.59 40.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.705 0.288 . . . . 0.0 111.148 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -112.99 126.2 55.23 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.351 0.66 . . . . 0.0 109.294 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.98 135.11 24.57 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -71.63 138.68 32.6 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.256 1.971 . . . . 0.0 109.189 172.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.4 -8.78 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.262 -176.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.0 t -67.35 -23.04 65.56 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -112.93 53.26 0.76 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.408 ' O ' HG12 ' A' ' 83' ' ' ILE . . . -58.12 -22.81 52.57 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.724 1.21 . . . . 0.0 112.413 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.23 -28.09 69.5 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.369 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.6 t -88.6 9.37 24.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.885 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 80' ' ' ALA . 37.5 mm -80.31 129.05 70.88 Favored Pre-proline 0 C--N 1.314 -0.955 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.43 130.29 39.79 Favored 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.982 2.455 . . . . 0.0 113.34 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.5 p -92.39 80.18 4.94 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.282 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.81 -179.44 6.99 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.469 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.9 t -100.82 134.74 43.35 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.61 -150.2 14.69 Favored Glycine 0 N--CA 1.418 -2.53 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.33 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.53 HG13 ' CH2' ' A' ' 146' ' ' TRP . 7.6 p -122.86 149.78 26.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -137.85 155.3 49.13 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.25 115.58 20.61 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 123.518 0.727 . . . . 0.0 109.559 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.4 t -91.6 121.51 42.14 Favored 'Isoleucine or valine' 0 C--O 1.258 1.528 0 CA-C-O 121.097 0.475 . . . . 0.0 110.944 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.521 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 61.8 m-85 -109.86 131.66 54.86 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 124.154 0.982 . . . . 0.0 108.651 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.501 ' OD1' ' HB2' ' A' ' 98' ' ' GLU . 1.3 p-10 -78.64 -168.16 1.31 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.53 ' H ' ' HD2' ' A' ' 95' ' ' LYS . 8.6 mptt -64.18 -24.92 67.85 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 123.168 0.587 . . . . 0.0 110.812 -176.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.0 m -81.91 2.2 31.64 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.025 0.53 . . . . 0.0 112.065 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.2 t70 68.92 24.76 6.26 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 123.419 1.58 . . . . 0.0 108.866 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.501 ' HB2' ' OD1' ' A' ' 94' ' ' ASP . 24.0 mm-40 -96.73 115.53 27.59 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.689 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.521 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 2.4 tm? -68.68 113.14 5.9 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 173.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.514 ' HB3' ' HG2' ' A' ' 158' ' ' PRO . 22.0 mt-30 -125.31 -13.21 6.71 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.692 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -146.57 114.96 6.7 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.563 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.549 HG21 ' HB ' ' A' ' 147' ' ' ILE . 27.4 m -103.41 149.86 7.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 172.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -160.35 152.47 23.24 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 119.502 -1.333 . . . . 0.0 112.419 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.411 HG22 ' HB ' ' A' ' 89' ' ' VAL . 20.5 pt -112.78 140.51 32.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.0 m -150.89 169.57 21.41 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -76.93 -42.96 37.25 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.455 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -138.8 98.55 3.58 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 65.1 mt -44.13 -57.41 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 125.05 1.34 . . . . 0.0 114.23 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.3 -41.94 63.36 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.76 -41.74 74.77 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.052 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.3 t -66.04 -49.05 69.06 Favored 'General case' 0 C--O 1.254 1.302 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.814 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 72.6 t -57.38 -53.51 42.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.097 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.1 t -62.92 -35.65 80.79 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.362 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.13 -61.77 2.32 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.95 -0.469 . . . . 0.0 112.019 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -79.29 -22.99 43.87 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.413 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 67.8 mt -76.63 -25.34 53.73 Favored 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.403 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -87.75 -18.67 28.91 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.822 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.8 m -74.41 -47.1 35.91 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -138.99 95.07 9.67 Favored Pre-proline 0 CA--C 1.554 1.12 0 CA-C-O 121.807 0.813 . . . . 0.0 110.28 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.598 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 11.7 Cg_exo -74.07 24.13 0.35 Allowed 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 123.859 3.039 . . . . 0.0 115.036 -176.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -65.27 -43.37 91.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.33 0.586 . . . . 0.0 109.87 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.2 mt -99.4 19.91 14.7 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.167 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.598 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 98.3 m -74.01 94.25 2.34 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.347 0.594 . . . . 0.0 111.722 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.84 -68.01 0.06 OUTLIER Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.4 p -159.71 163.26 34.9 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.72 140.7 40.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 120.963 0.411 . . . . 0.0 110.341 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 92.2 mttt -106.11 126.35 52.1 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.6 m -113.38 133.84 57.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.007 0.432 . . . . 0.0 111.405 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -124.82 101.54 0.66 Allowed Glycine 0 N--CA 1.417 -2.596 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -84.72 109.67 18.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.33 164.36 2.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.135 -173.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -59.39 -62.74 1.65 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.775 0.672 . . . . 0.0 110.937 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -99.92 146.55 32.09 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -82.31 32.47 0.52 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 122.405 2.07 . . . . 0.0 109.92 172.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.499 ' HB3' HG22 ' A' ' 138' ' ' VAL . 13.5 t70 -77.01 135.36 38.66 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.653 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -58.81 -31.63 68.63 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.31 -46.04 51.92 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.481 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.499 HG22 ' HB3' ' A' ' 135' ' ' ASP . 11.9 m -68.42 -32.65 56.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.756 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 94.5 mt -65.25 -51.3 61.69 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.903 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.4 m -65.65 -35.32 80.46 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.721 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.508 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 28.2 tt0 -61.67 -52.67 63.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.47 -42.39 99.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.545 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.482 ' NE1' HG23 ' A' ' 102' ' ' VAL . 84.6 t90 -53.5 -50.95 64.3 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.476 0.71 . . . . 0.0 109.497 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 58.9 tttm -59.97 -52.56 64.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.387 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.593 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 85.5 mt -58.54 -49.76 76.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.376 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.53 ' CH2' HG13 ' A' ' 89' ' ' VAL . 41.8 m0 -59.32 -48.77 80.36 Favored 'General case' 0 C--O 1.249 1.038 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.549 ' HB ' HG21 ' A' ' 102' ' ' VAL . 12.6 tt -63.42 -42.75 97.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.795 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.629 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 45.2 mt-10 -62.68 -33.31 74.82 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.72 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 20.6 mm-40 -55.92 -51.06 68.96 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.311 0.577 . . . . 0.0 110.447 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.485 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 2.7 t60 -77.89 -21.19 51.61 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.281 -175.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 147' ' ' ILE . 68.1 mt -68.99 -32.28 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.189 0.519 . . . . 0.0 109.889 175.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 148' ' ' GLU . 74.9 mmtt -77.71 -48.27 17.1 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.058 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 150' ' ' HIS . 7.7 p -71.28 -56.8 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 47.0 p -106.16 -27.59 10.98 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.339 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 151' ' ' ILE . . . 98.11 31.84 6.39 Favored Glycine 0 CA--C 1.502 -0.777 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.947 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -94.25 101.81 13.8 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.8 p -129.45 79.24 74.29 Favored Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.514 ' HG2' ' HB3' ' A' ' 100' ' ' GLN . 4.2 Cg_exo -84.47 165.88 12.31 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.6 2.867 . . . . 0.0 113.738 -172.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -47.87 -27.77 8.99 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 124.889 3.726 . . . . 0.0 114.807 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -63.86 -39.83 97.77 Favored Glycine 0 CA--C 1.523 0.548 0 O-C-N 123.305 0.378 . . . . 0.0 112.473 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 161' ' ' ASN . 2.4 m120 . . . . . 0 CA--C 1.501 -0.936 0 CA-C-O 121.042 0.448 . . . . 0.0 111.202 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.492 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 11.0 mmpt? . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.967 0.413 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 p -78.56 163.48 25.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 123.327 0.651 . . . . 0.0 110.87 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.51 ' HG ' ' CG ' ' A' ' 146' ' ' TRP . 10.7 mt -51.82 -33.26 35.02 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -177.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.8 m -62.35 -25.87 68.14 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.958 0.409 . . . . 0.0 110.71 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -96.98 -12.05 23.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.217 0.532 . . . . 0.0 110.341 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.8 m -78.55 145.96 34.55 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.11 -174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -84.01 153.39 23.88 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.258 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.451 HD21 ' HB2' ' A' ' 125' ' ' SER . 3.4 tm? -108.87 134.81 51.05 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 124.413 1.085 . . . . 0.0 109.684 -173.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 128' ' ' VAL . 3.2 mm? -125.43 138.72 32.34 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -72.63 141.86 35.12 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.71 2.274 . . . . 0.0 110.627 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.58 -13.76 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.451 -176.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.3 t -66.48 -28.86 68.91 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.432 0.634 . . . . 0.0 110.206 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -103.49 53.79 0.76 Allowed 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.929 0.871 . . . . 0.0 109.408 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -57.43 -18.56 18.69 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.789 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.55 -24.34 45.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.013 0.435 . . . . 0.0 110.077 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.1 m -88.43 -1.28 57.95 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.982 0.42 . . . . 0.0 111.234 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 80' ' ' ALA . 44.9 mm -72.18 128.15 89.41 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -51.5 132.67 41.22 Favored 'Trans proline' 0 C--O 1.241 0.657 0 C-N-CA 123.525 2.817 . . . . 0.0 113.147 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.4 p -94.92 28.58 2.68 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.407 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.59 -176.85 3.61 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.027 -176.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.3 t -98.6 145.24 27.04 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.481 ' HA2' HG12 ' A' ' 131' ' ' VAL . . . 159.55 -148.26 16.7 Favored Glycine 0 N--CA 1.416 -2.696 0 C-N-CA 119.802 -1.19 . . . . 0.0 112.729 177.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.68 150.56 29.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -138.31 154.15 49.01 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.97 121.41 34.35 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.628 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.24 124.08 46.59 Favored 'Isoleucine or valine' 0 C--O 1.27 2.146 0 O-C-N 123.641 0.588 . . . . 0.0 110.228 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -114.82 142.02 47.11 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.684 1.194 . . . . 0.0 108.949 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 96' ' ' SER . 4.8 p-10 -90.95 -164.16 1.14 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -70.07 -12.32 61.52 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 122.465 0.306 . . . . 0.0 111.603 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.404 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 5.0 m -94.59 -2.47 51.42 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 66.6 26.78 9.7 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.148 0.979 . . . . 0.0 109.754 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -90.18 127.92 36.23 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-O 121.078 0.466 . . . . 0.0 110.571 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.403 HD21 HG13 ' A' ' 102' ' ' VAL . 3.3 tm? -76.55 119.64 20.66 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.407 ' HA ' ' HG2' ' A' ' 158' ' ' PRO . 49.6 mt-30 -128.17 -18.4 4.12 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.257 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -147.29 118.15 7.63 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.354 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.448 HG23 ' NE1' ' A' ' 143' ' ' TRP . 11.6 m -109.27 139.62 31.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -149.54 158.0 27.48 Favored Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.711 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.3 pt -115.59 147.81 18.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.0 m -154.08 156.21 36.86 Favored 'General case' 0 C--O 1.251 1.134 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.18 -27.99 29.63 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -127.39 105.88 8.83 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 112' ' ' VAL . 78.0 mt -61.05 -60.79 2.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.145 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -44.69 -58.06 3.29 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -175.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.38 -37.23 86.38 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.6 m -71.59 -46.38 59.44 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 123.23 0.331 . . . . 0.0 110.815 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 108' ' ' ILE . 85.3 t -58.68 -56.06 19.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.449 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 16.6 m -57.16 -42.05 80.33 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 124.248 0.968 . . . . 0.0 111.619 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.89 -59.08 5.22 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -73.06 -24.06 60.64 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 69.8 mt -73.13 -33.35 65.47 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.827 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 113' ' ' SER . 34.8 mmtp -78.7 -20.2 50.68 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.118 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.7 m -80.92 -46.26 15.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.471 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.46 92.78 26.86 Favored Pre-proline 0 CA--C 1.557 1.226 0 CA-C-O 121.815 0.817 . . . . 0.0 110.295 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.569 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 3.8 Cg_exo -76.48 16.64 0.86 Allowed 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 123.933 3.089 . . . . 0.0 114.126 -175.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.27 -38.08 89.18 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.618 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.8 mt -101.51 20.55 15.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.745 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.569 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 90.4 m -75.04 93.12 2.69 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.647 176.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.03 -65.86 0.07 OUTLIER Glycine 0 N--CA 1.435 -1.405 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.451 ' HB2' HD21 ' A' ' 74' ' ' LEU . 19.8 p -158.89 167.52 29.19 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.0 p -144.82 139.24 23.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.464 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -106.56 137.53 44.41 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.46 HG22 HD23 ' A' ' 75' ' ' LEU . 33.6 m -125.7 133.35 69.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.359 0.599 . . . . 0.0 111.785 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -112.89 102.58 1.31 Allowed Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.07 115.48 20.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.481 HG12 ' HA2' ' A' ' 88' ' ' GLY . 12.2 p -108.33 138.3 35.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -66.83 -45.17 79.11 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.306 0.574 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -94.5 114.2 62.85 Favored Pre-proline 0 C--N 1.292 -1.919 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.639 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -82.91 32.92 0.52 Allowed 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 123.049 2.499 . . . . 0.0 111.755 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.439 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 17.6 t70 -73.59 136.86 43.99 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.814 -177.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -61.1 -30.14 70.18 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.69 -50.42 36.72 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.2 t -60.96 -39.76 83.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 O-C-N 124.179 0.924 . . . . 0.0 110.591 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.2 mt -61.47 -55.32 32.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.513 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.0 m -60.78 -38.4 85.16 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.038 0.447 . . . . 0.0 111.025 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -59.71 -52.63 64.65 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.205 1.002 . . . . 0.0 110.765 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.29 94.84 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.156 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.448 ' NE1' HG23 ' A' ' 102' ' ' VAL . 89.3 t90 -56.4 -45.21 80.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.533 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -63.89 -43.32 96.37 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.737 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.7 -46.2 90.7 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.066 0.46 . . . . 0.0 110.929 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.51 ' CG ' ' HG ' ' A' ' 69' ' ' LEU . 26.0 m0 -63.9 -46.28 85.58 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.511 ' O ' HG13 ' A' ' 151' ' ' ILE . 7.9 tt -63.25 -42.12 95.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.547 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.439 ' HB3' ' NZ ' ' A' ' 152' ' ' LYS . 49.8 mt-10 -64.77 -31.6 72.9 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 146' ' ' TRP . 7.1 mm-40 -50.42 -50.63 51.38 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.558 0.536 . . . . 0.0 110.02 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.458 ' HA ' HG22 ' A' ' 153' ' ' VAL 0.282 33.2 m-70 -81.95 -28.45 32.72 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -178.464 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 147' ' ' ILE . 71.3 mt -57.06 -40.52 73.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 120.943 0.401 . . . . 0.0 110.137 172.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.439 ' NZ ' ' HB3' ' A' ' 148' ' ' GLU . 62.3 mttp -75.32 -46.69 31.8 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 150' ' ' HIS . 30.9 m -78.04 -39.69 25.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -175.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 33.1 p -119.1 -35.32 3.65 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.951 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.92 17.23 59.93 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -85.14 108.22 17.59 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.13 0.49 . . . . 0.0 111.787 -177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 40.8 t -128.3 84.19 63.94 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 173.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.407 ' HG2' ' HA ' ' A' ' 100' ' ' GLN . 11.4 Cg_exo -76.41 164.51 30.67 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 122.798 2.332 . . . . 0.0 111.923 -178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.34 -31.05 45.49 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 123.159 2.573 . . . . 0.0 112.697 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.29 -24.13 71.96 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.176 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.31 -1.149 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 CA--C 1.507 -0.699 0 CA-C-O 122.116 0.96 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.0 p -129.92 164.33 24.44 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.894 -170.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.508 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 17.9 mt -68.86 -13.59 62.51 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 t -70.25 -19.6 63.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.322 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -104.72 1.33 29.23 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.508 ' OG1' ' HA ' ' A' ' 69' ' ' LEU . 6.8 m -92.78 134.53 34.97 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -172.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.16 152.35 38.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.295 1.038 . . . . 0.0 110.681 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -109.75 129.59 55.6 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.406 HD23 HG22 ' A' ' 128' ' ' VAL . 4.3 mm? -121.02 136.04 25.31 Favored Pre-proline 0 C--N 1.307 -1.247 0 C-N-CA 123.762 0.825 . . . . 0.0 109.705 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.5 139.64 41.62 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.348 2.032 . . . . 0.0 110.247 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.03 -12.98 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.248 0.547 . . . . 0.0 111.469 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.0 t -74.62 -20.81 59.76 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.466 0.651 . . . . 0.0 109.968 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -104.85 53.15 0.73 Allowed 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.807 0.813 . . . . 0.0 109.557 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.5 ' HB1' ' OG ' ' A' ' 113' ' ' SER . . . -56.13 -28.94 59.86 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.835 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.41 -26.23 67.89 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.6 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.3 t -92.08 -4.98 53.65 Favored 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.737 0.815 . . . . 0.0 110.38 -174.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.49 HG12 ' HA ' ' A' ' 80' ' ' ALA . 43.9 mm -72.14 130.36 86.51 Favored Pre-proline 0 N--CA 1.443 -0.808 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.85 131.38 38.01 Favored 'Trans proline' 0 C--O 1.248 0.982 0 C-N-CA 123.348 2.699 . . . . 0.0 112.976 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.0 p -91.39 27.59 1.91 Allowed 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.66 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.95 -176.95 3.6 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.825 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.6 t -96.85 154.33 17.36 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 154.15 -154.1 25.28 Favored Glycine 0 N--CA 1.423 -2.185 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.264 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.632 HG12 HG22 ' A' ' 104' ' ' ILE . 3.7 m -112.41 152.12 14.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 123.708 0.803 . . . . 0.0 110.045 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -144.69 154.35 42.67 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -130.78 126.23 35.81 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 123.248 0.619 . . . . 0.0 109.394 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.4 t -102.97 126.0 57.29 Favored 'Isoleucine or valine' 0 C--O 1.263 1.793 0 CA-C-O 121.102 0.477 . . . . 0.0 110.032 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -113.09 133.44 55.0 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -79.16 -169.44 1.84 Allowed 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.525 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.451 ' H ' ' HD2' ' A' ' 95' ' ' LYS . 8.5 mptt -57.22 -36.38 70.82 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.733 0.413 . . . . 0.0 110.29 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.3 m -77.46 0.5 22.44 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.536 0.734 . . . . 0.0 111.586 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.0 t70 65.88 27.16 10.99 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 122.752 1.263 . . . . 0.0 110.246 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -98.64 137.4 37.33 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.252 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.69 125.08 28.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.538 ' O ' ' HG2' ' A' ' 158' ' ' PRO . 41.9 mt-30 -129.1 -17.11 3.93 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.103 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.475 ' HA ' ' OD1' ' A' ' 161' ' ' ASN . 89.5 t80 -154.61 126.0 7.39 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 118.635 -1.226 . . . . 0.0 111.911 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.42 HG21 ' HB ' ' A' ' 147' ' ' ILE . 25.5 m -114.62 145.05 20.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 170.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.0 168.95 31.33 Favored Glycine 0 C--N 1.281 -2.487 0 C-N-CA 119.276 -1.44 . . . . 0.0 112.709 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.632 HG22 HG12 ' A' ' 89' ' ' VAL . 17.3 pt -120.13 148.53 23.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.4 t -150.84 155.63 39.59 Favored 'General case' 0 N--CA 1.417 -2.112 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.593 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.91 -23.12 24.02 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -141.67 98.19 3.3 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.0 mt -55.26 -60.4 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.46 -47.72 27.05 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.75 90.65 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 p -79.05 -43.1 24.92 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.607 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 76.3 t -55.47 -54.76 21.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 O-C-N 123.294 0.371 . . . . 0.0 110.805 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.5 ' OG ' ' HB1' ' A' ' 80' ' ' ALA . 20.1 m -56.94 -46.9 81.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 123.924 0.765 . . . . 0.0 110.696 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.5 -55.08 38.24 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.046 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.261 29.2 p80 -71.53 -26.44 62.66 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 89.9 mt -78.13 -27.68 48.29 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.233 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 113' ' ' SER . 74.9 mmtt -84.9 -9.15 58.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.166 0.508 . . . . 0.0 110.314 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.6 t -93.32 -50.57 5.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.08 94.48 27.71 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-O 121.742 0.782 . . . . 0.0 110.507 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.666 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 15.0 Cg_exo -71.88 19.58 0.28 Allowed 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.986 3.124 . . . . 0.0 114.322 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.68 -43.42 98.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.462 0.649 . . . . 0.0 109.755 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.1 mt -100.35 20.13 15.38 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.911 -176.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.666 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 91.0 m -77.16 86.03 3.63 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.706 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.42 -63.96 0.09 OUTLIER Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 175.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.0 p -164.01 157.56 18.55 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 123.004 0.522 . . . . 0.0 109.601 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.21 139.0 46.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-O 121.018 0.437 . . . . 0.0 110.472 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.451 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 74.6 mttt -106.71 137.48 44.66 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.406 HG22 HD23 ' A' ' 75' ' ' LEU . 27.4 m -124.02 132.61 71.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.038 0.447 . . . . 0.0 110.802 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -117.18 99.37 0.83 Allowed Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.68 117.56 29.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.454 0.645 . . . . 0.0 109.743 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.92 131.18 69.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.58 8.4 7.96 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -108.35 107.62 60.33 Favored Pre-proline 0 N--CA 1.423 -1.783 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -84.04 26.42 0.65 Allowed 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.558 2.172 . . . . 0.0 110.713 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.53 ' HB3' HG22 ' A' ' 138' ' ' VAL . 14.1 t70 -71.92 127.83 33.82 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -62.51 -28.4 69.82 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -173.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.54 -33.34 54.18 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.359 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 135' ' ' ASP . 10.1 m -77.38 -32.71 18.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.833 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 97.0 mt -64.25 -46.73 82.46 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.0 m -67.03 -33.92 76.58 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.225 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.603 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 62.9 tt0 -64.56 -50.82 65.78 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.528 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.23 -41.17 98.17 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.376 0.422 . . . . 0.0 110.234 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -55.61 -47.36 76.67 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.588 0.709 . . . . 0.0 109.592 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.78 -42.78 98.2 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.875 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 60.9 mt -64.98 -47.46 77.48 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.812 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -62.45 -46.11 90.01 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.015 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.584 ' O ' HG13 ' A' ' 151' ' ' ILE . 13.0 tt -67.15 -46.88 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.543 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -67.47 -29.28 68.69 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -175.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.497 ' O ' HG22 ' A' ' 153' ' ' VAL . 9.2 pt-20 -65.11 -44.09 89.89 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.931 176.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -69.96 -24.1 63.29 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 147' ' ' ILE . 57.1 mt -66.77 -43.73 89.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 172.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -71.27 -50.64 30.64 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 149' ' ' GLU . 35.2 m -80.01 -40.37 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -176.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.6 p -116.99 -4.84 11.47 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -174.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.37 34.33 89.61 Favored Glycine 0 C--O 1.222 -0.643 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.871 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -93.64 110.2 21.81 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.463 HG22 HG12 ' A' ' 151' ' ' ILE . 19.9 t -141.4 79.07 17.83 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 173.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.538 ' HG2' ' O ' ' A' ' 100' ' ' GLN . 3.1 Cg_exo -82.77 160.47 16.33 Favored 'Trans proline' 0 C--O 1.248 0.982 0 C-N-CA 122.66 2.24 . . . . 0.0 112.834 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -56.48 -17.17 20.75 Favored 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 124.268 3.312 . . . . 0.0 113.997 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -67.69 -38.79 90.22 Favored Glycine 0 CA--C 1.523 0.588 0 O-C-N 123.573 0.546 . . . . 0.0 112.892 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.475 ' OD1' ' HA ' ' A' ' 101' ' ' PHE . 11.0 m120 . . . . . 0 CA--C 1.492 -1.252 0 CA-C-O 121.991 0.9 . . . . 0.0 111.634 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt . . . . . 0 N--CA 1.433 -1.296 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.8 m -76.52 164.59 25.8 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 121.38 0.61 . . . . 0.0 111.719 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.444 HD11 ' OH ' ' A' ' 93' ' ' TYR . 3.1 tm? -46.52 -40.03 11.87 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 126.637 1.975 . . . . 0.0 114.108 -174.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.0 m -56.24 -32.83 64.85 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.314 0.578 . . . . 0.0 111.891 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -102.72 10.0 38.82 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.356 -0.384 . . . . 0.0 112.029 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.586 HG21 ' CH2' ' A' ' 146' ' ' TRP . 30.1 m -85.58 147.66 26.3 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.256 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.08 149.64 46.31 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.23 0.612 . . . . 0.0 111.262 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -110.65 133.49 53.27 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.829 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.51 HD23 HG22 ' A' ' 128' ' ' VAL . 3.5 mm? -127.26 141.53 41.08 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 174.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -79.97 144.84 17.23 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.082 1.854 . . . . 0.0 110.885 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.482 HD11 ' SG ' ' A' ' 123' ' ' CYS . 0.1 OUTLIER -80.03 -12.95 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.094 0.473 . . . . 0.0 110.676 -178.077 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.25 -11.81 61.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 124.522 1.129 . . . . 0.0 111.205 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -128.19 53.42 1.81 Allowed 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -54.86 -19.15 5.9 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.996 -175.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -78.21 -20.39 51.91 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.321 0.582 . . . . 0.0 110.577 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.0 m -91.11 6.81 43.47 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.234 0.54 . . . . 0.0 110.769 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.455 HG12 ' HA ' ' A' ' 80' ' ' ALA . 41.4 mm -82.56 130.05 60.3 Favored Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.436 ' HG2' HD11 ' A' ' 130' ' ' ILE . 90.1 Cg_exo -53.23 137.02 63.54 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.531 2.821 . . . . 0.0 113.287 178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.3 p -101.52 27.13 6.57 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.813 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.25 -175.99 3.39 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.649 -174.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.9 t -95.39 141.56 28.8 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 158.87 -153.43 24.55 Favored Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.511 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.577 HG12 HG22 ' A' ' 104' ' ' ILE . 1.8 m -109.21 150.56 11.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 C-N-CA 124.393 1.077 . . . . 0.0 110.06 -177.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -142.78 148.43 37.15 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.38 118.04 21.57 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.244 0.618 . . . . 0.0 109.883 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.5 t -97.32 127.59 49.43 Favored 'Isoleucine or valine' 0 C--O 1.263 1.782 0 CA-C-O 121.358 0.599 . . . . 0.0 111.895 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.444 ' OH ' HD11 ' A' ' 69' ' ' LEU . 43.3 m-85 -107.4 146.47 31.61 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 125.047 1.339 . . . . 0.0 109.32 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -95.2 -172.24 2.62 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.4 ' HD2' ' HA2' ' A' ' 124' ' ' GLY . 31.6 mmmt -65.34 -23.05 66.9 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 m -77.13 -4.08 42.67 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.78 0.8 . . . . 0.0 109.396 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.3 t70 66.12 29.57 9.81 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.727 1.611 . . . . 0.0 109.626 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 5.1 mm-40 -99.14 144.1 28.66 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 114.066 -1.425 . . . . 0.0 108.255 175.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.516 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 1.5 tm? -85.89 125.12 33.09 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.515 ' O ' ' HG2' ' A' ' 158' ' ' PRO . 1.4 mp0 -116.5 -23.55 8.22 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 123.978 0.799 . . . . 0.0 113.013 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -149.4 120.47 7.73 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 117.587 -1.645 . . . . 0.0 112.715 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.613 HG21 ' HB ' ' A' ' 147' ' ' ILE . 30.5 m -105.06 145.29 13.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.809 171.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.55 166.97 30.84 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.544 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.577 HG22 HG12 ' A' ' 89' ' ' VAL . 10.5 pt -123.0 144.84 31.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 122.889 0.476 . . . . 0.0 109.806 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.2 m -152.62 157.37 40.88 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.334 0.588 . . . . 0.0 111.526 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -86.74 -22.18 26.13 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 172.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -137.44 91.33 2.59 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.596 -1.183 . . . . 0.0 108.086 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.19 -62.3 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -173.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.77 -43.19 27.2 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -175.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.4 -48.57 79.13 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.054 0.221 . . . . 0.0 111.526 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.3 m -65.04 -41.51 95.13 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 120.683 0.277 . . . . 0.0 111.154 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.6 t -61.7 -57.15 13.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.009 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.5 p -60.85 -35.61 77.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 123.778 0.674 . . . . 0.0 111.811 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.77 -61.27 2.39 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 122.975 0.51 . . . . 0.0 111.642 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -79.57 -21.68 44.76 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -73.02 -41.28 64.41 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.77 -15.1 59.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.556 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.6 m -80.9 -59.09 2.8 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.3 95.25 47.28 Favored Pre-proline 0 N--CA 1.428 -1.528 0 CA-C-O 122.087 0.946 . . . . 0.0 110.847 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.53 21.12 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.794 2.996 . . . . 0.0 113.22 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -69.1 -33.21 73.14 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.2 mt -94.59 21.49 7.23 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.169 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.482 ' SG ' HD11 ' A' ' 77' ' ' ILE . 38.2 t -68.61 108.37 3.32 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 176.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.4 ' HA2' ' HD2' ' A' ' 95' ' ' LYS . . . -160.35 -72.82 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 175.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.3 p -169.41 173.17 6.68 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.9 p -144.49 139.8 23.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -106.27 129.91 54.22 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.51 HG22 HD23 ' A' ' 75' ' ' LEU . 35.3 m -122.54 136.1 60.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.436 0.636 . . . . 0.0 111.52 -175.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -116.59 96.79 0.73 Allowed Glycine 0 N--CA 1.418 -2.511 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.436 HD11 ' HG2' ' A' ' 84' ' ' PRO . 2.7 mp -78.74 114.27 19.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.504 HG22 ' H ' ' A' ' 133' ' ' GLU . 13.6 p -104.5 124.13 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.705 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -78.83 -5.17 52.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.499 0.666 . . . . 0.0 110.582 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.504 ' H ' HG22 ' A' ' 131' ' ' VAL . 11.2 mm-40 -111.65 84.31 5.11 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 172.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.83 39.29 0.7 Allowed 'Trans proline' 0 N--CA 1.48 0.684 0 C-N-CA 123.619 2.879 . . . . 0.0 113.026 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.52 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 14.4 t70 -76.87 138.88 40.04 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.059 -175.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -54.15 -38.09 65.13 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.892 1.277 . . . . 0.0 113.494 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.02 -44.57 54.01 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.84 -43.58 95.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.775 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 96.5 mt -57.25 -52.88 63.53 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.125 0.488 . . . . 0.0 110.708 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.6 m -69.42 -34.37 74.36 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.117 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.489 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 52.9 tt0 -66.84 -45.65 77.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.071 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.9 -38.21 90.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.174 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.516 ' NE1' HG23 ' A' ' 102' ' ' VAL . 89.3 t90 -55.72 -48.58 74.94 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -60.9 -38.24 85.02 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.372 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.606 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 71.4 mt -63.97 -56.92 11.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.274 0.559 . . . . 0.0 109.559 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.586 ' CH2' HG21 ' A' ' 72' ' ' THR . 20.8 m0 -54.61 -50.48 67.98 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.613 ' HB ' HG21 ' A' ' 102' ' ' VAL . 13.1 tt -61.51 -46.53 96.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.334 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -66.45 -27.23 67.66 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 17.5 mm-40 -59.94 -46.13 90.37 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 121.224 0.535 . . . . 0.0 109.671 175.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.516 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 7.5 t60 -81.8 -21.43 37.71 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.578 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 147' ' ' ILE . 53.7 mt -67.2 -53.51 32.48 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.71 -26.2 68.54 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -175.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 150' ' ' HIS . 11.3 p -84.37 -35.73 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.4 t -137.86 -2.88 1.87 Allowed 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -174.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 78.93 29.28 52.14 Favored Glycine 0 CA--C 1.516 0.126 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.816 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -91.82 108.86 20.22 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.444 HG22 HG12 ' A' ' 151' ' ' ILE . 2.1 t -142.78 90.36 7.72 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 173.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.515 ' HG2' ' O ' ' A' ' 100' ' ' GLN . 7.9 Cg_exo -80.17 159.67 23.47 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.986 2.457 . . . . 0.0 113.21 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -43.14 -40.79 9.3 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 124.822 3.682 . . . . 0.0 115.262 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -65.23 -23.2 69.74 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 114.395 0.518 . . . . 0.0 114.395 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 C--N 1.315 -0.905 0 CA-C-O 121.467 0.651 . . . . 0.0 111.062 178.769 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 110.651 -0.129 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.0 m -72.93 177.24 5.04 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.1 mt -52.65 -25.27 10.32 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -171.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -68.71 -30.92 69.67 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.864 0.364 . . . . 0.0 110.695 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -87.62 -20.44 26.35 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.315 0.579 . . . . 0.0 110.752 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.421 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 4.4 m -74.99 133.74 41.62 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.219 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -71.53 154.02 41.76 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.056 0.455 . . . . 0.0 111.042 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -108.7 125.1 51.53 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.561 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.449 HD23 HG22 ' A' ' 128' ' ' VAL . 4.0 mm? -113.4 130.73 23.4 Favored Pre-proline 0 C--N 1.3 -1.583 0 C-N-CA 123.881 0.873 . . . . 0.0 109.411 174.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.87 139.59 36.7 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.179 1.919 . . . . 0.0 110.163 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.45 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -76.72 -13.48 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.431 -175.351 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.3 t -69.6 -25.67 64.07 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.433 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -109.63 54.25 0.67 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 122.29 1.043 . . . . 0.0 110.098 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.488 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -57.04 -19.76 20.67 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.822 -1.535 . . . . 0.0 113.302 -176.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -73.57 -19.6 60.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.434 0.635 . . . . 0.0 110.965 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.0 m -93.13 2.43 56.71 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.559 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 80' ' ' ALA . 47.0 mm -76.7 126.62 85.7 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.57 130.66 41.33 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.535 2.157 . . . . 0.0 113.21 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.0 p -94.05 30.65 1.82 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.247 1.023 . . . . 0.0 109.731 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.48 -179.78 4.45 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.445 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 106' ' ' ARG . 15.4 t -93.71 138.38 31.98 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.17 -155.61 26.81 Favored Glycine 0 N--CA 1.421 -2.33 0 C-N-CA 119.362 -1.399 . . . . 0.0 113.049 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.497 HG21 ' HB3' ' A' ' 142' ' ' ALA . 7.5 t -115.78 151.6 17.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -176.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -140.56 148.11 40.48 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.462 ' HB1' HD23 ' A' ' 99' ' ' LEU . . . -125.12 118.29 25.8 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.887 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.81 115.02 29.2 Favored 'Isoleucine or valine' 0 C--O 1.262 1.712 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.586 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 4.9 m-85 -100.32 137.28 38.96 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.92 -168.36 2.21 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.365 0.602 . . . . 0.0 110.891 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -64.99 -29.57 70.5 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.42 1.088 . . . . 0.0 111.271 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.1 t -81.42 -1.25 45.0 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.806 0.812 . . . . 0.0 109.363 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 t70 73.95 27.74 1.6 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.635 1.574 . . . . 0.0 112.538 172.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 11.8 pt-20 -120.09 166.65 13.11 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 117.588 -1.645 . . . . 0.0 111.207 172.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.462 HD23 ' HB1' ' A' ' 91' ' ' ALA . 2.9 tm? -80.29 130.14 34.99 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.913 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -118.11 -47.13 2.59 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.106 171.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -124.1 125.74 45.0 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.789 -173.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.444 HG13 HD21 ' A' ' 99' ' ' LEU . 5.0 m -114.42 140.92 32.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.28 162.09 29.38 Favored Glycine 0 N--CA 1.42 -2.423 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.185 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.8 pt -124.82 151.7 30.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.6 t -159.92 159.23 32.08 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 106' ' ' ARG . 0.4 OUTLIER -82.35 -15.35 53.11 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 176.6 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -140.87 96.89 3.08 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.0 mt -56.34 -52.69 49.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.841 -177.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.14 -46.22 61.89 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.81 -48.23 81.54 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.733 0.413 . . . . 0.0 111.702 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.9 m -68.53 -44.21 75.06 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.239 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.6 t -57.94 -58.78 4.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.392 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 43.5 p -63.05 -32.06 73.34 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.51 -61.16 2.26 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.512 ' HA ' ' OG ' ' A' ' 118' ' ' SER . 19.7 p80 -77.15 -21.88 53.41 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -174.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.425 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 53.6 mt -76.09 -23.97 55.0 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.779 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -89.46 -31.01 17.89 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.046 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 115' ' ' HIS . 4.2 p -73.99 -27.91 61.21 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.352 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.23 98.07 3.78 Favored Pre-proline 0 CA--C 1.559 1.31 0 CA-C-O 121.899 0.857 . . . . 0.0 110.691 173.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.793 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 94.5 Cg_endo -82.21 22.39 0.87 Allowed 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 123.288 2.659 . . . . 0.0 113.514 -177.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -63.42 -43.34 97.75 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.707 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.1 mt -104.99 18.01 23.13 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.161 0.505 . . . . 0.0 110.954 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.793 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 83.0 m -78.65 99.78 6.74 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.732 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.34 -49.48 0.06 OUTLIER Glycine 0 C--N 1.3 -1.43 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.0 p -165.59 168.14 16.66 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.095 0.958 . . . . 0.0 109.633 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.66 137.08 31.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-O 121.081 0.467 . . . . 0.0 110.48 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.421 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 98.1 mttt -106.43 138.58 42.36 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.449 HG22 HD23 ' A' ' 75' ' ' LEU . 27.0 m -124.19 130.99 73.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.136 0.493 . . . . 0.0 112.179 -176.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -118.33 102.11 0.94 Allowed Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mp -94.89 136.47 25.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 121.031 0.443 . . . . 0.0 110.154 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.97 141.67 44.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.99 -46.09 90.76 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -88.39 116.33 65.93 Favored Pre-proline 0 C--N 1.308 -1.199 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.163 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.32 39.41 0.78 Allowed 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 123.488 2.792 . . . . 0.0 112.539 -175.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.426 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 23.9 t70 -73.74 129.2 37.45 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.996 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -61.81 -27.85 69.05 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.54 -45.47 59.14 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.3 t -62.07 -41.46 91.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 O-C-N 124.192 0.932 . . . . 0.0 110.171 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 90.3 mt -63.03 -50.48 70.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.679 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 48.8 m -63.57 -33.63 76.02 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 120.914 0.388 . . . . 0.0 110.793 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.34 -54.88 34.03 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.805 1.242 . . . . 0.0 110.378 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.497 ' HB3' HG21 ' A' ' 89' ' ' VAL . . . -64.77 -39.39 93.53 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.217 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -55.39 -45.68 76.6 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.304 0.642 . . . . 0.0 109.303 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -61.09 -46.27 91.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.79 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.2 mp -60.36 -38.37 83.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.851 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.433 ' O ' ' HG3' ' A' ' 149' ' ' GLU . 41.0 m0 -73.64 -46.87 44.05 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.957 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.432 ' HB ' HG21 ' A' ' 102' ' ' VAL . 12.7 tt -65.9 -40.98 89.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.444 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.72 -36.44 80.59 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.564 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -60.95 -39.12 88.27 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.331 -179.015 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.46 ' HA ' HG12 ' A' ' 153' ' ' VAL . 2.6 t60 -79.46 -31.25 42.43 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.132 -175.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.455 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 70.9 mt -70.87 -32.34 48.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.422 0.63 . . . . 0.0 109.87 175.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -84.85 -33.42 22.87 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 149' ' ' GLU . 14.8 p -83.52 -51.43 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.483 HG23 HG13 ' A' ' 153' ' ' VAL . 71.1 p -108.78 -35.54 6.37 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.172 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 151' ' ' ILE . . . 99.71 28.27 7.53 Favored Glycine 0 C--N 1.317 -0.519 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.719 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.82 125.75 47.35 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.51 87.78 10.16 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-O 121.904 0.859 . . . . 0.0 109.881 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -69.98 160.58 49.12 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.16 3.24 . . . . 0.0 113.811 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -45.7 -35.51 13.22 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 124.997 3.798 . . . . 0.0 115.365 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -70.84 -26.18 74.45 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.88 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 C--N 1.318 -0.796 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.31 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.438 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.541 ' HB2' ' OE2' ' A' ' 149' ' ' GLU . 28.1 p -121.99 179.29 4.57 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.481 HD13 ' OH ' ' A' ' 93' ' ' TYR . 38.9 mt -73.93 -17.17 61.06 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.6 m -72.28 -20.34 61.53 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.47 0.653 . . . . 0.0 109.648 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -92.18 -3.31 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.016 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.475 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.6 m -98.81 150.5 21.8 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.955 -172.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 9.4 pt-20 -90.25 155.01 19.3 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.176 0.99 . . . . 0.0 109.845 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.0 125.11 48.62 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -123.66 141.01 35.47 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.068 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -71.37 134.55 24.86 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.192 1.928 . . . . 0.0 109.215 170.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -21.53 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.0 t -73.29 -26.7 61.18 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.193 0.521 . . . . 0.0 110.678 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -94.56 56.09 2.04 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.845 0.831 . . . . 0.0 110.12 177.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.583 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -48.84 -21.57 0.66 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.204 1.402 . . . . 0.0 114.015 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -64.56 -27.57 69.05 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.433 0.635 . . . . 0.0 110.763 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.408 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 22.8 m -83.09 1.43 40.29 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.083 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.583 HG12 ' HA ' ' A' ' 80' ' ' ALA . 26.8 mm -90.75 113.97 59.74 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 82' ' ' SER . 72.2 Cg_exo -54.7 135.27 66.54 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.737 2.958 . . . . 0.0 112.593 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.7 p -98.6 34.21 2.09 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.969 0.89 . . . . 0.0 110.885 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.73 -176.64 3.19 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.174 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.7 t -95.96 145.62 25.26 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.17 -149.13 15.27 Favored Glycine 0 N--CA 1.416 -2.69 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.266 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.49 HG13 ' CH2' ' A' ' 146' ' ' TRP . 6.7 p -125.98 149.26 30.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -176.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -137.37 149.85 47.28 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.901 0.382 . . . . 0.0 110.747 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.32 117.6 28.2 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.278 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.31 116.75 34.16 Favored 'Isoleucine or valine' 0 C--O 1.26 1.627 0 CA-C-O 121.092 0.472 . . . . 0.0 110.753 -177.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.481 ' OH ' HD13 ' A' ' 69' ' ' LEU . 88.3 m-85 -106.35 134.42 49.51 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.705 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -79.18 -171.0 2.47 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -58.46 -30.79 67.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.808 0.843 . . . . 0.0 111.093 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.4 m -82.72 1.72 37.33 Favored 'General case' 0 C--O 1.25 1.114 0 C-N-CA 123.506 0.722 . . . . 0.0 112.269 -176.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.2 t70 69.41 26.68 5.17 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.499 1.142 . . . . 0.0 109.39 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 4.3 mm-40 -102.13 140.14 36.81 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.925 176.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.507 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 2.8 tm? -89.69 110.84 21.7 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.464 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.464 ' HA ' ' HG2' ' A' ' 158' ' ' PRO . 2.4 mp0 -105.13 -25.99 12.27 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.051 177.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -143.82 120.96 11.47 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 118.822 -1.151 . . . . 0.0 113.54 -176.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.479 HG13 HD11 ' A' ' 99' ' ' LEU . 6.2 m -108.51 144.01 17.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 169.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -154.84 158.86 28.61 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.4 pt -117.25 144.3 25.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.6 m -150.75 160.39 43.89 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.147 0.498 . . . . 0.0 111.113 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -84.97 -21.85 29.39 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -136.13 105.46 6.03 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.55 -58.01 8.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 123.535 0.522 . . . . 0.0 111.92 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.17 -55.28 10.79 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.07 99.56 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 123.064 0.227 . . . . 0.0 111.316 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.2 t -65.87 -51.23 60.59 Favored 'General case' 0 C--O 1.251 1.148 0 O-C-N 123.774 0.671 . . . . 0.0 110.019 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 56.6 t -56.14 -54.77 23.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.972 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 22.9 t -60.12 -44.41 94.92 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 123.779 0.674 . . . . 0.0 111.1 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.75 -54.12 38.45 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -80.07 -26.3 39.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.441 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 66.9 mt -77.68 -26.48 50.31 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.845 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 113' ' ' SER . 33.7 mmtp -78.84 -26.05 44.12 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.395 174.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.2 t -74.0 -53.85 9.16 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.346 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.0 p -129.05 99.04 22.43 Favored Pre-proline 0 N--CA 1.431 -1.381 0 CA-C-O 121.996 0.903 . . . . 0.0 110.767 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.838 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 73.9 Cg_endo -79.56 11.53 2.67 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 123.525 2.817 . . . . 0.0 113.653 -177.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -58.03 -42.93 86.37 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 123.984 0.913 . . . . 0.0 109.865 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.0 mt -104.16 20.29 18.58 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.898 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.838 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 96.8 m -85.99 92.75 8.78 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.188 0.518 . . . . 0.0 111.944 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.42 -60.4 0.09 OUTLIER Glycine 0 C--N 1.299 -1.5 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 173.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 9.8 p -156.06 161.62 40.39 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.5 p -138.53 139.6 41.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-O 121.007 0.432 . . . . 0.0 110.159 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.475 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 82.9 mttt -106.54 128.36 54.05 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 174.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.86 136.16 56.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.095 0.474 . . . . 0.0 111.137 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.52 110.02 1.26 Allowed Glycine 0 N--CA 1.425 -2.064 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 130' ' ' ILE . 2.7 mp -94.24 104.91 16.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 133' ' ' GLU . 9.2 p -89.17 134.56 28.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.269 -177.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -65.12 -30.02 70.92 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.23 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.402 ' H ' HG22 ' A' ' 131' ' ' VAL . 16.5 pt-20 -109.24 100.67 42.05 Favored Pre-proline 0 N--CA 1.439 -1.016 0 CA-C-O 121.362 0.601 . . . . 0.0 109.768 174.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.72 37.92 0.71 Allowed 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.916 2.411 . . . . 0.0 112.282 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.448 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 22.3 t70 -69.15 143.77 54.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.188 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -52.44 -44.44 65.49 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.493 0.717 . . . . 0.0 112.337 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.11 -38.76 69.24 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.409 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.06 -42.04 90.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 96.7 mt -58.33 -47.73 82.81 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.5 m -66.04 -38.88 89.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.633 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -62.63 -45.39 93.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.85 0.357 . . . . 0.0 110.091 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.6 -50.06 75.03 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.914 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -53.55 -47.81 69.67 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.143 0.977 . . . . 0.0 110.492 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 14.6 tmtt? -63.37 -45.78 89.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.633 -176.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.476 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 11.0 mp -67.41 -38.86 85.27 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.691 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.49 ' CH2' HG13 ' A' ' 89' ' ' VAL . 27.2 m0 -63.16 -45.01 93.87 Favored 'General case' 0 C--O 1.257 1.482 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.471 ' O ' HG13 ' A' ' 151' ' ' ILE . 12.7 tt -65.41 -39.14 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.397 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 38.0 mt-10 -57.71 -42.5 83.88 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-O 118.9 -0.572 . . . . 0.0 111.967 176.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.541 ' OE2' ' HB2' ' A' ' 68' ' ' SER . 6.8 mm-40 -46.39 -51.84 14.14 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.782 0.676 . . . . 0.0 110.059 178.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.507 ' CG ' ' HB3' ' A' ' 99' ' ' LEU 0.34 13.7 m-70 -78.88 -27.85 44.04 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 179.177 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 147' ' ' ILE . 76.5 mt -61.18 -47.5 93.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.536 0.684 . . . . 0.0 109.319 172.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -68.1 -50.4 55.19 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.309 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 149' ' ' GLU . 16.9 m -80.75 -26.77 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -174.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.3 t -138.13 -26.25 0.93 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.39 23.5 16.47 Favored Glycine 0 C--N 1.316 -0.54 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.69 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -78.88 112.96 16.57 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.06 74.26 21.63 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 170.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.464 ' HG2' ' HA ' ' A' ' 100' ' ' GLN . 9.2 Cg_endo -90.88 168.84 3.69 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 123.219 2.612 . . . . 0.0 114.09 -171.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -56.74 -17.73 24.18 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 124.0 3.134 . . . . 0.0 113.727 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -67.8 -38.48 89.5 Favored Glycine 0 C--O 1.219 -0.794 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 . . . . . 0 C--O 1.243 0.729 0 CA-C-O 121.574 0.702 . . . . 0.0 109.734 -179.47 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.425 ' HB2' ' OE2' ' A' ' 71' ' ' GLU . 57.8 mtpt . . . . . 0 N--CA 1.442 -0.827 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.1 p -110.49 172.09 7.07 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.824 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.94 -27.77 68.47 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.455 0.702 . . . . 0.0 110.983 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 m -62.67 -31.1 71.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.573 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.425 ' OE2' ' HB2' ' A' ' 67' ' ' LYS . 29.5 mt-10 -95.03 2.62 55.32 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.124 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.506 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.1 m -91.29 145.42 24.67 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.491 -176.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 17.0 pt-20 -89.31 151.05 22.31 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -113.88 130.61 56.47 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.814 0.34 . . . . 0.0 110.84 -172.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -128.35 127.77 23.68 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -63.49 138.11 63.48 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.181 1.921 . . . . 0.0 109.616 173.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -14.46 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -172.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.7 t -65.58 -30.97 71.78 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.265 0.555 . . . . 0.0 110.081 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.62 53.07 0.82 Allowed 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 122.41 1.1 . . . . 0.0 109.377 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.582 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -56.64 -24.24 46.94 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.702 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.73 -31.1 71.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.378 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.5 m -92.39 3.46 55.4 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.582 HG12 ' HA ' ' A' ' 80' ' ' ALA . 44.6 mm -69.2 125.02 91.65 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -52.9 129.76 34.49 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.006 2.47 . . . . 0.0 113.71 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 p -95.5 32.79 1.72 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.089 0.947 . . . . 0.0 111.048 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.05 -176.96 3.23 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.924 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.4 m -93.42 149.67 21.05 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 123.504 0.502 . . . . 0.0 110.105 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.62 -153.78 24.99 Favored Glycine 0 N--CA 1.417 -2.571 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.435 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.59 ' HB ' ' CH2' ' A' ' 146' ' ' TRP . 2.6 t -114.36 151.3 16.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -175.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -140.31 151.88 45.41 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.02 174.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 127' ' ' LYS . . . -130.24 120.76 24.95 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 123.554 0.742 . . . . 0.0 109.697 -178.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.51 125.93 45.06 Favored 'Isoleucine or valine' 0 C--O 1.263 1.801 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.314 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -112.64 132.58 55.1 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 124.156 0.983 . . . . 0.0 109.234 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -77.61 -173.26 2.9 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 123.825 0.703 . . . . 0.0 110.542 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -55.42 -31.08 61.57 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.1 t -95.46 11.55 32.54 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 122.021 -0.425 . . . . 0.0 110.885 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.45 33.16 13.89 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 176.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -102.99 125.37 49.72 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 118.571 -1.252 . . . . 0.0 111.914 172.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.495 HD23 ' HB1' ' A' ' 91' ' ' ALA . 2.5 tm? -60.71 112.68 2.11 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.637 174.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.418 ' HB3' ' HG2' ' A' ' 158' ' ' PRO . 48.5 mt-30 -124.52 -14.66 6.81 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.24 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -144.16 125.33 14.56 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.371 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.474 HG21 ' HB ' ' A' ' 147' ' ' ILE . 22.1 m -117.11 151.76 18.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 173.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -160.3 160.04 31.36 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.4 pt -124.91 147.28 29.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.6 t -157.46 164.56 37.31 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.457 ' HD3' ' O ' ' A' ' 106' ' ' ARG . 0.6 OUTLIER -80.55 -28.03 37.4 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.339 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -131.09 99.4 4.87 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 77.7 mt -57.83 -52.01 63.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.261 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.63 -52.46 39.36 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.82 -47.18 87.52 Favored 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 123.456 0.473 . . . . 0.0 111.147 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.0 t -62.8 -50.78 69.63 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.435 -177.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.0 t -59.22 -52.97 54.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.028 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.4 m -63.13 -35.35 79.99 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 123.337 0.398 . . . . 0.0 111.812 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.09 -61.14 1.99 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.37 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.276 21.5 p80 -73.5 -25.92 60.66 Favored 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -174.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.4 mt -77.62 -24.06 49.67 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.681 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -87.48 -9.13 55.41 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.204 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.6 m -92.07 -51.61 5.1 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.59 95.73 42.33 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-O 121.681 0.753 . . . . 0.0 111.052 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.822 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 3.1 Cg_exo -79.27 32.56 0.47 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.58 2.853 . . . . 0.0 112.877 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -70.33 -43.17 70.81 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.779 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.1 mt -114.12 21.87 14.37 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.706 -174.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.822 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 94.7 m -76.06 93.06 3.24 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -127.25 -61.84 0.14 Allowed Glycine 0 C--N 1.307 -1.073 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.0 m -158.78 166.93 30.78 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.2 p -133.83 142.32 41.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.268 0.556 . . . . 0.0 110.088 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 91' ' ' ALA . 30.6 mmtm -105.67 129.22 53.94 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.21 136.36 60.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.272 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.44 100.06 0.79 Allowed Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 130' ' ' ILE . 2.5 mp -88.06 101.66 11.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -101.09 134.53 40.93 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.797 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.015 -174.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -66.48 -34.61 78.31 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -83.89 117.33 68.4 Favored Pre-proline 0 C--N 1.301 -1.513 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.871 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -91.49 21.03 0.82 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.879 2.386 . . . . 0.0 111.787 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.97 131.39 45.39 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.944 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -59.19 -33.39 70.9 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.849 -174.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.81 -45.27 68.25 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.29 -44.23 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.16 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 99.0 mt -59.77 -45.78 91.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.944 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.3 m -69.36 -38.43 78.08 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.479 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.563 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 29.0 tt0 -62.29 -51.23 68.52 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.329 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.3 -40.84 95.64 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.41 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.451 ' O ' HG22 ' A' ' 147' ' ' ILE . 79.3 t90 -51.41 -46.64 62.98 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.49 0.716 . . . . 0.0 109.603 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.44 -50.92 57.22 Favored 'General case' 0 C--O 1.211 -0.951 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.486 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 85.5 mt -51.57 -41.63 61.29 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.242 0.617 . . . . 0.0 111.673 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.59 ' CH2' ' HB ' ' A' ' 89' ' ' VAL . 31.6 m0 -69.68 -57.79 4.71 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.444 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.613 ' O ' HG12 ' A' ' 151' ' ' ILE . 15.1 tt -67.25 -42.16 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 C-N-CA 119.644 -0.823 . . . . 0.0 111.844 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.442 ' HA ' ' CG1' ' A' ' 151' ' ' ILE . 26.7 mt-10 -67.64 -28.62 67.88 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -174.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.507 ' O ' HG22 ' A' ' 153' ' ' VAL . 12.3 pt-20 -67.31 -37.45 83.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 118.887 -1.125 . . . . 0.0 109.063 175.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -75.41 -30.05 59.95 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 120.579 -0.449 . . . . 0.0 109.792 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 147' ' ' ILE . 41.8 mm -58.82 -44.49 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 121.272 0.558 . . . . 0.0 109.712 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -81.18 -36.25 30.38 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -174.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 149' ' ' GLU . 31.3 m -97.14 -24.84 4.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.95 -1.67 7.17 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 56.44 33.87 62.74 Favored Glycine 0 N--CA 1.47 0.926 0 N-CA-C 117.473 1.749 . . . . 0.0 117.473 170.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -100.16 108.3 20.38 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 118.225 1.012 . . . . 0.0 111.459 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.575 HG22 HD12 ' A' ' 151' ' ' ILE . 1.9 t -126.57 78.0 72.87 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.418 ' HG2' ' HB3' ' A' ' 100' ' ' GLN . 7.4 Cg_exo -77.77 155.2 30.82 Favored 'Trans proline' 0 C--O 1.257 1.444 0 C-N-CA 122.93 2.42 . . . . 0.0 113.225 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.9 -22.49 54.6 Favored 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 123.425 2.75 . . . . 0.0 111.893 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -56.66 -37.68 77.81 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.581 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 . . . . . 0 C--N 1.3 -1.584 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.206 -178.49 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.1 mttp . . . . . 0 N--CA 1.441 -0.914 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.2 m -124.84 165.75 17.48 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.188 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.0 mt -57.79 -26.82 62.46 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.142 1.377 . . . . 0.0 113.85 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.3 m -65.68 -21.81 66.58 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.947 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -98.93 -10.44 22.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.334 0.588 . . . . 0.0 110.401 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.51 ' HB ' ' HD3' ' A' ' 127' ' ' LYS . 3.2 m -83.28 136.88 34.22 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.325 -171.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.74 154.06 28.81 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 120.614 0.245 . . . . 0.0 110.882 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -108.4 128.72 55.02 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.244 0.618 . . . . 0.0 110.634 -172.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -121.96 131.01 24.5 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -66.08 139.0 54.2 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.119 1.879 . . . . 0.0 109.489 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.442 HG13 ' SG ' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -72.14 -12.9 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-O 121.384 0.611 . . . . 0.0 111.926 -174.65 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.5 p -75.45 -26.35 58.21 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.885 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.09 53.57 0.8 Allowed 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 122.167 0.984 . . . . 0.0 109.97 177.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -59.21 -22.84 61.66 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 113.792 -1.549 . . . . 0.0 112.329 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.11 -24.1 64.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.583 0.706 . . . . 0.0 109.497 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.9 t -93.91 4.97 53.14 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.391 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.575 HG12 ' HA ' ' A' ' 80' ' ' ALA . 43.5 mm -81.15 124.93 80.59 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.406 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 82.9 Cg_exo -51.58 133.95 45.19 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.287 2.658 . . . . 0.0 112.926 177.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.2 p -96.47 29.07 3.04 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.9 0.857 . . . . 0.0 110.578 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.05 -176.58 3.47 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.545 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.6 t -101.54 142.15 33.34 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.3 -147.85 12.73 Favored Glycine 0 N--CA 1.413 -2.854 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.488 HG13 ' CH2' ' A' ' 146' ' ' TRP . 7.6 p -126.01 148.81 30.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -136.57 149.04 47.87 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 120.9 0.381 . . . . 0.0 110.537 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.26 121.82 41.39 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.603 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.479 HG11 HD21 ' A' ' 116' ' ' LEU . 57.7 t -96.81 114.23 33.18 Favored 'Isoleucine or valine' 0 C--O 1.265 1.894 0 CA-C-O 121.171 0.51 . . . . 0.0 110.363 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 70.6 m-85 -102.52 133.86 46.81 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.379 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -81.21 -172.34 3.72 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -67.07 -16.3 64.25 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.8 m -88.8 1.6 54.98 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 122.277 0.231 . . . . 0.0 110.469 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 67.83 27.01 7.5 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.147 0.979 . . . . 0.0 110.715 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 4.6 mm-40 -103.85 151.72 22.76 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.402 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.502 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 3.0 tm? -102.47 110.99 23.1 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.426 -174.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.435 ' HB3' ' HG3' ' A' ' 158' ' ' PRO . 2.0 mp0 -107.4 -32.96 7.52 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.903 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -131.6 134.99 46.61 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.262 -0.975 . . . . 0.0 112.049 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.46 HG13 HD11 ' A' ' 99' ' ' LEU . 4.5 m -130.47 142.8 42.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -153.8 153.96 25.19 Favored Glycine 0 N--CA 1.425 -2.063 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.086 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.403 HG22 ' HB ' ' A' ' 89' ' ' VAL . 18.8 pt -111.87 141.13 28.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.3 m -149.86 163.77 37.16 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 120.901 0.382 . . . . 0.0 111.55 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -82.92 -30.61 28.29 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -131.56 104.31 6.89 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 84' ' ' PRO . 73.2 mt -60.25 -53.57 46.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 O-C-N 123.162 0.289 . . . . 0.0 111.72 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.01 -58.53 4.32 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.84 89.33 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.286 0.366 . . . . 0.0 111.349 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.9 m -63.46 -49.61 72.99 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.249 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.4 t -58.15 -54.68 29.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.0 m -58.56 -43.75 89.46 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.049 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.66 -59.93 4.16 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -77.1 -30.8 55.48 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.479 HD21 HG11 ' A' ' 92' ' ' VAL . 77.7 mt -76.59 -27.74 55.91 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 119.542 -0.863 . . . . 0.0 113.054 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -81.35 -19.03 43.65 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.891 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.9 m -81.68 -57.76 3.31 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.381 175.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.0 p -116.13 96.26 46.86 Favored Pre-proline 0 N--CA 1.441 -0.914 0 CA-C-O 122.421 1.105 . . . . 0.0 109.987 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' A' ' 123' ' ' CYS . 82.1 Cg_endo -83.68 22.76 0.89 Allowed 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.154 2.569 . . . . 0.0 113.749 -175.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -64.52 -32.2 73.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.006 0.908 . . . . 0.0 109.719 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.4 mt -113.5 21.48 15.08 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.171 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 120' ' ' PRO . 34.9 t -75.52 78.99 2.54 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.383 -178.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -130.89 -56.83 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.4 p -165.38 164.09 19.74 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 122.664 0.385 . . . . 0.0 110.508 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.51 137.04 36.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 120.963 0.411 . . . . 0.0 109.956 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.51 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 77.3 mttt -106.53 130.61 54.27 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 173.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.1 m -113.92 133.72 59.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 120.892 0.377 . . . . 0.0 111.16 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -123.22 106.19 0.98 Allowed Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 130' ' ' ILE . 2.8 mp -93.26 111.78 25.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.6 164.07 2.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.99 -41.68 74.08 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 135' ' ' ASP . 47.4 mt-10 -100.48 116.97 63.75 Favored Pre-proline 0 C--N 1.303 -1.416 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.957 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -81.02 27.09 0.58 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.783 2.322 . . . . 0.0 109.763 173.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 133' ' ' GLU . 29.1 t70 -85.96 145.87 26.94 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.426 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -53.7 -42.75 68.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.08 -37.75 88.59 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 120.977 0.418 . . . . 0.0 111.629 -177.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.439 HG21 ' HB2' ' A' ' 133' ' ' GLU . 34.0 t -79.52 -40.82 21.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.105 -176.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.07 -46.53 90.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.242 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.0 m -67.68 -33.82 75.69 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.337 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -65.61 -48.37 72.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.184 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.23 -43.92 96.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.942 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.404 ' NE1' HG23 ' A' ' 102' ' ' VAL . 91.6 t90 -55.04 -43.32 73.67 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.351 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 25.1 mmtt -60.86 -58.51 8.12 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.582 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 10.9 mp -55.79 -38.13 69.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 118.306 0.503 . . . . 0.0 112.297 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.488 ' CH2' HG13 ' A' ' 89' ' ' VAL . 27.0 m0 -65.12 -53.08 50.83 Favored 'General case' 0 C--O 1.265 1.88 0 O-C-N 123.518 0.511 . . . . 0.0 111.698 177.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.442 ' O ' HG12 ' A' ' 151' ' ' ILE . 8.5 tt -62.42 -46.69 95.81 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.649 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 144' ' ' LYS . 53.6 mm-40 -60.04 -30.95 69.53 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 123.457 0.703 . . . . 0.0 112.596 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 30.8 mm-40 -56.31 -56.85 15.93 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.469 0.652 . . . . 0.0 109.673 174.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.502 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 27.0 m-70 -73.17 -31.89 64.51 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.582 -0.847 . . . . 0.0 113.138 -177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 147' ' ' ILE . 35.3 mm -57.06 -42.81 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 120.423 0.154 . . . . 0.0 111.024 175.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -72.86 -58.36 3.39 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.28 -22.93 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.2 t -129.49 -24.89 2.72 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.109 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 76.55 34.66 43.8 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.783 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -89.85 115.1 26.92 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.459 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.43 86.87 2.38 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-O 122.213 1.006 . . . . 0.0 110.029 175.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.435 ' HG3' ' HB3' ' A' ' 100' ' ' GLN . 67.8 Cg_endo -90.68 169.12 3.83 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 123.02 2.48 . . . . 0.0 112.266 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -51.23 -18.23 4.81 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 124.594 3.53 . . . . 0.0 114.993 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.15 -41.57 86.3 Favored Glycine 0 C--N 1.31 -0.887 0 CA-C-N 116.498 -0.319 . . . . 0.0 112.407 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 61.4 t30 . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 122.767 1.27 . . . . 0.0 109.065 -175.771 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? . . . . . 0 N--CA 1.436 -1.174 0 CA-C-O 120.95 0.405 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.8 p -114.43 -174.15 2.43 Favored 'General case' 0 N--CA 1.414 -2.233 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.207 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.72 -26.21 68.57 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.82 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.6 m -61.81 -30.0 70.53 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.18 0.992 . . . . 0.0 111.109 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -87.06 -1.06 57.6 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.155 0.582 . . . . 0.0 110.165 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.446 ' HB ' ' HD3' ' A' ' 127' ' ' LYS . 27.3 m -114.33 145.45 41.77 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -170.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.94 156.97 17.58 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.03 0.532 . . . . 0.0 110.862 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -115.51 134.34 55.16 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.769 0.828 . . . . 0.0 110.766 -172.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -130.47 129.44 22.79 Favored Pre-proline 0 C--O 1.214 -0.77 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 53.1 Cg_exo -62.79 147.68 94.37 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.074 1.85 . . . . 0.0 110.376 172.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -5.41 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -172.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.0 p -69.44 -26.21 64.49 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 121.16 0.505 . . . . 0.0 111.271 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.26 52.77 0.71 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.692 0.758 . . . . 0.0 110.538 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -60.51 -27.13 67.36 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.027 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.16 -24.33 64.97 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.355 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.5 m -93.01 2.09 56.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.963 0.411 . . . . 0.0 110.966 -177.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 80' ' ' ALA . 46.5 mm -79.25 130.53 68.77 Favored Pre-proline 0 C--O 1.243 0.746 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.554 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -52.3 140.39 52.44 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 124.2 3.267 . . . . 0.0 113.61 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.4 p -98.68 29.53 3.68 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.501 0.667 . . . . 0.0 111.387 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.57 -177.08 3.68 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.157 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.8 t -99.97 152.01 20.68 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 154.28 -143.36 9.97 Favored Glycine 0 N--CA 1.412 -2.933 0 C-N-CA 119.847 -1.168 . . . . 0.0 112.47 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.608 HG12 HG22 ' A' ' 104' ' ' ILE . 3.2 m -119.31 149.36 21.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 C-N-CA 123.485 0.714 . . . . 0.0 110.029 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -143.34 146.06 33.22 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.672 0.273 . . . . 0.0 110.28 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -118.45 127.27 53.5 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.054 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -105.4 118.86 53.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.28 0.562 . . . . 0.0 110.938 -176.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 43.9 m-85 -108.52 141.05 40.98 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -80.32 -169.79 2.25 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HD2' ' HA2' ' A' ' 124' ' ' GLY . 4.9 mmmp? -67.38 -15.2 63.55 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.9 m -89.19 -3.1 58.7 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 65.51 35.29 7.33 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.686 1.194 . . . . 0.0 112.221 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -100.72 145.16 28.82 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.361 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -90.46 109.2 20.33 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.35 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -105.85 -41.99 5.27 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.915 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -125.29 139.38 53.76 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.425 0.631 . . . . 0.0 112.477 -171.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.54 146.31 33.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 172.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.67 165.67 30.61 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 119.756 -1.212 . . . . 0.0 111.815 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.608 HG22 HG12 ' A' ' 89' ' ' VAL . 15.4 pt -116.99 155.0 18.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.0 t -158.64 160.16 36.19 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.183 0.515 . . . . 0.0 110.082 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -85.51 -22.31 28.23 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -142.55 91.97 2.37 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 70.2 mt -50.87 -60.03 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 123.857 0.863 . . . . 0.0 112.468 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.74 -46.25 29.73 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.18 -55.05 39.93 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.503 0.502 . . . . 0.0 111.075 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.2 m -61.42 -46.07 91.65 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.761 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 75.7 t -56.63 -54.94 22.76 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 C-N-CA 123.023 0.529 . . . . 0.0 111.263 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.1 t -61.29 -46.7 89.24 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 123.259 0.349 . . . . 0.0 110.606 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.27 -60.24 3.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -75.12 -21.94 58.54 Favored 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 118.619 -1.232 . . . . 0.0 113.752 -172.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.0 mt -79.68 -24.19 41.93 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.483 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -88.12 -25.29 23.08 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.39 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.9 t -76.74 -42.03 42.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.823 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.54 91.27 14.15 Favored Pre-proline 0 N--CA 1.437 -1.108 0 CA-C-O 121.895 0.855 . . . . 0.0 110.473 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.737 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 2.7 Cg_exo -75.72 18.31 0.62 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.263 2.642 . . . . 0.0 113.62 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -59.91 -42.96 95.04 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.25 1.02 . . . . 0.0 110.6 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.2 mt -107.18 20.54 18.84 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.435 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.737 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 66.3 m -72.56 120.87 18.77 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.539 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.518 ' HA2' ' HD2' ' A' ' 95' ' ' LYS . . . -163.79 -70.39 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 174.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . 21.8 m -146.48 159.37 43.49 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 9.6 p -139.87 139.01 38.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.034 0.445 . . . . 0.0 110.45 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 91' ' ' ALA . 46.5 mttp -106.51 142.2 36.55 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.47 126.0 71.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.633 0.73 . . . . 0.0 112.325 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -113.69 102.67 1.26 Allowed Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 mp -84.63 121.94 37.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 133' ' ' GLU . 14.5 p -125.33 131.05 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.67 -0.62 57.14 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.518 0.675 . . . . 0.0 111.422 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.462 ' H ' HG22 ' A' ' 131' ' ' VAL . 20.7 mm-40 -94.8 109.66 45.1 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -88.8 32.37 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.353 2.035 . . . . 0.0 112.557 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.435 ' HB3' HG22 ' A' ' 138' ' ' VAL . 11.4 t70 -83.51 139.68 32.76 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -176.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 mmmm -59.44 -34.45 72.53 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.69 -43.44 69.03 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 123.113 0.258 . . . . 0.0 110.825 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 135' ' ' ASP . 17.4 m -69.42 -34.52 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 120.768 0.318 . . . . 0.0 110.911 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.2 mt -66.52 -52.34 46.83 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.007 0.432 . . . . 0.0 110.082 177.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.6 m -65.58 -30.41 71.14 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.064 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.507 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 58.6 tt0 -62.57 -54.21 43.14 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.817 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.21 -37.62 86.0 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 123.992 0.808 . . . . 0.0 110.105 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -54.34 -47.95 71.96 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 123.617 0.573 . . . . 0.0 110.109 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 98.0 mttt -64.63 -49.74 69.88 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.21 177.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.587 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 93.7 mt -50.83 -47.39 60.17 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.416 0.448 . . . . 0.0 111.439 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -63.08 -53.9 46.48 Favored 'General case' 0 C--O 1.265 1.871 0 C-N-CA 123.287 0.635 . . . . 0.0 112.604 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 151' ' ' ILE . 10.4 tt -64.33 -41.13 91.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.741 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 67.4 mt-10 -65.55 -30.05 70.75 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 119.265 -0.398 . . . . 0.0 111.92 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 21.0 mm-40 -54.89 -48.17 73.35 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . 0.272 13.4 m-70 -76.28 -29.54 57.46 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 147' ' ' ILE . 77.3 mt -61.31 -43.94 97.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 173.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -66.78 -49.65 65.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.7 m -79.28 -33.12 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.529 HG23 ' HG2' ' A' ' 156' ' ' LYS . 6.8 t -133.16 -28.06 1.55 Allowed 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.686 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.1 33.18 5.56 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.524 -0.845 . . . . 0.0 112.259 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.529 ' HG2' HG23 ' A' ' 154' ' ' THR . 42.7 mmtm -83.59 111.64 19.29 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.448 0.642 . . . . 0.0 112.583 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 p -155.84 70.96 5.3 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.746 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -90.11 165.3 4.71 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.33 2.687 . . . . 0.0 113.105 -174.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -51.68 -23.87 16.39 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 124.092 3.195 . . . . 0.0 114.275 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -67.49 -20.75 72.03 Favored Glycine 0 C--O 1.205 -1.658 0 C-N-CA 121.821 -0.228 . . . . 0.0 112.9 177.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.311 -1.099 0 CA-C-O 121.656 0.741 . . . . 0.0 109.93 -175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? . . . . . 0 N--CA 1.444 -0.745 0 CA-C-O 121.05 0.452 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.9 p -130.84 161.73 31.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.674 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.456 ' H ' ' HG3' ' A' ' 149' ' ' GLU . 72.2 mt -59.77 -28.16 67.17 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.408 0.683 . . . . 0.0 111.03 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.0 m -61.29 -20.61 63.09 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.896 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -111.28 8.03 21.31 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.92 -0.487 . . . . 0.0 110.497 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.528 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.0 m -96.19 135.88 37.41 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.257 -172.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 13.1 pt-20 -69.9 150.05 47.17 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.901 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 125' ' ' SER . 3.1 tm? -118.3 121.22 39.88 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -173.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.13 126.16 27.22 Favored Pre-proline 0 C--N 1.296 -1.724 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -63.76 139.65 70.01 Favored 'Trans proline' 0 C--N 1.326 -0.621 0 C-N-CA 121.903 1.735 . . . . 0.0 108.507 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -70.23 -12.31 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-O 121.422 0.63 . . . . 0.0 111.189 -174.568 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 p -67.6 -31.71 71.93 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.355 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -97.85 55.48 1.19 Allowed 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.43 0.633 . . . . 0.0 111.045 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.514 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -53.3 -23.39 9.04 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.441 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -69.35 -24.97 63.97 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.114 0.483 . . . . 0.0 110.971 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.8 m -89.64 6.88 39.32 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.465 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.514 HG12 ' HA ' ' A' ' 80' ' ' ALA . 38.1 mm -85.6 115.76 62.85 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -56.27 132.43 51.85 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 123.235 2.624 . . . . 0.0 113.492 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.9 p -89.58 36.38 0.84 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.758 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.32 -176.66 3.15 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.608 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.3 t -104.42 150.11 24.82 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.49 -146.21 13.81 Favored Glycine 0 N--CA 1.414 -2.782 0 C-N-CA 120.26 -0.972 . . . . 0.0 111.264 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.6 p -121.04 147.29 24.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -137.54 151.92 48.91 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 120.916 0.389 . . . . 0.0 110.522 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.422 ' HB1' ' CD2' ' A' ' 99' ' ' LEU . . . -123.32 124.43 42.95 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 124.001 0.92 . . . . 0.0 108.818 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.9 t -101.47 124.94 55.54 Favored 'Isoleucine or valine' 0 C--O 1.262 1.759 0 CA-C-O 121.166 0.508 . . . . 0.0 110.85 -176.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.45 ' HD2' ' O ' ' A' ' 97' ' ' ASP . 12.5 m-85 -111.28 133.11 53.85 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -78.92 -167.19 1.06 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.94 0.4 . . . . 0.0 110.972 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -57.86 -27.44 63.24 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.823 0.849 . . . . 0.0 111.077 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.7 m -86.03 -1.68 57.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.874 0.369 . . . . 0.0 110.397 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.45 ' O ' ' HD2' ' A' ' 93' ' ' TYR . 25.7 t70 64.36 34.65 10.35 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 124.849 1.26 . . . . 0.0 109.156 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 32.7 mm-40 -100.4 124.83 46.41 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.621 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.511 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 3.1 tm? -66.91 118.06 9.87 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -127.28 -14.67 5.34 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.526 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -147.26 133.88 19.89 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.334 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.495 HG23 ' NE1' ' A' ' 143' ' ' TRP . 16.3 m -124.06 138.02 55.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.162 174.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -155.98 157.49 27.86 Favored Glycine 0 C--N 1.305 -1.191 0 C-N-CA 119.788 -1.196 . . . . 0.0 112.846 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.9 144.01 21.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 123.126 0.57 . . . . 0.0 109.899 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 m -150.41 161.06 43.24 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-O 120.546 0.213 . . . . 0.0 110.642 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -85.67 -24.3 27.1 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -135.11 101.95 5.04 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 74.3 mt -60.1 -50.35 80.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.056 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.2 -57.35 9.91 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.67 96.73 Favored 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 123.38 0.425 . . . . 0.0 111.044 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.3 t -58.74 -61.18 2.81 Favored 'General case' 0 C--O 1.252 1.22 0 O-C-N 123.872 0.732 . . . . 0.0 109.961 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.4 t -54.66 -53.54 30.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 123.455 0.702 . . . . 0.0 111.581 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.0 t -59.48 -45.43 91.7 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.814 0.696 . . . . 0.0 111.385 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.26 -48.12 79.51 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -75.04 -27.88 60.2 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 119.069 -1.052 . . . . 0.0 113.536 -176.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 88.7 mt -73.62 -26.28 60.71 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.983 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -86.27 -17.7 33.97 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.466 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.0 m -83.63 -40.26 19.22 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.93 97.0 5.88 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-O 121.702 0.763 . . . . 0.0 110.581 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.607 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 9.8 Cg_exo -73.76 13.72 0.74 Allowed 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 123.757 2.971 . . . . 0.0 114.291 -177.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -55.56 -39.49 70.7 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.435 0.694 . . . . 0.0 111.063 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.2 mt -109.46 20.81 17.79 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.004 -177.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.607 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 63.6 m -70.82 120.29 16.2 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.222 174.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.427 ' N ' HD12 ' A' ' 77' ' ' ILE . . . -170.44 -68.9 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.496 ' HB2' HD21 ' A' ' 74' ' ' LEU . 2.0 p -152.06 152.49 32.46 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 114.882 -0.659 . . . . 0.0 109.695 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.12 137.23 48.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.112 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.528 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 95.0 mttt -106.89 131.36 54.07 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.86 137.28 55.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 120.932 0.396 . . . . 0.0 111.326 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.04 107.68 1.35 Allowed Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.79 109.85 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-O 121.717 0.77 . . . . 0.0 110.985 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.8 p -111.28 125.78 68.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -87.25 -13.06 44.83 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.384 -172.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -92.36 113.83 60.47 Favored Pre-proline 0 N--CA 1.427 -1.595 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -77.84 45.41 1.78 Allowed 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 123.379 2.719 . . . . 0.0 112.923 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.494 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 10.0 t70 -82.18 121.29 26.43 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -67.15 -27.49 67.34 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.13 -39.44 25.59 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.45 -41.62 90.71 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 O-C-N 123.299 0.375 . . . . 0.0 110.265 176.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.0 mt -57.59 -48.12 80.25 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.907 0.384 . . . . 0.0 110.491 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.2 m -69.05 -35.99 77.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.77 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -65.63 -44.78 85.41 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 122.891 0.477 . . . . 0.0 109.977 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.83 -45.04 94.46 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.495 ' NE1' HG23 ' A' ' 102' ' ' VAL . 90.4 t90 -54.07 -44.25 70.97 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.583 176.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -63.96 -52.9 57.55 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.513 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.57 -38.52 78.04 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.413 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 23.5 m0 -64.27 -46.58 83.08 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.618 ' O ' HG12 ' A' ' 151' ' ' ILE . 10.5 tt -63.16 -45.09 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.244 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 17.8 mm-40 -57.26 -39.07 74.86 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.61 0.764 . . . . 0.0 111.674 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 69' ' ' LEU . 4.4 mm-40 -52.09 -49.33 63.78 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.431 0.692 . . . . 0.0 111.6 174.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.511 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 12.7 t60 -80.16 -23.4 41.1 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.892 -177.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.618 HG12 ' O ' ' A' ' 147' ' ' ILE . 43.2 mm -63.39 -50.68 77.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.028 174.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 148' ' ' GLU . 68.3 mttm -56.45 -45.05 81.04 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.966 0.412 . . . . 0.0 111.338 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 33.9 m -80.9 -33.47 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 41.4 p -130.88 -36.11 1.38 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 119.336 -0.945 . . . . 0.0 113.097 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.96 30.7 41.87 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.512 -175.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -82.01 116.58 21.69 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 122.535 -0.391 . . . . 0.0 110.327 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.9 t -131.14 80.34 68.95 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 173.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -75.72 162.37 35.37 Favored 'Trans proline' 0 C--O 1.241 0.662 0 C-N-CA 122.925 2.417 . . . . 0.0 112.517 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.0 -17.5 19.56 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 124.457 3.438 . . . . 0.0 113.432 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -77.57 -38.88 27.07 Favored Glycine 0 C--N 1.304 -1.195 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.858 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.239 0.517 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? . . . . . 0 N--CA 1.436 -1.141 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.9 p -116.69 156.48 27.04 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.739 -175.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 18.7 mt -64.21 -13.38 48.58 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.2 m -68.7 -22.55 64.35 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.566 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -101.84 6.85 41.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.775 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 69' ' ' LEU . 6.9 m -104.02 137.61 41.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -172.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -83.27 161.01 21.61 Favored 'General case' 0 C--O 1.246 0.903 0 O-C-N 123.282 0.364 . . . . 0.0 110.315 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -117.41 130.32 56.41 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.028 0.531 . . . . 0.0 110.572 -174.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.02 120.7 22.62 Favored Pre-proline 0 C--N 1.311 -1.087 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 75.6 Cg_exo -61.41 140.3 87.07 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.001 1.801 . . . . 0.0 109.593 172.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.67 -12.02 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -170.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.4 t -67.01 -35.87 80.89 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 120.78 0.324 . . . . 0.0 110.832 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -90.34 53.91 2.61 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.38 1.086 . . . . 0.0 110.457 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.542 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -60.56 -20.05 59.28 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.58 -177.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -78.09 -22.88 48.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.479 0.657 . . . . 0.0 109.623 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 m -91.49 0.2 57.54 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.836 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.542 HG12 ' HA ' ' A' ' 80' ' ' ALA . 39.2 mm -78.86 121.46 83.46 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -51.64 130.31 33.15 Favored 'Trans proline' 0 C--O 1.252 1.225 0 C-N-CA 123.596 2.864 . . . . 0.0 114.234 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.8 p -91.43 77.02 5.83 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-O 122.285 1.04 . . . . 0.0 109.248 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.406 ' O ' HG13 ' A' ' 108' ' ' ILE . . . -148.89 176.23 10.59 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.535 -177.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 t -92.19 147.27 23.06 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 160.46 -154.03 25.0 Favored Glycine 0 N--CA 1.415 -2.734 0 C-N-CA 120.117 -1.04 . . . . 0.0 110.967 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.449 HG13 ' CH2' ' A' ' 146' ' ' TRP . 7.6 p -123.62 146.83 28.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -136.09 150.18 49.02 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 120.693 0.282 . . . . 0.0 110.351 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.34 124.37 44.39 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.826 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -97.85 118.99 45.28 Favored 'Isoleucine or valine' 0 C--O 1.264 1.829 0 C-N-CA 123.071 0.548 . . . . 0.0 110.969 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 96.4 m-85 -113.13 145.73 40.44 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.522 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.41 ' C ' ' HA3' ' A' ' 124' ' ' GLY . 4.7 p-10 -89.85 -167.95 2.0 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.524 ' HD2' ' HA2' ' A' ' 124' ' ' GLY . 3.0 mmmp? -69.47 -18.14 63.68 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.773 -0.58 . . . . 0.0 111.572 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 m -85.09 -1.49 56.92 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 60.59 34.1 20.27 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 125.554 1.542 . . . . 0.0 113.55 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 40.5 mt-10 -105.19 154.57 20.03 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.433 174.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.483 HD11 HG13 ' A' ' 102' ' ' VAL . 3.4 tm? -93.19 113.51 25.75 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.725 -172.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.402 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 2.3 mp0 -107.49 -29.32 9.28 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.216 176.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -143.63 138.73 29.2 Favored 'General case' 0 C--O 1.214 -0.771 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.227 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.518 HG23 ' NE1' ' A' ' 143' ' ' TRP . 30.9 m -129.64 148.79 33.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 172.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.66 162.88 31.87 Favored Glycine 0 N--CA 1.422 -2.262 0 C-N-CA 119.989 -1.1 . . . . 0.0 112.382 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.7 pt -118.06 150.37 20.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 123.469 0.707 . . . . 0.0 109.407 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.4 t -157.0 170.36 22.72 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-O 121.288 0.566 . . . . 0.0 110.756 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -90.86 -25.48 19.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.672 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -142.9 90.92 2.24 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 86' ' ' ALA . 78.6 mt -39.21 -60.45 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.777 1.631 . . . . 0.0 114.256 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.51 -41.23 29.36 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.6 -47.77 71.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.043 0.449 . . . . 0.0 110.992 -175.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.1 m -70.88 -40.11 72.44 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.9 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 79.6 t -56.46 -57.16 10.07 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 O-C-N 123.308 0.38 . . . . 0.0 110.786 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.478 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 22.7 t -60.46 -46.84 88.6 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.804 0.69 . . . . 0.0 111.442 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -51.26 -53.18 37.89 Favored 'General case' 0 C--O 1.25 1.114 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -81.95 -22.17 36.83 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 118.791 -1.164 . . . . 0.0 113.674 -178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.8 mt -75.73 -29.71 58.99 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.849 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 113' ' ' SER . 34.1 mmtp -75.62 -24.76 56.52 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 121.67 0.748 . . . . 0.0 109.021 175.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.7 m -76.42 -54.28 6.96 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.587 174.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 m -113.27 90.56 17.01 Favored Pre-proline 0 C--O 1.243 0.712 0 CA-C-O 121.877 0.846 . . . . 0.0 112.852 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.733 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 11.6 Cg_exo -73.85 -3.93 14.58 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.726 2.284 . . . . 0.0 112.253 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.06 -29.72 70.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.504 0.668 . . . . 0.0 109.557 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.9 mt -99.64 10.98 40.4 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.134 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.733 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 83.8 m -72.51 106.01 4.42 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.383 173.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.524 ' HA2' ' HD2' ' A' ' 95' ' ' LYS . . . -148.82 -73.74 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 173.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . 3.6 m -146.51 155.7 42.72 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.05 138.37 47.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 O-C-N 122.0 -0.438 . . . . 0.0 109.924 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.413 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 81.0 mttt -106.12 133.81 50.24 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.74 126.12 74.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.554 0.692 . . . . 0.0 112.188 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -117.02 106.1 1.4 Allowed Glycine 0 N--CA 1.423 -2.191 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.56 111.76 26.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.9 p -92.39 139.54 17.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.54 -44.48 50.89 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.785 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -75.08 114.43 34.99 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 172.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -88.9 37.74 0.42 Allowed 'Trans proline' 0 C--N 1.321 -0.907 0 C-N-CA 122.513 2.142 . . . . 0.0 111.776 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.429 ' HB3' HG22 ' A' ' 138' ' ' VAL . 14.2 t70 -74.11 134.65 42.89 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -177.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -60.7 -29.98 69.67 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -176.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.9 -41.89 61.46 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.429 HG22 ' HB3' ' A' ' 135' ' ' ASP . 16.2 m -69.55 -31.29 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 120.583 -0.447 . . . . 0.0 109.908 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 92.9 mt -64.28 -48.9 73.93 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.971 175.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.9 m -68.33 -34.12 75.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.384 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.596 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 28.9 tt0 -62.87 -50.18 71.9 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.067 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.87 97.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.29 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.518 ' NE1' HG23 ' A' ' 102' ' ' VAL . 90.6 t90 -56.02 -47.13 78.37 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.984 176.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -62.4 -42.61 99.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.078 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 67.9 mt -63.05 -52.22 63.66 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.674 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.449 ' CH2' HG13 ' A' ' 89' ' ' VAL . 28.5 m0 -56.85 -48.24 78.54 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.338 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 151' ' ' ILE . 11.2 tt -63.55 -43.79 98.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.659 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.7 -29.99 70.61 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 9.5 mm-40 -64.53 -41.77 96.18 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.017 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.45 ' HA ' HG22 ' A' ' 153' ' ' VAL 0.261 60.5 m-70 -76.89 -29.94 55.98 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.505 -0.878 . . . . 0.0 112.853 178.067 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 147' ' ' ILE . 71.9 mt -58.29 -37.98 66.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 171.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -78.82 -49.82 12.32 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.45 HG22 ' HA ' ' A' ' 150' ' ' HIS . 27.8 m -78.7 -20.85 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -174.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 156' ' ' LYS . 6.8 t -138.01 -31.27 0.78 Allowed 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.299 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 88.65 11.2 66.33 Favored Glycine 0 CA--C 1.502 -0.735 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.018 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.413 ' H ' HG23 ' A' ' 154' ' ' THR . 44.7 mmtm -83.13 103.94 12.94 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.33 0.586 . . . . 0.0 110.592 -177.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.4 p -140.49 76.1 25.72 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.293 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 14.1 Cg_exo -73.67 159.47 45.65 Favored 'Trans proline' 0 C--O 1.249 1.035 0 C-N-CA 123.194 2.596 . . . . 0.0 112.349 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.5 -23.88 26.55 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.995 3.13 . . . . 0.0 113.958 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -59.14 -41.82 96.81 Favored Glycine 0 CA--C 1.497 -1.037 0 CA-C-O 121.104 0.28 . . . . 0.0 112.671 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.305 -1.342 0 CA-C-O 121.926 0.87 . . . . 0.0 108.971 -175.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.56 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 7.8 mmpt? . . . . . 0 N--CA 1.436 -1.14 0 CA-C-O 120.867 0.365 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.663 ' HB3' ' OE1' ' A' ' 149' ' ' GLU . 66.6 m -133.04 175.49 9.33 Favored 'General case' 0 N--CA 1.422 -1.843 0 O-C-N 122.015 -0.428 . . . . 0.0 111.448 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.2 mt -70.76 -23.52 62.43 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 m -69.83 -15.85 63.17 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.189 0.995 . . . . 0.0 109.323 176.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -107.83 8.21 28.58 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.63 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.6 m -103.7 142.09 34.94 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.58 149.24 40.2 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 123.735 0.647 . . . . 0.0 111.284 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.11 133.07 51.39 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.8 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.73 128.73 24.53 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -67.41 142.85 61.28 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.786 1.657 . . . . 0.0 109.357 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.42 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -69.16 -11.79 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.422 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.3 p -66.53 -37.75 85.68 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.505 0.669 . . . . 0.0 110.249 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -95.14 50.89 1.29 Allowed 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.845 0.831 . . . . 0.0 110.525 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.409 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -59.78 -27.76 66.84 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.944 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -73.26 -20.92 60.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.532 0.682 . . . . 0.0 110.39 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.0 m -95.99 7.52 46.16 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.406 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' A' ' 80' ' ' ALA . 46.1 mm -78.1 130.59 71.97 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -53.07 132.1 46.08 Favored 'Trans proline' 0 C--O 1.242 0.725 0 C-N-CA 123.417 2.745 . . . . 0.0 113.457 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.9 p -95.3 34.74 1.38 Allowed 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.306 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.402 ' O ' HG13 ' A' ' 108' ' ' ILE . . . -101.98 179.36 4.35 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.957 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 t -95.97 140.04 31.3 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.3 -154.08 24.08 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 119.915 -1.136 . . . . 0.0 111.998 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.585 HG12 HG22 ' A' ' 104' ' ' ILE . 4.4 m -108.29 146.83 13.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 123.823 0.849 . . . . 0.0 109.88 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -141.36 154.98 45.96 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB1' ' CD2' ' A' ' 99' ' ' LEU . . . -135.06 126.45 28.47 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.278 -178.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.63 122.05 52.15 Favored 'Isoleucine or valine' 0 C--O 1.269 2.107 0 CA-C-O 120.932 0.396 . . . . 0.0 110.463 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 77.5 m-85 -109.43 137.92 46.56 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.888 1.275 . . . . 0.0 108.759 177.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -83.61 -166.86 1.5 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.516 ' HE3' ' O ' ' A' ' 123' ' ' CYS . 8.2 mptt -65.21 -26.42 68.12 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 122.913 0.485 . . . . 0.0 111.209 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.8 m -85.51 1.25 49.72 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 122.816 0.447 . . . . 0.0 110.591 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 65.7 28.72 11.02 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 123.87 0.868 . . . . 0.0 111.21 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 156' ' ' LYS . 45.4 mt-10 -100.26 123.32 44.36 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.618 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.481 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.0 tm? -70.04 127.74 33.88 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.199 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.457 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 43.6 mt-30 -126.99 -43.31 1.68 Allowed 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.992 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -126.06 121.51 33.17 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 118.819 -1.153 . . . . 0.0 112.143 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.412 HG13 HD11 ' A' ' 99' ' ' LEU . 19.5 m -112.1 151.72 14.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.99 160.73 30.61 Favored Glycine 0 N--CA 1.425 -2.094 0 C-N-CA 119.382 -1.389 . . . . 0.0 112.655 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.585 HG22 HG12 ' A' ' 89' ' ' VAL . 15.2 pt -119.07 137.3 53.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 m -152.34 166.36 32.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.914 0.387 . . . . 0.0 111.676 -177.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -85.11 -32.68 22.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.066 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -127.7 106.01 8.85 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 86' ' ' ALA . 73.9 mt -61.74 -59.61 4.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.624 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.94 -56.74 5.08 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.2 95.05 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.982 0.176 . . . . 0.0 111.276 -177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.4 m -64.28 -47.84 78.01 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.715 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.75 -55.09 26.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.005 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.9 m -57.33 -42.55 82.14 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.073 0.858 . . . . 0.0 111.781 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.98 -56.43 21.81 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 122.695 0.398 . . . . 0.0 111.889 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.27 23.7 p80 -71.61 -22.16 61.75 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.0 mt -73.75 -27.24 61.07 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.12 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -87.56 -15.67 36.78 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.253 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.5 m -87.02 -42.89 12.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.335 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.7 p -135.21 91.46 19.19 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-O 121.722 0.773 . . . . 0.0 110.007 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.631 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 7.4 Cg_exo -75.01 12.35 1.24 Allowed 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 123.396 2.73 . . . . 0.0 114.11 -176.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.38 -42.98 96.96 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.99 0.424 . . . . 0.0 109.958 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 39.7 mt -94.87 18.26 12.18 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.184 -176.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.631 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 84.8 m -76.85 85.6 3.42 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.467 0.651 . . . . 0.0 112.486 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -128.74 -59.59 0.11 Allowed Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 11.3 p -164.7 158.05 17.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -132.23 141.02 46.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -109.44 138.81 45.25 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 135.06 65.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.085 0.469 . . . . 0.0 110.739 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.3 99.75 0.74 Allowed Glycine 0 N--CA 1.419 -2.497 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.66 108.86 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.532 HG22 ' H ' ' A' ' 133' ' ' GLU . 7.7 p -99.06 131.03 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.73 8.37 10.18 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.579 0.704 . . . . 0.0 111.977 -175.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.532 ' H ' HG22 ' A' ' 131' ' ' VAL . 31.8 mt-10 -124.84 91.73 48.92 Favored Pre-proline 0 N--CA 1.421 -1.879 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 171.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.65 31.52 0.48 Allowed 'Trans proline' 0 N--CA 1.481 0.794 0 C-N-CA 123.102 2.534 . . . . 0.0 112.083 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.41 141.69 28.97 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.214 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -58.34 -26.57 63.25 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -67.14 -44.91 78.63 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.3 t -75.53 -40.05 40.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.402 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.22 -51.42 70.04 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.797 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 29.3 m -67.58 -32.42 73.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.011 0.434 . . . . 0.0 110.539 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.52 ' O ' HD22 ' A' ' 145' ' ' LEU . 51.7 tt0 -64.35 -56.7 12.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.264 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.27 92.28 Favored 'General case' 0 C--O 1.225 -0.197 0 O-C-N 123.221 0.326 . . . . 0.0 110.147 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -53.69 -43.77 69.22 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.733 0.813 . . . . 0.0 109.726 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.573 ' HE3' ' OE1' ' A' ' 148' ' ' GLU . 56.9 tptt -64.27 -43.98 93.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.361 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 141' ' ' GLN . 2.5 mm? -64.3 -42.57 96.3 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.735 178.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -62.09 -49.14 77.12 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.063 -0.972 . . . . 0.0 112.044 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.516 ' O ' HG13 ' A' ' 151' ' ' ILE . 13.7 tt -69.21 -45.74 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.258 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.573 ' OE1' ' HE3' ' A' ' 144' ' ' LYS . 30.5 mt-10 -68.64 -29.61 68.13 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -175.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.663 ' OE1' ' HB3' ' A' ' 68' ' ' SER . 5.4 pt-20 -67.09 -42.72 84.14 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 118.459 -1.297 . . . . 0.0 108.683 176.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.437 ' N ' ' HG3' ' A' ' 149' ' ' GLU 0.263 24.5 m-70 -74.88 -23.38 58.38 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -179.287 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 147' ' ' ILE . 76.8 mt -66.87 -30.47 49.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -84.42 -42.57 15.52 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 149' ' ' GLU . 5.2 p -80.94 -51.47 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.0 p -96.79 -28.63 14.18 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 121.663 -0.648 . . . . 0.0 111.931 -176.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.96 29.92 62.72 Favored Glycine 0 N--CA 1.467 0.702 0 CA-C-N 114.727 -1.124 . . . . 0.0 115.415 174.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 26.1 mtpp -91.47 -70.58 0.68 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 117.391 0.595 . . . . 0.0 110.702 -176.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.289 7.7 p 41.4 83.27 0.21 Allowed Pre-proline 0 CA--C 1.567 1.613 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 58.9 Cg_endo -70.11 169.26 19.79 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.945 2.43 . . . . 0.0 112.593 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -45.75 -25.7 2.69 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 125.175 3.917 . . . . 0.0 115.694 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -57.64 -47.84 85.66 Favored Glycine 0 C--O 1.238 0.365 0 O-C-N 123.55 0.532 . . . . 0.0 113.388 -175.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.6 m120 . . . . . 0 CA--C 1.497 -1.093 0 CA-C-O 121.005 0.431 . . . . 0.0 111.785 -179.441 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.7 mttp . . . . . 0 CA--C 1.495 -1.156 0 CA-C-O 121.809 0.814 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.2 m -136.78 172.48 12.95 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.482 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.51 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 61.3 mt -59.87 -16.14 26.74 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.8 1.24 . . . . 0.0 114.241 -175.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.424 HG23 ' HG3' ' A' ' 71' ' ' GLU . 12.5 t -65.32 -19.97 66.19 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.24 0.616 . . . . 0.0 111.164 176.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.424 ' HG3' HG23 ' A' ' 70' ' ' THR . 31.7 mt-10 -106.45 -7.36 17.62 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.426 0.631 . . . . 0.0 110.263 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.51 ' OG1' ' HA ' ' A' ' 69' ' ' LEU . 4.4 m -84.94 129.6 34.78 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.131 -172.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -81.56 150.99 27.92 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.806 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -104.99 129.1 53.51 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 123.277 0.631 . . . . 0.0 109.657 -175.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.2 140.27 35.71 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -68.27 145.56 66.42 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.532 2.155 . . . . 0.0 110.133 173.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -13.54 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-O 121.429 0.633 . . . . 0.0 110.667 -177.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.4 t -78.42 -15.1 59.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -97.95 47.89 1.01 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.804 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.513 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -61.42 -28.95 69.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.295 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -69.18 -26.02 64.64 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.001 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.7 m -90.87 -5.53 55.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.393 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.513 HG12 ' HA ' ' A' ' 80' ' ' ALA . 44.1 mm -70.16 125.28 91.92 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -178.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.51 134.96 66.99 Favored 'Trans proline' 0 C--O 1.244 0.823 0 C-N-CA 123.049 2.5 . . . . 0.0 113.399 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.8 p -91.81 26.77 2.28 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.925 0.869 . . . . 0.0 109.727 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.91 -178.73 4.18 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.405 -173.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.5 t -95.83 138.85 32.89 Favored 'General case' 0 N--CA 1.425 -1.704 0 O-C-N 124.034 0.833 . . . . 0.0 109.404 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.46 -151.22 20.25 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 118.503 -1.808 . . . . 0.0 114.422 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.416 ' HB ' ' CH2' ' A' ' 146' ' ' TRP . 5.6 t -120.34 150.28 23.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -139.25 149.26 44.12 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.346 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.14 120.59 34.67 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 123.918 0.887 . . . . 0.0 109.32 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.7 t -99.69 121.76 50.73 Favored 'Isoleucine or valine' 0 C--O 1.263 1.804 0 CA-C-O 121.059 0.457 . . . . 0.0 110.608 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -109.66 132.06 54.49 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.45 -172.48 4.16 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.774 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.54 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -65.18 -22.27 66.88 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.382 0.673 . . . . 0.0 112.201 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.9 m -84.68 0.39 50.53 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 123.001 0.52 . . . . 0.0 109.986 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 69.33 16.55 8.35 Favored 'General case' 0 C--O 1.249 1.079 0 C-N-CA 125.023 1.329 . . . . 0.0 111.707 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -86.84 135.77 33.21 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.124 0.488 . . . . 0.0 110.322 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.489 HD11 HG13 ' A' ' 102' ' ' VAL . 3.4 tm? -80.75 112.22 17.93 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 174.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -125.0 -13.72 6.78 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.944 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.429 ' HA ' ' OD1' ' A' ' 161' ' ' ASN . 57.4 t80 -145.83 122.65 11.26 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 118.707 -1.197 . . . . 0.0 111.08 177.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' A' ' 147' ' ' ILE . 18.6 m -123.27 141.32 44.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 171.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -157.23 157.91 28.47 Favored Glycine 0 N--CA 1.413 -2.895 0 C-N-CA 119.068 -1.539 . . . . 0.0 111.719 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.7 pt -110.91 137.84 41.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 121.192 0.52 . . . . 0.0 109.733 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.5 m -149.77 136.41 19.28 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HD2' ' C ' ' A' ' 106' ' ' ARG . 4.5 ppt_? -76.74 -12.0 59.92 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.751 0.786 . . . . 0.0 109.894 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -133.7 86.76 2.32 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.6 mt -55.68 -55.32 18.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.157 -174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.64 -60.25 2.3 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.05 -37.99 87.06 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.033 0.208 . . . . 0.0 111.432 -176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.7 t -63.65 -55.32 24.42 Favored 'General case' 0 C--O 1.248 0.985 0 O-C-N 123.836 0.71 . . . . 0.0 109.913 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.9 t -57.94 -51.61 68.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.351 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.9 m -60.1 -37.92 81.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.327 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.13 -58.86 6.8 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 120.937 0.399 . . . . 0.0 111.47 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -77.63 -22.36 50.84 Favored 'General case' 0 C--O 1.203 -1.367 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.04 -26.03 25.58 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 119.062 -1.055 . . . . 0.0 113.326 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -88.12 -16.95 32.09 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.3 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -94.81 -20.1 19.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.004 0.43 . . . . 0.0 111.158 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.9 p -152.73 94.0 3.19 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-O 121.809 0.814 . . . . 0.0 110.534 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.667 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 16.1 Cg_exo -68.84 14.28 0.2 Allowed 'Trans proline' 0 CA--C 1.556 1.579 0 C-N-CA 124.123 3.215 . . . . 0.0 116.729 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -66.39 -28.27 68.5 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 121.464 -0.773 . . . . 0.0 111.503 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.9 mt -107.25 20.86 18.38 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 121.683 -0.636 . . . . 0.0 111.502 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.667 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 89.4 m -79.68 99.05 7.21 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.73 -65.28 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.6 p -160.05 162.05 34.09 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.095 0.558 . . . . 0.0 109.52 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.38 137.78 43.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-O 121.155 0.503 . . . . 0.0 110.375 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.509 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 79.5 mttt -109.11 137.27 47.27 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.36 138.69 53.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 120.57 0.224 . . . . 0.0 110.863 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.72 113.34 1.85 Allowed Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.32 107.59 18.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 p -93.53 143.22 11.97 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.572 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -58.63 -50.21 74.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.275 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -94.52 119.42 66.35 Favored Pre-proline 0 C--N 1.303 -1.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.176 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.07 27.16 0.62 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.066 2.51 . . . . 0.0 110.877 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.15 133.56 50.04 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.402 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -59.54 -33.77 71.82 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.85 -42.24 58.34 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.55 -43.07 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.004 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.69 -49.26 78.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.74 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 44.8 m -69.1 -31.1 69.58 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.084 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.492 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 27.9 tt0 -63.26 -50.64 69.36 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 122.946 0.498 . . . . 0.0 109.884 178.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.85 -45.26 93.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.698 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -51.13 -46.69 62.02 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.251 1.021 . . . . 0.0 110.284 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -61.0 -48.82 80.04 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.179 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 61.7 mt -62.8 -43.23 99.35 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.79 -176.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.416 ' CH2' ' HB ' ' A' ' 89' ' ' VAL . 30.8 m0 -61.48 -47.51 85.35 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.21 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.514 ' O ' HG13 ' A' ' 151' ' ' ILE . 14.9 tt -67.68 -39.75 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.404 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -62.74 -33.71 75.69 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 153' ' ' VAL . 7.3 mm-40 -55.24 -45.95 76.02 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.401 0.619 . . . . 0.0 109.685 173.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.468 ' HA ' HG12 ' A' ' 153' ' ' VAL 0.255 74.3 m-70 -80.5 -27.36 37.74 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.295 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 147' ' ' ILE . 79.8 mt -61.29 -41.07 88.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -71.06 -43.98 66.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.326 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 150' ' ' HIS . 7.3 p -81.7 -56.4 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.4 p -99.47 -34.36 10.3 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 121.811 -0.556 . . . . 0.0 112.264 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.74 34.67 27.21 Favored Glycine 0 C--N 1.304 -1.226 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.715 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -106.83 106.49 17.05 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.76 87.52 46.41 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 173.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -86.14 169.87 8.53 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 123.896 3.064 . . . . 0.0 113.251 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -45.23 -30.57 5.3 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 124.928 3.752 . . . . 0.0 116.177 -175.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.76 -30.31 72.67 Favored Glycine 0 C--O 1.246 0.896 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.312 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 101' ' ' PHE . 14.7 m120 . . . . . 0 C--N 1.311 -1.075 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.429 ' HD3' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.44 -0.944 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.7 m -114.41 168.98 9.38 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.331 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 146' ' ' TRP . 2.9 tm? -65.32 -35.0 79.65 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.429 1.092 . . . . 0.0 109.829 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.8 m -55.97 -28.69 58.2 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.798 176.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -93.94 -4.08 50.45 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.752 -0.593 . . . . 0.0 111.575 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.548 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.3 m -78.02 141.67 38.73 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -173.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -88.45 148.64 24.08 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.659 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.06 133.94 48.16 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 122.84 0.456 . . . . 0.0 109.94 -174.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -126.44 126.45 24.61 Favored Pre-proline 0 C--N 1.315 -0.928 0 C-N-CA 123.652 0.781 . . . . 0.0 108.902 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.522 ' HB2' HG22 ' A' ' 78' ' ' THR . 25.5 Cg_exo -67.67 141.85 56.28 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 121.843 1.695 . . . . 0.0 109.139 172.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -5.0 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -174.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 76' ' ' PRO . 9.1 t -68.32 -30.0 68.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -99.43 52.97 0.94 Allowed 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.364 1.078 . . . . 0.0 109.61 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.55 -24.11 66.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.102 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -76.32 -19.41 58.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.782 0.801 . . . . 0.0 110.244 176.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.3 t -87.49 -6.97 58.15 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.243 -174.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.7 mm -67.43 125.84 91.71 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.391 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -53.77 137.37 67.45 Favored 'Trans proline' 0 C--O 1.243 0.739 0 C-N-CA 123.584 2.856 . . . . 0.0 113.95 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.8 p -93.69 35.72 1.12 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.25 1.024 . . . . 0.0 109.129 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.445 ' O ' HG13 ' A' ' 108' ' ' ILE . . . -102.64 175.37 5.52 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.229 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.7 t -97.53 134.76 40.32 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.28 -154.88 24.68 Favored Glycine 0 N--CA 1.412 -2.902 0 C-N-CA 119.952 -1.118 . . . . 0.0 111.069 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.458 ' HB ' ' CH2' ' A' ' 146' ' ' TRP . 3.2 t -115.24 156.44 16.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -145.61 149.52 34.68 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.58 121.97 35.15 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.462 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.9 t -94.93 118.74 41.75 Favored 'Isoleucine or valine' 0 C--O 1.259 1.558 0 CA-C-O 121.332 0.587 . . . . 0.0 110.351 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.559 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 7.3 m-85 -108.82 134.49 51.44 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.367 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.92 -179.33 6.92 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -73.99 3.18 7.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -175.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.5 m -94.18 0.0 55.49 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 171.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 t70 61.51 62.94 1.24 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.036 1.334 . . . . 0.0 108.538 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -141.39 146.49 36.67 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.3 -177.698 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.418 HD11 HG13 ' A' ' 102' ' ' VAL . 3.3 tm? -96.3 116.67 29.4 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.92 0.762 . . . . 0.0 110.745 -172.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.467 ' HA ' ' HG2' ' A' ' 158' ' ' PRO . 2.4 mp0 -112.08 -28.39 8.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.329 178.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -145.91 127.07 14.72 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.12 -1.032 . . . . 0.0 112.493 -175.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.434 HG23 ' NE1' ' A' ' 143' ' ' TRP . 20.0 m -114.98 143.55 24.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 172.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.46 170.38 31.03 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.4 pt -133.14 146.84 31.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.1 t -151.22 162.42 40.92 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.979 -0.289 . . . . 0.0 110.29 -176.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -85.38 -22.67 28.3 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -142.43 86.16 1.94 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 86' ' ' ALA . 73.0 mt -43.94 -52.45 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.663 1.185 . . . . 0.0 113.304 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.65 -40.33 19.52 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.78 -51.76 37.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.444 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.9 m -63.19 -45.92 89.5 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.688 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.31 -57.13 11.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.33 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.4 t -62.94 -40.89 99.01 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 123.404 0.44 . . . . 0.0 111.13 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.69 -54.31 47.67 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.261 19.7 p80 -78.69 -25.79 44.81 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 118.922 -1.111 . . . . 0.0 113.94 -177.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 70.5 mt -75.19 -28.35 59.97 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 119.781 -0.767 . . . . 0.0 112.127 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -86.11 -23.34 26.67 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.738 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.1 m -72.89 -46.36 53.2 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.4 p -139.26 91.69 11.02 Favored Pre-proline 0 N--CA 1.438 -1.075 0 CA-C-O 122.22 1.009 . . . . 0.0 110.022 177.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -74.84 29.75 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.945 3.096 . . . . 0.0 113.82 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -70.83 -42.87 69.64 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.362 0.601 . . . . 0.0 110.533 -177.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.62 21.29 4.08 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.219 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 35.9 m -71.56 99.32 2.04 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.334 0.587 . . . . 0.0 111.856 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.32 -59.9 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.1 p -164.72 160.84 20.24 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.79 138.01 46.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.548 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 97.9 mttt -106.71 135.36 48.38 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.0 m -120.88 131.41 72.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 120.81 0.338 . . . . 0.0 110.1 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -115.81 106.58 1.57 Allowed Glycine 0 N--CA 1.408 -3.228 0 C-N-CA 119.868 -1.158 . . . . 0.0 111.85 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 mp -82.23 112.37 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.25 144.26 20.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.31 4.51 53.37 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.204 -171.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -94.58 112.4 57.69 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -84.73 8.32 4.7 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 122.592 2.195 . . . . 0.0 116.065 -170.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.407 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 16.1 t70 -97.64 146.81 24.95 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.131 -174.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -54.85 -34.67 63.16 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.692 1.197 . . . . 0.0 111.891 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.96 -44.23 90.08 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 120.658 0.266 . . . . 0.0 110.665 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.46 -36.38 48.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.615 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 95.1 mt -60.82 -45.08 95.86 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.1 m -71.94 -32.14 67.02 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 121.072 0.463 . . . . 0.0 110.698 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.437 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 26.6 tt0 -63.69 -46.31 86.06 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 175.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.77 -42.25 95.24 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.843 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.434 ' NE1' HG23 ' A' ' 102' ' ' VAL . 91.9 t90 -49.83 -45.89 50.67 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.488 0.715 . . . . 0.0 109.633 176.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.643 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 84.6 mttt -62.09 -50.74 70.74 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.13 177.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 86.9 mt -54.32 -47.54 72.36 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.532 0.52 . . . . 0.0 110.679 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 69' ' ' LEU . 14.3 m0 -62.02 -54.46 41.26 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.538 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.446 ' O ' HG12 ' A' ' 151' ' ' ILE . 11.1 tt -59.19 -42.78 87.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 O-C-N 123.424 0.452 . . . . 0.0 110.274 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 37.3 mt-10 -56.01 -47.67 77.34 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 123.547 0.53 . . . . 0.0 110.913 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.404 ' O ' HG22 ' A' ' 153' ' ' VAL . 15.4 mt-10 -56.86 -47.02 81.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.41 ' HA ' HG22 ' A' ' 153' ' ' VAL . 0.6 OUTLIER -82.83 -28.2 30.33 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 118.496 -1.282 . . . . 0.0 112.751 -176.11 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.523 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 38.2 pt -76.85 -26.77 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.906 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -78.5 -30.9 47.47 Favored 'General case' 0 C--N 1.264 -3.123 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.079 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 150' ' ' HIS . 35.1 m -86.57 -46.33 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 176.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 70.8 p -99.99 -19.02 16.76 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 119.409 -0.917 . . . . 0.0 113.031 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 151' ' ' ILE . . . 67.52 34.69 84.99 Favored Glycine 0 N--CA 1.468 0.822 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 174.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -78.95 -74.94 0.26 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 117.1 0.45 . . . . 0.0 111.958 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.1 t 54.13 69.52 2.12 Favored Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 123.865 0.866 . . . . 0.0 109.014 -174.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.467 ' HG2' ' HA ' ' A' ' 100' ' ' GLN . 2.8 Cg_exo -81.44 156.94 19.27 Favored 'Trans proline' 0 C--O 1.242 0.696 0 C-N-CA 122.804 2.336 . . . . 0.0 112.84 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.92 -35.92 41.96 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 124.298 3.332 . . . . 0.0 114.159 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -64.86 -30.52 78.21 Favored Glycine 0 CA--C 1.498 -1.011 0 O-C-N 123.336 0.397 . . . . 0.0 112.933 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.42 ' OD1' HG22 ' A' ' 102' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.297 -1.677 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -176.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.529 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.22 -41.98 15.11 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 123.137 0.273 . . . . 0.0 111.462 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -167.29 -164.52 0.61 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.92 110.98 1.95 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 71' ' ' GLU . 8.1 p -78.68 135.93 24.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.248 -175.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -112.66 -53.77 2.68 Favored 'General case' 0 C--O 1.205 -1.253 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.417 ' HB3' ' OE2' ' A' ' 149' ' ' GLU . 15.6 m -113.32 164.64 13.31 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.568 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.402 HD13 ' OH ' ' A' ' 93' ' ' TYR . 35.0 mt -62.33 -28.02 69.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.159 0.983 . . . . 0.0 111.404 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 m -59.45 -21.91 60.73 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.033 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 66' ' ' VAL . 31.8 mt-10 -104.92 11.58 33.43 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 122.717 0.407 . . . . 0.0 110.264 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.436 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 8.1 m -104.7 142.9 33.88 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -173.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -86.26 159.64 19.38 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.506 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.11 133.35 53.12 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.524 HD23 HG22 ' A' ' 128' ' ' VAL . 3.7 mm? -128.17 138.87 33.92 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -74.93 143.53 29.41 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.41 2.074 . . . . 0.0 110.573 173.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.62 -15.74 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-O 120.913 0.387 . . . . 0.0 112.01 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p -71.77 -38.21 70.38 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 121.615 0.722 . . . . 0.0 111.183 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -93.16 54.2 2.09 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.873 0.844 . . . . 0.0 110.645 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.52 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -56.38 -18.41 10.91 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.425 -1.261 . . . . 0.0 112.981 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -72.25 -27.25 62.39 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.52 0.676 . . . . 0.0 109.692 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.9 m -93.89 3.3 55.6 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.977 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.52 HG12 ' HA ' ' A' ' 80' ' ' ALA . 38.1 mm -79.63 128.56 74.34 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.26 130.65 41.79 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.957 2.438 . . . . 0.0 113.335 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.1 p -92.9 39.01 1.03 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.224 1.011 . . . . 0.0 109.475 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -109.55 177.63 4.68 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.259 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.6 t -93.94 140.53 29.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.75 -155.08 26.15 Favored Glycine 0 N--CA 1.417 -2.62 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.641 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.477 HG13 ' CH2' ' A' ' 146' ' ' TRP . 6.3 p -121.23 149.17 24.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -137.63 149.58 46.72 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 120.848 0.356 . . . . 0.0 110.543 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.403 ' HB1' HD23 ' A' ' 99' ' ' LEU . . . -122.14 118.65 29.18 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.79 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.6 t -91.78 121.0 41.87 Favored 'Isoleucine or valine' 0 C--O 1.263 1.787 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.367 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 67.4 m-85 -108.76 130.0 55.37 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.691 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -76.91 -175.08 3.35 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.231 0.539 . . . . 0.0 110.257 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.464 ' H ' ' HD2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -57.83 -28.09 63.76 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 124.14 0.976 . . . . 0.0 113.547 -178.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.7 m -91.74 3.45 55.07 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.803 0.335 . . . . 0.0 111.492 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.4 t70 62.33 67.75 0.71 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-O 122.724 1.25 . . . . 0.0 111.598 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 8.1 mm-40 -136.82 145.73 44.82 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.556 -1.656 . . . . 0.0 109.814 174.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.512 HD21 HG13 ' A' ' 102' ' ' VAL . 3.0 tm? -89.87 116.71 28.15 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.308 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -122.86 -14.49 7.64 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.259 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.58 115.03 5.91 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.819 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.512 HG13 HD21 ' A' ' 99' ' ' LEU . 12.3 m -111.21 142.26 24.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.79 159.76 29.81 Favored Glycine 0 N--CA 1.424 -2.14 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.227 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.2 pt -115.09 139.94 38.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.5 m -151.0 157.77 43.3 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.635 ' HD3' ' O ' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -79.3 -23.32 43.61 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -135.49 105.39 6.2 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 173.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.4 mt -60.14 -56.94 14.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.38 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.95 -50.73 45.56 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.559 0.744 . . . . 0.0 112.767 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.23 -52.19 66.73 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 123.75 0.656 . . . . 0.0 111.109 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.1 t -61.26 -48.62 80.6 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.293 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 54.7 t -56.9 -54.48 29.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 123.103 0.561 . . . . 0.0 111.097 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.0 m -61.04 -35.53 77.15 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 123.607 0.567 . . . . 0.0 111.463 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.91 -58.96 3.97 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.836 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.497 ' HB3' HG11 ' A' ' 171' ' ' VAL 0.287 19.6 p80 -74.8 -24.66 58.68 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -175.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.6 mt -77.93 -24.82 48.14 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.217 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 117' ' ' LYS . 73.0 mmtt -85.49 -16.82 38.31 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.867 175.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.0 t -80.55 -50.48 9.95 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.58 85.0 61.3 Favored Pre-proline 0 CA--C 1.557 1.236 0 CA-C-O 122.341 1.067 . . . . 0.0 109.929 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.494 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 16.6 Cg_exo -71.87 12.02 0.62 Allowed 'Trans proline' 0 N--CA 1.479 0.623 0 C-N-CA 124.031 3.154 . . . . 0.0 114.806 -176.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -66.47 -39.32 88.73 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.341 0.591 . . . . 0.0 109.886 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.8 mt -88.16 20.71 3.08 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.092 0.473 . . . . 0.0 111.802 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.494 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 89.2 m -79.99 99.44 7.64 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 121.497 0.665 . . . . 0.0 111.069 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.43 -64.64 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 174.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.4 p -161.43 162.92 30.73 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.9 p -137.14 137.05 46.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.436 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 94.8 mttt -106.4 125.56 51.15 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 175.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.524 HG22 HD23 ' A' ' 75' ' ' LEU . 33.0 m -115.34 134.35 58.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.412 0.625 . . . . 0.0 111.929 -174.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.65 96.16 0.63 Allowed Glycine 0 N--CA 1.422 -2.249 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 130' ' ' ILE . 2.6 mp -89.27 121.37 39.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 133' ' ' GLU . 10.2 p -116.12 125.25 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 175.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -72.38 -8.87 57.24 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.461 ' H ' HG22 ' A' ' 131' ' ' VAL . 38.3 mt-10 -89.62 122.06 68.55 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -83.12 27.12 0.62 Allowed 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.769 2.313 . . . . 0.0 113.224 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.432 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 24.2 t70 -78.96 129.38 34.42 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.532 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -69.9 -31.15 68.79 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.422 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.72 -38.45 62.29 Favored 'General case' 0 C--O 1.203 -1.37 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.297 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.401 HG23 ' OD2' ' A' ' 135' ' ' ASP . 97.6 t -59.09 -43.75 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 92.4 mt -59.08 -48.4 81.75 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.345 0.593 . . . . 0.0 110.244 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.6 m -70.69 -34.3 71.82 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.272 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.45 -47.05 74.4 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 123.109 0.564 . . . . 0.0 109.759 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.83 -49.25 78.43 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -49.17 -43.9 42.38 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.002 0.921 . . . . 0.0 110.305 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -65.55 -48.71 71.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.43 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.64 -37.12 85.09 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.773 0.321 . . . . 0.0 110.871 177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.477 ' CH2' HG13 ' A' ' 89' ' ' VAL . 25.0 m0 -63.47 -53.55 50.29 Favored 'General case' 0 C--O 1.254 1.333 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.53 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.465 ' HB ' HG21 ' A' ' 102' ' ' VAL . 11.8 tt -63.41 -41.21 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.829 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -60.24 -36.94 78.9 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 153' ' ' VAL . 24.4 mt-10 -54.96 -46.97 75.11 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 118.94 0.791 . . . . 0.0 110.56 176.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.504 ' CG ' ' HB3' ' A' ' 99' ' ' LEU 0.323 18.9 m-70 -77.85 -29.81 50.67 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 118.769 -1.172 . . . . 0.0 114.011 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 147' ' ' ILE . 68.7 mt -60.68 -44.87 98.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 172.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.27 -48.65 64.44 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.433 HG22 ' HA ' ' A' ' 150' ' ' HIS . 21.8 m -80.01 -32.1 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -175.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.7 t -131.7 -30.21 1.66 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.44 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.41 15.61 56.78 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.642 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -77.11 120.56 22.37 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 42.8 t -138.46 80.65 26.57 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -77.69 161.48 30.71 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.431 2.754 . . . . 0.0 113.278 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -52.84 -23.77 21.81 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 124.543 3.495 . . . . 0.0 114.197 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.4 -29.97 75.77 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.574 -0.346 . . . . 0.0 112.87 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -95.34 -8.68 35.08 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.347 1.07 . . . . 0.0 110.17 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -98.55 154.69 17.72 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.954 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 28.2 m -86.71 77.42 9.33 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.6 0.714 . . . . 0.0 110.194 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -123.98 -104.36 1.62 Allowed Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -92.04 111.11 22.53 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -87.42 86.91 7.28 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.791 0.805 . . . . 0.0 111.055 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 19.5 m -79.02 -31.29 44.64 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.543 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -87.7 -15.58 36.72 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.854 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.9 t -93.54 -33.66 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.214 0.531 . . . . 0.0 110.262 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -121.57 104.74 9.86 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.497 HG11 ' HB3' ' A' ' 115' ' ' HIS . 35.8 m -111.42 131.43 62.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -170.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 10.3 m 66.7 1.05 2.06 Favored 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 124.99 1.316 . . . . 0.0 112.853 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 92.1 mt -85.33 -27.2 26.07 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.526 -0.733 . . . . 0.0 110.486 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . 0.279 20.7 mm-40 45.7 72.56 0.21 Allowed 'General case' 0 C--O 1.244 0.796 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -148.24 47.33 1.06 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.945 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -74.91 96.75 3.19 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 170.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -76.02 93.71 3.32 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.258 -164.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -176.78 89.43 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -77.14 158.5 30.37 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.041 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 21.5 p80 . . . . . 0 C--N 1.298 -1.662 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.504 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 52.3 ttm . . . . . 0 CA--C 1.513 -0.451 0 CA-C-O 121.223 0.535 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.37 178.06 7.84 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.8 m -108.97 135.22 50.51 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.83 110.48 1.55 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.0 t -61.33 118.07 3.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.226 -173.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -95.39 -82.01 0.39 Allowed 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.992 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.2 m -123.25 -179.08 4.18 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.76 -17.75 63.46 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.3 m -63.69 -26.76 68.81 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.789 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -84.16 -20.53 32.29 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.436 0.636 . . . . 0.0 109.668 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.487 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 2.7 m -76.82 154.35 33.98 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.036 -0.983 . . . . 0.0 113.512 -168.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -100.9 158.61 15.86 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.887 0.875 . . . . 0.0 109.133 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.68 128.82 55.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.98 0.419 . . . . 0.0 110.175 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.492 HD23 HG22 ' A' ' 128' ' ' VAL . 3.9 mm? -123.01 129.09 25.1 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -65.39 143.84 77.82 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 121.663 1.575 . . . . 0.0 108.74 170.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.596 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -65.12 -13.19 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -176.333 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.8 p -76.12 -16.22 59.93 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.56 0.695 . . . . 0.0 110.809 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -92.97 30.58 1.57 Allowed 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -49.53 -40.33 37.52 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.532 1.133 . . . . 0.0 113.414 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -72.95 -17.95 61.43 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.642 0.734 . . . . 0.0 110.789 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.0 m -103.65 -1.05 28.75 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.389 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 80' ' ' ALA . 48.4 mm -65.38 134.07 95.57 Favored Pre-proline 0 C--O 1.243 0.731 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.59 129.92 31.48 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.84 2.36 . . . . 0.0 112.205 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.4 p -99.16 49.51 0.95 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.872 0.844 . . . . 0.0 109.922 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -124.99 -179.44 4.55 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.983 -176.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.7 t -95.37 145.02 25.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.27 -156.5 28.43 Favored Glycine 0 N--CA 1.414 -2.79 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.538 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.574 HG12 HG22 ' A' ' 104' ' ' ILE . 3.2 m -110.67 151.05 12.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 123.996 0.918 . . . . 0.0 109.916 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -141.85 147.18 36.76 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 120.713 0.292 . . . . 0.0 110.214 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.91 122.22 37.38 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.77 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.57 117.05 40.21 Favored 'Isoleucine or valine' 0 C--O 1.26 1.655 0 C-N-CA 123.377 0.671 . . . . 0.0 110.36 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.621 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 47.1 m-85 -107.39 134.5 50.36 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -79.94 -167.93 1.45 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.262 0.554 . . . . 0.0 112.114 -174.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -56.88 -32.56 65.98 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.244 1.417 . . . . 0.0 110.667 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.9 m -90.72 7.42 39.65 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.924 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 69.93 16.45 7.67 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.347 1.07 . . . . 0.0 111.055 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -92.3 139.63 30.41 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 120.93 -1.106 . . . . 0.0 110.327 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.621 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.3 tm? -82.43 129.68 34.95 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.645 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -125.78 -43.52 1.85 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 123.771 0.669 . . . . 0.0 111.078 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -124.29 131.09 53.5 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.835 -171.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.9 m -123.02 151.85 27.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 174.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -158.82 168.67 35.01 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.282 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.574 HG22 HG12 ' A' ' 89' ' ' VAL . 9.5 pt -120.35 144.76 28.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 123.259 0.624 . . . . 0.0 109.958 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 71.1 m -150.03 154.64 38.51 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.916 0.389 . . . . 0.0 111.61 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -78.59 -28.16 45.73 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -142.23 103.16 4.24 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.4 mt -55.2 -54.7 21.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.462 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.14 -43.79 64.21 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.08 -54.8 24.39 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 123.381 0.426 . . . . 0.0 111.904 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.1 m -70.86 -41.14 71.8 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.81 -56.74 15.38 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.8 m -58.3 -40.22 81.41 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 123.753 0.658 . . . . 0.0 111.228 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.03 -55.64 30.39 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 120.989 0.423 . . . . 0.0 111.281 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -75.03 -27.39 60.04 Favored 'General case' 0 C--O 1.21 -0.99 0 C-N-CA 119.275 -0.97 . . . . 0.0 113.265 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.442 HD22 ' SG ' ' A' ' 123' ' ' CYS . 64.5 mt -76.33 -24.49 54.28 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.051 -0.659 . . . . 0.0 112.061 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -88.71 -11.21 45.82 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.305 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.2 m -90.64 -43.62 10.05 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.89 175.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.31 93.85 24.72 Favored Pre-proline 0 CA--C 1.551 1.008 0 CA-C-O 121.826 0.822 . . . . 0.0 110.727 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.82 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 6.2 Cg_exo -77.41 10.65 2.4 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.388 2.725 . . . . 0.0 113.779 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.13 -42.33 85.58 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.695 0.798 . . . . 0.0 112.259 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.3 mt -105.84 20.67 18.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.181 0.515 . . . . 0.0 110.432 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.82 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 81.5 m -80.72 88.62 5.76 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -127.0 -55.11 0.14 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.9 p -158.76 162.73 37.13 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.99 136.22 42.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.487 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 67.6 mttm -106.6 125.54 51.14 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.492 HG22 HD23 ' A' ' 75' ' ' LEU . 32.8 m -114.51 133.54 60.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.102 0.477 . . . . 0.0 111.292 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.13 104.32 1.0 Allowed Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 mp -87.72 133.22 30.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 133' ' ' GLU . 14.5 p -122.46 151.68 26.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -95.61 7.0 47.53 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.69 0.757 . . . . 0.0 110.425 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.426 ' H ' HG22 ' A' ' 131' ' ' VAL . 36.5 mt-10 -127.08 99.88 27.88 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.789 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -84.84 34.03 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.388 2.726 . . . . 0.0 113.511 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -85.07 140.13 31.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -58.7 -28.31 65.67 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.98 -43.07 62.66 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -66.09 -42.51 91.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.11 -46.69 87.95 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.704 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 43.2 m -71.27 -28.22 63.99 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.748 0.309 . . . . 0.0 110.755 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.2 -54.6 42.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.83 -41.16 99.21 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 123.928 0.767 . . . . 0.0 110.148 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.47 ' O ' HG22 ' A' ' 147' ' ' ILE . 90.4 t90 -53.51 -46.88 70.26 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.735 0.814 . . . . 0.0 109.39 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -57.79 -50.98 71.45 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.424 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 4.0 mm? -57.7 -49.61 75.95 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.297 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -57.69 -51.99 67.26 Favored 'General case' 0 C--O 1.255 1.353 0 O-C-N 124.488 1.117 . . . . 0.0 112.23 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.583 ' O ' HG12 ' A' ' 151' ' ' ILE . 11.7 tt -70.21 -51.07 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.4 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.88 -33.12 74.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 153' ' ' VAL . 10.1 pt-20 -63.86 -42.88 97.43 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.17 177.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -74.88 -27.21 60.14 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 147' ' ' ILE . 44.8 mm -62.09 -45.66 98.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.05 -37.95 78.84 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.649 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 149' ' ' GLU . 5.5 p -88.52 -60.13 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.1 p -90.71 -28.72 18.14 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 70.81 34.86 66.05 Favored Glycine 0 N--CA 1.467 0.761 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.018 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 99' ' ' LEU . 71.9 mmtt -87.36 114.98 24.46 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 122.528 0.331 . . . . 0.0 110.521 -176.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.9 t -133.9 87.86 34.04 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -88.2 153.28 6.85 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.826 2.351 . . . . 0.0 112.358 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.422 ' HA ' ' HB2' ' A' ' 162' ' ' LYS . 76.3 Cg_exo -51.98 -27.39 28.26 Favored 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 123.908 3.072 . . . . 0.0 113.245 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 166' ' ' ASN . . . -63.51 -37.57 94.99 Favored Glycine 0 CA--C 1.502 -0.778 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.86 177.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -93.66 -24.93 17.7 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.243 0.544 . . . . 0.0 109.934 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 162' ' ' LYS . 6.9 mtpm? -68.94 171.26 8.32 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.008 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.8 m -82.89 85.98 7.03 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-O 121.914 0.864 . . . . 0.0 109.324 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -175.58 -159.29 21.27 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -127.09 128.75 46.73 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 118.178 0.989 . . . . 0.0 111.135 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.433 ' HB3' ' HA2' ' A' ' 160' ' ' GLY . 6.5 t30 -143.46 164.01 31.51 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 1.6 m -55.62 -4.85 0.11 Allowed 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -172.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -87.96 -31.31 19.45 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 121.183 -0.948 . . . . 0.0 111.359 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.01 -1.11 8.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.182 0.515 . . . . 0.0 111.098 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -150.12 107.78 3.67 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -178.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.87 117.85 27.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.106 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 33.4 m 67.4 -59.65 0.4 Allowed 'General case' 0 CA--C 1.558 1.267 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 173.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -84.68 82.98 8.18 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 122.145 -0.347 . . . . 0.0 111.058 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 178.99 172.53 0.8 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -108.05 -21.3 12.86 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -64.44 117.99 8.1 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -134.42 152.26 51.69 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.343 -174.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -98.66 170.07 9.05 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -159.79 140.08 11.88 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 . . . . . 0 C--N 1.304 -1.372 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.226 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 C--O 1.238 0.459 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.67 26.72 14.65 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.356 1.062 . . . . 0.0 112.775 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 m -74.83 137.42 41.84 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.612 176.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.17 134.99 23.59 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.787 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 71' ' ' GLU . 31.7 t -97.72 129.88 47.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -108.73 -36.83 6.05 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.627 -173.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.8 m -134.7 169.48 17.26 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.912 -0.492 . . . . 0.0 110.882 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.7 mt -58.33 -22.85 54.75 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.334 1.053 . . . . 0.0 112.107 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.456 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 38.2 m -60.68 -44.16 96.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 124.116 0.966 . . . . 0.0 112.067 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.456 ' OE2' ' HB ' ' A' ' 70' ' ' THR . 1.5 mp0 -89.62 3.98 50.89 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.126 0.488 . . . . 0.0 110.25 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.549 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 3.2 m -92.96 128.45 38.82 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.501 -175.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 16.6 pt-20 -78.69 159.19 28.11 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 122.74 0.416 . . . . 0.0 110.982 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.51 125.26 54.01 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 122.659 0.384 . . . . 0.0 110.583 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -124.19 131.09 24.17 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.416 ' HD2' ' HG3' ' A' ' 79' ' ' GLU . 24.2 Cg_exo -65.89 149.68 86.28 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 121.988 1.792 . . . . 0.0 110.014 173.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.412 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -71.91 -12.29 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.874 -0.516 . . . . 0.0 111.814 -176.481 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.4 p -78.02 -17.79 56.67 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.171 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.416 ' HG3' ' HD2' ' A' ' 76' ' ' PRO . 21.8 mm-40 -94.14 38.93 1.08 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.521 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -57.93 -29.5 65.18 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.053 0.941 . . . . 0.0 112.496 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.27 -20.76 60.03 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.374 0.606 . . . . 0.0 110.4 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.7 m -96.88 6.71 48.14 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.519 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.521 HG12 ' HA ' ' A' ' 80' ' ' ALA . 45.2 mm -77.43 123.03 86.86 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -56.22 130.39 39.92 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.976 2.451 . . . . 0.0 113.695 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.1 p -91.6 76.26 5.78 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.344 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.3 177.79 8.37 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.629 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.9 t -91.18 137.72 32.15 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.401 ' HA2' HG12 ' A' ' 131' ' ' VAL . . . 164.46 -149.56 16.65 Favored Glycine 0 N--CA 1.414 -2.833 0 C-N-CA 119.482 -1.342 . . . . 0.0 112.732 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.508 HG13 ' CH2' ' A' ' 146' ' ' TRP . 4.8 p -128.34 149.75 33.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -136.25 157.14 47.53 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.436 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . . . -127.69 114.83 17.84 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 123.775 0.83 . . . . 0.0 109.442 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.1 t -89.0 119.25 35.8 Favored 'Isoleucine or valine' 0 C--O 1.264 1.834 0 CA-C-O 120.944 0.402 . . . . 0.0 111.008 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 7.3 m-85 -103.35 127.18 50.76 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.165 0.986 . . . . 0.0 109.052 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -79.52 -168.54 1.58 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.555 0.693 . . . . 0.0 112.242 -173.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -57.7 -41.46 81.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.683 1.193 . . . . 0.0 109.993 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.8 t -84.83 12.11 7.99 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.841 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 70.94 20.17 5.45 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 32.7 mt-10 -103.62 148.83 25.54 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 118.865 -1.134 . . . . 0.0 112.211 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.422 HD23 ' HB1' ' A' ' 91' ' ' ALA . 2.1 tm? -80.02 117.72 21.11 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.813 174.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 158' ' ' PRO . 1.7 mp0 -113.85 -39.51 3.97 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.15 173.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -124.45 115.25 20.61 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.564 -1.254 . . . . 0.0 112.248 -171.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.409 HG23 ' NE1' ' A' ' 143' ' ' TRP . 22.3 m -98.55 147.22 7.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 172.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.19 147.79 17.94 Favored Glycine 0 C--N 1.283 -2.396 0 C-N-CA 118.876 -1.631 . . . . 0.0 112.418 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.4 pt -112.7 138.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 m -152.52 161.54 42.44 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 106' ' ' ARG . 16.0 tpt180 -81.68 -22.56 37.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.502 0.668 . . . . 0.0 109.875 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.439 HD22 ' H ' ' A' ' 110' ' ' ALA . 6.6 t30 -141.91 100.2 3.69 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.1 mt -48.61 -58.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.91 1.284 . . . . 0.0 113.528 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.63 -53.89 13.5 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' H ' HD22 ' A' ' 107' ' ' ASN . . . -59.47 -36.47 76.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.424 -177.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.4 t -76.11 -52.01 11.03 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.6 t -55.63 -54.45 25.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.429 0.691 . . . . 0.0 111.785 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 m -59.93 -47.77 84.43 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.405 0.44 . . . . 0.0 111.218 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.34 -55.2 36.58 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.257 24.1 p80 -76.84 -25.51 53.28 Favored 'General case' 0 C--O 1.216 -0.658 0 C-N-CA 118.516 -1.274 . . . . 0.0 113.959 -175.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 72.2 mt -77.91 -36.17 49.82 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.499 -0.88 . . . . 0.0 112.056 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -75.97 -19.12 58.99 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.451 -0.899 . . . . 0.0 110.645 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 57.3 m -80.3 -42.71 22.55 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.754 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -134.9 95.06 15.74 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 121.912 0.863 . . . . 0.0 110.804 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.74 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 83.1 Cg_endo -81.42 24.4 0.7 Allowed 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 123.418 2.745 . . . . 0.0 114.633 -174.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -67.41 -34.26 76.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.826 0.822 . . . . 0.0 110.254 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.8 mt -109.37 20.78 17.86 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.242 0.544 . . . . 0.0 110.549 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.74 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 67.5 m -81.14 84.06 6.64 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -122.93 -58.12 0.2 Allowed Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 174.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 12.4 p -163.18 169.19 19.68 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 123.652 0.781 . . . . 0.0 109.048 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.95 139.59 36.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-O 121.257 0.551 . . . . 0.0 109.852 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.549 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 89.4 mttt -106.34 132.51 52.3 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.72 139.18 45.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.274 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.95 101.21 0.61 Allowed Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.61 120.67 35.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.401 HG12 ' HA2' ' A' ' 88' ' ' GLY . 7.7 p -110.06 130.86 62.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -79.32 -19.08 51.24 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.09 0.471 . . . . 0.0 111.845 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -105.14 101.02 28.0 Favored Pre-proline 0 N--CA 1.435 -1.18 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -86.11 36.24 0.5 Allowed 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 123.061 2.507 . . . . 0.0 112.449 -173.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.69 137.37 54.08 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -61.25 -31.49 71.29 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 123.066 0.229 . . . . 0.0 111.475 -173.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.14 -35.27 66.47 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.814 0.34 . . . . 0.0 110.148 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 63.9 t -69.74 -41.44 79.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.316 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.8 mt -59.52 -48.12 82.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.064 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.7 m -64.58 -36.51 84.48 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.553 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.69 -52.29 63.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.083 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.43 -46.06 91.41 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.163 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.409 ' NE1' HG23 ' A' ' 102' ' ' VAL . 86.4 t90 -51.09 -48.84 61.57 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 123.944 0.778 . . . . 0.0 109.421 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.554 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 88.5 tttt -63.58 -57.17 10.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.072 -177.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.506 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 10.4 mp -58.32 -41.65 85.02 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.508 ' CH2' HG13 ' A' ' 89' ' ' VAL . 30.0 m0 -57.79 -52.35 65.83 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-O 120.739 0.304 . . . . 0.0 111.723 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.478 ' O ' HG13 ' A' ' 151' ' ' ILE . 14.5 tt -66.93 -39.07 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.765 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 53.0 mt-10 -60.65 -39.42 88.23 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 21.7 mm-40 -56.67 -44.49 81.45 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.97 0.414 . . . . 0.0 110.853 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -76.73 -30.26 56.54 Favored 'General case' 0 C--O 1.249 1.068 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.535 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 147' ' ' ILE . 74.7 mt -67.12 -45.7 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 122.23 0.212 . . . . 0.0 111.263 178.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -62.46 -38.68 90.75 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 149' ' ' GLU . 7.7 p -81.23 -54.63 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.417 HG23 HG13 ' A' ' 153' ' ' VAL . 69.2 p -105.82 -36.28 7.07 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.148 -173.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.68 17.95 57.45 Favored Glycine 0 C--N 1.311 -0.811 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.71 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -75.27 107.29 7.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 117.105 0.453 . . . . 0.0 109.82 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.2 106.75 33.15 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.406 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 13.1 Cg_endo -90.36 162.37 4.54 Favored 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 122.908 2.405 . . . . 0.0 112.913 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 162' ' ' LYS . 50.8 Cg_exo -60.66 -25.39 80.81 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.107 2.538 . . . . 0.0 112.844 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -64.87 -33.65 87.8 Favored Glycine 0 C--N 1.33 0.224 0 N-CA-C 114.348 0.499 . . . . 0.0 114.348 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.428 HD22 ' HA ' ' A' ' 161' ' ' ASN . 3.3 m120 -92.25 -19.55 22.07 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-O 121.454 0.645 . . . . 0.0 111.922 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 159' ' ' PRO . 7.8 mtpm? -70.55 130.99 43.29 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 173.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.2 m -55.33 109.78 0.59 Allowed 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -173.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 169.03 175.38 38.34 Favored Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -87.65 110.87 20.72 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.571 ' O ' ' HG2' ' A' ' 170' ' ' LYS . 28.2 t-20 -122.76 155.91 35.55 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.97 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.9 m -50.02 -32.74 16.03 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.665 1.186 . . . . 0.0 113.361 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -74.97 -19.54 60.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.41 ' O ' HD11 ' A' ' 173' ' ' LEU . 27.3 m -108.96 -12.67 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 120.805 0.336 . . . . 0.0 111.463 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 166' ' ' ASN . 13.1 ptmm? -106.43 85.21 2.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.062 0.934 . . . . 0.0 110.993 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 13.4 p -128.46 -136.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.499 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.7 m -41.45 -45.78 3.26 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.235 1.814 . . . . 0.0 112.844 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.41 HD11 ' O ' ' A' ' 169' ' ' VAL . 2.7 pp -64.15 -21.93 66.74 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -111.0 5.64 20.44 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.751 0.786 . . . . 0.0 111.212 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -81.8 -28.1 33.34 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 171.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -84.05 134.07 34.63 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -75.02 113.94 12.92 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -61.37 -28.82 69.51 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 123.877 0.735 . . . . 0.0 111.755 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 43.1 t60 58.16 31.18 20.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.294 1.038 . . . . 0.0 110.669 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 9.7 t60 . . . . . 0 C--N 1.301 -1.534 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 -178.564 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.512 -0.511 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.68 14.3 24.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.191 0.52 . . . . 0.0 110.228 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 130' ' ' ILE . 32.9 m -112.94 144.33 42.7 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 59.83 55.88 3.73 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.289 0.993 . . . . 0.0 109.427 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 t -92.02 137.78 21.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.482 -174.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -115.48 -51.91 2.67 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.2 p -107.28 156.72 18.57 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.98 -175.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.16 -24.17 66.6 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.37 1.068 . . . . 0.0 109.882 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.1 m -60.0 -26.88 66.4 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.218 1.007 . . . . 0.0 110.68 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -93.52 -10.42 34.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.385 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.484 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 3.1 m -81.13 126.15 31.12 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -172.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 12.3 pt-20 -79.85 155.45 27.82 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.916 0.388 . . . . 0.0 111.942 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -103.13 128.75 49.94 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 123.633 0.773 . . . . 0.0 109.873 -174.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -122.46 136.15 26.27 Favored Pre-proline 0 C--N 1.307 -1.255 0 C-N-CA 123.767 0.827 . . . . 0.0 109.212 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -73.52 140.02 29.31 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.355 2.037 . . . . 0.0 109.84 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.5 -11.24 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -174.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.8 t -71.41 -23.89 61.95 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.021 0.438 . . . . 0.0 110.308 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.96 53.79 0.68 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.208 1.004 . . . . 0.0 110.244 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.507 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -62.35 -22.11 65.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.177 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.85 -16.55 60.68 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.747 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.3 m -94.14 -1.9 53.51 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.099 0.476 . . . . 0.0 110.419 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 80' ' ' ALA . 43.4 mm -77.05 129.79 77.38 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.04 129.81 36.25 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.94 2.426 . . . . 0.0 113.236 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.5 p -90.81 65.77 5.87 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.633 0.73 . . . . 0.0 109.615 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.98 -177.88 4.83 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.999 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.3 t -99.03 143.34 29.42 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.37 -147.78 13.74 Favored Glycine 0 N--CA 1.415 -2.756 0 C-N-CA 119.462 -1.352 . . . . 0.0 112.725 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.512 HG13 ' CH2' ' A' ' 146' ' ' TRP . 5.0 p -127.34 149.0 32.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 C-N-CA 123.542 0.737 . . . . 0.0 109.235 -174.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -141.49 156.01 45.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 120.832 0.348 . . . . 0.0 110.197 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.46 121.08 33.88 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.299 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 50.2 t -96.88 119.03 44.41 Favored 'Isoleucine or valine' 0 C--O 1.259 1.557 0 CA-C-O 121.25 0.548 . . . . 0.0 110.582 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 47.3 m-85 -110.69 137.24 48.61 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.305 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 98' ' ' GLU . 2.8 p30 -80.58 -169.46 2.15 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.736 -0.785 . . . . 0.0 110.657 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -57.73 -23.78 53.68 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.371 1.069 . . . . 0.0 112.688 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.2 t -108.91 17.53 21.67 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 120.718 0.294 . . . . 0.0 111.143 -174.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.2 t70 66.71 20.78 10.67 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 123.028 1.394 . . . . 0.0 110.713 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.49 ' HB2' ' OD2' ' A' ' 94' ' ' ASP . 80.5 mm-40 -83.64 104.26 13.62 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.856 175.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.555 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.0 tm? -66.19 115.46 6.21 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 174.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.432 ' HB3' ' HG2' ' A' ' 158' ' ' PRO . 43.1 mt-30 -122.64 -13.5 7.94 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -148.17 125.4 11.51 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.169 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.492 HG13 HD11 ' A' ' 99' ' ' LEU . 21.9 m -117.08 143.77 26.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 171.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -150.66 157.58 27.26 Favored Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 119.693 -1.241 . . . . 0.0 112.249 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.2 pt -117.36 134.55 60.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.2 m -146.49 161.96 39.33 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.009 0.433 . . . . 0.0 111.574 -175.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -76.9 -34.25 57.73 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.255 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -132.71 109.31 9.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.8 mt -56.76 -58.14 6.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.774 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.85 -50.26 64.12 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.1 -50.27 72.61 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.569 0.543 . . . . 0.0 111.193 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.4 t -63.3 -52.14 63.17 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.213 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.5 t -55.54 -53.94 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 C-N-CA 123.012 0.525 . . . . 0.0 110.529 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.3 m -58.32 -47.49 83.55 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 123.792 0.683 . . . . 0.0 111.381 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.58 -58.18 8.87 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 123.483 0.489 . . . . 0.0 111.617 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -72.13 -26.4 62.1 Favored 'General case' 0 C--O 1.209 -1.066 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.8 mt -74.78 -28.01 60.56 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.416 -0.913 . . . . 0.0 111.159 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -87.08 -3.75 59.1 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.433 0.635 . . . . 0.0 110.483 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.9 m -95.28 -51.07 4.75 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.16 97.95 27.84 Favored Pre-proline 0 N--CA 1.428 -1.539 0 CA-C-O 121.597 0.713 . . . . 0.0 111.108 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.807 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 6.5 Cg_exo -77.53 24.64 0.5 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.66 2.907 . . . . 0.0 113.156 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -62.17 -41.39 98.27 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.301 1.04 . . . . 0.0 110.72 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.3 mt -119.94 21.19 11.99 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.099 -172.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.807 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 72.9 m -74.27 88.99 2.03 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.169 0.509 . . . . 0.0 112.276 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.39 -55.18 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.4 p -161.97 161.6 28.68 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.6 p -139.75 139.28 38.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 120.982 0.42 . . . . 0.0 110.372 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.484 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 63.0 mttm -108.03 129.72 55.11 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 26.2 m -120.16 139.35 47.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.884 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.24 114.44 1.64 Allowed Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 64' ' ' SER . 2.7 mp -90.66 113.42 26.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.6 p -101.25 142.46 15.97 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -88.46 -5.61 58.14 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.204 0.526 . . . . 0.0 111.907 -171.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -125.93 92.27 46.45 Favored Pre-proline 0 N--CA 1.43 -1.445 0 CA-C-O 121.683 0.754 . . . . 0.0 109.222 174.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.39 46.75 1.89 Allowed 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 123.617 2.878 . . . . 0.0 111.892 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -80.54 141.53 35.03 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -53.26 -39.34 63.8 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.66 -38.53 64.92 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.486 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.9 t -70.52 -40.39 77.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.957 0.408 . . . . 0.0 110.149 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 92.6 mt -61.1 -48.03 83.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.347 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 36.4 m -68.47 -30.61 69.51 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.913 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.519 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 58.4 tt0 -62.93 -54.13 43.3 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.82 96.82 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 123.932 0.77 . . . . 0.0 109.869 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.459 ' NE1' HG23 ' A' ' 102' ' ' VAL . 89.9 t90 -52.31 -49.31 64.45 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.923 0.764 . . . . 0.0 109.755 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -63.03 -47.08 84.56 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.416 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.572 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 80.5 mt -59.2 -49.54 77.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.079 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.512 ' CH2' HG13 ' A' ' 89' ' ' VAL . 26.0 m0 -62.56 -48.26 80.27 Favored 'General case' 0 C--O 1.256 1.402 0 O-C-N 123.995 0.81 . . . . 0.0 112.068 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.599 ' O ' HG12 ' A' ' 151' ' ' ILE . 9.1 tt -63.01 -43.25 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.364 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.522 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 31.9 mt-10 -60.42 -29.91 69.29 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 6.6 mm-40 -59.68 -49.31 78.22 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.443 ' HA ' HG22 ' A' ' 153' ' ' VAL 0.259 17.2 m-70 -78.5 -22.08 47.96 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -178.585 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 147' ' ' ILE . 48.3 mm -60.51 -42.6 91.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 148' ' ' GLU . 39.9 mttm -81.6 -46.34 14.55 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.176 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 149' ' ' GLU . 30.7 m -78.73 -46.49 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.4 p -110.88 -6.56 14.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 119.04 -1.064 . . . . 0.0 112.697 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.42 26.12 70.48 Favored Glycine 0 C--N 1.336 0.541 0 O-C-N 123.742 0.651 . . . . 0.0 113.803 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -91.36 109.02 20.29 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.18 0.514 . . . . 0.0 112.041 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 t -131.41 78.94 70.79 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.432 ' HG2' ' HB3' ' A' ' 100' ' ' GLN . 5.0 Cg_endo -90.4 160.53 4.51 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.177 2.585 . . . . 0.0 112.426 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.54 -34.27 19.68 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 124.354 3.37 . . . . 0.0 115.047 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -69.34 -27.38 73.67 Favored Glycine 0 CA--C 1.501 -0.833 0 C-N-CA 121.375 -0.44 . . . . 0.0 112.595 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.416 ' ND2' HD12 ' A' ' 147' ' ' ILE . 0.2 OUTLIER -103.39 -20.41 14.09 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.244 0.545 . . . . 0.0 109.75 -177.092 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -75.73 -69.01 0.52 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.8 p -92.85 155.15 17.81 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -78.68 78.22 1.68 Allowed Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.496 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -64.62 120.05 11.65 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -56.15 -33.51 65.28 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 124.298 1.039 . . . . 0.0 112.514 -173.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.2 m -64.49 -34.56 78.49 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 120.806 0.336 . . . . 0.0 110.85 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.41 -56.53 3.27 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.75 -32.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp 60.06 12.5 3.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.681 1.192 . . . . 0.0 114.014 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.03 0.76 10.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 CA-C-O 122.873 1.32 . . . . 0.0 108.872 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 4.9 m -99.33 66.94 1.53 Allowed 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.758 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.549 HD13 ' H ' ' A' ' 173' ' ' LEU . 0.0 OUTLIER -60.79 110.0 1.2 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.773 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 70.15 -62.12 0.44 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.727 1.611 . . . . 0.0 111.122 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -141.09 178.18 7.55 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 125.053 1.341 . . . . 0.0 108.027 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -63.01 116.11 5.02 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -79.21 139.48 37.94 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.246 0.546 . . . . 0.0 111.292 -175.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -111.22 103.45 11.87 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.081 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 78.3 t60 66.62 88.22 0.11 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.114 0.884 . . . . 0.0 112.165 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 3.0 t60 . . . . . 0 C--N 1.314 -0.935 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.468 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.466 0.372 0 CA-C-O 120.444 0.164 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -126.61 -21.55 4.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.981 0.42 . . . . 0.0 110.278 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.2 t -140.84 -68.72 0.4 Allowed 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 38.84 96.52 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.725 1.61 . . . . 0.0 115.068 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.43 110.16 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.068 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -56.11 -60.49 3.41 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -168.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.51 ' HB2' ' OE1' ' A' ' 149' ' ' GLU . 36.9 p -149.65 170.3 19.01 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.98 -176.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.48 HD22 ' HD2' ' A' ' 127' ' ' LYS . 17.8 mt -71.4 -23.45 61.88 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 123.423 0.689 . . . . 0.0 110.31 177.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 m -63.6 -25.51 68.26 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.862 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -102.7 8.08 39.61 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.1 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.405 ' HB ' ' HD3' ' A' ' 127' ' ' LYS . 22.5 m -103.57 141.06 36.67 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 122.001 -0.437 . . . . 0.0 110.768 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.01 151.41 35.62 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-O 120.921 0.391 . . . . 0.0 111.116 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -107.0 133.17 52.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.678 -173.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.33 132.07 24.31 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 123.312 0.645 . . . . 0.0 109.551 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -70.47 139.41 37.72 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.333 2.022 . . . . 0.0 109.48 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.76 -7.05 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -174.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 t -69.7 -31.13 68.99 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.103 0.478 . . . . 0.0 109.726 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -98.49 53.68 1.04 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.901 0.858 . . . . 0.0 109.767 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.94 -28.62 57.75 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.842 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.36 -33.17 65.44 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.245 1.018 . . . . 0.0 111.627 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.8 m -96.88 12.59 31.69 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -172.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.6 mm -80.93 128.13 72.38 Favored Pre-proline 0 N--CA 1.446 -0.642 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.73 130.74 40.15 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.143 2.562 . . . . 0.0 114.128 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.1 p -92.97 31.68 1.38 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 122.178 0.99 . . . . 0.0 110.655 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.75 -179.09 3.84 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.114 -177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 t -93.6 147.86 22.62 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.59 -150.09 21.19 Favored Glycine 0 N--CA 1.419 -2.488 0 C-N-CA 119.692 -1.242 . . . . 0.0 112.686 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.611 HG12 HG22 ' A' ' 104' ' ' ILE . 2.5 m -115.42 149.02 17.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 124.336 1.055 . . . . 0.0 109.55 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -144.22 160.24 41.31 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.408 ' HB1' ' CD2' ' A' ' 99' ' ' LEU . . . -141.02 131.68 25.6 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.707 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.1 t -106.61 126.84 62.4 Favored 'Isoleucine or valine' 0 C--O 1.26 1.615 0 CA-C-O 121.097 0.475 . . . . 0.0 110.669 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -113.19 135.13 54.16 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.469 1.107 . . . . 0.0 108.551 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -85.56 -170.26 3.03 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.553 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.501 ' H ' ' HD2' ' A' ' 95' ' ' LYS . 6.7 mptt -63.06 -25.38 68.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.76 0.824 . . . . 0.0 111.372 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.3 m -82.39 4.78 22.68 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.112 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.5 t70 69.77 19.16 7.28 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.474 1.11 . . . . 0.0 111.621 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -111.12 147.09 35.63 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.596 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.455 HD11 HG13 ' A' ' 102' ' ' VAL . 2.8 tm? -78.27 125.85 29.94 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.264 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -127.92 -13.84 5.12 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 123.925 0.766 . . . . 0.0 112.634 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.457 ' HA ' ' OD1' ' A' ' 161' ' ' ASN . 92.5 t80 -147.63 120.66 8.81 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.515 -0.874 . . . . 0.0 112.741 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.455 HG13 HD11 ' A' ' 99' ' ' LEU . 17.5 m -109.95 142.11 23.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 170.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -146.36 167.76 27.93 Favored Glycine 0 C--N 1.294 -1.759 0 C-N-CA 119.987 -1.101 . . . . 0.0 112.422 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.611 HG22 HG12 ' A' ' 89' ' ' VAL . 15.0 pt -125.86 147.98 30.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.4 t -157.17 164.08 38.17 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.113 0.483 . . . . 0.0 110.032 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.1 -17.9 24.32 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -142.81 87.09 1.97 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 77.7 mt -47.24 -54.94 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.483 1.113 . . . . 0.0 113.231 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.27 -30.57 12.13 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.54 -57.91 3.67 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -176.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.2 m -60.56 -43.95 96.69 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.462 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.7 t -58.48 -60.19 2.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.075 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.6 m -60.73 -44.01 97.18 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 123.827 0.705 . . . . 0.0 110.813 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.418 ' HB1' ' HD3' ' A' ' 170' ' ' LYS . . . -60.39 -50.69 72.57 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.114 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -77.05 -25.27 52.25 Favored 'General case' 0 C--O 1.204 -1.305 0 C-N-CA 118.343 -1.343 . . . . 0.0 112.056 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 64.2 mt -73.93 -28.66 61.63 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.612 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.39 -7.41 59.31 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.294 175.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.7 m -90.01 -52.96 4.7 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.9 m -117.65 102.4 51.7 Favored Pre-proline 0 N--CA 1.435 -1.193 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.817 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 16.4 Cg_exo -73.33 4.03 4.2 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.858 2.372 . . . . 0.0 110.575 173.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -55.83 -44.36 77.87 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 125.328 1.451 . . . . 0.0 111.0 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 75.1 mt -105.35 11.15 33.11 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.407 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.817 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 90.4 m -67.95 96.66 0.61 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.621 0.724 . . . . 0.0 111.873 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.4 -63.31 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.569 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 174.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.3 p -155.64 162.13 40.66 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.35 137.83 33.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.48 ' HD2' HD22 ' A' ' 69' ' ' LEU . 97.4 mttt -108.22 142.21 38.82 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.68 137.57 56.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 120.698 0.285 . . . . 0.0 110.904 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.73 108.92 0.83 Allowed Glycine 0 N--CA 1.423 -2.223 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.51 113.4 23.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 133' ' ' GLU . 7.4 p -100.98 132.32 46.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -69.02 -27.29 65.54 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.9 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.426 ' HB3' HG21 ' A' ' 138' ' ' VAL . 41.1 mt-10 -85.01 110.7 30.35 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -97.07 19.0 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.752 2.301 . . . . 0.0 113.607 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.503 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 14.8 t70 -72.97 140.09 47.16 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -57.93 -33.12 68.46 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.61 -38.73 47.47 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.187 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 135' ' ' ASP . 10.5 m -71.3 -31.96 45.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.316 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.2 mt -62.36 -46.1 90.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.1 m -69.34 -30.59 68.66 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.43 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.491 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 29.7 tt0 -66.68 -47.43 72.46 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 122.781 0.433 . . . . 0.0 110.778 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.22 90.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -50.88 -45.47 60.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.5 1.12 . . . . 0.0 110.027 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.75 -48.09 83.36 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.645 1.178 . . . . 0.0 111.31 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 69.6 mt -63.77 -41.57 97.94 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.128 0.489 . . . . 0.0 110.543 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -62.24 -50.62 71.0 Favored 'General case' 0 C--O 1.257 1.499 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.971 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 151' ' ' ILE . 14.1 tt -66.71 -40.73 86.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.285 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -65.38 -34.44 78.31 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.51 ' OE1' ' HB2' ' A' ' 68' ' ' SER . 3.8 pt-20 -63.12 -37.36 86.91 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 118.282 -1.367 . . . . 0.0 109.225 176.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.443 ' HA ' HG12 ' A' ' 153' ' ' VAL 0.263 72.8 m-70 -73.91 -31.91 63.3 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 177.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 147' ' ' ILE . 71.1 mt -61.35 -38.27 79.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 174.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' A' ' 149' ' ' GLU . 59.4 pttt -83.0 -20.96 34.08 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 149' ' ' GLU . 12.6 p -101.75 -41.42 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.9 t -113.16 -19.33 11.87 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.546 -0.721 . . . . 0.0 111.714 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.58 8.61 82.78 Favored Glycine 0 C--O 1.239 0.44 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.449 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -76.91 128.32 34.33 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.8 p -158.6 77.37 3.3 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 113.192 -1.822 . . . . 0.0 106.725 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -83.42 167.55 13.5 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.925 3.083 . . . . 0.0 113.893 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.565 ' HA ' ' HB2' ' A' ' 162' ' ' LYS . 11.3 Cg_endo -54.18 -13.82 5.49 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 125.184 3.923 . . . . 0.0 115.475 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -70.85 -42.29 61.11 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 175.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' A' ' 101' ' ' PHE . 18.9 m120 -91.61 -30.77 16.17 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-O 121.007 0.432 . . . . 0.0 110.985 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 159' ' ' PRO . 56.0 mtpt -72.8 161.42 30.75 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 172.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.1 m -76.2 101.23 5.31 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.95 -61.03 0.02 OUTLIER Glycine 0 N--CA 1.426 -2.03 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.017 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -125.61 128.25 47.59 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 117.048 0.424 . . . . 0.0 111.693 -174.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -92.47 -12.18 32.71 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 15.8 m -60.94 -16.8 46.58 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-O 121.713 0.768 . . . . 0.0 112.217 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -82.94 -13.72 55.51 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.547 -0.72 . . . . 0.0 111.612 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.24 -33.48 2.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.418 ' HD3' ' HB1' ' A' ' 114' ' ' ALA . 57.4 tttp 77.01 135.79 0.06 Allowed 'General case' 0 C--O 1.243 0.75 0 C-N-CA 126.197 1.799 . . . . 0.0 109.84 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 32.8 t -83.3 80.56 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.709 0.766 . . . . 0.0 110.224 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 12.9 p -115.07 -47.67 2.85 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.701 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 76.07 -179.78 0.16 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.0 1.32 . . . . 0.0 112.509 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -42.12 95.26 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -95.66 95.16 8.16 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 168.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -56.79 99.15 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -168.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -100.6 169.23 9.19 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.492 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -108.68 106.84 17.06 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -125.29 -70.21 0.76 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.038 0.447 . . . . 0.0 110.126 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 . . . . . 0 C--N 1.303 -1.425 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.467 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 CA--C 1.496 -1.108 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.28 150.02 40.81 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.5 m -77.09 115.85 17.23 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 79.46 145.62 0.09 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.136 1.374 . . . . 0.0 111.704 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 t -59.43 136.2 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.917 0.887 . . . . 0.0 110.984 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -86.52 -77.48 0.31 Allowed 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.5 p -120.63 176.24 5.61 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.34 -33.0 70.6 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.114 1.366 . . . . 0.0 112.379 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -67.19 -16.25 64.19 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.902 0.858 . . . . 0.0 110.508 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -109.23 13.13 24.54 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.343 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.402 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 13.2 m -105.05 155.28 19.13 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.731 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -94.88 151.61 19.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 125' ' ' SER . 3.1 tm? -104.59 133.22 49.82 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.396 0.617 . . . . 0.0 110.661 -174.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.4 HD23 HG22 ' A' ' 128' ' ' VAL . 3.8 mm? -127.91 136.19 28.63 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 115.098 -0.955 . . . . 0.0 108.601 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -71.16 140.84 38.33 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.209 1.939 . . . . 0.0 109.405 172.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.67 -11.65 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.105 0.478 . . . . 0.0 111.51 -174.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.9 p -68.51 -39.58 81.18 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.09 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -96.95 54.13 1.25 Allowed 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.342 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.531 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -61.9 -17.57 57.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.746 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.78 -23.79 64.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.585 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.9 m -88.69 -0.57 57.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.631 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.531 HG12 ' HA ' ' A' ' 80' ' ' ALA . 45.3 mm -77.82 133.91 65.46 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -56.21 129.61 35.75 Favored 'Trans proline' 0 C--O 1.251 1.155 0 C-N-CA 122.196 1.93 . . . . 0.0 112.413 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.8 p -95.13 70.86 3.28 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 121.873 0.844 . . . . 0.0 108.995 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.06 -176.34 5.05 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.064 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.6 t -97.68 134.82 40.35 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.977 0.418 . . . . 0.0 110.099 -173.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.34 -152.17 19.9 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.517 HG13 ' CH2' ' A' ' 146' ' ' TRP . 6.2 p -124.71 147.34 29.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -177.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -135.95 151.89 50.41 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 120.756 0.312 . . . . 0.0 110.223 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.08 123.16 41.68 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.081 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.5 t -95.46 118.35 41.47 Favored 'Isoleucine or valine' 0 C--O 1.263 1.773 0 C-N-CA 123.387 0.675 . . . . 0.0 110.32 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.501 ' CE1' ' HB2' ' A' ' 99' ' ' LEU . 96.8 m-85 -106.91 134.53 49.93 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.113 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.496 ' O ' ' HA3' ' A' ' 124' ' ' GLY . 3.9 p-10 -78.64 -166.96 0.96 Allowed 'General case' 0 C--N 1.317 -0.822 0 O-C-N 123.666 0.604 . . . . 0.0 111.116 -175.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 123' ' ' CYS . 75.4 mmtt -53.0 -34.57 56.84 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.719 1.208 . . . . 0.0 111.311 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.5 m -82.31 -2.93 54.26 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.192 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.9 t70 67.44 23.44 9.08 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.677 1.191 . . . . 0.0 108.297 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.457 ' OE1' HG21 ' A' ' 154' ' ' THR . 0.1 OUTLIER -99.67 158.71 15.58 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.501 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 3.5 tm? -97.71 124.57 42.09 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.69 0.757 . . . . 0.0 111.612 -169.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.508 HE21 ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -119.75 -45.91 2.48 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.738 173.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -124.88 134.63 52.63 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.525 -173.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.498 HG23 ' NE1' ' A' ' 143' ' ' TRP . 17.4 m -126.2 145.2 34.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -150.95 155.76 26.32 Favored Glycine 0 N--CA 1.42 -2.379 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.964 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.8 pt -110.56 139.14 35.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.0 t -142.93 155.03 44.64 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.358 0.599 . . . . 0.0 110.664 -175.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -87.04 -26.29 23.8 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -142.93 84.74 1.85 Allowed 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 69.5 mt -44.47 -58.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.245 1.418 . . . . 0.0 114.767 -172.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.2 -44.48 22.37 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.13 -34.29 76.08 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.2 t -79.53 -45.81 18.56 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.9 -53.54 36.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.066 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.4 p -61.63 -44.83 96.25 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 123.47 0.481 . . . . 0.0 111.625 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.13 -61.3 2.56 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -78.14 -23.78 47.61 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 119.014 -1.074 . . . . 0.0 113.827 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.419 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 80.7 mt -81.83 -30.7 32.02 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.413 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -88.21 -9.88 51.58 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.04 -1.064 . . . . 0.0 109.826 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.3 t -82.94 -47.37 11.85 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.34 95.14 18.56 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-O 121.765 0.793 . . . . 0.0 110.339 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.807 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 2.8 Cg_exo -76.65 24.47 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.64 2.893 . . . . 0.0 114.499 -176.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.57 -42.47 82.53 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.428 0.632 . . . . 0.0 111.078 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 75.4 mt -102.95 21.27 15.97 Favored 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.558 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.807 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 84.0 m -85.81 105.03 16.03 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 94' ' ' ASP . . . -137.81 -58.95 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 173.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.471 ' HB2' HD21 ' A' ' 74' ' ' LEU . 56.9 p -156.4 169.09 25.4 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.1 p -142.09 133.97 26.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.092 0.472 . . . . 0.0 109.924 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.402 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 56.4 mttp -106.94 125.83 51.52 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.4 HG22 HD23 ' A' ' 75' ' ' LEU . 28.5 m -113.34 135.22 53.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.254 0.549 . . . . 0.0 111.286 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.77 98.31 0.67 Allowed Glycine 0 N--CA 1.414 -2.798 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.373 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 40.5 mm -75.75 112.44 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.101 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.5 m -98.39 145.95 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.113 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -71.26 -36.94 71.92 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.208 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.49 ' HB2' HG11 ' A' ' 138' ' ' VAL . 18.8 mm-40 -92.39 105.09 12.85 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -93.76 27.78 0.32 Allowed 'Trans proline' 0 C--O 1.243 0.748 0 C-N-CA 122.737 2.291 . . . . 0.0 113.352 -174.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.456 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 15.7 t70 -89.98 144.12 26.19 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -53.38 -34.31 57.17 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.51 68.68 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.49 HG11 ' HB2' ' A' ' 133' ' ' GLU . 21.8 t -69.78 -34.72 61.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.762 -175.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 96.6 mt -62.17 -53.44 55.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.156 175.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.5 m -66.9 -30.48 70.64 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.326 0.584 . . . . 0.0 110.373 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -65.01 -50.91 64.43 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 123.656 0.782 . . . . 0.0 109.425 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.42 -43.61 98.57 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.498 ' NE1' HG23 ' A' ' 102' ' ' VAL . 79.6 t90 -52.73 -46.66 67.51 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.119 176.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -66.79 -44.88 80.1 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.211 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.552 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 11.1 mp -61.14 -41.77 97.33 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.151 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.517 ' CH2' HG13 ' A' ' 89' ' ' VAL . 33.6 m0 -62.38 -50.66 70.69 Favored 'General case' 0 C--O 1.254 1.314 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 151' ' ' ILE . 8.9 tt -62.51 -40.73 89.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.382 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.37 -32.49 74.16 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 22.3 mm-40 -56.12 -41.63 75.57 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.724 0.773 . . . . 0.0 109.96 175.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.415 ' HA ' HG12 ' A' ' 153' ' ' VAL 0.321 5.4 m-70 -83.46 -26.37 30.35 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.297 -1.361 . . . . 0.0 113.768 176.18 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 147' ' ' ILE . 73.6 mt -61.22 -42.61 94.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 O-C-N 121.974 -0.454 . . . . 0.0 110.372 173.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -69.43 -34.7 74.82 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 150' ' ' HIS . 12.1 p -92.01 -40.81 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.457 HG21 ' OE1' ' A' ' 98' ' ' GLU . 3.7 t -118.55 -35.28 3.78 Favored 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -176.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 74.76 34.3 53.65 Favored Glycine 0 N--CA 1.47 0.962 0 C-N-CA 120.429 -0.891 . . . . 0.0 114.207 175.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -65.23 -66.37 0.55 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.28 12.2 p 41.13 75.99 0.55 Allowed Pre-proline 0 CA--C 1.573 1.859 0 C-N-CA 125.002 1.321 . . . . 0.0 113.951 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -90.72 161.49 4.19 Favored 'Trans proline' 0 CA--C 1.556 1.603 0 C-N-CA 123.245 2.63 . . . . 0.0 114.085 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -50.38 -34.12 39.98 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 124.435 3.423 . . . . 0.0 114.472 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 165' ' ' ASN . . . -59.35 -45.33 95.62 Favored Glycine 0 CA--C 1.495 -1.194 0 CA-C-O 121.121 0.29 . . . . 0.0 112.762 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.76 -25.75 53.76 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.42 1.105 . . . . 0.0 108.715 -174.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -83.77 0.8 45.83 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.333 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.0 m 68.83 13.8 8.88 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.525 1.13 . . . . 0.0 111.854 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -80.06 -23.42 61.48 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.463 ' HB3' ' HA2' ' A' ' 160' ' ' GLY . 24.5 t30 -105.89 112.79 25.99 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -73.06 -25.93 61.09 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.046 -174.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.3 m -48.77 -35.27 13.94 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -171.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 -72.04 -21.3 61.55 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.2 m -124.62 13.23 4.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.481 0.658 . . . . 0.0 110.086 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -87.5 33.4 0.7 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.925 0.869 . . . . 0.0 110.128 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.75 90.76 2.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 4.9 m -145.63 123.27 11.81 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -80.31 -69.61 0.58 Allowed 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.57 151.92 22.61 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -80.14 144.61 32.9 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 121.172 -0.211 . . . . 0.0 110.767 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -70.78 110.04 5.33 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -91.29 169.51 10.75 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.695 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 41.9 m80 76.69 179.42 0.16 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.837 1.255 . . . . 0.0 109.077 -173.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -97.25 90.82 5.25 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 75.9 t60 . . . . . 0 C--N 1.304 -1.402 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.436 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.5 ttm . . . . . 0 CA--C 1.506 -0.741 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -158.61 -179.0 7.68 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.5 m -144.65 73.69 1.38 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 64.01 -173.91 0.17 Allowed 'General case' 0 C--O 1.245 0.855 0 CA-C-N 114.299 -1.318 . . . . 0.0 111.125 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.1 t -76.73 126.47 37.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.39 -77.49 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.323 0.582 . . . . 0.0 111.578 -174.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.516 ' HA ' ' CD1' ' A' ' 146' ' ' TRP . 70.1 m -147.89 -178.78 6.46 Favored 'General case' 0 N--CA 1.413 -2.278 0 O-C-N 122.001 -0.437 . . . . 0.0 110.495 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -54.44 -24.75 21.39 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.785 1.634 . . . . 0.0 113.725 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.1 m -66.56 -29.14 69.15 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.103 0.478 . . . . 0.0 111.296 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -107.74 11.24 28.5 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.522 0.677 . . . . 0.0 110.911 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.402 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 10.1 m -97.17 136.03 38.27 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.409 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 12.6 pt-20 -74.45 149.59 40.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.705 0.288 . . . . 0.0 111.148 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -112.99 126.2 55.23 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.351 0.66 . . . . 0.0 109.294 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.98 135.11 24.57 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -71.63 138.68 32.6 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.256 1.971 . . . . 0.0 109.189 172.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.4 -8.78 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.262 -176.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.0 t -67.35 -23.04 65.56 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -112.93 53.26 0.76 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.408 ' O ' HG12 ' A' ' 83' ' ' ILE . . . -58.12 -22.81 52.57 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.724 1.21 . . . . 0.0 112.413 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.23 -28.09 69.5 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.369 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.6 t -88.6 9.37 24.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.885 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 80' ' ' ALA . 37.5 mm -80.31 129.05 70.88 Favored Pre-proline 0 C--N 1.314 -0.955 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.43 130.29 39.79 Favored 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.982 2.455 . . . . 0.0 113.34 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.5 p -92.39 80.18 4.94 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.282 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.81 -179.44 6.99 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.469 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.9 t -100.82 134.74 43.35 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.61 -150.2 14.69 Favored Glycine 0 N--CA 1.418 -2.53 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.33 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.53 HG13 ' CH2' ' A' ' 146' ' ' TRP . 7.6 p -122.86 149.78 26.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -137.85 155.3 49.13 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.25 115.58 20.61 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 123.518 0.727 . . . . 0.0 109.559 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.4 t -91.6 121.51 42.14 Favored 'Isoleucine or valine' 0 C--O 1.258 1.528 0 CA-C-O 121.097 0.475 . . . . 0.0 110.944 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.521 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 61.8 m-85 -109.86 131.66 54.86 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 124.154 0.982 . . . . 0.0 108.651 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.501 ' OD1' ' HB2' ' A' ' 98' ' ' GLU . 1.3 p-10 -78.64 -168.16 1.31 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.53 ' H ' ' HD2' ' A' ' 95' ' ' LYS . 8.6 mptt -64.18 -24.92 67.85 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 123.168 0.587 . . . . 0.0 110.812 -176.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.0 m -81.91 2.2 31.64 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.025 0.53 . . . . 0.0 112.065 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.2 t70 68.92 24.76 6.26 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 123.419 1.58 . . . . 0.0 108.866 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.501 ' HB2' ' OD1' ' A' ' 94' ' ' ASP . 24.0 mm-40 -96.73 115.53 27.59 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.689 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.521 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 2.4 tm? -68.68 113.14 5.9 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 173.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.514 ' HB3' ' HG2' ' A' ' 158' ' ' PRO . 22.0 mt-30 -125.31 -13.21 6.71 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.692 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -146.57 114.96 6.7 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.563 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.549 HG21 ' HB ' ' A' ' 147' ' ' ILE . 27.4 m -103.41 149.86 7.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 172.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -160.35 152.47 23.24 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 119.502 -1.333 . . . . 0.0 112.419 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.411 HG22 ' HB ' ' A' ' 89' ' ' VAL . 20.5 pt -112.78 140.51 32.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.0 m -150.89 169.57 21.41 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -76.93 -42.96 37.25 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.455 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -138.8 98.55 3.58 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 65.1 mt -44.13 -57.41 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 125.05 1.34 . . . . 0.0 114.23 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.3 -41.94 63.36 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.76 -41.74 74.77 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.052 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.471 ' HA ' HG23 ' A' ' 171' ' ' VAL . 34.3 t -66.04 -49.05 69.06 Favored 'General case' 0 C--O 1.254 1.302 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.814 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 72.6 t -57.38 -53.51 42.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.097 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.1 t -62.92 -35.65 80.79 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.362 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.13 -61.77 2.32 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.95 -0.469 . . . . 0.0 112.019 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -79.29 -22.99 43.87 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.413 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 67.8 mt -76.63 -25.34 53.73 Favored 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.403 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -87.75 -18.67 28.91 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.822 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.8 m -74.41 -47.1 35.91 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -138.99 95.07 9.67 Favored Pre-proline 0 CA--C 1.554 1.12 0 CA-C-O 121.807 0.813 . . . . 0.0 110.28 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.598 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 11.7 Cg_exo -74.07 24.13 0.35 Allowed 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 123.859 3.039 . . . . 0.0 115.036 -176.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -65.27 -43.37 91.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.33 0.586 . . . . 0.0 109.87 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.2 mt -99.4 19.91 14.7 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.167 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.598 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 98.3 m -74.01 94.25 2.34 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.347 0.594 . . . . 0.0 111.722 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.84 -68.01 0.06 OUTLIER Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.4 p -159.71 163.26 34.9 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.72 140.7 40.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 120.963 0.411 . . . . 0.0 110.341 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 92.2 mttt -106.11 126.35 52.1 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.6 m -113.38 133.84 57.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.007 0.432 . . . . 0.0 111.405 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -124.82 101.54 0.66 Allowed Glycine 0 N--CA 1.417 -2.596 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -84.72 109.67 18.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.33 164.36 2.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.135 -173.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -59.39 -62.74 1.65 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.775 0.672 . . . . 0.0 110.937 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -99.92 146.55 32.09 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -82.31 32.47 0.52 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 122.405 2.07 . . . . 0.0 109.92 172.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.499 ' HB3' HG22 ' A' ' 138' ' ' VAL . 13.5 t70 -77.01 135.36 38.66 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.653 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -58.81 -31.63 68.63 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.31 -46.04 51.92 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.481 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.499 HG22 ' HB3' ' A' ' 135' ' ' ASP . 11.9 m -68.42 -32.65 56.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.756 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 94.5 mt -65.25 -51.3 61.69 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.903 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.4 m -65.65 -35.32 80.46 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.721 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.508 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 28.2 tt0 -61.67 -52.67 63.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.47 -42.39 99.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.545 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.482 ' NE1' HG23 ' A' ' 102' ' ' VAL . 84.6 t90 -53.5 -50.95 64.3 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.476 0.71 . . . . 0.0 109.497 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 58.9 tttm -59.97 -52.56 64.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.387 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.593 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 85.5 mt -58.54 -49.76 76.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.376 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.53 ' CH2' HG13 ' A' ' 89' ' ' VAL . 41.8 m0 -59.32 -48.77 80.36 Favored 'General case' 0 C--O 1.249 1.038 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.549 ' HB ' HG21 ' A' ' 102' ' ' VAL . 12.6 tt -63.42 -42.75 97.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.795 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.629 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 45.2 mt-10 -62.68 -33.31 74.82 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.72 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 20.6 mm-40 -55.92 -51.06 68.96 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.311 0.577 . . . . 0.0 110.447 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.485 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 2.7 t60 -77.89 -21.19 51.61 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.281 -175.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 147' ' ' ILE . 68.1 mt -68.99 -32.28 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.189 0.519 . . . . 0.0 109.889 175.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 148' ' ' GLU . 74.9 mmtt -77.71 -48.27 17.1 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.058 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 150' ' ' HIS . 7.7 p -71.28 -56.8 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 47.0 p -106.16 -27.59 10.98 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.339 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 151' ' ' ILE . . . 98.11 31.84 6.39 Favored Glycine 0 CA--C 1.502 -0.777 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.947 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -94.25 101.81 13.8 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.8 p -129.45 79.24 74.29 Favored Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.514 ' HG2' ' HB3' ' A' ' 100' ' ' GLN . 4.2 Cg_exo -84.47 165.88 12.31 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.6 2.867 . . . . 0.0 113.738 -172.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 162' ' ' LYS . 81.0 Cg_exo -47.87 -27.77 8.99 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 124.889 3.726 . . . . 0.0 114.807 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -63.86 -39.83 97.77 Favored Glycine 0 CA--C 1.523 0.548 0 O-C-N 123.305 0.378 . . . . 0.0 112.473 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 161' ' ' ASN . 2.4 m120 -94.65 -20.82 19.24 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 121.042 0.448 . . . . 0.0 111.202 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.417 ' HB2' ' HA ' ' A' ' 159' ' ' PRO . 62.2 mtpt -76.53 171.43 14.65 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.802 174.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 6.8 m -78.57 141.46 38.08 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.01 -11.79 11.65 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.202 -0.999 . . . . 0.0 114.112 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -114.5 129.71 56.68 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 117.621 0.71 . . . . 0.0 110.546 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -113.61 -8.89 13.27 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.984 0.421 . . . . 0.0 109.882 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.9 m -59.8 -43.38 94.47 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 122.834 0.454 . . . . 0.0 111.397 -176.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -87.24 -14.03 42.16 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.882 0.372 . . . . 0.0 111.292 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.5 t -95.0 -9.71 9.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.553 0.692 . . . . 0.0 110.169 -176.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 174' ' ' GLU . 39.7 tttm -77.09 79.58 3.62 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.761 0.791 . . . . 0.0 110.962 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' A' ' 111' ' ' SER . 3.9 p -104.3 -33.36 3.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.792 173.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 14.9 t -128.53 146.98 50.67 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 68.31 164.42 0.23 Allowed 'General case' 0 C--O 1.245 0.829 0 CA-C-O 121.805 0.812 . . . . 0.0 111.974 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.425 ' HA ' ' HE2' ' A' ' 170' ' ' LYS . 34.3 mm-40 -92.55 -19.48 21.9 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.343 175.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 70.72 -44.02 0.57 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.304 1.442 . . . . 0.0 112.714 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -72.32 109.84 6.33 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -72.65 134.65 45.2 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 59.45 67.78 0.86 Allowed 'General case' 0 CA--C 1.506 -0.74 0 O-C-N 124.191 0.932 . . . . 0.0 108.764 -167.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -86.4 75.79 9.74 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.465 1.126 . . . . 0.0 110.082 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 3.7 t60 . . . . . 0 N--CA 1.416 -2.147 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -178.51 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 CA--C 1.512 -0.493 0 CA-C-O 120.857 0.361 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -140.17 -58.84 0.54 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.0 m -163.7 98.35 0.88 Allowed 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.03 171.38 10.78 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.8 p -101.66 157.64 4.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.492 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 11.0 mmpt? -82.58 -173.53 4.67 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 122.893 0.477 . . . . 0.0 110.786 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 p -78.56 163.48 25.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 123.327 0.651 . . . . 0.0 110.87 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.51 ' HG ' ' CG ' ' A' ' 146' ' ' TRP . 10.7 mt -51.82 -33.26 35.02 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -177.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.8 m -62.35 -25.87 68.14 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.958 0.409 . . . . 0.0 110.71 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -96.98 -12.05 23.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.217 0.532 . . . . 0.0 110.341 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.8 m -78.55 145.96 34.55 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.11 -174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -84.01 153.39 23.88 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.258 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.451 HD21 ' HB2' ' A' ' 125' ' ' SER . 3.4 tm? -108.87 134.81 51.05 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 124.413 1.085 . . . . 0.0 109.684 -173.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 128' ' ' VAL . 3.2 mm? -125.43 138.72 32.34 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -72.63 141.86 35.12 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.71 2.274 . . . . 0.0 110.627 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.58 -13.76 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.451 -176.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.3 t -66.48 -28.86 68.91 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.432 0.634 . . . . 0.0 110.206 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -103.49 53.79 0.76 Allowed 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.929 0.871 . . . . 0.0 109.408 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -57.43 -18.56 18.69 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.789 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.55 -24.34 45.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.013 0.435 . . . . 0.0 110.077 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.1 m -88.43 -1.28 57.95 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.982 0.42 . . . . 0.0 111.234 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 80' ' ' ALA . 44.9 mm -72.18 128.15 89.41 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -51.5 132.67 41.22 Favored 'Trans proline' 0 C--O 1.241 0.657 0 C-N-CA 123.525 2.817 . . . . 0.0 113.147 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.4 p -94.92 28.58 2.68 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.407 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.59 -176.85 3.61 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.027 -176.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.3 t -98.6 145.24 27.04 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.481 ' HA2' HG12 ' A' ' 131' ' ' VAL . . . 159.55 -148.26 16.7 Favored Glycine 0 N--CA 1.416 -2.696 0 C-N-CA 119.802 -1.19 . . . . 0.0 112.729 177.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.68 150.56 29.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -138.31 154.15 49.01 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.97 121.41 34.35 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.628 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.24 124.08 46.59 Favored 'Isoleucine or valine' 0 C--O 1.27 2.146 0 O-C-N 123.641 0.588 . . . . 0.0 110.228 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -114.82 142.02 47.11 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.684 1.194 . . . . 0.0 108.949 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 96' ' ' SER . 4.8 p-10 -90.95 -164.16 1.14 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -70.07 -12.32 61.52 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 122.465 0.306 . . . . 0.0 111.603 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.404 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 5.0 m -94.59 -2.47 51.42 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 66.6 26.78 9.7 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.148 0.979 . . . . 0.0 109.754 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -90.18 127.92 36.23 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-O 121.078 0.466 . . . . 0.0 110.571 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.403 HD21 HG13 ' A' ' 102' ' ' VAL . 3.3 tm? -76.55 119.64 20.66 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.407 ' HA ' ' HG2' ' A' ' 158' ' ' PRO . 49.6 mt-30 -128.17 -18.4 4.12 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.257 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -147.29 118.15 7.63 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.354 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.448 HG23 ' NE1' ' A' ' 143' ' ' TRP . 11.6 m -109.27 139.62 31.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -149.54 158.0 27.48 Favored Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.711 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.3 pt -115.59 147.81 18.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.0 m -154.08 156.21 36.86 Favored 'General case' 0 C--O 1.251 1.134 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.18 -27.99 29.63 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -127.39 105.88 8.83 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 112' ' ' VAL . 78.0 mt -61.05 -60.79 2.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.145 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -44.69 -58.06 3.29 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -175.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.38 -37.23 86.38 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.6 m -71.59 -46.38 59.44 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 123.23 0.331 . . . . 0.0 110.815 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 108' ' ' ILE . 85.3 t -58.68 -56.06 19.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.449 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 16.6 m -57.16 -42.05 80.33 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 124.248 0.968 . . . . 0.0 111.619 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.89 -59.08 5.22 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -73.06 -24.06 60.64 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 69.8 mt -73.13 -33.35 65.47 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.827 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 113' ' ' SER . 34.8 mmtp -78.7 -20.2 50.68 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.118 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.7 m -80.92 -46.26 15.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.471 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.46 92.78 26.86 Favored Pre-proline 0 CA--C 1.557 1.226 0 CA-C-O 121.815 0.817 . . . . 0.0 110.295 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.569 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 3.8 Cg_exo -76.48 16.64 0.86 Allowed 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 123.933 3.089 . . . . 0.0 114.126 -175.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.27 -38.08 89.18 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.618 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.8 mt -101.51 20.55 15.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.745 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.569 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 90.4 m -75.04 93.12 2.69 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.647 176.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.03 -65.86 0.07 OUTLIER Glycine 0 N--CA 1.435 -1.405 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.451 ' HB2' HD21 ' A' ' 74' ' ' LEU . 19.8 p -158.89 167.52 29.19 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.0 p -144.82 139.24 23.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.464 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -106.56 137.53 44.41 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.46 HG22 HD23 ' A' ' 75' ' ' LEU . 33.6 m -125.7 133.35 69.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.359 0.599 . . . . 0.0 111.785 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -112.89 102.58 1.31 Allowed Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.07 115.48 20.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.481 HG12 ' HA2' ' A' ' 88' ' ' GLY . 12.2 p -108.33 138.3 35.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -66.83 -45.17 79.11 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.306 0.574 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -94.5 114.2 62.85 Favored Pre-proline 0 C--N 1.292 -1.919 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.639 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -82.91 32.92 0.52 Allowed 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 123.049 2.499 . . . . 0.0 111.755 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.439 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 17.6 t70 -73.59 136.86 43.99 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.814 -177.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -61.1 -30.14 70.18 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.69 -50.42 36.72 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.2 t -60.96 -39.76 83.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 O-C-N 124.179 0.924 . . . . 0.0 110.591 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.2 mt -61.47 -55.32 32.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.513 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.0 m -60.78 -38.4 85.16 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.038 0.447 . . . . 0.0 111.025 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -59.71 -52.63 64.65 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.205 1.002 . . . . 0.0 110.765 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.29 94.84 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.156 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.448 ' NE1' HG23 ' A' ' 102' ' ' VAL . 89.3 t90 -56.4 -45.21 80.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.533 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -63.89 -43.32 96.37 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.737 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.7 -46.2 90.7 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.066 0.46 . . . . 0.0 110.929 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.51 ' CG ' ' HG ' ' A' ' 69' ' ' LEU . 26.0 m0 -63.9 -46.28 85.58 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.511 ' O ' HG13 ' A' ' 151' ' ' ILE . 7.9 tt -63.25 -42.12 95.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.547 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.439 ' HB3' ' NZ ' ' A' ' 152' ' ' LYS . 49.8 mt-10 -64.77 -31.6 72.9 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 146' ' ' TRP . 7.1 mm-40 -50.42 -50.63 51.38 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.558 0.536 . . . . 0.0 110.02 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.458 ' HA ' HG22 ' A' ' 153' ' ' VAL 0.282 33.2 m-70 -81.95 -28.45 32.72 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -178.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 147' ' ' ILE . 71.3 mt -57.06 -40.52 73.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 120.943 0.401 . . . . 0.0 110.137 172.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.439 ' NZ ' ' HB3' ' A' ' 148' ' ' GLU . 62.3 mttp -75.32 -46.69 31.8 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 150' ' ' HIS . 30.9 m -78.04 -39.69 25.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -175.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 33.1 p -119.1 -35.32 3.65 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.951 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.92 17.23 59.93 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -85.14 108.22 17.59 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.13 0.49 . . . . 0.0 111.787 -177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 40.8 t -128.3 84.19 63.94 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 173.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.407 ' HG2' ' HA ' ' A' ' 100' ' ' GLN . 11.4 Cg_exo -76.41 164.51 30.67 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 122.798 2.332 . . . . 0.0 111.923 -178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.437 ' HA ' ' CD ' ' A' ' 162' ' ' LYS . 72.4 Cg_exo -52.34 -31.05 45.49 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 123.159 2.573 . . . . 0.0 112.697 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.29 -24.13 71.96 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.176 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.69 -9.74 42.73 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.437 ' CD ' ' HA ' ' A' ' 159' ' ' PRO . 7.7 mtpm? -79.49 170.77 16.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.685 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 14.4 t -110.43 138.44 46.82 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 144.66 -141.18 9.81 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -72.15 113.17 8.89 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 174.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.508 ' HB3' HG22 ' A' ' 169' ' ' VAL . 27.3 t-20 -134.39 135.06 42.36 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.529 -174.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.2 m -70.49 -22.18 62.68 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.858 0.863 . . . . 0.0 112.35 -176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -88.31 -47.82 8.12 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 166' ' ' ASN . 33.0 m -83.26 -30.02 8.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.19 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.33 134.96 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.37 1.468 . . . . 0.0 113.634 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 51.9 t -87.15 -48.08 15.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 21.7 m -101.36 109.46 21.3 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 172.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -60.66 -33.58 73.03 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -170.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.0 -23.04 41.8 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 121.138 -0.225 . . . . 0.0 110.415 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.8 t60 53.74 80.44 0.11 Allowed 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.586 1.155 . . . . 0.0 107.944 -171.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -72.18 114.24 10.08 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -174.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -80.0 110.58 15.53 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.05 -175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -81.94 115.06 20.94 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -80.49 117.1 20.92 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.092 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 9.3 t60 . . . . . 0 C--N 1.301 -1.522 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 CA--C 1.508 -0.656 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -169.29 -35.83 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.927 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.5 m -95.12 107.51 19.58 Favored 'General case' 0 C--O 1.253 1.28 0 CA-C-O 121.321 0.581 . . . . 0.0 111.584 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -150.09 123.54 9.05 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 36.6 t -116.34 143.47 26.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -104.79 -52.61 2.83 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 122.116 0.96 . . . . 0.0 108.945 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.0 p -129.92 164.33 24.44 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.894 -170.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.508 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 17.9 mt -68.86 -13.59 62.51 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 t -70.25 -19.6 63.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.322 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -104.72 1.33 29.23 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.508 ' OG1' ' HA ' ' A' ' 69' ' ' LEU . 6.8 m -92.78 134.53 34.97 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -172.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.16 152.35 38.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.295 1.038 . . . . 0.0 110.681 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -109.75 129.59 55.6 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.406 HD23 HG22 ' A' ' 128' ' ' VAL . 4.3 mm? -121.02 136.04 25.31 Favored Pre-proline 0 C--N 1.307 -1.247 0 C-N-CA 123.762 0.825 . . . . 0.0 109.705 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.5 139.64 41.62 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.348 2.032 . . . . 0.0 110.247 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.03 -12.98 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.248 0.547 . . . . 0.0 111.469 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.0 t -74.62 -20.81 59.76 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.466 0.651 . . . . 0.0 109.968 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -104.85 53.15 0.73 Allowed 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.807 0.813 . . . . 0.0 109.557 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.5 ' HB1' ' OG ' ' A' ' 113' ' ' SER . . . -56.13 -28.94 59.86 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.835 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.41 -26.23 67.89 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.6 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.3 t -92.08 -4.98 53.65 Favored 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.737 0.815 . . . . 0.0 110.38 -174.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.49 HG12 ' HA ' ' A' ' 80' ' ' ALA . 43.9 mm -72.14 130.36 86.51 Favored Pre-proline 0 N--CA 1.443 -0.808 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.85 131.38 38.01 Favored 'Trans proline' 0 C--O 1.248 0.982 0 C-N-CA 123.348 2.699 . . . . 0.0 112.976 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.0 p -91.39 27.59 1.91 Allowed 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.66 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.95 -176.95 3.6 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.825 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.6 t -96.85 154.33 17.36 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 154.15 -154.1 25.28 Favored Glycine 0 N--CA 1.423 -2.185 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.264 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.632 HG12 HG22 ' A' ' 104' ' ' ILE . 3.7 m -112.41 152.12 14.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 123.708 0.803 . . . . 0.0 110.045 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -144.69 154.35 42.67 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -130.78 126.23 35.81 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 123.248 0.619 . . . . 0.0 109.394 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.4 t -102.97 126.0 57.29 Favored 'Isoleucine or valine' 0 C--O 1.263 1.793 0 CA-C-O 121.102 0.477 . . . . 0.0 110.032 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -113.09 133.44 55.0 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -79.16 -169.44 1.84 Allowed 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.525 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.451 ' H ' ' HD2' ' A' ' 95' ' ' LYS . 8.5 mptt -57.22 -36.38 70.82 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.733 0.413 . . . . 0.0 110.29 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.3 m -77.46 0.5 22.44 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.536 0.734 . . . . 0.0 111.586 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.0 t70 65.88 27.16 10.99 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 122.752 1.263 . . . . 0.0 110.246 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -98.64 137.4 37.33 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.252 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.69 125.08 28.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.538 ' O ' ' HG2' ' A' ' 158' ' ' PRO . 41.9 mt-30 -129.1 -17.11 3.93 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.103 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.475 ' HA ' ' OD1' ' A' ' 161' ' ' ASN . 89.5 t80 -154.61 126.0 7.39 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 118.635 -1.226 . . . . 0.0 111.911 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.42 HG21 ' HB ' ' A' ' 147' ' ' ILE . 25.5 m -114.62 145.05 20.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 170.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.0 168.95 31.33 Favored Glycine 0 C--N 1.281 -2.487 0 C-N-CA 119.276 -1.44 . . . . 0.0 112.709 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.632 HG22 HG12 ' A' ' 89' ' ' VAL . 17.3 pt -120.13 148.53 23.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.4 t -150.84 155.63 39.59 Favored 'General case' 0 N--CA 1.417 -2.112 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.593 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.91 -23.12 24.02 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -141.67 98.19 3.3 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.0 mt -55.26 -60.4 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.46 -47.72 27.05 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.75 90.65 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 p -79.05 -43.1 24.92 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.607 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 76.3 t -55.47 -54.76 21.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 O-C-N 123.294 0.371 . . . . 0.0 110.805 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.5 ' OG ' ' HB1' ' A' ' 80' ' ' ALA . 20.1 m -56.94 -46.9 81.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 123.924 0.765 . . . . 0.0 110.696 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.5 -55.08 38.24 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.046 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.261 29.2 p80 -71.53 -26.44 62.66 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 89.9 mt -78.13 -27.68 48.29 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.233 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 113' ' ' SER . 74.9 mmtt -84.9 -9.15 58.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.166 0.508 . . . . 0.0 110.314 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.6 t -93.32 -50.57 5.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.08 94.48 27.71 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-O 121.742 0.782 . . . . 0.0 110.507 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.666 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 15.0 Cg_exo -71.88 19.58 0.28 Allowed 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.986 3.124 . . . . 0.0 114.322 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.68 -43.42 98.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.462 0.649 . . . . 0.0 109.755 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.1 mt -100.35 20.13 15.38 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.911 -176.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.666 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 91.0 m -77.16 86.03 3.63 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.706 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.42 -63.96 0.09 OUTLIER Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 175.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.0 p -164.01 157.56 18.55 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 123.004 0.522 . . . . 0.0 109.601 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.21 139.0 46.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-O 121.018 0.437 . . . . 0.0 110.472 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.451 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 74.6 mttt -106.71 137.48 44.66 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.406 HG22 HD23 ' A' ' 75' ' ' LEU . 27.4 m -124.02 132.61 71.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.038 0.447 . . . . 0.0 110.802 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -117.18 99.37 0.83 Allowed Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.68 117.56 29.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.454 0.645 . . . . 0.0 109.743 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.92 131.18 69.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.58 8.4 7.96 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -108.35 107.62 60.33 Favored Pre-proline 0 N--CA 1.423 -1.783 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -84.04 26.42 0.65 Allowed 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.558 2.172 . . . . 0.0 110.713 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.53 ' HB3' HG22 ' A' ' 138' ' ' VAL . 14.1 t70 -71.92 127.83 33.82 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -62.51 -28.4 69.82 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -173.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.54 -33.34 54.18 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.359 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 135' ' ' ASP . 10.1 m -77.38 -32.71 18.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.833 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 97.0 mt -64.25 -46.73 82.46 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.0 m -67.03 -33.92 76.58 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.225 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.603 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 62.9 tt0 -64.56 -50.82 65.78 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.528 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.23 -41.17 98.17 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.376 0.422 . . . . 0.0 110.234 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -55.61 -47.36 76.67 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.588 0.709 . . . . 0.0 109.592 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.78 -42.78 98.2 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.875 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 60.9 mt -64.98 -47.46 77.48 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.812 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -62.45 -46.11 90.01 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.015 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.584 ' O ' HG13 ' A' ' 151' ' ' ILE . 13.0 tt -67.15 -46.88 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.543 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -67.47 -29.28 68.69 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -175.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.497 ' O ' HG22 ' A' ' 153' ' ' VAL . 9.2 pt-20 -65.11 -44.09 89.89 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.931 176.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -69.96 -24.1 63.29 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 147' ' ' ILE . 57.1 mt -66.77 -43.73 89.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 172.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -71.27 -50.64 30.64 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 149' ' ' GLU . 35.2 m -80.01 -40.37 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -176.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.6 p -116.99 -4.84 11.47 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -174.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.37 34.33 89.61 Favored Glycine 0 C--O 1.222 -0.643 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.871 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -93.64 110.2 21.81 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.463 HG22 HG12 ' A' ' 151' ' ' ILE . 19.9 t -141.4 79.07 17.83 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 173.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.538 ' HG2' ' O ' ' A' ' 100' ' ' GLN . 3.1 Cg_exo -82.77 160.47 16.33 Favored 'Trans proline' 0 C--O 1.248 0.982 0 C-N-CA 122.66 2.24 . . . . 0.0 112.834 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -56.48 -17.17 20.75 Favored 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 124.268 3.312 . . . . 0.0 113.997 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -67.69 -38.79 90.22 Favored Glycine 0 CA--C 1.523 0.588 0 O-C-N 123.573 0.546 . . . . 0.0 112.892 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.475 ' OD1' ' HA ' ' A' ' 101' ' ' PHE . 11.0 m120 -87.54 -21.75 25.24 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 121.991 0.9 . . . . 0.0 111.634 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -83.88 160.47 21.13 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 174.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 57.9 m -87.1 79.77 8.55 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 117.817 -1.553 . . . . 0.0 109.781 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -140.97 -49.6 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 113.687 -1.597 . . . . 0.0 109.351 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -117.03 110.16 17.9 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.431 ' OD1' ' HG3' ' A' ' 170' ' ' LYS . 19.4 t-20 -114.62 11.68 17.03 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.381 0.61 . . . . 0.0 110.126 -174.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 28.7 m -56.25 -24.57 43.44 Favored 'General case' 0 CA--C 1.559 1.309 0 CA-C-O 121.294 0.569 . . . . 0.0 112.003 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -73.11 -22.68 60.5 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.1 -0.375 . . . . 0.0 111.274 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 53.3 t -102.98 -33.87 3.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.431 ' HG3' ' OD1' ' A' ' 166' ' ' ASN . 55.8 mtpt -68.88 1.4 3.4 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.74 -32.05 56.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.278 0.561 . . . . 0.0 110.684 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 4.6 m -92.71 -9.54 40.37 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.344 0.592 . . . . 0.0 109.539 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 170' ' ' LYS . 4.3 mm? -85.06 67.47 10.21 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.822 0.82 . . . . 0.0 112.65 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.581 ' OE2' ' HA ' ' A' ' 177' ' ' HIS . 37.1 tt0 -104.45 98.96 8.66 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -68.57 -47.36 66.98 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -100.04 90.41 4.38 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.581 ' HA ' ' OE2' ' A' ' 174' ' ' GLU . 16.2 p80 -69.47 117.03 10.56 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -66.33 127.36 31.92 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.98 -171.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -179.54 -39.11 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 10.5 p80 . . . . . 0 CA--C 1.497 -1.064 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 175.277 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -138.18 147.39 43.78 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 131' ' ' VAL . 16.2 m -73.77 101.49 3.73 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.86 0.362 . . . . 0.0 110.406 177.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.458 ' HA ' HG23 ' A' ' 131' ' ' VAL . . . -119.81 95.67 4.87 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 172.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.65 142.53 16.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.541 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -79.8 -152.55 0.07 Allowed 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.931 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.8 m -76.52 164.59 25.8 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 121.38 0.61 . . . . 0.0 111.719 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.444 HD11 ' OH ' ' A' ' 93' ' ' TYR . 3.1 tm? -46.52 -40.03 11.87 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 126.637 1.975 . . . . 0.0 114.108 -174.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.0 m -56.24 -32.83 64.85 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.314 0.578 . . . . 0.0 111.891 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -102.72 10.0 38.82 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.356 -0.384 . . . . 0.0 112.029 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.586 HG21 ' CH2' ' A' ' 146' ' ' TRP . 30.1 m -85.58 147.66 26.3 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.256 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.08 149.64 46.31 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.23 0.612 . . . . 0.0 111.262 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -110.65 133.49 53.27 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.829 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.51 HD23 HG22 ' A' ' 128' ' ' VAL . 3.5 mm? -127.26 141.53 41.08 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 174.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -79.97 144.84 17.23 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.082 1.854 . . . . 0.0 110.885 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.482 HD11 ' SG ' ' A' ' 123' ' ' CYS . 0.1 OUTLIER -80.03 -12.95 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.094 0.473 . . . . 0.0 110.676 -178.077 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.25 -11.81 61.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 124.522 1.129 . . . . 0.0 111.205 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -128.19 53.42 1.81 Allowed 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -54.86 -19.15 5.9 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.996 -175.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -78.21 -20.39 51.91 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.321 0.582 . . . . 0.0 110.577 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.0 m -91.11 6.81 43.47 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.234 0.54 . . . . 0.0 110.769 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.455 HG12 ' HA ' ' A' ' 80' ' ' ALA . 41.4 mm -82.56 130.05 60.3 Favored Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.436 ' HG2' HD11 ' A' ' 130' ' ' ILE . 90.1 Cg_exo -53.23 137.02 63.54 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.531 2.821 . . . . 0.0 113.287 178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.3 p -101.52 27.13 6.57 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.813 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.25 -175.99 3.39 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.649 -174.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.9 t -95.39 141.56 28.8 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 158.87 -153.43 24.55 Favored Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.511 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.577 HG12 HG22 ' A' ' 104' ' ' ILE . 1.8 m -109.21 150.56 11.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 C-N-CA 124.393 1.077 . . . . 0.0 110.06 -177.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -142.78 148.43 37.15 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.38 118.04 21.57 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.244 0.618 . . . . 0.0 109.883 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.5 t -97.32 127.59 49.43 Favored 'Isoleucine or valine' 0 C--O 1.263 1.782 0 CA-C-O 121.358 0.599 . . . . 0.0 111.895 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.444 ' OH ' HD11 ' A' ' 69' ' ' LEU . 43.3 m-85 -107.4 146.47 31.61 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 125.047 1.339 . . . . 0.0 109.32 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -95.2 -172.24 2.62 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.4 ' HD2' ' HA2' ' A' ' 124' ' ' GLY . 31.6 mmmt -65.34 -23.05 66.9 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 m -77.13 -4.08 42.67 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.78 0.8 . . . . 0.0 109.396 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.3 t70 66.12 29.57 9.81 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.727 1.611 . . . . 0.0 109.626 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 5.1 mm-40 -99.14 144.1 28.66 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 114.066 -1.425 . . . . 0.0 108.255 175.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.516 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 1.5 tm? -85.89 125.12 33.09 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.515 ' O ' ' HG2' ' A' ' 158' ' ' PRO . 1.4 mp0 -116.5 -23.55 8.22 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 123.978 0.799 . . . . 0.0 113.013 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -149.4 120.47 7.73 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 117.587 -1.645 . . . . 0.0 112.715 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.613 HG21 ' HB ' ' A' ' 147' ' ' ILE . 30.5 m -105.06 145.29 13.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.809 171.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.55 166.97 30.84 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.544 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.577 HG22 HG12 ' A' ' 89' ' ' VAL . 10.5 pt -123.0 144.84 31.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 122.889 0.476 . . . . 0.0 109.806 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.2 m -152.62 157.37 40.88 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.334 0.588 . . . . 0.0 111.526 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -86.74 -22.18 26.13 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 172.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -137.44 91.33 2.59 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.596 -1.183 . . . . 0.0 108.086 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.19 -62.3 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -173.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.77 -43.19 27.2 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -175.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.4 -48.57 79.13 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.054 0.221 . . . . 0.0 111.526 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.3 m -65.04 -41.51 95.13 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 120.683 0.277 . . . . 0.0 111.154 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.6 t -61.7 -57.15 13.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.009 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.5 p -60.85 -35.61 77.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 123.778 0.674 . . . . 0.0 111.811 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.77 -61.27 2.39 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 122.975 0.51 . . . . 0.0 111.642 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 168' ' ' PHE . 27.5 p80 -79.57 -21.68 44.76 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -73.02 -41.28 64.41 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.77 -15.1 59.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.556 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.6 m -80.9 -59.09 2.8 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.3 95.25 47.28 Favored Pre-proline 0 N--CA 1.428 -1.528 0 CA-C-O 122.087 0.946 . . . . 0.0 110.847 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.53 21.12 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.794 2.996 . . . . 0.0 113.22 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -69.1 -33.21 73.14 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.2 mt -94.59 21.49 7.23 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.169 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.482 ' SG ' HD11 ' A' ' 77' ' ' ILE . 38.2 t -68.61 108.37 3.32 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 176.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.4 ' HA2' ' HD2' ' A' ' 95' ' ' LYS . . . -160.35 -72.82 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 175.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.3 p -169.41 173.17 6.68 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.9 p -144.49 139.8 23.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -106.27 129.91 54.22 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.51 HG22 HD23 ' A' ' 75' ' ' LEU . 35.3 m -122.54 136.1 60.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.436 0.636 . . . . 0.0 111.52 -175.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -116.59 96.79 0.73 Allowed Glycine 0 N--CA 1.418 -2.511 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.436 HD11 ' HG2' ' A' ' 84' ' ' PRO . 2.7 mp -78.74 114.27 19.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.504 HG22 ' H ' ' A' ' 133' ' ' GLU . 13.6 p -104.5 124.13 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.705 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -78.83 -5.17 52.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.499 0.666 . . . . 0.0 110.582 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.504 ' H ' HG22 ' A' ' 131' ' ' VAL . 11.2 mm-40 -111.65 84.31 5.11 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 172.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.83 39.29 0.7 Allowed 'Trans proline' 0 N--CA 1.48 0.684 0 C-N-CA 123.619 2.879 . . . . 0.0 113.026 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.52 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 14.4 t70 -76.87 138.88 40.04 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.059 -175.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -54.15 -38.09 65.13 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.892 1.277 . . . . 0.0 113.494 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.02 -44.57 54.01 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.84 -43.58 95.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.775 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 96.5 mt -57.25 -52.88 63.53 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.125 0.488 . . . . 0.0 110.708 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.6 m -69.42 -34.37 74.36 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.117 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.489 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 52.9 tt0 -66.84 -45.65 77.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.071 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.9 -38.21 90.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.174 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.516 ' NE1' HG23 ' A' ' 102' ' ' VAL . 89.3 t90 -55.72 -48.58 74.94 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -60.9 -38.24 85.02 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.372 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.606 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 71.4 mt -63.97 -56.92 11.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.274 0.559 . . . . 0.0 109.559 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.586 ' CH2' HG21 ' A' ' 72' ' ' THR . 20.8 m0 -54.61 -50.48 67.98 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.613 ' HB ' HG21 ' A' ' 102' ' ' VAL . 13.1 tt -61.51 -46.53 96.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.334 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -66.45 -27.23 67.66 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 17.5 mm-40 -59.94 -46.13 90.37 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 121.224 0.535 . . . . 0.0 109.671 175.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.516 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 7.5 t60 -81.8 -21.43 37.71 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.578 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 147' ' ' ILE . 53.7 mt -67.2 -53.51 32.48 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.71 -26.2 68.54 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -175.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 150' ' ' HIS . 11.3 p -84.37 -35.73 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.4 t -137.86 -2.88 1.87 Allowed 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -174.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 78.93 29.28 52.14 Favored Glycine 0 CA--C 1.516 0.126 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.816 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -91.82 108.86 20.22 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.505 ' O ' ' HD2' ' A' ' 162' ' ' LYS . 2.1 t -142.78 90.36 7.72 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 173.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.515 ' HG2' ' O ' ' A' ' 100' ' ' GLN . 7.9 Cg_exo -80.17 159.67 23.47 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.986 2.457 . . . . 0.0 113.21 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -43.14 -40.79 9.3 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 124.822 3.682 . . . . 0.0 115.262 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -65.23 -23.2 69.74 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 114.395 0.518 . . . . 0.0 114.395 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -103.43 -19.63 14.35 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.467 0.651 . . . . 0.0 111.062 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.505 ' HD2' ' O ' ' A' ' 157' ' ' VAL . 61.0 mtpt -79.46 -65.03 1.05 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.089 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.3 m -102.95 -152.72 0.45 Allowed 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.293 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -75.57 143.33 30.18 Favored Glycine 0 N--CA 1.422 -2.249 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.36 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -73.01 122.58 21.97 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 40.1 m-80 -103.34 -79.54 0.53 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.977 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 39.4 m -60.92 -32.56 72.04 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -170.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' A' ' 115' ' ' HIS . 12.5 m-85 -76.04 -7.09 53.88 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.033 -174.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.53 14.99 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 123.052 0.541 . . . . 0.0 109.638 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 173' ' ' LEU . 16.0 tptm -85.05 -16.15 41.67 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 41.5 t 53.56 -79.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 127.062 2.145 . . . . 0.0 115.229 172.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 14.9 m -95.84 -44.42 7.41 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.323 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.448 ' HB2' ' HG3' ' A' ' 170' ' ' LYS . 82.9 mt -65.16 -40.62 94.58 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.253 -173.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -126.39 70.06 1.24 Allowed 'General case' 0 N--CA 1.425 -1.72 0 CA-C-O 121.905 0.86 . . . . 0.0 109.049 174.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 -86.23 -49.67 7.54 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 174.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -101.03 116.56 33.14 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -66.23 108.0 2.15 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -109.58 147.17 33.46 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -167.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -100.9 -162.49 0.94 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 75.8 m80 . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.556 176.704 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 84.5 mtp . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.89 77.7 1.27 Allowed 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 m -100.8 28.51 5.14 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.681 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -151.6 106.09 3.22 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.037 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 50.7 t -84.56 140.69 15.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.84 -178.12 6.25 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.651 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.0 m -72.93 177.24 5.04 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.1 mt -52.65 -25.27 10.32 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -171.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -68.71 -30.92 69.67 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.864 0.364 . . . . 0.0 110.695 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -87.62 -20.44 26.35 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.315 0.579 . . . . 0.0 110.752 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.421 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 4.4 m -74.99 133.74 41.62 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.219 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -71.53 154.02 41.76 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.056 0.455 . . . . 0.0 111.042 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -108.7 125.1 51.53 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.561 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.449 HD23 HG22 ' A' ' 128' ' ' VAL . 4.0 mm? -113.4 130.73 23.4 Favored Pre-proline 0 C--N 1.3 -1.583 0 C-N-CA 123.881 0.873 . . . . 0.0 109.411 174.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.87 139.59 36.7 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.179 1.919 . . . . 0.0 110.163 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.45 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -76.72 -13.48 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.431 -175.351 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.3 t -69.6 -25.67 64.07 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.433 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -109.63 54.25 0.67 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 122.29 1.043 . . . . 0.0 110.098 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.488 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -57.04 -19.76 20.67 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.822 -1.535 . . . . 0.0 113.302 -176.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -73.57 -19.6 60.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.434 0.635 . . . . 0.0 110.965 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.0 m -93.13 2.43 56.71 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.559 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 80' ' ' ALA . 47.0 mm -76.7 126.62 85.7 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.57 130.66 41.33 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.535 2.157 . . . . 0.0 113.21 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.0 p -94.05 30.65 1.82 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.247 1.023 . . . . 0.0 109.731 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.48 -179.78 4.45 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.445 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 106' ' ' ARG . 15.4 t -93.71 138.38 31.98 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.17 -155.61 26.81 Favored Glycine 0 N--CA 1.421 -2.33 0 C-N-CA 119.362 -1.399 . . . . 0.0 113.049 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.497 HG21 ' HB3' ' A' ' 142' ' ' ALA . 7.5 t -115.78 151.6 17.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -176.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -140.56 148.11 40.48 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.462 ' HB1' HD23 ' A' ' 99' ' ' LEU . . . -125.12 118.29 25.8 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.887 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.81 115.02 29.2 Favored 'Isoleucine or valine' 0 C--O 1.262 1.712 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.586 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 4.9 m-85 -100.32 137.28 38.96 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.92 -168.36 2.21 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.365 0.602 . . . . 0.0 110.891 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -64.99 -29.57 70.5 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.42 1.088 . . . . 0.0 111.271 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.1 t -81.42 -1.25 45.0 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.806 0.812 . . . . 0.0 109.363 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 t70 73.95 27.74 1.6 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.635 1.574 . . . . 0.0 112.538 172.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 11.8 pt-20 -120.09 166.65 13.11 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 117.588 -1.645 . . . . 0.0 111.207 172.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.462 HD23 ' HB1' ' A' ' 91' ' ' ALA . 2.9 tm? -80.29 130.14 34.99 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.913 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -118.11 -47.13 2.59 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.106 171.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -124.1 125.74 45.0 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.789 -173.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.444 HG13 HD21 ' A' ' 99' ' ' LEU . 5.0 m -114.42 140.92 32.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.28 162.09 29.38 Favored Glycine 0 N--CA 1.42 -2.423 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.185 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.8 pt -124.82 151.7 30.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.6 t -159.92 159.23 32.08 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 106' ' ' ARG . 0.4 OUTLIER -82.35 -15.35 53.11 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 176.6 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -140.87 96.89 3.08 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.0 mt -56.34 -52.69 49.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.841 -177.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.14 -46.22 61.89 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.81 -48.23 81.54 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.733 0.413 . . . . 0.0 111.702 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.9 m -68.53 -44.21 75.06 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.239 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.6 t -57.94 -58.78 4.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.392 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 43.5 p -63.05 -32.06 73.34 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.51 -61.16 2.26 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.512 ' HA ' ' OG ' ' A' ' 118' ' ' SER . 19.7 p80 -77.15 -21.88 53.41 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -174.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.425 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 53.6 mt -76.09 -23.97 55.0 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.779 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -89.46 -31.01 17.89 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.046 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 115' ' ' HIS . 4.2 p -73.99 -27.91 61.21 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.352 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.23 98.07 3.78 Favored Pre-proline 0 CA--C 1.559 1.31 0 CA-C-O 121.899 0.857 . . . . 0.0 110.691 173.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.793 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 94.5 Cg_endo -82.21 22.39 0.87 Allowed 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 123.288 2.659 . . . . 0.0 113.514 -177.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -63.42 -43.34 97.75 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.707 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.1 mt -104.99 18.01 23.13 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.161 0.505 . . . . 0.0 110.954 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.793 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 83.0 m -78.65 99.78 6.74 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.732 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.34 -49.48 0.06 OUTLIER Glycine 0 C--N 1.3 -1.43 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.0 p -165.59 168.14 16.66 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.095 0.958 . . . . 0.0 109.633 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.66 137.08 31.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-O 121.081 0.467 . . . . 0.0 110.48 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.421 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 98.1 mttt -106.43 138.58 42.36 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.449 HG22 HD23 ' A' ' 75' ' ' LEU . 27.0 m -124.19 130.99 73.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.136 0.493 . . . . 0.0 112.179 -176.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -118.33 102.11 0.94 Allowed Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mp -94.89 136.47 25.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 121.031 0.443 . . . . 0.0 110.154 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.97 141.67 44.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.99 -46.09 90.76 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -88.39 116.33 65.93 Favored Pre-proline 0 C--N 1.308 -1.199 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.163 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.32 39.41 0.78 Allowed 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 123.488 2.792 . . . . 0.0 112.539 -175.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.426 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 23.9 t70 -73.74 129.2 37.45 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.996 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -61.81 -27.85 69.05 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.54 -45.47 59.14 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.3 t -62.07 -41.46 91.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 O-C-N 124.192 0.932 . . . . 0.0 110.171 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 90.3 mt -63.03 -50.48 70.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.679 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 48.8 m -63.57 -33.63 76.02 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 120.914 0.388 . . . . 0.0 110.793 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.34 -54.88 34.03 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.805 1.242 . . . . 0.0 110.378 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.497 ' HB3' HG21 ' A' ' 89' ' ' VAL . . . -64.77 -39.39 93.53 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.217 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -55.39 -45.68 76.6 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.304 0.642 . . . . 0.0 109.303 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -61.09 -46.27 91.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.79 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.2 mp -60.36 -38.37 83.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.851 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.433 ' O ' ' HG3' ' A' ' 149' ' ' GLU . 41.0 m0 -73.64 -46.87 44.05 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.957 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.432 ' HB ' HG21 ' A' ' 102' ' ' VAL . 12.7 tt -65.9 -40.98 89.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.444 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.72 -36.44 80.59 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.564 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -60.95 -39.12 88.27 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.331 -179.015 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.46 ' HA ' HG12 ' A' ' 153' ' ' VAL . 2.6 t60 -79.46 -31.25 42.43 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.132 -175.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.455 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 70.9 mt -70.87 -32.34 48.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.422 0.63 . . . . 0.0 109.87 175.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -84.85 -33.42 22.87 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 149' ' ' GLU . 14.8 p -83.52 -51.43 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.483 HG23 HG13 ' A' ' 153' ' ' VAL . 71.1 p -108.78 -35.54 6.37 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.172 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 151' ' ' ILE . . . 99.71 28.27 7.53 Favored Glycine 0 C--N 1.317 -0.519 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.719 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.82 125.75 47.35 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.51 87.78 10.16 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-O 121.904 0.859 . . . . 0.0 109.881 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -69.98 160.58 49.12 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.16 3.24 . . . . 0.0 113.811 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 162' ' ' LYS . 5.7 Cg_exo -45.7 -35.51 13.22 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 124.997 3.798 . . . . 0.0 115.365 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -70.84 -26.18 74.45 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.88 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -84.87 -25.82 27.76 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.456 ' HD3' ' HA ' ' A' ' 159' ' ' PRO . 6.5 mtpm? -83.73 -176.08 6.12 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.621 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.1 m -85.97 85.21 7.38 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.612 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.07 127.23 2.15 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -79.26 110.29 14.39 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -132.32 162.42 31.09 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.9 m -55.4 -28.27 53.02 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.786 0.834 . . . . 0.0 112.256 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.403 ' HA ' ' HB2' ' A' ' 115' ' ' HIS . 62.0 m-85 -67.83 -19.68 65.09 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 176.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 25.0 t -106.55 -8.41 10.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp 64.09 -165.49 0.24 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.074 0.95 . . . . 0.0 109.506 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 55.2 t -90.32 -52.59 10.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 57.4 p 63.17 -47.88 0.22 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 126.715 2.006 . . . . 0.0 115.407 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 96.6 mt -54.2 -51.8 63.25 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 175' ' ' HIS . 0.6 OUTLIER -159.88 174.57 14.24 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -174.854 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.408 ' H ' ' CD ' ' A' ' 174' ' ' GLU . 81.0 t60 -84.91 -36.75 21.26 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 122.363 0.265 . . . . 0.0 110.309 176.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -80.45 90.68 5.66 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.49 0.662 . . . . 0.0 109.942 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -84.5 118.28 24.21 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.032 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -146.58 -60.39 0.3 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -97.45 -35.6 10.61 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 33.2 m80 . . . . . 0 C--O 1.205 -1.253 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 174.818 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 C--O 1.236 0.386 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.86 100.31 11.49 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.0 t -99.02 -35.49 10.03 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.23 116.46 32.86 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.4 t -104.08 120.33 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 121.146 0.498 . . . . 0.0 110.832 -175.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.438 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -128.39 -72.59 0.61 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.124 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.541 ' HB2' ' OE2' ' A' ' 149' ' ' GLU . 28.1 p -121.99 179.29 4.57 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.481 HD13 ' OH ' ' A' ' 93' ' ' TYR . 38.9 mt -73.93 -17.17 61.06 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.6 m -72.28 -20.34 61.53 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.47 0.653 . . . . 0.0 109.648 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -92.18 -3.31 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.016 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.475 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.6 m -98.81 150.5 21.8 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.955 -172.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 9.4 pt-20 -90.25 155.01 19.3 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.176 0.99 . . . . 0.0 109.845 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.0 125.11 48.62 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -123.66 141.01 35.47 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.068 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -71.37 134.55 24.86 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.192 1.928 . . . . 0.0 109.215 170.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -21.53 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.0 t -73.29 -26.7 61.18 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.193 0.521 . . . . 0.0 110.678 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -94.56 56.09 2.04 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.845 0.831 . . . . 0.0 110.12 177.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.583 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -48.84 -21.57 0.66 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.204 1.402 . . . . 0.0 114.015 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -64.56 -27.57 69.05 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.433 0.635 . . . . 0.0 110.763 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.408 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 22.8 m -83.09 1.43 40.29 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.083 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.583 HG12 ' HA ' ' A' ' 80' ' ' ALA . 26.8 mm -90.75 113.97 59.74 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 82' ' ' SER . 72.2 Cg_exo -54.7 135.27 66.54 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.737 2.958 . . . . 0.0 112.593 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.7 p -98.6 34.21 2.09 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.969 0.89 . . . . 0.0 110.885 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.73 -176.64 3.19 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.174 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.7 t -95.96 145.62 25.26 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.17 -149.13 15.27 Favored Glycine 0 N--CA 1.416 -2.69 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.266 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.49 HG13 ' CH2' ' A' ' 146' ' ' TRP . 6.7 p -125.98 149.26 30.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -176.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -137.37 149.85 47.28 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.901 0.382 . . . . 0.0 110.747 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.32 117.6 28.2 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.278 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.31 116.75 34.16 Favored 'Isoleucine or valine' 0 C--O 1.26 1.627 0 CA-C-O 121.092 0.472 . . . . 0.0 110.753 -177.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.481 ' OH ' HD13 ' A' ' 69' ' ' LEU . 88.3 m-85 -106.35 134.42 49.51 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.705 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -79.18 -171.0 2.47 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -58.46 -30.79 67.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.808 0.843 . . . . 0.0 111.093 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.4 m -82.72 1.72 37.33 Favored 'General case' 0 C--O 1.25 1.114 0 C-N-CA 123.506 0.722 . . . . 0.0 112.269 -176.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.2 t70 69.41 26.68 5.17 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.499 1.142 . . . . 0.0 109.39 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 4.3 mm-40 -102.13 140.14 36.81 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.925 176.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.507 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 2.8 tm? -89.69 110.84 21.7 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.464 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.464 ' HA ' ' HG2' ' A' ' 158' ' ' PRO . 2.4 mp0 -105.13 -25.99 12.27 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.051 177.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -143.82 120.96 11.47 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 118.822 -1.151 . . . . 0.0 113.54 -176.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.479 HG13 HD11 ' A' ' 99' ' ' LEU . 6.2 m -108.51 144.01 17.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 169.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -154.84 158.86 28.61 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.4 pt -117.25 144.3 25.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.6 m -150.75 160.39 43.89 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.147 0.498 . . . . 0.0 111.113 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -84.97 -21.85 29.39 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -136.13 105.46 6.03 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.55 -58.01 8.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 123.535 0.522 . . . . 0.0 111.92 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.17 -55.28 10.79 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.07 99.56 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 123.064 0.227 . . . . 0.0 111.316 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.2 t -65.87 -51.23 60.59 Favored 'General case' 0 C--O 1.251 1.148 0 O-C-N 123.774 0.671 . . . . 0.0 110.019 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 56.6 t -56.14 -54.77 23.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.972 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 22.9 t -60.12 -44.41 94.92 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 123.779 0.674 . . . . 0.0 111.1 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.75 -54.12 38.45 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -80.07 -26.3 39.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.441 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 66.9 mt -77.68 -26.48 50.31 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.845 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 113' ' ' SER . 33.7 mmtp -78.84 -26.05 44.12 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.395 174.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.2 t -74.0 -53.85 9.16 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.346 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.0 p -129.05 99.04 22.43 Favored Pre-proline 0 N--CA 1.431 -1.381 0 CA-C-O 121.996 0.903 . . . . 0.0 110.767 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.838 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 73.9 Cg_endo -79.56 11.53 2.67 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 123.525 2.817 . . . . 0.0 113.653 -177.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -58.03 -42.93 86.37 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 123.984 0.913 . . . . 0.0 109.865 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.0 mt -104.16 20.29 18.58 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.898 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.838 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 96.8 m -85.99 92.75 8.78 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.188 0.518 . . . . 0.0 111.944 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.42 -60.4 0.09 OUTLIER Glycine 0 C--N 1.299 -1.5 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 173.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 9.8 p -156.06 161.62 40.39 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.5 p -138.53 139.6 41.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-O 121.007 0.432 . . . . 0.0 110.159 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.475 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 82.9 mttt -106.54 128.36 54.05 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 174.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.86 136.16 56.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.095 0.474 . . . . 0.0 111.137 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.52 110.02 1.26 Allowed Glycine 0 N--CA 1.425 -2.064 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 130' ' ' ILE . 2.7 mp -94.24 104.91 16.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 133' ' ' GLU . 9.2 p -89.17 134.56 28.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.269 -177.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -65.12 -30.02 70.92 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.23 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.402 ' H ' HG22 ' A' ' 131' ' ' VAL . 16.5 pt-20 -109.24 100.67 42.05 Favored Pre-proline 0 N--CA 1.439 -1.016 0 CA-C-O 121.362 0.601 . . . . 0.0 109.768 174.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.72 37.92 0.71 Allowed 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.916 2.411 . . . . 0.0 112.282 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.448 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 22.3 t70 -69.15 143.77 54.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.188 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -52.44 -44.44 65.49 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.493 0.717 . . . . 0.0 112.337 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.11 -38.76 69.24 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.409 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.06 -42.04 90.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 96.7 mt -58.33 -47.73 82.81 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.5 m -66.04 -38.88 89.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.633 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -62.63 -45.39 93.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.85 0.357 . . . . 0.0 110.091 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.6 -50.06 75.03 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.914 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -53.55 -47.81 69.67 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.143 0.977 . . . . 0.0 110.492 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 14.6 tmtt? -63.37 -45.78 89.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.633 -176.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.476 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 11.0 mp -67.41 -38.86 85.27 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.691 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.49 ' CH2' HG13 ' A' ' 89' ' ' VAL . 27.2 m0 -63.16 -45.01 93.87 Favored 'General case' 0 C--O 1.257 1.482 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.471 ' O ' HG13 ' A' ' 151' ' ' ILE . 12.7 tt -65.41 -39.14 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.397 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 38.0 mt-10 -57.71 -42.5 83.88 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-O 118.9 -0.572 . . . . 0.0 111.967 176.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.541 ' OE2' ' HB2' ' A' ' 68' ' ' SER . 6.8 mm-40 -46.39 -51.84 14.14 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.782 0.676 . . . . 0.0 110.059 178.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.507 ' CG ' ' HB3' ' A' ' 99' ' ' LEU 0.34 13.7 m-70 -78.88 -27.85 44.04 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 179.177 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 147' ' ' ILE . 76.5 mt -61.18 -47.5 93.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.536 0.684 . . . . 0.0 109.319 172.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -68.1 -50.4 55.19 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.309 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 149' ' ' GLU . 16.9 m -80.75 -26.77 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -174.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.3 t -138.13 -26.25 0.93 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.39 23.5 16.47 Favored Glycine 0 C--N 1.316 -0.54 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.69 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -78.88 112.96 16.57 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.06 74.26 21.63 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 170.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.464 ' HG2' ' HA ' ' A' ' 100' ' ' GLN . 9.2 Cg_endo -90.88 168.84 3.69 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 123.219 2.612 . . . . 0.0 114.09 -171.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.447 ' HA ' ' HB2' ' A' ' 162' ' ' LYS . 71.1 Cg_exo -56.74 -17.73 24.18 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 124.0 3.134 . . . . 0.0 113.727 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -67.8 -38.48 89.5 Favored Glycine 0 C--O 1.219 -0.794 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -94.09 -33.11 13.5 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.574 0.702 . . . . 0.0 109.734 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.447 ' HB2' ' HA ' ' A' ' 159' ' ' PRO . 28.5 mtpp -75.51 176.33 7.67 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.478 175.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.5 m -82.34 88.04 6.57 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 173.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -146.77 -54.34 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.861 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.44 ' O ' HG22 ' A' ' 169' ' ' VAL . 23.6 t-20 -95.4 110.25 22.31 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 175.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -71.06 -8.19 51.67 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -171.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 m -72.39 -45.78 58.22 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.928 0.394 . . . . 0.0 110.152 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -82.34 -44.54 16.06 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.632 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 165' ' ' ASN . 35.9 m -86.99 13.91 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -172.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -77.94 134.37 37.89 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.046 -1.062 . . . . 0.0 108.92 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 30.8 t -93.3 156.38 3.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 14.9 m -55.69 -42.81 75.72 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-O 121.157 0.503 . . . . 0.0 109.983 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.35 118.59 27.85 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 174.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -100.51 150.64 22.46 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.319 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -125.13 108.72 12.08 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 172.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -86.12 92.28 8.69 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-O 121.782 0.801 . . . . 0.0 110.783 -172.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -72.6 97.84 2.22 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.223 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -154.85 23.33 0.45 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.091 0.948 . . . . 0.0 109.941 175.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -93.0 -14.06 27.89 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 . . . . . 0 N--CA 1.421 -1.907 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 176.281 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.0 mtp . . . . . 0 CA--C 1.506 -0.731 0 CA-C-O 121.266 0.555 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.91 102.53 11.54 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 169.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.7 m -94.42 -45.86 7.27 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.361 0.601 . . . . 0.0 111.002 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.22 99.79 12.29 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.491 HG11 ' HZ2' ' A' ' 146' ' ' TRP . 24.2 t -127.05 124.68 65.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.321 -176.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.425 ' HB2' ' OE2' ' A' ' 71' ' ' GLU . 57.8 mtpt -117.03 -54.23 2.43 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.1 p -110.49 172.09 7.07 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.824 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.94 -27.77 68.47 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.455 0.702 . . . . 0.0 110.983 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 m -62.67 -31.1 71.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.573 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.425 ' OE2' ' HB2' ' A' ' 67' ' ' LYS . 29.5 mt-10 -95.03 2.62 55.32 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.124 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.506 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.1 m -91.29 145.42 24.67 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.491 -176.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 17.0 pt-20 -89.31 151.05 22.31 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -113.88 130.61 56.47 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.814 0.34 . . . . 0.0 110.84 -172.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -128.35 127.77 23.68 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -63.49 138.11 63.48 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.181 1.921 . . . . 0.0 109.616 173.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -14.46 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -172.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.7 t -65.58 -30.97 71.78 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.265 0.555 . . . . 0.0 110.081 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.62 53.07 0.82 Allowed 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 122.41 1.1 . . . . 0.0 109.377 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.582 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -56.64 -24.24 46.94 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.702 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.73 -31.1 71.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.378 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.5 m -92.39 3.46 55.4 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.582 HG12 ' HA ' ' A' ' 80' ' ' ALA . 44.6 mm -69.2 125.02 91.65 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -52.9 129.76 34.49 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.006 2.47 . . . . 0.0 113.71 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 p -95.5 32.79 1.72 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.089 0.947 . . . . 0.0 111.048 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.05 -176.96 3.23 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.924 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.4 m -93.42 149.67 21.05 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 123.504 0.502 . . . . 0.0 110.105 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.62 -153.78 24.99 Favored Glycine 0 N--CA 1.417 -2.571 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.435 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.59 ' HB ' ' CH2' ' A' ' 146' ' ' TRP . 2.6 t -114.36 151.3 16.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -175.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -140.31 151.88 45.41 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.02 174.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 127' ' ' LYS . . . -130.24 120.76 24.95 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 123.554 0.742 . . . . 0.0 109.697 -178.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.51 125.93 45.06 Favored 'Isoleucine or valine' 0 C--O 1.263 1.801 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.314 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -112.64 132.58 55.1 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 124.156 0.983 . . . . 0.0 109.234 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -77.61 -173.26 2.9 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 123.825 0.703 . . . . 0.0 110.542 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -55.42 -31.08 61.57 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.1 t -95.46 11.55 32.54 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 122.021 -0.425 . . . . 0.0 110.885 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.45 33.16 13.89 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 176.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -102.99 125.37 49.72 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 118.571 -1.252 . . . . 0.0 111.914 172.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.495 HD23 ' HB1' ' A' ' 91' ' ' ALA . 2.5 tm? -60.71 112.68 2.11 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.637 174.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.418 ' HB3' ' HG2' ' A' ' 158' ' ' PRO . 48.5 mt-30 -124.52 -14.66 6.81 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.24 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -144.16 125.33 14.56 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.371 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.474 HG21 ' HB ' ' A' ' 147' ' ' ILE . 22.1 m -117.11 151.76 18.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 173.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -160.3 160.04 31.36 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.4 pt -124.91 147.28 29.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.6 t -157.46 164.56 37.31 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.457 ' HD3' ' O ' ' A' ' 106' ' ' ARG . 0.6 OUTLIER -80.55 -28.03 37.4 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.339 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -131.09 99.4 4.87 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 77.7 mt -57.83 -52.01 63.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.261 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.63 -52.46 39.36 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.82 -47.18 87.52 Favored 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 123.456 0.473 . . . . 0.0 111.147 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.0 t -62.8 -50.78 69.63 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.435 -177.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.0 t -59.22 -52.97 54.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.028 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.4 m -63.13 -35.35 79.99 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 123.337 0.398 . . . . 0.0 111.812 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.09 -61.14 1.99 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.37 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.276 21.5 p80 -73.5 -25.92 60.66 Favored 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -174.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.4 mt -77.62 -24.06 49.67 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.681 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -87.48 -9.13 55.41 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.204 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.6 m -92.07 -51.61 5.1 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.59 95.73 42.33 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-O 121.681 0.753 . . . . 0.0 111.052 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.822 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 3.1 Cg_exo -79.27 32.56 0.47 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.58 2.853 . . . . 0.0 112.877 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -70.33 -43.17 70.81 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.779 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.1 mt -114.12 21.87 14.37 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.706 -174.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.822 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 94.7 m -76.06 93.06 3.24 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -127.25 -61.84 0.14 Allowed Glycine 0 C--N 1.307 -1.073 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.0 m -158.78 166.93 30.78 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.2 p -133.83 142.32 41.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.268 0.556 . . . . 0.0 110.088 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 91' ' ' ALA . 30.6 mmtm -105.67 129.22 53.94 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.21 136.36 60.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.272 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.44 100.06 0.79 Allowed Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 130' ' ' ILE . 2.5 mp -88.06 101.66 11.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -101.09 134.53 40.93 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.797 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.015 -174.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -66.48 -34.61 78.31 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -83.89 117.33 68.4 Favored Pre-proline 0 C--N 1.301 -1.513 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.871 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -91.49 21.03 0.82 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.879 2.386 . . . . 0.0 111.787 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.97 131.39 45.39 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.944 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -59.19 -33.39 70.9 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.849 -174.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.81 -45.27 68.25 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.29 -44.23 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.16 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 99.0 mt -59.77 -45.78 91.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.944 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.3 m -69.36 -38.43 78.08 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.479 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.563 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 29.0 tt0 -62.29 -51.23 68.52 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.329 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.3 -40.84 95.64 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.41 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.451 ' O ' HG22 ' A' ' 147' ' ' ILE . 79.3 t90 -51.41 -46.64 62.98 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.49 0.716 . . . . 0.0 109.603 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.44 -50.92 57.22 Favored 'General case' 0 C--O 1.211 -0.951 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.486 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 85.5 mt -51.57 -41.63 61.29 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.242 0.617 . . . . 0.0 111.673 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.59 ' CH2' ' HB ' ' A' ' 89' ' ' VAL . 31.6 m0 -69.68 -57.79 4.71 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.444 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.613 ' O ' HG12 ' A' ' 151' ' ' ILE . 15.1 tt -67.25 -42.16 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 C-N-CA 119.644 -0.823 . . . . 0.0 111.844 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.442 ' HA ' ' CG1' ' A' ' 151' ' ' ILE . 26.7 mt-10 -67.64 -28.62 67.88 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -174.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.507 ' O ' HG22 ' A' ' 153' ' ' VAL . 12.3 pt-20 -67.31 -37.45 83.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 118.887 -1.125 . . . . 0.0 109.063 175.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -75.41 -30.05 59.95 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 120.579 -0.449 . . . . 0.0 109.792 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 147' ' ' ILE . 41.8 mm -58.82 -44.49 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 121.272 0.558 . . . . 0.0 109.712 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -81.18 -36.25 30.38 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -174.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 149' ' ' GLU . 31.3 m -97.14 -24.84 4.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.95 -1.67 7.17 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 56.44 33.87 62.74 Favored Glycine 0 N--CA 1.47 0.926 0 N-CA-C 117.473 1.749 . . . . 0.0 117.473 170.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -100.16 108.3 20.38 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 118.225 1.012 . . . . 0.0 111.459 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.575 HG22 HD12 ' A' ' 151' ' ' ILE . 1.9 t -126.57 78.0 72.87 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.418 ' HG2' ' HB3' ' A' ' 100' ' ' GLN . 7.4 Cg_exo -77.77 155.2 30.82 Favored 'Trans proline' 0 C--O 1.257 1.444 0 C-N-CA 122.93 2.42 . . . . 0.0 113.225 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.9 -22.49 54.6 Favored 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 123.425 2.75 . . . . 0.0 111.893 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -56.66 -37.68 77.81 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.581 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -100.61 -27.24 13.5 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.206 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -76.01 -82.1 0.08 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.025 0.441 . . . . 0.0 110.663 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.9 t -179.38 164.42 1.33 Allowed 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.18 -21.05 15.87 Favored Glycine 0 C--N 1.307 -1.059 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.196 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -100.89 163.42 12.31 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.419 ' OD1' ' HA ' ' A' ' 174' ' ' GLU . 6.4 t30 -131.68 -21.9 2.45 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 171.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.409 HG22 ' HA ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -58.4 -21.04 49.12 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -174.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -83.28 -14.62 52.7 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 120.112 -0.635 . . . . 0.0 112.424 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' A' ' 170' ' ' LYS . 34.4 m -101.46 -34.59 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 119.586 -0.845 . . . . 0.0 109.678 173.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 169' ' ' VAL . 68.2 mmtt -168.71 146.11 3.86 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.041 1.736 . . . . 0.0 108.367 175.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.409 ' HA ' HG22 ' A' ' 167' ' ' THR . 14.9 p -58.15 -52.48 58.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 19.6 m -124.32 -20.53 5.2 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.775 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.31 105.43 3.48 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.47 0.652 . . . . 0.0 110.539 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.419 ' HA ' ' OD1' ' A' ' 166' ' ' ASN . 9.8 pt-20 -81.16 134.63 35.66 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.752 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -121.88 -71.66 0.72 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.283 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -86.27 84.99 7.34 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.084 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -73.63 138.56 44.9 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.367 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -124.97 152.17 44.53 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -139.54 141.96 37.24 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.915 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 78.3 t60 . . . . . 0 N--CA 1.418 -2.035 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.597 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 52.1 tpp . . . . . 0 CA--C 1.515 -0.372 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -141.27 132.27 26.14 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p -79.65 -15.71 57.1 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.496 0.665 . . . . 0.0 110.785 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.89 81.67 8.45 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.726 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.81 127.35 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -113.62 -53.53 2.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.2 m -124.84 165.75 17.48 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.188 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.0 mt -57.79 -26.82 62.46 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.142 1.377 . . . . 0.0 113.85 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.3 m -65.68 -21.81 66.58 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.947 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -98.93 -10.44 22.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.334 0.588 . . . . 0.0 110.401 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.51 ' HB ' ' HD3' ' A' ' 127' ' ' LYS . 3.2 m -83.28 136.88 34.22 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.325 -171.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.74 154.06 28.81 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 120.614 0.245 . . . . 0.0 110.882 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -108.4 128.72 55.02 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.244 0.618 . . . . 0.0 110.634 -172.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -121.96 131.01 24.5 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -66.08 139.0 54.2 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.119 1.879 . . . . 0.0 109.489 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.442 HG13 ' SG ' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -72.14 -12.9 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-O 121.384 0.611 . . . . 0.0 111.926 -174.65 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.5 p -75.45 -26.35 58.21 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.885 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.09 53.57 0.8 Allowed 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 122.167 0.984 . . . . 0.0 109.97 177.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -59.21 -22.84 61.66 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 113.792 -1.549 . . . . 0.0 112.329 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.11 -24.1 64.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.583 0.706 . . . . 0.0 109.497 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.9 t -93.91 4.97 53.14 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.391 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.575 HG12 ' HA ' ' A' ' 80' ' ' ALA . 43.5 mm -81.15 124.93 80.59 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.406 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 82.9 Cg_exo -51.58 133.95 45.19 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.287 2.658 . . . . 0.0 112.926 177.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.2 p -96.47 29.07 3.04 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.9 0.857 . . . . 0.0 110.578 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.05 -176.58 3.47 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.545 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.6 t -101.54 142.15 33.34 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.3 -147.85 12.73 Favored Glycine 0 N--CA 1.413 -2.854 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.488 HG13 ' CH2' ' A' ' 146' ' ' TRP . 7.6 p -126.01 148.81 30.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -136.57 149.04 47.87 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 120.9 0.381 . . . . 0.0 110.537 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.26 121.82 41.39 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.603 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.479 HG11 HD21 ' A' ' 116' ' ' LEU . 57.7 t -96.81 114.23 33.18 Favored 'Isoleucine or valine' 0 C--O 1.265 1.894 0 CA-C-O 121.171 0.51 . . . . 0.0 110.363 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 70.6 m-85 -102.52 133.86 46.81 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.379 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -81.21 -172.34 3.72 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -67.07 -16.3 64.25 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.8 m -88.8 1.6 54.98 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 122.277 0.231 . . . . 0.0 110.469 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 67.83 27.01 7.5 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.147 0.979 . . . . 0.0 110.715 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 4.6 mm-40 -103.85 151.72 22.76 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.402 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.502 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 3.0 tm? -102.47 110.99 23.1 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.426 -174.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.435 ' HB3' ' HG3' ' A' ' 158' ' ' PRO . 2.0 mp0 -107.4 -32.96 7.52 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.903 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -131.6 134.99 46.61 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.262 -0.975 . . . . 0.0 112.049 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.46 HG13 HD11 ' A' ' 99' ' ' LEU . 4.5 m -130.47 142.8 42.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -153.8 153.96 25.19 Favored Glycine 0 N--CA 1.425 -2.063 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.086 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.403 HG22 ' HB ' ' A' ' 89' ' ' VAL . 18.8 pt -111.87 141.13 28.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.3 m -149.86 163.77 37.16 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 120.901 0.382 . . . . 0.0 111.55 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -82.92 -30.61 28.29 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -131.56 104.31 6.89 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 84' ' ' PRO . 73.2 mt -60.25 -53.57 46.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 O-C-N 123.162 0.289 . . . . 0.0 111.72 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.01 -58.53 4.32 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.84 89.33 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.286 0.366 . . . . 0.0 111.349 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.9 m -63.46 -49.61 72.99 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.249 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.4 t -58.15 -54.68 29.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.0 m -58.56 -43.75 89.46 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.049 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.66 -59.93 4.16 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -77.1 -30.8 55.48 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.479 HD21 HG11 ' A' ' 92' ' ' VAL . 77.7 mt -76.59 -27.74 55.91 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 119.542 -0.863 . . . . 0.0 113.054 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -81.35 -19.03 43.65 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.891 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.9 m -81.68 -57.76 3.31 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.381 175.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.0 p -116.13 96.26 46.86 Favored Pre-proline 0 N--CA 1.441 -0.914 0 CA-C-O 122.421 1.105 . . . . 0.0 109.987 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' A' ' 123' ' ' CYS . 82.1 Cg_endo -83.68 22.76 0.89 Allowed 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.154 2.569 . . . . 0.0 113.749 -175.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -64.52 -32.2 73.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.006 0.908 . . . . 0.0 109.719 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.4 mt -113.5 21.48 15.08 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.171 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 120' ' ' PRO . 34.9 t -75.52 78.99 2.54 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.383 -178.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -130.89 -56.83 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.4 p -165.38 164.09 19.74 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 122.664 0.385 . . . . 0.0 110.508 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.51 137.04 36.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 120.963 0.411 . . . . 0.0 109.956 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.51 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 77.3 mttt -106.53 130.61 54.27 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 173.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.1 m -113.92 133.72 59.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 120.892 0.377 . . . . 0.0 111.16 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -123.22 106.19 0.98 Allowed Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 130' ' ' ILE . 2.8 mp -93.26 111.78 25.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.6 164.07 2.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.99 -41.68 74.08 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 135' ' ' ASP . 47.4 mt-10 -100.48 116.97 63.75 Favored Pre-proline 0 C--N 1.303 -1.416 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.957 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -81.02 27.09 0.58 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.783 2.322 . . . . 0.0 109.763 173.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 133' ' ' GLU . 29.1 t70 -85.96 145.87 26.94 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.426 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -53.7 -42.75 68.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.08 -37.75 88.59 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 120.977 0.418 . . . . 0.0 111.629 -177.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.439 HG21 ' HB2' ' A' ' 133' ' ' GLU . 34.0 t -79.52 -40.82 21.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.105 -176.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.07 -46.53 90.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.242 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.0 m -67.68 -33.82 75.69 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.337 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -65.61 -48.37 72.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.184 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.23 -43.92 96.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.942 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.404 ' NE1' HG23 ' A' ' 102' ' ' VAL . 91.6 t90 -55.04 -43.32 73.67 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.351 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 25.1 mmtt -60.86 -58.51 8.12 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.582 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 10.9 mp -55.79 -38.13 69.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 118.306 0.503 . . . . 0.0 112.297 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.488 ' CH2' HG13 ' A' ' 89' ' ' VAL . 27.0 m0 -65.12 -53.08 50.83 Favored 'General case' 0 C--O 1.265 1.88 0 O-C-N 123.518 0.511 . . . . 0.0 111.698 177.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.442 ' O ' HG12 ' A' ' 151' ' ' ILE . 8.5 tt -62.42 -46.69 95.81 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.649 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 144' ' ' LYS . 53.6 mm-40 -60.04 -30.95 69.53 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 123.457 0.703 . . . . 0.0 112.596 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 30.8 mm-40 -56.31 -56.85 15.93 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.469 0.652 . . . . 0.0 109.673 174.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.502 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 27.0 m-70 -73.17 -31.89 64.51 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.582 -0.847 . . . . 0.0 113.138 -177.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 147' ' ' ILE . 35.3 mm -57.06 -42.81 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 120.423 0.154 . . . . 0.0 111.024 175.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -72.86 -58.36 3.39 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.28 -22.93 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.2 t -129.49 -24.89 2.72 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.109 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 76.55 34.66 43.8 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.783 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -89.85 115.1 26.92 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.459 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.43 86.87 2.38 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-O 122.213 1.006 . . . . 0.0 110.029 175.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.435 ' HG3' ' HB3' ' A' ' 100' ' ' GLN . 67.8 Cg_endo -90.68 169.12 3.83 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 123.02 2.48 . . . . 0.0 112.266 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.402 ' HA ' ' HD2' ' A' ' 162' ' ' LYS . 86.5 Cg_exo -51.23 -18.23 4.81 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 124.594 3.53 . . . . 0.0 114.993 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.15 -41.57 86.3 Favored Glycine 0 C--N 1.31 -0.887 0 CA-C-N 116.498 -0.319 . . . . 0.0 112.407 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -92.96 5.71 50.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.767 1.27 . . . . 0.0 109.065 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 159' ' ' PRO . 35.3 mttm -114.81 -170.34 1.72 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 174.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.8 t -102.35 89.87 3.71 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 172.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.15 -58.61 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.212 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -92.75 110.05 21.49 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -80.97 -25.81 37.04 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.768 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.3 m -56.97 -25.77 58.71 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -77.3 -25.9 51.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.8 t -108.22 -24.01 4.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 121.558 0.694 . . . . 0.0 109.864 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.502 ' HE2' ' HA ' ' A' ' 170' ' ' LYS . 3.1 mmpt? 73.69 -71.85 0.13 Allowed 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.637 1.575 . . . . 0.0 112.508 -176.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 44.8 t 58.68 76.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 122.106 0.955 . . . . 0.0 109.45 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 52.6 m -77.25 -30.73 54.61 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.626 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.51 88.07 7.57 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.411 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -99.14 -31.36 11.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.985 0.898 . . . . 0.0 108.946 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -139.6 171.27 14.49 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -99.82 142.62 31.06 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -71.93 93.79 1.39 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.41 0.624 . . . . 0.0 111.432 -176.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -104.79 -13.82 15.74 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.041 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -161.79 -49.53 0.04 OUTLIER 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 173.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 . . . . . 0 C--N 1.307 -1.265 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.252 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 CA--C 1.504 -0.801 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.34 99.97 0.44 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.603 0.716 . . . . 0.0 109.916 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 m -103.51 173.89 6.11 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.942 -175.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.35 103.76 15.97 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.847 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.5 t -86.34 117.0 30.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -104.68 -86.77 0.45 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.513 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.8 p -114.43 -174.15 2.43 Favored 'General case' 0 N--CA 1.414 -2.233 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.207 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.72 -26.21 68.57 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.82 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.6 m -61.81 -30.0 70.53 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.18 0.992 . . . . 0.0 111.109 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -87.06 -1.06 57.6 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.155 0.582 . . . . 0.0 110.165 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.446 ' HB ' ' HD3' ' A' ' 127' ' ' LYS . 27.3 m -114.33 145.45 41.77 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -170.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.94 156.97 17.58 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.03 0.532 . . . . 0.0 110.862 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -115.51 134.34 55.16 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.769 0.828 . . . . 0.0 110.766 -172.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -130.47 129.44 22.79 Favored Pre-proline 0 C--O 1.214 -0.77 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 53.1 Cg_exo -62.79 147.68 94.37 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.074 1.85 . . . . 0.0 110.376 172.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -5.41 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -172.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.0 p -69.44 -26.21 64.49 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 121.16 0.505 . . . . 0.0 111.271 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.26 52.77 0.71 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.692 0.758 . . . . 0.0 110.538 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -60.51 -27.13 67.36 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.027 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.16 -24.33 64.97 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.355 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.5 m -93.01 2.09 56.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.963 0.411 . . . . 0.0 110.966 -177.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 80' ' ' ALA . 46.5 mm -79.25 130.53 68.77 Favored Pre-proline 0 C--O 1.243 0.746 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.554 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -52.3 140.39 52.44 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 124.2 3.267 . . . . 0.0 113.61 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.4 p -98.68 29.53 3.68 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.501 0.667 . . . . 0.0 111.387 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.57 -177.08 3.68 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.157 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.8 t -99.97 152.01 20.68 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 154.28 -143.36 9.97 Favored Glycine 0 N--CA 1.412 -2.933 0 C-N-CA 119.847 -1.168 . . . . 0.0 112.47 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.608 HG12 HG22 ' A' ' 104' ' ' ILE . 3.2 m -119.31 149.36 21.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 C-N-CA 123.485 0.714 . . . . 0.0 110.029 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -143.34 146.06 33.22 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.672 0.273 . . . . 0.0 110.28 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -118.45 127.27 53.5 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.054 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -105.4 118.86 53.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.28 0.562 . . . . 0.0 110.938 -176.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 43.9 m-85 -108.52 141.05 40.98 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -80.32 -169.79 2.25 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HD2' ' HA2' ' A' ' 124' ' ' GLY . 4.9 mmmp? -67.38 -15.2 63.55 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.9 m -89.19 -3.1 58.7 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 65.51 35.29 7.33 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.686 1.194 . . . . 0.0 112.221 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -100.72 145.16 28.82 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.361 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -90.46 109.2 20.33 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.35 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -105.85 -41.99 5.27 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.915 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -125.29 139.38 53.76 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.425 0.631 . . . . 0.0 112.477 -171.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.54 146.31 33.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 172.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.67 165.67 30.61 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 119.756 -1.212 . . . . 0.0 111.815 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.608 HG22 HG12 ' A' ' 89' ' ' VAL . 15.4 pt -116.99 155.0 18.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.0 t -158.64 160.16 36.19 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.183 0.515 . . . . 0.0 110.082 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -85.51 -22.31 28.23 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -142.55 91.97 2.37 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 70.2 mt -50.87 -60.03 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 123.857 0.863 . . . . 0.0 112.468 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.74 -46.25 29.73 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.18 -55.05 39.93 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.503 0.502 . . . . 0.0 111.075 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.2 m -61.42 -46.07 91.65 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.761 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 75.7 t -56.63 -54.94 22.76 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 C-N-CA 123.023 0.529 . . . . 0.0 111.263 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.1 t -61.29 -46.7 89.24 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 123.259 0.349 . . . . 0.0 110.606 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.27 -60.24 3.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -75.12 -21.94 58.54 Favored 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 118.619 -1.232 . . . . 0.0 113.752 -172.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.0 mt -79.68 -24.19 41.93 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.483 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -88.12 -25.29 23.08 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.39 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.9 t -76.74 -42.03 42.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.823 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.54 91.27 14.15 Favored Pre-proline 0 N--CA 1.437 -1.108 0 CA-C-O 121.895 0.855 . . . . 0.0 110.473 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.737 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 2.7 Cg_exo -75.72 18.31 0.62 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.263 2.642 . . . . 0.0 113.62 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -59.91 -42.96 95.04 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.25 1.02 . . . . 0.0 110.6 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.2 mt -107.18 20.54 18.84 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.435 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.737 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 66.3 m -72.56 120.87 18.77 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.539 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.518 ' HA2' ' HD2' ' A' ' 95' ' ' LYS . . . -163.79 -70.39 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 174.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . 21.8 m -146.48 159.37 43.49 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 9.6 p -139.87 139.01 38.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.034 0.445 . . . . 0.0 110.45 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 91' ' ' ALA . 46.5 mttp -106.51 142.2 36.55 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.47 126.0 71.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.633 0.73 . . . . 0.0 112.325 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -113.69 102.67 1.26 Allowed Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 mp -84.63 121.94 37.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 133' ' ' GLU . 14.5 p -125.33 131.05 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.67 -0.62 57.14 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.518 0.675 . . . . 0.0 111.422 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.462 ' H ' HG22 ' A' ' 131' ' ' VAL . 20.7 mm-40 -94.8 109.66 45.1 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -88.8 32.37 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.353 2.035 . . . . 0.0 112.557 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.435 ' HB3' HG22 ' A' ' 138' ' ' VAL . 11.4 t70 -83.51 139.68 32.76 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -176.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 mmmm -59.44 -34.45 72.53 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.69 -43.44 69.03 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 123.113 0.258 . . . . 0.0 110.825 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 135' ' ' ASP . 17.4 m -69.42 -34.52 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 120.768 0.318 . . . . 0.0 110.911 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.2 mt -66.52 -52.34 46.83 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.007 0.432 . . . . 0.0 110.082 177.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.6 m -65.58 -30.41 71.14 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.064 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.507 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 58.6 tt0 -62.57 -54.21 43.14 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.817 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.21 -37.62 86.0 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 123.992 0.808 . . . . 0.0 110.105 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -54.34 -47.95 71.96 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 123.617 0.573 . . . . 0.0 110.109 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 98.0 mttt -64.63 -49.74 69.88 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.21 177.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.587 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 93.7 mt -50.83 -47.39 60.17 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.416 0.448 . . . . 0.0 111.439 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -63.08 -53.9 46.48 Favored 'General case' 0 C--O 1.265 1.871 0 C-N-CA 123.287 0.635 . . . . 0.0 112.604 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 151' ' ' ILE . 10.4 tt -64.33 -41.13 91.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.741 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 67.4 mt-10 -65.55 -30.05 70.75 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 119.265 -0.398 . . . . 0.0 111.92 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 21.0 mm-40 -54.89 -48.17 73.35 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . 0.272 13.4 m-70 -76.28 -29.54 57.46 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 147' ' ' ILE . 77.3 mt -61.31 -43.94 97.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 173.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -66.78 -49.65 65.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.7 m -79.28 -33.12 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.529 HG23 ' HG2' ' A' ' 156' ' ' LYS . 6.8 t -133.16 -28.06 1.55 Allowed 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.686 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.1 33.18 5.56 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.524 -0.845 . . . . 0.0 112.259 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.529 ' HG2' HG23 ' A' ' 154' ' ' THR . 42.7 mmtm -83.59 111.64 19.29 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.448 0.642 . . . . 0.0 112.583 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 p -155.84 70.96 5.3 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.746 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -90.11 165.3 4.71 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.33 2.687 . . . . 0.0 113.105 -174.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -51.68 -23.87 16.39 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 124.092 3.195 . . . . 0.0 114.275 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -67.49 -20.75 72.03 Favored Glycine 0 C--O 1.205 -1.658 0 C-N-CA 121.821 -0.228 . . . . 0.0 112.9 177.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.86 -8.88 13.13 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.656 0.741 . . . . 0.0 109.93 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -84.34 -176.24 6.16 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.0 m -62.53 -33.52 75.07 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 124.57 1.148 . . . . 0.0 112.721 -176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.52 50.11 3.23 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.411 ' ND2' HG13 ' A' ' 169' ' ' VAL . 22.6 t30 -115.06 140.98 48.62 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 122.873 0.469 . . . . 0.0 109.922 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -131.63 -68.33 0.65 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -60.44 -24.53 65.28 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -169.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -85.47 -21.05 28.86 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.613 -0.679 . . . . 0.0 112.697 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.411 HG13 ' ND2' ' A' ' 165' ' ' ASN . 11.7 m -104.85 -26.72 3.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.755 176.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 69.02 88.04 0.11 Allowed 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -175.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 14.3 p -48.4 115.02 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -170.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.0 t -178.59 -44.0 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.929 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 64.9 mt -95.83 102.9 14.75 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.176 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 54.51 100.51 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.914 1.686 . . . . 0.0 115.547 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -130.04 134.74 47.6 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 169.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -76.52 100.26 5.22 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.246 -175.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -82.26 113.56 20.16 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.624 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 83.4 t60 71.35 116.09 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.2 1.0 . . . . 0.0 111.547 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -92.16 136.71 32.96 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 . . . . . 0 C--N 1.29 -1.985 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.684 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.509 -0.616 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -167.6 161.3 13.54 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 t -121.14 166.85 13.35 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.1 69.53 5.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.885 0.85 . . . . 0.0 110.24 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.51 120.53 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.072 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -123.98 -28.25 3.79 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.645 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.9 p -130.84 161.73 31.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.674 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.456 ' H ' ' HG3' ' A' ' 149' ' ' GLU . 72.2 mt -59.77 -28.16 67.17 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.408 0.683 . . . . 0.0 111.03 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.0 m -61.29 -20.61 63.09 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.896 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -111.28 8.03 21.31 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.92 -0.487 . . . . 0.0 110.497 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.528 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.0 m -96.19 135.88 37.41 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.257 -172.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 13.1 pt-20 -69.9 150.05 47.17 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.901 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 125' ' ' SER . 3.1 tm? -118.3 121.22 39.88 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -173.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.13 126.16 27.22 Favored Pre-proline 0 C--N 1.296 -1.724 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -63.76 139.65 70.01 Favored 'Trans proline' 0 C--N 1.326 -0.621 0 C-N-CA 121.903 1.735 . . . . 0.0 108.507 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -70.23 -12.31 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-O 121.422 0.63 . . . . 0.0 111.189 -174.568 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 p -67.6 -31.71 71.93 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.355 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -97.85 55.48 1.19 Allowed 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.43 0.633 . . . . 0.0 111.045 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.514 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -53.3 -23.39 9.04 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.441 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -69.35 -24.97 63.97 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.114 0.483 . . . . 0.0 110.971 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.8 m -89.64 6.88 39.32 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.465 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.514 HG12 ' HA ' ' A' ' 80' ' ' ALA . 38.1 mm -85.6 115.76 62.85 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -56.27 132.43 51.85 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 123.235 2.624 . . . . 0.0 113.492 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.9 p -89.58 36.38 0.84 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.758 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.32 -176.66 3.15 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.608 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.3 t -104.42 150.11 24.82 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.49 -146.21 13.81 Favored Glycine 0 N--CA 1.414 -2.782 0 C-N-CA 120.26 -0.972 . . . . 0.0 111.264 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.6 p -121.04 147.29 24.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -137.54 151.92 48.91 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 120.916 0.389 . . . . 0.0 110.522 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.422 ' HB1' ' CD2' ' A' ' 99' ' ' LEU . . . -123.32 124.43 42.95 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 124.001 0.92 . . . . 0.0 108.818 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.9 t -101.47 124.94 55.54 Favored 'Isoleucine or valine' 0 C--O 1.262 1.759 0 CA-C-O 121.166 0.508 . . . . 0.0 110.85 -176.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.45 ' HD2' ' O ' ' A' ' 97' ' ' ASP . 12.5 m-85 -111.28 133.11 53.85 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -78.92 -167.19 1.06 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.94 0.4 . . . . 0.0 110.972 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -57.86 -27.44 63.24 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.823 0.849 . . . . 0.0 111.077 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.7 m -86.03 -1.68 57.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.874 0.369 . . . . 0.0 110.397 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.45 ' O ' ' HD2' ' A' ' 93' ' ' TYR . 25.7 t70 64.36 34.65 10.35 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 124.849 1.26 . . . . 0.0 109.156 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 32.7 mm-40 -100.4 124.83 46.41 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.621 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.511 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 3.1 tm? -66.91 118.06 9.87 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -127.28 -14.67 5.34 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.526 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -147.26 133.88 19.89 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.334 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.495 HG23 ' NE1' ' A' ' 143' ' ' TRP . 16.3 m -124.06 138.02 55.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.162 174.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -155.98 157.49 27.86 Favored Glycine 0 C--N 1.305 -1.191 0 C-N-CA 119.788 -1.196 . . . . 0.0 112.846 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.9 144.01 21.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 123.126 0.57 . . . . 0.0 109.899 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 m -150.41 161.06 43.24 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-O 120.546 0.213 . . . . 0.0 110.642 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -85.67 -24.3 27.1 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -135.11 101.95 5.04 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 74.3 mt -60.1 -50.35 80.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.056 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.2 -57.35 9.91 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.67 96.73 Favored 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 123.38 0.425 . . . . 0.0 111.044 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.3 t -58.74 -61.18 2.81 Favored 'General case' 0 C--O 1.252 1.22 0 O-C-N 123.872 0.732 . . . . 0.0 109.961 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.4 t -54.66 -53.54 30.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 123.455 0.702 . . . . 0.0 111.581 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.0 t -59.48 -45.43 91.7 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.814 0.696 . . . . 0.0 111.385 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.26 -48.12 79.51 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -75.04 -27.88 60.2 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 119.069 -1.052 . . . . 0.0 113.536 -176.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 88.7 mt -73.62 -26.28 60.71 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.983 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -86.27 -17.7 33.97 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.466 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.0 m -83.63 -40.26 19.22 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.93 97.0 5.88 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-O 121.702 0.763 . . . . 0.0 110.581 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.607 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 9.8 Cg_exo -73.76 13.72 0.74 Allowed 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 123.757 2.971 . . . . 0.0 114.291 -177.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -55.56 -39.49 70.7 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.435 0.694 . . . . 0.0 111.063 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.2 mt -109.46 20.81 17.79 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.004 -177.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.607 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 63.6 m -70.82 120.29 16.2 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.222 174.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.427 ' N ' HD12 ' A' ' 77' ' ' ILE . . . -170.44 -68.9 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.496 ' HB2' HD21 ' A' ' 74' ' ' LEU . 2.0 p -152.06 152.49 32.46 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 114.882 -0.659 . . . . 0.0 109.695 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.12 137.23 48.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.112 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.528 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 95.0 mttt -106.89 131.36 54.07 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.86 137.28 55.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 120.932 0.396 . . . . 0.0 111.326 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.04 107.68 1.35 Allowed Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.79 109.85 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-O 121.717 0.77 . . . . 0.0 110.985 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.8 p -111.28 125.78 68.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -87.25 -13.06 44.83 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.384 -172.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -92.36 113.83 60.47 Favored Pre-proline 0 N--CA 1.427 -1.595 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -77.84 45.41 1.78 Allowed 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 123.379 2.719 . . . . 0.0 112.923 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.494 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 10.0 t70 -82.18 121.29 26.43 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -67.15 -27.49 67.34 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.13 -39.44 25.59 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.45 -41.62 90.71 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 O-C-N 123.299 0.375 . . . . 0.0 110.265 176.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.0 mt -57.59 -48.12 80.25 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.907 0.384 . . . . 0.0 110.491 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.2 m -69.05 -35.99 77.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.77 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -65.63 -44.78 85.41 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 122.891 0.477 . . . . 0.0 109.977 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.83 -45.04 94.46 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.495 ' NE1' HG23 ' A' ' 102' ' ' VAL . 90.4 t90 -54.07 -44.25 70.97 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.583 176.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -63.96 -52.9 57.55 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.513 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.57 -38.52 78.04 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.413 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 23.5 m0 -64.27 -46.58 83.08 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.618 ' O ' HG12 ' A' ' 151' ' ' ILE . 10.5 tt -63.16 -45.09 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.244 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 17.8 mm-40 -57.26 -39.07 74.86 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.61 0.764 . . . . 0.0 111.674 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 69' ' ' LEU . 4.4 mm-40 -52.09 -49.33 63.78 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.431 0.692 . . . . 0.0 111.6 174.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.511 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 12.7 t60 -80.16 -23.4 41.1 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.892 -177.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.618 HG12 ' O ' ' A' ' 147' ' ' ILE . 43.2 mm -63.39 -50.68 77.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.028 174.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 148' ' ' GLU . 68.3 mttm -56.45 -45.05 81.04 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.966 0.412 . . . . 0.0 111.338 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 33.9 m -80.9 -33.47 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 41.4 p -130.88 -36.11 1.38 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 119.336 -0.945 . . . . 0.0 113.097 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.96 30.7 41.87 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.512 -175.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -82.01 116.58 21.69 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 122.535 -0.391 . . . . 0.0 110.327 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.459 ' O ' ' HE2' ' A' ' 162' ' ' LYS . 10.9 t -131.14 80.34 68.95 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 173.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -75.72 162.37 35.37 Favored 'Trans proline' 0 C--O 1.241 0.662 0 C-N-CA 122.925 2.417 . . . . 0.0 112.517 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.417 ' HA ' ' HD2' ' A' ' 162' ' ' LYS . 70.9 Cg_exo -56.0 -17.5 19.56 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 124.457 3.438 . . . . 0.0 113.432 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 165' ' ' ASN . . . -77.57 -38.88 27.07 Favored Glycine 0 C--N 1.304 -1.195 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.858 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -22.3 33.01 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 157' ' ' VAL . 41.3 mttm -81.53 176.14 9.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.148 176.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.5 m -87.44 70.83 9.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 172.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.8 -91.82 0.49 Allowed Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.546 ' O ' ' HA2' ' A' ' 160' ' ' GLY . 56.8 m-80 -97.98 110.14 22.77 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -118.65 28.82 8.08 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.417 -173.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 2.9 m -58.31 -17.76 22.17 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.444 1.098 . . . . 0.0 110.596 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -76.88 -12.44 59.96 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.544 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.35 8.38 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 O-C-N 122.224 -0.298 . . . . 0.0 111.31 176.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 167' ' ' THR . 55.7 tptt -167.16 109.06 0.66 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.831 0.348 . . . . 0.0 110.876 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.5 p -103.15 127.07 57.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 171.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 8.1 m -86.11 -52.74 5.49 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 120.991 0.424 . . . . 0.0 110.601 -174.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -133.83 133.65 41.86 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -94.74 124.47 38.8 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.742 0.782 . . . . 0.0 111.985 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -134.16 159.78 39.84 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -87.33 83.85 7.29 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.989 0.899 . . . . 0.0 108.695 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -107.0 93.61 4.65 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.568 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -131.48 85.91 2.3 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.083 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.7 t60 65.88 15.48 10.08 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.697 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 . . . . . 0 CA--C 1.486 -1.484 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.498 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 54.8 ttp . . . . . 0 C--O 1.217 -0.623 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.38 -54.8 6.88 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.0 m 71.37 149.33 0.09 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.709 1.204 . . . . 0.0 113.471 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.98 74.57 7.97 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 173.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.406 HG23 ' HB2' ' A' ' 71' ' ' GLU . 5.3 p -74.68 135.09 28.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 113.13 -1.85 . . . . 0.0 113.872 -171.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -117.06 -42.64 2.91 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 169.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.9 p -116.69 156.48 27.04 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.739 -175.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 18.7 mt -64.21 -13.38 48.58 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.2 m -68.7 -22.55 64.35 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.566 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.406 ' HB2' HG23 ' A' ' 66' ' ' VAL . 24.4 mt-10 -101.84 6.85 41.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.775 -178.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 69' ' ' LEU . 6.9 m -104.02 137.61 41.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -172.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -83.27 161.01 21.61 Favored 'General case' 0 C--O 1.246 0.903 0 O-C-N 123.282 0.364 . . . . 0.0 110.315 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -117.41 130.32 56.41 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.028 0.531 . . . . 0.0 110.572 -174.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.02 120.7 22.62 Favored Pre-proline 0 C--N 1.311 -1.087 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 75.6 Cg_exo -61.41 140.3 87.07 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.001 1.801 . . . . 0.0 109.593 172.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.67 -12.02 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -170.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.4 t -67.01 -35.87 80.89 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 120.78 0.324 . . . . 0.0 110.832 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -90.34 53.91 2.61 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.38 1.086 . . . . 0.0 110.457 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.542 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -60.56 -20.05 59.28 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.58 -177.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -78.09 -22.88 48.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.479 0.657 . . . . 0.0 109.623 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 m -91.49 0.2 57.54 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.836 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.542 HG12 ' HA ' ' A' ' 80' ' ' ALA . 39.2 mm -78.86 121.46 83.46 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -51.64 130.31 33.15 Favored 'Trans proline' 0 C--O 1.252 1.225 0 C-N-CA 123.596 2.864 . . . . 0.0 114.234 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.8 p -91.43 77.02 5.83 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-O 122.285 1.04 . . . . 0.0 109.248 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.406 ' O ' HG13 ' A' ' 108' ' ' ILE . . . -148.89 176.23 10.59 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.535 -177.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 t -92.19 147.27 23.06 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 160.46 -154.03 25.0 Favored Glycine 0 N--CA 1.415 -2.734 0 C-N-CA 120.117 -1.04 . . . . 0.0 110.967 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.449 HG13 ' CH2' ' A' ' 146' ' ' TRP . 7.6 p -123.62 146.83 28.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -136.09 150.18 49.02 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 120.693 0.282 . . . . 0.0 110.351 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.34 124.37 44.39 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.826 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -97.85 118.99 45.28 Favored 'Isoleucine or valine' 0 C--O 1.264 1.829 0 C-N-CA 123.071 0.548 . . . . 0.0 110.969 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 96.4 m-85 -113.13 145.73 40.44 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.522 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.41 ' C ' ' HA3' ' A' ' 124' ' ' GLY . 4.7 p-10 -89.85 -167.95 2.0 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.524 ' HD2' ' HA2' ' A' ' 124' ' ' GLY . 3.0 mmmp? -69.47 -18.14 63.68 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.773 -0.58 . . . . 0.0 111.572 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 m -85.09 -1.49 56.92 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 60.59 34.1 20.27 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 125.554 1.542 . . . . 0.0 113.55 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 40.5 mt-10 -105.19 154.57 20.03 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.433 174.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.483 HD11 HG13 ' A' ' 102' ' ' VAL . 3.4 tm? -93.19 113.51 25.75 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.725 -172.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.402 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 2.3 mp0 -107.49 -29.32 9.28 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.216 176.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -143.63 138.73 29.2 Favored 'General case' 0 C--O 1.214 -0.771 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.227 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.518 HG23 ' NE1' ' A' ' 143' ' ' TRP . 30.9 m -129.64 148.79 33.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 172.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.66 162.88 31.87 Favored Glycine 0 N--CA 1.422 -2.262 0 C-N-CA 119.989 -1.1 . . . . 0.0 112.382 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.7 pt -118.06 150.37 20.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 123.469 0.707 . . . . 0.0 109.407 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.4 t -157.0 170.36 22.72 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-O 121.288 0.566 . . . . 0.0 110.756 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -90.86 -25.48 19.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.672 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -142.9 90.92 2.24 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 86' ' ' ALA . 78.6 mt -39.21 -60.45 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.777 1.631 . . . . 0.0 114.256 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.51 -41.23 29.36 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.6 -47.77 71.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.043 0.449 . . . . 0.0 110.992 -175.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.1 m -70.88 -40.11 72.44 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.9 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 79.6 t -56.46 -57.16 10.07 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 O-C-N 123.308 0.38 . . . . 0.0 110.786 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.478 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 22.7 t -60.46 -46.84 88.6 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.804 0.69 . . . . 0.0 111.442 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -51.26 -53.18 37.89 Favored 'General case' 0 C--O 1.25 1.114 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -81.95 -22.17 36.83 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 118.791 -1.164 . . . . 0.0 113.674 -178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.8 mt -75.73 -29.71 58.99 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.849 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 113' ' ' SER . 34.1 mmtp -75.62 -24.76 56.52 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 121.67 0.748 . . . . 0.0 109.021 175.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.7 m -76.42 -54.28 6.96 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.587 174.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 m -113.27 90.56 17.01 Favored Pre-proline 0 C--O 1.243 0.712 0 CA-C-O 121.877 0.846 . . . . 0.0 112.852 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.733 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 11.6 Cg_exo -73.85 -3.93 14.58 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.726 2.284 . . . . 0.0 112.253 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.06 -29.72 70.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.504 0.668 . . . . 0.0 109.557 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.9 mt -99.64 10.98 40.4 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.134 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.733 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 83.8 m -72.51 106.01 4.42 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.383 173.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.524 ' HA2' ' HD2' ' A' ' 95' ' ' LYS . . . -148.82 -73.74 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 173.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . 3.6 m -146.51 155.7 42.72 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.05 138.37 47.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 O-C-N 122.0 -0.438 . . . . 0.0 109.924 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.413 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 81.0 mttt -106.12 133.81 50.24 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.74 126.12 74.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.554 0.692 . . . . 0.0 112.188 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -117.02 106.1 1.4 Allowed Glycine 0 N--CA 1.423 -2.191 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.56 111.76 26.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.9 p -92.39 139.54 17.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.54 -44.48 50.89 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.785 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -75.08 114.43 34.99 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 172.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -88.9 37.74 0.42 Allowed 'Trans proline' 0 C--N 1.321 -0.907 0 C-N-CA 122.513 2.142 . . . . 0.0 111.776 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.429 ' HB3' HG22 ' A' ' 138' ' ' VAL . 14.2 t70 -74.11 134.65 42.89 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -177.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -60.7 -29.98 69.67 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -176.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.9 -41.89 61.46 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.429 HG22 ' HB3' ' A' ' 135' ' ' ASP . 16.2 m -69.55 -31.29 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 120.583 -0.447 . . . . 0.0 109.908 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 92.9 mt -64.28 -48.9 73.93 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.971 175.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.9 m -68.33 -34.12 75.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.384 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.596 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 28.9 tt0 -62.87 -50.18 71.9 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.067 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.87 97.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.29 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.518 ' NE1' HG23 ' A' ' 102' ' ' VAL . 90.6 t90 -56.02 -47.13 78.37 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.984 176.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -62.4 -42.61 99.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.078 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 67.9 mt -63.05 -52.22 63.66 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.674 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.449 ' CH2' HG13 ' A' ' 89' ' ' VAL . 28.5 m0 -56.85 -48.24 78.54 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.338 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 151' ' ' ILE . 11.2 tt -63.55 -43.79 98.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.659 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.7 -29.99 70.61 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 9.5 mm-40 -64.53 -41.77 96.18 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.017 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.45 ' HA ' HG22 ' A' ' 153' ' ' VAL 0.261 60.5 m-70 -76.89 -29.94 55.98 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.505 -0.878 . . . . 0.0 112.853 178.067 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 147' ' ' ILE . 71.9 mt -58.29 -37.98 66.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 171.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -78.82 -49.82 12.32 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.45 HG22 ' HA ' ' A' ' 150' ' ' HIS . 27.8 m -78.7 -20.85 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -174.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 156' ' ' LYS . 6.8 t -138.01 -31.27 0.78 Allowed 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.299 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 88.65 11.2 66.33 Favored Glycine 0 CA--C 1.502 -0.735 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.018 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.413 ' H ' HG23 ' A' ' 154' ' ' THR . 44.7 mmtm -83.13 103.94 12.94 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.33 0.586 . . . . 0.0 110.592 -177.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.4 p -140.49 76.1 25.72 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.293 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 14.1 Cg_exo -73.67 159.47 45.65 Favored 'Trans proline' 0 C--O 1.249 1.035 0 C-N-CA 123.194 2.596 . . . . 0.0 112.349 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.5 -23.88 26.55 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.995 3.13 . . . . 0.0 113.958 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -59.14 -41.82 96.81 Favored Glycine 0 CA--C 1.497 -1.037 0 CA-C-O 121.104 0.28 . . . . 0.0 112.671 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.5 -30.83 57.38 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.926 0.87 . . . . 0.0 108.971 -175.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -87.45 1.23 54.02 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.193 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 47.2 t 71.13 112.53 0.06 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 122.016 0.912 . . . . 0.0 109.12 -170.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -176.17 -54.14 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -79.32 112.67 16.79 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 172.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -83.46 11.22 7.27 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.1 p -75.21 -22.13 58.18 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-O 121.423 0.63 . . . . 0.0 110.607 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -82.56 -29.57 30.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.534 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.6 m -103.72 -4.43 9.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.507 0.67 . . . . 0.0 110.305 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 49.2 tptt 77.51 -61.81 0.4 Allowed 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.415 1.886 . . . . 0.0 111.451 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 29.6 m -81.98 156.19 4.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-O 120.734 0.302 . . . . 0.0 110.304 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 16.3 m -88.37 96.27 10.52 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.877 0.37 . . . . 0.0 111.099 -175.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.77 -60.06 2.37 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.3 147.47 23.17 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 71.27 159.69 0.21 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 124.887 1.367 . . . . 0.0 107.599 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -100.69 140.27 35.2 Favored 'General case' 0 C--N 1.286 -2.173 0 O-C-N 120.399 -1.438 . . . . 0.0 112.586 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -69.79 97.29 1.07 Allowed 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.749 0.785 . . . . 0.0 111.069 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -85.96 122.44 30.0 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.708 -177.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -69.27 119.1 13.02 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 7.0 t60 . . . . . 0 C--N 1.298 -1.658 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.739 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 CA--C 1.499 -0.989 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.35 111.73 22.98 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.5 m -69.82 120.92 16.3 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.909 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.452 ' HA ' HG23 ' A' ' 131' ' ' VAL . . . -120.07 112.48 19.18 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.8 133.74 31.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.661 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.56 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 7.8 mmpt? -88.06 -70.13 0.65 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.27 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.663 ' HB3' ' OE1' ' A' ' 149' ' ' GLU . 66.6 m -133.04 175.49 9.33 Favored 'General case' 0 N--CA 1.422 -1.843 0 O-C-N 122.015 -0.428 . . . . 0.0 111.448 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.2 mt -70.76 -23.52 62.43 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 m -69.83 -15.85 63.17 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.189 0.995 . . . . 0.0 109.323 176.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -107.83 8.21 28.58 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.63 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.6 m -103.7 142.09 34.94 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.58 149.24 40.2 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 123.735 0.647 . . . . 0.0 111.284 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.11 133.07 51.39 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.8 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.73 128.73 24.53 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -67.41 142.85 61.28 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.786 1.657 . . . . 0.0 109.357 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.42 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -69.16 -11.79 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.422 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.3 p -66.53 -37.75 85.68 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.505 0.669 . . . . 0.0 110.249 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -95.14 50.89 1.29 Allowed 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.845 0.831 . . . . 0.0 110.525 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.409 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -59.78 -27.76 66.84 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.944 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -73.26 -20.92 60.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.532 0.682 . . . . 0.0 110.39 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.0 m -95.99 7.52 46.16 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.406 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' A' ' 80' ' ' ALA . 46.1 mm -78.1 130.59 71.97 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -53.07 132.1 46.08 Favored 'Trans proline' 0 C--O 1.242 0.725 0 C-N-CA 123.417 2.745 . . . . 0.0 113.457 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.9 p -95.3 34.74 1.38 Allowed 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.306 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.402 ' O ' HG13 ' A' ' 108' ' ' ILE . . . -101.98 179.36 4.35 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.957 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 t -95.97 140.04 31.3 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.3 -154.08 24.08 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 119.915 -1.136 . . . . 0.0 111.998 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.585 HG12 HG22 ' A' ' 104' ' ' ILE . 4.4 m -108.29 146.83 13.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 123.823 0.849 . . . . 0.0 109.88 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -141.36 154.98 45.96 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB1' ' CD2' ' A' ' 99' ' ' LEU . . . -135.06 126.45 28.47 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.278 -178.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.63 122.05 52.15 Favored 'Isoleucine or valine' 0 C--O 1.269 2.107 0 CA-C-O 120.932 0.396 . . . . 0.0 110.463 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 77.5 m-85 -109.43 137.92 46.56 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.888 1.275 . . . . 0.0 108.759 177.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -83.61 -166.86 1.5 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.516 ' HE3' ' O ' ' A' ' 123' ' ' CYS . 8.2 mptt -65.21 -26.42 68.12 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 122.913 0.485 . . . . 0.0 111.209 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.8 m -85.51 1.25 49.72 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 122.816 0.447 . . . . 0.0 110.591 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 65.7 28.72 11.02 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 123.87 0.868 . . . . 0.0 111.21 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 156' ' ' LYS . 45.4 mt-10 -100.26 123.32 44.36 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.618 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.481 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.0 tm? -70.04 127.74 33.88 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.199 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.457 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 43.6 mt-30 -126.99 -43.31 1.68 Allowed 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.992 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -126.06 121.51 33.17 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 118.819 -1.153 . . . . 0.0 112.143 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.412 HG13 HD11 ' A' ' 99' ' ' LEU . 19.5 m -112.1 151.72 14.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.99 160.73 30.61 Favored Glycine 0 N--CA 1.425 -2.094 0 C-N-CA 119.382 -1.389 . . . . 0.0 112.655 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.585 HG22 HG12 ' A' ' 89' ' ' VAL . 15.2 pt -119.07 137.3 53.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 m -152.34 166.36 32.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.914 0.387 . . . . 0.0 111.676 -177.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -85.11 -32.68 22.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.066 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -127.7 106.01 8.85 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 86' ' ' ALA . 73.9 mt -61.74 -59.61 4.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.624 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.94 -56.74 5.08 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.2 95.05 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.982 0.176 . . . . 0.0 111.276 -177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.4 m -64.28 -47.84 78.01 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.715 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.75 -55.09 26.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.005 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.9 m -57.33 -42.55 82.14 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.073 0.858 . . . . 0.0 111.781 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.98 -56.43 21.81 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 122.695 0.398 . . . . 0.0 111.889 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.27 23.7 p80 -71.61 -22.16 61.75 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.0 mt -73.75 -27.24 61.07 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.12 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -87.56 -15.67 36.78 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.253 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.5 m -87.02 -42.89 12.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.335 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.7 p -135.21 91.46 19.19 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-O 121.722 0.773 . . . . 0.0 110.007 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.631 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 7.4 Cg_exo -75.01 12.35 1.24 Allowed 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 123.396 2.73 . . . . 0.0 114.11 -176.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.38 -42.98 96.96 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.99 0.424 . . . . 0.0 109.958 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 39.7 mt -94.87 18.26 12.18 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.184 -176.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.631 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 84.8 m -76.85 85.6 3.42 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.467 0.651 . . . . 0.0 112.486 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -128.74 -59.59 0.11 Allowed Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 11.3 p -164.7 158.05 17.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -132.23 141.02 46.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -109.44 138.81 45.25 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 135.06 65.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.085 0.469 . . . . 0.0 110.739 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.3 99.75 0.74 Allowed Glycine 0 N--CA 1.419 -2.497 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.66 108.86 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.532 HG22 ' H ' ' A' ' 133' ' ' GLU . 7.7 p -99.06 131.03 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.73 8.37 10.18 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.579 0.704 . . . . 0.0 111.977 -175.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.532 ' H ' HG22 ' A' ' 131' ' ' VAL . 31.8 mt-10 -124.84 91.73 48.92 Favored Pre-proline 0 N--CA 1.421 -1.879 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 171.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.65 31.52 0.48 Allowed 'Trans proline' 0 N--CA 1.481 0.794 0 C-N-CA 123.102 2.534 . . . . 0.0 112.083 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.41 141.69 28.97 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.214 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -58.34 -26.57 63.25 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -67.14 -44.91 78.63 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.3 t -75.53 -40.05 40.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.402 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.22 -51.42 70.04 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.797 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 29.3 m -67.58 -32.42 73.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.011 0.434 . . . . 0.0 110.539 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.52 ' O ' HD22 ' A' ' 145' ' ' LEU . 51.7 tt0 -64.35 -56.7 12.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.264 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.27 92.28 Favored 'General case' 0 C--O 1.225 -0.197 0 O-C-N 123.221 0.326 . . . . 0.0 110.147 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -53.69 -43.77 69.22 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.733 0.813 . . . . 0.0 109.726 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.573 ' HE3' ' OE1' ' A' ' 148' ' ' GLU . 56.9 tptt -64.27 -43.98 93.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.361 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 141' ' ' GLN . 2.5 mm? -64.3 -42.57 96.3 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.735 178.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -62.09 -49.14 77.12 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.063 -0.972 . . . . 0.0 112.044 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.516 ' O ' HG13 ' A' ' 151' ' ' ILE . 13.7 tt -69.21 -45.74 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.258 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.573 ' OE1' ' HE3' ' A' ' 144' ' ' LYS . 30.5 mt-10 -68.64 -29.61 68.13 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -175.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.663 ' OE1' ' HB3' ' A' ' 68' ' ' SER . 5.4 pt-20 -67.09 -42.72 84.14 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 118.459 -1.297 . . . . 0.0 108.683 176.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.437 ' N ' ' HG3' ' A' ' 149' ' ' GLU 0.263 24.5 m-70 -74.88 -23.38 58.38 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -179.287 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 147' ' ' ILE . 76.8 mt -66.87 -30.47 49.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -84.42 -42.57 15.52 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 149' ' ' GLU . 5.2 p -80.94 -51.47 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.0 p -96.79 -28.63 14.18 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 121.663 -0.648 . . . . 0.0 111.931 -176.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.96 29.92 62.72 Favored Glycine 0 N--CA 1.467 0.702 0 CA-C-N 114.727 -1.124 . . . . 0.0 115.415 174.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 26.1 mtpp -91.47 -70.58 0.68 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 117.391 0.595 . . . . 0.0 110.702 -176.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.289 7.7 p 41.4 83.27 0.21 Allowed Pre-proline 0 CA--C 1.567 1.613 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 58.9 Cg_endo -70.11 169.26 19.79 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.945 2.43 . . . . 0.0 112.593 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -45.75 -25.7 2.69 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 125.175 3.917 . . . . 0.0 115.694 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -57.64 -47.84 85.66 Favored Glycine 0 C--O 1.238 0.365 0 O-C-N 123.55 0.532 . . . . 0.0 113.388 -175.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -85.72 -20.36 29.45 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 121.005 0.431 . . . . 0.0 111.785 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -64.26 -71.54 0.17 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.872 175.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 30.8 p 178.35 151.85 0.29 Allowed 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.383 0.673 . . . . 0.0 109.58 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.21 178.4 15.86 Favored Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.154 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -102.4 110.83 22.9 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -118.38 161.76 19.44 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.4 m -60.31 -19.03 53.5 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.201 1.4 . . . . 0.0 111.341 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -70.88 -27.77 64.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.108 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.52 -28.77 2.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 65.81 -83.53 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.097 1.359 . . . . 0.0 111.75 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 29.9 m -125.12 -0.41 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-O 121.079 0.466 . . . . 0.0 110.219 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 50.3 m -81.96 71.54 9.0 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 122.255 1.026 . . . . 0.0 111.224 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -116.32 119.94 37.31 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 171.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . 0.25 11.2 pt-20 -75.49 75.47 2.54 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.859 1.314 . . . . 0.0 113.334 -176.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -140.65 88.92 2.23 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -80.33 85.41 5.82 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 119.334 -0.947 . . . . 0.0 108.998 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -48.83 117.84 2.28 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.194 -1.821 . . . . 0.0 112.334 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -147.86 80.5 1.49 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.929 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -86.34 82.16 8.09 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.566 -0.853 . . . . 0.0 111.2 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 . . . . . 0 C--N 1.313 -0.978 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.353 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.51 -0.565 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.09 97.64 6.93 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.7 m -88.58 -41.63 12.56 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.102 0.477 . . . . 0.0 109.733 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.74 142.62 3.74 Favored 'General case' 0 C--O 1.25 1.082 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' A' ' 71' ' ' GLU . 7.2 p -64.82 125.58 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 124.326 1.016 . . . . 0.0 109.833 177.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -100.05 -53.73 3.07 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.809 0.814 . . . . 0.0 108.937 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.2 m -136.78 172.48 12.95 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.482 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.51 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 61.3 mt -59.87 -16.14 26.74 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.8 1.24 . . . . 0.0 114.241 -175.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.424 HG23 ' HG3' ' A' ' 71' ' ' GLU . 12.5 t -65.32 -19.97 66.19 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.24 0.616 . . . . 0.0 111.164 176.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.442 ' HB2' HG23 ' A' ' 66' ' ' VAL . 31.7 mt-10 -106.45 -7.36 17.62 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.426 0.631 . . . . 0.0 110.263 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.51 ' OG1' ' HA ' ' A' ' 69' ' ' LEU . 4.4 m -84.94 129.6 34.78 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.131 -172.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -81.56 150.99 27.92 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.806 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -104.99 129.1 53.51 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 123.277 0.631 . . . . 0.0 109.657 -175.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.2 140.27 35.71 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -68.27 145.56 66.42 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.532 2.155 . . . . 0.0 110.133 173.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -13.54 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-O 121.429 0.633 . . . . 0.0 110.667 -177.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.4 t -78.42 -15.1 59.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -97.95 47.89 1.01 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.804 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.513 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -61.42 -28.95 69.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.295 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -69.18 -26.02 64.64 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.001 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.7 m -90.87 -5.53 55.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.393 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.513 HG12 ' HA ' ' A' ' 80' ' ' ALA . 44.1 mm -70.16 125.28 91.92 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -178.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.51 134.96 66.99 Favored 'Trans proline' 0 C--O 1.244 0.823 0 C-N-CA 123.049 2.5 . . . . 0.0 113.399 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.8 p -91.81 26.77 2.28 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.925 0.869 . . . . 0.0 109.727 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.91 -178.73 4.18 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.405 -173.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.5 t -95.83 138.85 32.89 Favored 'General case' 0 N--CA 1.425 -1.704 0 O-C-N 124.034 0.833 . . . . 0.0 109.404 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.46 -151.22 20.25 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 118.503 -1.808 . . . . 0.0 114.422 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.416 ' HB ' ' CH2' ' A' ' 146' ' ' TRP . 5.6 t -120.34 150.28 23.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -139.25 149.26 44.12 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.346 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.14 120.59 34.67 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 123.918 0.887 . . . . 0.0 109.32 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.7 t -99.69 121.76 50.73 Favored 'Isoleucine or valine' 0 C--O 1.263 1.804 0 CA-C-O 121.059 0.457 . . . . 0.0 110.608 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -109.66 132.06 54.49 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.45 -172.48 4.16 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.774 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.54 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -65.18 -22.27 66.88 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.382 0.673 . . . . 0.0 112.201 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.9 m -84.68 0.39 50.53 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 123.001 0.52 . . . . 0.0 109.986 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 69.33 16.55 8.35 Favored 'General case' 0 C--O 1.249 1.079 0 C-N-CA 125.023 1.329 . . . . 0.0 111.707 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -86.84 135.77 33.21 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.124 0.488 . . . . 0.0 110.322 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.489 HD11 HG13 ' A' ' 102' ' ' VAL . 3.4 tm? -80.75 112.22 17.93 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 174.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -125.0 -13.72 6.78 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.944 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.429 ' HA ' ' OD1' ' A' ' 161' ' ' ASN . 57.4 t80 -145.83 122.65 11.26 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 118.707 -1.197 . . . . 0.0 111.08 177.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' A' ' 147' ' ' ILE . 18.6 m -123.27 141.32 44.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 171.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -157.23 157.91 28.47 Favored Glycine 0 N--CA 1.413 -2.895 0 C-N-CA 119.068 -1.539 . . . . 0.0 111.719 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.7 pt -110.91 137.84 41.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 121.192 0.52 . . . . 0.0 109.733 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.5 m -149.77 136.41 19.28 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HD2' ' C ' ' A' ' 106' ' ' ARG . 4.5 ppt_? -76.74 -12.0 59.92 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.751 0.786 . . . . 0.0 109.894 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -133.7 86.76 2.32 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.6 mt -55.68 -55.32 18.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.157 -174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.64 -60.25 2.3 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.05 -37.99 87.06 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.033 0.208 . . . . 0.0 111.432 -176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.7 t -63.65 -55.32 24.42 Favored 'General case' 0 C--O 1.248 0.985 0 O-C-N 123.836 0.71 . . . . 0.0 109.913 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.9 t -57.94 -51.61 68.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.351 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.9 m -60.1 -37.92 81.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.327 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.13 -58.86 6.8 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 120.937 0.399 . . . . 0.0 111.47 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -77.63 -22.36 50.84 Favored 'General case' 0 C--O 1.203 -1.367 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.04 -26.03 25.58 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 119.062 -1.055 . . . . 0.0 113.326 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -88.12 -16.95 32.09 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.3 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -94.81 -20.1 19.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.004 0.43 . . . . 0.0 111.158 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.9 p -152.73 94.0 3.19 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-O 121.809 0.814 . . . . 0.0 110.534 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.667 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 16.1 Cg_exo -68.84 14.28 0.2 Allowed 'Trans proline' 0 CA--C 1.556 1.579 0 C-N-CA 124.123 3.215 . . . . 0.0 116.729 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -66.39 -28.27 68.5 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 121.464 -0.773 . . . . 0.0 111.503 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.418 ' HG ' ' CZ ' ' A' ' 168' ' ' PHE . 61.9 mt -107.25 20.86 18.38 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 121.683 -0.636 . . . . 0.0 111.502 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.667 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 89.4 m -79.68 99.05 7.21 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.73 -65.28 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.6 p -160.05 162.05 34.09 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.095 0.558 . . . . 0.0 109.52 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.38 137.78 43.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-O 121.155 0.503 . . . . 0.0 110.375 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.509 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 79.5 mttt -109.11 137.27 47.27 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.36 138.69 53.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 120.57 0.224 . . . . 0.0 110.863 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.72 113.34 1.85 Allowed Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.32 107.59 18.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 p -93.53 143.22 11.97 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.572 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -58.63 -50.21 74.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.275 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -94.52 119.42 66.35 Favored Pre-proline 0 C--N 1.303 -1.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.176 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.07 27.16 0.62 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.066 2.51 . . . . 0.0 110.877 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.15 133.56 50.04 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.402 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -59.54 -33.77 71.82 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.85 -42.24 58.34 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.55 -43.07 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.004 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.69 -49.26 78.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.74 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 44.8 m -69.1 -31.1 69.58 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.084 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.492 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 27.9 tt0 -63.26 -50.64 69.36 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 122.946 0.498 . . . . 0.0 109.884 178.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.85 -45.26 93.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.698 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -51.13 -46.69 62.02 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.251 1.021 . . . . 0.0 110.284 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -61.0 -48.82 80.04 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.179 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 61.7 mt -62.8 -43.23 99.35 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.79 -176.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.416 ' CH2' ' HB ' ' A' ' 89' ' ' VAL . 30.8 m0 -61.48 -47.51 85.35 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.21 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.514 ' O ' HG13 ' A' ' 151' ' ' ILE . 14.9 tt -67.68 -39.75 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.404 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -62.74 -33.71 75.69 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 153' ' ' VAL . 7.3 mm-40 -55.24 -45.95 76.02 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.401 0.619 . . . . 0.0 109.685 173.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.468 ' HA ' HG12 ' A' ' 153' ' ' VAL 0.255 74.3 m-70 -80.5 -27.36 37.74 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.295 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 147' ' ' ILE . 79.8 mt -61.29 -41.07 88.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -71.06 -43.98 66.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.326 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 150' ' ' HIS . 7.3 p -81.7 -56.4 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.4 p -99.47 -34.36 10.3 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 121.811 -0.556 . . . . 0.0 112.264 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.74 34.67 27.21 Favored Glycine 0 C--N 1.304 -1.226 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.715 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -106.83 106.49 17.05 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.76 87.52 46.41 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 173.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -86.14 169.87 8.53 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 123.896 3.064 . . . . 0.0 113.251 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -45.23 -30.57 5.3 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 124.928 3.752 . . . . 0.0 116.177 -175.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.76 -30.31 72.67 Favored Glycine 0 C--O 1.246 0.896 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.312 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 101' ' ' PHE . 14.7 m120 -101.47 -21.07 14.87 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -68.8 162.62 25.96 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 38.3 m -69.03 103.53 1.88 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.791 0.805 . . . . 0.0 111.38 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 156.67 -158.55 28.84 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -125.18 167.72 14.43 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -162.09 160.26 27.16 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.6 m -52.98 -25.36 11.77 Favored 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 124.284 1.033 . . . . 0.0 112.412 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.418 ' CZ ' ' HG ' ' A' ' 122' ' ' LEU . 64.6 m-85 -84.78 -4.47 59.07 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 177.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.17 -34.12 5.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -176.16 140.51 0.4 Allowed 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 28.5 m -75.31 116.72 18.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 121.614 0.721 . . . . 0.0 112.321 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 16.7 m -105.58 -17.16 14.5 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.942 176.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.34 107.91 19.07 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -96.43 -46.17 6.48 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.378 1.085 . . . . 0.0 109.009 -178.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -86.34 99.89 11.92 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.221 -170.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -70.32 142.16 52.24 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.621 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -100.14 107.59 19.5 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 70.43 109.06 0.06 Allowed 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 123.984 0.914 . . . . 0.0 112.082 -171.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -121.76 14.46 10.89 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 . . . . . 0 N--CA 1.421 -1.886 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -176.236 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.36 27.54 15.51 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.597 1.159 . . . . 0.0 112.978 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 m -95.03 31.47 1.88 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 122.018 0.913 . . . . 0.0 110.676 -176.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.11 155.18 26.47 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.1 t -89.6 120.22 38.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-O 120.687 0.28 . . . . 0.0 110.551 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.429 ' HD3' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -106.32 -47.89 3.7 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 177.713 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.7 m -114.41 168.98 9.38 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.331 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 146' ' ' TRP . 2.9 tm? -65.32 -35.0 79.65 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.429 1.092 . . . . 0.0 109.829 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.8 m -55.97 -28.69 58.2 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.798 176.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -93.94 -4.08 50.45 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.752 -0.593 . . . . 0.0 111.575 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.548 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.3 m -78.02 141.67 38.73 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -173.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -88.45 148.64 24.08 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.659 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.06 133.94 48.16 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 122.84 0.456 . . . . 0.0 109.94 -174.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -126.44 126.45 24.61 Favored Pre-proline 0 C--N 1.315 -0.928 0 C-N-CA 123.652 0.781 . . . . 0.0 108.902 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.522 ' HB2' HG22 ' A' ' 78' ' ' THR . 25.5 Cg_exo -67.67 141.85 56.28 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 121.843 1.695 . . . . 0.0 109.139 172.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -5.0 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -174.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 76' ' ' PRO . 9.1 t -68.32 -30.0 68.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -99.43 52.97 0.94 Allowed 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.364 1.078 . . . . 0.0 109.61 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.55 -24.11 66.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.102 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -76.32 -19.41 58.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.782 0.801 . . . . 0.0 110.244 176.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.3 t -87.49 -6.97 58.15 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.243 -174.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.7 mm -67.43 125.84 91.71 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.391 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -53.77 137.37 67.45 Favored 'Trans proline' 0 C--O 1.243 0.739 0 C-N-CA 123.584 2.856 . . . . 0.0 113.95 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.8 p -93.69 35.72 1.12 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.25 1.024 . . . . 0.0 109.129 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.445 ' O ' HG13 ' A' ' 108' ' ' ILE . . . -102.64 175.37 5.52 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.229 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.7 t -97.53 134.76 40.32 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.28 -154.88 24.68 Favored Glycine 0 N--CA 1.412 -2.902 0 C-N-CA 119.952 -1.118 . . . . 0.0 111.069 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.458 ' HB ' ' CH2' ' A' ' 146' ' ' TRP . 3.2 t -115.24 156.44 16.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -145.61 149.52 34.68 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.58 121.97 35.15 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.462 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.9 t -94.93 118.74 41.75 Favored 'Isoleucine or valine' 0 C--O 1.259 1.558 0 CA-C-O 121.332 0.587 . . . . 0.0 110.351 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.559 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 7.3 m-85 -108.82 134.49 51.44 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.367 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.92 -179.33 6.92 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -73.99 3.18 7.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -175.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.5 m -94.18 0.0 55.49 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 171.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 t70 61.51 62.94 1.24 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.036 1.334 . . . . 0.0 108.538 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -141.39 146.49 36.67 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.3 -177.698 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.418 HD11 HG13 ' A' ' 102' ' ' VAL . 3.3 tm? -96.3 116.67 29.4 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.92 0.762 . . . . 0.0 110.745 -172.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.467 ' HA ' ' HG2' ' A' ' 158' ' ' PRO . 2.4 mp0 -112.08 -28.39 8.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.329 178.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -145.91 127.07 14.72 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.12 -1.032 . . . . 0.0 112.493 -175.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.434 HG23 ' NE1' ' A' ' 143' ' ' TRP . 20.0 m -114.98 143.55 24.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 172.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.46 170.38 31.03 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.4 pt -133.14 146.84 31.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.1 t -151.22 162.42 40.92 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.979 -0.289 . . . . 0.0 110.29 -176.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -85.38 -22.67 28.3 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -142.43 86.16 1.94 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 86' ' ' ALA . 73.0 mt -43.94 -52.45 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.663 1.185 . . . . 0.0 113.304 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.65 -40.33 19.52 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.78 -51.76 37.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.444 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.9 m -63.19 -45.92 89.5 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.688 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.31 -57.13 11.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.33 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.4 t -62.94 -40.89 99.01 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 123.404 0.44 . . . . 0.0 111.13 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.69 -54.31 47.67 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.261 19.7 p80 -78.69 -25.79 44.81 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 118.922 -1.111 . . . . 0.0 113.94 -177.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 70.5 mt -75.19 -28.35 59.97 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 119.781 -0.767 . . . . 0.0 112.127 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -86.11 -23.34 26.67 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.738 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.1 m -72.89 -46.36 53.2 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.4 p -139.26 91.69 11.02 Favored Pre-proline 0 N--CA 1.438 -1.075 0 CA-C-O 122.22 1.009 . . . . 0.0 110.022 177.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -74.84 29.75 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.945 3.096 . . . . 0.0 113.82 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -70.83 -42.87 69.64 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.362 0.601 . . . . 0.0 110.533 -177.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.62 21.29 4.08 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.219 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 35.9 m -71.56 99.32 2.04 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.334 0.587 . . . . 0.0 111.856 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.32 -59.9 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.1 p -164.72 160.84 20.24 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.79 138.01 46.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.548 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 97.9 mttt -106.71 135.36 48.38 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.0 m -120.88 131.41 72.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 120.81 0.338 . . . . 0.0 110.1 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -115.81 106.58 1.57 Allowed Glycine 0 N--CA 1.408 -3.228 0 C-N-CA 119.868 -1.158 . . . . 0.0 111.85 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 mp -82.23 112.37 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.25 144.26 20.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.31 4.51 53.37 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.204 -171.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -94.58 112.4 57.69 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -84.73 8.32 4.7 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 122.592 2.195 . . . . 0.0 116.065 -170.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.407 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 16.1 t70 -97.64 146.81 24.95 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.131 -174.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -54.85 -34.67 63.16 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.692 1.197 . . . . 0.0 111.891 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.96 -44.23 90.08 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 120.658 0.266 . . . . 0.0 110.665 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.46 -36.38 48.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.615 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 95.1 mt -60.82 -45.08 95.86 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.1 m -71.94 -32.14 67.02 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 121.072 0.463 . . . . 0.0 110.698 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.437 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 26.6 tt0 -63.69 -46.31 86.06 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 175.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.77 -42.25 95.24 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.843 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.434 ' NE1' HG23 ' A' ' 102' ' ' VAL . 91.9 t90 -49.83 -45.89 50.67 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.488 0.715 . . . . 0.0 109.633 176.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.643 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 84.6 mttt -62.09 -50.74 70.74 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.13 177.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 86.9 mt -54.32 -47.54 72.36 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.532 0.52 . . . . 0.0 110.679 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 69' ' ' LEU . 14.3 m0 -62.02 -54.46 41.26 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.538 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.446 ' O ' HG12 ' A' ' 151' ' ' ILE . 11.1 tt -59.19 -42.78 87.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 O-C-N 123.424 0.452 . . . . 0.0 110.274 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 37.3 mt-10 -56.01 -47.67 77.34 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 123.547 0.53 . . . . 0.0 110.913 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.404 ' O ' HG22 ' A' ' 153' ' ' VAL . 15.4 mt-10 -56.86 -47.02 81.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.41 ' HA ' HG22 ' A' ' 153' ' ' VAL . 0.6 OUTLIER -82.83 -28.2 30.33 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 118.496 -1.282 . . . . 0.0 112.751 -176.11 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.523 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 38.2 pt -76.85 -26.77 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.906 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -78.5 -30.9 47.47 Favored 'General case' 0 C--N 1.264 -3.123 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.079 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 150' ' ' HIS . 35.1 m -86.57 -46.33 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 176.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 70.8 p -99.99 -19.02 16.76 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 119.409 -0.917 . . . . 0.0 113.031 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 151' ' ' ILE . . . 67.52 34.69 84.99 Favored Glycine 0 N--CA 1.468 0.822 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 174.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -78.95 -74.94 0.26 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 117.1 0.45 . . . . 0.0 111.958 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.41 HG12 ' CG ' ' A' ' 162' ' ' LYS . 5.1 t 54.13 69.52 2.12 Favored Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 123.865 0.866 . . . . 0.0 109.014 -174.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.467 ' HG2' ' HA ' ' A' ' 100' ' ' GLN . 2.8 Cg_exo -81.44 156.94 19.27 Favored 'Trans proline' 0 C--O 1.242 0.696 0 C-N-CA 122.804 2.336 . . . . 0.0 112.84 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.92 -35.92 41.96 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 124.298 3.332 . . . . 0.0 114.159 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -64.86 -30.52 78.21 Favored Glycine 0 CA--C 1.498 -1.011 0 O-C-N 123.336 0.397 . . . . 0.0 112.933 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.42 ' OD1' HG22 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -94.27 -29.57 15.0 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -176.593 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.41 ' CG ' HG12 ' A' ' 157' ' ' VAL . 60.4 mtpt -71.47 -54.0 12.07 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.879 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.2 m -112.27 154.61 25.36 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.433 -173.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -88.23 9.23 75.92 Favored Glycine 0 C--N 1.316 -0.574 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.977 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -118.11 110.65 17.88 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 122.171 -0.605 . . . . 0.0 109.971 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -179.84 158.55 0.78 Allowed 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 22.3 m -56.34 -32.9 65.13 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 118.321 0.509 . . . . 0.0 111.391 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -70.69 -11.91 61.23 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.1 t -118.83 7.34 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 122.122 0.963 . . . . 0.0 109.097 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -92.38 36.8 0.99 Allowed 'General case' 0 C--N 1.316 -0.891 0 O-C-N 121.668 -0.645 . . . . 0.0 112.179 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.1 t -85.85 82.93 2.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.835 0.826 . . . . 0.0 110.909 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -93.5 153.97 18.16 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 170.817 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.31 -46.25 74.09 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 119.502 1.046 . . . . 0.0 111.261 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.46 32.94 2.61 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 120.952 0.406 . . . . 0.0 110.578 176.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.429 ' HB2' ' HB ' ' A' ' 172' ' ' THR . 12.4 t60 -68.23 -42.39 79.84 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -79.3 124.48 28.43 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 171.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -100.47 113.79 26.85 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -57.31 -34.55 68.84 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.904 0.753 . . . . 0.0 111.624 -174.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -97.67 90.59 5.05 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--N 1.299 -1.626 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.535 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.7 mptt . . . . . 0 C--O 1.205 -1.253 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.417 ' HB3' ' OE2' ' A' ' 149' ' ' GLU . 15.6 m -113.32 164.64 13.31 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.568 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.402 HD13 ' OH ' ' A' ' 93' ' ' TYR . 35.0 mt -62.33 -28.02 69.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.159 0.983 . . . . 0.0 111.404 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 m -59.45 -21.91 60.73 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.033 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -104.92 11.58 33.43 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 122.717 0.407 . . . . 0.0 110.264 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.436 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 8.1 m -104.7 142.9 33.88 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -173.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -86.26 159.64 19.38 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.506 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.11 133.35 53.12 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.524 HD23 HG22 ' A' ' 128' ' ' VAL . 3.7 mm? -128.17 138.87 33.92 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -74.93 143.53 29.41 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.41 2.074 . . . . 0.0 110.573 173.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.62 -15.74 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-O 120.913 0.387 . . . . 0.0 112.01 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p -71.77 -38.21 70.38 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 121.615 0.722 . . . . 0.0 111.183 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -93.16 54.2 2.09 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.873 0.844 . . . . 0.0 110.645 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.52 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -56.38 -18.41 10.91 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.425 -1.261 . . . . 0.0 112.981 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -72.25 -27.25 62.39 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.52 0.676 . . . . 0.0 109.692 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.9 m -93.89 3.3 55.6 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.977 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.52 HG12 ' HA ' ' A' ' 80' ' ' ALA . 38.1 mm -79.63 128.56 74.34 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.26 130.65 41.79 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.957 2.438 . . . . 0.0 113.335 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.1 p -92.9 39.01 1.03 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.224 1.011 . . . . 0.0 109.475 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -109.55 177.63 4.68 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.259 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.6 t -93.94 140.53 29.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.75 -155.08 26.15 Favored Glycine 0 N--CA 1.417 -2.62 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.641 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.477 HG13 ' CH2' ' A' ' 146' ' ' TRP . 6.3 p -121.23 149.17 24.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -137.63 149.58 46.72 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 120.848 0.356 . . . . 0.0 110.543 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.403 ' HB1' HD23 ' A' ' 99' ' ' LEU . . . -122.14 118.65 29.18 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.79 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.6 t -91.78 121.0 41.87 Favored 'Isoleucine or valine' 0 C--O 1.263 1.787 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.367 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 67.4 m-85 -108.76 130.0 55.37 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.691 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -76.91 -175.08 3.35 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.231 0.539 . . . . 0.0 110.257 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.464 ' H ' ' HD2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -57.83 -28.09 63.76 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 124.14 0.976 . . . . 0.0 113.547 -178.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.7 m -91.74 3.45 55.07 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.803 0.335 . . . . 0.0 111.492 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.4 t70 62.33 67.75 0.71 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-O 122.724 1.25 . . . . 0.0 111.598 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 8.1 mm-40 -136.82 145.73 44.82 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.556 -1.656 . . . . 0.0 109.814 174.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.512 HD21 HG13 ' A' ' 102' ' ' VAL . 3.0 tm? -89.87 116.71 28.15 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.308 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -122.86 -14.49 7.64 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.259 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.58 115.03 5.91 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.819 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.512 HG13 HD21 ' A' ' 99' ' ' LEU . 12.3 m -111.21 142.26 24.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.79 159.76 29.81 Favored Glycine 0 N--CA 1.424 -2.14 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.227 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.2 pt -115.09 139.94 38.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.5 m -151.0 157.77 43.3 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.635 ' HD3' ' O ' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -79.3 -23.32 43.61 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -135.49 105.39 6.2 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 173.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.4 mt -60.14 -56.94 14.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.38 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.95 -50.73 45.56 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.559 0.744 . . . . 0.0 112.767 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.23 -52.19 66.73 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 123.75 0.656 . . . . 0.0 111.109 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.1 t -61.26 -48.62 80.6 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.293 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 54.7 t -56.9 -54.48 29.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 123.103 0.561 . . . . 0.0 111.097 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.0 m -61.04 -35.53 77.15 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 123.607 0.567 . . . . 0.0 111.463 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.91 -58.96 3.97 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.836 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.287 19.6 p80 -74.8 -24.66 58.68 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -175.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.6 mt -77.93 -24.82 48.14 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.217 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 117' ' ' LYS . 73.0 mmtt -85.49 -16.82 38.31 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.867 175.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.0 t -80.55 -50.48 9.95 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.58 85.0 61.3 Favored Pre-proline 0 CA--C 1.557 1.236 0 CA-C-O 122.341 1.067 . . . . 0.0 109.929 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.494 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 16.6 Cg_exo -71.87 12.02 0.62 Allowed 'Trans proline' 0 N--CA 1.479 0.623 0 C-N-CA 124.031 3.154 . . . . 0.0 114.806 -176.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -66.47 -39.32 88.73 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.341 0.591 . . . . 0.0 109.886 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.8 mt -88.16 20.71 3.08 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.092 0.473 . . . . 0.0 111.802 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.494 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 89.2 m -79.99 99.44 7.64 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 121.497 0.665 . . . . 0.0 111.069 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.43 -64.64 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 174.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.4 p -161.43 162.92 30.73 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.9 p -137.14 137.05 46.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.436 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 94.8 mttt -106.4 125.56 51.15 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 175.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.524 HG22 HD23 ' A' ' 75' ' ' LEU . 33.0 m -115.34 134.35 58.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.412 0.625 . . . . 0.0 111.929 -174.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.65 96.16 0.63 Allowed Glycine 0 N--CA 1.422 -2.249 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 130' ' ' ILE . 2.6 mp -89.27 121.37 39.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 133' ' ' GLU . 10.2 p -116.12 125.25 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 175.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -72.38 -8.87 57.24 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.461 ' H ' HG22 ' A' ' 131' ' ' VAL . 38.3 mt-10 -89.62 122.06 68.55 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -83.12 27.12 0.62 Allowed 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.769 2.313 . . . . 0.0 113.224 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.432 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 24.2 t70 -78.96 129.38 34.42 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.532 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -69.9 -31.15 68.79 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.422 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.72 -38.45 62.29 Favored 'General case' 0 C--O 1.203 -1.37 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.297 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.401 HG23 ' OD2' ' A' ' 135' ' ' ASP . 97.6 t -59.09 -43.75 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 92.4 mt -59.08 -48.4 81.75 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.345 0.593 . . . . 0.0 110.244 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.6 m -70.69 -34.3 71.82 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.272 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.45 -47.05 74.4 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 123.109 0.564 . . . . 0.0 109.759 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.83 -49.25 78.43 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -49.17 -43.9 42.38 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.002 0.921 . . . . 0.0 110.305 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -65.55 -48.71 71.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.43 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.64 -37.12 85.09 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.773 0.321 . . . . 0.0 110.871 177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.477 ' CH2' HG13 ' A' ' 89' ' ' VAL . 25.0 m0 -63.47 -53.55 50.29 Favored 'General case' 0 C--O 1.254 1.333 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.53 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.465 ' HB ' HG21 ' A' ' 102' ' ' VAL . 11.8 tt -63.41 -41.21 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.829 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -60.24 -36.94 78.9 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 153' ' ' VAL . 24.4 mt-10 -54.96 -46.97 75.11 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 118.94 0.791 . . . . 0.0 110.56 176.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.504 ' CG ' ' HB3' ' A' ' 99' ' ' LEU 0.323 18.9 m-70 -77.85 -29.81 50.67 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 118.769 -1.172 . . . . 0.0 114.011 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 147' ' ' ILE . 68.7 mt -60.68 -44.87 98.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 172.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.27 -48.65 64.44 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.433 HG22 ' HA ' ' A' ' 150' ' ' HIS . 21.8 m -80.01 -32.1 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -175.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.7 t -131.7 -30.21 1.66 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.44 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.41 15.61 56.78 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.642 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -77.11 120.56 22.37 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 42.8 t -138.46 80.65 26.57 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -77.69 161.48 30.71 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.431 2.754 . . . . 0.0 113.278 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -52.84 -23.77 21.81 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 124.543 3.495 . . . . 0.0 114.197 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.4 -29.97 75.77 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.574 -0.346 . . . . 0.0 112.87 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 C--N 1.314 -0.947 0 CA-C-O 122.347 1.07 . . . . 0.0 110.17 -178.609 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.2 m -123.25 -179.08 4.18 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.76 -17.75 63.46 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.3 m -63.69 -26.76 68.81 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.789 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -84.16 -20.53 32.29 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.436 0.636 . . . . 0.0 109.668 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.487 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 2.7 m -76.82 154.35 33.98 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.036 -0.983 . . . . 0.0 113.512 -168.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -100.9 158.61 15.86 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.887 0.875 . . . . 0.0 109.133 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.68 128.82 55.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.98 0.419 . . . . 0.0 110.175 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.492 HD23 HG22 ' A' ' 128' ' ' VAL . 3.9 mm? -123.01 129.09 25.1 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -65.39 143.84 77.82 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 121.663 1.575 . . . . 0.0 108.74 170.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.596 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -65.12 -13.19 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -176.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.8 p -76.12 -16.22 59.93 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.56 0.695 . . . . 0.0 110.809 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -92.97 30.58 1.57 Allowed 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -49.53 -40.33 37.52 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.532 1.133 . . . . 0.0 113.414 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -72.95 -17.95 61.43 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.642 0.734 . . . . 0.0 110.789 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.0 m -103.65 -1.05 28.75 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.389 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 80' ' ' ALA . 48.4 mm -65.38 134.07 95.57 Favored Pre-proline 0 C--O 1.243 0.731 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.59 129.92 31.48 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.84 2.36 . . . . 0.0 112.205 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.4 p -99.16 49.51 0.95 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.872 0.844 . . . . 0.0 109.922 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -124.99 -179.44 4.55 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.983 -176.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.7 t -95.37 145.02 25.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.27 -156.5 28.43 Favored Glycine 0 N--CA 1.414 -2.79 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.538 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.574 HG12 HG22 ' A' ' 104' ' ' ILE . 3.2 m -110.67 151.05 12.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 123.996 0.918 . . . . 0.0 109.916 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -141.85 147.18 36.76 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 120.713 0.292 . . . . 0.0 110.214 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.91 122.22 37.38 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.77 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.57 117.05 40.21 Favored 'Isoleucine or valine' 0 C--O 1.26 1.655 0 C-N-CA 123.377 0.671 . . . . 0.0 110.36 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.621 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 47.1 m-85 -107.39 134.5 50.36 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -79.94 -167.93 1.45 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.262 0.554 . . . . 0.0 112.114 -174.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -56.88 -32.56 65.98 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.244 1.417 . . . . 0.0 110.667 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.9 m -90.72 7.42 39.65 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.924 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 69.93 16.45 7.67 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.347 1.07 . . . . 0.0 111.055 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -92.3 139.63 30.41 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 120.93 -1.106 . . . . 0.0 110.327 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.621 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.3 tm? -82.43 129.68 34.95 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.645 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -125.78 -43.52 1.85 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 123.771 0.669 . . . . 0.0 111.078 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -124.29 131.09 53.5 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.835 -171.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.9 m -123.02 151.85 27.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 174.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -158.82 168.67 35.01 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.282 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.574 HG22 HG12 ' A' ' 89' ' ' VAL . 9.5 pt -120.35 144.76 28.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 123.259 0.624 . . . . 0.0 109.958 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 71.1 m -150.03 154.64 38.51 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.916 0.389 . . . . 0.0 111.61 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -78.59 -28.16 45.73 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -142.23 103.16 4.24 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.4 mt -55.2 -54.7 21.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.462 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.14 -43.79 64.21 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.08 -54.8 24.39 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 123.381 0.426 . . . . 0.0 111.904 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.1 m -70.86 -41.14 71.8 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.81 -56.74 15.38 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.8 m -58.3 -40.22 81.41 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 123.753 0.658 . . . . 0.0 111.228 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.03 -55.64 30.39 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 120.989 0.423 . . . . 0.0 111.281 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -75.03 -27.39 60.04 Favored 'General case' 0 C--O 1.21 -0.99 0 C-N-CA 119.275 -0.97 . . . . 0.0 113.265 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.442 HD22 ' SG ' ' A' ' 123' ' ' CYS . 64.5 mt -76.33 -24.49 54.28 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.051 -0.659 . . . . 0.0 112.061 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -88.71 -11.21 45.82 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.305 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.2 m -90.64 -43.62 10.05 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.89 175.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.31 93.85 24.72 Favored Pre-proline 0 CA--C 1.551 1.008 0 CA-C-O 121.826 0.822 . . . . 0.0 110.727 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.82 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 6.2 Cg_exo -77.41 10.65 2.4 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.388 2.725 . . . . 0.0 113.779 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.13 -42.33 85.58 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.695 0.798 . . . . 0.0 112.259 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.3 mt -105.84 20.67 18.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.181 0.515 . . . . 0.0 110.432 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.82 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 81.5 m -80.72 88.62 5.76 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -127.0 -55.11 0.14 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.9 p -158.76 162.73 37.13 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.99 136.22 42.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.487 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 67.6 mttm -106.6 125.54 51.14 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.492 HG22 HD23 ' A' ' 75' ' ' LEU . 32.8 m -114.51 133.54 60.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.102 0.477 . . . . 0.0 111.292 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.13 104.32 1.0 Allowed Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 mp -87.72 133.22 30.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 133' ' ' GLU . 14.5 p -122.46 151.68 26.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -95.61 7.0 47.53 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.69 0.757 . . . . 0.0 110.425 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.426 ' H ' HG22 ' A' ' 131' ' ' VAL . 36.5 mt-10 -127.08 99.88 27.88 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.789 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -84.84 34.03 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.388 2.726 . . . . 0.0 113.511 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -85.07 140.13 31.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -58.7 -28.31 65.67 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.98 -43.07 62.66 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -66.09 -42.51 91.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.11 -46.69 87.95 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.704 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 43.2 m -71.27 -28.22 63.99 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.748 0.309 . . . . 0.0 110.755 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.2 -54.6 42.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.83 -41.16 99.21 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 123.928 0.767 . . . . 0.0 110.148 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.47 ' O ' HG22 ' A' ' 147' ' ' ILE . 90.4 t90 -53.51 -46.88 70.26 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.735 0.814 . . . . 0.0 109.39 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -57.79 -50.98 71.45 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.424 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 4.0 mm? -57.7 -49.61 75.95 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.297 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -57.69 -51.99 67.26 Favored 'General case' 0 C--O 1.255 1.353 0 O-C-N 124.488 1.117 . . . . 0.0 112.23 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.583 ' O ' HG12 ' A' ' 151' ' ' ILE . 11.7 tt -70.21 -51.07 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.4 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.88 -33.12 74.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 153' ' ' VAL . 10.1 pt-20 -63.86 -42.88 97.43 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.17 177.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -74.88 -27.21 60.14 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 147' ' ' ILE . 44.8 mm -62.09 -45.66 98.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.05 -37.95 78.84 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.649 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 149' ' ' GLU . 5.5 p -88.52 -60.13 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.1 p -90.71 -28.72 18.14 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 70.81 34.86 66.05 Favored Glycine 0 N--CA 1.467 0.761 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.018 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 99' ' ' LEU . 71.9 mmtt -87.36 114.98 24.46 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 122.528 0.331 . . . . 0.0 110.521 -176.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.9 t -133.9 87.86 34.04 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -88.2 153.28 6.85 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.826 2.351 . . . . 0.0 112.358 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.98 -27.39 28.26 Favored 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 123.908 3.072 . . . . 0.0 113.245 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -63.51 -37.57 94.99 Favored Glycine 0 CA--C 1.502 -0.778 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.86 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 C--N 1.306 -1.313 0 CA-C-O 121.243 0.544 . . . . 0.0 109.934 -177.321 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 C--O 1.214 -0.793 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.8 m -134.7 169.48 17.26 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.912 -0.492 . . . . 0.0 110.882 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.7 mt -58.33 -22.85 54.75 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.334 1.053 . . . . 0.0 112.107 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.456 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 38.2 m -60.68 -44.16 96.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 124.116 0.966 . . . . 0.0 112.067 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.456 ' OE2' ' HB ' ' A' ' 70' ' ' THR . 1.5 mp0 -89.62 3.98 50.89 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.126 0.488 . . . . 0.0 110.25 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.549 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 3.2 m -92.96 128.45 38.82 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.501 -175.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 16.6 pt-20 -78.69 159.19 28.11 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 122.74 0.416 . . . . 0.0 110.982 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.51 125.26 54.01 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 122.659 0.384 . . . . 0.0 110.583 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -124.19 131.09 24.17 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.416 ' HD2' ' HG3' ' A' ' 79' ' ' GLU . 24.2 Cg_exo -65.89 149.68 86.28 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 121.988 1.792 . . . . 0.0 110.014 173.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.412 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -71.91 -12.29 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.874 -0.516 . . . . 0.0 111.814 -176.481 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.4 p -78.02 -17.79 56.67 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.171 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.416 ' HG3' ' HD2' ' A' ' 76' ' ' PRO . 21.8 mm-40 -94.14 38.93 1.08 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.521 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -57.93 -29.5 65.18 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.053 0.941 . . . . 0.0 112.496 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.27 -20.76 60.03 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.374 0.606 . . . . 0.0 110.4 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.7 m -96.88 6.71 48.14 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.519 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.521 HG12 ' HA ' ' A' ' 80' ' ' ALA . 45.2 mm -77.43 123.03 86.86 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -56.22 130.39 39.92 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.976 2.451 . . . . 0.0 113.695 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.1 p -91.6 76.26 5.78 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.344 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.3 177.79 8.37 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.629 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.9 t -91.18 137.72 32.15 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.401 ' HA2' HG12 ' A' ' 131' ' ' VAL . . . 164.46 -149.56 16.65 Favored Glycine 0 N--CA 1.414 -2.833 0 C-N-CA 119.482 -1.342 . . . . 0.0 112.732 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.508 HG13 ' CH2' ' A' ' 146' ' ' TRP . 4.8 p -128.34 149.75 33.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -136.25 157.14 47.53 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.436 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . . . -127.69 114.83 17.84 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 123.775 0.83 . . . . 0.0 109.442 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.1 t -89.0 119.25 35.8 Favored 'Isoleucine or valine' 0 C--O 1.264 1.834 0 CA-C-O 120.944 0.402 . . . . 0.0 111.008 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 7.3 m-85 -103.35 127.18 50.76 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.165 0.986 . . . . 0.0 109.052 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -79.52 -168.54 1.58 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.555 0.693 . . . . 0.0 112.242 -173.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -57.7 -41.46 81.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.683 1.193 . . . . 0.0 109.993 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.8 t -84.83 12.11 7.99 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.841 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 70.94 20.17 5.45 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 32.7 mt-10 -103.62 148.83 25.54 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 118.865 -1.134 . . . . 0.0 112.211 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.422 HD23 ' HB1' ' A' ' 91' ' ' ALA . 2.1 tm? -80.02 117.72 21.11 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.813 174.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 158' ' ' PRO . 1.7 mp0 -113.85 -39.51 3.97 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.15 173.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -124.45 115.25 20.61 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.564 -1.254 . . . . 0.0 112.248 -171.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.409 HG23 ' NE1' ' A' ' 143' ' ' TRP . 22.3 m -98.55 147.22 7.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 172.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.19 147.79 17.94 Favored Glycine 0 C--N 1.283 -2.396 0 C-N-CA 118.876 -1.631 . . . . 0.0 112.418 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.4 pt -112.7 138.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 m -152.52 161.54 42.44 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 106' ' ' ARG . 16.0 tpt180 -81.68 -22.56 37.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.502 0.668 . . . . 0.0 109.875 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.439 HD22 ' H ' ' A' ' 110' ' ' ALA . 6.6 t30 -141.91 100.2 3.69 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.1 mt -48.61 -58.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.91 1.284 . . . . 0.0 113.528 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.63 -53.89 13.5 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' H ' HD22 ' A' ' 107' ' ' ASN . . . -59.47 -36.47 76.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.424 -177.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.4 t -76.11 -52.01 11.03 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.6 t -55.63 -54.45 25.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.429 0.691 . . . . 0.0 111.785 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 m -59.93 -47.77 84.43 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.405 0.44 . . . . 0.0 111.218 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.34 -55.2 36.58 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.257 24.1 p80 -76.84 -25.51 53.28 Favored 'General case' 0 C--O 1.216 -0.658 0 C-N-CA 118.516 -1.274 . . . . 0.0 113.959 -175.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 72.2 mt -77.91 -36.17 49.82 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.499 -0.88 . . . . 0.0 112.056 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -75.97 -19.12 58.99 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.451 -0.899 . . . . 0.0 110.645 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 57.3 m -80.3 -42.71 22.55 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.754 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -134.9 95.06 15.74 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 121.912 0.863 . . . . 0.0 110.804 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.74 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 83.1 Cg_endo -81.42 24.4 0.7 Allowed 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 123.418 2.745 . . . . 0.0 114.633 -174.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -67.41 -34.26 76.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.826 0.822 . . . . 0.0 110.254 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.8 mt -109.37 20.78 17.86 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.242 0.544 . . . . 0.0 110.549 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.74 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 67.5 m -81.14 84.06 6.64 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -122.93 -58.12 0.2 Allowed Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 174.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 12.4 p -163.18 169.19 19.68 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 123.652 0.781 . . . . 0.0 109.048 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.95 139.59 36.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-O 121.257 0.551 . . . . 0.0 109.852 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.549 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 89.4 mttt -106.34 132.51 52.3 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.72 139.18 45.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.274 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.95 101.21 0.61 Allowed Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.61 120.67 35.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.401 HG12 ' HA2' ' A' ' 88' ' ' GLY . 7.7 p -110.06 130.86 62.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -79.32 -19.08 51.24 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.09 0.471 . . . . 0.0 111.845 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -105.14 101.02 28.0 Favored Pre-proline 0 N--CA 1.435 -1.18 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -86.11 36.24 0.5 Allowed 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 123.061 2.507 . . . . 0.0 112.449 -173.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.69 137.37 54.08 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -61.25 -31.49 71.29 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 123.066 0.229 . . . . 0.0 111.475 -173.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.14 -35.27 66.47 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.814 0.34 . . . . 0.0 110.148 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 63.9 t -69.74 -41.44 79.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.316 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.8 mt -59.52 -48.12 82.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.064 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.7 m -64.58 -36.51 84.48 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.553 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -62.69 -52.29 63.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.083 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.43 -46.06 91.41 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.163 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.409 ' NE1' HG23 ' A' ' 102' ' ' VAL . 86.4 t90 -51.09 -48.84 61.57 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 123.944 0.778 . . . . 0.0 109.421 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.554 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 88.5 tttt -63.58 -57.17 10.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.072 -177.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.506 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 10.4 mp -58.32 -41.65 85.02 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.508 ' CH2' HG13 ' A' ' 89' ' ' VAL . 30.0 m0 -57.79 -52.35 65.83 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-O 120.739 0.304 . . . . 0.0 111.723 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.478 ' O ' HG13 ' A' ' 151' ' ' ILE . 14.5 tt -66.93 -39.07 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.765 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 53.0 mt-10 -60.65 -39.42 88.23 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 21.7 mm-40 -56.67 -44.49 81.45 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.97 0.414 . . . . 0.0 110.853 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -76.73 -30.26 56.54 Favored 'General case' 0 C--O 1.249 1.068 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.535 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 147' ' ' ILE . 74.7 mt -67.12 -45.7 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 122.23 0.212 . . . . 0.0 111.263 178.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -62.46 -38.68 90.75 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 149' ' ' GLU . 7.7 p -81.23 -54.63 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.417 HG23 HG13 ' A' ' 153' ' ' VAL . 69.2 p -105.82 -36.28 7.07 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.148 -173.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.68 17.95 57.45 Favored Glycine 0 C--N 1.311 -0.811 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.71 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -75.27 107.29 7.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 117.105 0.453 . . . . 0.0 109.82 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.2 106.75 33.15 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.406 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 13.1 Cg_endo -90.36 162.37 4.54 Favored 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 122.908 2.405 . . . . 0.0 112.913 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.66 -25.39 80.81 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.107 2.538 . . . . 0.0 112.844 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -64.87 -33.65 87.8 Favored Glycine 0 C--N 1.33 0.224 0 N-CA-C 114.348 0.499 . . . . 0.0 114.348 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.428 HD22 ' HA ' ' A' ' 161' ' ' ASN . 3.3 m120 . . . . . 0 C--O 1.246 0.888 0 CA-C-O 121.454 0.645 . . . . 0.0 111.922 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? . . . . . 0 N--CA 1.439 -0.99 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.2 p -107.28 156.72 18.57 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.98 -175.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.16 -24.17 66.6 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.37 1.068 . . . . 0.0 109.882 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.1 m -60.0 -26.88 66.4 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.218 1.007 . . . . 0.0 110.68 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -93.52 -10.42 34.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.385 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.484 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 3.1 m -81.13 126.15 31.12 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -172.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 12.3 pt-20 -79.85 155.45 27.82 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.916 0.388 . . . . 0.0 111.942 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -103.13 128.75 49.94 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 123.633 0.773 . . . . 0.0 109.873 -174.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -122.46 136.15 26.27 Favored Pre-proline 0 C--N 1.307 -1.255 0 C-N-CA 123.767 0.827 . . . . 0.0 109.212 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -73.52 140.02 29.31 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.355 2.037 . . . . 0.0 109.84 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.5 -11.24 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -174.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.8 t -71.41 -23.89 61.95 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.021 0.438 . . . . 0.0 110.308 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.96 53.79 0.68 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.208 1.004 . . . . 0.0 110.244 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.507 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -62.35 -22.11 65.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.177 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.85 -16.55 60.68 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.747 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.3 m -94.14 -1.9 53.51 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.099 0.476 . . . . 0.0 110.419 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 80' ' ' ALA . 43.4 mm -77.05 129.79 77.38 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.04 129.81 36.25 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.94 2.426 . . . . 0.0 113.236 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.5 p -90.81 65.77 5.87 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.633 0.73 . . . . 0.0 109.615 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.98 -177.88 4.83 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.999 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.3 t -99.03 143.34 29.42 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.37 -147.78 13.74 Favored Glycine 0 N--CA 1.415 -2.756 0 C-N-CA 119.462 -1.352 . . . . 0.0 112.725 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.512 HG13 ' CH2' ' A' ' 146' ' ' TRP . 5.0 p -127.34 149.0 32.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 C-N-CA 123.542 0.737 . . . . 0.0 109.235 -174.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -141.49 156.01 45.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 120.832 0.348 . . . . 0.0 110.197 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.46 121.08 33.88 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.299 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 50.2 t -96.88 119.03 44.41 Favored 'Isoleucine or valine' 0 C--O 1.259 1.557 0 CA-C-O 121.25 0.548 . . . . 0.0 110.582 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 47.3 m-85 -110.69 137.24 48.61 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.305 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 98' ' ' GLU . 2.8 p30 -80.58 -169.46 2.15 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.736 -0.785 . . . . 0.0 110.657 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -57.73 -23.78 53.68 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.371 1.069 . . . . 0.0 112.688 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.2 t -108.91 17.53 21.67 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 120.718 0.294 . . . . 0.0 111.143 -174.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.2 t70 66.71 20.78 10.67 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 123.028 1.394 . . . . 0.0 110.713 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.49 ' HB2' ' OD2' ' A' ' 94' ' ' ASP . 80.5 mm-40 -83.64 104.26 13.62 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.856 175.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.555 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.0 tm? -66.19 115.46 6.21 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 174.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.432 ' HB3' ' HG2' ' A' ' 158' ' ' PRO . 43.1 mt-30 -122.64 -13.5 7.94 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -148.17 125.4 11.51 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.169 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.492 HG13 HD11 ' A' ' 99' ' ' LEU . 21.9 m -117.08 143.77 26.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 171.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -150.66 157.58 27.26 Favored Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 119.693 -1.241 . . . . 0.0 112.249 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.2 pt -117.36 134.55 60.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.2 m -146.49 161.96 39.33 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.009 0.433 . . . . 0.0 111.574 -175.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -76.9 -34.25 57.73 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.255 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -132.71 109.31 9.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.8 mt -56.76 -58.14 6.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.774 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.85 -50.26 64.12 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.1 -50.27 72.61 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.569 0.543 . . . . 0.0 111.193 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.4 t -63.3 -52.14 63.17 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.213 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.5 t -55.54 -53.94 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 C-N-CA 123.012 0.525 . . . . 0.0 110.529 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.3 m -58.32 -47.49 83.55 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 123.792 0.683 . . . . 0.0 111.381 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.58 -58.18 8.87 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 123.483 0.489 . . . . 0.0 111.617 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -72.13 -26.4 62.1 Favored 'General case' 0 C--O 1.209 -1.066 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.8 mt -74.78 -28.01 60.56 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.416 -0.913 . . . . 0.0 111.159 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -87.08 -3.75 59.1 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.433 0.635 . . . . 0.0 110.483 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.9 m -95.28 -51.07 4.75 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.16 97.95 27.84 Favored Pre-proline 0 N--CA 1.428 -1.539 0 CA-C-O 121.597 0.713 . . . . 0.0 111.108 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.807 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 6.5 Cg_exo -77.53 24.64 0.5 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.66 2.907 . . . . 0.0 113.156 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -62.17 -41.39 98.27 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.301 1.04 . . . . 0.0 110.72 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.3 mt -119.94 21.19 11.99 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.099 -172.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.807 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 72.9 m -74.27 88.99 2.03 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.169 0.509 . . . . 0.0 112.276 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.39 -55.18 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.4 p -161.97 161.6 28.68 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.6 p -139.75 139.28 38.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 120.982 0.42 . . . . 0.0 110.372 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.484 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 63.0 mttm -108.03 129.72 55.11 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 26.2 m -120.16 139.35 47.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.884 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.24 114.44 1.64 Allowed Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.66 113.42 26.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.6 p -101.25 142.46 15.97 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -88.46 -5.61 58.14 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.204 0.526 . . . . 0.0 111.907 -171.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -125.93 92.27 46.45 Favored Pre-proline 0 N--CA 1.43 -1.445 0 CA-C-O 121.683 0.754 . . . . 0.0 109.222 174.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.39 46.75 1.89 Allowed 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 123.617 2.878 . . . . 0.0 111.892 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -80.54 141.53 35.03 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -53.26 -39.34 63.8 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.66 -38.53 64.92 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.486 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.9 t -70.52 -40.39 77.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.957 0.408 . . . . 0.0 110.149 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 92.6 mt -61.1 -48.03 83.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.347 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 36.4 m -68.47 -30.61 69.51 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.913 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.519 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 58.4 tt0 -62.93 -54.13 43.3 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.82 96.82 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 123.932 0.77 . . . . 0.0 109.869 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.459 ' NE1' HG23 ' A' ' 102' ' ' VAL . 89.9 t90 -52.31 -49.31 64.45 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.923 0.764 . . . . 0.0 109.755 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -63.03 -47.08 84.56 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.416 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.572 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 80.5 mt -59.2 -49.54 77.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.079 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.512 ' CH2' HG13 ' A' ' 89' ' ' VAL . 26.0 m0 -62.56 -48.26 80.27 Favored 'General case' 0 C--O 1.256 1.402 0 O-C-N 123.995 0.81 . . . . 0.0 112.068 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.599 ' O ' HG12 ' A' ' 151' ' ' ILE . 9.1 tt -63.01 -43.25 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.364 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.522 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 31.9 mt-10 -60.42 -29.91 69.29 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 6.6 mm-40 -59.68 -49.31 78.22 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.443 ' HA ' HG22 ' A' ' 153' ' ' VAL 0.259 17.2 m-70 -78.5 -22.08 47.96 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -178.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 147' ' ' ILE . 48.3 mm -60.51 -42.6 91.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 148' ' ' GLU . 39.9 mttm -81.6 -46.34 14.55 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.176 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 149' ' ' GLU . 30.7 m -78.73 -46.49 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.4 p -110.88 -6.56 14.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 119.04 -1.064 . . . . 0.0 112.697 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.42 26.12 70.48 Favored Glycine 0 C--N 1.336 0.541 0 O-C-N 123.742 0.651 . . . . 0.0 113.803 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -91.36 109.02 20.29 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.18 0.514 . . . . 0.0 112.041 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 t -131.41 78.94 70.79 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.432 ' HG2' ' HB3' ' A' ' 100' ' ' GLN . 5.0 Cg_endo -90.4 160.53 4.51 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.177 2.585 . . . . 0.0 112.426 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.54 -34.27 19.68 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 124.354 3.37 . . . . 0.0 115.047 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -69.34 -27.38 73.67 Favored Glycine 0 CA--C 1.501 -0.833 0 C-N-CA 121.375 -0.44 . . . . 0.0 112.595 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.416 ' ND2' HD12 ' A' ' 147' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.312 -1.05 0 CA-C-O 121.244 0.545 . . . . 0.0 109.75 -177.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp . . . . . 0 C--O 1.219 -0.528 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.51 ' HB2' ' OE1' ' A' ' 149' ' ' GLU . 36.9 p -149.65 170.3 19.01 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.98 -176.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.48 HD22 ' HD2' ' A' ' 127' ' ' LYS . 17.8 mt -71.4 -23.45 61.88 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 123.423 0.689 . . . . 0.0 110.31 177.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 m -63.6 -25.51 68.26 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.862 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -102.7 8.08 39.61 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.1 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.405 ' HB ' ' HD3' ' A' ' 127' ' ' LYS . 22.5 m -103.57 141.06 36.67 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 122.001 -0.437 . . . . 0.0 110.768 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.01 151.41 35.62 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-O 120.921 0.391 . . . . 0.0 111.116 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -107.0 133.17 52.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.678 -173.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.33 132.07 24.31 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 123.312 0.645 . . . . 0.0 109.551 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -70.47 139.41 37.72 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.333 2.022 . . . . 0.0 109.48 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.76 -7.05 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -174.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 t -69.7 -31.13 68.99 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.103 0.478 . . . . 0.0 109.726 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -98.49 53.68 1.04 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.901 0.858 . . . . 0.0 109.767 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.94 -28.62 57.75 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.842 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.36 -33.17 65.44 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.245 1.018 . . . . 0.0 111.627 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.8 m -96.88 12.59 31.69 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -172.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.6 mm -80.93 128.13 72.38 Favored Pre-proline 0 N--CA 1.446 -0.642 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.73 130.74 40.15 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.143 2.562 . . . . 0.0 114.128 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.1 p -92.97 31.68 1.38 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 122.178 0.99 . . . . 0.0 110.655 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.75 -179.09 3.84 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.114 -177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 t -93.6 147.86 22.62 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.59 -150.09 21.19 Favored Glycine 0 N--CA 1.419 -2.488 0 C-N-CA 119.692 -1.242 . . . . 0.0 112.686 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.611 HG12 HG22 ' A' ' 104' ' ' ILE . 2.5 m -115.42 149.02 17.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 124.336 1.055 . . . . 0.0 109.55 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -144.22 160.24 41.31 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.408 ' HB1' ' CD2' ' A' ' 99' ' ' LEU . . . -141.02 131.68 25.6 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.707 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.1 t -106.61 126.84 62.4 Favored 'Isoleucine or valine' 0 C--O 1.26 1.615 0 CA-C-O 121.097 0.475 . . . . 0.0 110.669 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -113.19 135.13 54.16 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.469 1.107 . . . . 0.0 108.551 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -85.56 -170.26 3.03 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.553 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.501 ' H ' ' HD2' ' A' ' 95' ' ' LYS . 6.7 mptt -63.06 -25.38 68.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.76 0.824 . . . . 0.0 111.372 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.3 m -82.39 4.78 22.68 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.112 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.5 t70 69.77 19.16 7.28 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.474 1.11 . . . . 0.0 111.621 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -111.12 147.09 35.63 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.596 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.455 HD11 HG13 ' A' ' 102' ' ' VAL . 2.8 tm? -78.27 125.85 29.94 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.264 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -127.92 -13.84 5.12 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 123.925 0.766 . . . . 0.0 112.634 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.457 ' HA ' ' OD1' ' A' ' 161' ' ' ASN . 92.5 t80 -147.63 120.66 8.81 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.515 -0.874 . . . . 0.0 112.741 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.455 HG13 HD11 ' A' ' 99' ' ' LEU . 17.5 m -109.95 142.11 23.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 170.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -146.36 167.76 27.93 Favored Glycine 0 C--N 1.294 -1.759 0 C-N-CA 119.987 -1.101 . . . . 0.0 112.422 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.611 HG22 HG12 ' A' ' 89' ' ' VAL . 15.0 pt -125.86 147.98 30.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.4 t -157.17 164.08 38.17 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.113 0.483 . . . . 0.0 110.032 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.1 -17.9 24.32 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.415 HD22 ' H ' ' A' ' 110' ' ' ALA . 1.6 t30 -142.81 87.09 1.97 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 77.7 mt -47.24 -54.94 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.483 1.113 . . . . 0.0 113.231 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.27 -30.57 12.13 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.415 ' H ' HD22 ' A' ' 107' ' ' ASN . . . -73.54 -57.91 3.67 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.2 m -60.56 -43.95 96.69 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.462 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.7 t -58.48 -60.19 2.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.075 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.6 m -60.73 -44.01 97.18 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 123.827 0.705 . . . . 0.0 110.813 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.39 -50.69 72.57 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.114 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -77.05 -25.27 52.25 Favored 'General case' 0 C--O 1.204 -1.305 0 C-N-CA 118.343 -1.343 . . . . 0.0 112.056 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 64.2 mt -73.93 -28.66 61.63 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.612 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.39 -7.41 59.31 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.294 175.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.7 m -90.01 -52.96 4.7 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.9 m -117.65 102.4 51.7 Favored Pre-proline 0 N--CA 1.435 -1.193 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.817 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 16.4 Cg_exo -73.33 4.03 4.2 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.858 2.372 . . . . 0.0 110.575 173.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -55.83 -44.36 77.87 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 125.328 1.451 . . . . 0.0 111.0 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 75.1 mt -105.35 11.15 33.11 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.407 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.817 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 90.4 m -67.95 96.66 0.61 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.621 0.724 . . . . 0.0 111.873 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.4 -63.31 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.569 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 174.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.3 p -155.64 162.13 40.66 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.35 137.83 33.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.48 ' HD2' HD22 ' A' ' 69' ' ' LEU . 97.4 mttt -108.22 142.21 38.82 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.68 137.57 56.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 120.698 0.285 . . . . 0.0 110.904 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.73 108.92 0.83 Allowed Glycine 0 N--CA 1.423 -2.223 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.51 113.4 23.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 133' ' ' GLU . 7.4 p -100.98 132.32 46.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -69.02 -27.29 65.54 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.9 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.426 ' HB3' HG21 ' A' ' 138' ' ' VAL . 41.1 mt-10 -85.01 110.7 30.35 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -97.07 19.0 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.752 2.301 . . . . 0.0 113.607 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.503 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 14.8 t70 -72.97 140.09 47.16 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -57.93 -33.12 68.46 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.61 -38.73 47.47 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.187 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 135' ' ' ASP . 10.5 m -71.3 -31.96 45.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.316 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.2 mt -62.36 -46.1 90.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.1 m -69.34 -30.59 68.66 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.43 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.491 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 29.7 tt0 -66.68 -47.43 72.46 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 122.781 0.433 . . . . 0.0 110.778 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.22 90.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -50.88 -45.47 60.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.5 1.12 . . . . 0.0 110.027 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.75 -48.09 83.36 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.645 1.178 . . . . 0.0 111.31 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 69.6 mt -63.77 -41.57 97.94 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.128 0.489 . . . . 0.0 110.543 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -62.24 -50.62 71.0 Favored 'General case' 0 C--O 1.257 1.499 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.971 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 151' ' ' ILE . 14.1 tt -66.71 -40.73 86.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.285 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -65.38 -34.44 78.31 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.51 ' OE1' ' HB2' ' A' ' 68' ' ' SER . 3.8 pt-20 -63.12 -37.36 86.91 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 118.282 -1.367 . . . . 0.0 109.225 176.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.443 ' HA ' HG12 ' A' ' 153' ' ' VAL 0.263 72.8 m-70 -73.91 -31.91 63.3 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 177.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 147' ' ' ILE . 71.1 mt -61.35 -38.27 79.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 174.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' A' ' 149' ' ' GLU . 59.4 pttt -83.0 -20.96 34.08 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 149' ' ' GLU . 12.6 p -101.75 -41.42 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.9 t -113.16 -19.33 11.87 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.546 -0.721 . . . . 0.0 111.714 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.58 8.61 82.78 Favored Glycine 0 C--O 1.239 0.44 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.449 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -76.91 128.32 34.33 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.8 p -158.6 77.37 3.3 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 113.192 -1.822 . . . . 0.0 106.725 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -83.42 167.55 13.5 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.925 3.083 . . . . 0.0 113.893 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.18 -13.82 5.49 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 125.184 3.923 . . . . 0.0 115.475 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -70.85 -42.29 61.11 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 175.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' A' ' 101' ' ' PHE . 18.9 m120 . . . . . 0 CA--C 1.496 -1.129 0 CA-C-O 121.007 0.432 . . . . 0.0 110.985 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 N--CA 1.443 -0.798 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.5 p -120.63 176.24 5.61 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.34 -33.0 70.6 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.114 1.366 . . . . 0.0 112.379 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -67.19 -16.25 64.19 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.902 0.858 . . . . 0.0 110.508 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -109.23 13.13 24.54 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.343 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.402 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 13.2 m -105.05 155.28 19.13 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.731 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -94.88 151.61 19.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 125' ' ' SER . 3.1 tm? -104.59 133.22 49.82 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.396 0.617 . . . . 0.0 110.661 -174.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.4 HD23 HG22 ' A' ' 128' ' ' VAL . 3.8 mm? -127.91 136.19 28.63 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 115.098 -0.955 . . . . 0.0 108.601 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -71.16 140.84 38.33 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.209 1.939 . . . . 0.0 109.405 172.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.67 -11.65 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.105 0.478 . . . . 0.0 111.51 -174.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.9 p -68.51 -39.58 81.18 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.09 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -96.95 54.13 1.25 Allowed 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.342 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.531 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -61.9 -17.57 57.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.746 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.78 -23.79 64.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.585 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.9 m -88.69 -0.57 57.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.631 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.531 HG12 ' HA ' ' A' ' 80' ' ' ALA . 45.3 mm -77.82 133.91 65.46 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -56.21 129.61 35.75 Favored 'Trans proline' 0 C--O 1.251 1.155 0 C-N-CA 122.196 1.93 . . . . 0.0 112.413 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.8 p -95.13 70.86 3.28 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 121.873 0.844 . . . . 0.0 108.995 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.06 -176.34 5.05 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.064 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.6 t -97.68 134.82 40.35 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.977 0.418 . . . . 0.0 110.099 -173.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.34 -152.17 19.9 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.517 HG13 ' CH2' ' A' ' 146' ' ' TRP . 6.2 p -124.71 147.34 29.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -177.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -135.95 151.89 50.41 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 120.756 0.312 . . . . 0.0 110.223 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.08 123.16 41.68 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.081 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.5 t -95.46 118.35 41.47 Favored 'Isoleucine or valine' 0 C--O 1.263 1.773 0 C-N-CA 123.387 0.675 . . . . 0.0 110.32 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.501 ' CE1' ' HB2' ' A' ' 99' ' ' LEU . 96.8 m-85 -106.91 134.53 49.93 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.113 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.496 ' O ' ' HA3' ' A' ' 124' ' ' GLY . 3.9 p-10 -78.64 -166.96 0.96 Allowed 'General case' 0 C--N 1.317 -0.822 0 O-C-N 123.666 0.604 . . . . 0.0 111.116 -175.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 123' ' ' CYS . 75.4 mmtt -53.0 -34.57 56.84 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.719 1.208 . . . . 0.0 111.311 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.5 m -82.31 -2.93 54.26 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.192 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.9 t70 67.44 23.44 9.08 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.677 1.191 . . . . 0.0 108.297 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.457 ' OE1' HG21 ' A' ' 154' ' ' THR . 0.1 OUTLIER -99.67 158.71 15.58 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.501 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 3.5 tm? -97.71 124.57 42.09 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.69 0.757 . . . . 0.0 111.612 -169.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.508 HE21 ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -119.75 -45.91 2.48 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.738 173.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -124.88 134.63 52.63 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.525 -173.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.639 HG22 HD21 ' A' ' 161' ' ' ASN . 17.4 m -126.2 145.2 34.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -150.95 155.76 26.32 Favored Glycine 0 N--CA 1.42 -2.379 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.964 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.8 pt -110.56 139.14 35.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.0 t -142.93 155.03 44.64 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.358 0.599 . . . . 0.0 110.664 -175.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -87.04 -26.29 23.8 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -142.93 84.74 1.85 Allowed 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 69.5 mt -44.47 -58.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.245 1.418 . . . . 0.0 114.767 -172.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.2 -44.48 22.37 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.13 -34.29 76.08 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.2 t -79.53 -45.81 18.56 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.9 -53.54 36.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.066 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.4 p -61.63 -44.83 96.25 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 123.47 0.481 . . . . 0.0 111.625 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.13 -61.3 2.56 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -78.14 -23.78 47.61 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 119.014 -1.074 . . . . 0.0 113.827 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.419 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 80.7 mt -81.83 -30.7 32.02 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.413 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -88.21 -9.88 51.58 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.04 -1.064 . . . . 0.0 109.826 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.3 t -82.94 -47.37 11.85 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.34 95.14 18.56 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-O 121.765 0.793 . . . . 0.0 110.339 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.807 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 2.8 Cg_exo -76.65 24.47 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.64 2.893 . . . . 0.0 114.499 -176.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.57 -42.47 82.53 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.428 0.632 . . . . 0.0 111.078 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 75.4 mt -102.95 21.27 15.97 Favored 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.558 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.807 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 84.0 m -85.81 105.03 16.03 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 94' ' ' ASP . . . -137.81 -58.95 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 173.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.471 ' HB2' HD21 ' A' ' 74' ' ' LEU . 56.9 p -156.4 169.09 25.4 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.1 p -142.09 133.97 26.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.092 0.472 . . . . 0.0 109.924 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.402 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 56.4 mttp -106.94 125.83 51.52 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.4 HG22 HD23 ' A' ' 75' ' ' LEU . 28.5 m -113.34 135.22 53.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.254 0.549 . . . . 0.0 111.286 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.77 98.31 0.67 Allowed Glycine 0 N--CA 1.414 -2.798 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.373 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 40.5 mm -75.75 112.44 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.101 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.5 m -98.39 145.95 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.113 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -71.26 -36.94 71.92 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.208 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.49 ' HB2' HG11 ' A' ' 138' ' ' VAL . 18.8 mm-40 -92.39 105.09 12.85 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -93.76 27.78 0.32 Allowed 'Trans proline' 0 C--O 1.243 0.748 0 C-N-CA 122.737 2.291 . . . . 0.0 113.352 -174.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.456 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 15.7 t70 -89.98 144.12 26.19 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -53.38 -34.31 57.17 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.51 68.68 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.49 HG11 ' HB2' ' A' ' 133' ' ' GLU . 21.8 t -69.78 -34.72 61.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.762 -175.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 96.6 mt -62.17 -53.44 55.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.156 175.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.5 m -66.9 -30.48 70.64 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.326 0.584 . . . . 0.0 110.373 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -65.01 -50.91 64.43 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 123.656 0.782 . . . . 0.0 109.425 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.42 -43.61 98.57 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.498 ' NE1' HG23 ' A' ' 102' ' ' VAL . 79.6 t90 -52.73 -46.66 67.51 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.119 176.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -66.79 -44.88 80.1 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.211 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.552 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 11.1 mp -61.14 -41.77 97.33 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.151 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.517 ' CH2' HG13 ' A' ' 89' ' ' VAL . 33.6 m0 -62.38 -50.66 70.69 Favored 'General case' 0 C--O 1.254 1.314 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 151' ' ' ILE . 8.9 tt -62.51 -40.73 89.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.382 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.37 -32.49 74.16 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 22.3 mm-40 -56.12 -41.63 75.57 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.724 0.773 . . . . 0.0 109.96 175.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.415 ' HA ' HG12 ' A' ' 153' ' ' VAL 0.321 5.4 m-70 -83.46 -26.37 30.35 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.297 -1.361 . . . . 0.0 113.768 176.18 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 147' ' ' ILE . 73.6 mt -61.22 -42.61 94.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 O-C-N 121.974 -0.454 . . . . 0.0 110.372 173.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -69.43 -34.7 74.82 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 150' ' ' HIS . 12.1 p -92.01 -40.81 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.457 HG21 ' OE1' ' A' ' 98' ' ' GLU . 3.7 t -118.55 -35.28 3.78 Favored 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -176.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 74.76 34.3 53.65 Favored Glycine 0 N--CA 1.47 0.962 0 C-N-CA 120.429 -0.891 . . . . 0.0 114.207 175.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -65.23 -66.37 0.55 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.28 12.2 p 41.13 75.99 0.55 Allowed Pre-proline 0 CA--C 1.573 1.859 0 C-N-CA 125.002 1.321 . . . . 0.0 113.951 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -90.72 161.49 4.19 Favored 'Trans proline' 0 CA--C 1.556 1.603 0 C-N-CA 123.245 2.63 . . . . 0.0 114.085 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -50.38 -34.12 39.98 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 124.435 3.423 . . . . 0.0 114.472 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -59.35 -45.33 95.62 Favored Glycine 0 CA--C 1.495 -1.194 0 CA-C-O 121.121 0.29 . . . . 0.0 112.762 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.639 HD21 HG22 ' A' ' 102' ' ' VAL . 34.0 t-20 . . . . . 0 C--N 1.301 -1.539 0 CA-C-O 122.42 1.105 . . . . 0.0 108.715 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.485 0 CA-C-O 121.323 0.582 . . . . 0.0 111.578 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.516 ' HA ' ' CD1' ' A' ' 146' ' ' TRP . 70.1 m -147.89 -178.78 6.46 Favored 'General case' 0 N--CA 1.413 -2.278 0 O-C-N 122.001 -0.437 . . . . 0.0 110.495 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -54.44 -24.75 21.39 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.785 1.634 . . . . 0.0 113.725 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.1 m -66.56 -29.14 69.15 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.103 0.478 . . . . 0.0 111.296 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -107.74 11.24 28.5 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.522 0.677 . . . . 0.0 110.911 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.402 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 10.1 m -97.17 136.03 38.27 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.409 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 12.6 pt-20 -74.45 149.59 40.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.705 0.288 . . . . 0.0 111.148 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -112.99 126.2 55.23 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.351 0.66 . . . . 0.0 109.294 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.98 135.11 24.57 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -71.63 138.68 32.6 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.256 1.971 . . . . 0.0 109.189 172.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.4 -8.78 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.262 -176.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.0 t -67.35 -23.04 65.56 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -112.93 53.26 0.76 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.408 ' O ' HG12 ' A' ' 83' ' ' ILE . . . -58.12 -22.81 52.57 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.724 1.21 . . . . 0.0 112.413 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.23 -28.09 69.5 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.369 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.6 t -88.6 9.37 24.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.885 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 80' ' ' ALA . 37.5 mm -80.31 129.05 70.88 Favored Pre-proline 0 C--N 1.314 -0.955 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.43 130.29 39.79 Favored 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.982 2.455 . . . . 0.0 113.34 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.5 p -92.39 80.18 4.94 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.282 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.81 -179.44 6.99 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.469 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.9 t -100.82 134.74 43.35 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.61 -150.2 14.69 Favored Glycine 0 N--CA 1.418 -2.53 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.33 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.53 HG13 ' CH2' ' A' ' 146' ' ' TRP . 7.6 p -122.86 149.78 26.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -137.85 155.3 49.13 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.25 115.58 20.61 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 123.518 0.727 . . . . 0.0 109.559 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.4 t -91.6 121.51 42.14 Favored 'Isoleucine or valine' 0 C--O 1.258 1.528 0 CA-C-O 121.097 0.475 . . . . 0.0 110.944 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.521 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 61.8 m-85 -109.86 131.66 54.86 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 124.154 0.982 . . . . 0.0 108.651 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.501 ' OD1' ' HB2' ' A' ' 98' ' ' GLU . 1.3 p-10 -78.64 -168.16 1.31 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.53 ' H ' ' HD2' ' A' ' 95' ' ' LYS . 8.6 mptt -64.18 -24.92 67.85 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 123.168 0.587 . . . . 0.0 110.812 -176.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.0 m -81.91 2.2 31.64 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.025 0.53 . . . . 0.0 112.065 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.2 t70 68.92 24.76 6.26 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 123.419 1.58 . . . . 0.0 108.866 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.501 ' HB2' ' OD1' ' A' ' 94' ' ' ASP . 24.0 mm-40 -96.73 115.53 27.59 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.689 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.521 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 2.4 tm? -68.68 113.14 5.9 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 173.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.514 ' HB3' ' HG2' ' A' ' 158' ' ' PRO . 22.0 mt-30 -125.31 -13.21 6.71 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.692 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -146.57 114.96 6.7 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.563 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.549 HG21 ' HB ' ' A' ' 147' ' ' ILE . 27.4 m -103.41 149.86 7.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 172.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -160.35 152.47 23.24 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 119.502 -1.333 . . . . 0.0 112.419 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.411 HG22 ' HB ' ' A' ' 89' ' ' VAL . 20.5 pt -112.78 140.51 32.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.0 m -150.89 169.57 21.41 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -76.93 -42.96 37.25 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.455 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -138.8 98.55 3.58 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 65.1 mt -44.13 -57.41 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 125.05 1.34 . . . . 0.0 114.23 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.3 -41.94 63.36 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.76 -41.74 74.77 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.052 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.3 t -66.04 -49.05 69.06 Favored 'General case' 0 C--O 1.254 1.302 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.814 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 72.6 t -57.38 -53.51 42.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.097 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.1 t -62.92 -35.65 80.79 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.362 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.13 -61.77 2.32 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.95 -0.469 . . . . 0.0 112.019 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -79.29 -22.99 43.87 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.413 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 67.8 mt -76.63 -25.34 53.73 Favored 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.403 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -87.75 -18.67 28.91 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.822 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.8 m -74.41 -47.1 35.91 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -138.99 95.07 9.67 Favored Pre-proline 0 CA--C 1.554 1.12 0 CA-C-O 121.807 0.813 . . . . 0.0 110.28 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.598 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 11.7 Cg_exo -74.07 24.13 0.35 Allowed 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 123.859 3.039 . . . . 0.0 115.036 -176.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -65.27 -43.37 91.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.33 0.586 . . . . 0.0 109.87 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.2 mt -99.4 19.91 14.7 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.167 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.598 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 98.3 m -74.01 94.25 2.34 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.347 0.594 . . . . 0.0 111.722 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.84 -68.01 0.06 OUTLIER Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.4 p -159.71 163.26 34.9 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.72 140.7 40.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 120.963 0.411 . . . . 0.0 110.341 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 92.2 mttt -106.11 126.35 52.1 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.6 m -113.38 133.84 57.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.007 0.432 . . . . 0.0 111.405 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -124.82 101.54 0.66 Allowed Glycine 0 N--CA 1.417 -2.596 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -84.72 109.67 18.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.33 164.36 2.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.135 -173.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -59.39 -62.74 1.65 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.775 0.672 . . . . 0.0 110.937 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -99.92 146.55 32.09 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -82.31 32.47 0.52 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 122.405 2.07 . . . . 0.0 109.92 172.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.499 ' HB3' HG22 ' A' ' 138' ' ' VAL . 13.5 t70 -77.01 135.36 38.66 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.653 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -58.81 -31.63 68.63 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.31 -46.04 51.92 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.481 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.499 HG22 ' HB3' ' A' ' 135' ' ' ASP . 11.9 m -68.42 -32.65 56.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.756 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 94.5 mt -65.25 -51.3 61.69 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.903 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.4 m -65.65 -35.32 80.46 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.721 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.508 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 28.2 tt0 -61.67 -52.67 63.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.47 -42.39 99.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.545 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.482 ' NE1' HG23 ' A' ' 102' ' ' VAL . 84.6 t90 -53.5 -50.95 64.3 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.476 0.71 . . . . 0.0 109.497 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 58.9 tttm -59.97 -52.56 64.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.387 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.593 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 85.5 mt -58.54 -49.76 76.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.376 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.53 ' CH2' HG13 ' A' ' 89' ' ' VAL . 41.8 m0 -59.32 -48.77 80.36 Favored 'General case' 0 C--O 1.249 1.038 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.549 ' HB ' HG21 ' A' ' 102' ' ' VAL . 12.6 tt -63.42 -42.75 97.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.795 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.629 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 45.2 mt-10 -62.68 -33.31 74.82 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.72 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 20.6 mm-40 -55.92 -51.06 68.96 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.311 0.577 . . . . 0.0 110.447 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.485 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 2.7 t60 -77.89 -21.19 51.61 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.281 -175.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 147' ' ' ILE . 68.1 mt -68.99 -32.28 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.189 0.519 . . . . 0.0 109.889 175.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 148' ' ' GLU . 74.9 mmtt -77.71 -48.27 17.1 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.058 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 150' ' ' HIS . 7.7 p -71.28 -56.8 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 47.0 p -106.16 -27.59 10.98 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.339 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 151' ' ' ILE . . . 98.11 31.84 6.39 Favored Glycine 0 CA--C 1.502 -0.777 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.947 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -94.25 101.81 13.8 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.8 p -129.45 79.24 74.29 Favored Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.514 ' HG2' ' HB3' ' A' ' 100' ' ' GLN . 4.2 Cg_exo -84.47 165.88 12.31 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.6 2.867 . . . . 0.0 113.738 -172.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -47.87 -27.77 8.99 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 124.889 3.726 . . . . 0.0 114.807 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -63.86 -39.83 97.77 Favored Glycine 0 CA--C 1.523 0.548 0 O-C-N 123.305 0.378 . . . . 0.0 112.473 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 161' ' ' ASN . 2.4 m120 . . . . . 0 CA--C 1.501 -0.936 0 CA-C-O 121.042 0.448 . . . . 0.0 111.202 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.492 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 11.0 mmpt? . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.967 0.413 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 p -78.56 163.48 25.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 123.327 0.651 . . . . 0.0 110.87 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.51 ' HG ' ' CG ' ' A' ' 146' ' ' TRP . 10.7 mt -51.82 -33.26 35.02 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -177.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.8 m -62.35 -25.87 68.14 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.958 0.409 . . . . 0.0 110.71 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -96.98 -12.05 23.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.217 0.532 . . . . 0.0 110.341 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.8 m -78.55 145.96 34.55 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.11 -174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -84.01 153.39 23.88 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.258 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.451 HD21 ' HB2' ' A' ' 125' ' ' SER . 3.4 tm? -108.87 134.81 51.05 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 124.413 1.085 . . . . 0.0 109.684 -173.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 128' ' ' VAL . 3.2 mm? -125.43 138.72 32.34 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -72.63 141.86 35.12 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.71 2.274 . . . . 0.0 110.627 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.58 -13.76 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.451 -176.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.3 t -66.48 -28.86 68.91 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.432 0.634 . . . . 0.0 110.206 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -103.49 53.79 0.76 Allowed 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.929 0.871 . . . . 0.0 109.408 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -57.43 -18.56 18.69 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.789 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.55 -24.34 45.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.013 0.435 . . . . 0.0 110.077 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.1 m -88.43 -1.28 57.95 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.982 0.42 . . . . 0.0 111.234 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 80' ' ' ALA . 44.9 mm -72.18 128.15 89.41 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -51.5 132.67 41.22 Favored 'Trans proline' 0 C--O 1.241 0.657 0 C-N-CA 123.525 2.817 . . . . 0.0 113.147 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.4 p -94.92 28.58 2.68 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.407 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.59 -176.85 3.61 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.027 -176.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.3 t -98.6 145.24 27.04 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.481 ' HA2' HG12 ' A' ' 131' ' ' VAL . . . 159.55 -148.26 16.7 Favored Glycine 0 N--CA 1.416 -2.696 0 C-N-CA 119.802 -1.19 . . . . 0.0 112.729 177.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.68 150.56 29.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -138.31 154.15 49.01 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.97 121.41 34.35 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.628 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.24 124.08 46.59 Favored 'Isoleucine or valine' 0 C--O 1.27 2.146 0 O-C-N 123.641 0.588 . . . . 0.0 110.228 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -114.82 142.02 47.11 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.684 1.194 . . . . 0.0 108.949 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 96' ' ' SER . 4.8 p-10 -90.95 -164.16 1.14 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -70.07 -12.32 61.52 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 122.465 0.306 . . . . 0.0 111.603 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.404 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 5.0 m -94.59 -2.47 51.42 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 66.6 26.78 9.7 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.148 0.979 . . . . 0.0 109.754 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -90.18 127.92 36.23 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-O 121.078 0.466 . . . . 0.0 110.571 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.403 HD21 HG13 ' A' ' 102' ' ' VAL . 3.3 tm? -76.55 119.64 20.66 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.407 ' HA ' ' HG2' ' A' ' 158' ' ' PRO . 49.6 mt-30 -128.17 -18.4 4.12 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.257 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -147.29 118.15 7.63 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.354 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.448 HG23 ' NE1' ' A' ' 143' ' ' TRP . 11.6 m -109.27 139.62 31.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -149.54 158.0 27.48 Favored Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.711 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.3 pt -115.59 147.81 18.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.0 m -154.08 156.21 36.86 Favored 'General case' 0 C--O 1.251 1.134 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.18 -27.99 29.63 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -127.39 105.88 8.83 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 112' ' ' VAL . 78.0 mt -61.05 -60.79 2.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.145 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -44.69 -58.06 3.29 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -175.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.38 -37.23 86.38 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.6 m -71.59 -46.38 59.44 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 123.23 0.331 . . . . 0.0 110.815 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 108' ' ' ILE . 85.3 t -58.68 -56.06 19.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.449 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 16.6 m -57.16 -42.05 80.33 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 124.248 0.968 . . . . 0.0 111.619 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.89 -59.08 5.22 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -73.06 -24.06 60.64 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 69.8 mt -73.13 -33.35 65.47 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.827 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 113' ' ' SER . 34.8 mmtp -78.7 -20.2 50.68 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.118 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.7 m -80.92 -46.26 15.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.471 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.46 92.78 26.86 Favored Pre-proline 0 CA--C 1.557 1.226 0 CA-C-O 121.815 0.817 . . . . 0.0 110.295 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.569 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 3.8 Cg_exo -76.48 16.64 0.86 Allowed 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 123.933 3.089 . . . . 0.0 114.126 -175.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.27 -38.08 89.18 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.618 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.8 mt -101.51 20.55 15.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.745 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.569 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 90.4 m -75.04 93.12 2.69 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.647 176.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.03 -65.86 0.07 OUTLIER Glycine 0 N--CA 1.435 -1.405 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.451 ' HB2' HD21 ' A' ' 74' ' ' LEU . 19.8 p -158.89 167.52 29.19 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.0 p -144.82 139.24 23.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.464 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -106.56 137.53 44.41 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.46 HG22 HD23 ' A' ' 75' ' ' LEU . 33.6 m -125.7 133.35 69.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.359 0.599 . . . . 0.0 111.785 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -112.89 102.58 1.31 Allowed Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.07 115.48 20.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.481 HG12 ' HA2' ' A' ' 88' ' ' GLY . 12.2 p -108.33 138.3 35.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -66.83 -45.17 79.11 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.306 0.574 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -94.5 114.2 62.85 Favored Pre-proline 0 C--N 1.292 -1.919 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.639 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -82.91 32.92 0.52 Allowed 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 123.049 2.499 . . . . 0.0 111.755 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.439 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 17.6 t70 -73.59 136.86 43.99 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.814 -177.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -61.1 -30.14 70.18 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.69 -50.42 36.72 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.2 t -60.96 -39.76 83.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 O-C-N 124.179 0.924 . . . . 0.0 110.591 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.2 mt -61.47 -55.32 32.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.513 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.0 m -60.78 -38.4 85.16 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.038 0.447 . . . . 0.0 111.025 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -59.71 -52.63 64.65 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.205 1.002 . . . . 0.0 110.765 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.29 94.84 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.156 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.448 ' NE1' HG23 ' A' ' 102' ' ' VAL . 89.3 t90 -56.4 -45.21 80.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.533 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -63.89 -43.32 96.37 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.737 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.7 -46.2 90.7 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.066 0.46 . . . . 0.0 110.929 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.51 ' CG ' ' HG ' ' A' ' 69' ' ' LEU . 26.0 m0 -63.9 -46.28 85.58 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.511 ' O ' HG13 ' A' ' 151' ' ' ILE . 7.9 tt -63.25 -42.12 95.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.547 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.439 ' HB3' ' NZ ' ' A' ' 152' ' ' LYS . 49.8 mt-10 -64.77 -31.6 72.9 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 146' ' ' TRP . 7.1 mm-40 -50.42 -50.63 51.38 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.558 0.536 . . . . 0.0 110.02 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.458 ' HA ' HG22 ' A' ' 153' ' ' VAL 0.282 33.2 m-70 -81.95 -28.45 32.72 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -178.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 147' ' ' ILE . 71.3 mt -57.06 -40.52 73.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 120.943 0.401 . . . . 0.0 110.137 172.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.439 ' NZ ' ' HB3' ' A' ' 148' ' ' GLU . 62.3 mttp -75.32 -46.69 31.8 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 150' ' ' HIS . 30.9 m -78.04 -39.69 25.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -175.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 33.1 p -119.1 -35.32 3.65 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.951 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.92 17.23 59.93 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -85.14 108.22 17.59 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.13 0.49 . . . . 0.0 111.787 -177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 40.8 t -128.3 84.19 63.94 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 173.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.407 ' HG2' ' HA ' ' A' ' 100' ' ' GLN . 11.4 Cg_exo -76.41 164.51 30.67 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 122.798 2.332 . . . . 0.0 111.923 -178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.34 -31.05 45.49 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 123.159 2.573 . . . . 0.0 112.697 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.29 -24.13 71.96 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.176 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.31 -1.149 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 CA--C 1.507 -0.699 0 CA-C-O 122.116 0.96 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.0 p -129.92 164.33 24.44 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.894 -170.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.508 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 17.9 mt -68.86 -13.59 62.51 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 t -70.25 -19.6 63.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.322 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -104.72 1.33 29.23 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.508 ' OG1' ' HA ' ' A' ' 69' ' ' LEU . 6.8 m -92.78 134.53 34.97 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -172.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.16 152.35 38.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.295 1.038 . . . . 0.0 110.681 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -109.75 129.59 55.6 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.406 HD23 HG22 ' A' ' 128' ' ' VAL . 4.3 mm? -121.02 136.04 25.31 Favored Pre-proline 0 C--N 1.307 -1.247 0 C-N-CA 123.762 0.825 . . . . 0.0 109.705 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.5 139.64 41.62 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.348 2.032 . . . . 0.0 110.247 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.03 -12.98 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.248 0.547 . . . . 0.0 111.469 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.0 t -74.62 -20.81 59.76 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.466 0.651 . . . . 0.0 109.968 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -104.85 53.15 0.73 Allowed 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.807 0.813 . . . . 0.0 109.557 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.5 ' HB1' ' OG ' ' A' ' 113' ' ' SER . . . -56.13 -28.94 59.86 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.835 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.41 -26.23 67.89 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.6 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.3 t -92.08 -4.98 53.65 Favored 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.737 0.815 . . . . 0.0 110.38 -174.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.49 HG12 ' HA ' ' A' ' 80' ' ' ALA . 43.9 mm -72.14 130.36 86.51 Favored Pre-proline 0 N--CA 1.443 -0.808 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.85 131.38 38.01 Favored 'Trans proline' 0 C--O 1.248 0.982 0 C-N-CA 123.348 2.699 . . . . 0.0 112.976 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.0 p -91.39 27.59 1.91 Allowed 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.66 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.95 -176.95 3.6 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.825 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.6 t -96.85 154.33 17.36 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 154.15 -154.1 25.28 Favored Glycine 0 N--CA 1.423 -2.185 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.264 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.632 HG12 HG22 ' A' ' 104' ' ' ILE . 3.7 m -112.41 152.12 14.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 123.708 0.803 . . . . 0.0 110.045 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -144.69 154.35 42.67 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -130.78 126.23 35.81 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 123.248 0.619 . . . . 0.0 109.394 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.4 t -102.97 126.0 57.29 Favored 'Isoleucine or valine' 0 C--O 1.263 1.793 0 CA-C-O 121.102 0.477 . . . . 0.0 110.032 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -113.09 133.44 55.0 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -79.16 -169.44 1.84 Allowed 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.525 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.451 ' H ' ' HD2' ' A' ' 95' ' ' LYS . 8.5 mptt -57.22 -36.38 70.82 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.733 0.413 . . . . 0.0 110.29 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.3 m -77.46 0.5 22.44 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.536 0.734 . . . . 0.0 111.586 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.0 t70 65.88 27.16 10.99 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 122.752 1.263 . . . . 0.0 110.246 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -98.64 137.4 37.33 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.252 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.69 125.08 28.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.538 ' O ' ' HG2' ' A' ' 158' ' ' PRO . 41.9 mt-30 -129.1 -17.11 3.93 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.103 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.475 ' HA ' ' OD1' ' A' ' 161' ' ' ASN . 89.5 t80 -154.61 126.0 7.39 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 118.635 -1.226 . . . . 0.0 111.911 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.42 HG21 ' HB ' ' A' ' 147' ' ' ILE . 25.5 m -114.62 145.05 20.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 170.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.0 168.95 31.33 Favored Glycine 0 C--N 1.281 -2.487 0 C-N-CA 119.276 -1.44 . . . . 0.0 112.709 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.632 HG22 HG12 ' A' ' 89' ' ' VAL . 17.3 pt -120.13 148.53 23.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.4 t -150.84 155.63 39.59 Favored 'General case' 0 N--CA 1.417 -2.112 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.593 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.91 -23.12 24.02 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.431 HD22 ' C ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -141.67 98.19 3.3 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.0 mt -55.26 -60.4 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.46 -47.72 27.05 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.75 90.65 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 p -79.05 -43.1 24.92 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.607 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 76.3 t -55.47 -54.76 21.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 O-C-N 123.294 0.371 . . . . 0.0 110.805 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.5 ' OG ' ' HB1' ' A' ' 80' ' ' ALA . 20.1 m -56.94 -46.9 81.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 123.924 0.765 . . . . 0.0 110.696 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.5 -55.08 38.24 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.046 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.261 29.2 p80 -71.53 -26.44 62.66 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 89.9 mt -78.13 -27.68 48.29 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.233 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 113' ' ' SER . 74.9 mmtt -84.9 -9.15 58.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.166 0.508 . . . . 0.0 110.314 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.6 t -93.32 -50.57 5.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.08 94.48 27.71 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-O 121.742 0.782 . . . . 0.0 110.507 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.666 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 15.0 Cg_exo -71.88 19.58 0.28 Allowed 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.986 3.124 . . . . 0.0 114.322 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.68 -43.42 98.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.462 0.649 . . . . 0.0 109.755 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.1 mt -100.35 20.13 15.38 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.911 -176.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.666 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 91.0 m -77.16 86.03 3.63 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.706 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.42 -63.96 0.09 OUTLIER Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 175.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.0 p -164.01 157.56 18.55 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 123.004 0.522 . . . . 0.0 109.601 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.21 139.0 46.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-O 121.018 0.437 . . . . 0.0 110.472 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.451 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 74.6 mttt -106.71 137.48 44.66 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.406 HG22 HD23 ' A' ' 75' ' ' LEU . 27.4 m -124.02 132.61 71.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.038 0.447 . . . . 0.0 110.802 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -117.18 99.37 0.83 Allowed Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.68 117.56 29.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.454 0.645 . . . . 0.0 109.743 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.92 131.18 69.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.58 8.4 7.96 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -108.35 107.62 60.33 Favored Pre-proline 0 N--CA 1.423 -1.783 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -84.04 26.42 0.65 Allowed 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.558 2.172 . . . . 0.0 110.713 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.53 ' HB3' HG22 ' A' ' 138' ' ' VAL . 14.1 t70 -71.92 127.83 33.82 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -62.51 -28.4 69.82 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -173.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.54 -33.34 54.18 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.359 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 135' ' ' ASP . 10.1 m -77.38 -32.71 18.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.833 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 97.0 mt -64.25 -46.73 82.46 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.0 m -67.03 -33.92 76.58 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.225 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.603 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 9.4 tt0 -64.56 -50.82 65.78 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.528 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.23 -41.17 98.17 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.376 0.422 . . . . 0.0 110.234 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -55.61 -47.36 76.67 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.588 0.709 . . . . 0.0 109.592 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.78 -42.78 98.2 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.875 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 60.9 mt -64.98 -47.46 77.48 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.812 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -62.45 -46.11 90.01 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.015 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.584 ' O ' HG13 ' A' ' 151' ' ' ILE . 13.0 tt -67.15 -46.88 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.543 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -67.47 -29.28 68.69 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -175.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.497 ' O ' HG22 ' A' ' 153' ' ' VAL . 9.2 pt-20 -65.11 -44.09 89.89 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.931 176.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -69.96 -24.1 63.29 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 147' ' ' ILE . 57.1 mt -66.77 -43.73 89.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 172.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -71.27 -50.64 30.64 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 149' ' ' GLU . 35.2 m -80.01 -40.37 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -176.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.6 p -116.99 -4.84 11.47 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -174.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.37 34.33 89.61 Favored Glycine 0 C--O 1.222 -0.643 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.871 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -93.64 110.2 21.81 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.463 HG22 HG12 ' A' ' 151' ' ' ILE . 19.9 t -141.4 79.07 17.83 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 173.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.538 ' HG2' ' O ' ' A' ' 100' ' ' GLN . 3.1 Cg_exo -82.77 160.47 16.33 Favored 'Trans proline' 0 C--O 1.248 0.982 0 C-N-CA 122.66 2.24 . . . . 0.0 112.834 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -56.48 -17.17 20.75 Favored 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 124.268 3.312 . . . . 0.0 113.997 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -67.69 -38.79 90.22 Favored Glycine 0 CA--C 1.523 0.588 0 O-C-N 123.573 0.546 . . . . 0.0 112.892 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.475 ' OD1' ' HA ' ' A' ' 101' ' ' PHE . 11.0 m120 . . . . . 0 CA--C 1.492 -1.252 0 CA-C-O 121.991 0.9 . . . . 0.0 111.634 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt . . . . . 0 N--CA 1.433 -1.296 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.8 m -76.52 164.59 25.8 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 121.38 0.61 . . . . 0.0 111.719 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.444 HD11 ' OH ' ' A' ' 93' ' ' TYR . 3.1 tm? -46.52 -40.03 11.87 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 126.637 1.975 . . . . 0.0 114.108 -174.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.0 m -56.24 -32.83 64.85 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.314 0.578 . . . . 0.0 111.891 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -102.72 10.0 38.82 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.356 -0.384 . . . . 0.0 112.029 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.586 HG21 ' CH2' ' A' ' 146' ' ' TRP . 30.1 m -85.58 147.66 26.3 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.256 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.08 149.64 46.31 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.23 0.612 . . . . 0.0 111.262 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -110.65 133.49 53.27 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.829 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.51 HD23 HG22 ' A' ' 128' ' ' VAL . 3.5 mm? -127.26 141.53 41.08 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 174.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -79.97 144.84 17.23 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.082 1.854 . . . . 0.0 110.885 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.482 HD11 ' SG ' ' A' ' 123' ' ' CYS . 0.1 OUTLIER -80.03 -12.95 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.094 0.473 . . . . 0.0 110.676 -178.077 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.25 -11.81 61.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 124.522 1.129 . . . . 0.0 111.205 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -128.19 53.42 1.81 Allowed 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -54.86 -19.15 5.9 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.996 -175.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -78.21 -20.39 51.91 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.321 0.582 . . . . 0.0 110.577 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.0 m -91.11 6.81 43.47 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.234 0.54 . . . . 0.0 110.769 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.455 HG12 ' HA ' ' A' ' 80' ' ' ALA . 41.4 mm -82.56 130.05 60.3 Favored Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.436 ' HG2' HD11 ' A' ' 130' ' ' ILE . 90.1 Cg_exo -53.23 137.02 63.54 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.531 2.821 . . . . 0.0 113.287 178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.3 p -101.52 27.13 6.57 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.813 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.25 -175.99 3.39 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.649 -174.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.9 t -95.39 141.56 28.8 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 158.87 -153.43 24.55 Favored Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.511 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.577 HG12 HG22 ' A' ' 104' ' ' ILE . 1.8 m -109.21 150.56 11.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 C-N-CA 124.393 1.077 . . . . 0.0 110.06 -177.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -142.78 148.43 37.15 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.38 118.04 21.57 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.244 0.618 . . . . 0.0 109.883 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.5 t -97.32 127.59 49.43 Favored 'Isoleucine or valine' 0 C--O 1.263 1.782 0 CA-C-O 121.358 0.599 . . . . 0.0 111.895 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.444 ' OH ' HD11 ' A' ' 69' ' ' LEU . 43.3 m-85 -107.4 146.47 31.61 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 125.047 1.339 . . . . 0.0 109.32 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -95.2 -172.24 2.62 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.4 ' HD2' ' HA2' ' A' ' 124' ' ' GLY . 31.6 mmmt -65.34 -23.05 66.9 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 m -77.13 -4.08 42.67 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.78 0.8 . . . . 0.0 109.396 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.3 t70 66.12 29.57 9.81 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.727 1.611 . . . . 0.0 109.626 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 5.1 mm-40 -99.14 144.1 28.66 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 114.066 -1.425 . . . . 0.0 108.255 175.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.516 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 1.5 tm? -85.89 125.12 33.09 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.515 ' O ' ' HG2' ' A' ' 158' ' ' PRO . 1.4 mp0 -116.5 -23.55 8.22 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 123.978 0.799 . . . . 0.0 113.013 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -149.4 120.47 7.73 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 117.587 -1.645 . . . . 0.0 112.715 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.613 HG21 ' HB ' ' A' ' 147' ' ' ILE . 30.5 m -105.06 145.29 13.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.809 171.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.55 166.97 30.84 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.544 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.577 HG22 HG12 ' A' ' 89' ' ' VAL . 10.5 pt -123.0 144.84 31.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 122.889 0.476 . . . . 0.0 109.806 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.2 m -152.62 157.37 40.88 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.334 0.588 . . . . 0.0 111.526 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -86.74 -22.18 26.13 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 172.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -137.44 91.33 2.59 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.596 -1.183 . . . . 0.0 108.086 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.19 -62.3 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -173.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.77 -43.19 27.2 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -175.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.4 -48.57 79.13 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.054 0.221 . . . . 0.0 111.526 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.3 m -65.04 -41.51 95.13 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 120.683 0.277 . . . . 0.0 111.154 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.6 t -61.7 -57.15 13.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.009 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.5 p -60.85 -35.61 77.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 123.778 0.674 . . . . 0.0 111.811 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.77 -61.27 2.39 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 122.975 0.51 . . . . 0.0 111.642 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -79.57 -21.68 44.76 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -73.02 -41.28 64.41 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.77 -15.1 59.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.556 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.6 m -80.9 -59.09 2.8 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.3 95.25 47.28 Favored Pre-proline 0 N--CA 1.428 -1.528 0 CA-C-O 122.087 0.946 . . . . 0.0 110.847 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.53 21.12 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.794 2.996 . . . . 0.0 113.22 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -69.1 -33.21 73.14 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.2 mt -94.59 21.49 7.23 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.169 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.482 ' SG ' HD11 ' A' ' 77' ' ' ILE . 38.2 t -68.61 108.37 3.32 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 176.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.4 ' HA2' ' HD2' ' A' ' 95' ' ' LYS . . . -160.35 -72.82 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 175.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.3 p -169.41 173.17 6.68 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.9 p -144.49 139.8 23.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -106.27 129.91 54.22 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.51 HG22 HD23 ' A' ' 75' ' ' LEU . 35.3 m -122.54 136.1 60.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.436 0.636 . . . . 0.0 111.52 -175.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -116.59 96.79 0.73 Allowed Glycine 0 N--CA 1.418 -2.511 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.436 HD11 ' HG2' ' A' ' 84' ' ' PRO . 2.7 mp -78.74 114.27 19.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.504 HG22 ' H ' ' A' ' 133' ' ' GLU . 13.6 p -104.5 124.13 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.705 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -78.83 -5.17 52.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.499 0.666 . . . . 0.0 110.582 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.504 ' H ' HG22 ' A' ' 131' ' ' VAL . 11.2 mm-40 -111.65 84.31 5.11 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 172.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.83 39.29 0.7 Allowed 'Trans proline' 0 N--CA 1.48 0.684 0 C-N-CA 123.619 2.879 . . . . 0.0 113.026 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.52 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 14.4 t70 -76.87 138.88 40.04 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.059 -175.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -54.15 -38.09 65.13 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.892 1.277 . . . . 0.0 113.494 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.02 -44.57 54.01 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.84 -43.58 95.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.775 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 96.5 mt -57.25 -52.88 63.53 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.125 0.488 . . . . 0.0 110.708 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.6 m -69.42 -34.37 74.36 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.117 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.489 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 52.9 tt0 -66.84 -45.65 77.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.071 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.9 -38.21 90.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.174 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.516 ' NE1' HG23 ' A' ' 102' ' ' VAL . 89.3 t90 -55.72 -48.58 74.94 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -60.9 -38.24 85.02 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.372 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.606 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 71.4 mt -63.97 -56.92 11.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.274 0.559 . . . . 0.0 109.559 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.586 ' CH2' HG21 ' A' ' 72' ' ' THR . 20.8 m0 -54.61 -50.48 67.98 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.613 ' HB ' HG21 ' A' ' 102' ' ' VAL . 13.1 tt -61.51 -46.53 96.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.334 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -66.45 -27.23 67.66 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 17.5 mm-40 -59.94 -46.13 90.37 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 121.224 0.535 . . . . 0.0 109.671 175.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.516 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 7.5 t60 -81.8 -21.43 37.71 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.578 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 147' ' ' ILE . 53.7 mt -67.2 -53.51 32.48 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.71 -26.2 68.54 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -175.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 150' ' ' HIS . 11.3 p -84.37 -35.73 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.4 t -137.86 -2.88 1.87 Allowed 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -174.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 78.93 29.28 52.14 Favored Glycine 0 CA--C 1.516 0.126 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.816 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -91.82 108.86 20.22 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.444 HG22 HG12 ' A' ' 151' ' ' ILE . 2.1 t -142.78 90.36 7.72 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 173.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.515 ' HG2' ' O ' ' A' ' 100' ' ' GLN . 7.9 Cg_exo -80.17 159.67 23.47 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.986 2.457 . . . . 0.0 113.21 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -43.14 -40.79 9.3 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 124.822 3.682 . . . . 0.0 115.262 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -65.23 -23.2 69.74 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 114.395 0.518 . . . . 0.0 114.395 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 C--N 1.315 -0.905 0 CA-C-O 121.467 0.651 . . . . 0.0 111.062 178.769 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 110.651 -0.129 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.0 m -72.93 177.24 5.04 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.1 mt -52.65 -25.27 10.32 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -171.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -68.71 -30.92 69.67 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.864 0.364 . . . . 0.0 110.695 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -87.62 -20.44 26.35 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.315 0.579 . . . . 0.0 110.752 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.421 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 4.4 m -74.99 133.74 41.62 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.219 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -71.53 154.02 41.76 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.056 0.455 . . . . 0.0 111.042 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -108.7 125.1 51.53 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.561 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.449 HD23 HG22 ' A' ' 128' ' ' VAL . 4.0 mm? -113.4 130.73 23.4 Favored Pre-proline 0 C--N 1.3 -1.583 0 C-N-CA 123.881 0.873 . . . . 0.0 109.411 174.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.87 139.59 36.7 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.179 1.919 . . . . 0.0 110.163 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.45 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -76.72 -13.48 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.431 -175.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.3 t -69.6 -25.67 64.07 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.433 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -109.63 54.25 0.67 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 122.29 1.043 . . . . 0.0 110.098 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.488 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -57.04 -19.76 20.67 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.822 -1.535 . . . . 0.0 113.302 -176.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -73.57 -19.6 60.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.434 0.635 . . . . 0.0 110.965 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.0 m -93.13 2.43 56.71 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.559 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 80' ' ' ALA . 47.0 mm -76.7 126.62 85.7 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.57 130.66 41.33 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.535 2.157 . . . . 0.0 113.21 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.0 p -94.05 30.65 1.82 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.247 1.023 . . . . 0.0 109.731 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.48 -179.78 4.45 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.445 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 106' ' ' ARG . 15.4 t -93.71 138.38 31.98 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.17 -155.61 26.81 Favored Glycine 0 N--CA 1.421 -2.33 0 C-N-CA 119.362 -1.399 . . . . 0.0 113.049 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.497 HG21 ' HB3' ' A' ' 142' ' ' ALA . 7.5 t -115.78 151.6 17.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -176.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -140.56 148.11 40.48 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.462 ' HB1' HD23 ' A' ' 99' ' ' LEU . . . -125.12 118.29 25.8 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.887 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.81 115.02 29.2 Favored 'Isoleucine or valine' 0 C--O 1.262 1.712 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.586 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 4.9 m-85 -100.32 137.28 38.96 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.92 -168.36 2.21 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.365 0.602 . . . . 0.0 110.891 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -64.99 -29.57 70.5 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.42 1.088 . . . . 0.0 111.271 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.1 t -81.42 -1.25 45.0 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.806 0.812 . . . . 0.0 109.363 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 t70 73.95 27.74 1.6 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.635 1.574 . . . . 0.0 112.538 172.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 11.8 pt-20 -120.09 166.65 13.11 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 117.588 -1.645 . . . . 0.0 111.207 172.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.462 HD23 ' HB1' ' A' ' 91' ' ' ALA . 2.9 tm? -80.29 130.14 34.99 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.913 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.404 HE21 ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -118.11 -47.13 2.59 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.106 171.36 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -124.1 125.74 45.0 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.789 -173.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.444 HG13 HD21 ' A' ' 99' ' ' LEU . 5.0 m -114.42 140.92 32.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.28 162.09 29.38 Favored Glycine 0 N--CA 1.42 -2.423 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.185 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.8 pt -124.82 151.7 30.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.6 t -159.92 159.23 32.08 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 106' ' ' ARG . 0.4 OUTLIER -82.35 -15.35 53.11 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 176.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -140.87 96.89 3.08 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.0 mt -56.34 -52.69 49.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.841 -177.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.14 -46.22 61.89 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.81 -48.23 81.54 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.733 0.413 . . . . 0.0 111.702 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.9 m -68.53 -44.21 75.06 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.239 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.6 t -57.94 -58.78 4.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.392 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 43.5 p -63.05 -32.06 73.34 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.51 -61.16 2.26 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.512 ' HA ' ' OG ' ' A' ' 118' ' ' SER . 19.7 p80 -77.15 -21.88 53.41 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -174.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.425 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 53.6 mt -76.09 -23.97 55.0 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.779 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -89.46 -31.01 17.89 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.046 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 115' ' ' HIS . 4.2 p -73.99 -27.91 61.21 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.352 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.23 98.07 3.78 Favored Pre-proline 0 CA--C 1.559 1.31 0 CA-C-O 121.899 0.857 . . . . 0.0 110.691 173.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.793 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 94.5 Cg_endo -82.21 22.39 0.87 Allowed 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 123.288 2.659 . . . . 0.0 113.514 -177.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -63.42 -43.34 97.75 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.707 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.1 mt -104.99 18.01 23.13 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.161 0.505 . . . . 0.0 110.954 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.793 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 83.0 m -78.65 99.78 6.74 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.732 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.34 -49.48 0.06 OUTLIER Glycine 0 C--N 1.3 -1.43 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.0 p -165.59 168.14 16.66 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.095 0.958 . . . . 0.0 109.633 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.66 137.08 31.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-O 121.081 0.467 . . . . 0.0 110.48 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.421 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 98.1 mttt -106.43 138.58 42.36 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.449 HG22 HD23 ' A' ' 75' ' ' LEU . 27.0 m -124.19 130.99 73.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.136 0.493 . . . . 0.0 112.179 -176.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -118.33 102.11 0.94 Allowed Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mp -94.89 136.47 25.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 121.031 0.443 . . . . 0.0 110.154 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.97 141.67 44.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.99 -46.09 90.76 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -88.39 116.33 65.93 Favored Pre-proline 0 C--N 1.308 -1.199 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.163 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.32 39.41 0.78 Allowed 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 123.488 2.792 . . . . 0.0 112.539 -175.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.426 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 23.9 t70 -73.74 129.2 37.45 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.996 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -61.81 -27.85 69.05 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.54 -45.47 59.14 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.3 t -62.07 -41.46 91.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 O-C-N 124.192 0.932 . . . . 0.0 110.171 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 90.3 mt -63.03 -50.48 70.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.679 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 48.8 m -63.57 -33.63 76.02 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 120.914 0.388 . . . . 0.0 110.793 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.34 -54.88 34.03 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.805 1.242 . . . . 0.0 110.378 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.497 ' HB3' HG21 ' A' ' 89' ' ' VAL . . . -64.77 -39.39 93.53 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.217 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -55.39 -45.68 76.6 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.304 0.642 . . . . 0.0 109.303 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -61.09 -46.27 91.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.79 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.2 mp -60.36 -38.37 83.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.851 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.433 ' O ' ' HG3' ' A' ' 149' ' ' GLU . 41.0 m0 -73.64 -46.87 44.05 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.957 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.432 ' HB ' HG21 ' A' ' 102' ' ' VAL . 12.7 tt -65.9 -40.98 89.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.444 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.72 -36.44 80.59 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.564 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -60.95 -39.12 88.27 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.331 -179.015 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.46 ' HA ' HG12 ' A' ' 153' ' ' VAL . 2.6 t60 -79.46 -31.25 42.43 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.132 -175.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.455 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 70.9 mt -70.87 -32.34 48.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.422 0.63 . . . . 0.0 109.87 175.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -84.85 -33.42 22.87 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 149' ' ' GLU . 14.8 p -83.52 -51.43 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.483 HG23 HG13 ' A' ' 153' ' ' VAL . 71.1 p -108.78 -35.54 6.37 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.172 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 151' ' ' ILE . . . 99.71 28.27 7.53 Favored Glycine 0 C--N 1.317 -0.519 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.719 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.82 125.75 47.35 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.51 87.78 10.16 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-O 121.904 0.859 . . . . 0.0 109.881 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -69.98 160.58 49.12 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.16 3.24 . . . . 0.0 113.811 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -45.7 -35.51 13.22 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 124.997 3.798 . . . . 0.0 115.365 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -70.84 -26.18 74.45 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.88 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 C--N 1.318 -0.796 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.31 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.438 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.541 ' HB2' ' OE2' ' A' ' 149' ' ' GLU . 28.1 p -121.99 179.29 4.57 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.481 HD13 ' OH ' ' A' ' 93' ' ' TYR . 38.9 mt -73.93 -17.17 61.06 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.6 m -72.28 -20.34 61.53 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.47 0.653 . . . . 0.0 109.648 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -92.18 -3.31 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.016 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.475 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.6 m -98.81 150.5 21.8 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.955 -172.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 9.4 pt-20 -90.25 155.01 19.3 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.176 0.99 . . . . 0.0 109.845 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.0 125.11 48.62 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -123.66 141.01 35.47 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.068 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -71.37 134.55 24.86 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.192 1.928 . . . . 0.0 109.215 170.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -21.53 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.0 t -73.29 -26.7 61.18 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.193 0.521 . . . . 0.0 110.678 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -94.56 56.09 2.04 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.845 0.831 . . . . 0.0 110.12 177.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.583 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -48.84 -21.57 0.66 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.204 1.402 . . . . 0.0 114.015 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -64.56 -27.57 69.05 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.433 0.635 . . . . 0.0 110.763 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.408 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 22.8 m -83.09 1.43 40.29 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.083 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.583 HG12 ' HA ' ' A' ' 80' ' ' ALA . 26.8 mm -90.75 113.97 59.74 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 82' ' ' SER . 72.2 Cg_exo -54.7 135.27 66.54 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.737 2.958 . . . . 0.0 112.593 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.7 p -98.6 34.21 2.09 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.969 0.89 . . . . 0.0 110.885 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.73 -176.64 3.19 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.174 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.7 t -95.96 145.62 25.26 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.17 -149.13 15.27 Favored Glycine 0 N--CA 1.416 -2.69 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.266 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.49 HG13 ' CH2' ' A' ' 146' ' ' TRP . 6.7 p -125.98 149.26 30.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -176.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -137.37 149.85 47.28 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.901 0.382 . . . . 0.0 110.747 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.32 117.6 28.2 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.278 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.31 116.75 34.16 Favored 'Isoleucine or valine' 0 C--O 1.26 1.627 0 CA-C-O 121.092 0.472 . . . . 0.0 110.753 -177.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.481 ' OH ' HD13 ' A' ' 69' ' ' LEU . 88.3 m-85 -106.35 134.42 49.51 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.705 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -79.18 -171.0 2.47 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -58.46 -30.79 67.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.808 0.843 . . . . 0.0 111.093 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.4 m -82.72 1.72 37.33 Favored 'General case' 0 C--O 1.25 1.114 0 C-N-CA 123.506 0.722 . . . . 0.0 112.269 -176.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.2 t70 69.41 26.68 5.17 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.499 1.142 . . . . 0.0 109.39 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 4.3 mm-40 -102.13 140.14 36.81 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.925 176.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.507 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 2.8 tm? -89.69 110.84 21.7 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.464 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.464 ' HA ' ' HG2' ' A' ' 158' ' ' PRO . 2.4 mp0 -105.13 -25.99 12.27 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.051 177.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -143.82 120.96 11.47 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 118.822 -1.151 . . . . 0.0 113.54 -176.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.479 HG13 HD11 ' A' ' 99' ' ' LEU . 6.2 m -108.51 144.01 17.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 169.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -154.84 158.86 28.61 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.4 pt -117.25 144.3 25.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.6 m -150.75 160.39 43.89 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.147 0.498 . . . . 0.0 111.113 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -84.97 -21.85 29.39 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -136.13 105.46 6.03 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.55 -58.01 8.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 123.535 0.522 . . . . 0.0 111.92 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.17 -55.28 10.79 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.07 99.56 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 123.064 0.227 . . . . 0.0 111.316 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.2 t -65.87 -51.23 60.59 Favored 'General case' 0 C--O 1.251 1.148 0 O-C-N 123.774 0.671 . . . . 0.0 110.019 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 56.6 t -56.14 -54.77 23.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.972 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 22.9 t -60.12 -44.41 94.92 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 123.779 0.674 . . . . 0.0 111.1 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.75 -54.12 38.45 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -80.07 -26.3 39.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.441 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 66.9 mt -77.68 -26.48 50.31 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.845 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 113' ' ' SER . 33.7 mmtp -78.84 -26.05 44.12 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.395 174.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.2 t -74.0 -53.85 9.16 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.346 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.0 p -129.05 99.04 22.43 Favored Pre-proline 0 N--CA 1.431 -1.381 0 CA-C-O 121.996 0.903 . . . . 0.0 110.767 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.838 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 73.9 Cg_endo -79.56 11.53 2.67 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 123.525 2.817 . . . . 0.0 113.653 -177.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -58.03 -42.93 86.37 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 123.984 0.913 . . . . 0.0 109.865 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.0 mt -104.16 20.29 18.58 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.898 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.838 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 96.8 m -85.99 92.75 8.78 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.188 0.518 . . . . 0.0 111.944 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.42 -60.4 0.09 OUTLIER Glycine 0 C--N 1.299 -1.5 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 173.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 9.8 p -156.06 161.62 40.39 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.5 p -138.53 139.6 41.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-O 121.007 0.432 . . . . 0.0 110.159 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.475 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 82.9 mttt -106.54 128.36 54.05 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 174.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.86 136.16 56.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.095 0.474 . . . . 0.0 111.137 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.52 110.02 1.26 Allowed Glycine 0 N--CA 1.425 -2.064 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 130' ' ' ILE . 2.7 mp -94.24 104.91 16.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 133' ' ' GLU . 9.2 p -89.17 134.56 28.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.269 -177.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -65.12 -30.02 70.92 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.23 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.402 ' H ' HG22 ' A' ' 131' ' ' VAL . 16.5 pt-20 -109.24 100.67 42.05 Favored Pre-proline 0 N--CA 1.439 -1.016 0 CA-C-O 121.362 0.601 . . . . 0.0 109.768 174.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.72 37.92 0.71 Allowed 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.916 2.411 . . . . 0.0 112.282 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.448 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 22.3 t70 -69.15 143.77 54.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.188 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -52.44 -44.44 65.49 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.493 0.717 . . . . 0.0 112.337 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.11 -38.76 69.24 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.409 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.06 -42.04 90.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 96.7 mt -58.33 -47.73 82.81 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.5 m -66.04 -38.88 89.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.633 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -62.63 -45.39 93.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.85 0.357 . . . . 0.0 110.091 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.6 -50.06 75.03 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.914 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -53.55 -47.81 69.67 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.143 0.977 . . . . 0.0 110.492 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 14.6 tmtt? -63.37 -45.78 89.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.633 -176.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.476 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 11.0 mp -67.41 -38.86 85.27 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.691 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.49 ' CH2' HG13 ' A' ' 89' ' ' VAL . 27.2 m0 -63.16 -45.01 93.87 Favored 'General case' 0 C--O 1.257 1.482 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.471 ' O ' HG13 ' A' ' 151' ' ' ILE . 12.7 tt -65.41 -39.14 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.397 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 38.0 mt-10 -57.71 -42.5 83.88 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-O 118.9 -0.572 . . . . 0.0 111.967 176.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.541 ' OE2' ' HB2' ' A' ' 68' ' ' SER . 6.8 mm-40 -46.39 -51.84 14.14 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.782 0.676 . . . . 0.0 110.059 178.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.507 ' CG ' ' HB3' ' A' ' 99' ' ' LEU 0.34 13.7 m-70 -78.88 -27.85 44.04 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 179.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 147' ' ' ILE . 76.5 mt -61.18 -47.5 93.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.536 0.684 . . . . 0.0 109.319 172.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -68.1 -50.4 55.19 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.309 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 149' ' ' GLU . 16.9 m -80.75 -26.77 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -174.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.3 t -138.13 -26.25 0.93 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.39 23.5 16.47 Favored Glycine 0 C--N 1.316 -0.54 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.69 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -78.88 112.96 16.57 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.06 74.26 21.63 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 170.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.464 ' HG2' ' HA ' ' A' ' 100' ' ' GLN . 9.2 Cg_endo -90.88 168.84 3.69 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 123.219 2.612 . . . . 0.0 114.09 -171.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -56.74 -17.73 24.18 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 124.0 3.134 . . . . 0.0 113.727 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -67.8 -38.48 89.5 Favored Glycine 0 C--O 1.219 -0.794 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 . . . . . 0 C--O 1.243 0.729 0 CA-C-O 121.574 0.702 . . . . 0.0 109.734 -179.47 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.425 ' HB2' ' OE2' ' A' ' 71' ' ' GLU . 57.8 mtpt . . . . . 0 N--CA 1.442 -0.827 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.1 p -110.49 172.09 7.07 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.824 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.94 -27.77 68.47 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.455 0.702 . . . . 0.0 110.983 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 m -62.67 -31.1 71.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.573 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.425 ' OE2' ' HB2' ' A' ' 67' ' ' LYS . 29.5 mt-10 -95.03 2.62 55.32 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.124 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.506 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.1 m -91.29 145.42 24.67 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.491 -176.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 17.0 pt-20 -89.31 151.05 22.31 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -113.88 130.61 56.47 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.814 0.34 . . . . 0.0 110.84 -172.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -128.35 127.77 23.68 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -63.49 138.11 63.48 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.181 1.921 . . . . 0.0 109.616 173.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -14.46 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -172.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.7 t -65.58 -30.97 71.78 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.265 0.555 . . . . 0.0 110.081 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.62 53.07 0.82 Allowed 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 122.41 1.1 . . . . 0.0 109.377 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.582 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -56.64 -24.24 46.94 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.702 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.73 -31.1 71.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.378 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.5 m -92.39 3.46 55.4 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.582 HG12 ' HA ' ' A' ' 80' ' ' ALA . 44.6 mm -69.2 125.02 91.65 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -52.9 129.76 34.49 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.006 2.47 . . . . 0.0 113.71 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 p -95.5 32.79 1.72 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.089 0.947 . . . . 0.0 111.048 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.05 -176.96 3.23 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.924 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.4 m -93.42 149.67 21.05 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 123.504 0.502 . . . . 0.0 110.105 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.62 -153.78 24.99 Favored Glycine 0 N--CA 1.417 -2.571 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.435 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.59 ' HB ' ' CH2' ' A' ' 146' ' ' TRP . 2.6 t -114.36 151.3 16.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -175.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -140.31 151.88 45.41 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.02 174.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 127' ' ' LYS . . . -130.24 120.76 24.95 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 123.554 0.742 . . . . 0.0 109.697 -178.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.51 125.93 45.06 Favored 'Isoleucine or valine' 0 C--O 1.263 1.801 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.314 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -112.64 132.58 55.1 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 124.156 0.983 . . . . 0.0 109.234 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -77.61 -173.26 2.9 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 123.825 0.703 . . . . 0.0 110.542 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -55.42 -31.08 61.57 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.1 t -95.46 11.55 32.54 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 122.021 -0.425 . . . . 0.0 110.885 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.45 33.16 13.89 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 176.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -102.99 125.37 49.72 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 118.571 -1.252 . . . . 0.0 111.914 172.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.495 HD23 ' HB1' ' A' ' 91' ' ' ALA . 2.5 tm? -60.71 112.68 2.11 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.637 174.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.418 ' HB3' ' HG2' ' A' ' 158' ' ' PRO . 48.5 mt-30 -124.52 -14.66 6.81 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.24 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -144.16 125.33 14.56 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.371 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.474 HG21 ' HB ' ' A' ' 147' ' ' ILE . 22.1 m -117.11 151.76 18.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 173.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -160.3 160.04 31.36 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.4 pt -124.91 147.28 29.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.6 t -157.46 164.56 37.31 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.457 ' HD3' ' O ' ' A' ' 106' ' ' ARG . 0.6 OUTLIER -80.55 -28.03 37.4 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.339 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -131.09 99.4 4.87 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 77.7 mt -57.83 -52.01 63.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.261 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.63 -52.46 39.36 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.82 -47.18 87.52 Favored 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 123.456 0.473 . . . . 0.0 111.147 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.0 t -62.8 -50.78 69.63 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.435 -177.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.0 t -59.22 -52.97 54.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.028 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.4 m -63.13 -35.35 79.99 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 123.337 0.398 . . . . 0.0 111.812 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.09 -61.14 1.99 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.37 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.276 21.5 p80 -73.5 -25.92 60.66 Favored 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -174.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.4 mt -77.62 -24.06 49.67 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.681 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -87.48 -9.13 55.41 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.204 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.6 m -92.07 -51.61 5.1 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.59 95.73 42.33 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-O 121.681 0.753 . . . . 0.0 111.052 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.822 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 3.1 Cg_exo -79.27 32.56 0.47 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.58 2.853 . . . . 0.0 112.877 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -70.33 -43.17 70.81 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.779 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.1 mt -114.12 21.87 14.37 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.706 -174.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.822 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 94.7 m -76.06 93.06 3.24 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -127.25 -61.84 0.14 Allowed Glycine 0 C--N 1.307 -1.073 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.0 m -158.78 166.93 30.78 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.2 p -133.83 142.32 41.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.268 0.556 . . . . 0.0 110.088 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 91' ' ' ALA . 30.6 mmtm -105.67 129.22 53.94 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.21 136.36 60.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.272 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.44 100.06 0.79 Allowed Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 130' ' ' ILE . 2.5 mp -88.06 101.66 11.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -101.09 134.53 40.93 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.797 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.015 -174.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -66.48 -34.61 78.31 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -83.89 117.33 68.4 Favored Pre-proline 0 C--N 1.301 -1.513 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.871 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -91.49 21.03 0.82 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.879 2.386 . . . . 0.0 111.787 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.97 131.39 45.39 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.944 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -59.19 -33.39 70.9 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.849 -174.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.81 -45.27 68.25 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.29 -44.23 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.16 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 99.0 mt -59.77 -45.78 91.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.944 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.3 m -69.36 -38.43 78.08 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.479 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.563 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 29.0 tt0 -62.29 -51.23 68.52 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.329 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.3 -40.84 95.64 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.41 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.451 ' O ' HG22 ' A' ' 147' ' ' ILE . 79.3 t90 -51.41 -46.64 62.98 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.49 0.716 . . . . 0.0 109.603 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.44 -50.92 57.22 Favored 'General case' 0 C--O 1.211 -0.951 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.486 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 85.5 mt -51.57 -41.63 61.29 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.242 0.617 . . . . 0.0 111.673 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.59 ' CH2' ' HB ' ' A' ' 89' ' ' VAL . 31.6 m0 -69.68 -57.79 4.71 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.444 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.613 ' O ' HG12 ' A' ' 151' ' ' ILE . 15.1 tt -67.25 -42.16 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 C-N-CA 119.644 -0.823 . . . . 0.0 111.844 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.442 ' HA ' ' CG1' ' A' ' 151' ' ' ILE . 26.7 mt-10 -67.64 -28.62 67.88 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -174.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.507 ' O ' HG22 ' A' ' 153' ' ' VAL . 12.3 pt-20 -67.31 -37.45 83.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 118.887 -1.125 . . . . 0.0 109.063 175.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -75.41 -30.05 59.95 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 120.579 -0.449 . . . . 0.0 109.792 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 147' ' ' ILE . 41.8 mm -58.82 -44.49 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 121.272 0.558 . . . . 0.0 109.712 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -81.18 -36.25 30.38 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -174.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 149' ' ' GLU . 31.3 m -97.14 -24.84 4.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.95 -1.67 7.17 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 56.44 33.87 62.74 Favored Glycine 0 N--CA 1.47 0.926 0 N-CA-C 117.473 1.749 . . . . 0.0 117.473 170.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -100.16 108.3 20.38 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 118.225 1.012 . . . . 0.0 111.459 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.575 HG22 HD12 ' A' ' 151' ' ' ILE . 1.9 t -126.57 78.0 72.87 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.418 ' HG2' ' HB3' ' A' ' 100' ' ' GLN . 7.4 Cg_exo -77.77 155.2 30.82 Favored 'Trans proline' 0 C--O 1.257 1.444 0 C-N-CA 122.93 2.42 . . . . 0.0 113.225 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.9 -22.49 54.6 Favored 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 123.425 2.75 . . . . 0.0 111.893 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -56.66 -37.68 77.81 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.581 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 . . . . . 0 C--N 1.3 -1.584 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.206 -178.49 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.1 mttp . . . . . 0 N--CA 1.441 -0.914 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.2 m -124.84 165.75 17.48 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.188 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.0 mt -57.79 -26.82 62.46 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.142 1.377 . . . . 0.0 113.85 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.3 m -65.68 -21.81 66.58 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.947 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -98.93 -10.44 22.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.334 0.588 . . . . 0.0 110.401 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.51 ' HB ' ' HD3' ' A' ' 127' ' ' LYS . 3.2 m -83.28 136.88 34.22 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.325 -171.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.74 154.06 28.81 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 120.614 0.245 . . . . 0.0 110.882 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -108.4 128.72 55.02 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.244 0.618 . . . . 0.0 110.634 -172.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -121.96 131.01 24.5 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -66.08 139.0 54.2 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.119 1.879 . . . . 0.0 109.489 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.442 HG13 ' SG ' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -72.14 -12.9 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-O 121.384 0.611 . . . . 0.0 111.926 -174.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.5 p -75.45 -26.35 58.21 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.885 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.09 53.57 0.8 Allowed 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 122.167 0.984 . . . . 0.0 109.97 177.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -59.21 -22.84 61.66 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 113.792 -1.549 . . . . 0.0 112.329 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.11 -24.1 64.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.583 0.706 . . . . 0.0 109.497 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.9 t -93.91 4.97 53.14 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.391 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.575 HG12 ' HA ' ' A' ' 80' ' ' ALA . 43.5 mm -81.15 124.93 80.59 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.406 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 82.9 Cg_exo -51.58 133.95 45.19 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.287 2.658 . . . . 0.0 112.926 177.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.2 p -96.47 29.07 3.04 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.9 0.857 . . . . 0.0 110.578 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.05 -176.58 3.47 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.545 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.6 t -101.54 142.15 33.34 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.3 -147.85 12.73 Favored Glycine 0 N--CA 1.413 -2.854 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.488 HG13 ' CH2' ' A' ' 146' ' ' TRP . 7.6 p -126.01 148.81 30.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -136.57 149.04 47.87 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 120.9 0.381 . . . . 0.0 110.537 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.26 121.82 41.39 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.603 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.479 HG11 HD21 ' A' ' 116' ' ' LEU . 57.7 t -96.81 114.23 33.18 Favored 'Isoleucine or valine' 0 C--O 1.265 1.894 0 CA-C-O 121.171 0.51 . . . . 0.0 110.363 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 70.6 m-85 -102.52 133.86 46.81 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.379 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -81.21 -172.34 3.72 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -67.07 -16.3 64.25 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.8 m -88.8 1.6 54.98 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 122.277 0.231 . . . . 0.0 110.469 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 67.83 27.01 7.5 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.147 0.979 . . . . 0.0 110.715 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 4.6 mm-40 -103.85 151.72 22.76 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.402 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.502 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 3.0 tm? -102.47 110.99 23.1 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.426 -174.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.435 ' HB3' ' HG3' ' A' ' 158' ' ' PRO . 2.0 mp0 -107.4 -32.96 7.52 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.903 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -131.6 134.99 46.61 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.262 -0.975 . . . . 0.0 112.049 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.46 HG13 HD11 ' A' ' 99' ' ' LEU . 4.5 m -130.47 142.8 42.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -153.8 153.96 25.19 Favored Glycine 0 N--CA 1.425 -2.063 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.086 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.403 HG22 ' HB ' ' A' ' 89' ' ' VAL . 18.8 pt -111.87 141.13 28.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.3 m -149.86 163.77 37.16 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 120.901 0.382 . . . . 0.0 111.55 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -82.92 -30.61 28.29 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -131.56 104.31 6.89 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 84' ' ' PRO . 73.2 mt -60.25 -53.57 46.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 O-C-N 123.162 0.289 . . . . 0.0 111.72 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.01 -58.53 4.32 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.84 89.33 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.286 0.366 . . . . 0.0 111.349 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.9 m -63.46 -49.61 72.99 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.249 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.4 t -58.15 -54.68 29.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.0 m -58.56 -43.75 89.46 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.049 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.66 -59.93 4.16 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -77.1 -30.8 55.48 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.479 HD21 HG11 ' A' ' 92' ' ' VAL . 77.7 mt -76.59 -27.74 55.91 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 119.542 -0.863 . . . . 0.0 113.054 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -81.35 -19.03 43.65 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.891 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.9 m -81.68 -57.76 3.31 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.381 175.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.0 p -116.13 96.26 46.86 Favored Pre-proline 0 N--CA 1.441 -0.914 0 CA-C-O 122.421 1.105 . . . . 0.0 109.987 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' A' ' 123' ' ' CYS . 82.1 Cg_endo -83.68 22.76 0.89 Allowed 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.154 2.569 . . . . 0.0 113.749 -175.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -64.52 -32.2 73.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.006 0.908 . . . . 0.0 109.719 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.4 mt -113.5 21.48 15.08 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.171 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 120' ' ' PRO . 34.9 t -75.52 78.99 2.54 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.383 -178.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -130.89 -56.83 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.4 p -165.38 164.09 19.74 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 122.664 0.385 . . . . 0.0 110.508 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.51 137.04 36.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 120.963 0.411 . . . . 0.0 109.956 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.51 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 77.3 mttt -106.53 130.61 54.27 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 173.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.1 m -113.92 133.72 59.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 120.892 0.377 . . . . 0.0 111.16 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -123.22 106.19 0.98 Allowed Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 130' ' ' ILE . 2.8 mp -93.26 111.78 25.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.6 164.07 2.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.99 -41.68 74.08 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 135' ' ' ASP . 47.4 mt-10 -100.48 116.97 63.75 Favored Pre-proline 0 C--N 1.303 -1.416 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.957 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -81.02 27.09 0.58 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.783 2.322 . . . . 0.0 109.763 173.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 133' ' ' GLU . 29.1 t70 -85.96 145.87 26.94 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.426 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -53.7 -42.75 68.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.08 -37.75 88.59 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 120.977 0.418 . . . . 0.0 111.629 -177.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.439 HG21 ' HB2' ' A' ' 133' ' ' GLU . 34.0 t -79.52 -40.82 21.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.105 -176.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.07 -46.53 90.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.242 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.0 m -67.68 -33.82 75.69 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.337 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -65.61 -48.37 72.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.184 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.23 -43.92 96.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.942 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.404 ' NE1' HG23 ' A' ' 102' ' ' VAL . 91.6 t90 -55.04 -43.32 73.67 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.351 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 25.1 mmtt -60.86 -58.51 8.12 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.582 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 10.9 mp -55.79 -38.13 69.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 118.306 0.503 . . . . 0.0 112.297 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.488 ' CH2' HG13 ' A' ' 89' ' ' VAL . 27.0 m0 -65.12 -53.08 50.83 Favored 'General case' 0 C--O 1.265 1.88 0 O-C-N 123.518 0.511 . . . . 0.0 111.698 177.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.442 ' O ' HG12 ' A' ' 151' ' ' ILE . 8.5 tt -62.42 -46.69 95.81 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.649 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 144' ' ' LYS . 53.6 mm-40 -60.04 -30.95 69.53 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 123.457 0.703 . . . . 0.0 112.596 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 30.8 mm-40 -56.31 -56.85 15.93 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.469 0.652 . . . . 0.0 109.673 174.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.502 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 27.0 m-70 -73.17 -31.89 64.51 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.582 -0.847 . . . . 0.0 113.138 -177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 147' ' ' ILE . 35.3 mm -57.06 -42.81 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 120.423 0.154 . . . . 0.0 111.024 175.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -72.86 -58.36 3.39 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.28 -22.93 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.2 t -129.49 -24.89 2.72 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.109 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 76.55 34.66 43.8 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.783 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -89.85 115.1 26.92 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.459 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.43 86.87 2.38 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-O 122.213 1.006 . . . . 0.0 110.029 175.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.435 ' HG3' ' HB3' ' A' ' 100' ' ' GLN . 67.8 Cg_endo -90.68 169.12 3.83 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 123.02 2.48 . . . . 0.0 112.266 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -51.23 -18.23 4.81 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 124.594 3.53 . . . . 0.0 114.993 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.15 -41.57 86.3 Favored Glycine 0 C--N 1.31 -0.887 0 CA-C-N 116.498 -0.319 . . . . 0.0 112.407 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 61.4 t30 . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 122.767 1.27 . . . . 0.0 109.065 -175.771 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? . . . . . 0 N--CA 1.436 -1.174 0 CA-C-O 120.95 0.405 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.8 p -114.43 -174.15 2.43 Favored 'General case' 0 N--CA 1.414 -2.233 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.207 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.72 -26.21 68.57 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.82 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.6 m -61.81 -30.0 70.53 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.18 0.992 . . . . 0.0 111.109 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -87.06 -1.06 57.6 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.155 0.582 . . . . 0.0 110.165 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.446 ' HB ' ' HD3' ' A' ' 127' ' ' LYS . 27.3 m -114.33 145.45 41.77 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -170.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.94 156.97 17.58 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.03 0.532 . . . . 0.0 110.862 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -115.51 134.34 55.16 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.769 0.828 . . . . 0.0 110.766 -172.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -130.47 129.44 22.79 Favored Pre-proline 0 C--O 1.214 -0.77 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 53.1 Cg_exo -62.79 147.68 94.37 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.074 1.85 . . . . 0.0 110.376 172.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -5.41 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -172.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.0 p -69.44 -26.21 64.49 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 121.16 0.505 . . . . 0.0 111.271 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.26 52.77 0.71 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.692 0.758 . . . . 0.0 110.538 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -60.51 -27.13 67.36 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.027 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.16 -24.33 64.97 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.355 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.5 m -93.01 2.09 56.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.963 0.411 . . . . 0.0 110.966 -177.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 80' ' ' ALA . 46.5 mm -79.25 130.53 68.77 Favored Pre-proline 0 C--O 1.243 0.746 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.554 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -52.3 140.39 52.44 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 124.2 3.267 . . . . 0.0 113.61 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.4 p -98.68 29.53 3.68 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.501 0.667 . . . . 0.0 111.387 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.57 -177.08 3.68 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.157 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.8 t -99.97 152.01 20.68 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 154.28 -143.36 9.97 Favored Glycine 0 N--CA 1.412 -2.933 0 C-N-CA 119.847 -1.168 . . . . 0.0 112.47 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.608 HG12 HG22 ' A' ' 104' ' ' ILE . 3.2 m -119.31 149.36 21.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 C-N-CA 123.485 0.714 . . . . 0.0 110.029 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -143.34 146.06 33.22 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.672 0.273 . . . . 0.0 110.28 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -118.45 127.27 53.5 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.054 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -105.4 118.86 53.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.28 0.562 . . . . 0.0 110.938 -176.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 43.9 m-85 -108.52 141.05 40.98 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -80.32 -169.79 2.25 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HD2' ' HA2' ' A' ' 124' ' ' GLY . 4.9 mmmp? -67.38 -15.2 63.55 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.9 m -89.19 -3.1 58.7 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 65.51 35.29 7.33 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.686 1.194 . . . . 0.0 112.221 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -100.72 145.16 28.82 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.361 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -90.46 109.2 20.33 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.35 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -105.85 -41.99 5.27 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.915 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -125.29 139.38 53.76 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.425 0.631 . . . . 0.0 112.477 -171.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.654 HG22 HD21 ' A' ' 161' ' ' ASN . 27.2 m -132.54 146.31 33.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 172.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.67 165.67 30.61 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 119.756 -1.212 . . . . 0.0 111.815 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.608 HG22 HG12 ' A' ' 89' ' ' VAL . 15.4 pt -116.99 155.0 18.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.0 t -158.64 160.16 36.19 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.183 0.515 . . . . 0.0 110.082 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -85.51 -22.31 28.23 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.402 HD22 ' C ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -142.55 91.97 2.37 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.057 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 70.2 mt -50.87 -60.03 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 123.857 0.863 . . . . 0.0 112.468 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.74 -46.25 29.73 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.18 -55.05 39.93 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.503 0.502 . . . . 0.0 111.075 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.2 m -61.42 -46.07 91.65 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.761 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 75.7 t -56.63 -54.94 22.76 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 C-N-CA 123.023 0.529 . . . . 0.0 111.263 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.1 t -61.29 -46.7 89.24 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 123.259 0.349 . . . . 0.0 110.606 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.27 -60.24 3.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -75.12 -21.94 58.54 Favored 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 118.619 -1.232 . . . . 0.0 113.752 -172.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.0 mt -79.68 -24.19 41.93 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.483 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -88.12 -25.29 23.08 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.39 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.9 t -76.74 -42.03 42.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.823 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.54 91.27 14.15 Favored Pre-proline 0 N--CA 1.437 -1.108 0 CA-C-O 121.895 0.855 . . . . 0.0 110.473 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.737 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 2.7 Cg_exo -75.72 18.31 0.62 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.263 2.642 . . . . 0.0 113.62 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -59.91 -42.96 95.04 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.25 1.02 . . . . 0.0 110.6 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.2 mt -107.18 20.54 18.84 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.435 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.737 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 66.3 m -72.56 120.87 18.77 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.539 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.518 ' HA2' ' HD2' ' A' ' 95' ' ' LYS . . . -163.79 -70.39 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 174.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . 21.8 m -146.48 159.37 43.49 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 9.6 p -139.87 139.01 38.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.034 0.445 . . . . 0.0 110.45 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 91' ' ' ALA . 46.5 mttp -106.51 142.2 36.55 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.47 126.0 71.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.633 0.73 . . . . 0.0 112.325 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -113.69 102.67 1.26 Allowed Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 mp -84.63 121.94 37.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 133' ' ' GLU . 14.5 p -125.33 131.05 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.67 -0.62 57.14 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.518 0.675 . . . . 0.0 111.422 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.462 ' H ' HG22 ' A' ' 131' ' ' VAL . 20.7 mm-40 -94.8 109.66 45.1 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -88.8 32.37 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.353 2.035 . . . . 0.0 112.557 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.435 ' HB3' HG22 ' A' ' 138' ' ' VAL . 11.4 t70 -83.51 139.68 32.76 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -176.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 mmmm -59.44 -34.45 72.53 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.69 -43.44 69.03 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 123.113 0.258 . . . . 0.0 110.825 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 135' ' ' ASP . 17.4 m -69.42 -34.52 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 120.768 0.318 . . . . 0.0 110.911 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.2 mt -66.52 -52.34 46.83 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.007 0.432 . . . . 0.0 110.082 177.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.6 m -65.58 -30.41 71.14 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.064 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.507 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 58.6 tt0 -62.57 -54.21 43.14 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.817 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.21 -37.62 86.0 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 123.992 0.808 . . . . 0.0 110.105 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -54.34 -47.95 71.96 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 123.617 0.573 . . . . 0.0 110.109 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 98.0 mttt -64.63 -49.74 69.88 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.21 177.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.587 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 93.7 mt -50.83 -47.39 60.17 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.416 0.448 . . . . 0.0 111.439 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -63.08 -53.9 46.48 Favored 'General case' 0 C--O 1.265 1.871 0 C-N-CA 123.287 0.635 . . . . 0.0 112.604 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 151' ' ' ILE . 10.4 tt -64.33 -41.13 91.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.741 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 67.4 mt-10 -65.55 -30.05 70.75 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 119.265 -0.398 . . . . 0.0 111.92 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 21.0 mm-40 -54.89 -48.17 73.35 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . 0.272 13.4 m-70 -76.28 -29.54 57.46 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 147' ' ' ILE . 77.3 mt -61.31 -43.94 97.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 173.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -66.78 -49.65 65.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.7 m -79.28 -33.12 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.529 HG23 ' HG2' ' A' ' 156' ' ' LYS . 6.8 t -133.16 -28.06 1.55 Allowed 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.686 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.1 33.18 5.56 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.524 -0.845 . . . . 0.0 112.259 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.529 ' HG2' HG23 ' A' ' 154' ' ' THR . 42.7 mmtm -83.59 111.64 19.29 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.448 0.642 . . . . 0.0 112.583 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 p -155.84 70.96 5.3 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.746 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -90.11 165.3 4.71 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.33 2.687 . . . . 0.0 113.105 -174.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -51.68 -23.87 16.39 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 124.092 3.195 . . . . 0.0 114.275 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -67.49 -20.75 72.03 Favored Glycine 0 C--O 1.205 -1.658 0 C-N-CA 121.821 -0.228 . . . . 0.0 112.9 177.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.654 HD21 HG22 ' A' ' 102' ' ' VAL . 16.5 t-20 . . . . . 0 C--N 1.311 -1.099 0 CA-C-O 121.656 0.741 . . . . 0.0 109.93 -175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? . . . . . 0 N--CA 1.444 -0.745 0 CA-C-O 121.05 0.452 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.9 p -130.84 161.73 31.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.674 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.456 ' H ' ' HG3' ' A' ' 149' ' ' GLU . 72.2 mt -59.77 -28.16 67.17 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.408 0.683 . . . . 0.0 111.03 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.0 m -61.29 -20.61 63.09 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.896 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -111.28 8.03 21.31 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.92 -0.487 . . . . 0.0 110.497 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.528 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.0 m -96.19 135.88 37.41 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.257 -172.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 13.1 pt-20 -69.9 150.05 47.17 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.901 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 125' ' ' SER . 3.1 tm? -118.3 121.22 39.88 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -173.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.13 126.16 27.22 Favored Pre-proline 0 C--N 1.296 -1.724 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -63.76 139.65 70.01 Favored 'Trans proline' 0 C--N 1.326 -0.621 0 C-N-CA 121.903 1.735 . . . . 0.0 108.507 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -70.23 -12.31 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-O 121.422 0.63 . . . . 0.0 111.189 -174.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 p -67.6 -31.71 71.93 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.355 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -97.85 55.48 1.19 Allowed 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.43 0.633 . . . . 0.0 111.045 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.514 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -53.3 -23.39 9.04 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.441 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -69.35 -24.97 63.97 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.114 0.483 . . . . 0.0 110.971 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.8 m -89.64 6.88 39.32 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.465 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.514 HG12 ' HA ' ' A' ' 80' ' ' ALA . 38.1 mm -85.6 115.76 62.85 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -56.27 132.43 51.85 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 123.235 2.624 . . . . 0.0 113.492 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.9 p -89.58 36.38 0.84 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.758 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.32 -176.66 3.15 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.608 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.3 t -104.42 150.11 24.82 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.49 -146.21 13.81 Favored Glycine 0 N--CA 1.414 -2.782 0 C-N-CA 120.26 -0.972 . . . . 0.0 111.264 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.6 p -121.04 147.29 24.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -137.54 151.92 48.91 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 120.916 0.389 . . . . 0.0 110.522 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.422 ' HB1' ' CD2' ' A' ' 99' ' ' LEU . . . -123.32 124.43 42.95 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 124.001 0.92 . . . . 0.0 108.818 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.9 t -101.47 124.94 55.54 Favored 'Isoleucine or valine' 0 C--O 1.262 1.759 0 CA-C-O 121.166 0.508 . . . . 0.0 110.85 -176.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.45 ' HD2' ' O ' ' A' ' 97' ' ' ASP . 12.5 m-85 -111.28 133.11 53.85 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -78.92 -167.19 1.06 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.94 0.4 . . . . 0.0 110.972 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -57.86 -27.44 63.24 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.823 0.849 . . . . 0.0 111.077 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.7 m -86.03 -1.68 57.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.874 0.369 . . . . 0.0 110.397 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.45 ' O ' ' HD2' ' A' ' 93' ' ' TYR . 25.7 t70 64.36 34.65 10.35 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 124.849 1.26 . . . . 0.0 109.156 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 32.7 mm-40 -100.4 124.83 46.41 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.621 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.511 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 3.1 tm? -66.91 118.06 9.87 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -127.28 -14.67 5.34 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.526 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -147.26 133.88 19.89 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.334 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.495 HG23 ' NE1' ' A' ' 143' ' ' TRP . 16.3 m -124.06 138.02 55.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.162 174.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -155.98 157.49 27.86 Favored Glycine 0 C--N 1.305 -1.191 0 C-N-CA 119.788 -1.196 . . . . 0.0 112.846 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.9 144.01 21.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 123.126 0.57 . . . . 0.0 109.899 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 m -150.41 161.06 43.24 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-O 120.546 0.213 . . . . 0.0 110.642 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -85.67 -24.3 27.1 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -135.11 101.95 5.04 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 74.3 mt -60.1 -50.35 80.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.056 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.2 -57.35 9.91 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.67 96.73 Favored 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 123.38 0.425 . . . . 0.0 111.044 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.3 t -58.74 -61.18 2.81 Favored 'General case' 0 C--O 1.252 1.22 0 O-C-N 123.872 0.732 . . . . 0.0 109.961 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.4 t -54.66 -53.54 30.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 123.455 0.702 . . . . 0.0 111.581 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.0 t -59.48 -45.43 91.7 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.814 0.696 . . . . 0.0 111.385 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.26 -48.12 79.51 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -75.04 -27.88 60.2 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 119.069 -1.052 . . . . 0.0 113.536 -176.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 88.7 mt -73.62 -26.28 60.71 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.983 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -86.27 -17.7 33.97 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.466 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.0 m -83.63 -40.26 19.22 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.93 97.0 5.88 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-O 121.702 0.763 . . . . 0.0 110.581 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.607 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 9.8 Cg_exo -73.76 13.72 0.74 Allowed 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 123.757 2.971 . . . . 0.0 114.291 -177.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -55.56 -39.49 70.7 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.435 0.694 . . . . 0.0 111.063 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.2 mt -109.46 20.81 17.79 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.004 -177.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.607 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 63.6 m -70.82 120.29 16.2 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.222 174.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.427 ' N ' HD12 ' A' ' 77' ' ' ILE . . . -170.44 -68.9 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.496 ' HB2' HD21 ' A' ' 74' ' ' LEU . 2.0 p -152.06 152.49 32.46 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 114.882 -0.659 . . . . 0.0 109.695 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.12 137.23 48.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.112 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.528 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 95.0 mttt -106.89 131.36 54.07 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.86 137.28 55.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 120.932 0.396 . . . . 0.0 111.326 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.04 107.68 1.35 Allowed Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.79 109.85 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-O 121.717 0.77 . . . . 0.0 110.985 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.8 p -111.28 125.78 68.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -87.25 -13.06 44.83 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.384 -172.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -92.36 113.83 60.47 Favored Pre-proline 0 N--CA 1.427 -1.595 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -77.84 45.41 1.78 Allowed 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 123.379 2.719 . . . . 0.0 112.923 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.494 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 10.0 t70 -82.18 121.29 26.43 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -67.15 -27.49 67.34 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.13 -39.44 25.59 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.45 -41.62 90.71 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 O-C-N 123.299 0.375 . . . . 0.0 110.265 176.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.0 mt -57.59 -48.12 80.25 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.907 0.384 . . . . 0.0 110.491 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.2 m -69.05 -35.99 77.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.77 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -65.63 -44.78 85.41 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 122.891 0.477 . . . . 0.0 109.977 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.83 -45.04 94.46 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.495 ' NE1' HG23 ' A' ' 102' ' ' VAL . 90.4 t90 -54.07 -44.25 70.97 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.583 176.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -63.96 -52.9 57.55 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.513 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.57 -38.52 78.04 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.413 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 23.5 m0 -64.27 -46.58 83.08 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.618 ' O ' HG12 ' A' ' 151' ' ' ILE . 10.5 tt -63.16 -45.09 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.244 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 17.8 mm-40 -57.26 -39.07 74.86 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.61 0.764 . . . . 0.0 111.674 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 69' ' ' LEU . 4.4 mm-40 -52.09 -49.33 63.78 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.431 0.692 . . . . 0.0 111.6 174.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.511 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 12.7 t60 -80.16 -23.4 41.1 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.892 -177.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.618 HG12 ' O ' ' A' ' 147' ' ' ILE . 43.2 mm -63.39 -50.68 77.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.028 174.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 148' ' ' GLU . 68.3 mttm -56.45 -45.05 81.04 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.966 0.412 . . . . 0.0 111.338 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 33.9 m -80.9 -33.47 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 41.4 p -130.88 -36.11 1.38 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 119.336 -0.945 . . . . 0.0 113.097 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.96 30.7 41.87 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.512 -175.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -82.01 116.58 21.69 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 122.535 -0.391 . . . . 0.0 110.327 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.9 t -131.14 80.34 68.95 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 173.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -75.72 162.37 35.37 Favored 'Trans proline' 0 C--O 1.241 0.662 0 C-N-CA 122.925 2.417 . . . . 0.0 112.517 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.0 -17.5 19.56 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 124.457 3.438 . . . . 0.0 113.432 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -77.57 -38.88 27.07 Favored Glycine 0 C--N 1.304 -1.195 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.858 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.239 0.517 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? . . . . . 0 N--CA 1.436 -1.141 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.9 p -116.69 156.48 27.04 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.739 -175.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 18.7 mt -64.21 -13.38 48.58 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.2 m -68.7 -22.55 64.35 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.566 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -101.84 6.85 41.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.775 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 69' ' ' LEU . 6.9 m -104.02 137.61 41.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -172.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -83.27 161.01 21.61 Favored 'General case' 0 C--O 1.246 0.903 0 O-C-N 123.282 0.364 . . . . 0.0 110.315 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -117.41 130.32 56.41 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.028 0.531 . . . . 0.0 110.572 -174.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.02 120.7 22.62 Favored Pre-proline 0 C--N 1.311 -1.087 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 75.6 Cg_exo -61.41 140.3 87.07 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.001 1.801 . . . . 0.0 109.593 172.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.67 -12.02 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -170.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.4 t -67.01 -35.87 80.89 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 120.78 0.324 . . . . 0.0 110.832 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -90.34 53.91 2.61 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.38 1.086 . . . . 0.0 110.457 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.542 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -60.56 -20.05 59.28 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.58 -177.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -78.09 -22.88 48.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.479 0.657 . . . . 0.0 109.623 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 m -91.49 0.2 57.54 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.836 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.542 HG12 ' HA ' ' A' ' 80' ' ' ALA . 39.2 mm -78.86 121.46 83.46 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -51.64 130.31 33.15 Favored 'Trans proline' 0 C--O 1.252 1.225 0 C-N-CA 123.596 2.864 . . . . 0.0 114.234 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.8 p -91.43 77.02 5.83 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-O 122.285 1.04 . . . . 0.0 109.248 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.406 ' O ' HG13 ' A' ' 108' ' ' ILE . . . -148.89 176.23 10.59 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.535 -177.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 t -92.19 147.27 23.06 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 160.46 -154.03 25.0 Favored Glycine 0 N--CA 1.415 -2.734 0 C-N-CA 120.117 -1.04 . . . . 0.0 110.967 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.449 HG13 ' CH2' ' A' ' 146' ' ' TRP . 7.6 p -123.62 146.83 28.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -136.09 150.18 49.02 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 120.693 0.282 . . . . 0.0 110.351 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.34 124.37 44.39 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.826 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -97.85 118.99 45.28 Favored 'Isoleucine or valine' 0 C--O 1.264 1.829 0 C-N-CA 123.071 0.548 . . . . 0.0 110.969 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 96.4 m-85 -113.13 145.73 40.44 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.522 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.41 ' C ' ' HA3' ' A' ' 124' ' ' GLY . 4.7 p-10 -89.85 -167.95 2.0 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.524 ' HD2' ' HA2' ' A' ' 124' ' ' GLY . 3.0 mmmp? -69.47 -18.14 63.68 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.773 -0.58 . . . . 0.0 111.572 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 m -85.09 -1.49 56.92 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 60.59 34.1 20.27 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 125.554 1.542 . . . . 0.0 113.55 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 40.5 mt-10 -105.19 154.57 20.03 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.433 174.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.483 HD11 HG13 ' A' ' 102' ' ' VAL . 3.4 tm? -93.19 113.51 25.75 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.725 -172.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.402 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 2.3 mp0 -107.49 -29.32 9.28 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.216 176.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -143.63 138.73 29.2 Favored 'General case' 0 C--O 1.214 -0.771 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.227 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.656 HG22 HD21 ' A' ' 161' ' ' ASN . 30.9 m -129.64 148.79 33.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 172.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.66 162.88 31.87 Favored Glycine 0 N--CA 1.422 -2.262 0 C-N-CA 119.989 -1.1 . . . . 0.0 112.382 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.7 pt -118.06 150.37 20.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 123.469 0.707 . . . . 0.0 109.407 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.4 t -157.0 170.36 22.72 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-O 121.288 0.566 . . . . 0.0 110.756 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -90.86 -25.48 19.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.672 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -142.9 90.92 2.24 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 86' ' ' ALA . 78.6 mt -39.21 -60.45 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.777 1.631 . . . . 0.0 114.256 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.51 -41.23 29.36 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.6 -47.77 71.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.043 0.449 . . . . 0.0 110.992 -175.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.1 m -70.88 -40.11 72.44 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.9 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 79.6 t -56.46 -57.16 10.07 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 O-C-N 123.308 0.38 . . . . 0.0 110.786 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.478 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 22.7 t -60.46 -46.84 88.6 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.804 0.69 . . . . 0.0 111.442 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -51.26 -53.18 37.89 Favored 'General case' 0 C--O 1.25 1.114 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -81.95 -22.17 36.83 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 118.791 -1.164 . . . . 0.0 113.674 -178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.8 mt -75.73 -29.71 58.99 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.849 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 113' ' ' SER . 34.1 mmtp -75.62 -24.76 56.52 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 121.67 0.748 . . . . 0.0 109.021 175.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.7 m -76.42 -54.28 6.96 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.587 174.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 m -113.27 90.56 17.01 Favored Pre-proline 0 C--O 1.243 0.712 0 CA-C-O 121.877 0.846 . . . . 0.0 112.852 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.733 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 11.6 Cg_exo -73.85 -3.93 14.58 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.726 2.284 . . . . 0.0 112.253 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.06 -29.72 70.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.504 0.668 . . . . 0.0 109.557 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.9 mt -99.64 10.98 40.4 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.134 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.733 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 83.8 m -72.51 106.01 4.42 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.383 173.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.524 ' HA2' ' HD2' ' A' ' 95' ' ' LYS . . . -148.82 -73.74 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 173.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . 3.6 m -146.51 155.7 42.72 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.05 138.37 47.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 O-C-N 122.0 -0.438 . . . . 0.0 109.924 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.413 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 81.0 mttt -106.12 133.81 50.24 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.74 126.12 74.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.554 0.692 . . . . 0.0 112.188 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -117.02 106.1 1.4 Allowed Glycine 0 N--CA 1.423 -2.191 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.56 111.76 26.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.9 p -92.39 139.54 17.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.54 -44.48 50.89 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.785 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -75.08 114.43 34.99 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 172.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -88.9 37.74 0.42 Allowed 'Trans proline' 0 C--N 1.321 -0.907 0 C-N-CA 122.513 2.142 . . . . 0.0 111.776 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.429 ' HB3' HG22 ' A' ' 138' ' ' VAL . 14.2 t70 -74.11 134.65 42.89 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -177.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -60.7 -29.98 69.67 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -176.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.9 -41.89 61.46 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.429 HG22 ' HB3' ' A' ' 135' ' ' ASP . 16.2 m -69.55 -31.29 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 120.583 -0.447 . . . . 0.0 109.908 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 92.9 mt -64.28 -48.9 73.93 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.971 175.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.9 m -68.33 -34.12 75.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.384 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.596 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 28.9 tt0 -62.87 -50.18 71.9 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.067 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.87 97.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.29 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.518 ' NE1' HG23 ' A' ' 102' ' ' VAL . 90.6 t90 -56.02 -47.13 78.37 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.984 176.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -62.4 -42.61 99.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.078 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 67.9 mt -63.05 -52.22 63.66 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.674 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.449 ' CH2' HG13 ' A' ' 89' ' ' VAL . 28.5 m0 -56.85 -48.24 78.54 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.338 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 151' ' ' ILE . 11.2 tt -63.55 -43.79 98.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.659 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.7 -29.99 70.61 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 9.5 mm-40 -64.53 -41.77 96.18 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.017 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.45 ' HA ' HG22 ' A' ' 153' ' ' VAL 0.261 60.5 m-70 -76.89 -29.94 55.98 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.505 -0.878 . . . . 0.0 112.853 178.067 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 147' ' ' ILE . 71.9 mt -58.29 -37.98 66.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 171.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -78.82 -49.82 12.32 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.45 HG22 ' HA ' ' A' ' 150' ' ' HIS . 27.8 m -78.7 -20.85 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -174.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 156' ' ' LYS . 6.8 t -138.01 -31.27 0.78 Allowed 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.299 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 88.65 11.2 66.33 Favored Glycine 0 CA--C 1.502 -0.735 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.018 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.413 ' H ' HG23 ' A' ' 154' ' ' THR . 44.7 mmtm -83.13 103.94 12.94 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.33 0.586 . . . . 0.0 110.592 -177.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.4 p -140.49 76.1 25.72 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.293 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 14.1 Cg_exo -73.67 159.47 45.65 Favored 'Trans proline' 0 C--O 1.249 1.035 0 C-N-CA 123.194 2.596 . . . . 0.0 112.349 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.5 -23.88 26.55 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.995 3.13 . . . . 0.0 113.958 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -59.14 -41.82 96.81 Favored Glycine 0 CA--C 1.497 -1.037 0 CA-C-O 121.104 0.28 . . . . 0.0 112.671 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.656 HD21 HG22 ' A' ' 102' ' ' VAL . 44.9 t-20 . . . . . 0 C--N 1.305 -1.342 0 CA-C-O 121.926 0.87 . . . . 0.0 108.971 -175.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.56 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 7.8 mmpt? . . . . . 0 N--CA 1.436 -1.14 0 CA-C-O 120.867 0.365 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.663 ' HB3' ' OE1' ' A' ' 149' ' ' GLU . 66.6 m -133.04 175.49 9.33 Favored 'General case' 0 N--CA 1.422 -1.843 0 O-C-N 122.015 -0.428 . . . . 0.0 111.448 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.2 mt -70.76 -23.52 62.43 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 m -69.83 -15.85 63.17 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.189 0.995 . . . . 0.0 109.323 176.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -107.83 8.21 28.58 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.63 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.6 m -103.7 142.09 34.94 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.58 149.24 40.2 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 123.735 0.647 . . . . 0.0 111.284 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.11 133.07 51.39 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.8 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.73 128.73 24.53 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -67.41 142.85 61.28 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.786 1.657 . . . . 0.0 109.357 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.42 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -69.16 -11.79 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.422 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.3 p -66.53 -37.75 85.68 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.505 0.669 . . . . 0.0 110.249 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -95.14 50.89 1.29 Allowed 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.845 0.831 . . . . 0.0 110.525 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.409 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -59.78 -27.76 66.84 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.944 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -73.26 -20.92 60.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.532 0.682 . . . . 0.0 110.39 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.0 m -95.99 7.52 46.16 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.406 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' A' ' 80' ' ' ALA . 46.1 mm -78.1 130.59 71.97 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -53.07 132.1 46.08 Favored 'Trans proline' 0 C--O 1.242 0.725 0 C-N-CA 123.417 2.745 . . . . 0.0 113.457 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.9 p -95.3 34.74 1.38 Allowed 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.306 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.402 ' O ' HG13 ' A' ' 108' ' ' ILE . . . -101.98 179.36 4.35 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.957 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 t -95.97 140.04 31.3 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.3 -154.08 24.08 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 119.915 -1.136 . . . . 0.0 111.998 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.585 HG12 HG22 ' A' ' 104' ' ' ILE . 4.4 m -108.29 146.83 13.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 123.823 0.849 . . . . 0.0 109.88 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -141.36 154.98 45.96 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB1' ' CD2' ' A' ' 99' ' ' LEU . . . -135.06 126.45 28.47 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.278 -178.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.63 122.05 52.15 Favored 'Isoleucine or valine' 0 C--O 1.269 2.107 0 CA-C-O 120.932 0.396 . . . . 0.0 110.463 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 77.5 m-85 -109.43 137.92 46.56 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.888 1.275 . . . . 0.0 108.759 177.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -83.61 -166.86 1.5 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.516 ' HE3' ' O ' ' A' ' 123' ' ' CYS . 8.2 mptt -65.21 -26.42 68.12 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 122.913 0.485 . . . . 0.0 111.209 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.8 m -85.51 1.25 49.72 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 122.816 0.447 . . . . 0.0 110.591 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 65.7 28.72 11.02 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 123.87 0.868 . . . . 0.0 111.21 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 156' ' ' LYS . 45.4 mt-10 -100.26 123.32 44.36 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.618 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.481 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.0 tm? -70.04 127.74 33.88 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.199 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.457 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 43.6 mt-30 -126.99 -43.31 1.68 Allowed 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.992 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -126.06 121.51 33.17 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 118.819 -1.153 . . . . 0.0 112.143 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.412 HG13 HD11 ' A' ' 99' ' ' LEU . 19.5 m -112.1 151.72 14.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.99 160.73 30.61 Favored Glycine 0 N--CA 1.425 -2.094 0 C-N-CA 119.382 -1.389 . . . . 0.0 112.655 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.585 HG22 HG12 ' A' ' 89' ' ' VAL . 15.2 pt -119.07 137.3 53.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 m -152.34 166.36 32.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.914 0.387 . . . . 0.0 111.676 -177.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -85.11 -32.68 22.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.066 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -127.7 106.01 8.85 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 86' ' ' ALA . 73.9 mt -61.74 -59.61 4.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.624 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.94 -56.74 5.08 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.2 95.05 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.982 0.176 . . . . 0.0 111.276 -177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.4 m -64.28 -47.84 78.01 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.715 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.75 -55.09 26.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.005 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.9 m -57.33 -42.55 82.14 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.073 0.858 . . . . 0.0 111.781 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.98 -56.43 21.81 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 122.695 0.398 . . . . 0.0 111.889 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.27 23.7 p80 -71.61 -22.16 61.75 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.0 mt -73.75 -27.24 61.07 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.12 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -87.56 -15.67 36.78 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.253 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.5 m -87.02 -42.89 12.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.335 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.7 p -135.21 91.46 19.19 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-O 121.722 0.773 . . . . 0.0 110.007 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.631 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 7.4 Cg_exo -75.01 12.35 1.24 Allowed 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 123.396 2.73 . . . . 0.0 114.11 -176.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.38 -42.98 96.96 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.99 0.424 . . . . 0.0 109.958 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 39.7 mt -94.87 18.26 12.18 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.184 -176.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.631 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 84.8 m -76.85 85.6 3.42 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.467 0.651 . . . . 0.0 112.486 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -128.74 -59.59 0.11 Allowed Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 11.3 p -164.7 158.05 17.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -132.23 141.02 46.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -109.44 138.81 45.25 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 135.06 65.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.085 0.469 . . . . 0.0 110.739 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.3 99.75 0.74 Allowed Glycine 0 N--CA 1.419 -2.497 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.66 108.86 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.532 HG22 ' H ' ' A' ' 133' ' ' GLU . 7.7 p -99.06 131.03 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.73 8.37 10.18 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.579 0.704 . . . . 0.0 111.977 -175.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.532 ' H ' HG22 ' A' ' 131' ' ' VAL . 31.8 mt-10 -124.84 91.73 48.92 Favored Pre-proline 0 N--CA 1.421 -1.879 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 171.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.65 31.52 0.48 Allowed 'Trans proline' 0 N--CA 1.481 0.794 0 C-N-CA 123.102 2.534 . . . . 0.0 112.083 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.41 141.69 28.97 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.214 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -58.34 -26.57 63.25 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -67.14 -44.91 78.63 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.3 t -75.53 -40.05 40.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.402 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.22 -51.42 70.04 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.797 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 29.3 m -67.58 -32.42 73.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.011 0.434 . . . . 0.0 110.539 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.52 ' O ' HD22 ' A' ' 145' ' ' LEU . 51.7 tt0 -64.35 -56.7 12.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.264 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.27 92.28 Favored 'General case' 0 C--O 1.225 -0.197 0 O-C-N 123.221 0.326 . . . . 0.0 110.147 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -53.69 -43.77 69.22 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.733 0.813 . . . . 0.0 109.726 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.573 ' HE3' ' OE1' ' A' ' 148' ' ' GLU . 56.9 tptt -64.27 -43.98 93.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.361 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 141' ' ' GLN . 2.5 mm? -64.3 -42.57 96.3 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.735 178.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -62.09 -49.14 77.12 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.063 -0.972 . . . . 0.0 112.044 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.516 ' O ' HG13 ' A' ' 151' ' ' ILE . 13.7 tt -69.21 -45.74 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.258 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.573 ' OE1' ' HE3' ' A' ' 144' ' ' LYS . 30.5 mt-10 -68.64 -29.61 68.13 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -175.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.663 ' OE1' ' HB3' ' A' ' 68' ' ' SER . 5.4 pt-20 -67.09 -42.72 84.14 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 118.459 -1.297 . . . . 0.0 108.683 176.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.437 ' N ' ' HG3' ' A' ' 149' ' ' GLU 0.263 24.5 m-70 -74.88 -23.38 58.38 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -179.287 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 147' ' ' ILE . 76.8 mt -66.87 -30.47 49.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -84.42 -42.57 15.52 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 149' ' ' GLU . 5.2 p -80.94 -51.47 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.0 p -96.79 -28.63 14.18 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 121.663 -0.648 . . . . 0.0 111.931 -176.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.96 29.92 62.72 Favored Glycine 0 N--CA 1.467 0.702 0 CA-C-N 114.727 -1.124 . . . . 0.0 115.415 174.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 26.1 mtpp -91.47 -70.58 0.68 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 117.391 0.595 . . . . 0.0 110.702 -176.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.289 7.7 p 41.4 83.27 0.21 Allowed Pre-proline 0 CA--C 1.567 1.613 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 58.9 Cg_endo -70.11 169.26 19.79 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.945 2.43 . . . . 0.0 112.593 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -45.75 -25.7 2.69 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 125.175 3.917 . . . . 0.0 115.694 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -57.64 -47.84 85.66 Favored Glycine 0 C--O 1.238 0.365 0 O-C-N 123.55 0.532 . . . . 0.0 113.388 -175.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.6 m120 . . . . . 0 CA--C 1.497 -1.093 0 CA-C-O 121.005 0.431 . . . . 0.0 111.785 -179.441 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.7 mttp . . . . . 0 CA--C 1.495 -1.156 0 CA-C-O 121.809 0.814 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.2 m -136.78 172.48 12.95 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.482 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.51 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 61.3 mt -59.87 -16.14 26.74 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.8 1.24 . . . . 0.0 114.241 -175.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.424 HG23 ' HG3' ' A' ' 71' ' ' GLU . 12.5 t -65.32 -19.97 66.19 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.24 0.616 . . . . 0.0 111.164 176.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.424 ' HG3' HG23 ' A' ' 70' ' ' THR . 31.7 mt-10 -106.45 -7.36 17.62 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.426 0.631 . . . . 0.0 110.263 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.51 ' OG1' ' HA ' ' A' ' 69' ' ' LEU . 4.4 m -84.94 129.6 34.78 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.131 -172.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -81.56 150.99 27.92 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.806 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -104.99 129.1 53.51 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 123.277 0.631 . . . . 0.0 109.657 -175.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.2 140.27 35.71 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -68.27 145.56 66.42 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.532 2.155 . . . . 0.0 110.133 173.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -13.54 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-O 121.429 0.633 . . . . 0.0 110.667 -177.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.4 t -78.42 -15.1 59.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -97.95 47.89 1.01 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.804 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.513 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -61.42 -28.95 69.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.295 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -69.18 -26.02 64.64 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.001 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.7 m -90.87 -5.53 55.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.393 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.513 HG12 ' HA ' ' A' ' 80' ' ' ALA . 44.1 mm -70.16 125.28 91.92 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -178.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.51 134.96 66.99 Favored 'Trans proline' 0 C--O 1.244 0.823 0 C-N-CA 123.049 2.5 . . . . 0.0 113.399 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.8 p -91.81 26.77 2.28 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.925 0.869 . . . . 0.0 109.727 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.91 -178.73 4.18 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.405 -173.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.5 t -95.83 138.85 32.89 Favored 'General case' 0 N--CA 1.425 -1.704 0 O-C-N 124.034 0.833 . . . . 0.0 109.404 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.46 -151.22 20.25 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 118.503 -1.808 . . . . 0.0 114.422 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.416 ' HB ' ' CH2' ' A' ' 146' ' ' TRP . 5.6 t -120.34 150.28 23.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -139.25 149.26 44.12 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.346 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.14 120.59 34.67 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 123.918 0.887 . . . . 0.0 109.32 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.7 t -99.69 121.76 50.73 Favored 'Isoleucine or valine' 0 C--O 1.263 1.804 0 CA-C-O 121.059 0.457 . . . . 0.0 110.608 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -109.66 132.06 54.49 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.45 -172.48 4.16 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.774 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.54 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -65.18 -22.27 66.88 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.382 0.673 . . . . 0.0 112.201 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.9 m -84.68 0.39 50.53 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 123.001 0.52 . . . . 0.0 109.986 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 69.33 16.55 8.35 Favored 'General case' 0 C--O 1.249 1.079 0 C-N-CA 125.023 1.329 . . . . 0.0 111.707 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -86.84 135.77 33.21 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.124 0.488 . . . . 0.0 110.322 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.489 HD11 HG13 ' A' ' 102' ' ' VAL . 3.4 tm? -80.75 112.22 17.93 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 174.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -125.0 -13.72 6.78 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.944 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.429 ' HA ' ' OD1' ' A' ' 161' ' ' ASN . 57.4 t80 -145.83 122.65 11.26 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 118.707 -1.197 . . . . 0.0 111.08 177.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' A' ' 147' ' ' ILE . 18.6 m -123.27 141.32 44.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 171.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -157.23 157.91 28.47 Favored Glycine 0 N--CA 1.413 -2.895 0 C-N-CA 119.068 -1.539 . . . . 0.0 111.719 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.7 pt -110.91 137.84 41.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 121.192 0.52 . . . . 0.0 109.733 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.5 m -149.77 136.41 19.28 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HD2' ' C ' ' A' ' 106' ' ' ARG . 4.5 ppt_? -76.74 -12.0 59.92 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.751 0.786 . . . . 0.0 109.894 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -133.7 86.76 2.32 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.6 mt -55.68 -55.32 18.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.157 -174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.64 -60.25 2.3 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.05 -37.99 87.06 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.033 0.208 . . . . 0.0 111.432 -176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.7 t -63.65 -55.32 24.42 Favored 'General case' 0 C--O 1.248 0.985 0 O-C-N 123.836 0.71 . . . . 0.0 109.913 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.9 t -57.94 -51.61 68.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.351 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.9 m -60.1 -37.92 81.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.327 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.13 -58.86 6.8 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 120.937 0.399 . . . . 0.0 111.47 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -77.63 -22.36 50.84 Favored 'General case' 0 C--O 1.203 -1.367 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.04 -26.03 25.58 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 119.062 -1.055 . . . . 0.0 113.326 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -88.12 -16.95 32.09 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.3 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -94.81 -20.1 19.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.004 0.43 . . . . 0.0 111.158 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.9 p -152.73 94.0 3.19 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-O 121.809 0.814 . . . . 0.0 110.534 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.667 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 16.1 Cg_exo -68.84 14.28 0.2 Allowed 'Trans proline' 0 CA--C 1.556 1.579 0 C-N-CA 124.123 3.215 . . . . 0.0 116.729 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -66.39 -28.27 68.5 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 121.464 -0.773 . . . . 0.0 111.503 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 61.9 mt -107.25 20.86 18.38 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 121.683 -0.636 . . . . 0.0 111.502 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.667 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 89.4 m -79.68 99.05 7.21 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.73 -65.28 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.6 p -160.05 162.05 34.09 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.095 0.558 . . . . 0.0 109.52 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.38 137.78 43.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-O 121.155 0.503 . . . . 0.0 110.375 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.509 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 79.5 mttt -109.11 137.27 47.27 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.36 138.69 53.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 120.57 0.224 . . . . 0.0 110.863 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.72 113.34 1.85 Allowed Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.32 107.59 18.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 p -93.53 143.22 11.97 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.572 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -58.63 -50.21 74.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.275 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -94.52 119.42 66.35 Favored Pre-proline 0 C--N 1.303 -1.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.176 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.07 27.16 0.62 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.066 2.51 . . . . 0.0 110.877 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.15 133.56 50.04 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.402 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -59.54 -33.77 71.82 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.85 -42.24 58.34 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.55 -43.07 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.004 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.69 -49.26 78.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.74 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 44.8 m -69.1 -31.1 69.58 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.084 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.492 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 27.9 tt0 -63.26 -50.64 69.36 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 122.946 0.498 . . . . 0.0 109.884 178.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.85 -45.26 93.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.698 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -51.13 -46.69 62.02 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.251 1.021 . . . . 0.0 110.284 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -61.0 -48.82 80.04 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.179 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 61.7 mt -62.8 -43.23 99.35 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.79 -176.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.416 ' CH2' ' HB ' ' A' ' 89' ' ' VAL . 30.8 m0 -61.48 -47.51 85.35 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.21 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.514 ' O ' HG13 ' A' ' 151' ' ' ILE . 14.9 tt -67.68 -39.75 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.404 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -62.74 -33.71 75.69 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 153' ' ' VAL . 7.3 mm-40 -55.24 -45.95 76.02 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.401 0.619 . . . . 0.0 109.685 173.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.468 ' HA ' HG12 ' A' ' 153' ' ' VAL 0.255 74.3 m-70 -80.5 -27.36 37.74 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.295 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 147' ' ' ILE . 79.8 mt -61.29 -41.07 88.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -71.06 -43.98 66.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.326 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 150' ' ' HIS . 7.3 p -81.7 -56.4 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.4 p -99.47 -34.36 10.3 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 121.811 -0.556 . . . . 0.0 112.264 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.74 34.67 27.21 Favored Glycine 0 C--N 1.304 -1.226 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.715 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -106.83 106.49 17.05 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.76 87.52 46.41 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 173.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -86.14 169.87 8.53 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 123.896 3.064 . . . . 0.0 113.251 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -45.23 -30.57 5.3 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 124.928 3.752 . . . . 0.0 116.177 -175.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.76 -30.31 72.67 Favored Glycine 0 C--O 1.246 0.896 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.312 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 101' ' ' PHE . 14.7 m120 . . . . . 0 C--N 1.311 -1.075 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.429 ' HD3' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.44 -0.944 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.7 m -114.41 168.98 9.38 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.331 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 146' ' ' TRP . 2.9 tm? -65.32 -35.0 79.65 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.429 1.092 . . . . 0.0 109.829 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.8 m -55.97 -28.69 58.2 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.798 176.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -93.94 -4.08 50.45 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.752 -0.593 . . . . 0.0 111.575 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.548 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.3 m -78.02 141.67 38.73 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -173.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -88.45 148.64 24.08 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.659 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.06 133.94 48.16 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 122.84 0.456 . . . . 0.0 109.94 -174.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -126.44 126.45 24.61 Favored Pre-proline 0 C--N 1.315 -0.928 0 C-N-CA 123.652 0.781 . . . . 0.0 108.902 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.522 ' HB2' HG22 ' A' ' 78' ' ' THR . 25.5 Cg_exo -67.67 141.85 56.28 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 121.843 1.695 . . . . 0.0 109.139 172.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -5.0 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -174.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 76' ' ' PRO . 9.1 t -68.32 -30.0 68.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -99.43 52.97 0.94 Allowed 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.364 1.078 . . . . 0.0 109.61 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.55 -24.11 66.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.102 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -76.32 -19.41 58.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.782 0.801 . . . . 0.0 110.244 176.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.3 t -87.49 -6.97 58.15 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.243 -174.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.7 mm -67.43 125.84 91.71 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.391 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -53.77 137.37 67.45 Favored 'Trans proline' 0 C--O 1.243 0.739 0 C-N-CA 123.584 2.856 . . . . 0.0 113.95 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.8 p -93.69 35.72 1.12 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.25 1.024 . . . . 0.0 109.129 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.445 ' O ' HG13 ' A' ' 108' ' ' ILE . . . -102.64 175.37 5.52 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.229 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.7 t -97.53 134.76 40.32 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.28 -154.88 24.68 Favored Glycine 0 N--CA 1.412 -2.902 0 C-N-CA 119.952 -1.118 . . . . 0.0 111.069 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.458 ' HB ' ' CH2' ' A' ' 146' ' ' TRP . 3.2 t -115.24 156.44 16.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -145.61 149.52 34.68 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.58 121.97 35.15 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.462 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.9 t -94.93 118.74 41.75 Favored 'Isoleucine or valine' 0 C--O 1.259 1.558 0 CA-C-O 121.332 0.587 . . . . 0.0 110.351 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.559 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 7.3 m-85 -108.82 134.49 51.44 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.367 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.92 -179.33 6.92 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -73.99 3.18 7.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -175.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.5 m -94.18 0.0 55.49 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 171.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 t70 61.51 62.94 1.24 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.036 1.334 . . . . 0.0 108.538 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -141.39 146.49 36.67 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.3 -177.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.418 HD11 HG13 ' A' ' 102' ' ' VAL . 3.3 tm? -96.3 116.67 29.4 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.92 0.762 . . . . 0.0 110.745 -172.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.467 ' HA ' ' HG2' ' A' ' 158' ' ' PRO . 2.4 mp0 -112.08 -28.39 8.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.329 178.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -145.91 127.07 14.72 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.12 -1.032 . . . . 0.0 112.493 -175.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.434 HG23 ' NE1' ' A' ' 143' ' ' TRP . 20.0 m -114.98 143.55 24.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 172.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.46 170.38 31.03 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.4 pt -133.14 146.84 31.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.1 t -151.22 162.42 40.92 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.979 -0.289 . . . . 0.0 110.29 -176.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -85.38 -22.67 28.3 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -142.43 86.16 1.94 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 86' ' ' ALA . 73.0 mt -43.94 -52.45 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.663 1.185 . . . . 0.0 113.304 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.65 -40.33 19.52 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.78 -51.76 37.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.444 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.9 m -63.19 -45.92 89.5 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.688 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.31 -57.13 11.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.33 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.4 t -62.94 -40.89 99.01 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 123.404 0.44 . . . . 0.0 111.13 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.69 -54.31 47.67 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.261 19.7 p80 -78.69 -25.79 44.81 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 118.922 -1.111 . . . . 0.0 113.94 -177.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 70.5 mt -75.19 -28.35 59.97 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 119.781 -0.767 . . . . 0.0 112.127 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -86.11 -23.34 26.67 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.738 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.1 m -72.89 -46.36 53.2 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.4 p -139.26 91.69 11.02 Favored Pre-proline 0 N--CA 1.438 -1.075 0 CA-C-O 122.22 1.009 . . . . 0.0 110.022 177.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -74.84 29.75 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.945 3.096 . . . . 0.0 113.82 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -70.83 -42.87 69.64 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.362 0.601 . . . . 0.0 110.533 -177.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.62 21.29 4.08 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.219 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 35.9 m -71.56 99.32 2.04 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.334 0.587 . . . . 0.0 111.856 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.32 -59.9 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.1 p -164.72 160.84 20.24 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.79 138.01 46.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.548 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 97.9 mttt -106.71 135.36 48.38 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.0 m -120.88 131.41 72.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 120.81 0.338 . . . . 0.0 110.1 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -115.81 106.58 1.57 Allowed Glycine 0 N--CA 1.408 -3.228 0 C-N-CA 119.868 -1.158 . . . . 0.0 111.85 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 mp -82.23 112.37 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.25 144.26 20.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.31 4.51 53.37 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.204 -171.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -94.58 112.4 57.69 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -84.73 8.32 4.7 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 122.592 2.195 . . . . 0.0 116.065 -170.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.407 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 16.1 t70 -97.64 146.81 24.95 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.131 -174.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -54.85 -34.67 63.16 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.692 1.197 . . . . 0.0 111.891 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.96 -44.23 90.08 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 120.658 0.266 . . . . 0.0 110.665 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.46 -36.38 48.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.615 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 95.1 mt -60.82 -45.08 95.86 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.1 m -71.94 -32.14 67.02 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 121.072 0.463 . . . . 0.0 110.698 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.437 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 26.6 tt0 -63.69 -46.31 86.06 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 175.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.77 -42.25 95.24 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.843 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.434 ' NE1' HG23 ' A' ' 102' ' ' VAL . 91.9 t90 -49.83 -45.89 50.67 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.488 0.715 . . . . 0.0 109.633 176.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.643 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 84.6 mttt -62.09 -50.74 70.74 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.13 177.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 86.9 mt -54.32 -47.54 72.36 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.532 0.52 . . . . 0.0 110.679 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 69' ' ' LEU . 14.3 m0 -62.02 -54.46 41.26 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.538 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.446 ' O ' HG12 ' A' ' 151' ' ' ILE . 11.1 tt -59.19 -42.78 87.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 O-C-N 123.424 0.452 . . . . 0.0 110.274 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 37.3 mt-10 -56.01 -47.67 77.34 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 123.547 0.53 . . . . 0.0 110.913 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.404 ' O ' HG22 ' A' ' 153' ' ' VAL . 15.4 mt-10 -56.86 -47.02 81.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.41 ' HA ' HG22 ' A' ' 153' ' ' VAL . 0.6 OUTLIER -82.83 -28.2 30.33 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 118.496 -1.282 . . . . 0.0 112.751 -176.11 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.523 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 38.2 pt -76.85 -26.77 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.906 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -78.5 -30.9 47.47 Favored 'General case' 0 C--N 1.264 -3.123 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.079 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 150' ' ' HIS . 35.1 m -86.57 -46.33 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 176.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 70.8 p -99.99 -19.02 16.76 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 119.409 -0.917 . . . . 0.0 113.031 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 151' ' ' ILE . . . 67.52 34.69 84.99 Favored Glycine 0 N--CA 1.468 0.822 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 174.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -78.95 -74.94 0.26 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 117.1 0.45 . . . . 0.0 111.958 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.1 t 54.13 69.52 2.12 Favored Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 123.865 0.866 . . . . 0.0 109.014 -174.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.467 ' HG2' ' HA ' ' A' ' 100' ' ' GLN . 2.8 Cg_exo -81.44 156.94 19.27 Favored 'Trans proline' 0 C--O 1.242 0.696 0 C-N-CA 122.804 2.336 . . . . 0.0 112.84 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.92 -35.92 41.96 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 124.298 3.332 . . . . 0.0 114.159 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -64.86 -30.52 78.21 Favored Glycine 0 CA--C 1.498 -1.011 0 O-C-N 123.336 0.397 . . . . 0.0 112.933 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.42 ' OD1' HG22 ' A' ' 102' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.297 -1.677 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -176.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.529 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.22 -41.98 15.11 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 123.137 0.273 . . . . 0.0 111.462 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -167.29 -164.52 0.61 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.92 110.98 1.95 Allowed 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 71' ' ' GLU . 8.1 p -78.68 135.93 24.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.248 -175.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -112.66 -53.77 2.68 Favored 'General case' 0 C--O 1.205 -1.253 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.417 ' HB3' ' OE2' ' A' ' 149' ' ' GLU . 15.6 m -113.32 164.64 13.31 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.568 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.402 HD13 ' OH ' ' A' ' 93' ' ' TYR . 35.0 mt -62.33 -28.02 69.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.159 0.983 . . . . 0.0 111.404 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.2 m -59.45 -21.91 60.73 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.033 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 66' ' ' VAL . 31.8 mt-10 -104.92 11.58 33.43 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 122.717 0.407 . . . . 0.0 110.264 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.436 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 8.1 m -104.7 142.9 33.88 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -173.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -86.26 159.64 19.38 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.506 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.11 133.35 53.12 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.524 HD23 HG22 ' A' ' 128' ' ' VAL . 3.7 mm? -128.17 138.87 33.92 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -74.93 143.53 29.41 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.41 2.074 . . . . 0.0 110.573 173.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.62 -15.74 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-O 120.913 0.387 . . . . 0.0 112.01 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p -71.77 -38.21 70.38 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 121.615 0.722 . . . . 0.0 111.183 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -93.16 54.2 2.09 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.873 0.844 . . . . 0.0 110.645 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.52 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -56.38 -18.41 10.91 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.425 -1.261 . . . . 0.0 112.981 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -72.25 -27.25 62.39 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.52 0.676 . . . . 0.0 109.692 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.9 m -93.89 3.3 55.6 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.977 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.52 HG12 ' HA ' ' A' ' 80' ' ' ALA . 38.1 mm -79.63 128.56 74.34 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.26 130.65 41.79 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.957 2.438 . . . . 0.0 113.335 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.1 p -92.9 39.01 1.03 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 122.224 1.011 . . . . 0.0 109.475 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -109.55 177.63 4.68 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.259 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.6 t -93.94 140.53 29.59 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.75 -155.08 26.15 Favored Glycine 0 N--CA 1.417 -2.62 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.641 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.477 HG13 ' CH2' ' A' ' 146' ' ' TRP . 6.3 p -121.23 149.17 24.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -137.63 149.58 46.72 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 120.848 0.356 . . . . 0.0 110.543 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.403 ' HB1' HD23 ' A' ' 99' ' ' LEU . . . -122.14 118.65 29.18 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.79 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.6 t -91.78 121.0 41.87 Favored 'Isoleucine or valine' 0 C--O 1.263 1.787 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.367 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 67.4 m-85 -108.76 130.0 55.37 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.691 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -76.91 -175.08 3.35 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.231 0.539 . . . . 0.0 110.257 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.464 ' H ' ' HD2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -57.83 -28.09 63.76 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 124.14 0.976 . . . . 0.0 113.547 -178.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.7 m -91.74 3.45 55.07 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.803 0.335 . . . . 0.0 111.492 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.4 t70 62.33 67.75 0.71 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-O 122.724 1.25 . . . . 0.0 111.598 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 8.1 mm-40 -136.82 145.73 44.82 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.556 -1.656 . . . . 0.0 109.814 174.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.512 HD21 HG13 ' A' ' 102' ' ' VAL . 3.0 tm? -89.87 116.71 28.15 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.308 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -122.86 -14.49 7.64 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.259 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.58 115.03 5.91 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.819 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.512 HG13 HD21 ' A' ' 99' ' ' LEU . 12.3 m -111.21 142.26 24.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.79 159.76 29.81 Favored Glycine 0 N--CA 1.424 -2.14 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.227 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.2 pt -115.09 139.94 38.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.5 m -151.0 157.77 43.3 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.635 ' HD3' ' O ' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -79.3 -23.32 43.61 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 177.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -135.49 105.39 6.2 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 173.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.4 mt -60.14 -56.94 14.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.38 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -49.95 -50.73 45.56 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.559 0.744 . . . . 0.0 112.767 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.23 -52.19 66.73 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 123.75 0.656 . . . . 0.0 111.109 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.1 t -61.26 -48.62 80.6 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.293 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 54.7 t -56.9 -54.48 29.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 123.103 0.561 . . . . 0.0 111.097 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.0 m -61.04 -35.53 77.15 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 123.607 0.567 . . . . 0.0 111.463 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.91 -58.96 3.97 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.836 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.497 ' HB3' HG11 ' A' ' 171' ' ' VAL 0.287 19.6 p80 -74.8 -24.66 58.68 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -175.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.6 mt -77.93 -24.82 48.14 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.217 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 117' ' ' LYS . 73.0 mmtt -85.49 -16.82 38.31 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.867 175.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.0 t -80.55 -50.48 9.95 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.58 85.0 61.3 Favored Pre-proline 0 CA--C 1.557 1.236 0 CA-C-O 122.341 1.067 . . . . 0.0 109.929 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.494 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 16.6 Cg_exo -71.87 12.02 0.62 Allowed 'Trans proline' 0 N--CA 1.479 0.623 0 C-N-CA 124.031 3.154 . . . . 0.0 114.806 -176.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -66.47 -39.32 88.73 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.341 0.591 . . . . 0.0 109.886 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.8 mt -88.16 20.71 3.08 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.092 0.473 . . . . 0.0 111.802 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.494 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 89.2 m -79.99 99.44 7.64 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 121.497 0.665 . . . . 0.0 111.069 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.43 -64.64 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 174.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.4 p -161.43 162.92 30.73 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.9 p -137.14 137.05 46.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.436 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 94.8 mttt -106.4 125.56 51.15 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 175.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.524 HG22 HD23 ' A' ' 75' ' ' LEU . 33.0 m -115.34 134.35 58.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.412 0.625 . . . . 0.0 111.929 -174.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.65 96.16 0.63 Allowed Glycine 0 N--CA 1.422 -2.249 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 130' ' ' ILE . 2.6 mp -89.27 121.37 39.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 133' ' ' GLU . 10.2 p -116.12 125.25 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 175.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -72.38 -8.87 57.24 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.461 ' H ' HG22 ' A' ' 131' ' ' VAL . 38.3 mt-10 -89.62 122.06 68.55 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -83.12 27.12 0.62 Allowed 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.769 2.313 . . . . 0.0 113.224 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.432 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 24.2 t70 -78.96 129.38 34.42 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.532 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -69.9 -31.15 68.79 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.422 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.72 -38.45 62.29 Favored 'General case' 0 C--O 1.203 -1.37 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.297 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.401 HG23 ' OD2' ' A' ' 135' ' ' ASP . 97.6 t -59.09 -43.75 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 92.4 mt -59.08 -48.4 81.75 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.345 0.593 . . . . 0.0 110.244 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 17.6 m -70.69 -34.3 71.82 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.272 -176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.45 -47.05 74.4 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 123.109 0.564 . . . . 0.0 109.759 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -58.83 -49.25 78.43 Favored 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -49.17 -43.9 42.38 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.002 0.921 . . . . 0.0 110.305 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -65.55 -48.71 71.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.43 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.64 -37.12 85.09 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.773 0.321 . . . . 0.0 110.871 177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.477 ' CH2' HG13 ' A' ' 89' ' ' VAL . 25.0 m0 -63.47 -53.55 50.29 Favored 'General case' 0 C--O 1.254 1.333 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.53 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.465 ' HB ' HG21 ' A' ' 102' ' ' VAL . 11.8 tt -63.41 -41.21 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.829 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -60.24 -36.94 78.9 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 153' ' ' VAL . 24.4 mt-10 -54.96 -46.97 75.11 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 118.94 0.791 . . . . 0.0 110.56 176.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.504 ' CG ' ' HB3' ' A' ' 99' ' ' LEU 0.323 18.9 m-70 -77.85 -29.81 50.67 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 118.769 -1.172 . . . . 0.0 114.011 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 147' ' ' ILE . 68.7 mt -60.68 -44.87 98.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 172.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.27 -48.65 64.44 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.433 HG22 ' HA ' ' A' ' 150' ' ' HIS . 21.8 m -80.01 -32.1 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -175.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.7 t -131.7 -30.21 1.66 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.44 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.41 15.61 56.78 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.642 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -77.11 120.56 22.37 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 42.8 t -138.46 80.65 26.57 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 173.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -77.69 161.48 30.71 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.431 2.754 . . . . 0.0 113.278 -176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -52.84 -23.77 21.81 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 124.543 3.495 . . . . 0.0 114.197 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.4 -29.97 75.77 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.574 -0.346 . . . . 0.0 112.87 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -95.34 -8.68 35.08 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 122.347 1.07 . . . . 0.0 110.17 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -98.55 154.69 17.72 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.954 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 28.2 m -86.71 77.42 9.33 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.6 0.714 . . . . 0.0 110.194 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -123.98 -104.36 1.62 Allowed Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -92.04 111.11 22.53 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -87.42 86.91 7.28 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.791 0.805 . . . . 0.0 111.055 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 19.5 m -79.02 -31.29 44.64 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.543 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -87.7 -15.58 36.72 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.854 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.9 t -93.54 -33.66 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.214 0.531 . . . . 0.0 110.262 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -121.57 104.74 9.86 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.497 HG11 ' HB3' ' A' ' 115' ' ' HIS . 35.8 m -111.42 131.43 62.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -170.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 10.3 m 66.7 1.05 2.06 Favored 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 124.99 1.316 . . . . 0.0 112.853 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 92.1 mt -85.33 -27.2 26.07 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.526 -0.733 . . . . 0.0 110.486 -177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . 0.279 20.7 mm-40 45.7 72.56 0.21 Allowed 'General case' 0 C--O 1.244 0.796 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -148.24 47.33 1.06 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.945 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -74.91 96.75 3.19 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 170.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -76.02 93.71 3.32 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.258 -164.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -176.78 89.43 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -77.14 158.5 30.37 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.041 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 21.5 p80 . . . . . 0 C--N 1.298 -1.662 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.504 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 52.3 ttm . . . . . 0 CA--C 1.513 -0.451 0 CA-C-O 121.223 0.535 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.37 178.06 7.84 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.8 m -108.97 135.22 50.51 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.83 110.48 1.55 Allowed 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.0 t -61.33 118.07 3.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.226 -173.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -95.39 -82.01 0.39 Allowed 'General case' 0 N--CA 1.427 -1.603 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.992 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.2 m -123.25 -179.08 4.18 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.7 mt -69.76 -17.75 63.46 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.3 m -63.69 -26.76 68.81 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.789 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -84.16 -20.53 32.29 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.436 0.636 . . . . 0.0 109.668 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.487 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 2.7 m -76.82 154.35 33.98 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.036 -0.983 . . . . 0.0 113.512 -168.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -100.9 158.61 15.86 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 123.887 0.875 . . . . 0.0 109.133 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -109.68 128.82 55.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.98 0.419 . . . . 0.0 110.175 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.492 HD23 HG22 ' A' ' 128' ' ' VAL . 3.9 mm? -123.01 129.09 25.1 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -65.39 143.84 77.82 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 121.663 1.575 . . . . 0.0 108.74 170.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.596 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -65.12 -13.19 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -176.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.8 p -76.12 -16.22 59.93 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.56 0.695 . . . . 0.0 110.809 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -92.97 30.58 1.57 Allowed 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -49.53 -40.33 37.52 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.532 1.133 . . . . 0.0 113.414 -176.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -72.95 -17.95 61.43 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.642 0.734 . . . . 0.0 110.789 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.0 m -103.65 -1.05 28.75 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.389 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 80' ' ' ALA . 48.4 mm -65.38 134.07 95.57 Favored Pre-proline 0 C--O 1.243 0.731 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.59 129.92 31.48 Favored 'Trans proline' 0 C--O 1.242 0.68 0 C-N-CA 122.84 2.36 . . . . 0.0 112.205 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.4 p -99.16 49.51 0.95 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.872 0.844 . . . . 0.0 109.922 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -124.99 -179.44 4.55 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.983 -176.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.7 t -95.37 145.02 25.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.27 -156.5 28.43 Favored Glycine 0 N--CA 1.414 -2.79 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.538 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.574 HG12 HG22 ' A' ' 104' ' ' ILE . 3.2 m -110.67 151.05 12.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 123.996 0.918 . . . . 0.0 109.916 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -141.85 147.18 36.76 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 120.713 0.292 . . . . 0.0 110.214 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.91 122.22 37.38 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.77 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.57 117.05 40.21 Favored 'Isoleucine or valine' 0 C--O 1.26 1.655 0 C-N-CA 123.377 0.671 . . . . 0.0 110.36 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.621 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 47.1 m-85 -107.39 134.5 50.36 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -79.94 -167.93 1.45 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.262 0.554 . . . . 0.0 112.114 -174.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -56.88 -32.56 65.98 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.244 1.417 . . . . 0.0 110.667 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.9 m -90.72 7.42 39.65 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.924 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.3 t70 69.93 16.45 7.67 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.347 1.07 . . . . 0.0 111.055 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -92.3 139.63 30.41 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 120.93 -1.106 . . . . 0.0 110.327 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.621 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.3 tm? -82.43 129.68 34.95 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.645 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -125.78 -43.52 1.85 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 123.771 0.669 . . . . 0.0 111.078 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -124.29 131.09 53.5 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.835 -171.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.9 m -123.02 151.85 27.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 174.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -158.82 168.67 35.01 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.282 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.574 HG22 HG12 ' A' ' 89' ' ' VAL . 9.5 pt -120.35 144.76 28.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 123.259 0.624 . . . . 0.0 109.958 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 71.1 m -150.03 154.64 38.51 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.916 0.389 . . . . 0.0 111.61 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -78.59 -28.16 45.73 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -142.23 103.16 4.24 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.4 mt -55.2 -54.7 21.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.462 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.14 -43.79 64.21 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.08 -54.8 24.39 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 123.381 0.426 . . . . 0.0 111.904 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.1 m -70.86 -41.14 71.8 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.81 -56.74 15.38 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.8 m -58.3 -40.22 81.41 Favored 'General case' 0 C--N 1.322 -0.594 0 O-C-N 123.753 0.658 . . . . 0.0 111.228 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.03 -55.64 30.39 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 120.989 0.423 . . . . 0.0 111.281 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -75.03 -27.39 60.04 Favored 'General case' 0 C--O 1.21 -0.99 0 C-N-CA 119.275 -0.97 . . . . 0.0 113.265 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.442 HD22 ' SG ' ' A' ' 123' ' ' CYS . 64.5 mt -76.33 -24.49 54.28 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.051 -0.659 . . . . 0.0 112.061 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -88.71 -11.21 45.82 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.305 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.2 m -90.64 -43.62 10.05 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.89 175.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.31 93.85 24.72 Favored Pre-proline 0 CA--C 1.551 1.008 0 CA-C-O 121.826 0.822 . . . . 0.0 110.727 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.82 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 6.2 Cg_exo -77.41 10.65 2.4 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.388 2.725 . . . . 0.0 113.779 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.13 -42.33 85.58 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.695 0.798 . . . . 0.0 112.259 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.3 mt -105.84 20.67 18.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.181 0.515 . . . . 0.0 110.432 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.82 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 81.5 m -80.72 88.62 5.76 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -127.0 -55.11 0.14 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.9 p -158.76 162.73 37.13 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.99 136.22 42.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.487 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 67.6 mttm -106.6 125.54 51.14 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 174.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.492 HG22 HD23 ' A' ' 75' ' ' LEU . 32.8 m -114.51 133.54 60.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.102 0.477 . . . . 0.0 111.292 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.13 104.32 1.0 Allowed Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 mp -87.72 133.22 30.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 133' ' ' GLU . 14.5 p -122.46 151.68 26.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -95.61 7.0 47.53 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.69 0.757 . . . . 0.0 110.425 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.426 ' H ' HG22 ' A' ' 131' ' ' VAL . 36.5 mt-10 -127.08 99.88 27.88 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.789 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -84.84 34.03 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.388 2.726 . . . . 0.0 113.511 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -85.07 140.13 31.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -58.7 -28.31 65.67 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.98 -43.07 62.66 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 46.4 t -66.09 -42.51 91.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.11 -46.69 87.95 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.704 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 43.2 m -71.27 -28.22 63.99 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.748 0.309 . . . . 0.0 110.755 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.2 -54.6 42.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.83 -41.16 99.21 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 123.928 0.767 . . . . 0.0 110.148 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.47 ' O ' HG22 ' A' ' 147' ' ' ILE . 90.4 t90 -53.51 -46.88 70.26 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.735 0.814 . . . . 0.0 109.39 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -57.79 -50.98 71.45 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.424 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 4.0 mm? -57.7 -49.61 75.95 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.297 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 20.2 m0 -57.69 -51.99 67.26 Favored 'General case' 0 C--O 1.255 1.353 0 O-C-N 124.488 1.117 . . . . 0.0 112.23 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.583 ' O ' HG12 ' A' ' 151' ' ' ILE . 11.7 tt -70.21 -51.07 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.4 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.88 -33.12 74.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -174.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 153' ' ' VAL . 10.1 pt-20 -63.86 -42.88 97.43 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.17 177.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -74.88 -27.21 60.14 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 147' ' ' ILE . 44.8 mm -62.09 -45.66 98.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.05 -37.95 78.84 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.649 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 149' ' ' GLU . 5.5 p -88.52 -60.13 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.1 p -90.71 -28.72 18.14 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 70.81 34.86 66.05 Favored Glycine 0 N--CA 1.467 0.761 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.018 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 99' ' ' LEU . 71.9 mmtt -87.36 114.98 24.46 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 122.528 0.331 . . . . 0.0 110.521 -176.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.9 t -133.9 87.86 34.04 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -88.2 153.28 6.85 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.826 2.351 . . . . 0.0 112.358 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.422 ' HA ' ' HB2' ' A' ' 162' ' ' LYS . 76.3 Cg_exo -51.98 -27.39 28.26 Favored 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 123.908 3.072 . . . . 0.0 113.245 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 166' ' ' ASN . . . -63.51 -37.57 94.99 Favored Glycine 0 CA--C 1.502 -0.778 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.86 177.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -93.66 -24.93 17.7 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.243 0.544 . . . . 0.0 109.934 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 162' ' ' LYS . 6.9 mtpm? -68.94 171.26 8.32 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.008 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.8 m -82.89 85.98 7.03 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-O 121.914 0.864 . . . . 0.0 109.324 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -175.58 -159.29 21.27 Favored Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -127.09 128.75 46.73 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 118.178 0.989 . . . . 0.0 111.135 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.433 ' HB3' ' HA2' ' A' ' 160' ' ' GLY . 6.5 t30 -143.46 164.01 31.51 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 1.6 m -55.62 -4.85 0.11 Allowed 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -172.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -87.96 -31.31 19.45 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 121.183 -0.948 . . . . 0.0 111.359 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.01 -1.11 8.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.182 0.515 . . . . 0.0 111.098 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.642 ' O ' ' HA ' ' A' ' 167' ' ' THR . 0.3 OUTLIER -150.12 107.78 3.67 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -178.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.87 117.85 27.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.106 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 33.4 m 67.4 -59.65 0.4 Allowed 'General case' 0 CA--C 1.558 1.267 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 173.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -84.68 82.98 8.18 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 122.145 -0.347 . . . . 0.0 111.058 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 178.99 172.53 0.8 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -108.05 -21.3 12.86 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -64.44 117.99 8.1 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 54.3 p-80 -134.42 152.26 51.69 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.343 -174.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -98.66 170.07 9.05 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -159.79 140.08 11.88 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 . . . . . 0 C--N 1.304 -1.372 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.226 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 C--O 1.238 0.459 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 63.67 26.72 14.65 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.356 1.062 . . . . 0.0 112.775 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 m -74.83 137.42 41.84 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.612 176.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.17 134.99 23.59 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.787 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 71' ' ' GLU . 31.7 t -97.72 129.88 47.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -108.73 -36.83 6.05 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.627 -173.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.8 m -134.7 169.48 17.26 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.912 -0.492 . . . . 0.0 110.882 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.7 mt -58.33 -22.85 54.75 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.334 1.053 . . . . 0.0 112.107 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.456 ' HB ' ' OE2' ' A' ' 71' ' ' GLU . 38.2 m -60.68 -44.16 96.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 124.116 0.966 . . . . 0.0 112.067 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.456 ' OE2' ' HB ' ' A' ' 70' ' ' THR . 1.5 mp0 -89.62 3.98 50.89 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.126 0.488 . . . . 0.0 110.25 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.549 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 3.2 m -92.96 128.45 38.82 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.501 -175.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 16.6 pt-20 -78.69 159.19 28.11 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 122.74 0.416 . . . . 0.0 110.982 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.51 125.26 54.01 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 122.659 0.384 . . . . 0.0 110.583 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -124.19 131.09 24.17 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.416 ' HD2' ' HG3' ' A' ' 79' ' ' GLU . 24.2 Cg_exo -65.89 149.68 86.28 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 121.988 1.792 . . . . 0.0 110.014 173.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.412 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -71.91 -12.29 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.874 -0.516 . . . . 0.0 111.814 -176.481 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.4 p -78.02 -17.79 56.67 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.171 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.416 ' HG3' ' HD2' ' A' ' 76' ' ' PRO . 21.8 mm-40 -94.14 38.93 1.08 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.521 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -57.93 -29.5 65.18 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.053 0.941 . . . . 0.0 112.496 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.27 -20.76 60.03 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.374 0.606 . . . . 0.0 110.4 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.7 m -96.88 6.71 48.14 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.519 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.521 HG12 ' HA ' ' A' ' 80' ' ' ALA . 45.2 mm -77.43 123.03 86.86 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -56.22 130.39 39.92 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.976 2.451 . . . . 0.0 113.695 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.1 p -91.6 76.26 5.78 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.344 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.3 177.79 8.37 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.629 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.9 t -91.18 137.72 32.15 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.401 ' HA2' HG12 ' A' ' 131' ' ' VAL . . . 164.46 -149.56 16.65 Favored Glycine 0 N--CA 1.414 -2.833 0 C-N-CA 119.482 -1.342 . . . . 0.0 112.732 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.508 HG13 ' CH2' ' A' ' 146' ' ' TRP . 4.8 p -128.34 149.75 33.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -136.25 157.14 47.53 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.436 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . . . -127.69 114.83 17.84 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 123.775 0.83 . . . . 0.0 109.442 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.1 t -89.0 119.25 35.8 Favored 'Isoleucine or valine' 0 C--O 1.264 1.834 0 CA-C-O 120.944 0.402 . . . . 0.0 111.008 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 7.3 m-85 -103.35 127.18 50.76 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.165 0.986 . . . . 0.0 109.052 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -79.52 -168.54 1.58 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.555 0.693 . . . . 0.0 112.242 -173.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -57.7 -41.46 81.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.683 1.193 . . . . 0.0 109.993 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.8 t -84.83 12.11 7.99 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.841 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 70.94 20.17 5.45 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 32.7 mt-10 -103.62 148.83 25.54 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 118.865 -1.134 . . . . 0.0 112.211 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.422 HD23 ' HB1' ' A' ' 91' ' ' ALA . 2.1 tm? -80.02 117.72 21.11 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.813 174.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 158' ' ' PRO . 1.7 mp0 -113.85 -39.51 3.97 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.15 173.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -124.45 115.25 20.61 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.564 -1.254 . . . . 0.0 112.248 -171.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.409 HG23 ' NE1' ' A' ' 143' ' ' TRP . 22.3 m -98.55 147.22 7.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 172.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.19 147.79 17.94 Favored Glycine 0 C--N 1.283 -2.396 0 C-N-CA 118.876 -1.631 . . . . 0.0 112.418 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.4 pt -112.7 138.96 40.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.6 m -152.52 161.54 42.44 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 106' ' ' ARG . 16.0 tpt180 -81.68 -22.56 37.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.502 0.668 . . . . 0.0 109.875 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.439 HD22 ' H ' ' A' ' 110' ' ' ALA . 6.6 t30 -141.91 100.2 3.69 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.1 mt -48.61 -58.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.91 1.284 . . . . 0.0 113.528 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.63 -53.89 13.5 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' H ' HD22 ' A' ' 107' ' ' ASN . . . -59.47 -36.47 76.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.424 -177.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.4 t -76.11 -52.01 11.03 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.6 t -55.63 -54.45 25.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.429 0.691 . . . . 0.0 111.785 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 m -59.93 -47.77 84.43 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.405 0.44 . . . . 0.0 111.218 -178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.34 -55.2 36.58 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -175.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.257 24.1 p80 -76.84 -25.51 53.28 Favored 'General case' 0 C--O 1.216 -0.658 0 C-N-CA 118.516 -1.274 . . . . 0.0 113.959 -175.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 72.2 mt -77.91 -36.17 49.82 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.499 -0.88 . . . . 0.0 112.056 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -75.97 -19.12 58.99 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.451 -0.899 . . . . 0.0 110.645 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 57.3 m -80.3 -42.71 22.55 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.754 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -134.9 95.06 15.74 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 121.912 0.863 . . . . 0.0 110.804 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.74 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 83.1 Cg_endo -81.42 24.4 0.7 Allowed 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 123.418 2.745 . . . . 0.0 114.633 -174.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -67.41 -34.26 76.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.826 0.822 . . . . 0.0 110.254 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.8 mt -109.37 20.78 17.86 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.242 0.544 . . . . 0.0 110.549 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.74 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 67.5 m -81.14 84.06 6.64 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -122.93 -58.12 0.2 Allowed Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 174.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 12.4 p -163.18 169.19 19.68 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 123.652 0.781 . . . . 0.0 109.048 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.95 139.59 36.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-O 121.257 0.551 . . . . 0.0 109.852 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.549 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 89.4 mttt -106.34 132.51 52.3 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.72 139.18 45.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.274 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.95 101.21 0.61 Allowed Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.61 120.67 35.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.401 HG12 ' HA2' ' A' ' 88' ' ' GLY . 7.7 p -110.06 130.86 62.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -79.32 -19.08 51.24 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.09 0.471 . . . . 0.0 111.845 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -105.14 101.02 28.0 Favored Pre-proline 0 N--CA 1.435 -1.18 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -86.11 36.24 0.5 Allowed 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 123.061 2.507 . . . . 0.0 112.449 -173.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.69 137.37 54.08 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -61.25 -31.49 71.29 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 123.066 0.229 . . . . 0.0 111.475 -173.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.14 -35.27 66.47 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 120.814 0.34 . . . . 0.0 110.148 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 63.9 t -69.74 -41.44 79.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.316 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.8 mt -59.52 -48.12 82.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.064 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.7 m -64.58 -36.51 84.48 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.553 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -62.69 -52.29 63.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.083 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.43 -46.06 91.41 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.163 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.409 ' NE1' HG23 ' A' ' 102' ' ' VAL . 86.4 t90 -51.09 -48.84 61.57 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 123.944 0.778 . . . . 0.0 109.421 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.554 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 88.5 tttt -63.58 -57.17 10.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.072 -177.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.506 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 10.4 mp -58.32 -41.65 85.02 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.508 ' CH2' HG13 ' A' ' 89' ' ' VAL . 30.0 m0 -57.79 -52.35 65.83 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-O 120.739 0.304 . . . . 0.0 111.723 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.478 ' O ' HG13 ' A' ' 151' ' ' ILE . 14.5 tt -66.93 -39.07 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.765 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 53.0 mt-10 -60.65 -39.42 88.23 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 21.7 mm-40 -56.67 -44.49 81.45 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.97 0.414 . . . . 0.0 110.853 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -76.73 -30.26 56.54 Favored 'General case' 0 C--O 1.249 1.068 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.535 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 147' ' ' ILE . 74.7 mt -67.12 -45.7 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 122.23 0.212 . . . . 0.0 111.263 178.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -62.46 -38.68 90.75 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 149' ' ' GLU . 7.7 p -81.23 -54.63 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.417 HG23 HG13 ' A' ' 153' ' ' VAL . 69.2 p -105.82 -36.28 7.07 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.425 -0.91 . . . . 0.0 112.148 -173.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.68 17.95 57.45 Favored Glycine 0 C--N 1.311 -0.811 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.71 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -75.27 107.29 7.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 117.105 0.453 . . . . 0.0 109.82 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.2 106.75 33.15 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.406 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 13.1 Cg_endo -90.36 162.37 4.54 Favored 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 122.908 2.405 . . . . 0.0 112.913 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 162' ' ' LYS . 50.8 Cg_exo -60.66 -25.39 80.81 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.107 2.538 . . . . 0.0 112.844 178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -64.87 -33.65 87.8 Favored Glycine 0 C--N 1.33 0.224 0 N-CA-C 114.348 0.499 . . . . 0.0 114.348 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.428 HD22 ' HA ' ' A' ' 161' ' ' ASN . 3.3 m120 -92.25 -19.55 22.07 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-O 121.454 0.645 . . . . 0.0 111.922 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 159' ' ' PRO . 7.8 mtpm? -70.55 130.99 43.29 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 173.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.2 m -55.33 109.78 0.59 Allowed 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -173.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 169.03 175.38 38.34 Favored Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -87.65 110.87 20.72 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.571 ' O ' ' HG2' ' A' ' 170' ' ' LYS . 28.2 t-20 -122.76 155.91 35.55 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.97 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.9 m -50.02 -32.74 16.03 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.665 1.186 . . . . 0.0 113.361 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -74.97 -19.54 60.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.41 ' O ' HD11 ' A' ' 173' ' ' LEU . 27.3 m -108.96 -12.67 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 120.805 0.336 . . . . 0.0 111.463 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 166' ' ' ASN . 13.1 ptmm? -106.43 85.21 2.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.062 0.934 . . . . 0.0 110.993 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 13.4 p -128.46 -136.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.499 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.7 m -41.45 -45.78 3.26 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.235 1.814 . . . . 0.0 112.844 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.41 HD11 ' O ' ' A' ' 169' ' ' VAL . 2.7 pp -64.15 -21.93 66.74 Favored 'General case' 0 C--O 1.208 -1.126 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -111.0 5.64 20.44 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.751 0.786 . . . . 0.0 111.212 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -81.8 -28.1 33.34 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 171.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -84.05 134.07 34.63 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -75.02 113.94 12.92 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -61.37 -28.82 69.51 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 123.877 0.735 . . . . 0.0 111.755 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 43.1 t60 58.16 31.18 20.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.294 1.038 . . . . 0.0 110.669 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 9.7 t60 . . . . . 0 C--N 1.301 -1.534 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 -178.564 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.512 -0.511 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.68 14.3 24.52 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.191 0.52 . . . . 0.0 110.228 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 130' ' ' ILE . 32.9 m -112.94 144.33 42.7 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 59.83 55.88 3.73 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.289 0.993 . . . . 0.0 109.427 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 t -92.02 137.78 21.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.482 -174.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -115.48 -51.91 2.67 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.2 p -107.28 156.72 18.57 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.98 -175.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.16 -24.17 66.6 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.37 1.068 . . . . 0.0 109.882 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.1 m -60.0 -26.88 66.4 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.218 1.007 . . . . 0.0 110.68 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -93.52 -10.42 34.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.385 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.484 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 3.1 m -81.13 126.15 31.12 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -172.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 12.3 pt-20 -79.85 155.45 27.82 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.916 0.388 . . . . 0.0 111.942 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -103.13 128.75 49.94 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 123.633 0.773 . . . . 0.0 109.873 -174.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -122.46 136.15 26.27 Favored Pre-proline 0 C--N 1.307 -1.255 0 C-N-CA 123.767 0.827 . . . . 0.0 109.212 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -73.52 140.02 29.31 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.355 2.037 . . . . 0.0 109.84 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.5 -11.24 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -174.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.8 t -71.41 -23.89 61.95 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.021 0.438 . . . . 0.0 110.308 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.96 53.79 0.68 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.208 1.004 . . . . 0.0 110.244 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.507 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -62.35 -22.11 65.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.177 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.85 -16.55 60.68 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.747 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.3 m -94.14 -1.9 53.51 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.099 0.476 . . . . 0.0 110.419 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 80' ' ' ALA . 43.4 mm -77.05 129.79 77.38 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.04 129.81 36.25 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.94 2.426 . . . . 0.0 113.236 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.5 p -90.81 65.77 5.87 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.633 0.73 . . . . 0.0 109.615 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -134.98 -177.88 4.83 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.999 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.3 t -99.03 143.34 29.42 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.37 -147.78 13.74 Favored Glycine 0 N--CA 1.415 -2.756 0 C-N-CA 119.462 -1.352 . . . . 0.0 112.725 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.512 HG13 ' CH2' ' A' ' 146' ' ' TRP . 5.0 p -127.34 149.0 32.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 C-N-CA 123.542 0.737 . . . . 0.0 109.235 -174.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -141.49 156.01 45.78 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 120.832 0.348 . . . . 0.0 110.197 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.46 121.08 33.88 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.299 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 50.2 t -96.88 119.03 44.41 Favored 'Isoleucine or valine' 0 C--O 1.259 1.557 0 CA-C-O 121.25 0.548 . . . . 0.0 110.582 -177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 47.3 m-85 -110.69 137.24 48.61 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.305 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 98' ' ' GLU . 2.8 p30 -80.58 -169.46 2.15 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.736 -0.785 . . . . 0.0 110.657 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -57.73 -23.78 53.68 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.371 1.069 . . . . 0.0 112.688 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.2 t -108.91 17.53 21.67 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 120.718 0.294 . . . . 0.0 111.143 -174.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.2 t70 66.71 20.78 10.67 Favored 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 123.028 1.394 . . . . 0.0 110.713 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.49 ' HB2' ' OD2' ' A' ' 94' ' ' ASP . 80.5 mm-40 -83.64 104.26 13.62 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.395 -0.821 . . . . 0.0 108.856 175.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.555 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.0 tm? -66.19 115.46 6.21 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 174.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.432 ' HB3' ' HG2' ' A' ' 158' ' ' PRO . 43.1 mt-30 -122.64 -13.5 7.94 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -148.17 125.4 11.51 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.169 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.492 HG13 HD11 ' A' ' 99' ' ' LEU . 21.9 m -117.08 143.77 26.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 171.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -150.66 157.58 27.26 Favored Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 119.693 -1.241 . . . . 0.0 112.249 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.2 pt -117.36 134.55 60.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 55.2 m -146.49 161.96 39.33 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.009 0.433 . . . . 0.0 111.574 -175.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -76.9 -34.25 57.73 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.255 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -132.71 109.31 9.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.8 mt -56.76 -58.14 6.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.774 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.85 -50.26 64.12 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.1 -50.27 72.61 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.569 0.543 . . . . 0.0 111.193 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.4 t -63.3 -52.14 63.17 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.213 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.5 t -55.54 -53.94 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 C-N-CA 123.012 0.525 . . . . 0.0 110.529 -178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.3 m -58.32 -47.49 83.55 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 123.792 0.683 . . . . 0.0 111.381 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.58 -58.18 8.87 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 123.483 0.489 . . . . 0.0 111.617 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -72.13 -26.4 62.1 Favored 'General case' 0 C--O 1.209 -1.066 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.8 mt -74.78 -28.01 60.56 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 119.416 -0.913 . . . . 0.0 111.159 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -87.08 -3.75 59.1 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.433 0.635 . . . . 0.0 110.483 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.9 m -95.28 -51.07 4.75 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.16 97.95 27.84 Favored Pre-proline 0 N--CA 1.428 -1.539 0 CA-C-O 121.597 0.713 . . . . 0.0 111.108 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.807 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 6.5 Cg_exo -77.53 24.64 0.5 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.66 2.907 . . . . 0.0 113.156 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -62.17 -41.39 98.27 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.301 1.04 . . . . 0.0 110.72 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.3 mt -119.94 21.19 11.99 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.099 -172.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.807 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 72.9 m -74.27 88.99 2.03 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.169 0.509 . . . . 0.0 112.276 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.39 -55.18 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.4 p -161.97 161.6 28.68 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.6 p -139.75 139.28 38.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 120.982 0.42 . . . . 0.0 110.372 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.484 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 63.0 mttm -108.03 129.72 55.11 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 26.2 m -120.16 139.35 47.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.884 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.24 114.44 1.64 Allowed Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 64' ' ' SER . 2.7 mp -90.66 113.42 26.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.6 p -101.25 142.46 15.97 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -88.46 -5.61 58.14 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.204 0.526 . . . . 0.0 111.907 -171.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -125.93 92.27 46.45 Favored Pre-proline 0 N--CA 1.43 -1.445 0 CA-C-O 121.683 0.754 . . . . 0.0 109.222 174.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.39 46.75 1.89 Allowed 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 123.617 2.878 . . . . 0.0 111.892 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -80.54 141.53 35.03 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -53.26 -39.34 63.8 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.66 -38.53 64.92 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.486 -178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.9 t -70.52 -40.39 77.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.957 0.408 . . . . 0.0 110.149 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 92.6 mt -61.1 -48.03 83.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.347 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 36.4 m -68.47 -30.61 69.51 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.913 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.519 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 58.4 tt0 -62.93 -54.13 43.3 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.82 96.82 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 123.932 0.77 . . . . 0.0 109.869 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.459 ' NE1' HG23 ' A' ' 102' ' ' VAL . 89.9 t90 -52.31 -49.31 64.45 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.923 0.764 . . . . 0.0 109.755 177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -63.03 -47.08 84.56 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.416 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.572 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 80.5 mt -59.2 -49.54 77.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.079 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.512 ' CH2' HG13 ' A' ' 89' ' ' VAL . 26.0 m0 -62.56 -48.26 80.27 Favored 'General case' 0 C--O 1.256 1.402 0 O-C-N 123.995 0.81 . . . . 0.0 112.068 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.599 ' O ' HG12 ' A' ' 151' ' ' ILE . 9.1 tt -63.01 -43.25 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.364 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.522 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 31.9 mt-10 -60.42 -29.91 69.29 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 6.6 mm-40 -59.68 -49.31 78.22 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.443 ' HA ' HG22 ' A' ' 153' ' ' VAL 0.259 17.2 m-70 -78.5 -22.08 47.96 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -178.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 147' ' ' ILE . 48.3 mm -60.51 -42.6 91.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 148' ' ' GLU . 39.9 mttm -81.6 -46.34 14.55 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.176 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 149' ' ' GLU . 30.7 m -78.73 -46.49 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.4 p -110.88 -6.56 14.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 119.04 -1.064 . . . . 0.0 112.697 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.42 26.12 70.48 Favored Glycine 0 C--N 1.336 0.541 0 O-C-N 123.742 0.651 . . . . 0.0 113.803 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -91.36 109.02 20.29 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.18 0.514 . . . . 0.0 112.041 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.9 t -131.41 78.94 70.79 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.432 ' HG2' ' HB3' ' A' ' 100' ' ' GLN . 5.0 Cg_endo -90.4 160.53 4.51 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.177 2.585 . . . . 0.0 112.426 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.54 -34.27 19.68 Favored 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 124.354 3.37 . . . . 0.0 115.047 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -69.34 -27.38 73.67 Favored Glycine 0 CA--C 1.501 -0.833 0 C-N-CA 121.375 -0.44 . . . . 0.0 112.595 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.416 ' ND2' HD12 ' A' ' 147' ' ' ILE . 0.2 OUTLIER -103.39 -20.41 14.09 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.244 0.545 . . . . 0.0 109.75 -177.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -75.73 -69.01 0.52 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.8 p -92.85 155.15 17.81 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -78.68 78.22 1.68 Allowed Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.496 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -64.62 120.05 11.65 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -56.15 -33.51 65.28 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 124.298 1.039 . . . . 0.0 112.514 -173.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.2 m -64.49 -34.56 78.49 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 120.806 0.336 . . . . 0.0 110.85 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.41 -56.53 3.27 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.75 -32.24 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp 60.06 12.5 3.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.681 1.192 . . . . 0.0 114.014 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.03 0.76 10.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 CA-C-O 122.873 1.32 . . . . 0.0 108.872 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 4.9 m -99.33 66.94 1.53 Allowed 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.758 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.549 HD13 ' H ' ' A' ' 173' ' ' LEU . 0.0 OUTLIER -60.79 110.0 1.2 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.773 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 70.15 -62.12 0.44 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.727 1.611 . . . . 0.0 111.122 -176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -141.09 178.18 7.55 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 125.053 1.341 . . . . 0.0 108.027 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -63.01 116.11 5.02 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -79.21 139.48 37.94 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.246 0.546 . . . . 0.0 111.292 -175.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -111.22 103.45 11.87 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.081 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 78.3 t60 66.62 88.22 0.11 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.114 0.884 . . . . 0.0 112.165 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 3.0 t60 . . . . . 0 C--N 1.314 -0.935 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.468 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.466 0.372 0 CA-C-O 120.444 0.164 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -126.61 -21.55 4.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.981 0.42 . . . . 0.0 110.278 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.2 t -140.84 -68.72 0.4 Allowed 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 38.84 96.52 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.725 1.61 . . . . 0.0 115.068 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.43 110.16 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.068 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -56.11 -60.49 3.41 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -168.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.51 ' HB2' ' OE1' ' A' ' 149' ' ' GLU . 36.9 p -149.65 170.3 19.01 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.98 -176.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.48 HD22 ' HD2' ' A' ' 127' ' ' LYS . 17.8 mt -71.4 -23.45 61.88 Favored 'General case' 0 CA--C 1.491 -1.289 0 C-N-CA 123.423 0.689 . . . . 0.0 110.31 177.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 m -63.6 -25.51 68.26 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.862 174.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -102.7 8.08 39.61 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.1 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.405 ' HB ' ' HD3' ' A' ' 127' ' ' LYS . 22.5 m -103.57 141.06 36.67 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 122.001 -0.437 . . . . 0.0 110.768 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.01 151.41 35.62 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-O 120.921 0.391 . . . . 0.0 111.116 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -107.0 133.17 52.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.678 -173.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.33 132.07 24.31 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 123.312 0.645 . . . . 0.0 109.551 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -70.47 139.41 37.72 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.333 2.022 . . . . 0.0 109.48 172.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.76 -7.05 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -174.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 t -69.7 -31.13 68.99 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.103 0.478 . . . . 0.0 109.726 177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -98.49 53.68 1.04 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.901 0.858 . . . . 0.0 109.767 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.94 -28.62 57.75 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.842 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -56.36 -33.17 65.44 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.245 1.018 . . . . 0.0 111.627 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.8 m -96.88 12.59 31.69 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -172.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.6 mm -80.93 128.13 72.38 Favored Pre-proline 0 N--CA 1.446 -0.642 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.73 130.74 40.15 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.143 2.562 . . . . 0.0 114.128 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.1 p -92.97 31.68 1.38 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 122.178 0.99 . . . . 0.0 110.655 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.75 -179.09 3.84 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.114 -177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 t -93.6 147.86 22.62 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.59 -150.09 21.19 Favored Glycine 0 N--CA 1.419 -2.488 0 C-N-CA 119.692 -1.242 . . . . 0.0 112.686 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.611 HG12 HG22 ' A' ' 104' ' ' ILE . 2.5 m -115.42 149.02 17.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 124.336 1.055 . . . . 0.0 109.55 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -144.22 160.24 41.31 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.408 ' HB1' ' CD2' ' A' ' 99' ' ' LEU . . . -141.02 131.68 25.6 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.707 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.1 t -106.61 126.84 62.4 Favored 'Isoleucine or valine' 0 C--O 1.26 1.615 0 CA-C-O 121.097 0.475 . . . . 0.0 110.669 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -113.19 135.13 54.16 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.469 1.107 . . . . 0.0 108.551 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -85.56 -170.26 3.03 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.553 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.501 ' H ' ' HD2' ' A' ' 95' ' ' LYS . 6.7 mptt -63.06 -25.38 68.34 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.76 0.824 . . . . 0.0 111.372 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.3 m -82.39 4.78 22.68 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.112 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.5 t70 69.77 19.16 7.28 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.474 1.11 . . . . 0.0 111.621 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -111.12 147.09 35.63 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.596 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.455 HD11 HG13 ' A' ' 102' ' ' VAL . 2.8 tm? -78.27 125.85 29.94 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.264 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -127.92 -13.84 5.12 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 123.925 0.766 . . . . 0.0 112.634 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.457 ' HA ' ' OD1' ' A' ' 161' ' ' ASN . 92.5 t80 -147.63 120.66 8.81 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.515 -0.874 . . . . 0.0 112.741 176.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.455 HG13 HD11 ' A' ' 99' ' ' LEU . 17.5 m -109.95 142.11 23.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 170.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -146.36 167.76 27.93 Favored Glycine 0 C--N 1.294 -1.759 0 C-N-CA 119.987 -1.101 . . . . 0.0 112.422 -177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.611 HG22 HG12 ' A' ' 89' ' ' VAL . 15.0 pt -125.86 147.98 30.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.4 t -157.17 164.08 38.17 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.113 0.483 . . . . 0.0 110.032 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.1 -17.9 24.32 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.415 HD22 ' H ' ' A' ' 110' ' ' ALA . 1.6 t30 -142.81 87.09 1.97 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 77.7 mt -47.24 -54.94 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.483 1.113 . . . . 0.0 113.231 -174.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.27 -30.57 12.13 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.415 ' H ' HD22 ' A' ' 107' ' ' ASN . . . -73.54 -57.91 3.67 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.2 m -60.56 -43.95 96.69 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.462 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.7 t -58.48 -60.19 2.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.075 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.6 m -60.73 -44.01 97.18 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 123.827 0.705 . . . . 0.0 110.813 -175.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.418 ' HB1' ' HD3' ' A' ' 170' ' ' LYS . . . -60.39 -50.69 72.57 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 116.272 -0.422 . . . . 0.0 112.114 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -77.05 -25.27 52.25 Favored 'General case' 0 C--O 1.204 -1.305 0 C-N-CA 118.343 -1.343 . . . . 0.0 112.056 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 64.2 mt -73.93 -28.66 61.63 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.612 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.39 -7.41 59.31 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.294 175.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.7 m -90.01 -52.96 4.7 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.9 m -117.65 102.4 51.7 Favored Pre-proline 0 N--CA 1.435 -1.193 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.817 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 16.4 Cg_exo -73.33 4.03 4.2 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.858 2.372 . . . . 0.0 110.575 173.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -55.83 -44.36 77.87 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 125.328 1.451 . . . . 0.0 111.0 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 75.1 mt -105.35 11.15 33.11 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.407 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.817 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 90.4 m -67.95 96.66 0.61 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.621 0.724 . . . . 0.0 111.873 177.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.4 -63.31 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.569 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 174.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.3 p -155.64 162.13 40.66 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.3 p -141.35 137.83 33.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.48 ' HD2' HD22 ' A' ' 69' ' ' LEU . 97.4 mttt -108.22 142.21 38.82 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.68 137.57 56.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 120.698 0.285 . . . . 0.0 110.904 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.73 108.92 0.83 Allowed Glycine 0 N--CA 1.423 -2.223 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.4 mp -85.51 113.4 23.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 133' ' ' GLU . 7.4 p -100.98 132.32 46.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -69.02 -27.29 65.54 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.9 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.426 ' HB3' HG21 ' A' ' 138' ' ' VAL . 41.1 mt-10 -85.01 110.7 30.35 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -97.07 19.0 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.752 2.301 . . . . 0.0 113.607 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.503 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 14.8 t70 -72.97 140.09 47.16 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -57.93 -33.12 68.46 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.61 -38.73 47.47 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.187 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 135' ' ' ASP . 10.5 m -71.3 -31.96 45.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.316 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.2 mt -62.36 -46.1 90.2 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 174.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.1 m -69.34 -30.59 68.66 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.43 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.491 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 29.7 tt0 -66.68 -47.43 72.46 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 122.781 0.433 . . . . 0.0 110.778 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.97 -45.22 90.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -50.88 -45.47 60.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.5 1.12 . . . . 0.0 110.027 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.75 -48.09 83.36 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.645 1.178 . . . . 0.0 111.31 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 69.6 mt -63.77 -41.57 97.94 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.128 0.489 . . . . 0.0 110.543 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -62.24 -50.62 71.0 Favored 'General case' 0 C--O 1.257 1.499 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.971 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 151' ' ' ILE . 14.1 tt -66.71 -40.73 86.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.285 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -65.38 -34.44 78.31 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.51 ' OE1' ' HB2' ' A' ' 68' ' ' SER . 3.8 pt-20 -63.12 -37.36 86.91 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 118.282 -1.367 . . . . 0.0 109.225 176.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.443 ' HA ' HG12 ' A' ' 153' ' ' VAL 0.263 72.8 m-70 -73.91 -31.91 63.3 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 177.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 147' ' ' ILE . 71.1 mt -61.35 -38.27 79.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 174.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.492 ' HE2' ' HA ' ' A' ' 149' ' ' GLU . 59.4 pttt -83.0 -20.96 34.08 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 149' ' ' GLU . 12.6 p -101.75 -41.42 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.9 t -113.16 -19.33 11.87 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.546 -0.721 . . . . 0.0 111.714 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.58 8.61 82.78 Favored Glycine 0 C--O 1.239 0.44 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.449 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -76.91 128.32 34.33 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.8 p -158.6 77.37 3.3 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 113.192 -1.822 . . . . 0.0 106.725 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -83.42 167.55 13.5 Favored 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 123.925 3.083 . . . . 0.0 113.893 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.565 ' HA ' ' HB2' ' A' ' 162' ' ' LYS . 11.3 Cg_endo -54.18 -13.82 5.49 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 125.184 3.923 . . . . 0.0 115.475 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -70.85 -42.29 61.11 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 175.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.457 ' OD1' ' HA ' ' A' ' 101' ' ' PHE . 18.9 m120 -91.61 -30.77 16.17 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-O 121.007 0.432 . . . . 0.0 110.985 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 159' ' ' PRO . 56.0 mtpt -72.8 161.42 30.75 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 172.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.1 m -76.2 101.23 5.31 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.95 -61.03 0.02 OUTLIER Glycine 0 N--CA 1.426 -2.03 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.017 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -125.61 128.25 47.59 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 117.048 0.424 . . . . 0.0 111.693 -174.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -92.47 -12.18 32.71 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 15.8 m -60.94 -16.8 46.58 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-O 121.713 0.768 . . . . 0.0 112.217 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -82.94 -13.72 55.51 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.547 -0.72 . . . . 0.0 111.612 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.24 -33.48 2.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.418 ' HD3' ' HB1' ' A' ' 114' ' ' ALA . 57.4 tttp 77.01 135.79 0.06 Allowed 'General case' 0 C--O 1.243 0.75 0 C-N-CA 126.197 1.799 . . . . 0.0 109.84 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 32.8 t -83.3 80.56 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.709 0.766 . . . . 0.0 110.224 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 12.9 p -115.07 -47.67 2.85 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.701 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 76.07 -179.78 0.16 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.0 1.32 . . . . 0.0 112.509 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -42.12 95.26 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -95.66 95.16 8.16 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 168.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -56.79 99.15 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -168.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -100.6 169.23 9.19 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.492 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -108.68 106.84 17.06 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -125.29 -70.21 0.76 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.038 0.447 . . . . 0.0 110.126 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 . . . . . 0 C--N 1.303 -1.425 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.467 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 CA--C 1.496 -1.108 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.28 150.02 40.81 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.5 m -77.09 115.85 17.23 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 79.46 145.62 0.09 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.136 1.374 . . . . 0.0 111.704 -176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 t -59.43 136.2 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.917 0.887 . . . . 0.0 110.984 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -86.52 -77.48 0.31 Allowed 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.5 p -120.63 176.24 5.61 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.5 mt -59.34 -33.0 70.6 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.114 1.366 . . . . 0.0 112.379 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -67.19 -16.25 64.19 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.902 0.858 . . . . 0.0 110.508 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -109.23 13.13 24.54 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.343 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.402 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 13.2 m -105.05 155.28 19.13 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.731 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -94.88 151.61 19.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 125' ' ' SER . 3.1 tm? -104.59 133.22 49.82 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.396 0.617 . . . . 0.0 110.661 -174.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.4 HD23 HG22 ' A' ' 128' ' ' VAL . 3.8 mm? -127.91 136.19 28.63 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 115.098 -0.955 . . . . 0.0 108.601 176.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -71.16 140.84 38.33 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.209 1.939 . . . . 0.0 109.405 172.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.67 -11.65 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.105 0.478 . . . . 0.0 111.51 -174.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.9 p -68.51 -39.58 81.18 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.09 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -96.95 54.13 1.25 Allowed 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.342 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.531 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -61.9 -17.57 57.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.746 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.78 -23.79 64.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.585 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.9 m -88.69 -0.57 57.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.631 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.531 HG12 ' HA ' ' A' ' 80' ' ' ALA . 45.3 mm -77.82 133.91 65.46 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -56.21 129.61 35.75 Favored 'Trans proline' 0 C--O 1.251 1.155 0 C-N-CA 122.196 1.93 . . . . 0.0 112.413 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.8 p -95.13 70.86 3.28 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 121.873 0.844 . . . . 0.0 108.995 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.06 -176.34 5.05 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.064 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.6 t -97.68 134.82 40.35 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.977 0.418 . . . . 0.0 110.099 -173.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.34 -152.17 19.9 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 111.179 -0.769 . . . . 0.0 111.179 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.517 HG13 ' CH2' ' A' ' 146' ' ' TRP . 6.2 p -124.71 147.34 29.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -177.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -135.95 151.89 50.41 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 120.756 0.312 . . . . 0.0 110.223 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.08 123.16 41.68 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.081 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.5 t -95.46 118.35 41.47 Favored 'Isoleucine or valine' 0 C--O 1.263 1.773 0 C-N-CA 123.387 0.675 . . . . 0.0 110.32 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.501 ' CE1' ' HB2' ' A' ' 99' ' ' LEU . 96.8 m-85 -106.91 134.53 49.93 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.113 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.496 ' O ' ' HA3' ' A' ' 124' ' ' GLY . 3.9 p-10 -78.64 -166.96 0.96 Allowed 'General case' 0 C--N 1.317 -0.822 0 O-C-N 123.666 0.604 . . . . 0.0 111.116 -175.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 123' ' ' CYS . 75.4 mmtt -53.0 -34.57 56.84 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.719 1.208 . . . . 0.0 111.311 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.5 m -82.31 -2.93 54.26 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.192 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.9 t70 67.44 23.44 9.08 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.677 1.191 . . . . 0.0 108.297 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.457 ' OE1' HG21 ' A' ' 154' ' ' THR . 0.1 OUTLIER -99.67 158.71 15.58 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.501 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 3.5 tm? -97.71 124.57 42.09 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.69 0.757 . . . . 0.0 111.612 -169.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.508 HE21 ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -119.75 -45.91 2.48 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.738 173.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -124.88 134.63 52.63 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.525 -173.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.639 HG22 HD21 ' A' ' 161' ' ' ASN . 17.4 m -126.2 145.2 34.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -150.95 155.76 26.32 Favored Glycine 0 N--CA 1.42 -2.379 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.964 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.8 pt -110.56 139.14 35.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.0 t -142.93 155.03 44.64 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.358 0.599 . . . . 0.0 110.664 -175.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -87.04 -26.29 23.8 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -142.93 84.74 1.85 Allowed 'General case' 0 C--O 1.244 0.775 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 69.5 mt -44.47 -58.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.245 1.418 . . . . 0.0 114.767 -172.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.2 -44.48 22.37 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.13 -34.29 76.08 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.2 t -79.53 -45.81 18.56 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.9 -53.54 36.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.066 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.4 p -61.63 -44.83 96.25 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 123.47 0.481 . . . . 0.0 111.625 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.13 -61.3 2.56 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -78.14 -23.78 47.61 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 119.014 -1.074 . . . . 0.0 113.827 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.419 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 80.7 mt -81.83 -30.7 32.02 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.413 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -88.21 -9.88 51.58 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.04 -1.064 . . . . 0.0 109.826 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.3 t -82.94 -47.37 11.85 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.34 95.14 18.56 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-O 121.765 0.793 . . . . 0.0 110.339 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.807 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 2.8 Cg_exo -76.65 24.47 0.46 Allowed 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.64 2.893 . . . . 0.0 114.499 -176.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.57 -42.47 82.53 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.428 0.632 . . . . 0.0 111.078 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 75.4 mt -102.95 21.27 15.97 Favored 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.558 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.807 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 84.0 m -85.81 105.03 16.03 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 94' ' ' ASP . . . -137.81 -58.95 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 173.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.471 ' HB2' HD21 ' A' ' 74' ' ' LEU . 56.9 p -156.4 169.09 25.4 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.1 p -142.09 133.97 26.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.092 0.472 . . . . 0.0 109.924 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.402 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 56.4 mttp -106.94 125.83 51.52 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.4 HG22 HD23 ' A' ' 75' ' ' LEU . 28.5 m -113.34 135.22 53.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.254 0.549 . . . . 0.0 111.286 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.77 98.31 0.67 Allowed Glycine 0 N--CA 1.414 -2.798 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.373 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 40.5 mm -75.75 112.44 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.101 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.5 m -98.39 145.95 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.113 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -71.26 -36.94 71.92 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.208 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.49 ' HB2' HG11 ' A' ' 138' ' ' VAL . 18.8 mm-40 -92.39 105.09 12.85 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -93.76 27.78 0.32 Allowed 'Trans proline' 0 C--O 1.243 0.748 0 C-N-CA 122.737 2.291 . . . . 0.0 113.352 -174.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.456 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 15.7 t70 -89.98 144.12 26.19 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -53.38 -34.31 57.17 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.51 68.68 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.49 HG11 ' HB2' ' A' ' 133' ' ' GLU . 21.8 t -69.78 -34.72 61.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.762 -175.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 96.6 mt -62.17 -53.44 55.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.156 175.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.5 m -66.9 -30.48 70.64 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.326 0.584 . . . . 0.0 110.373 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -65.01 -50.91 64.43 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 123.656 0.782 . . . . 0.0 109.425 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.42 -43.61 98.57 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.498 ' NE1' HG23 ' A' ' 102' ' ' VAL . 79.6 t90 -52.73 -46.66 67.51 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.119 176.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -66.79 -44.88 80.1 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.211 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.552 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 11.1 mp -61.14 -41.77 97.33 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.151 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.517 ' CH2' HG13 ' A' ' 89' ' ' VAL . 33.6 m0 -62.38 -50.66 70.69 Favored 'General case' 0 C--O 1.254 1.314 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 151' ' ' ILE . 8.9 tt -62.51 -40.73 89.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.382 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.37 -32.49 74.16 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 22.3 mm-40 -56.12 -41.63 75.57 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.724 0.773 . . . . 0.0 109.96 175.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.415 ' HA ' HG12 ' A' ' 153' ' ' VAL 0.321 5.4 m-70 -83.46 -26.37 30.35 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.297 -1.361 . . . . 0.0 113.768 176.18 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 147' ' ' ILE . 73.6 mt -61.22 -42.61 94.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 O-C-N 121.974 -0.454 . . . . 0.0 110.372 173.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -69.43 -34.7 74.82 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 150' ' ' HIS . 12.1 p -92.01 -40.81 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.457 HG21 ' OE1' ' A' ' 98' ' ' GLU . 3.7 t -118.55 -35.28 3.78 Favored 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -176.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 74.76 34.3 53.65 Favored Glycine 0 N--CA 1.47 0.962 0 C-N-CA 120.429 -0.891 . . . . 0.0 114.207 175.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -65.23 -66.37 0.55 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.28 12.2 p 41.13 75.99 0.55 Allowed Pre-proline 0 CA--C 1.573 1.859 0 C-N-CA 125.002 1.321 . . . . 0.0 113.951 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -90.72 161.49 4.19 Favored 'Trans proline' 0 CA--C 1.556 1.603 0 C-N-CA 123.245 2.63 . . . . 0.0 114.085 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -50.38 -34.12 39.98 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 124.435 3.423 . . . . 0.0 114.472 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 165' ' ' ASN . . . -59.35 -45.33 95.62 Favored Glycine 0 CA--C 1.495 -1.194 0 CA-C-O 121.121 0.29 . . . . 0.0 112.762 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.639 HD21 HG22 ' A' ' 102' ' ' VAL . 34.0 t-20 -76.76 -25.75 53.76 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.42 1.105 . . . . 0.0 108.715 -174.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -83.77 0.8 45.83 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.333 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.0 m 68.83 13.8 8.88 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.525 1.13 . . . . 0.0 111.854 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -80.06 -23.42 61.48 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.463 ' HB3' ' HA2' ' A' ' 160' ' ' GLY . 24.5 t30 -105.89 112.79 25.99 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -73.06 -25.93 61.09 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.046 -174.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.3 m -48.77 -35.27 13.94 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -171.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 22.5 m-30 -72.04 -21.3 61.55 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.2 m -124.62 13.23 4.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.481 0.658 . . . . 0.0 110.086 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -87.5 33.4 0.7 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.925 0.869 . . . . 0.0 110.128 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.75 90.76 2.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 4.9 m -145.63 123.27 11.81 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -80.31 -69.61 0.58 Allowed 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.57 151.92 22.61 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 52.0 m170 -80.14 144.61 32.9 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 121.172 -0.211 . . . . 0.0 110.767 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -70.78 110.04 5.33 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -91.29 169.51 10.75 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.695 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 41.9 m80 76.69 179.42 0.16 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.837 1.255 . . . . 0.0 109.077 -173.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -97.25 90.82 5.25 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 75.9 t60 . . . . . 0 C--N 1.304 -1.402 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.436 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.5 ttm . . . . . 0 CA--C 1.506 -0.741 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -158.61 -179.0 7.68 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 45.5 m -144.65 73.69 1.38 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 64.01 -173.91 0.17 Allowed 'General case' 0 C--O 1.245 0.855 0 CA-C-N 114.299 -1.318 . . . . 0.0 111.125 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.1 t -76.73 126.47 37.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.39 -77.49 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.323 0.582 . . . . 0.0 111.578 -174.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.516 ' HA ' ' CD1' ' A' ' 146' ' ' TRP . 70.1 m -147.89 -178.78 6.46 Favored 'General case' 0 N--CA 1.413 -2.278 0 O-C-N 122.001 -0.437 . . . . 0.0 110.495 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -54.44 -24.75 21.39 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.785 1.634 . . . . 0.0 113.725 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.1 m -66.56 -29.14 69.15 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.103 0.478 . . . . 0.0 111.296 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -107.74 11.24 28.5 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.522 0.677 . . . . 0.0 110.911 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.402 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 10.1 m -97.17 136.03 38.27 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.409 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 12.6 pt-20 -74.45 149.59 40.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.705 0.288 . . . . 0.0 111.148 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -112.99 126.2 55.23 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.351 0.66 . . . . 0.0 109.294 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.98 135.11 24.57 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -71.63 138.68 32.6 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.256 1.971 . . . . 0.0 109.189 172.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.4 -8.78 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.262 -176.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.0 t -67.35 -23.04 65.56 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -112.93 53.26 0.76 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.408 ' O ' HG12 ' A' ' 83' ' ' ILE . . . -58.12 -22.81 52.57 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.724 1.21 . . . . 0.0 112.413 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.23 -28.09 69.5 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.369 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.6 t -88.6 9.37 24.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.885 -174.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 80' ' ' ALA . 37.5 mm -80.31 129.05 70.88 Favored Pre-proline 0 C--N 1.314 -0.955 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -55.43 130.29 39.79 Favored 'Trans proline' 0 C--O 1.251 1.169 0 C-N-CA 122.982 2.455 . . . . 0.0 113.34 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.5 p -92.39 80.18 4.94 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.282 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.81 -179.44 6.99 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.469 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.9 t -100.82 134.74 43.35 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.61 -150.2 14.69 Favored Glycine 0 N--CA 1.418 -2.53 0 C-N-CA 120.379 -0.915 . . . . 0.0 111.33 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.53 HG13 ' CH2' ' A' ' 146' ' ' TRP . 7.6 p -122.86 149.78 26.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -137.85 155.3 49.13 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.25 115.58 20.61 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 123.518 0.727 . . . . 0.0 109.559 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.4 t -91.6 121.51 42.14 Favored 'Isoleucine or valine' 0 C--O 1.258 1.528 0 CA-C-O 121.097 0.475 . . . . 0.0 110.944 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.521 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 61.8 m-85 -109.86 131.66 54.86 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 124.154 0.982 . . . . 0.0 108.651 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.501 ' OD1' ' HB2' ' A' ' 98' ' ' GLU . 1.3 p-10 -78.64 -168.16 1.31 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.53 ' H ' ' HD2' ' A' ' 95' ' ' LYS . 8.6 mptt -64.18 -24.92 67.85 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 123.168 0.587 . . . . 0.0 110.812 -176.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.0 m -81.91 2.2 31.64 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.025 0.53 . . . . 0.0 112.065 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.2 t70 68.92 24.76 6.26 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 123.419 1.58 . . . . 0.0 108.866 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.501 ' HB2' ' OD1' ' A' ' 94' ' ' ASP . 24.0 mm-40 -96.73 115.53 27.59 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.689 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.521 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 2.4 tm? -68.68 113.14 5.9 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 173.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.514 ' HB3' ' HG2' ' A' ' 158' ' ' PRO . 22.0 mt-30 -125.31 -13.21 6.71 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.692 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -146.57 114.96 6.7 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.563 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.549 HG21 ' HB ' ' A' ' 147' ' ' ILE . 27.4 m -103.41 149.86 7.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 172.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -160.35 152.47 23.24 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 119.502 -1.333 . . . . 0.0 112.419 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.411 HG22 ' HB ' ' A' ' 89' ' ' VAL . 20.5 pt -112.78 140.51 32.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.0 m -150.89 169.57 21.41 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -76.93 -42.96 37.25 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.455 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -138.8 98.55 3.58 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 65.1 mt -44.13 -57.41 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 125.05 1.34 . . . . 0.0 114.23 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.3 -41.94 63.36 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.76 -41.74 74.77 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.052 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.471 ' HA ' HG23 ' A' ' 171' ' ' VAL . 34.3 t -66.04 -49.05 69.06 Favored 'General case' 0 C--O 1.254 1.302 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.814 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 72.6 t -57.38 -53.51 42.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.097 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.1 t -62.92 -35.65 80.79 Favored 'General case' 0 CA--C 1.551 0.981 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.362 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.13 -61.77 2.32 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.95 -0.469 . . . . 0.0 112.019 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -79.29 -22.99 43.87 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.413 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 67.8 mt -76.63 -25.34 53.73 Favored 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.403 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -87.75 -18.67 28.91 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.822 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.8 m -74.41 -47.1 35.91 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 p -138.99 95.07 9.67 Favored Pre-proline 0 CA--C 1.554 1.12 0 CA-C-O 121.807 0.813 . . . . 0.0 110.28 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.598 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 11.7 Cg_exo -74.07 24.13 0.35 Allowed 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 123.859 3.039 . . . . 0.0 115.036 -176.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -65.27 -43.37 91.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.33 0.586 . . . . 0.0 109.87 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.2 mt -99.4 19.91 14.7 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.167 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.598 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 98.3 m -74.01 94.25 2.34 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.347 0.594 . . . . 0.0 111.722 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.84 -68.01 0.06 OUTLIER Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.4 p -159.71 163.26 34.9 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.7 p -137.72 140.7 40.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 120.963 0.411 . . . . 0.0 110.341 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 92.2 mttt -106.11 126.35 52.1 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.6 m -113.38 133.84 57.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.007 0.432 . . . . 0.0 111.405 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -124.82 101.54 0.66 Allowed Glycine 0 N--CA 1.417 -2.596 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -84.72 109.67 18.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.33 164.36 2.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.135 -173.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -59.39 -62.74 1.65 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.775 0.672 . . . . 0.0 110.937 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -99.92 146.55 32.09 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -82.31 32.47 0.52 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 122.405 2.07 . . . . 0.0 109.92 172.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.499 ' HB3' HG22 ' A' ' 138' ' ' VAL . 13.5 t70 -77.01 135.36 38.66 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.653 -172.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -58.81 -31.63 68.63 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.31 -46.04 51.92 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.481 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.499 HG22 ' HB3' ' A' ' 135' ' ' ASP . 11.9 m -68.42 -32.65 56.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.756 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 94.5 mt -65.25 -51.3 61.69 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.903 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 26.4 m -65.65 -35.32 80.46 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.721 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.508 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 28.2 tt0 -61.67 -52.67 63.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.508 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.47 -42.39 99.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.545 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.482 ' NE1' HG23 ' A' ' 102' ' ' VAL . 84.6 t90 -53.5 -50.95 64.3 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.476 0.71 . . . . 0.0 109.497 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 58.9 tttm -59.97 -52.56 64.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.387 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.593 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 85.5 mt -58.54 -49.76 76.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.376 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.53 ' CH2' HG13 ' A' ' 89' ' ' VAL . 41.8 m0 -59.32 -48.77 80.36 Favored 'General case' 0 C--O 1.249 1.038 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.549 ' HB ' HG21 ' A' ' 102' ' ' VAL . 12.6 tt -63.42 -42.75 97.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.795 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.629 ' O ' ' HG2' ' A' ' 152' ' ' LYS . 45.2 mt-10 -62.68 -33.31 74.82 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.72 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 20.6 mm-40 -55.92 -51.06 68.96 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.311 0.577 . . . . 0.0 110.447 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.485 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 2.7 t60 -77.89 -21.19 51.61 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.281 -175.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 147' ' ' ILE . 68.1 mt -68.99 -32.28 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.189 0.519 . . . . 0.0 109.889 175.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 148' ' ' GLU . 74.9 mmtt -77.71 -48.27 17.1 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.058 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.406 HG12 ' HA ' ' A' ' 150' ' ' HIS . 7.7 p -71.28 -56.8 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 47.0 p -106.16 -27.59 10.98 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.339 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 151' ' ' ILE . . . 98.11 31.84 6.39 Favored Glycine 0 CA--C 1.502 -0.777 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.947 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -94.25 101.81 13.8 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.8 p -129.45 79.24 74.29 Favored Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.514 ' HG2' ' HB3' ' A' ' 100' ' ' GLN . 4.2 Cg_exo -84.47 165.88 12.31 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.6 2.867 . . . . 0.0 113.738 -172.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 162' ' ' LYS . 81.0 Cg_exo -47.87 -27.77 8.99 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 124.889 3.726 . . . . 0.0 114.807 -179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -63.86 -39.83 97.77 Favored Glycine 0 CA--C 1.523 0.548 0 O-C-N 123.305 0.378 . . . . 0.0 112.473 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 161' ' ' ASN . 2.4 m120 -94.65 -20.82 19.24 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 121.042 0.448 . . . . 0.0 111.202 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.417 ' HB2' ' HA ' ' A' ' 159' ' ' PRO . 62.2 mtpt -76.53 171.43 14.65 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.802 174.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 6.8 m -78.57 141.46 38.08 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.01 -11.79 11.65 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.202 -0.999 . . . . 0.0 114.112 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -114.5 129.71 56.68 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 117.621 0.71 . . . . 0.0 110.546 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -113.61 -8.89 13.27 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.984 0.421 . . . . 0.0 109.882 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.9 m -59.8 -43.38 94.47 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 122.834 0.454 . . . . 0.0 111.397 -176.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -87.24 -14.03 42.16 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.882 0.372 . . . . 0.0 111.292 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.5 t -95.0 -9.71 9.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.553 0.692 . . . . 0.0 110.169 -176.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 174' ' ' GLU . 39.7 tttm -77.09 79.58 3.62 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.761 0.791 . . . . 0.0 110.962 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' A' ' 111' ' ' SER . 3.9 p -104.3 -33.36 3.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.792 173.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 14.9 t -128.53 146.98 50.67 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 68.31 164.42 0.23 Allowed 'General case' 0 C--O 1.245 0.829 0 CA-C-O 121.805 0.812 . . . . 0.0 111.974 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.425 ' HA ' ' HE2' ' A' ' 170' ' ' LYS . 34.3 mm-40 -92.55 -19.48 21.9 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.343 175.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 70.72 -44.02 0.57 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.304 1.442 . . . . 0.0 112.714 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -72.32 109.84 6.33 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -72.65 134.65 45.2 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 59.45 67.78 0.86 Allowed 'General case' 0 CA--C 1.506 -0.74 0 O-C-N 124.191 0.932 . . . . 0.0 108.764 -167.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.407 ' CE1' ' HG3' ' A' ' 174' ' ' GLU . 11.7 p80 -86.4 75.79 9.74 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.465 1.126 . . . . 0.0 110.082 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 3.7 t60 . . . . . 0 N--CA 1.416 -2.147 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -178.51 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 CA--C 1.512 -0.493 0 CA-C-O 120.857 0.361 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -140.17 -58.84 0.54 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.0 m -163.7 98.35 0.88 Allowed 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.03 171.38 10.78 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.8 p -101.66 157.64 4.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.492 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 11.0 mmpt? -82.58 -173.53 4.67 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 122.893 0.477 . . . . 0.0 110.786 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 p -78.56 163.48 25.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 123.327 0.651 . . . . 0.0 110.87 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.51 ' HG ' ' CG ' ' A' ' 146' ' ' TRP . 10.7 mt -51.82 -33.26 35.02 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -177.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.8 m -62.35 -25.87 68.14 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.958 0.409 . . . . 0.0 110.71 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -96.98 -12.05 23.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.217 0.532 . . . . 0.0 110.341 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.8 m -78.55 145.96 34.55 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.11 -174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -84.01 153.39 23.88 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.258 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.451 HD21 ' HB2' ' A' ' 125' ' ' SER . 3.4 tm? -108.87 134.81 51.05 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 124.413 1.085 . . . . 0.0 109.684 -173.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 128' ' ' VAL . 3.2 mm? -125.43 138.72 32.34 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -72.63 141.86 35.12 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.71 2.274 . . . . 0.0 110.627 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.58 -13.76 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.451 -176.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.3 t -66.48 -28.86 68.91 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.432 0.634 . . . . 0.0 110.206 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -103.49 53.79 0.76 Allowed 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 121.929 0.871 . . . . 0.0 109.408 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -57.43 -18.56 18.69 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.789 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.55 -24.34 45.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.013 0.435 . . . . 0.0 110.077 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.1 m -88.43 -1.28 57.95 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.982 0.42 . . . . 0.0 111.234 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 80' ' ' ALA . 44.9 mm -72.18 128.15 89.41 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -51.5 132.67 41.22 Favored 'Trans proline' 0 C--O 1.241 0.657 0 C-N-CA 123.525 2.817 . . . . 0.0 113.147 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.4 p -94.92 28.58 2.68 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.407 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.59 -176.85 3.61 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.027 -176.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.3 t -98.6 145.24 27.04 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.481 ' HA2' HG12 ' A' ' 131' ' ' VAL . . . 159.55 -148.26 16.7 Favored Glycine 0 N--CA 1.416 -2.696 0 C-N-CA 119.802 -1.19 . . . . 0.0 112.729 177.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.68 150.56 29.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -138.31 154.15 49.01 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.97 121.41 34.35 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.628 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.1 t -94.24 124.08 46.59 Favored 'Isoleucine or valine' 0 C--O 1.27 2.146 0 O-C-N 123.641 0.588 . . . . 0.0 110.228 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -114.82 142.02 47.11 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 124.684 1.194 . . . . 0.0 108.949 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 96' ' ' SER . 4.8 p-10 -90.95 -164.16 1.14 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -70.07 -12.32 61.52 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 122.465 0.306 . . . . 0.0 111.603 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.404 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 5.0 m -94.59 -2.47 51.42 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 66.6 26.78 9.7 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.148 0.979 . . . . 0.0 109.754 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -90.18 127.92 36.23 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-O 121.078 0.466 . . . . 0.0 110.571 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.403 HD21 HG13 ' A' ' 102' ' ' VAL . 3.3 tm? -76.55 119.64 20.66 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.407 ' HA ' ' HG2' ' A' ' 158' ' ' PRO . 49.6 mt-30 -128.17 -18.4 4.12 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.257 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -147.29 118.15 7.63 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.354 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.448 HG23 ' NE1' ' A' ' 143' ' ' TRP . 11.6 m -109.27 139.62 31.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -149.54 158.0 27.48 Favored Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.711 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 16.3 pt -115.59 147.81 18.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.0 m -154.08 156.21 36.86 Favored 'General case' 0 C--O 1.251 1.134 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.18 -27.99 29.63 Favored 'General case' 0 C--O 1.218 -0.571 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -127.39 105.88 8.83 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 112' ' ' VAL . 78.0 mt -61.05 -60.79 2.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.145 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -44.69 -58.06 3.29 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -175.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.38 -37.23 86.38 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.6 m -71.59 -46.38 59.44 Favored 'General case' 0 C--O 1.249 1.057 0 O-C-N 123.23 0.331 . . . . 0.0 110.815 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 108' ' ' ILE . 85.3 t -58.68 -56.06 19.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.449 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 16.6 m -57.16 -42.05 80.33 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 124.248 0.968 . . . . 0.0 111.619 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.89 -59.08 5.22 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -73.06 -24.06 60.64 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 69.8 mt -73.13 -33.35 65.47 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.827 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 113' ' ' SER . 34.8 mmtp -78.7 -20.2 50.68 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.118 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.7 m -80.92 -46.26 15.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.471 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.46 92.78 26.86 Favored Pre-proline 0 CA--C 1.557 1.226 0 CA-C-O 121.815 0.817 . . . . 0.0 110.295 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.569 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 3.8 Cg_exo -76.48 16.64 0.86 Allowed 'Trans proline' 0 C--O 1.248 1.017 0 C-N-CA 123.933 3.089 . . . . 0.0 114.126 -175.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.27 -38.08 89.18 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.618 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.8 mt -101.51 20.55 15.84 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.745 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.569 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 90.4 m -75.04 93.12 2.69 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.647 176.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.03 -65.86 0.07 OUTLIER Glycine 0 N--CA 1.435 -1.405 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.451 ' HB2' HD21 ' A' ' 74' ' ' LEU . 19.8 p -158.89 167.52 29.19 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.0 p -144.82 139.24 23.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.464 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -106.56 137.53 44.41 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 173.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.46 HG22 HD23 ' A' ' 75' ' ' LEU . 33.6 m -125.7 133.35 69.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 121.359 0.599 . . . . 0.0 111.785 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -112.89 102.58 1.31 Allowed Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.07 115.48 20.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.481 HG12 ' HA2' ' A' ' 88' ' ' GLY . 12.2 p -108.33 138.3 35.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -66.83 -45.17 79.11 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.306 0.574 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -94.5 114.2 62.85 Favored Pre-proline 0 C--N 1.292 -1.919 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.639 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -82.91 32.92 0.52 Allowed 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 123.049 2.499 . . . . 0.0 111.755 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.439 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 17.6 t70 -73.59 136.86 43.99 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.814 -177.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -61.1 -30.14 70.18 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.69 -50.42 36.72 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.2 t -60.96 -39.76 83.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 O-C-N 124.179 0.924 . . . . 0.0 110.591 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.2 mt -61.47 -55.32 32.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.513 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.0 m -60.78 -38.4 85.16 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.038 0.447 . . . . 0.0 111.025 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -59.71 -52.63 64.65 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 124.205 1.002 . . . . 0.0 110.765 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.29 94.84 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.156 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.448 ' NE1' HG23 ' A' ' 102' ' ' VAL . 89.3 t90 -56.4 -45.21 80.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.533 177.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -63.89 -43.32 96.37 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.737 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.7 -46.2 90.7 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.066 0.46 . . . . 0.0 110.929 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.51 ' CG ' ' HG ' ' A' ' 69' ' ' LEU . 26.0 m0 -63.9 -46.28 85.58 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.511 ' O ' HG13 ' A' ' 151' ' ' ILE . 7.9 tt -63.25 -42.12 95.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.547 177.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.439 ' HB3' ' NZ ' ' A' ' 152' ' ' LYS . 49.8 mt-10 -64.77 -31.6 72.9 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 146' ' ' TRP . 7.1 mm-40 -50.42 -50.63 51.38 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.558 0.536 . . . . 0.0 110.02 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.458 ' HA ' HG22 ' A' ' 153' ' ' VAL 0.282 33.2 m-70 -81.95 -28.45 32.72 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -178.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 147' ' ' ILE . 71.3 mt -57.06 -40.52 73.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 120.943 0.401 . . . . 0.0 110.137 172.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.439 ' NZ ' ' HB3' ' A' ' 148' ' ' GLU . 62.3 mttp -75.32 -46.69 31.8 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 150' ' ' HIS . 30.9 m -78.04 -39.69 25.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -175.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 33.1 p -119.1 -35.32 3.65 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.951 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.92 17.23 59.93 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -85.14 108.22 17.59 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.13 0.49 . . . . 0.0 111.787 -177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 40.8 t -128.3 84.19 63.94 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 173.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.407 ' HG2' ' HA ' ' A' ' 100' ' ' GLN . 11.4 Cg_exo -76.41 164.51 30.67 Favored 'Trans proline' 0 C--N 1.323 -0.8 0 C-N-CA 122.798 2.332 . . . . 0.0 111.923 -178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.437 ' HA ' ' CD ' ' A' ' 162' ' ' LYS . 72.4 Cg_exo -52.34 -31.05 45.49 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 123.159 2.573 . . . . 0.0 112.697 177.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.29 -24.13 71.96 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.176 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.69 -9.74 42.73 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.437 ' CD ' ' HA ' ' A' ' 159' ' ' PRO . 7.7 mtpm? -79.49 170.77 16.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.685 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 14.4 t -110.43 138.44 46.82 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 144.66 -141.18 9.81 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -72.15 113.17 8.89 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 174.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.508 ' HB3' HG22 ' A' ' 169' ' ' VAL . 27.3 t-20 -134.39 135.06 42.36 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.529 -174.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.2 m -70.49 -22.18 62.68 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.858 0.863 . . . . 0.0 112.35 -176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -88.31 -47.82 8.12 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.508 HG22 ' HB3' ' A' ' 166' ' ' ASN . 33.0 m -83.26 -30.02 8.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.19 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.33 134.96 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.37 1.468 . . . . 0.0 113.634 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 51.9 t -87.15 -48.08 15.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 21.7 m -101.36 109.46 21.3 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 172.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -60.66 -33.58 73.03 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -170.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.0 -23.04 41.8 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 121.138 -0.225 . . . . 0.0 110.415 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 3.8 t60 53.74 80.44 0.11 Allowed 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.586 1.155 . . . . 0.0 107.944 -171.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -72.18 114.24 10.08 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -174.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -80.0 110.58 15.53 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.05 -175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -81.94 115.06 20.94 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -80.49 117.1 20.92 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.092 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 9.3 t60 . . . . . 0 C--N 1.301 -1.522 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 CA--C 1.508 -0.656 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -169.29 -35.83 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.927 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.5 m -95.12 107.51 19.58 Favored 'General case' 0 C--O 1.253 1.28 0 CA-C-O 121.321 0.581 . . . . 0.0 111.584 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -150.09 123.54 9.05 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 36.6 t -116.34 143.47 26.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -104.79 -52.61 2.83 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 122.116 0.96 . . . . 0.0 108.945 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.0 p -129.92 164.33 24.44 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.894 -170.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.508 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 17.9 mt -68.86 -13.59 62.51 Favored 'General case' 0 C--O 1.246 0.894 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 t -70.25 -19.6 63.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.322 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -104.72 1.33 29.23 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.508 ' OG1' ' HA ' ' A' ' 69' ' ' LEU . 6.8 m -92.78 134.53 34.97 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -172.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.16 152.35 38.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.295 1.038 . . . . 0.0 110.681 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -109.75 129.59 55.6 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.406 HD23 HG22 ' A' ' 128' ' ' VAL . 4.3 mm? -121.02 136.04 25.31 Favored Pre-proline 0 C--N 1.307 -1.247 0 C-N-CA 123.762 0.825 . . . . 0.0 109.705 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.5 139.64 41.62 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.348 2.032 . . . . 0.0 110.247 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.03 -12.98 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.248 0.547 . . . . 0.0 111.469 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.0 t -74.62 -20.81 59.76 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.466 0.651 . . . . 0.0 109.968 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -104.85 53.15 0.73 Allowed 'General case' 0 N--CA 1.422 -1.827 0 CA-C-O 121.807 0.813 . . . . 0.0 109.557 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.5 ' HB1' ' OG ' ' A' ' 113' ' ' SER . . . -56.13 -28.94 59.86 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.835 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.41 -26.23 67.89 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.6 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.3 t -92.08 -4.98 53.65 Favored 'General case' 0 C--O 1.248 0.994 0 C-N-CA 123.737 0.815 . . . . 0.0 110.38 -174.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.49 HG12 ' HA ' ' A' ' 80' ' ' ALA . 43.9 mm -72.14 130.36 86.51 Favored Pre-proline 0 N--CA 1.443 -0.808 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.85 131.38 38.01 Favored 'Trans proline' 0 C--O 1.248 0.982 0 C-N-CA 123.348 2.699 . . . . 0.0 112.976 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.0 p -91.39 27.59 1.91 Allowed 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.66 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.95 -176.95 3.6 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.825 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.6 t -96.85 154.33 17.36 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 154.15 -154.1 25.28 Favored Glycine 0 N--CA 1.423 -2.185 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.264 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.632 HG12 HG22 ' A' ' 104' ' ' ILE . 3.7 m -112.41 152.12 14.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 123.708 0.803 . . . . 0.0 110.045 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -144.69 154.35 42.67 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -130.78 126.23 35.81 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 123.248 0.619 . . . . 0.0 109.394 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.4 t -102.97 126.0 57.29 Favored 'Isoleucine or valine' 0 C--O 1.263 1.793 0 CA-C-O 121.102 0.477 . . . . 0.0 110.032 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -113.09 133.44 55.0 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -79.16 -169.44 1.84 Allowed 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.525 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.451 ' H ' ' HD2' ' A' ' 95' ' ' LYS . 8.5 mptt -57.22 -36.38 70.82 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 122.733 0.413 . . . . 0.0 110.29 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.3 m -77.46 0.5 22.44 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.536 0.734 . . . . 0.0 111.586 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.0 t70 65.88 27.16 10.99 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 122.752 1.263 . . . . 0.0 110.246 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -98.64 137.4 37.33 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.252 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.69 125.08 28.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.538 ' O ' ' HG2' ' A' ' 158' ' ' PRO . 41.9 mt-30 -129.1 -17.11 3.93 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.103 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.475 ' HA ' ' OD1' ' A' ' 161' ' ' ASN . 89.5 t80 -154.61 126.0 7.39 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 118.635 -1.226 . . . . 0.0 111.911 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.42 HG21 ' HB ' ' A' ' 147' ' ' ILE . 25.5 m -114.62 145.05 20.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 170.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.0 168.95 31.33 Favored Glycine 0 C--N 1.281 -2.487 0 C-N-CA 119.276 -1.44 . . . . 0.0 112.709 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.632 HG22 HG12 ' A' ' 89' ' ' VAL . 17.3 pt -120.13 148.53 23.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.4 t -150.84 155.63 39.59 Favored 'General case' 0 N--CA 1.417 -2.112 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.593 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.91 -23.12 24.02 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.431 HD22 ' C ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -141.67 98.19 3.3 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 174.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.0 mt -55.26 -60.4 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.46 -47.72 27.05 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.75 90.65 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 p -79.05 -43.1 24.92 Favored 'General case' 0 C--O 1.249 1.052 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.607 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 76.3 t -55.47 -54.76 21.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 O-C-N 123.294 0.371 . . . . 0.0 110.805 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.5 ' OG ' ' HB1' ' A' ' 80' ' ' ALA . 20.1 m -56.94 -46.9 81.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 123.924 0.765 . . . . 0.0 110.696 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.5 -55.08 38.24 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.046 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.261 29.2 p80 -71.53 -26.44 62.66 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -176.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 89.9 mt -78.13 -27.68 48.29 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.233 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 113' ' ' SER . 74.9 mmtt -84.9 -9.15 58.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.166 0.508 . . . . 0.0 110.314 176.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.6 t -93.32 -50.57 5.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.08 94.48 27.71 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-O 121.742 0.782 . . . . 0.0 110.507 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.666 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 15.0 Cg_exo -71.88 19.58 0.28 Allowed 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.986 3.124 . . . . 0.0 114.322 -177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.68 -43.42 98.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.462 0.649 . . . . 0.0 109.755 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.1 mt -100.35 20.13 15.38 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.911 -176.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.666 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 91.0 m -77.16 86.03 3.63 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.706 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.42 -63.96 0.09 OUTLIER Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 175.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.0 p -164.01 157.56 18.55 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 123.004 0.522 . . . . 0.0 109.601 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.9 p -136.21 139.0 46.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-O 121.018 0.437 . . . . 0.0 110.472 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.451 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 74.6 mttt -106.71 137.48 44.66 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.406 HG22 HD23 ' A' ' 75' ' ' LEU . 27.4 m -124.02 132.61 71.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.038 0.447 . . . . 0.0 110.802 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -117.18 99.37 0.83 Allowed Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -83.68 117.56 29.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.454 0.645 . . . . 0.0 109.743 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.92 131.18 69.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.58 8.4 7.96 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -108.35 107.62 60.33 Favored Pre-proline 0 N--CA 1.423 -1.783 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 174.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -84.04 26.42 0.65 Allowed 'Trans proline' 0 C--O 1.243 0.743 0 C-N-CA 122.558 2.172 . . . . 0.0 110.713 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.53 ' HB3' HG22 ' A' ' 138' ' ' VAL . 14.1 t70 -71.92 127.83 33.82 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -62.51 -28.4 69.82 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -173.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.54 -33.34 54.18 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.359 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 135' ' ' ASP . 10.1 m -77.38 -32.71 18.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.833 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 97.0 mt -64.25 -46.73 82.46 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 28.0 m -67.03 -33.92 76.58 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.225 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.603 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 9.4 tt0 -64.56 -50.82 65.78 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.528 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.23 -41.17 98.17 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.376 0.422 . . . . 0.0 110.234 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -55.61 -47.36 76.67 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.588 0.709 . . . . 0.0 109.592 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.78 -42.78 98.2 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.875 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 60.9 mt -64.98 -47.46 77.48 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.812 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -62.45 -46.11 90.01 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.015 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.584 ' O ' HG13 ' A' ' 151' ' ' ILE . 13.0 tt -67.15 -46.88 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.543 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -67.47 -29.28 68.69 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -175.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.497 ' O ' HG22 ' A' ' 153' ' ' VAL . 9.2 pt-20 -65.11 -44.09 89.89 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.931 176.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -69.96 -24.1 63.29 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 147' ' ' ILE . 57.1 mt -66.77 -43.73 89.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 172.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -71.27 -50.64 30.64 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 149' ' ' GLU . 35.2 m -80.01 -40.37 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -176.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.6 p -116.99 -4.84 11.47 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -174.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.37 34.33 89.61 Favored Glycine 0 C--O 1.222 -0.643 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.871 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -93.64 110.2 21.81 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.463 HG22 HG12 ' A' ' 151' ' ' ILE . 19.9 t -141.4 79.07 17.83 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 173.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.538 ' HG2' ' O ' ' A' ' 100' ' ' GLN . 3.1 Cg_exo -82.77 160.47 16.33 Favored 'Trans proline' 0 C--O 1.248 0.982 0 C-N-CA 122.66 2.24 . . . . 0.0 112.834 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -56.48 -17.17 20.75 Favored 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 124.268 3.312 . . . . 0.0 113.997 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -67.69 -38.79 90.22 Favored Glycine 0 CA--C 1.523 0.588 0 O-C-N 123.573 0.546 . . . . 0.0 112.892 177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.475 ' OD1' ' HA ' ' A' ' 101' ' ' PHE . 11.0 m120 -87.54 -21.75 25.24 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 121.991 0.9 . . . . 0.0 111.634 178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -83.88 160.47 21.13 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 174.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 57.9 m -87.1 79.77 8.55 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 117.817 -1.553 . . . . 0.0 109.781 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -140.97 -49.6 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 113.687 -1.597 . . . . 0.0 109.351 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -117.03 110.16 17.9 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.431 ' OD1' ' HG3' ' A' ' 170' ' ' LYS . 19.4 t-20 -114.62 11.68 17.03 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.381 0.61 . . . . 0.0 110.126 -174.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 28.7 m -56.25 -24.57 43.44 Favored 'General case' 0 CA--C 1.559 1.309 0 CA-C-O 121.294 0.569 . . . . 0.0 112.003 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -73.11 -22.68 60.5 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.1 -0.375 . . . . 0.0 111.274 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 53.3 t -102.98 -33.87 3.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.431 ' HG3' ' OD1' ' A' ' 166' ' ' ASN . 55.8 mtpt -68.88 1.4 3.4 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.74 -32.05 56.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.278 0.561 . . . . 0.0 110.684 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 4.6 m -92.71 -9.54 40.37 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.344 0.592 . . . . 0.0 109.539 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 170' ' ' LYS . 4.3 mm? -85.06 67.47 10.21 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.822 0.82 . . . . 0.0 112.65 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.581 ' OE2' ' HA ' ' A' ' 177' ' ' HIS . 37.1 tt0 -104.45 98.96 8.66 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -68.57 -47.36 66.98 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -100.04 90.41 4.38 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.581 ' HA ' ' OE2' ' A' ' 174' ' ' GLU . 16.2 p80 -69.47 117.03 10.56 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -66.33 127.36 31.92 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.98 -171.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -179.54 -39.11 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 10.5 p80 . . . . . 0 CA--C 1.497 -1.064 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 175.277 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -138.18 147.39 43.78 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 131' ' ' VAL . 16.2 m -73.77 101.49 3.73 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.86 0.362 . . . . 0.0 110.406 177.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.458 ' HA ' HG23 ' A' ' 131' ' ' VAL . . . -119.81 95.67 4.87 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 172.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.65 142.53 16.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.541 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -79.8 -152.55 0.07 Allowed 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.931 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.8 m -76.52 164.59 25.8 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 121.38 0.61 . . . . 0.0 111.719 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.444 HD11 ' OH ' ' A' ' 93' ' ' TYR . 3.1 tm? -46.52 -40.03 11.87 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 126.637 1.975 . . . . 0.0 114.108 -174.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.0 m -56.24 -32.83 64.85 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.314 0.578 . . . . 0.0 111.891 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -102.72 10.0 38.82 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.356 -0.384 . . . . 0.0 112.029 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.586 HG21 ' CH2' ' A' ' 146' ' ' TRP . 30.1 m -85.58 147.66 26.3 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.256 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -71.08 149.64 46.31 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.23 0.612 . . . . 0.0 111.262 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -110.65 133.49 53.27 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.829 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.51 HD23 HG22 ' A' ' 128' ' ' VAL . 3.5 mm? -127.26 141.53 41.08 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 174.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -79.97 144.84 17.23 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.082 1.854 . . . . 0.0 110.885 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.482 HD11 ' SG ' ' A' ' 123' ' ' CYS . 0.1 OUTLIER -80.03 -12.95 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 121.094 0.473 . . . . 0.0 110.676 -178.077 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -70.25 -11.81 61.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 124.522 1.129 . . . . 0.0 111.205 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -128.19 53.42 1.81 Allowed 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.455 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -54.86 -19.15 5.9 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.996 -175.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -78.21 -20.39 51.91 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.321 0.582 . . . . 0.0 110.577 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.0 m -91.11 6.81 43.47 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.234 0.54 . . . . 0.0 110.769 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.455 HG12 ' HA ' ' A' ' 80' ' ' ALA . 41.4 mm -82.56 130.05 60.3 Favored Pre-proline 0 N--CA 1.445 -0.687 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.436 ' HG2' HD11 ' A' ' 130' ' ' ILE . 90.1 Cg_exo -53.23 137.02 63.54 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.531 2.821 . . . . 0.0 113.287 178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.3 p -101.52 27.13 6.57 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.813 -176.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.25 -175.99 3.39 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.649 -174.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.9 t -95.39 141.56 28.8 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 158.87 -153.43 24.55 Favored Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.511 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.577 HG12 HG22 ' A' ' 104' ' ' ILE . 1.8 m -109.21 150.56 11.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 C-N-CA 124.393 1.077 . . . . 0.0 110.06 -177.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -142.78 148.43 37.15 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.38 118.04 21.57 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.244 0.618 . . . . 0.0 109.883 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.5 t -97.32 127.59 49.43 Favored 'Isoleucine or valine' 0 C--O 1.263 1.782 0 CA-C-O 121.358 0.599 . . . . 0.0 111.895 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.444 ' OH ' HD11 ' A' ' 69' ' ' LEU . 43.3 m-85 -107.4 146.47 31.61 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 125.047 1.339 . . . . 0.0 109.32 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -95.2 -172.24 2.62 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.4 ' HD2' ' HA2' ' A' ' 124' ' ' GLY . 31.6 mmmt -65.34 -23.05 66.9 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 m -77.13 -4.08 42.67 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.78 0.8 . . . . 0.0 109.396 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.3 t70 66.12 29.57 9.81 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 125.727 1.611 . . . . 0.0 109.626 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 5.1 mm-40 -99.14 144.1 28.66 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-N 114.066 -1.425 . . . . 0.0 108.255 175.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.516 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 1.5 tm? -85.89 125.12 33.09 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.515 ' O ' ' HG2' ' A' ' 158' ' ' PRO . 1.4 mp0 -116.5 -23.55 8.22 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 123.978 0.799 . . . . 0.0 113.013 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -149.4 120.47 7.73 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 117.587 -1.645 . . . . 0.0 112.715 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.613 HG21 ' HB ' ' A' ' 147' ' ' ILE . 30.5 m -105.06 145.29 13.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.809 171.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.55 166.97 30.84 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.544 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.577 HG22 HG12 ' A' ' 89' ' ' VAL . 10.5 pt -123.0 144.84 31.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 C-N-CA 122.889 0.476 . . . . 0.0 109.806 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.2 m -152.62 157.37 40.88 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.334 0.588 . . . . 0.0 111.526 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -86.74 -22.18 26.13 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 172.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -137.44 91.33 2.59 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.596 -1.183 . . . . 0.0 108.086 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.19 -62.3 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -173.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.77 -43.19 27.2 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -175.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.4 -48.57 79.13 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.054 0.221 . . . . 0.0 111.526 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.3 m -65.04 -41.51 95.13 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 120.683 0.277 . . . . 0.0 111.154 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.6 t -61.7 -57.15 13.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.009 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.5 p -60.85 -35.61 77.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 123.778 0.674 . . . . 0.0 111.811 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.77 -61.27 2.39 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 122.975 0.51 . . . . 0.0 111.642 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 168' ' ' PHE . 27.5 p80 -79.57 -21.68 44.76 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -73.02 -41.28 64.41 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.77 -15.1 59.34 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.556 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.521 ' HA ' ' CE1' ' A' ' 175' ' ' HIS . 49.6 m -80.9 -59.09 2.8 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.3 95.25 47.28 Favored Pre-proline 0 N--CA 1.428 -1.528 0 CA-C-O 122.087 0.946 . . . . 0.0 110.847 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -73.53 21.12 0.36 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.794 2.996 . . . . 0.0 113.22 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -69.1 -33.21 73.14 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 40.2 mt -94.59 21.49 7.23 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.169 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.482 ' SG ' HD11 ' A' ' 77' ' ' ILE . 38.2 t -68.61 108.37 3.32 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 107.508 -1.294 . . . . 0.0 107.508 176.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.4 ' HA2' ' HD2' ' A' ' 95' ' ' LYS . . . -160.35 -72.82 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 175.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.3 p -169.41 173.17 6.68 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.9 p -144.49 139.8 23.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -106.27 129.91 54.22 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.51 HG22 HD23 ' A' ' 75' ' ' LEU . 35.3 m -122.54 136.1 60.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-O 121.436 0.636 . . . . 0.0 111.52 -175.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -116.59 96.79 0.73 Allowed Glycine 0 N--CA 1.418 -2.511 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.436 HD11 ' HG2' ' A' ' 84' ' ' PRO . 2.7 mp -78.74 114.27 19.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.504 HG22 ' H ' ' A' ' 133' ' ' GLU . 13.6 p -104.5 124.13 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.705 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -78.83 -5.17 52.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.499 0.666 . . . . 0.0 110.582 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.504 ' H ' HG22 ' A' ' 131' ' ' VAL . 11.2 mm-40 -111.65 84.31 5.11 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 172.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.83 39.29 0.7 Allowed 'Trans proline' 0 N--CA 1.48 0.684 0 C-N-CA 123.619 2.879 . . . . 0.0 113.026 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.52 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 14.4 t70 -76.87 138.88 40.04 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.059 -175.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -54.15 -38.09 65.13 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 124.892 1.277 . . . . 0.0 113.494 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.02 -44.57 54.01 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.84 -43.58 95.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.775 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 96.5 mt -57.25 -52.88 63.53 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.125 0.488 . . . . 0.0 110.708 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.6 m -69.42 -34.37 74.36 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.117 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.489 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 52.9 tt0 -66.84 -45.65 77.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.071 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.9 -38.21 90.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.174 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.516 ' NE1' HG23 ' A' ' 102' ' ' VAL . 89.3 t90 -55.72 -48.58 74.94 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -60.9 -38.24 85.02 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.372 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.606 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 71.4 mt -63.97 -56.92 11.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.274 0.559 . . . . 0.0 109.559 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.586 ' CH2' HG21 ' A' ' 72' ' ' THR . 20.8 m0 -54.61 -50.48 67.98 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.613 ' HB ' HG21 ' A' ' 102' ' ' VAL . 13.1 tt -61.51 -46.53 96.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.334 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -66.45 -27.23 67.66 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 17.5 mm-40 -59.94 -46.13 90.37 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-O 121.224 0.535 . . . . 0.0 109.671 175.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.516 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 7.5 t60 -81.8 -21.43 37.71 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.578 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 147' ' ' ILE . 53.7 mt -67.2 -53.51 32.48 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.604 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.71 -26.2 68.54 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -175.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 150' ' ' HIS . 11.3 p -84.37 -35.73 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.4 t -137.86 -2.88 1.87 Allowed 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -174.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 78.93 29.28 52.14 Favored Glycine 0 CA--C 1.516 0.126 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.816 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -91.82 108.86 20.22 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.505 ' O ' ' HD2' ' A' ' 162' ' ' LYS . 2.1 t -142.78 90.36 7.72 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 173.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.515 ' HG2' ' O ' ' A' ' 100' ' ' GLN . 7.9 Cg_exo -80.17 159.67 23.47 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.986 2.457 . . . . 0.0 113.21 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -43.14 -40.79 9.3 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 124.822 3.682 . . . . 0.0 115.262 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -65.23 -23.2 69.74 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 114.395 0.518 . . . . 0.0 114.395 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -103.43 -19.63 14.35 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.467 0.651 . . . . 0.0 111.062 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.505 ' HD2' ' O ' ' A' ' 157' ' ' VAL . 61.0 mtpt -79.46 -65.03 1.05 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.089 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.3 m -102.95 -152.72 0.45 Allowed 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.293 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -75.57 143.33 30.18 Favored Glycine 0 N--CA 1.422 -2.249 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.36 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -73.01 122.58 21.97 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 40.1 m-80 -103.34 -79.54 0.53 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.977 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 39.4 m -60.92 -32.56 72.04 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -170.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' A' ' 115' ' ' HIS . 12.5 m-85 -76.04 -7.09 53.88 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.033 -174.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.9 m -135.53 14.99 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 123.052 0.541 . . . . 0.0 109.638 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 173' ' ' LEU . 16.0 tptm -85.05 -16.15 41.67 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 41.5 t 53.56 -79.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 127.062 2.145 . . . . 0.0 115.229 172.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 14.9 m -95.84 -44.42 7.41 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.323 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.448 ' HB2' ' HG3' ' A' ' 170' ' ' LYS . 82.9 mt -65.16 -40.62 94.58 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.253 -173.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -126.39 70.06 1.24 Allowed 'General case' 0 N--CA 1.425 -1.72 0 CA-C-O 121.905 0.86 . . . . 0.0 109.049 174.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.521 ' CE1' ' HA ' ' A' ' 118' ' ' SER . 20.0 t60 -86.23 -49.67 7.54 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 174.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -101.03 116.56 33.14 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -66.23 108.0 2.15 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -109.58 147.17 33.46 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -167.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -100.9 -162.49 0.94 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 75.8 m80 . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.556 176.704 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 84.5 mtp . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.89 77.7 1.27 Allowed 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.4 m -100.8 28.51 5.14 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.681 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -151.6 106.09 3.22 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.037 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 50.7 t -84.56 140.69 15.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.84 -178.12 6.25 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.651 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.0 m -72.93 177.24 5.04 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 98.1 mt -52.65 -25.27 10.32 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -171.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -68.71 -30.92 69.67 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.864 0.364 . . . . 0.0 110.695 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -87.62 -20.44 26.35 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.315 0.579 . . . . 0.0 110.752 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.421 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 4.4 m -74.99 133.74 41.62 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.219 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -71.53 154.02 41.76 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.056 0.455 . . . . 0.0 111.042 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -108.7 125.1 51.53 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.561 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.449 HD23 HG22 ' A' ' 128' ' ' VAL . 4.0 mm? -113.4 130.73 23.4 Favored Pre-proline 0 C--N 1.3 -1.583 0 C-N-CA 123.881 0.873 . . . . 0.0 109.411 174.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.87 139.59 36.7 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.179 1.919 . . . . 0.0 110.163 173.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.45 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -76.72 -13.48 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.431 -175.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.3 t -69.6 -25.67 64.07 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.433 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -109.63 54.25 0.67 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 122.29 1.043 . . . . 0.0 110.098 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.488 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -57.04 -19.76 20.67 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.822 -1.535 . . . . 0.0 113.302 -176.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -73.57 -19.6 60.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.434 0.635 . . . . 0.0 110.965 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.0 m -93.13 2.43 56.71 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.559 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 80' ' ' ALA . 47.0 mm -76.7 126.62 85.7 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.57 130.66 41.33 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.535 2.157 . . . . 0.0 113.21 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.0 p -94.05 30.65 1.82 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.247 1.023 . . . . 0.0 109.731 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.48 -179.78 4.45 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.445 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 106' ' ' ARG . 15.4 t -93.71 138.38 31.98 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.17 -155.61 26.81 Favored Glycine 0 N--CA 1.421 -2.33 0 C-N-CA 119.362 -1.399 . . . . 0.0 113.049 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.497 HG21 ' HB3' ' A' ' 142' ' ' ALA . 7.5 t -115.78 151.6 17.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -176.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -140.56 148.11 40.48 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.462 ' HB1' HD23 ' A' ' 99' ' ' LEU . . . -125.12 118.29 25.8 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.887 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.81 115.02 29.2 Favored 'Isoleucine or valine' 0 C--O 1.262 1.712 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.586 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 4.9 m-85 -100.32 137.28 38.96 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.92 -168.36 2.21 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.365 0.602 . . . . 0.0 110.891 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -64.99 -29.57 70.5 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.42 1.088 . . . . 0.0 111.271 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.1 t -81.42 -1.25 45.0 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.806 0.812 . . . . 0.0 109.363 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 t70 73.95 27.74 1.6 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.635 1.574 . . . . 0.0 112.538 172.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 11.8 pt-20 -120.09 166.65 13.11 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 117.588 -1.645 . . . . 0.0 111.207 172.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.462 HD23 ' HB1' ' A' ' 91' ' ' ALA . 2.9 tm? -80.29 130.14 34.99 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.913 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.404 HE21 ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -118.11 -47.13 2.59 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.106 171.36 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -124.1 125.74 45.0 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.789 -173.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.444 HG13 HD21 ' A' ' 99' ' ' LEU . 5.0 m -114.42 140.92 32.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.28 162.09 29.38 Favored Glycine 0 N--CA 1.42 -2.423 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.185 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.8 pt -124.82 151.7 30.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.6 t -159.92 159.23 32.08 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 106' ' ' ARG . 0.4 OUTLIER -82.35 -15.35 53.11 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 176.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -140.87 96.89 3.08 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.0 mt -56.34 -52.69 49.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.841 -177.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -51.14 -46.22 61.89 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.81 -48.23 81.54 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.733 0.413 . . . . 0.0 111.702 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.9 m -68.53 -44.21 75.06 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.239 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 57.6 t -57.94 -58.78 4.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.392 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 43.5 p -63.05 -32.06 73.34 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.51 -61.16 2.26 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.512 ' HA ' ' OG ' ' A' ' 118' ' ' SER . 19.7 p80 -77.15 -21.88 53.41 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -174.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.425 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 53.6 mt -76.09 -23.97 55.0 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.779 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -89.46 -31.01 17.89 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.046 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 115' ' ' HIS . 4.2 p -73.99 -27.91 61.21 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.352 177.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.23 98.07 3.78 Favored Pre-proline 0 CA--C 1.559 1.31 0 CA-C-O 121.899 0.857 . . . . 0.0 110.691 173.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.793 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 94.5 Cg_endo -82.21 22.39 0.87 Allowed 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 123.288 2.659 . . . . 0.0 113.514 -177.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -63.42 -43.34 97.75 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.707 -176.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.1 mt -104.99 18.01 23.13 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.161 0.505 . . . . 0.0 110.954 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.793 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 83.0 m -78.65 99.78 6.74 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.732 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.34 -49.48 0.06 OUTLIER Glycine 0 C--N 1.3 -1.43 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.0 p -165.59 168.14 16.66 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.095 0.958 . . . . 0.0 109.633 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.66 137.08 31.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-O 121.081 0.467 . . . . 0.0 110.48 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.421 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 98.1 mttt -106.43 138.58 42.36 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.449 HG22 HD23 ' A' ' 75' ' ' LEU . 27.0 m -124.19 130.99 73.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.136 0.493 . . . . 0.0 112.179 -176.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -118.33 102.11 0.94 Allowed Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 mp -94.89 136.47 25.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-O 121.031 0.443 . . . . 0.0 110.154 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.97 141.67 44.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.99 -46.09 90.76 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -88.39 116.33 65.93 Favored Pre-proline 0 C--N 1.308 -1.199 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.163 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.32 39.41 0.78 Allowed 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 123.488 2.792 . . . . 0.0 112.539 -175.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.426 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 23.9 t70 -73.74 129.2 37.45 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.996 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -61.81 -27.85 69.05 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.54 -45.47 59.14 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.3 t -62.07 -41.46 91.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 O-C-N 124.192 0.932 . . . . 0.0 110.171 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 90.3 mt -63.03 -50.48 70.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.679 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 48.8 m -63.57 -33.63 76.02 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 120.914 0.388 . . . . 0.0 110.793 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.34 -54.88 34.03 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.805 1.242 . . . . 0.0 110.378 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.497 ' HB3' HG21 ' A' ' 89' ' ' VAL . . . -64.77 -39.39 93.53 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.217 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -55.39 -45.68 76.6 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.304 0.642 . . . . 0.0 109.303 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -61.09 -46.27 91.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.79 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.2 mp -60.36 -38.37 83.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.851 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.433 ' O ' ' HG3' ' A' ' 149' ' ' GLU . 41.0 m0 -73.64 -46.87 44.05 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.957 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.432 ' HB ' HG21 ' A' ' 102' ' ' VAL . 12.7 tt -65.9 -40.98 89.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.444 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -67.72 -36.44 80.59 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.564 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -60.95 -39.12 88.27 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.331 -179.015 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.46 ' HA ' HG12 ' A' ' 153' ' ' VAL . 2.6 t60 -79.46 -31.25 42.43 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.132 -175.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.455 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 70.9 mt -70.87 -32.34 48.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.422 0.63 . . . . 0.0 109.87 175.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -84.85 -33.42 22.87 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 149' ' ' GLU . 14.8 p -83.52 -51.43 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.483 HG23 HG13 ' A' ' 153' ' ' VAL . 71.1 p -108.78 -35.54 6.37 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.172 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 151' ' ' ILE . . . 99.71 28.27 7.53 Favored Glycine 0 C--N 1.317 -0.519 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.719 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.82 125.75 47.35 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.51 87.78 10.16 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-O 121.904 0.859 . . . . 0.0 109.881 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -69.98 160.58 49.12 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.16 3.24 . . . . 0.0 113.811 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 162' ' ' LYS . 5.7 Cg_exo -45.7 -35.51 13.22 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 124.997 3.798 . . . . 0.0 115.365 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -70.84 -26.18 74.45 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.88 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -84.87 -25.82 27.76 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.456 ' HD3' ' HA ' ' A' ' 159' ' ' PRO . 6.5 mtpm? -83.73 -176.08 6.12 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.621 176.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.1 m -85.97 85.21 7.38 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.612 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.07 127.23 2.15 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -79.26 110.29 14.39 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -132.32 162.42 31.09 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.9 m -55.4 -28.27 53.02 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.786 0.834 . . . . 0.0 112.256 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.403 ' HA ' ' HB2' ' A' ' 115' ' ' HIS . 62.0 m-85 -67.83 -19.68 65.09 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 176.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 25.0 t -106.55 -8.41 10.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp 64.09 -165.49 0.24 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.074 0.95 . . . . 0.0 109.506 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 55.2 t -90.32 -52.59 10.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 57.4 p 63.17 -47.88 0.22 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 126.715 2.006 . . . . 0.0 115.407 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 96.6 mt -54.2 -51.8 63.25 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 175' ' ' HIS . 0.6 OUTLIER -159.88 174.57 14.24 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -174.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.408 ' H ' ' CD ' ' A' ' 174' ' ' GLU . 81.0 t60 -84.91 -36.75 21.26 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 122.363 0.265 . . . . 0.0 110.309 176.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -80.45 90.68 5.66 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.49 0.662 . . . . 0.0 109.942 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -84.5 118.28 24.21 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.032 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -146.58 -60.39 0.3 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -97.45 -35.6 10.61 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 33.2 m80 . . . . . 0 C--O 1.205 -1.253 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 174.818 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 C--O 1.236 0.386 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.86 100.31 11.49 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.0 t -99.02 -35.49 10.03 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.23 116.46 32.86 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.4 t -104.08 120.33 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 121.146 0.498 . . . . 0.0 110.832 -175.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.438 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -128.39 -72.59 0.61 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 176.124 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.541 ' HB2' ' OE2' ' A' ' 149' ' ' GLU . 28.1 p -121.99 179.29 4.57 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.481 HD13 ' OH ' ' A' ' 93' ' ' TYR . 38.9 mt -73.93 -17.17 61.06 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.6 m -72.28 -20.34 61.53 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.47 0.653 . . . . 0.0 109.648 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -92.18 -3.31 55.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.016 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.475 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.6 m -98.81 150.5 21.8 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.955 -172.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 9.4 pt-20 -90.25 155.01 19.3 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.176 0.99 . . . . 0.0 109.845 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.0 125.11 48.62 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -123.66 141.01 35.47 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.068 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -71.37 134.55 24.86 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.192 1.928 . . . . 0.0 109.215 170.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -21.53 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.0 t -73.29 -26.7 61.18 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.193 0.521 . . . . 0.0 110.678 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -94.56 56.09 2.04 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.845 0.831 . . . . 0.0 110.12 177.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.583 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -48.84 -21.57 0.66 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.204 1.402 . . . . 0.0 114.015 -176.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -64.56 -27.57 69.05 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.433 0.635 . . . . 0.0 110.763 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.408 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 22.8 m -83.09 1.43 40.29 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.083 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.583 HG12 ' HA ' ' A' ' 80' ' ' ALA . 26.8 mm -90.75 113.97 59.74 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 82' ' ' SER . 72.2 Cg_exo -54.7 135.27 66.54 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.737 2.958 . . . . 0.0 112.593 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.7 p -98.6 34.21 2.09 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.969 0.89 . . . . 0.0 110.885 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.73 -176.64 3.19 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.174 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.7 t -95.96 145.62 25.26 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 165.17 -149.13 15.27 Favored Glycine 0 N--CA 1.416 -2.69 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.266 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.49 HG13 ' CH2' ' A' ' 146' ' ' TRP . 6.7 p -125.98 149.26 30.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -176.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -137.37 149.85 47.28 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.901 0.382 . . . . 0.0 110.747 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.32 117.6 28.2 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.278 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.3 t -92.31 116.75 34.16 Favored 'Isoleucine or valine' 0 C--O 1.26 1.627 0 CA-C-O 121.092 0.472 . . . . 0.0 110.753 -177.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.481 ' OH ' HD13 ' A' ' 69' ' ' LEU . 88.3 m-85 -106.35 134.42 49.51 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.705 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -79.18 -171.0 2.47 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -58.46 -30.79 67.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.808 0.843 . . . . 0.0 111.093 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.4 m -82.72 1.72 37.33 Favored 'General case' 0 C--O 1.25 1.114 0 C-N-CA 123.506 0.722 . . . . 0.0 112.269 -176.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.2 t70 69.41 26.68 5.17 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 122.499 1.142 . . . . 0.0 109.39 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 4.3 mm-40 -102.13 140.14 36.81 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.925 176.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.507 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 2.8 tm? -89.69 110.84 21.7 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.464 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.464 ' HA ' ' HG2' ' A' ' 158' ' ' PRO . 2.4 mp0 -105.13 -25.99 12.27 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.051 177.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -143.82 120.96 11.47 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 118.822 -1.151 . . . . 0.0 113.54 -176.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.479 HG13 HD11 ' A' ' 99' ' ' LEU . 6.2 m -108.51 144.01 17.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 169.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -154.84 158.86 28.61 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.4 pt -117.25 144.3 25.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.6 m -150.75 160.39 43.89 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.147 0.498 . . . . 0.0 111.113 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -84.97 -21.85 29.39 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -136.13 105.46 6.03 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.55 -58.01 8.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 123.535 0.522 . . . . 0.0 111.92 -178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.17 -55.28 10.79 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.07 99.56 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 123.064 0.227 . . . . 0.0 111.316 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.2 t -65.87 -51.23 60.59 Favored 'General case' 0 C--O 1.251 1.148 0 O-C-N 123.774 0.671 . . . . 0.0 110.019 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 56.6 t -56.14 -54.77 23.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.972 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 22.9 t -60.12 -44.41 94.92 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 123.779 0.674 . . . . 0.0 111.1 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -52.75 -54.12 38.45 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -80.07 -26.3 39.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.441 ' HB3' ' SG ' ' A' ' 123' ' ' CYS . 66.9 mt -77.68 -26.48 50.31 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.845 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 113' ' ' SER . 33.7 mmtp -78.84 -26.05 44.12 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.395 174.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.2 t -74.0 -53.85 9.16 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.346 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.0 p -129.05 99.04 22.43 Favored Pre-proline 0 N--CA 1.431 -1.381 0 CA-C-O 121.996 0.903 . . . . 0.0 110.767 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.838 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 73.9 Cg_endo -79.56 11.53 2.67 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 123.525 2.817 . . . . 0.0 113.653 -177.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -58.03 -42.93 86.37 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 123.984 0.913 . . . . 0.0 109.865 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.0 mt -104.16 20.29 18.58 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.898 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.838 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 96.8 m -85.99 92.75 8.78 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.188 0.518 . . . . 0.0 111.944 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.42 -60.4 0.09 OUTLIER Glycine 0 C--N 1.299 -1.5 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 173.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 9.8 p -156.06 161.62 40.39 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.5 p -138.53 139.6 41.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-O 121.007 0.432 . . . . 0.0 110.159 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.475 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 82.9 mttt -106.54 128.36 54.05 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 174.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.86 136.16 56.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.095 0.474 . . . . 0.0 111.137 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.52 110.02 1.26 Allowed Glycine 0 N--CA 1.425 -2.064 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 130' ' ' ILE . 2.7 mp -94.24 104.91 16.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 133' ' ' GLU . 9.2 p -89.17 134.56 28.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.269 -177.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -65.12 -30.02 70.92 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.23 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.402 ' H ' HG22 ' A' ' 131' ' ' VAL . 16.5 pt-20 -109.24 100.67 42.05 Favored Pre-proline 0 N--CA 1.439 -1.016 0 CA-C-O 121.362 0.601 . . . . 0.0 109.768 174.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.72 37.92 0.71 Allowed 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.916 2.411 . . . . 0.0 112.282 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.448 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 22.3 t70 -69.15 143.77 54.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.188 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -52.44 -44.44 65.49 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.493 0.717 . . . . 0.0 112.337 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.11 -38.76 69.24 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.409 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.06 -42.04 90.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 96.7 mt -58.33 -47.73 82.81 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.5 m -66.04 -38.88 89.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.633 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -62.63 -45.39 93.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.85 0.357 . . . . 0.0 110.091 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.6 -50.06 75.03 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.914 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -53.55 -47.81 69.67 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.143 0.977 . . . . 0.0 110.492 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 14.6 tmtt? -63.37 -45.78 89.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.633 -176.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.476 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 11.0 mp -67.41 -38.86 85.27 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.049 -0.661 . . . . 0.0 111.691 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.49 ' CH2' HG13 ' A' ' 89' ' ' VAL . 27.2 m0 -63.16 -45.01 93.87 Favored 'General case' 0 C--O 1.257 1.482 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.471 ' O ' HG13 ' A' ' 151' ' ' ILE . 12.7 tt -65.41 -39.14 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.397 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 38.0 mt-10 -57.71 -42.5 83.88 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-O 118.9 -0.572 . . . . 0.0 111.967 176.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.541 ' OE2' ' HB2' ' A' ' 68' ' ' SER . 6.8 mm-40 -46.39 -51.84 14.14 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.782 0.676 . . . . 0.0 110.059 178.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.507 ' CG ' ' HB3' ' A' ' 99' ' ' LEU 0.34 13.7 m-70 -78.88 -27.85 44.04 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 179.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 147' ' ' ILE . 76.5 mt -61.18 -47.5 93.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 121.536 0.684 . . . . 0.0 109.319 172.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -68.1 -50.4 55.19 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.309 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 149' ' ' GLU . 16.9 m -80.75 -26.77 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -174.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.3 t -138.13 -26.25 0.93 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.39 23.5 16.47 Favored Glycine 0 C--N 1.316 -0.54 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.69 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -78.88 112.96 16.57 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.06 74.26 21.63 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 170.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.464 ' HG2' ' HA ' ' A' ' 100' ' ' GLN . 9.2 Cg_endo -90.88 168.84 3.69 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 123.219 2.612 . . . . 0.0 114.09 -171.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.447 ' HA ' ' HB2' ' A' ' 162' ' ' LYS . 71.1 Cg_exo -56.74 -17.73 24.18 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 124.0 3.134 . . . . 0.0 113.727 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -67.8 -38.48 89.5 Favored Glycine 0 C--O 1.219 -0.794 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -94.09 -33.11 13.5 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.574 0.702 . . . . 0.0 109.734 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.447 ' HB2' ' HA ' ' A' ' 159' ' ' PRO . 28.5 mtpp -75.51 176.33 7.67 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.478 175.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.5 m -82.34 88.04 6.57 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 173.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -146.77 -54.34 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.861 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.44 ' O ' HG22 ' A' ' 169' ' ' VAL . 23.6 t-20 -95.4 110.25 22.31 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 175.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -71.06 -8.19 51.67 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -171.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 m -72.39 -45.78 58.22 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.928 0.394 . . . . 0.0 110.152 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -82.34 -44.54 16.06 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.632 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 165' ' ' ASN . 35.9 m -86.99 13.91 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -172.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -77.94 134.37 37.89 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.046 -1.062 . . . . 0.0 108.92 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 30.8 t -93.3 156.38 3.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 14.9 m -55.69 -42.81 75.72 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-O 121.157 0.503 . . . . 0.0 109.983 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.35 118.59 27.85 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 174.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -100.51 150.64 22.46 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.319 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -125.13 108.72 12.08 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 172.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -86.12 92.28 8.69 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-O 121.782 0.801 . . . . 0.0 110.783 -172.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -72.6 97.84 2.22 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.223 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -154.85 23.33 0.45 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.091 0.948 . . . . 0.0 109.941 175.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -93.0 -14.06 27.89 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 . . . . . 0 N--CA 1.421 -1.907 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 176.281 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.0 mtp . . . . . 0 CA--C 1.506 -0.731 0 CA-C-O 121.266 0.555 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.91 102.53 11.54 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 169.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.7 m -94.42 -45.86 7.27 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.361 0.601 . . . . 0.0 111.002 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.22 99.79 12.29 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.491 HG11 ' HZ2' ' A' ' 146' ' ' TRP . 24.2 t -127.05 124.68 65.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.321 -176.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.425 ' HB2' ' OE2' ' A' ' 71' ' ' GLU . 57.8 mtpt -117.03 -54.23 2.43 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 60.1 p -110.49 172.09 7.07 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.824 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.94 -27.77 68.47 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.455 0.702 . . . . 0.0 110.983 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 m -62.67 -31.1 71.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.573 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.425 ' OE2' ' HB2' ' A' ' 67' ' ' LYS . 29.5 mt-10 -95.03 2.62 55.32 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.124 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.506 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.1 m -91.29 145.42 24.67 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.491 -176.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 17.0 pt-20 -89.31 151.05 22.31 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -113.88 130.61 56.47 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.814 0.34 . . . . 0.0 110.84 -172.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -128.35 127.77 23.68 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -63.49 138.11 63.48 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.181 1.921 . . . . 0.0 109.616 173.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.88 -14.46 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -172.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.7 t -65.58 -30.97 71.78 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.265 0.555 . . . . 0.0 110.081 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.62 53.07 0.82 Allowed 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 122.41 1.1 . . . . 0.0 109.377 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.582 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -56.64 -24.24 46.94 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.702 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.73 -31.1 71.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.378 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.5 m -92.39 3.46 55.4 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.582 HG12 ' HA ' ' A' ' 80' ' ' ALA . 44.6 mm -69.2 125.02 91.65 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -52.9 129.76 34.49 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.006 2.47 . . . . 0.0 113.71 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 p -95.5 32.79 1.72 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 122.089 0.947 . . . . 0.0 111.048 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.05 -176.96 3.23 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.924 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.4 m -93.42 149.67 21.05 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 123.504 0.502 . . . . 0.0 110.105 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.62 -153.78 24.99 Favored Glycine 0 N--CA 1.417 -2.571 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.435 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.59 ' HB ' ' CH2' ' A' ' 146' ' ' TRP . 2.6 t -114.36 151.3 16.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -175.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -140.31 151.88 45.41 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.02 174.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 127' ' ' LYS . . . -130.24 120.76 24.95 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 123.554 0.742 . . . . 0.0 109.697 -178.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.7 t -92.51 125.93 45.06 Favored 'Isoleucine or valine' 0 C--O 1.263 1.801 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.314 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -112.64 132.58 55.1 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 124.156 0.983 . . . . 0.0 109.234 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -77.61 -173.26 2.9 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 123.825 0.703 . . . . 0.0 110.542 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -55.42 -31.08 61.57 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.1 t -95.46 11.55 32.54 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 122.021 -0.425 . . . . 0.0 110.885 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.45 33.16 13.89 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 176.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -102.99 125.37 49.72 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 118.571 -1.252 . . . . 0.0 111.914 172.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.495 HD23 ' HB1' ' A' ' 91' ' ' ALA . 2.5 tm? -60.71 112.68 2.11 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.637 174.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.418 ' HB3' ' HG2' ' A' ' 158' ' ' PRO . 48.5 mt-30 -124.52 -14.66 6.81 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.24 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -144.16 125.33 14.56 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.371 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.474 HG21 ' HB ' ' A' ' 147' ' ' ILE . 22.1 m -117.11 151.76 18.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 173.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -160.3 160.04 31.36 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.4 pt -124.91 147.28 29.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.6 t -157.46 164.56 37.31 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.457 ' HD3' ' O ' ' A' ' 106' ' ' ARG . 0.6 OUTLIER -80.55 -28.03 37.4 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.339 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -131.09 99.4 4.87 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 77.7 mt -57.83 -52.01 63.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.261 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -50.63 -52.46 39.36 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.82 -47.18 87.52 Favored 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 123.456 0.473 . . . . 0.0 111.147 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.0 t -62.8 -50.78 69.63 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.435 -177.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.0 t -59.22 -52.97 54.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.028 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 25.4 m -63.13 -35.35 79.99 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 123.337 0.398 . . . . 0.0 111.812 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.09 -61.14 1.99 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.37 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.276 21.5 p80 -73.5 -25.92 60.66 Favored 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -174.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.4 mt -77.62 -24.06 49.67 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.681 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -87.48 -9.13 55.41 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.204 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.6 m -92.07 -51.61 5.1 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.59 95.73 42.33 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-O 121.681 0.753 . . . . 0.0 111.052 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.822 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 3.1 Cg_exo -79.27 32.56 0.47 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.58 2.853 . . . . 0.0 112.877 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -70.33 -43.17 70.81 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.779 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 91.1 mt -114.12 21.87 14.37 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.706 -174.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.822 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 94.7 m -76.06 93.06 3.24 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -127.25 -61.84 0.14 Allowed Glycine 0 C--N 1.307 -1.073 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.0 m -158.78 166.93 30.78 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.2 p -133.83 142.32 41.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.268 0.556 . . . . 0.0 110.088 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 91' ' ' ALA . 30.6 mmtm -105.67 129.22 53.94 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.21 136.36 60.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.272 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.44 100.06 0.79 Allowed Glycine 0 N--CA 1.422 -2.257 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 130' ' ' ILE . 2.5 mp -88.06 101.66 11.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -101.09 134.53 40.93 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.797 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.015 -174.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -66.48 -34.61 78.31 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -83.89 117.33 68.4 Favored Pre-proline 0 C--N 1.301 -1.513 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.871 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -91.49 21.03 0.82 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.879 2.386 . . . . 0.0 111.787 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.97 131.39 45.39 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.944 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -59.19 -33.39 70.9 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.849 -174.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.81 -45.27 68.25 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.29 -44.23 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.16 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 99.0 mt -59.77 -45.78 91.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.944 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.3 m -69.36 -38.43 78.08 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.479 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.563 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 29.0 tt0 -62.29 -51.23 68.52 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.329 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.3 -40.84 95.64 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.41 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.451 ' O ' HG22 ' A' ' 147' ' ' ILE . 79.3 t90 -51.41 -46.64 62.98 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.49 0.716 . . . . 0.0 109.603 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.44 -50.92 57.22 Favored 'General case' 0 C--O 1.211 -0.951 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.486 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 85.5 mt -51.57 -41.63 61.29 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.242 0.617 . . . . 0.0 111.673 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.59 ' CH2' ' HB ' ' A' ' 89' ' ' VAL . 31.6 m0 -69.68 -57.79 4.71 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.444 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.613 ' O ' HG12 ' A' ' 151' ' ' ILE . 15.1 tt -67.25 -42.16 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 C-N-CA 119.644 -0.823 . . . . 0.0 111.844 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.442 ' HA ' ' CG1' ' A' ' 151' ' ' ILE . 26.7 mt-10 -67.64 -28.62 67.88 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -174.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.507 ' O ' HG22 ' A' ' 153' ' ' VAL . 12.3 pt-20 -67.31 -37.45 83.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 118.887 -1.125 . . . . 0.0 109.063 175.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -75.41 -30.05 59.95 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 120.579 -0.449 . . . . 0.0 109.792 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 147' ' ' ILE . 41.8 mm -58.82 -44.49 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 121.272 0.558 . . . . 0.0 109.712 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -81.18 -36.25 30.38 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -174.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 149' ' ' GLU . 31.3 m -97.14 -24.84 4.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.95 -1.67 7.17 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 56.44 33.87 62.74 Favored Glycine 0 N--CA 1.47 0.926 0 N-CA-C 117.473 1.749 . . . . 0.0 117.473 170.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -100.16 108.3 20.38 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 118.225 1.012 . . . . 0.0 111.459 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.575 HG22 HD12 ' A' ' 151' ' ' ILE . 1.9 t -126.57 78.0 72.87 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.418 ' HG2' ' HB3' ' A' ' 100' ' ' GLN . 7.4 Cg_exo -77.77 155.2 30.82 Favored 'Trans proline' 0 C--O 1.257 1.444 0 C-N-CA 122.93 2.42 . . . . 0.0 113.225 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.9 -22.49 54.6 Favored 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 123.425 2.75 . . . . 0.0 111.893 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -56.66 -37.68 77.81 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.581 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -100.61 -27.24 13.5 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.206 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -76.01 -82.1 0.08 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.025 0.441 . . . . 0.0 110.663 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.9 t -179.38 164.42 1.33 Allowed 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.18 -21.05 15.87 Favored Glycine 0 C--N 1.307 -1.059 0 C-N-CA 120.292 -0.956 . . . . 0.0 111.196 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -100.89 163.42 12.31 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.419 ' OD1' ' HA ' ' A' ' 174' ' ' GLU . 6.4 t30 -131.68 -21.9 2.45 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 171.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.409 HG22 ' HA ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -58.4 -21.04 49.12 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -174.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -83.28 -14.62 52.7 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 120.112 -0.635 . . . . 0.0 112.424 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' A' ' 170' ' ' LYS . 34.4 m -101.46 -34.59 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 119.586 -0.845 . . . . 0.0 109.678 173.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 169' ' ' VAL . 68.2 mmtt -168.71 146.11 3.86 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.041 1.736 . . . . 0.0 108.367 175.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.409 ' HA ' HG22 ' A' ' 167' ' ' THR . 14.9 p -58.15 -52.48 58.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 19.6 m -124.32 -20.53 5.2 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.775 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.31 105.43 3.48 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.47 0.652 . . . . 0.0 110.539 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.419 ' HA ' ' OD1' ' A' ' 166' ' ' ASN . 9.8 pt-20 -81.16 134.63 35.66 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.752 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -121.88 -71.66 0.72 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.283 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -86.27 84.99 7.34 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.084 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -73.63 138.56 44.9 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.367 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -124.97 152.17 44.53 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -139.54 141.96 37.24 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.353 -0.539 . . . . 0.0 109.915 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 78.3 t60 . . . . . 0 N--CA 1.418 -2.035 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.597 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 52.1 tpp . . . . . 0 CA--C 1.515 -0.372 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -141.27 132.27 26.14 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 p -79.65 -15.71 57.1 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.496 0.665 . . . . 0.0 110.785 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.89 81.67 8.45 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.726 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.81 127.35 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -113.62 -53.53 2.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.2 m -124.84 165.75 17.48 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.188 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.0 mt -57.79 -26.82 62.46 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.142 1.377 . . . . 0.0 113.85 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.3 m -65.68 -21.81 66.58 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.947 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -98.93 -10.44 22.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.334 0.588 . . . . 0.0 110.401 -178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.51 ' HB ' ' HD3' ' A' ' 127' ' ' LYS . 3.2 m -83.28 136.88 34.22 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.325 -171.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.74 154.06 28.81 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 120.614 0.245 . . . . 0.0 110.882 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -108.4 128.72 55.02 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.244 0.618 . . . . 0.0 110.634 -172.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -121.96 131.01 24.5 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -66.08 139.0 54.2 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.119 1.879 . . . . 0.0 109.489 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.442 HG13 ' SG ' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -72.14 -12.9 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-O 121.384 0.611 . . . . 0.0 111.926 -174.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.5 p -75.45 -26.35 58.21 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.885 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.09 53.57 0.8 Allowed 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 122.167 0.984 . . . . 0.0 109.97 177.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -59.21 -22.84 61.66 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 113.792 -1.549 . . . . 0.0 112.329 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.11 -24.1 64.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.583 0.706 . . . . 0.0 109.497 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.9 t -93.91 4.97 53.14 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.391 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.575 HG12 ' HA ' ' A' ' 80' ' ' ALA . 43.5 mm -81.15 124.93 80.59 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.406 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 82.9 Cg_exo -51.58 133.95 45.19 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 123.287 2.658 . . . . 0.0 112.926 177.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.2 p -96.47 29.07 3.04 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.9 0.857 . . . . 0.0 110.578 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.05 -176.58 3.47 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.545 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.6 t -101.54 142.15 33.34 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.3 -147.85 12.73 Favored Glycine 0 N--CA 1.413 -2.854 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.488 HG13 ' CH2' ' A' ' 146' ' ' TRP . 7.6 p -126.01 148.81 30.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -176.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -136.57 149.04 47.87 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 120.9 0.381 . . . . 0.0 110.537 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -118.26 121.82 41.39 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.603 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.479 HG11 HD21 ' A' ' 116' ' ' LEU . 57.7 t -96.81 114.23 33.18 Favored 'Isoleucine or valine' 0 C--O 1.265 1.894 0 CA-C-O 121.171 0.51 . . . . 0.0 110.363 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 70.6 m-85 -102.52 133.86 46.81 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.379 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -81.21 -172.34 3.72 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -67.07 -16.3 64.25 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.8 m -88.8 1.6 54.98 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 122.277 0.231 . . . . 0.0 110.469 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 67.83 27.01 7.5 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.147 0.979 . . . . 0.0 110.715 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 4.6 mm-40 -103.85 151.72 22.76 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.402 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.502 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 3.0 tm? -102.47 110.99 23.1 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.426 -174.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.435 ' HB3' ' HG3' ' A' ' 158' ' ' PRO . 2.0 mp0 -107.4 -32.96 7.52 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.903 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -131.6 134.99 46.61 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.262 -0.975 . . . . 0.0 112.049 -174.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.46 HG13 HD11 ' A' ' 99' ' ' LEU . 4.5 m -130.47 142.8 42.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -153.8 153.96 25.19 Favored Glycine 0 N--CA 1.425 -2.063 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.086 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.403 HG22 ' HB ' ' A' ' 89' ' ' VAL . 18.8 pt -111.87 141.13 28.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 43.3 m -149.86 163.77 37.16 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 120.901 0.382 . . . . 0.0 111.55 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -82.92 -30.61 28.29 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -131.56 104.31 6.89 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 84' ' ' PRO . 73.2 mt -60.25 -53.57 46.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 O-C-N 123.162 0.289 . . . . 0.0 111.72 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.01 -58.53 4.32 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.84 89.33 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.286 0.366 . . . . 0.0 111.349 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.9 m -63.46 -49.61 72.99 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.249 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 69.4 t -58.15 -54.68 29.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.0 m -58.56 -43.75 89.46 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.245 -0.889 . . . . 0.0 112.049 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.66 -59.93 4.16 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -77.1 -30.8 55.48 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.479 HD21 HG11 ' A' ' 92' ' ' VAL . 77.7 mt -76.59 -27.74 55.91 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 119.542 -0.863 . . . . 0.0 113.054 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -81.35 -19.03 43.65 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.691 -0.804 . . . . 0.0 109.891 175.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.9 m -81.68 -57.76 3.31 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.381 175.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.0 p -116.13 96.26 46.86 Favored Pre-proline 0 N--CA 1.441 -0.914 0 CA-C-O 122.421 1.105 . . . . 0.0 109.987 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' A' ' 123' ' ' CYS . 82.1 Cg_endo -83.68 22.76 0.89 Allowed 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.154 2.569 . . . . 0.0 113.749 -175.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -64.52 -32.2 73.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.006 0.908 . . . . 0.0 109.719 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.4 mt -113.5 21.48 15.08 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.171 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 120' ' ' PRO . 34.9 t -75.52 78.99 2.54 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.383 -178.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -130.89 -56.83 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.4 p -165.38 164.09 19.74 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 122.664 0.385 . . . . 0.0 110.508 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.51 137.04 36.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 120.963 0.411 . . . . 0.0 109.956 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.51 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 77.3 mttt -106.53 130.61 54.27 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 173.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.1 m -113.92 133.72 59.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 120.892 0.377 . . . . 0.0 111.16 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -123.22 106.19 0.98 Allowed Glycine 0 N--CA 1.423 -2.208 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 130' ' ' ILE . 2.8 mp -93.26 111.78 25.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.6 164.07 2.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.99 -41.68 74.08 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 135' ' ' ASP . 47.4 mt-10 -100.48 116.97 63.75 Favored Pre-proline 0 C--N 1.303 -1.416 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.957 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -81.02 27.09 0.58 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.783 2.322 . . . . 0.0 109.763 173.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.451 ' H ' ' C ' ' A' ' 133' ' ' GLU . 29.1 t70 -85.96 145.87 26.94 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.426 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -53.7 -42.75 68.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.08 -37.75 88.59 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 120.977 0.418 . . . . 0.0 111.629 -177.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.439 HG21 ' HB2' ' A' ' 133' ' ' GLU . 34.0 t -79.52 -40.82 21.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.105 -176.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.07 -46.53 90.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.242 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.0 m -67.68 -33.82 75.69 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.337 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -65.61 -48.37 72.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.184 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.23 -43.92 96.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.942 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.404 ' NE1' HG23 ' A' ' 102' ' ' VAL . 91.6 t90 -55.04 -43.32 73.67 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.351 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 25.1 mmtt -60.86 -58.51 8.12 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.582 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 10.9 mp -55.79 -38.13 69.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 118.306 0.503 . . . . 0.0 112.297 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.488 ' CH2' HG13 ' A' ' 89' ' ' VAL . 27.0 m0 -65.12 -53.08 50.83 Favored 'General case' 0 C--O 1.265 1.88 0 O-C-N 123.518 0.511 . . . . 0.0 111.698 177.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.442 ' O ' HG12 ' A' ' 151' ' ' ILE . 8.5 tt -62.42 -46.69 95.81 Favored 'Isoleucine or valine' 0 C--N 1.344 0.355 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.649 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 144' ' ' LYS . 53.6 mm-40 -60.04 -30.95 69.53 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 123.457 0.703 . . . . 0.0 112.596 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 30.8 mm-40 -56.31 -56.85 15.93 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.469 0.652 . . . . 0.0 109.673 174.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.502 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 27.0 m-70 -73.17 -31.89 64.51 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.582 -0.847 . . . . 0.0 113.138 -177.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 147' ' ' ILE . 35.3 mm -57.06 -42.81 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 120.423 0.154 . . . . 0.0 111.024 175.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -72.86 -58.36 3.39 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.28 -22.93 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.2 t -129.49 -24.89 2.72 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.109 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 76.55 34.66 43.8 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.783 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -89.85 115.1 26.92 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.459 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.43 86.87 2.38 Favored Pre-proline 0 C--N 1.314 -0.97 0 CA-C-O 122.213 1.006 . . . . 0.0 110.029 175.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.435 ' HG3' ' HB3' ' A' ' 100' ' ' GLN . 67.8 Cg_endo -90.68 169.12 3.83 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 123.02 2.48 . . . . 0.0 112.266 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.402 ' HA ' ' HD2' ' A' ' 162' ' ' LYS . 86.5 Cg_exo -51.23 -18.23 4.81 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 124.594 3.53 . . . . 0.0 114.993 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.15 -41.57 86.3 Favored Glycine 0 C--N 1.31 -0.887 0 CA-C-N 116.498 -0.319 . . . . 0.0 112.407 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -92.96 5.71 50.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.767 1.27 . . . . 0.0 109.065 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 159' ' ' PRO . 35.3 mttm -114.81 -170.34 1.72 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 174.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.8 t -102.35 89.87 3.71 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 172.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.15 -58.61 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.212 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -92.75 110.05 21.49 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 175.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -80.97 -25.81 37.04 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.768 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.3 m -56.97 -25.77 58.71 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -77.3 -25.9 51.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.8 t -108.22 -24.01 4.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 121.558 0.694 . . . . 0.0 109.864 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.502 ' HE2' ' HA ' ' A' ' 170' ' ' LYS . 3.1 mmpt? 73.69 -71.85 0.13 Allowed 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.637 1.575 . . . . 0.0 112.508 -176.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 44.8 t 58.68 76.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 122.106 0.955 . . . . 0.0 109.45 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 52.6 m -77.25 -30.73 54.61 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.626 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.51 88.07 7.57 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.411 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -99.14 -31.36 11.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.985 0.898 . . . . 0.0 108.946 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -139.6 171.27 14.49 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -99.82 142.62 31.06 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 176.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -71.93 93.79 1.39 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.41 0.624 . . . . 0.0 111.432 -176.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -104.79 -13.82 15.74 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.041 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -161.79 -49.53 0.04 OUTLIER 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 173.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 . . . . . 0 C--N 1.307 -1.265 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.252 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 CA--C 1.504 -0.801 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.34 99.97 0.44 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.603 0.716 . . . . 0.0 109.916 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.1 m -103.51 173.89 6.11 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.942 -175.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.35 103.76 15.97 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.847 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.5 t -86.34 117.0 30.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -104.68 -86.77 0.45 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.513 -176.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.8 p -114.43 -174.15 2.43 Favored 'General case' 0 N--CA 1.414 -2.233 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.207 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.72 -26.21 68.57 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.82 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.6 m -61.81 -30.0 70.53 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.18 0.992 . . . . 0.0 111.109 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -87.06 -1.06 57.6 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.155 0.582 . . . . 0.0 110.165 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.446 ' HB ' ' HD3' ' A' ' 127' ' ' LYS . 27.3 m -114.33 145.45 41.77 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -170.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.94 156.97 17.58 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.03 0.532 . . . . 0.0 110.862 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -115.51 134.34 55.16 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.769 0.828 . . . . 0.0 110.766 -172.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -130.47 129.44 22.79 Favored Pre-proline 0 C--O 1.214 -0.77 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 53.1 Cg_exo -62.79 147.68 94.37 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.074 1.85 . . . . 0.0 110.376 172.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.8 -5.41 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -172.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.0 p -69.44 -26.21 64.49 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 121.16 0.505 . . . . 0.0 111.271 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.26 52.77 0.71 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.692 0.758 . . . . 0.0 110.538 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -60.51 -27.13 67.36 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.027 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.16 -24.33 64.97 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.355 176.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.5 m -93.01 2.09 56.97 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.963 0.411 . . . . 0.0 110.966 -177.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 80' ' ' ALA . 46.5 mm -79.25 130.53 68.77 Favored Pre-proline 0 C--O 1.243 0.746 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.554 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -52.3 140.39 52.44 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 124.2 3.267 . . . . 0.0 113.61 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.4 p -98.68 29.53 3.68 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.501 0.667 . . . . 0.0 111.387 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.57 -177.08 3.68 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.157 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.8 t -99.97 152.01 20.68 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 154.28 -143.36 9.97 Favored Glycine 0 N--CA 1.412 -2.933 0 C-N-CA 119.847 -1.168 . . . . 0.0 112.47 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.608 HG12 HG22 ' A' ' 104' ' ' ILE . 3.2 m -119.31 149.36 21.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 C-N-CA 123.485 0.714 . . . . 0.0 110.029 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -143.34 146.06 33.22 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.672 0.273 . . . . 0.0 110.28 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 126' ' ' VAL . . . -118.45 127.27 53.5 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.054 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -105.4 118.86 53.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.28 0.562 . . . . 0.0 110.938 -176.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 43.9 m-85 -108.52 141.05 40.98 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -80.32 -169.79 2.25 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HD2' ' HA2' ' A' ' 124' ' ' GLY . 4.9 mmmp? -67.38 -15.2 63.55 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.9 m -89.19 -3.1 58.7 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 65.51 35.29 7.33 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.686 1.194 . . . . 0.0 112.221 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -100.72 145.16 28.82 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 175.361 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -90.46 109.2 20.33 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.35 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -105.85 -41.99 5.27 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.915 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -125.29 139.38 53.76 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.425 0.631 . . . . 0.0 112.477 -171.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.654 HG22 HD21 ' A' ' 161' ' ' ASN . 27.2 m -132.54 146.31 33.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 172.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.67 165.67 30.61 Favored Glycine 0 N--CA 1.418 -2.545 0 C-N-CA 119.756 -1.212 . . . . 0.0 111.815 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.608 HG22 HG12 ' A' ' 89' ' ' VAL . 15.4 pt -116.99 155.0 18.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.0 t -158.64 160.16 36.19 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.183 0.515 . . . . 0.0 110.082 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -85.51 -22.31 28.23 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.402 HD22 ' C ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -142.55 91.97 2.37 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.057 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 70.2 mt -50.87 -60.03 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 123.857 0.863 . . . . 0.0 112.468 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.74 -46.25 29.73 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.18 -55.05 39.93 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.503 0.502 . . . . 0.0 111.075 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.2 m -61.42 -46.07 91.65 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.761 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 75.7 t -56.63 -54.94 22.76 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 C-N-CA 123.023 0.529 . . . . 0.0 111.263 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.1 t -61.29 -46.7 89.24 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 123.259 0.349 . . . . 0.0 110.606 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.27 -60.24 3.86 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -75.12 -21.94 58.54 Favored 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 118.619 -1.232 . . . . 0.0 113.752 -172.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.0 mt -79.68 -24.19 41.93 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.483 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -88.12 -25.29 23.08 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.39 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.9 t -76.74 -42.03 42.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.823 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.54 91.27 14.15 Favored Pre-proline 0 N--CA 1.437 -1.108 0 CA-C-O 121.895 0.855 . . . . 0.0 110.473 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.737 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 2.7 Cg_exo -75.72 18.31 0.62 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.263 2.642 . . . . 0.0 113.62 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -59.91 -42.96 95.04 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.25 1.02 . . . . 0.0 110.6 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.2 mt -107.18 20.54 18.84 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.435 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.737 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 66.3 m -72.56 120.87 18.77 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.539 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.518 ' HA2' ' HD2' ' A' ' 95' ' ' LYS . . . -163.79 -70.39 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 174.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . 21.8 m -146.48 159.37 43.49 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 91' ' ' ALA . 9.6 p -139.87 139.01 38.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.034 0.445 . . . . 0.0 110.45 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 91' ' ' ALA . 46.5 mttp -106.51 142.2 36.55 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.47 126.0 71.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.633 0.73 . . . . 0.0 112.325 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -113.69 102.67 1.26 Allowed Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 mp -84.63 121.94 37.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 133' ' ' GLU . 14.5 p -125.33 131.05 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.67 -0.62 57.14 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.518 0.675 . . . . 0.0 111.422 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.462 ' H ' HG22 ' A' ' 131' ' ' VAL . 20.7 mm-40 -94.8 109.66 45.1 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -88.8 32.37 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.353 2.035 . . . . 0.0 112.557 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.435 ' HB3' HG22 ' A' ' 138' ' ' VAL . 11.4 t70 -83.51 139.68 32.76 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -176.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.5 mmmm -59.44 -34.45 72.53 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.69 -43.44 69.03 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 123.113 0.258 . . . . 0.0 110.825 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 135' ' ' ASP . 17.4 m -69.42 -34.52 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 120.768 0.318 . . . . 0.0 110.911 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.2 mt -66.52 -52.34 46.83 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.007 0.432 . . . . 0.0 110.082 177.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.6 m -65.58 -30.41 71.14 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.064 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.507 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 58.6 tt0 -62.57 -54.21 43.14 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.817 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.21 -37.62 86.0 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 123.992 0.808 . . . . 0.0 110.105 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -54.34 -47.95 71.96 Favored 'General case' 0 C--O 1.242 0.661 0 O-C-N 123.617 0.573 . . . . 0.0 110.109 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 98.0 mttt -64.63 -49.74 69.88 Favored 'General case' 0 C--O 1.209 -1.03 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.21 177.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.587 ' O ' ' HG2' ' A' ' 149' ' ' GLU . 93.7 mt -50.83 -47.39 60.17 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.416 0.448 . . . . 0.0 111.439 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -63.08 -53.9 46.48 Favored 'General case' 0 C--O 1.265 1.871 0 C-N-CA 123.287 0.635 . . . . 0.0 112.604 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 151' ' ' ILE . 10.4 tt -64.33 -41.13 91.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.741 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 67.4 mt-10 -65.55 -30.05 70.75 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 119.265 -0.398 . . . . 0.0 111.92 -178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 21.0 mm-40 -54.89 -48.17 73.35 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . 0.272 13.4 m-70 -76.28 -29.54 57.46 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 147' ' ' ILE . 77.3 mt -61.31 -43.94 97.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 173.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -66.78 -49.65 65.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.7 m -79.28 -33.12 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.529 HG23 ' HG2' ' A' ' 156' ' ' LYS . 6.8 t -133.16 -28.06 1.55 Allowed 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.686 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.1 33.18 5.56 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.524 -0.845 . . . . 0.0 112.259 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.529 ' HG2' HG23 ' A' ' 154' ' ' THR . 42.7 mmtm -83.59 111.64 19.29 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.448 0.642 . . . . 0.0 112.583 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 p -155.84 70.96 5.3 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.746 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -90.11 165.3 4.71 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 123.33 2.687 . . . . 0.0 113.105 -174.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -51.68 -23.87 16.39 Favored 'Trans proline' 0 C--N 1.367 1.524 0 C-N-CA 124.092 3.195 . . . . 0.0 114.275 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -67.49 -20.75 72.03 Favored Glycine 0 C--O 1.205 -1.658 0 C-N-CA 121.821 -0.228 . . . . 0.0 112.9 177.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.654 HD21 HG22 ' A' ' 102' ' ' VAL . 16.5 t-20 -113.86 -8.88 13.13 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.656 0.741 . . . . 0.0 109.93 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -84.34 -176.24 6.16 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.0 m -62.53 -33.52 75.07 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 124.57 1.148 . . . . 0.0 112.721 -176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.52 50.11 3.23 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.411 ' ND2' HG13 ' A' ' 169' ' ' VAL . 22.6 t30 -115.06 140.98 48.62 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 122.873 0.469 . . . . 0.0 109.922 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -131.63 -68.33 0.65 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -60.44 -24.53 65.28 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -169.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -85.47 -21.05 28.86 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.613 -0.679 . . . . 0.0 112.697 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.411 HG13 ' ND2' ' A' ' 165' ' ' ASN . 11.7 m -104.85 -26.72 3.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.755 176.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 69.02 88.04 0.11 Allowed 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -175.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 14.3 p -48.4 115.02 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -170.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.0 t -178.59 -44.0 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.929 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 64.9 mt -95.83 102.9 14.75 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.176 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 54.51 100.51 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.914 1.686 . . . . 0.0 115.547 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -130.04 134.74 47.6 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 169.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -76.52 100.26 5.22 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.246 -175.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -82.26 113.56 20.16 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.624 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 83.4 t60 71.35 116.09 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.2 1.0 . . . . 0.0 111.547 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -92.16 136.71 32.96 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 . . . . . 0 C--N 1.29 -1.985 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.684 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.509 -0.616 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -167.6 161.3 13.54 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 t -121.14 166.85 13.35 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -79.1 69.53 5.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.885 0.85 . . . . 0.0 110.24 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.51 120.53 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.072 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -123.98 -28.25 3.79 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.645 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.9 p -130.84 161.73 31.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.674 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.456 ' H ' ' HG3' ' A' ' 149' ' ' GLU . 72.2 mt -59.77 -28.16 67.17 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.408 0.683 . . . . 0.0 111.03 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.0 m -61.29 -20.61 63.09 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.896 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -111.28 8.03 21.31 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.92 -0.487 . . . . 0.0 110.497 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.528 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.0 m -96.19 135.88 37.41 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.257 -172.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 13.1 pt-20 -69.9 150.05 47.17 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.901 176.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 125' ' ' SER . 3.1 tm? -118.3 121.22 39.88 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -173.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.13 126.16 27.22 Favored Pre-proline 0 C--N 1.296 -1.724 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -63.76 139.65 70.01 Favored 'Trans proline' 0 C--N 1.326 -0.621 0 C-N-CA 121.903 1.735 . . . . 0.0 108.507 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -70.23 -12.31 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-O 121.422 0.63 . . . . 0.0 111.189 -174.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.8 p -67.6 -31.71 71.93 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.355 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -97.85 55.48 1.19 Allowed 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.43 0.633 . . . . 0.0 111.045 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.514 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -53.3 -23.39 9.04 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.441 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -69.35 -24.97 63.97 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.114 0.483 . . . . 0.0 110.971 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.8 m -89.64 6.88 39.32 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.465 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.514 HG12 ' HA ' ' A' ' 80' ' ' ALA . 38.1 mm -85.6 115.76 62.85 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -56.27 132.43 51.85 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 123.235 2.624 . . . . 0.0 113.492 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.9 p -89.58 36.38 0.84 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.758 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.32 -176.66 3.15 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.608 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.3 t -104.42 150.11 24.82 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.49 -146.21 13.81 Favored Glycine 0 N--CA 1.414 -2.782 0 C-N-CA 120.26 -0.972 . . . . 0.0 111.264 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 6.6 p -121.04 147.29 24.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -137.54 151.92 48.91 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 120.916 0.389 . . . . 0.0 110.522 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.422 ' HB1' ' CD2' ' A' ' 99' ' ' LEU . . . -123.32 124.43 42.95 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 124.001 0.92 . . . . 0.0 108.818 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.9 t -101.47 124.94 55.54 Favored 'Isoleucine or valine' 0 C--O 1.262 1.759 0 CA-C-O 121.166 0.508 . . . . 0.0 110.85 -176.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.45 ' HD2' ' O ' ' A' ' 97' ' ' ASP . 12.5 m-85 -111.28 133.11 53.85 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -78.92 -167.19 1.06 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.94 0.4 . . . . 0.0 110.972 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -57.86 -27.44 63.24 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.823 0.849 . . . . 0.0 111.077 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.7 m -86.03 -1.68 57.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.874 0.369 . . . . 0.0 110.397 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.45 ' O ' ' HD2' ' A' ' 93' ' ' TYR . 25.7 t70 64.36 34.65 10.35 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 124.849 1.26 . . . . 0.0 109.156 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 32.7 mm-40 -100.4 124.83 46.41 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.621 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.511 ' HB3' ' CG ' ' A' ' 150' ' ' HIS . 3.1 tm? -66.91 118.06 9.87 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -127.28 -14.67 5.34 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.987 -1.006 . . . . 0.0 112.526 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -147.26 133.88 19.89 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.334 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.495 HG23 ' NE1' ' A' ' 143' ' ' TRP . 16.3 m -124.06 138.02 55.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.162 174.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -155.98 157.49 27.86 Favored Glycine 0 C--N 1.305 -1.191 0 C-N-CA 119.788 -1.196 . . . . 0.0 112.846 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.9 144.01 21.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 123.126 0.57 . . . . 0.0 109.899 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 m -150.41 161.06 43.24 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-O 120.546 0.213 . . . . 0.0 110.642 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.1 tpt180 -85.67 -24.3 27.1 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -135.11 101.95 5.04 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 74.3 mt -60.1 -50.35 80.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.056 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.2 -57.35 9.91 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.67 96.73 Favored 'General case' 0 CA--C 1.508 -0.66 0 O-C-N 123.38 0.425 . . . . 0.0 111.044 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.3 t -58.74 -61.18 2.81 Favored 'General case' 0 C--O 1.252 1.22 0 O-C-N 123.872 0.732 . . . . 0.0 109.961 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.4 t -54.66 -53.54 30.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 123.455 0.702 . . . . 0.0 111.581 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.0 t -59.48 -45.43 91.7 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.814 0.696 . . . . 0.0 111.385 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.26 -48.12 79.51 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -75.04 -27.88 60.2 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 119.069 -1.052 . . . . 0.0 113.536 -176.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 88.7 mt -73.62 -26.28 60.71 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.983 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -86.27 -17.7 33.97 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.466 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.0 m -83.63 -40.26 19.22 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.93 97.0 5.88 Favored Pre-proline 0 CA--C 1.553 1.084 0 CA-C-O 121.702 0.763 . . . . 0.0 110.581 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.607 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 9.8 Cg_exo -73.76 13.72 0.74 Allowed 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 123.757 2.971 . . . . 0.0 114.291 -177.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -55.56 -39.49 70.7 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.435 0.694 . . . . 0.0 111.063 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 62.2 mt -109.46 20.81 17.79 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.004 -177.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.607 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 63.6 m -70.82 120.29 16.2 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.222 174.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.427 ' N ' HD12 ' A' ' 77' ' ' ILE . . . -170.44 -68.9 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.496 ' HB2' HD21 ' A' ' 74' ' ' LEU . 2.0 p -152.06 152.49 32.46 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 114.882 -0.659 . . . . 0.0 109.695 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.12 137.23 48.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.112 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.528 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 95.0 mttt -106.89 131.36 54.07 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.86 137.28 55.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 120.932 0.396 . . . . 0.0 111.326 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.04 107.68 1.35 Allowed Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.79 109.85 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-O 121.717 0.77 . . . . 0.0 110.985 -176.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.8 p -111.28 125.78 68.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -87.25 -13.06 44.83 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.384 -172.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -92.36 113.83 60.47 Favored Pre-proline 0 N--CA 1.427 -1.595 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -77.84 45.41 1.78 Allowed 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 123.379 2.719 . . . . 0.0 112.923 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.494 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 10.0 t70 -82.18 121.29 26.43 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -67.15 -27.49 67.34 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -81.13 -39.44 25.59 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.45 -41.62 90.71 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 O-C-N 123.299 0.375 . . . . 0.0 110.265 176.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 98.0 mt -57.59 -48.12 80.25 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.907 0.384 . . . . 0.0 110.491 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.2 m -69.05 -35.99 77.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.77 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -65.63 -44.78 85.41 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 122.891 0.477 . . . . 0.0 109.977 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.83 -45.04 94.46 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.495 ' NE1' HG23 ' A' ' 102' ' ' VAL . 90.4 t90 -54.07 -44.25 70.97 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.583 176.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -63.96 -52.9 57.55 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.513 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.57 -38.52 78.04 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.413 ' O ' ' HB2' ' A' ' 149' ' ' GLU . 23.5 m0 -64.27 -46.58 83.08 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.618 ' O ' HG12 ' A' ' 151' ' ' ILE . 10.5 tt -63.16 -45.09 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.244 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 152' ' ' LYS . 17.8 mm-40 -57.26 -39.07 74.86 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.61 0.764 . . . . 0.0 111.674 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 69' ' ' LEU . 4.4 mm-40 -52.09 -49.33 63.78 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.431 0.692 . . . . 0.0 111.6 174.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.511 ' CG ' ' HB3' ' A' ' 99' ' ' LEU . 12.7 t60 -80.16 -23.4 41.1 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.892 -177.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.618 HG12 ' O ' ' A' ' 147' ' ' ILE . 43.2 mm -63.39 -50.68 77.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.028 174.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 148' ' ' GLU . 68.3 mttm -56.45 -45.05 81.04 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.966 0.412 . . . . 0.0 111.338 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 33.9 m -80.9 -33.47 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 41.4 p -130.88 -36.11 1.38 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 119.336 -0.945 . . . . 0.0 113.097 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.96 30.7 41.87 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.512 -175.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -82.01 116.58 21.69 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 122.535 -0.391 . . . . 0.0 110.327 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.459 ' O ' ' HE2' ' A' ' 162' ' ' LYS . 10.9 t -131.14 80.34 68.95 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 173.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -75.72 162.37 35.37 Favored 'Trans proline' 0 C--O 1.241 0.662 0 C-N-CA 122.925 2.417 . . . . 0.0 112.517 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.417 ' HA ' ' HD2' ' A' ' 162' ' ' LYS . 70.9 Cg_exo -56.0 -17.5 19.56 Favored 'Trans proline' 0 C--N 1.367 1.52 0 C-N-CA 124.457 3.438 . . . . 0.0 113.432 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 165' ' ' ASN . . . -77.57 -38.88 27.07 Favored Glycine 0 C--N 1.304 -1.195 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.858 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -22.3 33.01 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 157' ' ' VAL . 41.3 mttm -81.53 176.14 9.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.148 176.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.5 m -87.44 70.83 9.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 172.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.8 -91.82 0.49 Allowed Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.546 ' O ' ' HA2' ' A' ' 160' ' ' GLY . 56.8 m-80 -97.98 110.14 22.77 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -118.65 28.82 8.08 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.417 -173.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 2.9 m -58.31 -17.76 22.17 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.444 1.098 . . . . 0.0 110.596 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -76.88 -12.44 59.96 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.544 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.35 8.38 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 O-C-N 122.224 -0.298 . . . . 0.0 111.31 176.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 167' ' ' THR . 55.7 tptt -167.16 109.06 0.66 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.831 0.348 . . . . 0.0 110.876 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.5 p -103.15 127.07 57.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 171.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 8.1 m -86.11 -52.74 5.49 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 120.991 0.424 . . . . 0.0 110.601 -174.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -133.83 133.65 41.86 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -94.74 124.47 38.8 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.742 0.782 . . . . 0.0 111.985 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -134.16 159.78 39.84 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -87.33 83.85 7.29 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.989 0.899 . . . . 0.0 108.695 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -107.0 93.61 4.65 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.568 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -131.48 85.91 2.3 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.083 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.7 t60 65.88 15.48 10.08 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.697 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 . . . . . 0 CA--C 1.486 -1.484 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.498 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 54.8 ttp . . . . . 0 C--O 1.217 -0.623 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.38 -54.8 6.88 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.0 m 71.37 149.33 0.09 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.709 1.204 . . . . 0.0 113.471 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.98 74.57 7.97 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 173.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.406 HG23 ' HB2' ' A' ' 71' ' ' GLU . 5.3 p -74.68 135.09 28.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 113.13 -1.85 . . . . 0.0 113.872 -171.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -117.06 -42.64 2.91 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 169.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.9 p -116.69 156.48 27.04 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.739 -175.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 18.7 mt -64.21 -13.38 48.58 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.2 m -68.7 -22.55 64.35 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.566 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.406 ' HB2' HG23 ' A' ' 66' ' ' VAL . 24.4 mt-10 -101.84 6.85 41.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.775 -178.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 69' ' ' LEU . 6.9 m -104.02 137.61 41.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -172.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -83.27 161.01 21.61 Favored 'General case' 0 C--O 1.246 0.903 0 O-C-N 123.282 0.364 . . . . 0.0 110.315 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -117.41 130.32 56.41 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.028 0.531 . . . . 0.0 110.572 -174.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.02 120.7 22.62 Favored Pre-proline 0 C--N 1.311 -1.087 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 75.6 Cg_exo -61.41 140.3 87.07 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.001 1.801 . . . . 0.0 109.593 172.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.67 -12.02 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -170.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.4 t -67.01 -35.87 80.89 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 120.78 0.324 . . . . 0.0 110.832 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -90.34 53.91 2.61 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.38 1.086 . . . . 0.0 110.457 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.542 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -60.56 -20.05 59.28 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.58 -177.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -78.09 -22.88 48.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.479 0.657 . . . . 0.0 109.623 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.5 m -91.49 0.2 57.54 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.836 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.542 HG12 ' HA ' ' A' ' 80' ' ' ALA . 39.2 mm -78.86 121.46 83.46 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -51.64 130.31 33.15 Favored 'Trans proline' 0 C--O 1.252 1.225 0 C-N-CA 123.596 2.864 . . . . 0.0 114.234 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.8 p -91.43 77.02 5.83 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-O 122.285 1.04 . . . . 0.0 109.248 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.406 ' O ' HG13 ' A' ' 108' ' ' ILE . . . -148.89 176.23 10.59 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.535 -177.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 t -92.19 147.27 23.06 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 160.46 -154.03 25.0 Favored Glycine 0 N--CA 1.415 -2.734 0 C-N-CA 120.117 -1.04 . . . . 0.0 110.967 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.449 HG13 ' CH2' ' A' ' 146' ' ' TRP . 7.6 p -123.62 146.83 28.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -136.09 150.18 49.02 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 120.693 0.282 . . . . 0.0 110.351 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.34 124.37 44.39 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.826 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -97.85 118.99 45.28 Favored 'Isoleucine or valine' 0 C--O 1.264 1.829 0 C-N-CA 123.071 0.548 . . . . 0.0 110.969 -176.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 96.4 m-85 -113.13 145.73 40.44 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.522 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.41 ' C ' ' HA3' ' A' ' 124' ' ' GLY . 4.7 p-10 -89.85 -167.95 2.0 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.524 ' HD2' ' HA2' ' A' ' 124' ' ' GLY . 3.0 mmmp? -69.47 -18.14 63.68 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.773 -0.58 . . . . 0.0 111.572 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 m -85.09 -1.49 56.92 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 60.59 34.1 20.27 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 125.554 1.542 . . . . 0.0 113.55 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 40.5 mt-10 -105.19 154.57 20.03 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.433 174.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.483 HD11 HG13 ' A' ' 102' ' ' VAL . 3.4 tm? -93.19 113.51 25.75 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.725 -172.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.402 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 2.3 mp0 -107.49 -29.32 9.28 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.216 176.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -143.63 138.73 29.2 Favored 'General case' 0 C--O 1.214 -0.771 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.227 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.656 HG22 HD21 ' A' ' 161' ' ' ASN . 30.9 m -129.64 148.79 33.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 172.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.66 162.88 31.87 Favored Glycine 0 N--CA 1.422 -2.262 0 C-N-CA 119.989 -1.1 . . . . 0.0 112.382 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.7 pt -118.06 150.37 20.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 123.469 0.707 . . . . 0.0 109.407 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.4 t -157.0 170.36 22.72 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-O 121.288 0.566 . . . . 0.0 110.756 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -90.86 -25.48 19.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.672 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -142.9 90.92 2.24 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 86' ' ' ALA . 78.6 mt -39.21 -60.45 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.777 1.631 . . . . 0.0 114.256 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -48.51 -41.23 29.36 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.6 -47.77 71.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.043 0.449 . . . . 0.0 110.992 -175.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.1 m -70.88 -40.11 72.44 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.9 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 79.6 t -56.46 -57.16 10.07 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 O-C-N 123.308 0.38 . . . . 0.0 110.786 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.478 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 22.7 t -60.46 -46.84 88.6 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.804 0.69 . . . . 0.0 111.442 -177.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -51.26 -53.18 37.89 Favored 'General case' 0 C--O 1.25 1.114 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -81.95 -22.17 36.83 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 118.791 -1.164 . . . . 0.0 113.674 -178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.8 mt -75.73 -29.71 58.99 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.849 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 113' ' ' SER . 34.1 mmtp -75.62 -24.76 56.52 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-O 121.67 0.748 . . . . 0.0 109.021 175.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.7 m -76.42 -54.28 6.96 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.587 174.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.0 m -113.27 90.56 17.01 Favored Pre-proline 0 C--O 1.243 0.712 0 CA-C-O 121.877 0.846 . . . . 0.0 112.852 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.733 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 11.6 Cg_exo -73.85 -3.93 14.58 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.726 2.284 . . . . 0.0 112.253 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.06 -29.72 70.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.504 0.668 . . . . 0.0 109.557 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 52.9 mt -99.64 10.98 40.4 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.134 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.733 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 83.8 m -72.51 106.01 4.42 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.383 173.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.524 ' HA2' ' HD2' ' A' ' 95' ' ' LYS . . . -148.82 -73.74 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 173.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . 3.6 m -146.51 155.7 42.72 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.05 138.37 47.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 O-C-N 122.0 -0.438 . . . . 0.0 109.924 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.413 ' HD3' ' HB ' ' A' ' 72' ' ' THR . 81.0 mttt -106.12 133.81 50.24 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.74 126.12 74.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.554 0.692 . . . . 0.0 112.188 -176.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -117.02 106.1 1.4 Allowed Glycine 0 N--CA 1.423 -2.191 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.56 111.76 26.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.9 p -92.39 139.54 17.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -74.54 -44.48 50.89 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.785 -176.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -75.08 114.43 34.99 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 172.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -88.9 37.74 0.42 Allowed 'Trans proline' 0 C--N 1.321 -0.907 0 C-N-CA 122.513 2.142 . . . . 0.0 111.776 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.429 ' HB3' HG22 ' A' ' 138' ' ' VAL . 14.2 t70 -74.11 134.65 42.89 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -177.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -60.7 -29.98 69.67 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -176.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.9 -41.89 61.46 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.429 HG22 ' HB3' ' A' ' 135' ' ' ASP . 16.2 m -69.55 -31.29 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 120.583 -0.447 . . . . 0.0 109.908 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 92.9 mt -64.28 -48.9 73.93 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.971 175.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.9 m -68.33 -34.12 75.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.384 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.596 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 28.9 tt0 -62.87 -50.18 71.9 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.067 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.87 97.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.29 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.518 ' NE1' HG23 ' A' ' 102' ' ' VAL . 90.6 t90 -56.02 -47.13 78.37 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.984 176.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -62.4 -42.61 99.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.078 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 67.9 mt -63.05 -52.22 63.66 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.674 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.449 ' CH2' HG13 ' A' ' 89' ' ' VAL . 28.5 m0 -56.85 -48.24 78.54 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.338 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 151' ' ' ILE . 11.2 tt -63.55 -43.79 98.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.659 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.7 -29.99 70.61 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 145' ' ' LEU . 9.5 mm-40 -64.53 -41.77 96.18 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.017 177.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.45 ' HA ' HG22 ' A' ' 153' ' ' VAL 0.261 60.5 m-70 -76.89 -29.94 55.98 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.505 -0.878 . . . . 0.0 112.853 178.067 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 147' ' ' ILE . 71.9 mt -58.29 -37.98 66.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 171.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 38.5 mtmm -78.82 -49.82 12.32 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.45 HG22 ' HA ' ' A' ' 150' ' ' HIS . 27.8 m -78.7 -20.85 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -174.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 156' ' ' LYS . 6.8 t -138.01 -31.27 0.78 Allowed 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.299 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 88.65 11.2 66.33 Favored Glycine 0 CA--C 1.502 -0.735 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.018 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.413 ' H ' HG23 ' A' ' 154' ' ' THR . 44.7 mmtm -83.13 103.94 12.94 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.33 0.586 . . . . 0.0 110.592 -177.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 4.4 p -140.49 76.1 25.72 Favored Pre-proline 0 C--N 1.294 -1.844 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.293 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 14.1 Cg_exo -73.67 159.47 45.65 Favored 'Trans proline' 0 C--O 1.249 1.035 0 C-N-CA 123.194 2.596 . . . . 0.0 112.349 -179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.5 -23.88 26.55 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.995 3.13 . . . . 0.0 113.958 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -59.14 -41.82 96.81 Favored Glycine 0 CA--C 1.497 -1.037 0 CA-C-O 121.104 0.28 . . . . 0.0 112.671 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.656 HD21 HG22 ' A' ' 102' ' ' VAL . 44.9 t-20 -76.5 -30.83 57.38 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.926 0.87 . . . . 0.0 108.971 -175.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -87.45 1.23 54.02 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.193 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 47.2 t 71.13 112.53 0.06 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 122.016 0.912 . . . . 0.0 109.12 -170.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -176.17 -54.14 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.905 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -79.32 112.67 16.79 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 172.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -83.46 11.22 7.27 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.1 p -75.21 -22.13 58.18 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-O 121.423 0.63 . . . . 0.0 110.607 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -82.56 -29.57 30.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.534 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.6 m -103.72 -4.43 9.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.507 0.67 . . . . 0.0 110.305 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 49.2 tptt 77.51 -61.81 0.4 Allowed 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.415 1.886 . . . . 0.0 111.451 174.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 29.6 m -81.98 156.19 4.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-O 120.734 0.302 . . . . 0.0 110.304 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 16.3 m -88.37 96.27 10.52 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.877 0.37 . . . . 0.0 111.099 -175.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.77 -60.06 2.37 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.3 147.47 23.17 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 9.4 t60 71.27 159.69 0.21 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 124.887 1.367 . . . . 0.0 107.599 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -100.69 140.27 35.2 Favored 'General case' 0 C--N 1.286 -2.173 0 O-C-N 120.399 -1.438 . . . . 0.0 112.586 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -69.79 97.29 1.07 Allowed 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.749 0.785 . . . . 0.0 111.069 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -85.96 122.44 30.0 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.708 -177.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -69.27 119.1 13.02 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 7.0 t60 . . . . . 0 C--N 1.298 -1.658 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.739 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 CA--C 1.499 -0.989 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.35 111.73 22.98 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.5 m -69.82 120.92 16.3 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.909 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.452 ' HA ' HG23 ' A' ' 131' ' ' VAL . . . -120.07 112.48 19.18 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.8 133.74 31.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.661 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.56 ' HA ' ' HE2' ' A' ' 67' ' ' LYS . 7.8 mmpt? -88.06 -70.13 0.65 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.27 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.663 ' HB3' ' OE1' ' A' ' 149' ' ' GLU . 66.6 m -133.04 175.49 9.33 Favored 'General case' 0 N--CA 1.422 -1.843 0 O-C-N 122.015 -0.428 . . . . 0.0 111.448 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.2 mt -70.76 -23.52 62.43 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -172.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 m -69.83 -15.85 63.17 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 122.189 0.995 . . . . 0.0 109.323 176.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -107.83 8.21 28.58 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.63 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.6 m -103.7 142.09 34.94 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.056 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.58 149.24 40.2 Favored 'General case' 0 C--O 1.248 1.022 0 O-C-N 123.735 0.647 . . . . 0.0 111.284 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.11 133.07 51.39 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.8 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.73 128.73 24.53 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -67.41 142.85 61.28 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.786 1.657 . . . . 0.0 109.357 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.42 HG13 ' HB3' ' A' ' 123' ' ' CYS . 0.2 OUTLIER -69.16 -11.79 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -176.422 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.3 p -66.53 -37.75 85.68 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.505 0.669 . . . . 0.0 110.249 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -95.14 50.89 1.29 Allowed 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.845 0.831 . . . . 0.0 110.525 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.409 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -59.78 -27.76 66.84 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.944 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -73.26 -20.92 60.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.532 0.682 . . . . 0.0 110.39 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.0 m -95.99 7.52 46.16 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.406 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' A' ' 80' ' ' ALA . 46.1 mm -78.1 130.59 71.97 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -53.07 132.1 46.08 Favored 'Trans proline' 0 C--O 1.242 0.725 0 C-N-CA 123.417 2.745 . . . . 0.0 113.457 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.9 p -95.3 34.74 1.38 Allowed 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.306 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.402 ' O ' HG13 ' A' ' 108' ' ' ILE . . . -101.98 179.36 4.35 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.957 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.1 t -95.97 140.04 31.3 Favored 'General case' 0 C--O 1.248 0.978 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.3 -154.08 24.08 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 119.915 -1.136 . . . . 0.0 111.998 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.585 HG12 HG22 ' A' ' 104' ' ' ILE . 4.4 m -108.29 146.83 13.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 123.823 0.849 . . . . 0.0 109.88 -177.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -141.36 154.98 45.96 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB1' ' CD2' ' A' ' 99' ' ' LEU . . . -135.06 126.45 28.47 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.278 -178.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.63 122.05 52.15 Favored 'Isoleucine or valine' 0 C--O 1.269 2.107 0 CA-C-O 120.932 0.396 . . . . 0.0 110.463 -178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 99' ' ' LEU . 77.5 m-85 -109.43 137.92 46.56 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.888 1.275 . . . . 0.0 108.759 177.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -83.61 -166.86 1.5 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.516 ' HE3' ' O ' ' A' ' 123' ' ' CYS . 8.2 mptt -65.21 -26.42 68.12 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 122.913 0.485 . . . . 0.0 111.209 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.8 m -85.51 1.25 49.72 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 122.816 0.447 . . . . 0.0 110.591 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 65.7 28.72 11.02 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 123.87 0.868 . . . . 0.0 111.21 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.444 ' HB3' ' HD2' ' A' ' 156' ' ' LYS . 45.4 mt-10 -100.26 123.32 44.36 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.618 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.481 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 3.0 tm? -70.04 127.74 33.88 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.199 178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.457 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 43.6 mt-30 -126.99 -43.31 1.68 Allowed 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.992 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -126.06 121.51 33.17 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 118.819 -1.153 . . . . 0.0 112.143 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.412 HG13 HD11 ' A' ' 99' ' ' LEU . 19.5 m -112.1 151.72 14.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.99 160.73 30.61 Favored Glycine 0 N--CA 1.425 -2.094 0 C-N-CA 119.382 -1.389 . . . . 0.0 112.655 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.585 HG22 HG12 ' A' ' 89' ' ' VAL . 15.2 pt -119.07 137.3 53.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 m -152.34 166.36 32.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.914 0.387 . . . . 0.0 111.676 -177.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -85.11 -32.68 22.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.066 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -127.7 106.01 8.85 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 86' ' ' ALA . 73.9 mt -61.74 -59.61 4.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.624 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.94 -56.74 5.08 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.2 95.05 Favored 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 122.982 0.176 . . . . 0.0 111.276 -177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.4 m -64.28 -47.84 78.01 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.715 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.75 -55.09 26.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.005 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.9 m -57.33 -42.55 82.14 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.073 0.858 . . . . 0.0 111.781 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.98 -56.43 21.81 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 122.695 0.398 . . . . 0.0 111.889 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.27 23.7 p80 -71.61 -22.16 61.75 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.0 mt -73.75 -27.24 61.07 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.12 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -87.56 -15.67 36.78 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.253 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.5 m -87.02 -42.89 12.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.335 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.7 p -135.21 91.46 19.19 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-O 121.722 0.773 . . . . 0.0 110.007 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.631 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 7.4 Cg_exo -75.01 12.35 1.24 Allowed 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 123.396 2.73 . . . . 0.0 114.11 -176.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.38 -42.98 96.96 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.99 0.424 . . . . 0.0 109.958 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 39.7 mt -94.87 18.26 12.18 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.184 -176.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.631 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 84.8 m -76.85 85.6 3.42 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.467 0.651 . . . . 0.0 112.486 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -128.74 -59.59 0.11 Allowed Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 11.3 p -164.7 158.05 17.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.2 p -132.23 141.02 46.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -109.44 138.81 45.25 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 135.06 65.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.085 0.469 . . . . 0.0 110.739 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.3 99.75 0.74 Allowed Glycine 0 N--CA 1.419 -2.497 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.66 108.86 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.532 HG22 ' H ' ' A' ' 133' ' ' GLU . 7.7 p -99.06 131.03 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.291 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.73 8.37 10.18 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.579 0.704 . . . . 0.0 111.977 -175.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.532 ' H ' HG22 ' A' ' 131' ' ' VAL . 31.8 mt-10 -124.84 91.73 48.92 Favored Pre-proline 0 N--CA 1.421 -1.879 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 171.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.65 31.52 0.48 Allowed 'Trans proline' 0 N--CA 1.481 0.794 0 C-N-CA 123.102 2.534 . . . . 0.0 112.083 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.41 141.69 28.97 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.214 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -58.34 -26.57 63.25 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -67.14 -44.91 78.63 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.3 t -75.53 -40.05 40.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.402 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.22 -51.42 70.04 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.797 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 29.3 m -67.58 -32.42 73.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.011 0.434 . . . . 0.0 110.539 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.52 ' O ' HD22 ' A' ' 145' ' ' LEU . 51.7 tt0 -64.35 -56.7 12.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.264 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.61 -42.27 92.28 Favored 'General case' 0 C--O 1.225 -0.197 0 O-C-N 123.221 0.326 . . . . 0.0 110.147 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -53.69 -43.77 69.22 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.733 0.813 . . . . 0.0 109.726 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.573 ' HE3' ' OE1' ' A' ' 148' ' ' GLU . 56.9 tptt -64.27 -43.98 93.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.361 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 141' ' ' GLN . 2.5 mm? -64.3 -42.57 96.3 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.735 178.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -62.09 -49.14 77.12 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.063 -0.972 . . . . 0.0 112.044 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.516 ' O ' HG13 ' A' ' 151' ' ' ILE . 13.7 tt -69.21 -45.74 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.258 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.573 ' OE1' ' HE3' ' A' ' 144' ' ' LYS . 30.5 mt-10 -68.64 -29.61 68.13 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -175.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.663 ' OE1' ' HB3' ' A' ' 68' ' ' SER . 5.4 pt-20 -67.09 -42.72 84.14 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 118.459 -1.297 . . . . 0.0 108.683 176.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.437 ' N ' ' HG3' ' A' ' 149' ' ' GLU 0.263 24.5 m-70 -74.88 -23.38 58.38 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -179.287 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 147' ' ' ILE . 76.8 mt -66.87 -30.47 49.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -84.42 -42.57 15.52 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 149' ' ' GLU . 5.2 p -80.94 -51.47 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.0 p -96.79 -28.63 14.18 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 121.663 -0.648 . . . . 0.0 111.931 -176.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 57.96 29.92 62.72 Favored Glycine 0 N--CA 1.467 0.702 0 CA-C-N 114.727 -1.124 . . . . 0.0 115.415 174.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 26.1 mtpp -91.47 -70.58 0.68 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 117.391 0.595 . . . . 0.0 110.702 -176.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.289 7.7 p 41.4 83.27 0.21 Allowed Pre-proline 0 CA--C 1.567 1.613 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 58.9 Cg_endo -70.11 169.26 19.79 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 122.945 2.43 . . . . 0.0 112.593 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -45.75 -25.7 2.69 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 125.175 3.917 . . . . 0.0 115.694 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -57.64 -47.84 85.66 Favored Glycine 0 C--O 1.238 0.365 0 O-C-N 123.55 0.532 . . . . 0.0 113.388 -175.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -85.72 -20.36 29.45 Favored 'General case' 0 CA--C 1.497 -1.093 0 CA-C-O 121.005 0.431 . . . . 0.0 111.785 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -64.26 -71.54 0.17 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.872 175.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 30.8 p 178.35 151.85 0.29 Allowed 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.383 0.673 . . . . 0.0 109.58 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.21 178.4 15.86 Favored Glycine 0 N--CA 1.43 -1.766 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.154 176.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -102.4 110.83 22.9 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -118.38 161.76 19.44 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -177.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.4 m -60.31 -19.03 53.5 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.201 1.4 . . . . 0.0 111.341 -177.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -70.88 -27.77 64.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.108 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.52 -28.77 2.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 65.81 -83.53 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.097 1.359 . . . . 0.0 111.75 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 29.9 m -125.12 -0.41 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-O 121.079 0.466 . . . . 0.0 110.219 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 50.3 m -81.96 71.54 9.0 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 122.255 1.026 . . . . 0.0 111.224 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -116.32 119.94 37.31 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 171.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . 0.25 11.2 pt-20 -75.49 75.47 2.54 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.859 1.314 . . . . 0.0 113.334 -176.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -140.65 88.92 2.23 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -80.33 85.41 5.82 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 119.334 -0.947 . . . . 0.0 108.998 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -48.83 117.84 2.28 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.194 -1.821 . . . . 0.0 112.334 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -147.86 80.5 1.49 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.929 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -86.34 82.16 8.09 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.566 -0.853 . . . . 0.0 111.2 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 . . . . . 0 C--N 1.313 -0.978 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.353 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.51 -0.565 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.09 97.64 6.93 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.7 m -88.58 -41.63 12.56 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.102 0.477 . . . . 0.0 109.733 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.74 142.62 3.74 Favored 'General case' 0 C--O 1.25 1.082 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' A' ' 71' ' ' GLU . 7.2 p -64.82 125.58 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 124.326 1.016 . . . . 0.0 109.833 177.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -100.05 -53.73 3.07 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.809 0.814 . . . . 0.0 108.937 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.2 m -136.78 172.48 12.95 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.482 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.51 ' HA ' ' OG1' ' A' ' 72' ' ' THR . 61.3 mt -59.87 -16.14 26.74 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.8 1.24 . . . . 0.0 114.241 -175.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.424 HG23 ' HG3' ' A' ' 71' ' ' GLU . 12.5 t -65.32 -19.97 66.19 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.24 0.616 . . . . 0.0 111.164 176.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.442 ' HB2' HG23 ' A' ' 66' ' ' VAL . 31.7 mt-10 -106.45 -7.36 17.62 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.426 0.631 . . . . 0.0 110.263 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.51 ' OG1' ' HA ' ' A' ' 69' ' ' LEU . 4.4 m -84.94 129.6 34.78 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.131 -172.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -81.56 150.99 27.92 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.806 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -104.99 129.1 53.51 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 123.277 0.631 . . . . 0.0 109.657 -175.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.2 140.27 35.71 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -68.27 145.56 66.42 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.532 2.155 . . . . 0.0 110.133 173.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -13.54 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-O 121.429 0.633 . . . . 0.0 110.667 -177.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.4 t -78.42 -15.1 59.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -97.95 47.89 1.01 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.804 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.513 ' HA ' HG12 ' A' ' 83' ' ' ILE . . . -61.42 -28.95 69.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.295 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -69.18 -26.02 64.64 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.001 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.7 m -90.87 -5.53 55.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.393 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.513 HG12 ' HA ' ' A' ' 80' ' ' ALA . 44.1 mm -70.16 125.28 91.92 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -178.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.51 134.96 66.99 Favored 'Trans proline' 0 C--O 1.244 0.823 0 C-N-CA 123.049 2.5 . . . . 0.0 113.399 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.8 p -91.81 26.77 2.28 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.925 0.869 . . . . 0.0 109.727 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.91 -178.73 4.18 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.405 -173.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.5 t -95.83 138.85 32.89 Favored 'General case' 0 N--CA 1.425 -1.704 0 O-C-N 124.034 0.833 . . . . 0.0 109.404 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.46 -151.22 20.25 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 118.503 -1.808 . . . . 0.0 114.422 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.416 ' HB ' ' CH2' ' A' ' 146' ' ' TRP . 5.6 t -120.34 150.28 23.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -175.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -139.25 149.26 44.12 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.346 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -122.14 120.59 34.67 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 123.918 0.887 . . . . 0.0 109.32 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.7 t -99.69 121.76 50.73 Favored 'Isoleucine or valine' 0 C--O 1.263 1.804 0 CA-C-O 121.059 0.457 . . . . 0.0 110.608 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -109.66 132.06 54.49 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.45 -172.48 4.16 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.774 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.54 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -65.18 -22.27 66.88 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.382 0.673 . . . . 0.0 112.201 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.9 m -84.68 0.39 50.53 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 123.001 0.52 . . . . 0.0 109.986 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 69.33 16.55 8.35 Favored 'General case' 0 C--O 1.249 1.079 0 C-N-CA 125.023 1.329 . . . . 0.0 111.707 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -86.84 135.77 33.21 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.124 0.488 . . . . 0.0 110.322 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.489 HD11 HG13 ' A' ' 102' ' ' VAL . 3.4 tm? -80.75 112.22 17.93 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 174.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -125.0 -13.72 6.78 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.944 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.429 ' HA ' ' OD1' ' A' ' 161' ' ' ASN . 57.4 t80 -145.83 122.65 11.26 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 118.707 -1.197 . . . . 0.0 111.08 177.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' A' ' 147' ' ' ILE . 18.6 m -123.27 141.32 44.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 171.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -157.23 157.91 28.47 Favored Glycine 0 N--CA 1.413 -2.895 0 C-N-CA 119.068 -1.539 . . . . 0.0 111.719 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.7 pt -110.91 137.84 41.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 121.192 0.52 . . . . 0.0 109.733 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.5 m -149.77 136.41 19.28 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HD2' ' C ' ' A' ' 106' ' ' ARG . 4.5 ppt_? -76.74 -12.0 59.92 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.751 0.786 . . . . 0.0 109.894 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -133.7 86.76 2.32 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.6 mt -55.68 -55.32 18.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.157 -174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -45.64 -60.25 2.3 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.05 -37.99 87.06 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.033 0.208 . . . . 0.0 111.432 -176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.7 t -63.65 -55.32 24.42 Favored 'General case' 0 C--O 1.248 0.985 0 O-C-N 123.836 0.71 . . . . 0.0 109.913 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.9 t -57.94 -51.61 68.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.351 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.9 m -60.1 -37.92 81.41 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.327 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.13 -58.86 6.8 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 120.937 0.399 . . . . 0.0 111.47 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -77.63 -22.36 50.84 Favored 'General case' 0 C--O 1.203 -1.367 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.04 -26.03 25.58 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 119.062 -1.055 . . . . 0.0 113.326 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -88.12 -16.95 32.09 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.3 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -94.81 -20.1 19.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.004 0.43 . . . . 0.0 111.158 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.9 p -152.73 94.0 3.19 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-O 121.809 0.814 . . . . 0.0 110.534 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.667 ' HA ' ' SG ' ' A' ' 123' ' ' CYS . 16.1 Cg_exo -68.84 14.28 0.2 Allowed 'Trans proline' 0 CA--C 1.556 1.579 0 C-N-CA 124.123 3.215 . . . . 0.0 116.729 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -66.39 -28.27 68.5 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 121.464 -0.773 . . . . 0.0 111.503 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.418 ' HG ' ' CZ ' ' A' ' 168' ' ' PHE . 61.9 mt -107.25 20.86 18.38 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 121.683 -0.636 . . . . 0.0 111.502 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.667 ' SG ' ' HA ' ' A' ' 120' ' ' PRO . 89.4 m -79.68 99.05 7.21 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.73 -65.28 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.6 p -160.05 162.05 34.09 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.095 0.558 . . . . 0.0 109.52 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.38 137.78 43.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-O 121.155 0.503 . . . . 0.0 110.375 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.509 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 79.5 mttt -109.11 137.27 47.27 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.36 138.69 53.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 120.57 0.224 . . . . 0.0 110.863 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.72 113.34 1.85 Allowed Glycine 0 N--CA 1.426 -2.025 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 mp -90.32 107.59 18.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 p -93.53 143.22 11.97 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.572 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -58.63 -50.21 74.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.275 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -94.52 119.42 66.35 Favored Pre-proline 0 C--N 1.303 -1.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.176 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -83.07 27.16 0.62 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.066 2.51 . . . . 0.0 110.877 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.15 133.56 50.04 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.402 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -59.54 -33.77 71.82 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -74.85 -42.24 58.34 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.55 -43.07 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.004 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.69 -49.26 78.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.74 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 44.8 m -69.1 -31.1 69.58 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.084 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.492 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 27.9 tt0 -63.26 -50.64 69.36 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 122.946 0.498 . . . . 0.0 109.884 178.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.85 -45.26 93.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.698 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -51.13 -46.69 62.02 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.251 1.021 . . . . 0.0 110.284 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -61.0 -48.82 80.04 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.179 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 61.7 mt -62.8 -43.23 99.35 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.79 -176.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.416 ' CH2' ' HB ' ' A' ' 89' ' ' VAL . 30.8 m0 -61.48 -47.51 85.35 Favored 'General case' 0 C--O 1.252 1.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.21 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.514 ' O ' HG13 ' A' ' 151' ' ' ILE . 14.9 tt -67.68 -39.75 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.404 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -62.74 -33.71 75.69 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 153' ' ' VAL . 7.3 mm-40 -55.24 -45.95 76.02 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.401 0.619 . . . . 0.0 109.685 173.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.468 ' HA ' HG12 ' A' ' 153' ' ' VAL 0.255 74.3 m-70 -80.5 -27.36 37.74 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.295 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 147' ' ' ILE . 79.8 mt -61.29 -41.07 88.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 172.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -71.06 -43.98 66.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.326 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 150' ' ' HIS . 7.3 p -81.7 -56.4 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.4 p -99.47 -34.36 10.3 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 121.811 -0.556 . . . . 0.0 112.264 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.74 34.67 27.21 Favored Glycine 0 C--N 1.304 -1.226 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.715 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -106.83 106.49 17.05 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.76 87.52 46.41 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 173.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -86.14 169.87 8.53 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 123.896 3.064 . . . . 0.0 113.251 -177.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -45.23 -30.57 5.3 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 124.928 3.752 . . . . 0.0 116.177 -175.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.76 -30.31 72.67 Favored Glycine 0 C--O 1.246 0.896 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.312 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 101' ' ' PHE . 14.7 m120 -101.47 -21.07 14.87 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -68.8 162.62 25.96 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 38.3 m -69.03 103.53 1.88 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.791 0.805 . . . . 0.0 111.38 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 156.67 -158.55 28.84 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -125.18 167.72 14.43 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -162.09 160.26 27.16 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.6 m -52.98 -25.36 11.77 Favored 'General case' 0 CA--C 1.567 1.629 0 C-N-CA 124.284 1.033 . . . . 0.0 112.412 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.418 ' CZ ' ' HG ' ' A' ' 122' ' ' LEU . 64.6 m-85 -84.78 -4.47 59.07 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 177.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.17 -34.12 5.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -176.16 140.51 0.4 Allowed 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 28.5 m -75.31 116.72 18.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-O 121.614 0.721 . . . . 0.0 112.321 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 16.7 m -105.58 -17.16 14.5 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.942 176.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.34 107.91 19.07 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -96.43 -46.17 6.48 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.378 1.085 . . . . 0.0 109.009 -178.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -86.34 99.89 11.92 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.221 -170.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -70.32 142.16 52.24 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 114.451 -1.249 . . . . 0.0 112.621 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -100.14 107.59 19.5 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 70.43 109.06 0.06 Allowed 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 123.984 0.914 . . . . 0.0 112.082 -171.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -121.76 14.46 10.89 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 174.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 . . . . . 0 N--CA 1.421 -1.886 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -176.236 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 58.36 27.54 15.51 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.597 1.159 . . . . 0.0 112.978 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 m -95.03 31.47 1.88 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 122.018 0.913 . . . . 0.0 110.676 -176.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.11 155.18 26.47 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.1 t -89.6 120.22 38.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-O 120.687 0.28 . . . . 0.0 110.551 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.429 ' HD3' ' N ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -106.32 -47.89 3.7 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 177.713 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.7 m -114.41 168.98 9.38 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.331 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 146' ' ' TRP . 2.9 tm? -65.32 -35.0 79.65 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.429 1.092 . . . . 0.0 109.829 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.8 m -55.97 -28.69 58.2 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.798 176.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -93.94 -4.08 50.45 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 121.752 -0.593 . . . . 0.0 111.575 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.548 ' CG2' ' HB3' ' A' ' 127' ' ' LYS . 5.3 m -78.02 141.67 38.73 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -173.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -88.45 148.64 24.08 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.659 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.06 133.94 48.16 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 122.84 0.456 . . . . 0.0 109.94 -174.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -126.44 126.45 24.61 Favored Pre-proline 0 C--N 1.315 -0.928 0 C-N-CA 123.652 0.781 . . . . 0.0 108.902 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.522 ' HB2' HG22 ' A' ' 78' ' ' THR . 25.5 Cg_exo -67.67 141.85 56.28 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 121.843 1.695 . . . . 0.0 109.139 172.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -5.0 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -174.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 76' ' ' PRO . 9.1 t -68.32 -30.0 68.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -99.43 52.97 0.94 Allowed 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.364 1.078 . . . . 0.0 109.61 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.55 -24.11 66.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.102 -178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -76.32 -19.41 58.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.782 0.801 . . . . 0.0 110.244 176.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.3 t -87.49 -6.97 58.15 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.243 -174.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.7 mm -67.43 125.84 91.71 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.391 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -53.77 137.37 67.45 Favored 'Trans proline' 0 C--O 1.243 0.739 0 C-N-CA 123.584 2.856 . . . . 0.0 113.95 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.8 p -93.69 35.72 1.12 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.25 1.024 . . . . 0.0 109.129 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.445 ' O ' HG13 ' A' ' 108' ' ' ILE . . . -102.64 175.37 5.52 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.229 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.7 t -97.53 134.76 40.32 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.28 -154.88 24.68 Favored Glycine 0 N--CA 1.412 -2.902 0 C-N-CA 119.952 -1.118 . . . . 0.0 111.069 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.458 ' HB ' ' CH2' ' A' ' 146' ' ' TRP . 3.2 t -115.24 156.44 16.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -145.61 149.52 34.68 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.58 121.97 35.15 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.462 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.9 t -94.93 118.74 41.75 Favored 'Isoleucine or valine' 0 C--O 1.259 1.558 0 CA-C-O 121.332 0.587 . . . . 0.0 110.351 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.559 ' HA ' ' O ' ' A' ' 98' ' ' GLU . 7.3 m-85 -108.82 134.49 51.44 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.367 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.92 -179.33 6.92 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -73.99 3.18 7.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -175.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.5 m -94.18 0.0 55.49 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 171.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 t70 61.51 62.94 1.24 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.036 1.334 . . . . 0.0 108.538 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -141.39 146.49 36.67 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.3 -177.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.418 HD11 HG13 ' A' ' 102' ' ' VAL . 3.3 tm? -96.3 116.67 29.4 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.92 0.762 . . . . 0.0 110.745 -172.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.467 ' HA ' ' HG2' ' A' ' 158' ' ' PRO . 2.4 mp0 -112.08 -28.39 8.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.329 178.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -145.91 127.07 14.72 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.12 -1.032 . . . . 0.0 112.493 -175.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.434 HG23 ' NE1' ' A' ' 143' ' ' TRP . 20.0 m -114.98 143.55 24.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 172.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.46 170.38 31.03 Favored Glycine 0 N--CA 1.426 -2.027 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.4 pt -133.14 146.84 31.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.1 t -151.22 162.42 40.92 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.979 -0.289 . . . . 0.0 110.29 -176.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -85.38 -22.67 28.3 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -142.43 86.16 1.94 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 86' ' ' ALA . 73.0 mt -43.94 -52.45 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.663 1.185 . . . . 0.0 113.304 -173.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -47.65 -40.33 19.52 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.78 -51.76 37.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.444 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.9 m -63.19 -45.92 89.5 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.688 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.31 -57.13 11.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.33 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.4 t -62.94 -40.89 99.01 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 123.404 0.44 . . . . 0.0 111.13 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.69 -54.31 47.67 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . 0.261 19.7 p80 -78.69 -25.79 44.81 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 118.922 -1.111 . . . . 0.0 113.94 -177.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 70.5 mt -75.19 -28.35 59.97 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 119.781 -0.767 . . . . 0.0 112.127 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -86.11 -23.34 26.67 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.738 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.1 m -72.89 -46.36 53.2 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.4 p -139.26 91.69 11.02 Favored Pre-proline 0 N--CA 1.438 -1.075 0 CA-C-O 122.22 1.009 . . . . 0.0 110.022 177.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -74.84 29.75 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.945 3.096 . . . . 0.0 113.82 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -70.83 -42.87 69.64 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.362 0.601 . . . . 0.0 110.533 -177.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.62 21.29 4.08 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.219 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 35.9 m -71.56 99.32 2.04 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.334 0.587 . . . . 0.0 111.856 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.32 -59.9 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.1 p -164.72 160.84 20.24 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.79 138.01 46.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.548 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 97.9 mttt -106.71 135.36 48.38 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 33.0 m -120.88 131.41 72.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 120.81 0.338 . . . . 0.0 110.1 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -115.81 106.58 1.57 Allowed Glycine 0 N--CA 1.408 -3.228 0 C-N-CA 119.868 -1.158 . . . . 0.0 111.85 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 mp -82.23 112.37 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.25 144.26 20.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -95.31 4.51 53.37 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.204 -171.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -94.58 112.4 57.69 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 175.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -84.73 8.32 4.7 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 122.592 2.195 . . . . 0.0 116.065 -170.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.407 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 16.1 t70 -97.64 146.81 24.95 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.131 -174.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -54.85 -34.67 63.16 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.692 1.197 . . . . 0.0 111.891 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.96 -44.23 90.08 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 120.658 0.266 . . . . 0.0 110.665 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.46 -36.38 48.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.615 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 135' ' ' ASP . 95.1 mt -60.82 -45.08 95.86 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 33.1 m -71.94 -32.14 67.02 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 121.072 0.463 . . . . 0.0 110.698 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.437 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 26.6 tt0 -63.69 -46.31 86.06 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 175.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.77 -42.25 95.24 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.843 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.434 ' NE1' HG23 ' A' ' 102' ' ' VAL . 91.9 t90 -49.83 -45.89 50.67 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.488 0.715 . . . . 0.0 109.633 176.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.643 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 84.6 mttt -62.09 -50.74 70.74 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.13 177.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 141' ' ' GLN . 86.9 mt -54.32 -47.54 72.36 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.532 0.52 . . . . 0.0 110.679 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 69' ' ' LEU . 14.3 m0 -62.02 -54.46 41.26 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.538 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.446 ' O ' HG12 ' A' ' 151' ' ' ILE . 11.1 tt -59.19 -42.78 87.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 O-C-N 123.424 0.452 . . . . 0.0 110.274 -177.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 37.3 mt-10 -56.01 -47.67 77.34 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 123.547 0.53 . . . . 0.0 110.913 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.404 ' O ' HG22 ' A' ' 153' ' ' VAL . 15.4 mt-10 -56.86 -47.02 81.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.41 ' HA ' HG22 ' A' ' 153' ' ' VAL . 0.6 OUTLIER -82.83 -28.2 30.33 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 118.496 -1.282 . . . . 0.0 112.751 -176.11 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.523 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 38.2 pt -76.85 -26.77 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.906 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -78.5 -30.9 47.47 Favored 'General case' 0 C--N 1.264 -3.123 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.079 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 150' ' ' HIS . 35.1 m -86.57 -46.33 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 176.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 70.8 p -99.99 -19.02 16.76 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 119.409 -0.917 . . . . 0.0 113.031 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 151' ' ' ILE . . . 67.52 34.69 84.99 Favored Glycine 0 N--CA 1.468 0.822 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 174.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -78.95 -74.94 0.26 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 117.1 0.45 . . . . 0.0 111.958 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.41 HG12 ' CG ' ' A' ' 162' ' ' LYS . 5.1 t 54.13 69.52 2.12 Favored Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 123.865 0.866 . . . . 0.0 109.014 -174.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.467 ' HG2' ' HA ' ' A' ' 100' ' ' GLN . 2.8 Cg_exo -81.44 156.94 19.27 Favored 'Trans proline' 0 C--O 1.242 0.696 0 C-N-CA 122.804 2.336 . . . . 0.0 112.84 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -49.92 -35.92 41.96 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 124.298 3.332 . . . . 0.0 114.159 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -64.86 -30.52 78.21 Favored Glycine 0 CA--C 1.498 -1.011 0 O-C-N 123.336 0.397 . . . . 0.0 112.933 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.42 ' OD1' HG22 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -94.27 -29.57 15.0 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -176.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.41 ' CG ' HG12 ' A' ' 157' ' ' VAL . 60.4 mtpt -71.47 -54.0 12.07 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.879 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.2 m -112.27 154.61 25.36 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.433 -173.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -88.23 9.23 75.92 Favored Glycine 0 C--N 1.316 -0.574 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.977 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -118.11 110.65 17.88 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 122.171 -0.605 . . . . 0.0 109.971 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -179.84 158.55 0.78 Allowed 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 22.3 m -56.34 -32.9 65.13 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 118.321 0.509 . . . . 0.0 111.391 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -70.69 -11.91 61.23 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.1 t -118.83 7.34 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-O 122.122 0.963 . . . . 0.0 109.097 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -92.38 36.8 0.99 Allowed 'General case' 0 C--N 1.316 -0.891 0 O-C-N 121.668 -0.645 . . . . 0.0 112.179 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.1 t -85.85 82.93 2.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.835 0.826 . . . . 0.0 110.909 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 175' ' ' HIS . 0.2 OUTLIER -93.5 153.97 18.16 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 170.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.31 -46.25 74.09 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 119.502 1.046 . . . . 0.0 111.261 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.46 32.94 2.61 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 120.952 0.406 . . . . 0.0 110.578 176.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.429 ' HB2' ' HB ' ' A' ' 172' ' ' THR . 12.4 t60 -68.23 -42.39 79.84 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -79.3 124.48 28.43 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 171.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -100.47 113.79 26.85 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -57.31 -34.55 68.84 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.904 0.753 . . . . 0.0 111.624 -174.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -97.67 90.59 5.05 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--N 1.299 -1.626 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.535 . . . . . . . . 0 0 . 1 stop_ save_